data_5mpl_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5mpl _Structure_validation_residue.Date_analyzed 2017-06-30 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.454 ' O ' HG22 ' A' ' 159' ' ' VAL . 9.1 p . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 109.881 -0.414 . . . . 74.34 109.881 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -128.56 18.69 6.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.168 0.509 . . . . 75.24 111.291 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.57 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 23.6 ttpt -151.15 131.69 13.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.814 -0.63 . . . . 75.3 109.608 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.486 HG13 ' HB ' ' A' ' 151' ' ' VAL . 2.1 pp -106.43 153.55 7.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.21 -0.45 . . . . 72.12 110.397 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.515 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 81.9 t80 -103.25 130.53 50.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.978 -0.555 . . . . 74.13 110.276 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.7 t -111.09 110.17 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.294 -0.412 . . . . 72.34 110.436 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.688 0 N-CA-C 111.205 -0.758 . . . . 61.15 111.205 177.098 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.418 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 8.1 pt-20 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.863 0.363 . . . . 71.11 110.854 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.54 ' HA ' HG23 ' A' ' 134' ' ' ILE . 13.3 tt0 -56.29 -50.25 71.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.449 -0.796 . . . . 75.03 112.41 -178.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.53 -33.65 76.41 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.877 -0.329 . . . . 74.13 110.665 -174.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.445 ' CD2' HD21 ' A' ' 171' ' ' ASN . 40.9 m80 -63.0 -53.64 50.86 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.012 0.434 . . . . 70.12 110.631 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.527 HD22 HG11 ' A' ' 170' ' ' VAL . 97.6 mt -62.25 -48.59 79.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.523 -0.762 . . . . 74.32 110.937 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -59.47 -40.88 88.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.252 -0.431 . . . . 74.3 110.985 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -59.47 -30.39 68.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.99 0.424 . . . . 72.32 111.278 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -88.92 -47.37 8.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.408 -0.36 . . . . 72.44 111.346 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -77.54 -14.63 59.62 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.308 0.484 . . . . 75.32 112.308 -172.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -65.3 -24.02 67.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.747 0.308 . . . . 75.22 111.414 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -65.24 -25.73 67.8 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.221 0.534 . . . . 74.35 110.641 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.469 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 88.5 m-85 -86.01 -37.84 18.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.675 -0.693 . . . . 64.22 111.148 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 177.44 -166.77 37.43 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.012 -1.089 . . . . 60.01 113.422 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.52 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 38.3 tptt -75.78 118.78 18.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.4 0.619 . . . . 74.24 111.464 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.46 HG23 HD13 ' A' ' 134' ' ' ILE . 34.3 mt -97.49 139.93 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.378 -0.828 . . . . 72.14 110.41 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.509 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 6.7 mm-40 -89.12 -71.2 0.61 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.317 -0.401 . . . . 52.4 111.237 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.47 157.42 27.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.645 0.259 . . . . 71.43 110.57 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.57 ' CD1' HG11 ' A' ' 151' ' ' VAL . 17.7 mm -113.02 111.64 37.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.174 -0.676 . . . . 71.11 109.174 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 22.4 mm-40 -90.27 95.0 9.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.988 -0.551 . . . . 74.33 110.786 -175.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.499 HD13 ' H ' ' A' ' 118' ' ' GLU . 11.1 mt -80.69 87.35 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.01 -1.107 . . . . 73.44 108.01 173.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 11.2 tpt . . . . . 0 C--N 1.325 -0.465 0 CA-C-O 121.581 0.705 . . . . 73.31 111.252 -170.582 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 40.6 p90 . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.72 0.295 . . . . 74.3 111.004 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -144.42 165.78 26.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.994 -0.548 . . . . 72.23 110.193 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.541 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 42.2 m-85 -129.64 150.67 50.86 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.947 -0.39 . . . . 61.31 109.947 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.57 HG11 ' CD1' ' A' ' 134' ' ' ILE . 59.0 t -122.9 112.38 33.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.981 -0.377 . . . . 74.12 109.981 176.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.57 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 26.1 m -88.08 127.52 35.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.027 -0.533 . . . . 74.12 110.591 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.506 ' CD2' HG13 ' A' ' 159' ' ' VAL . 92.4 m-85 -109.59 152.24 25.77 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.143 -0.317 . . . . 62.32 110.143 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.52 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 31.9 t70 -75.34 -18.31 60.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.225 0.536 . . . . 71.04 110.547 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.459 ' OD2' ' HB3' ' A' ' 157' ' ' ASP . 24.0 t70 -132.61 153.21 51.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.618 -0.719 . . . . 75.04 111.123 -177.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.4 ' O ' HG21 ' A' ' 159' ' ' VAL . 2.1 p-80 -95.53 5.03 52.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.26 -0.427 . . . . 74.11 111.883 -178.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.459 ' HB3' ' OD2' ' A' ' 155' ' ' ASP . 13.2 t70 -91.81 -37.23 13.07 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.506 -0.553 . . . . 73.12 109.506 171.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.5 m -58.6 -27.59 64.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.749 -0.66 . . . . 64.51 110.901 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.506 HG13 ' CD2' ' A' ' 153' ' ' PHE . 13.0 m -80.42 -20.99 11.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 75.34 111.367 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.35 -38.4 71.63 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.691 0.281 . . . . 71.41 110.672 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.469 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.1 mptp? -65.03 -19.22 65.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.302 0.572 . . . . 74.2 110.68 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 81.9 mt -96.78 -53.62 7.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.573 -0.739 . . . . 75.23 111.227 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.496 ' HB ' ' HG2' ' A' ' 179' ' ' LYS . 35.3 m -64.56 -20.82 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.586 0.587 . . . . 75.15 112.586 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.74 -28.41 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 74.45 111.072 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -105.16 142.19 35.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.004 -0.544 . . . . 71.32 109.655 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.444 ' CE ' ' HG3' ' A' ' 176' ' ' GLU . 87.4 tttt -87.04 -71.39 0.56 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 121.033 -0.267 . . . . 75.3 110.997 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.605 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 3.7 m-85 -79.19 116.62 19.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.207 0.527 . . . . 74.32 111.971 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -117.51 140.63 49.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.19 -0.914 . . . . 63.31 109.492 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 174' ' ' ASN . 57.4 m -92.37 109.28 20.66 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.089 0.471 . . . . 63.44 111.232 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.527 HG11 HD22 ' A' ' 121' ' ' LEU . 43.3 t -120.06 136.27 57.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.928 -0.578 . . . . 72.11 109.464 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.445 HD21 ' CD2' ' A' ' 120' ' ' HIS . 23.5 t-20 70.57 -12.84 0.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.929 0.491 . . . . 74.43 111.497 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 122.2 -3.62 10.5 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.514 -0.634 . . . . 73.05 111.514 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -112.34 138.68 48.72 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.662 -0.496 . . . . 73.35 109.662 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 169' ' ' THR . 60.0 t30 -88.65 103.8 16.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.755 -0.461 . . . . 74.14 109.755 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 34.0 m -106.77 173.16 6.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.058 -0.519 . . . . 73.13 110.76 -174.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.444 ' HG3' ' CE ' ' A' ' 166' ' ' LYS . 9.0 tt0 -97.58 123.92 41.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.11 0.481 . . . . 74.02 110.756 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 48.4 t -118.84 131.13 72.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.926 -0.579 . . . . 75.11 110.475 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -144.34 173.38 11.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.857 -0.611 . . . . 74.54 109.842 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.496 ' HG2' ' HB ' ' A' ' 163' ' ' VAL . 31.9 mtpt -68.54 125.62 27.07 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.685 -0.487 . . . . 74.53 109.685 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -81.01 89.68 5.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.911 0.386 . . . . 62.41 111.482 -175.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.623 ' H ' HD23 ' A' ' 181' ' ' LEU . 2.3 pt? -86.4 141.99 28.76 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.875 -0.602 . . . . 75.32 109.41 175.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.476 ' HB3' ' HG3' ' A' ' 185' ' ' GLU . 30.0 t -58.0 152.7 15.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.482 -0.326 . . . . 70.4 110.804 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.51 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 22.1 pttp -60.07 -21.9 62.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.173 0.511 . . . . 72.03 110.368 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -49.32 55.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.542 -0.754 . . . . 73.12 109.197 174.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.476 ' HG3' ' HB3' ' A' ' 182' ' ' SER . 30.0 mt-10 -73.38 -37.97 65.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.209 -0.905 . . . . 74.11 111.138 -176.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.51 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 21.7 ptm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 71.33 111.129 -175.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.523 HG13 ' HB3' ' A' ' 179' ' ' LYS . 11.5 p . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 109.656 -0.498 . . . . 73.23 109.656 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.469 ' HE3' ' N ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -104.49 -6.34 20.73 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.736 0.303 . . . . 73.25 111.81 -175.038 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.712 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.0 ttpt -133.99 140.73 46.91 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.86 -0.422 . . . . 74.21 109.86 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.603 ' CG2' HG13 ' A' ' 159' ' ' VAL . 4.9 pt -108.07 158.03 8.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.991 0.424 . . . . 75.42 110.973 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.445 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 46.8 t80 -107.72 121.61 45.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.469 -0.787 . . . . 73.54 109.296 177.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.7 t -105.21 102.46 13.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.864 0.364 . . . . 74.24 110.902 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 110.849 -0.9 . . . . 61.44 110.849 175.655 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.425 ' CG ' ' HD2' ' A' ' 119' ' ' HIS . 11.5 pt-20 . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.754 0.312 . . . . 64.2 111.363 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.553 ' HA ' HG21 ' A' ' 134' ' ' ILE . 10.9 tt0 -58.96 -45.46 90.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 75.14 112.242 -174.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.425 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -64.22 -30.33 71.39 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 120.491 -0.484 . . . . 74.4 110.176 -176.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -64.38 -56.6 13.28 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.471 -0.331 . . . . 73.22 110.529 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.446 HD11 HG12 ' A' ' 170' ' ' VAL . 1.7 mm? -60.32 -51.9 67.54 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.233 -0.439 . . . . 73.44 110.737 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -58.29 -53.51 57.47 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.847 -0.615 . . . . 70.3 111.439 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.73 -28.34 63.79 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.066 0.46 . . . . 73.11 111.843 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -86.24 -43.16 13.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.939 0.4 . . . . 75.12 111.299 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.416 ' CD1' HG23 ' A' ' 151' ' ' VAL . 41.8 m-85 -86.84 -15.5 38.96 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.718 0.636 . . . . 72.1 112.718 -172.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -22.22 66.23 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.342 0.591 . . . . 71.4 110.352 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -69.28 -19.11 63.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.264 -0.88 . . . . 74.25 110.479 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.422 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 66.7 m-85 -90.63 -34.8 15.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.873 -0.603 . . . . 75.3 110.819 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 174.82 -168.02 40.46 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.072 -1.061 . . . . 74.25 113.299 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -74.91 116.78 16.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.528 0.68 . . . . 70.53 111.573 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.438 HG23 HD13 ' A' ' 134' ' ' ILE . 40.8 mt -94.76 139.63 18.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.194 -0.912 . . . . 74.34 110.401 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -84.2 -73.03 0.44 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.889 -0.596 . . . . 74.21 110.67 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.6 m -141.81 152.17 18.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.352 -0.386 . . . . 74.5 110.57 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.597 ' CD1' HG11 ' A' ' 151' ' ' VAL . 31.7 mm -105.22 107.92 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.489 -0.56 . . . . 71.44 109.489 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 57.7 mt-10 -89.58 96.49 10.72 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.332 0.586 . . . . 64.45 110.611 -176.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.6 mt -80.04 128.28 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.589 -0.732 . . . . 74.41 109.497 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.422 ' HB3' ' O ' ' A' ' 148' ' ' PHE . 22.1 tpp . . . . . 0 C--N 1.324 -0.517 0 CA-C-O 121.352 0.596 . . . . 73.11 110.341 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.422 ' O ' ' HB3' ' A' ' 137' ' ' MET . 41.8 p90 . . . . . 0 C--O 1.234 0.254 0 CA-C-O 121.187 0.517 . . . . 73.44 111.847 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.13 169.16 18.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.793 -0.64 . . . . 63.23 110.333 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.539 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 73.1 m-85 -130.84 145.01 51.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.066 -0.515 . . . . 73.44 110.297 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.597 HG11 ' CD1' ' A' ' 134' ' ' ILE . 15.8 t -120.52 108.33 22.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.738 -0.467 . . . . 63.13 109.738 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.712 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 62.7 m -88.64 123.84 33.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.527 -0.306 . . . . 75.4 110.289 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.517 ' CD2' HG22 ' A' ' 159' ' ' VAL . 90.8 m-85 -105.5 153.3 21.93 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.831 -0.433 . . . . 75.43 109.831 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -69.28 -30.81 69.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.364 0.602 . . . . 71.53 110.334 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.434 ' O ' HG21 ' A' ' 159' ' ' VAL . 5.0 t70 -122.36 145.54 48.16 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.416 -0.811 . . . . 72.23 110.185 -175.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -82.4 -13.58 56.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.291 -0.413 . . . . 71.33 110.907 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.96 -43.87 61.77 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.064 0.459 . . . . 51.43 110.506 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.6 m -63.16 -28.11 69.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.758 -0.655 . . . . 70.13 110.468 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.603 HG13 ' CG2' ' A' ' 107' ' ' ILE . 29.1 t -70.99 -36.61 64.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.722 -0.672 . . . . 75.23 110.185 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.504 ' HA ' HG23 ' A' ' 163' ' ' VAL . 21.0 t70 -59.98 -36.46 77.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.724 -0.671 . . . . 74.53 110.86 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.422 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 38.0 mmtt -60.68 -24.96 66.01 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.545 0.688 . . . . 73.13 110.222 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.509 HG23 HD13 ' A' ' 107' ' ' ILE . 86.3 mt -95.51 -50.39 11.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.142 -0.935 . . . . 71.32 111.338 -173.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.584 ' HB ' ' HG2' ' A' ' 179' ' ' LYS . 19.8 m -68.96 -17.53 22.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.469 0.544 . . . . 72.33 112.469 -173.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.01 -29.92 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.013 0.375 . . . . 75.12 112.013 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -110.26 174.58 5.8 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.465 -0.568 . . . . 74.12 109.465 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.547 ' HE3' ' HG3' ' A' ' 176' ' ' GLU . 53.2 tttp -114.65 -60.95 1.82 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.75 0.309 . . . . 73.33 111.224 -173.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 11.8 m-30 -77.06 104.17 7.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.448 0.642 . . . . 73.13 111.249 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.407 ' CE1' HG21 ' A' ' 162' ' ' ILE . 9.2 m-70 -102.27 173.16 6.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.097 -0.956 . . . . 75.51 109.988 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 28.1 m -124.48 98.56 5.79 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.081 0.467 . . . . 74.42 111.076 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.446 HG12 HD11 ' A' ' 121' ' ' LEU . 58.2 t -109.52 131.8 59.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.603 -0.518 . . . . 74.34 109.603 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 63.67 14.94 8.56 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.588 0.709 . . . . 72.41 110.475 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.09 -4.64 81.34 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.851 -0.69 . . . . 62.45 112.413 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.517 ' O ' ' HA ' ' A' ' 169' ' ' THR . 39.6 m80 -98.73 157.37 16.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.814 0.34 . . . . 64.42 110.512 -177.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -84.74 118.48 24.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.059 -0.519 . . . . 74.4 109.724 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 36.8 m -118.38 173.47 6.8 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.833 -0.621 . . . . 73.12 110.305 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.547 ' HG3' ' HE3' ' A' ' 166' ' ' LYS . 1.3 tm-20 -130.24 114.68 15.96 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.571 -0.529 . . . . 63.3 109.571 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 2.3 m -113.71 147.34 17.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.202 0.525 . . . . 72.13 111.671 -171.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -134.2 172.09 13.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 73.54 110.643 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.584 ' HG2' ' HB ' ' A' ' 163' ' ' VAL . 28.6 mtpt -77.9 111.52 13.83 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.361 -0.978 . . . . 74.41 108.361 172.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -72.04 107.67 4.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.287 0.565 . . . . 64.13 112.32 -172.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.622 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.6 pt? -101.24 134.18 44.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.468 -0.787 . . . . 73.43 109.061 173.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.4 m -47.64 135.37 11.57 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.386 0.429 . . . . 72.14 111.535 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.787 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 16.2 pttp -56.93 -32.48 66.01 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.175 -0.466 . . . . 72.21 111.203 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -59.44 -34.4 72.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.888 -0.596 . . . . 75.25 110.458 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -93.0 -37.16 12.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.516 -0.766 . . . . 74.32 110.886 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.787 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 25.3 ptm . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.595 -0.275 . . . . 72.45 110.822 -177.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.437 HG13 ' CG ' ' A' ' 179' ' ' LYS . 13.0 p . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 120.755 0.312 . . . . 74.2 110.439 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.747 ' HA ' HG22 ' A' ' 159' ' ' VAL . 25.7 mtmt -119.29 -1.76 10.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.162 -0.472 . . . . 65.1 111.449 -177.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.596 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 28.6 ttpt -124.78 133.9 52.97 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.072 0.463 . . . . 74.44 109.936 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.505 HG12 ' HB ' ' A' ' 151' ' ' VAL . 10.5 pt -107.43 162.99 5.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.908 -0.587 . . . . 61.34 111.036 -178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 55.9 t80 -113.74 119.28 36.85 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.53 -0.759 . . . . 72.15 109.884 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.3 t -109.85 106.41 20.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.147 -0.479 . . . . 72.35 109.878 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.678 0 C-N-CA 120.901 -0.666 . . . . 75.41 112.068 -178.311 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.439 ' CG ' ' HD2' ' A' ' 119' ' ' HIS . 12.6 pt-20 . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 110.544 -0.169 . . . . 73.4 110.544 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.503 ' HA ' HG23 ' A' ' 134' ' ' ILE . 8.0 tt0 -52.52 -50.63 62.43 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.485 0.55 . . . . 71.43 112.485 -175.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.439 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 1.3 p80 -63.36 -27.23 69.17 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.15 -0.22 . . . . 75.12 110.864 -175.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.511 ' CD2' HD21 ' A' ' 171' ' ' ASN . 35.5 m80 -68.53 -50.03 55.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.829 -0.169 . . . . 74.05 110.726 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.469 HD11 HG13 ' A' ' 170' ' ' VAL . 1.2 mm? -60.4 -51.69 68.42 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.644 -0.502 . . . . 75.32 109.644 175.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -55.21 -50.37 69.58 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.542 -0.753 . . . . 74.24 111.285 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -54.35 -36.12 63.49 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.89 0.376 . . . . 65.21 112.012 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -84.64 -39.93 18.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.384 -0.371 . . . . 74.31 111.15 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.419 ' CD1' HG22 ' A' ' 151' ' ' VAL . 50.9 m-85 -87.26 -17.05 33.43 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.461 0.541 . . . . 72.2 112.461 -173.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -20.82 64.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.836 0.351 . . . . 75.1 111.923 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -77.78 -16.44 58.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.024 0.44 . . . . 72.23 110.562 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.47 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 52.9 m-85 -85.01 -41.28 15.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 73.35 110.279 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.44 ' HA3' ' HB3' ' A' ' 158' ' ' SER . . . -172.21 -170.11 35.71 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.987 -0.625 . . . . 62.3 112.151 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -79.59 122.06 26.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.384 0.612 . . . . 75.41 111.508 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.479 HG21 HD13 ' A' ' 134' ' ' ILE . 43.5 mt -95.84 138.43 21.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.33 -0.85 . . . . 64.4 110.837 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -81.37 -76.65 0.24 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.665 -0.698 . . . . 73.33 110.362 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.2 m -141.48 161.27 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 74.41 110.47 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.608 ' CD1' HG12 ' A' ' 151' ' ' VAL . 23.1 mm -116.42 122.7 70.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 110.03 -0.359 . . . . 75.23 110.03 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -104.46 121.54 43.65 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.79 -0.448 . . . . 74.35 109.79 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.7 mt -95.61 -8.43 9.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.706 0.289 . . . . 72.03 110.797 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.429 ' HA ' ' HE1' ' A' ' 137' ' ' MET . 8.5 tpp . . . . . 0 C--O 1.235 0.31 0 CA-C-O 122.113 0.958 . . . . 72.13 110.208 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.8 p90 . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.797 -0.816 . . . . 74.15 108.797 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.52 172.92 12.11 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.089 0.471 . . . . 62.04 111.141 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.411 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 58.4 m-85 -131.78 136.98 47.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.624 -0.716 . . . . 73.23 109.85 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.608 HG12 ' CD1' ' A' ' 134' ' ' ILE . 42.2 t -116.06 110.37 31.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.379 -0.373 . . . . 71.02 110.315 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.596 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 9.0 m -87.05 125.45 34.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.386 -0.37 . . . . 60.31 110.094 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.459 ' CE1' HG12 ' A' ' 131' ' ' ILE . 98.2 m-85 -105.75 150.39 25.57 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.756 0.312 . . . . 74.21 110.175 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -69.73 -22.55 63.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.033 -0.531 . . . . 63.32 111.059 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -136.77 144.86 43.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.896 -0.593 . . . . 73.52 109.711 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.507 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.5 p-80 -75.46 -12.88 60.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.881 0.372 . . . . 73.41 110.293 177.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.93 -46.36 88.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 63.22 110.18 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.44 ' HB3' ' HA3' ' A' ' 129' ' ' GLY . 11.7 m -62.87 -21.64 66.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 74.32 111.08 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.747 HG22 ' HA ' ' A' ' 105' ' ' LYS . 20.2 t -80.75 -29.77 11.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.768 -0.651 . . . . 73.21 111.138 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -36.9 85.34 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.424 -0.353 . . . . 62.21 111.869 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.47 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.5 mptp? -70.24 -16.48 63.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.265 0.555 . . . . 72.5 110.572 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.413 ' CG2' HG13 ' A' ' 177' ' ' VAL . 95.9 mt -100.54 -55.06 6.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.65 -0.705 . . . . 75.12 111.731 -172.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.536 ' HB ' ' HE3' ' A' ' 179' ' ' LYS . 28.9 m -61.07 -21.98 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.903 0.705 . . . . 70.22 112.903 -174.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.4 pp -67.27 -29.57 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.017 0.437 . . . . 63.3 111.095 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -106.23 142.65 35.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.949 -0.569 . . . . 73.52 109.722 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.525 ' HE3' ' HG3' ' A' ' 176' ' ' GLU . 79.2 tttt -92.17 -71.67 0.63 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 121.057 -0.257 . . . . 72.24 111.065 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.489 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 22.7 m-85 -78.59 108.81 12.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.132 0.491 . . . . 71.35 111.307 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -106.38 158.55 16.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 65.32 110.046 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 20.2 m -96.33 100.75 12.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.801 0.334 . . . . 71.5 110.788 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.469 HG13 HD11 ' A' ' 121' ' ' LEU . 46.9 t -116.5 132.61 65.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.622 -0.51 . . . . 71.3 109.622 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.511 HD21 ' CD2' ' A' ' 120' ' ' HIS . 28.1 t-20 63.92 20.43 12.2 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 122.056 0.931 . . . . 71.51 109.834 -177.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 73.39 19.45 79.67 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.558 -0.746 . . . . 63.41 111.624 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -125.22 149.59 47.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.768 -0.456 . . . . 74.12 109.768 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.459 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 9.9 t30 -86.19 117.3 24.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.884 0.373 . . . . 60.52 110.847 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 30.9 m -129.23 158.74 38.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.989 -0.55 . . . . 64.32 110.206 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.525 ' HG3' ' HE3' ' A' ' 166' ' ' LYS . 16.1 tt0 -89.98 135.17 33.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.945 0.402 . . . . 72.42 110.681 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 64.5 t -128.8 132.0 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 115.945 -0.57 . . . . 72.24 110.562 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -150.85 -177.63 6.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.525 -0.761 . . . . 72.25 109.452 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.536 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 9.2 mptt -68.47 130.32 42.54 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.859 -0.336 . . . . 72.13 110.345 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.409 ' HB1' ' C ' ' A' ' 107' ' ' ILE . . . -86.33 92.85 8.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.864 0.364 . . . . 74.44 111.129 176.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.487 HD21 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -81.5 135.23 35.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.568 -0.53 . . . . 64.13 109.568 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.5 m -50.73 142.65 10.92 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.382 0.426 . . . . 75.34 111.387 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.668 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 8.3 pttp -58.78 -31.69 68.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.064 0.459 . . . . 73.4 110.306 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -65.08 -37.7 88.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.601 -0.727 . . . . 64.11 110.522 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -83.44 -37.17 23.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.551 -0.749 . . . . 62.41 111.09 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.668 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 9.3 ptp . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.848 0.356 . . . . 74.13 110.247 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.444 HG13 ' HE3' ' A' ' 179' ' ' LYS . 13.1 p . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 120.855 0.359 . . . . 75.24 110.491 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.524 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 12.2 mtmt -119.0 18.0 13.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.308 0.575 . . . . 74.12 110.776 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.459 ' HZ1' ' HB3' ' A' ' 106' ' ' LYS . 4.8 ttpm? -146.02 132.6 19.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.532 -0.758 . . . . 74.14 109.48 177.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.532 HG12 ' HB ' ' A' ' 151' ' ' VAL . 13.3 pt -103.64 164.04 3.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.108 0.48 . . . . 71.31 111.059 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 63.5 t80 -114.07 113.65 25.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.428 -0.805 . . . . 73.34 110.009 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.5 t -104.54 97.95 6.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.114 -0.494 . . . . 74.45 110.034 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.661 0 C-N-CA 120.685 -0.769 . . . . 45.34 112.566 -176.392 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.48 ' O ' HD21 ' A' ' 121' ' ' LEU . 10.6 pt-20 . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 109.893 -0.41 . . . . 72.12 109.893 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.535 ' HG3' ' HB ' ' A' ' 134' ' ' ILE . 16.4 tt0 -55.2 -50.01 70.48 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.773 0.657 . . . . 71.45 112.773 -174.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.441 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.2 p80 -63.24 -27.29 69.25 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.753 -0.379 . . . . 74.55 110.694 -176.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -70.17 -51.53 30.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.318 -0.401 . . . . 74.21 110.356 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.496 HD12 HG13 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -58.59 -49.29 78.01 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.262 -0.426 . . . . 73.34 110.286 178.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -59.01 -53.62 56.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.745 -0.662 . . . . 71.25 111.717 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -59.99 -29.17 68.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.762 0.315 . . . . 73.34 111.702 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.42 ' CD1' HG22 ' A' ' 170' ' ' VAL . 90.4 t80 -83.09 -43.42 16.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.499 -0.319 . . . . 73.55 110.966 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.426 ' CD1' HG21 ' A' ' 151' ' ' VAL . 46.0 m-85 -87.02 -15.3 39.08 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.729 0.64 . . . . 74.23 112.729 -173.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -22.12 66.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.088 0.471 . . . . 75.54 110.589 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -65.93 -31.06 71.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.761 -0.654 . . . . 70.04 110.082 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -80.85 -27.52 36.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.498 -0.773 . . . . 62.24 111.37 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.07 -166.84 39.75 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.352 -0.928 . . . . 74.31 112.689 177.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -80.68 120.45 24.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.326 0.584 . . . . 74.2 110.959 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.478 HG21 HD13 ' A' ' 134' ' ' ILE . 43.1 mt -93.28 141.38 14.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.46 -0.791 . . . . 70.43 110.572 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.9 -71.19 0.55 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.699 -0.682 . . . . 70.11 110.451 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.3 m -143.5 160.99 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.387 -0.369 . . . . 71.14 110.656 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.594 ' CD1' HG13 ' A' ' 151' ' ' VAL . 18.8 mm -116.41 128.95 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.946 0.403 . . . . 72.01 110.275 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -115.28 115.2 26.26 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.857 -0.61 . . . . 75.53 109.733 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.0 mt -84.04 -11.52 11.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.058 0.456 . . . . 75.11 110.363 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.433 ' HB3' ' O ' ' A' ' 148' ' ' PHE . 21.4 tpp . . . . . 0 C--O 1.237 0.43 0 CA-C-O 122.325 1.059 . . . . 64.31 110.173 -174.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.433 ' O ' ' HB3' ' A' ' 137' ' ' MET . 38.3 p90 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.856 -0.424 . . . . 73.15 109.856 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.53 169.45 10.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.192 0.52 . . . . 72.14 111.055 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -135.49 128.89 32.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.541 -0.754 . . . . 74.54 109.574 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.594 HG13 ' CD1' ' A' ' 134' ' ' ILE . 29.7 t -108.82 110.24 31.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.755 -0.461 . . . . 74.51 109.755 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.412 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 16.4 m -86.47 125.35 33.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.451 -0.34 . . . . 75.42 110.272 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.549 ' CD2' HG13 ' A' ' 159' ' ' VAL . 97.1 m-85 -108.79 156.52 19.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.804 0.335 . . . . 73.14 110.279 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.21 -24.08 63.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.879 -0.6 . . . . 75.04 110.861 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -133.95 150.12 51.28 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.078 -0.51 . . . . 74.34 111.188 -173.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.541 ' O ' HG23 ' A' ' 159' ' ' VAL . 2.5 p-80 -88.57 -5.13 58.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.053 -0.521 . . . . 75.42 110.723 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -73.39 -42.72 61.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.16 0.505 . . . . 72.12 110.119 174.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 m -63.85 -33.13 75.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.528 -0.76 . . . . 75.12 111.428 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.549 HG13 ' CD2' ' A' ' 153' ' ' PHE . 4.7 m -72.82 -22.24 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.501 -0.318 . . . . 74.35 110.987 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.4 ' HA ' HG22 ' A' ' 163' ' ' VAL . 33.2 t70 -63.84 -44.97 91.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.4 . . . . 74.15 111.395 -174.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -8.28 31.91 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.178 0.513 . . . . 71.54 110.508 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.488 HG23 HD12 ' A' ' 107' ' ' ILE . 69.6 mt -100.83 -50.04 10.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.665 -0.698 . . . . 72.34 110.688 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.4 HG22 ' HA ' ' A' ' 160' ' ' ASP . 27.0 m -73.37 -15.43 17.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.675 -0.693 . . . . 74.22 112.77 -175.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.91 -30.05 46.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 64.52 110.979 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.412 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 15.5 pt20 -105.52 -173.37 2.28 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.684 -0.487 . . . . 72.41 109.684 173.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.497 ' HE3' ' HG3' ' A' ' 176' ' ' GLU . 46.6 tttp -127.42 -69.37 0.75 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.706 0.288 . . . . 64.43 110.56 -176.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -70.89 120.28 16.25 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.912 0.387 . . . . 73.21 110.681 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.434 ' CE1' HG21 ' A' ' 162' ' ' ILE . 28.1 m-70 -116.62 141.56 48.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.812 -0.631 . . . . 75.32 110.006 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.5 m -93.52 81.96 4.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.249 0.547 . . . . 75.24 110.585 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.496 HG13 HD12 ' A' ' 121' ' ' LEU . 22.0 t -96.33 122.15 47.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.875 -0.602 . . . . 74.44 109.744 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.9 t30 63.39 16.37 9.48 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.866 0.841 . . . . 75.43 110.248 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 87.5 -3.55 86.35 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.955 -0.641 . . . . 60.1 111.866 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -88.77 150.42 22.95 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.611 -0.514 . . . . 75.21 109.611 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -97.34 103.51 15.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.871 0.367 . . . . 75.24 110.442 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 31.2 m -116.74 155.08 29.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.153 -0.476 . . . . 65.14 110.436 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.497 ' HG3' ' HE3' ' A' ' 166' ' ' LYS . 11.4 tt0 -94.3 125.46 38.96 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.718 -0.475 . . . . 71.43 109.718 177.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 51.1 t -121.39 134.38 64.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.106 0.479 . . . . 74.54 111.258 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -146.21 -176.97 5.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.46 -0.791 . . . . 73.3 108.911 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.444 ' HE3' HG13 ' A' ' 104' ' ' VAL . 2.5 ptpp? -75.32 126.93 32.03 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.532 -0.467 . . . . 72.51 110.756 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -79.61 101.66 8.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.963 -0.562 . . . . 64.13 111.07 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.629 HD21 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -94.24 138.45 32.23 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.01 -0.737 . . . . 73.34 109.01 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.461 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 4.3 m -50.97 140.32 15.74 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.55 0.531 . . . . 74.32 110.773 -176.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.764 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.7 pttp -62.57 -22.63 66.5 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.876 0.369 . . . . 75.21 110.856 -177.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -66.79 -42.3 86.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.868 -0.606 . . . . 73.34 109.728 173.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.461 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 35.1 mt-10 -77.1 -38.45 52.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.757 -0.656 . . . . 71.22 110.664 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.764 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 19.8 ptm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.354 -0.385 . . . . 74.35 110.791 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.462 ' O ' HG21 ' A' ' 159' ' ' VAL . 12.8 p . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 109.598 -0.519 . . . . 73.41 109.598 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.54 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 19.8 mtmt -121.37 9.04 10.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.171 0.51 . . . . 73.15 111.578 -176.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.625 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 28.6 ttpt -138.58 135.97 35.52 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.915 -0.584 . . . . 74.55 109.466 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.514 HD13 HG23 ' A' ' 162' ' ' ILE . 6.7 pt -107.31 159.28 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.943 0.402 . . . . 74.53 110.638 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 57.1 t80 -108.43 115.18 29.63 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.847 -0.615 . . . . 63.55 109.847 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.7 t -102.77 103.48 15.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.796 -0.446 . . . . 74.03 109.796 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.839 0 CA-C-N 115.858 -0.61 . . . . 71.22 111.974 -177.219 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.502 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 11.9 pt-20 . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.767 0.318 . . . . 71.22 111.644 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.672 ' HG2' ' CG1' ' A' ' 134' ' ' ILE . 3.1 tm-20 -55.28 -54.75 39.56 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.634 -0.712 . . . . 60.53 111.714 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.414 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.3 p80 -63.2 -31.02 72.07 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.961 -0.296 . . . . 74.24 111.089 -175.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.502 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 65.3 m80 -63.46 -60.32 3.52 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.261 0.553 . . . . 73.11 110.539 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.528 ' HA ' HG21 ' A' ' 170' ' ' VAL . 89.0 mt -61.41 -44.13 97.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.337 -0.847 . . . . 63.12 110.602 -177.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.526 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.5 OUTLIER -60.21 -42.63 95.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.674 -0.694 . . . . 70.52 110.846 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -58.1 -32.9 68.54 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.271 0.557 . . . . 75.43 111.438 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -88.2 -43.46 11.6 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.708 -0.678 . . . . 71.03 111.668 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 43.1 m-85 -83.74 -15.03 50.12 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.596 0.591 . . . . 73.21 112.596 -173.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.8 -19.45 65.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.115 0.484 . . . . 55.14 111.394 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -69.56 -25.15 63.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.867 -0.606 . . . . 74.32 110.441 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.454 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 80.2 m-85 -86.44 -32.06 21.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.898 -0.592 . . . . 74.12 110.368 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.601 ' HA3' ' HB3' ' A' ' 158' ' ' SER . . . -178.95 179.16 48.93 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.123 -0.791 . . . . 53.51 111.123 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -78.67 131.93 36.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.68 0.753 . . . . 74.35 109.846 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 122' ' ' ARG . 50.2 mt -98.85 137.21 27.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.317 -0.856 . . . . 75.32 110.984 -176.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -81.35 -70.44 0.54 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.819 -0.628 . . . . 71.22 110.757 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.31 159.69 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.523 -0.308 . . . . 73.12 110.72 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.672 ' CG1' ' HG2' ' A' ' 118' ' ' GLU . 18.8 mm -117.13 109.34 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.802 -0.444 . . . . 73.05 109.802 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -85.24 95.77 9.29 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.202 -0.666 . . . . 74.53 109.202 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.8 mt -73.15 -15.84 17.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.133 0.492 . . . . 74.45 110.58 -176.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 19.7 tpp . . . . . 0 C--O 1.236 0.394 0 CA-C-O 122.023 0.916 . . . . 74.44 110.872 178.186 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.1 p90 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 109.448 -0.575 . . . . 75.4 109.448 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -133.07 158.28 43.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.036 0.446 . . . . 62.34 111.201 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -119.58 122.85 42.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.904 -0.589 . . . . 73.14 109.768 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.614 HG12 ' CD1' ' A' ' 134' ' ' ILE . 61.7 t -99.92 109.86 25.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.569 0.223 . . . . 73.2 110.567 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.625 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 19.1 m -88.63 126.8 35.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.313 -0.403 . . . . 74.1 110.858 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.546 ' CD2' HG13 ' A' ' 159' ' ' VAL . 89.1 m-85 -108.64 154.35 22.11 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.514 -0.55 . . . . 65.42 109.514 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.27 -33.49 73.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.947 -0.76 . . . . 61.51 108.947 174.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -112.96 143.91 43.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.602 -1.181 . . . . 74.52 111.543 -172.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.619 ' O ' HG23 ' A' ' 159' ' ' VAL . 2.9 p-80 -88.87 -12.72 41.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.716 -0.674 . . . . 71.22 110.178 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.62 -36.31 73.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.364 0.602 . . . . 74.52 109.605 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.603 ' HA ' ' HE2' ' A' ' 161' ' ' LYS . 13.0 m -75.67 -19.69 58.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.199 -0.909 . . . . 72.34 111.687 -175.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 156' ' ' HIS . 4.0 m -81.54 -22.31 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.758 0.313 . . . . 70.52 110.833 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.436 ' HA ' HG21 ' A' ' 163' ' ' VAL . 27.8 t70 -68.23 -40.53 82.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.342 -0.39 . . . . 73.11 111.429 -172.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.603 ' HE2' ' HA ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -62.63 -19.08 63.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.327 0.584 . . . . 65.13 110.247 178.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.514 HG23 HD13 ' A' ' 107' ' ' ILE . 90.4 mt -94.66 -55.2 6.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.412 -0.813 . . . . 73.43 111.23 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.769 HG22 ' HZ1' ' A' ' 179' ' ' LYS . 27.5 m -66.28 -14.62 17.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.645 0.609 . . . . 72.41 112.645 -173.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.426 HD13 ' N ' ' A' ' 165' ' ' GLN . 2.6 pp -72.51 -28.67 28.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.901 0.381 . . . . 73.32 110.817 176.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.473 ' HB3' ' NE2' ' A' ' 168' ' ' HIS . 5.9 tt0 -101.97 148.82 24.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.436 -0.579 . . . . 71.2 109.436 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.636 ' HE2' ' CE2' ' A' ' 167' ' ' TYR . 83.7 tttt -93.83 -61.21 1.58 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.828 0.346 . . . . 74.4 111.014 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.636 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 22.1 m-85 -82.51 108.6 16.04 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.188 0.518 . . . . 74.53 111.382 -176.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.473 ' NE2' ' HB3' ' A' ' 165' ' ' GLN . 27.5 m-70 -111.49 142.04 44.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.556 -0.747 . . . . 75.54 110.4 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.6 m -103.1 104.92 15.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.15 0.5 . . . . 73.31 111.096 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 121' ' ' LEU . 6.3 p -130.17 140.89 47.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.782 -0.645 . . . . 74.32 109.403 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.14 -15.48 0.6 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.569 0.7 . . . . 74.32 109.459 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 113.34 2.22 24.65 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.64 -0.984 . . . . 54.23 110.64 -173.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -109.48 134.24 52.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.311 -0.444 . . . . 73.53 109.818 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -86.28 106.19 17.18 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.443 -0.577 . . . . 70.33 109.443 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 63.9 m -115.99 -177.86 3.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.986 -0.552 . . . . 70.54 110.797 -175.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.596 ' OE2' ' HE3' ' A' ' 166' ' ' LYS . 14.3 tt0 -111.31 132.64 54.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.625 -0.261 . . . . 74.2 110.593 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.7 m -121.86 144.46 31.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.082 0.468 . . . . 64.34 110.495 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -135.33 173.72 11.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.118 -0.492 . . . . 73.44 110.215 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.769 ' HZ1' HG22 ' A' ' 163' ' ' VAL . 66.4 mttm -70.09 119.03 13.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.645 -1.243 . . . . 75.43 107.645 167.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.477 ' HB1' ' C ' ' A' ' 107' ' ' ILE . . . -75.87 93.05 3.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.111 0.482 . . . . 73.35 111.674 -175.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.616 HD22 ' H ' ' A' ' 181' ' ' LEU . 2.4 pt? -90.73 138.3 31.69 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.935 -0.765 . . . . 75.2 108.935 173.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.426 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 12.7 m -56.43 151.83 12.53 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.136 0.273 . . . . 74.22 110.64 -176.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.778 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.1 pttp -59.14 -28.38 66.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.353 0.597 . . . . 75.23 109.7 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -60.51 -42.36 96.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.977 -1.011 . . . . 74.24 110.628 173.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.426 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 32.7 mt-10 -85.68 -35.21 21.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.395 -0.82 . . . . 72.1 110.768 -174.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.778 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.6 ptm . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.513 . . . . 63.01 110.587 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.447 ' O ' HG22 ' A' ' 159' ' ' VAL . 8.7 p . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 109.918 -0.401 . . . . 71.55 109.918 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.444 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 19.3 mtmt -122.32 20.13 10.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.324 0.583 . . . . 71.3 110.991 -177.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.601 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 30.0 ttpt -150.85 136.94 18.36 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.377 -0.829 . . . . 73.23 108.973 174.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.527 HD12 HG21 ' A' ' 162' ' ' ILE . 2.7 pt -110.12 153.95 11.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.937 0.399 . . . . 74.52 110.342 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 74.0 t80 -100.89 120.74 40.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.736 -0.665 . . . . 73.25 110.012 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.429 HG11 HD12 ' A' ' 121' ' ' LEU . 47.0 t -107.6 113.67 44.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.753 0.311 . . . . 73.51 110.411 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.529 0 C-N-CA 120.657 -0.782 . . . . 73.02 112.598 -179.379 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.539 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 10.2 pt-20 . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.326 0.107 . . . . 71.21 110.862 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.558 ' H ' HD13 ' A' ' 136' ' ' ILE . 19.1 tt0 -55.87 -53.19 59.78 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.58 0.585 . . . . 74.54 112.58 -174.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.475 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.0 p80 -59.09 -30.51 68.15 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.071 -0.251 . . . . 74.34 110.581 -175.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.539 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 41.9 m80 -64.91 -55.95 16.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.157 -0.474 . . . . 71.33 110.327 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -61.24 -48.07 83.13 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.296 -0.411 . . . . 72.13 110.689 -179.408 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.403 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 3.1 tpp180 -61.65 -48.98 78.39 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.263 -0.426 . . . . 73.23 111.49 -176.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.55 -31.52 68.04 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.31 0.576 . . . . 64.45 110.958 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.403 ' HE1' ' HB3' ' A' ' 168' ' ' HIS . 38.8 t80 -86.83 -44.21 11.9 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.834 -0.621 . . . . 74.0 111.305 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.409 ' CD1' HG21 ' A' ' 151' ' ' VAL . 47.2 m-85 -86.16 -13.84 45.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.054 0.761 . . . . 72.31 113.054 -172.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.51 -22.27 65.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.047 0.451 . . . . 74.4 110.839 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -66.6 -25.8 66.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.731 -0.668 . . . . 61.35 110.463 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.452 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 72.1 m-85 -84.88 -30.24 24.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.663 -0.699 . . . . 75.42 110.851 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.431 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 175.93 -174.8 47.14 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.717 -0.754 . . . . 75.13 111.881 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.436 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 20.1 ptmt -79.11 129.55 34.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.811 0.815 . . . . 74.23 109.976 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.47 HG23 HD12 ' A' ' 134' ' ' ILE . 48.1 mt -98.94 142.56 14.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.246 -0.888 . . . . 73.41 110.528 -176.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -85.89 -75.63 0.37 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.953 -0.567 . . . . 72.33 110.159 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.6 m -139.35 155.56 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.327 -0.397 . . . . 71.52 110.611 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.592 ' CD1' HG12 ' A' ' 151' ' ' VAL . 24.0 mm -110.87 107.8 23.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.25 -0.648 . . . . 74.33 109.25 175.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 88.0 mt-10 -91.2 97.54 11.19 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.098 0.475 . . . . 73.2 110.955 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.558 HD13 ' H ' ' A' ' 118' ' ' GLU . 32.3 mt -81.1 103.75 8.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.313 -0.625 . . . . 75.13 109.313 176.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.6 tpp . . . . . 0 C--N 1.326 -0.441 0 CA-C-O 121.425 0.631 . . . . 71.25 110.668 -177.795 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 35.4 p90 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.245 -0.28 . . . . 73.34 110.245 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.96 169.48 17.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.212 -0.449 . . . . 72.35 110.764 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.557 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 66.6 m-85 -130.79 137.35 49.4 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.016 -0.538 . . . . 73.11 110.011 -177.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.592 HG12 ' CD1' ' A' ' 134' ' ' ILE . 18.7 t -112.27 107.13 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.811 -0.441 . . . . 75.14 109.811 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.601 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 18.4 m -86.94 126.03 34.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.323 -0.399 . . . . 70.33 110.359 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -109.41 152.1 25.8 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.776 -0.453 . . . . 71.53 109.776 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.436 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 26.9 t70 -75.45 -22.54 57.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.404 0.621 . . . . 74.12 109.735 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -124.84 139.52 53.77 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.327 -0.851 . . . . 73.54 110.441 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.587 ' O ' HG21 ' A' ' 159' ' ' VAL . 3.8 p-80 -81.63 -5.65 58.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.345 0.593 . . . . 70.13 109.955 175.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.43 -44.11 83.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.751 -0.659 . . . . 71.15 109.991 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.431 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 3.3 m -60.15 -39.25 85.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.17 -0.923 . . . . 73.12 111.729 -177.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.587 HG21 ' O ' ' A' ' 156' ' ' HIS . 6.5 m -70.86 -25.91 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.391 -0.368 . . . . 74.52 111.452 -174.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -69.44 -22.32 63.66 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.578 0.214 . . . . 74.44 111.578 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.452 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 0.5 OUTLIER -89.32 -1.35 58.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.389 0.614 . . . . 64.4 109.644 177.142 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.527 HG21 HD12 ' A' ' 107' ' ' ILE . 92.5 mt -108.53 -54.6 5.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.432 -0.803 . . . . 63.03 110.782 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.499 HG13 ' HG2' ' A' ' 179' ' ' LYS . 23.9 m -71.75 -3.55 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.851 -0.613 . . . . 74.54 112.589 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.515 HD11 ' N ' ' A' ' 165' ' ' GLN . 2.1 pp -74.39 -30.71 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.73 0.3 . . . . 74.32 111.227 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.515 ' N ' HD11 ' A' ' 164' ' ' ILE . 12.0 pt20 -114.34 176.54 5.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.916 -0.402 . . . . 73.44 109.916 173.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.548 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 79.8 tttt -113.24 -59.46 2.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.566 -0.288 . . . . 71.2 111.631 -174.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 21.0 m-85 -78.19 107.75 11.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.127 0.489 . . . . 71.23 111.083 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.403 ' HB3' ' HE1' ' A' ' 124' ' ' TYR . 16.5 m-70 -107.47 135.63 48.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.635 -0.711 . . . . 73.41 110.536 178.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.7 m -93.55 97.45 10.51 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.797 -0.638 . . . . 73.4 111.233 -175.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.99 139.44 50.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.994 -0.743 . . . . 73.31 108.994 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 71.43 -7.19 1.23 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.292 0.568 . . . . 71.31 110.275 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 108.04 -0.29 33.61 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.57 -0.612 . . . . 62.35 111.57 -176.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -115.93 146.57 41.97 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.178 -0.305 . . . . 72.32 110.178 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -90.3 104.86 17.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.981 0.896 . . . . 65.13 110.496 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 25.8 p -95.37 172.22 8.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.315 -0.857 . . . . 74.31 110.017 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.548 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 38.0 tt0 -107.99 121.39 44.71 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.85 -0.426 . . . . 75.4 109.85 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 2.8 m -109.86 145.78 16.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.983 0.42 . . . . 62.42 110.558 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -135.39 170.77 15.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.112 -0.495 . . . . 74.53 110.147 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.564 ' HB3' ' HZ3' ' A' ' 179' ' ' LYS . 8.1 mtpm? -73.42 114.4 11.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.458 -0.941 . . . . 73.11 108.458 169.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -72.11 97.57 1.95 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.262 0.553 . . . . 62.22 111.735 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.685 HD22 ' H ' ' A' ' 181' ' ' LEU . 2.3 pt? -96.75 138.3 34.51 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.488 -0.778 . . . . 72.2 109.133 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.493 ' HB3' ' HG2' ' A' ' 185' ' ' GLU . 36.3 t -49.89 145.36 5.57 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.279 0.362 . . . . 63.23 110.959 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.609 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 22.4 pttp -62.64 -23.51 67.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.152 0.501 . . . . 75.02 109.908 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -73.75 -41.4 62.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.507 -0.77 . . . . 63.42 109.487 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.493 ' HG2' ' HB3' ' A' ' 182' ' ' SER . 56.1 mm-40 -73.44 -40.85 63.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.321 -0.854 . . . . 75.3 110.943 -177.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.609 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 12.5 ptp . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 120.784 0.326 . . . . 72.24 110.734 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.505 HG22 ' HB3' ' A' ' 179' ' ' LYS . 2.1 t . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 110.365 -0.235 . . . . 73.32 110.365 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.626 ' HA ' HG22 ' A' ' 159' ' ' VAL . 4.8 mtmt -118.33 9.04 12.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.886 0.374 . . . . 74.54 111.345 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.584 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.9 ttpt -147.02 138.4 24.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.88 0.372 . . . . 72.14 110.068 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.559 ' CG2' HG12 ' A' ' 159' ' ' VAL . 7.4 pt -109.18 162.42 6.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.208 -0.451 . . . . 71.04 111.203 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 54.3 t80 -109.14 121.28 44.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.747 -0.661 . . . . 73.33 109.912 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.1 t -105.05 104.71 17.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.899 0.38 . . . . 54.41 110.694 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.518 0 N-CA-C 111.321 -0.712 . . . . 63.15 111.321 178.242 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.413 ' CG ' ' HD2' ' A' ' 119' ' ' HIS . 11.2 pt-20 . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 120.823 0.344 . . . . 70.04 111.71 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.546 ' HA ' HG21 ' A' ' 134' ' ' ILE . 21.5 tt0 -51.69 -56.58 12.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.282 -0.872 . . . . 65.42 112.318 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.413 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.0 p80 -61.83 -31.05 71.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.352 -0.386 . . . . 65.33 111.065 -174.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -67.6 -59.38 3.39 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.25 0.548 . . . . 73.45 110.064 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.541 HD21 HG13 ' A' ' 170' ' ' VAL . 68.8 mt -57.2 -49.58 75.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.066 -0.97 . . . . 73.42 110.973 -177.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.429 ' HG3' HD12 ' A' ' 131' ' ' ILE . 4.7 ttp180 -62.03 -37.79 86.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 74.43 111.38 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.17 -29.61 68.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.982 0.42 . . . . 64.3 110.872 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -91.67 -46.98 7.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.045 -0.525 . . . . 75.34 111.622 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -77.2 -14.01 59.85 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.595 0.591 . . . . 74.41 112.595 -172.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.83 -22.16 66.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.11 0.481 . . . . 64.22 110.912 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.81 -30.89 71.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.712 -0.676 . . . . 75.34 110.858 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.423 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 76.6 m-85 -82.48 -31.04 29.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.129 -0.487 . . . . 74.54 111.253 -175.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.577 ' HA3' ' HB3' ' A' ' 158' ' ' SER . . . 172.66 -170.91 43.98 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.822 -1.18 . . . . 62.3 113.381 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -75.86 114.19 14.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.526 0.679 . . . . 74.21 111.342 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.461 HG23 HD12 ' A' ' 134' ' ' ILE . 35.3 mt -87.27 142.18 13.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.15 -0.932 . . . . 75.41 110.039 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -86.66 -74.68 0.42 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.106 -0.497 . . . . 73.13 110.315 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.1 m -143.86 152.37 16.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.135 -0.484 . . . . 61.4 110.079 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.597 ' CD1' HG11 ' A' ' 151' ' ' VAL . 16.2 mm -103.47 105.63 18.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.867 -0.79 . . . . 64.24 108.867 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -85.42 94.7 9.05 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.052 -0.522 . . . . 75.33 110.247 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.537 HD11 ' H ' ' A' ' 118' ' ' GLU . 31.5 mt -80.79 119.94 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.653 -0.703 . . . . 73.33 109.802 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 21.4 tpp . . . . . 0 C--N 1.322 -0.608 0 CA-C-O 121.709 0.766 . . . . 75.42 109.434 176.545 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 47.9 p90 . . . . . 0 C--O 1.236 0.379 0 CA-C-O 121.077 0.465 . . . . 74.35 111.384 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.94 166.88 26.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.857 -0.611 . . . . 72.14 110.824 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -122.38 131.42 53.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.949 -0.569 . . . . 74.21 109.707 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.597 HG11 ' CD1' ' A' ' 134' ' ' ILE . 47.7 t -104.56 109.66 28.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.776 0.322 . . . . 75.51 110.324 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.584 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 12.3 m -88.02 129.51 35.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.894 -0.593 . . . . 71.41 110.175 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.499 ' CD2' HG21 ' A' ' 159' ' ' VAL . 97.8 m-85 -111.58 150.61 29.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.821 -0.437 . . . . 74.1 109.821 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.49 -13.01 60.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.575 0.703 . . . . 54.33 110.235 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -129.41 147.63 51.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.312 -0.858 . . . . 75.23 109.969 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -85.57 -15.41 42.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.074 0.464 . . . . 73.24 110.441 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -71.73 -39.67 69.92 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.079 -0.509 . . . . 44.31 110.047 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.577 ' HB3' ' HA3' ' A' ' 129' ' ' GLY . 0.8 OUTLIER -59.94 -35.29 74.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.619 -0.719 . . . . 75.42 110.1 178.438 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.626 HG22 ' HA ' ' A' ' 105' ' ' LYS . 22.0 t -70.22 -35.86 65.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.04 -0.982 . . . . 73.05 110.816 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.35 -38.75 92.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.897 -0.592 . . . . 74.12 112.289 -171.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.423 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -66.25 -22.15 66.31 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.337 0.589 . . . . 73.22 110.316 178.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.463 HG23 HD13 ' A' ' 107' ' ' ILE . 96.0 mt -93.59 -49.3 12.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.377 -0.829 . . . . 75.13 111.478 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.552 ' HB ' ' HE2' ' A' ' 179' ' ' LYS . 34.8 m -69.37 -14.94 19.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.591 0.589 . . . . 72.15 112.591 -173.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -75.73 -27.73 18.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.173 0.511 . . . . 72.44 110.664 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -103.36 143.84 32.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.773 -0.649 . . . . 61.43 110.158 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.637 ' HE2' ' CE2' ' A' ' 167' ' ' TYR . 83.0 tttt -91.85 -64.25 1.14 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.865 0.364 . . . . 75.11 110.714 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.637 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 15.5 m-30 -84.27 105.22 14.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.423 0.63 . . . . 75.35 112.216 -175.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -106.24 149.79 26.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.959 -1.018 . . . . 74.51 109.424 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 53.5 m -102.6 103.12 13.41 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.956 0.408 . . . . 74.31 110.975 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.541 HG13 HD21 ' A' ' 121' ' ' LEU . 31.3 t -116.8 131.38 69.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.06 -0.518 . . . . 73.44 109.85 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.7 t30 59.53 27.27 16.41 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.482 0.658 . . . . 74.14 110.401 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 76.02 5.59 80.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.854 -0.689 . . . . 72.32 112.386 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -109.11 133.09 53.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.787 0.327 . . . . 74.43 110.127 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 10.7 t30 -77.9 122.6 25.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.29 -0.414 . . . . 72.23 109.91 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 24.2 p -126.33 165.61 18.69 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.442 -0.345 . . . . 75.3 110.943 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.53 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 15.7 tt0 -108.58 118.85 37.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.998 -0.546 . . . . 72.32 110.017 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 86.9 t -110.82 132.87 58.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.17 0.51 . . . . 71.32 111.297 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -127.01 177.91 6.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.549 -0.75 . . . . 74.25 109.823 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.552 ' HE2' ' HB ' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -77.59 123.64 26.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.405 -0.961 . . . . 74.24 108.405 170.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.433 ' HB3' ' C ' ' A' ' 107' ' ' ILE . . . -75.3 92.87 2.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.147 0.499 . . . . 72.35 112.089 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.588 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.5 pt? -88.13 131.24 34.78 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.537 -0.912 . . . . 74.51 108.537 171.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.5 m -58.31 153.8 14.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.476 -0.329 . . . . 73.34 110.938 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.619 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.4 pttp -63.45 -14.8 54.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.091 0.472 . . . . 75.12 111.238 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 11.4 tm0? -78.57 -43.51 26.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.099 -0.704 . . . . 61.5 109.099 173.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -73.0 -41.88 63.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.32 -0.854 . . . . 73.31 110.958 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.619 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 21.1 ptm . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 72.43 110.442 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 179' ' ' LYS . 38.9 t . . . . . 0 N--CA 1.455 -0.202 0 N-CA-C 110.032 -0.358 . . . . 74.13 110.032 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.541 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 6.4 mtmt -115.79 -3.96 12.18 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.132 0.419 . . . . 65.23 112.132 -178.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.568 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.8 ttpt -135.46 134.11 39.24 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.028 -0.36 . . . . 75.14 110.028 175.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.666 HG22 HG13 ' A' ' 159' ' ' VAL . 3.3 pt -104.45 155.3 6.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.064 0.459 . . . . 75.12 110.745 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 41.8 t80 -104.83 122.93 46.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.551 -0.75 . . . . 74.3 109.785 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.2 t -110.65 98.59 7.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.432 -0.581 . . . . 75.13 109.432 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.674 -0.774 . . . . 62.13 113.185 -173.492 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.413 ' O ' HD21 ' A' ' 121' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 110.157 -0.312 . . . . 71.41 110.157 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.53 ' HG3' ' HB ' ' A' ' 134' ' ' ILE . 12.7 tt0 -55.79 -49.95 71.79 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 112.294 0.479 . . . . 65.14 112.294 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.53 -29.86 69.39 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 120.752 -0.379 . . . . 72.3 110.25 -175.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.526 ' CD2' HD21 ' A' ' 171' ' ' ASN . 37.2 m80 -65.56 -55.87 15.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.374 -0.376 . . . . 73.43 111.009 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.413 HD21 ' O ' ' A' ' 117' ' ' GLU . 1.0 OUTLIER -59.38 -47.71 84.4 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.944 0.402 . . . . 74.32 110.472 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.31 -46.32 90.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.042 -0.526 . . . . 72.44 111.385 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -57.18 -32.01 66.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.106 0.479 . . . . 50.41 111.602 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 168' ' ' HIS . 50.6 t80 -90.63 -44.1 9.74 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.182 -0.463 . . . . 73.52 111.411 -177.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -82.77 -12.83 57.21 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.674 0.62 . . . . 70.34 112.674 -172.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -61.47 -27.25 68.44 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.68 0.276 . . . . 75.35 111.556 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -74.82 -14.96 60.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.906 0.384 . . . . 74.31 110.903 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -90.0 -26.63 20.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.312 -0.403 . . . . 64.12 110.868 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 158' ' ' SER . . . 169.56 -170.97 43.02 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.508 -0.853 . . . . 63.23 112.533 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -75.86 122.27 23.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.28 0.562 . . . . 64.02 111.18 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.462 HG21 HD13 ' A' ' 134' ' ' ILE . 46.7 mt -95.59 137.9 22.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.415 -0.811 . . . . 74.34 110.296 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.428 ' HG2' ' N ' ' A' ' 154' ' ' ASP . 13.5 mm-40 -85.35 -70.57 0.58 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.934 -0.575 . . . . 73.43 110.403 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.22 158.75 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.531 -0.304 . . . . 73.24 110.472 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.598 ' CD1' HG11 ' A' ' 151' ' ' VAL . 23.5 mm -113.73 117.67 56.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.929 -0.397 . . . . 73.33 109.929 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 59.7 mt-10 -100.49 117.81 35.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.589 -0.522 . . . . 70.1 109.589 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.7 mt -91.65 3.76 7.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.53 0.681 . . . . 72.42 109.255 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.459 ' HE2' ' HA ' ' A' ' 137' ' ' MET . 8.4 tpp . . . . . 0 C--O 1.232 0.174 0 CA-C-N 114.857 -1.065 . . . . 72.05 109.588 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 29.0 p90 . . . . . 0 C--O 1.234 0.268 0 N-CA-C 109.402 -0.592 . . . . 73.13 109.402 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -136.42 172.11 13.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.214 0.53 . . . . 72.55 111.827 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.538 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 56.5 m-85 -133.32 134.97 44.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.334 -0.848 . . . . 74.52 109.433 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.598 HG11 ' CD1' ' A' ' 134' ' ' ILE . 21.2 t -112.93 108.52 25.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.858 -0.423 . . . . 72.23 109.858 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.568 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 6.7 m -88.14 127.19 35.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.168 -0.469 . . . . 75.3 110.461 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.49 ' CD2' HG21 ' A' ' 159' ' ' VAL . 86.8 m-85 -111.81 151.33 29.16 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.923 -0.399 . . . . 74.54 109.923 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.428 ' N ' ' HG2' ' A' ' 132' ' ' GLU . 28.1 t70 -76.91 -14.66 59.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.776 0.798 . . . . 74.14 110.042 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.424 ' OD1' ' HB3' ' A' ' 157' ' ' ASP . 37.0 t70 -123.93 133.32 53.75 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.002 -0.999 . . . . 51.22 111.043 -173.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.541 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.1 p-80 -85.11 -2.07 57.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.3 -0.409 . . . . 60.03 111.357 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.424 ' HB3' ' OD1' ' A' ' 155' ' ' ASP . 22.1 t70 -94.56 -37.05 11.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.183 0.516 . . . . 44.04 109.614 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.84 ' HA ' ' HE3' ' A' ' 161' ' ' LYS . 18.5 m -57.36 -32.03 66.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.482 -0.781 . . . . 64.52 110.482 175.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.666 HG13 HG22 ' A' ' 107' ' ' ILE . 46.9 t -70.83 -29.11 36.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.462 -0.79 . . . . 74.41 110.873 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -65.64 -45.57 82.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.907 -0.588 . . . . 72.32 111.608 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.84 ' HE3' ' HA ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -65.99 -12.6 56.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.119 0.485 . . . . 75.43 111.148 178.072 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.49 HG21 HD13 ' A' ' 107' ' ' ILE . 96.9 mt -93.3 -51.8 10.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.036 -0.529 . . . . 75.32 110.84 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.459 HG13 HG11 ' A' ' 159' ' ' VAL . 25.7 m -68.25 -15.75 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.516 0.562 . . . . 61.24 112.516 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.7 pp -73.82 -27.26 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.976 0.417 . . . . 73.5 110.574 177.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -102.76 150.09 23.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.092 -0.707 . . . . 72.42 109.092 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.507 ' HE2' ' HG3' ' A' ' 176' ' ' GLU . 86.6 tttt -100.16 -59.6 1.68 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.794 -0.362 . . . . 72.13 111.1 -176.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -88.19 113.43 23.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.404 0.621 . . . . 74.13 111.177 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.425 ' HB3' ' CE1' ' A' ' 124' ' ' TYR . 32.7 m-70 -109.24 139.4 44.22 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.153 -0.931 . . . . 74.11 110.219 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.2 m -92.58 101.48 13.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.123 0.487 . . . . 71.42 111.124 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 171' ' ' ASN . 4.2 p -134.15 140.02 47.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.956 -0.565 . . . . 74.23 109.728 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.526 HD21 ' CD2' ' A' ' 120' ' ' HIS . 24.7 t-20 71.71 1.16 3.78 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.729 0.776 . . . . 60.54 110.042 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.67 8.32 63.93 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.478 -0.783 . . . . 50.43 111.556 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -117.9 154.52 31.74 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.094 -0.336 . . . . 71.04 110.094 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -83.31 98.71 9.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.101 0.477 . . . . 72.23 110.341 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 78.6 m -101.22 123.66 45.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.817 -0.629 . . . . 74.4 111.07 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.507 ' HG3' ' HE2' ' A' ' 166' ' ' LYS . 3.8 tm-20 -83.7 122.92 29.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.518 -0.764 . . . . 73.12 109.738 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.4 m -118.74 148.77 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.202 -0.454 . . . . 73.23 111.189 -171.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -139.59 173.4 11.57 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.036 0.446 . . . . 71.13 111.503 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.47 ' HB3' HG23 ' A' ' 104' ' ' VAL . 47.9 mttm -71.73 117.56 13.47 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.08 -1.081 . . . . 72.4 108.08 166.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -76.98 93.6 3.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.076 0.465 . . . . 72.3 111.862 -175.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.566 ' H ' HD23 ' A' ' 181' ' ' LEU . 2.7 pt? -91.37 131.84 36.59 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.696 -0.853 . . . . 71.15 108.696 170.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.6 m -53.97 148.56 10.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.449 -0.341 . . . . 71.44 110.857 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.914 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.0 pttp -61.74 -26.54 68.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.288 0.566 . . . . 74.43 109.625 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -56.52 -38.6 72.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.994 -1.003 . . . . 73.3 110.525 172.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -95.17 -38.4 10.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.454 -0.794 . . . . 73.12 110.974 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.914 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 23.1 ptm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 72.44 110.792 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 179' ' ' LYS . 31.9 t . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 110.138 -0.319 . . . . 52.44 110.138 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.663 ' HA ' HG23 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -110.33 -9.74 14.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.885 0.374 . . . . 61.45 110.501 -179.058 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.592 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 32.2 ttpt -126.18 135.57 51.79 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.065 0.46 . . . . 71.43 110.397 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.538 ' CG2' HG13 ' A' ' 159' ' ' VAL . 7.5 pt -104.61 161.28 4.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.163 0.506 . . . . 74.32 111.544 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 67.8 t80 -108.21 115.64 30.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.157 -0.929 . . . . 64.34 109.802 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.2 t -104.24 106.33 20.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.134 -0.321 . . . . 71.23 110.134 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.474 0 C-N-CA 120.948 -0.644 . . . . 61.13 112.524 -176.393 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.493 ' CG ' ' HD2' ' A' ' 119' ' ' HIS . 12.0 pt-20 . . . . . 0 N--CA 1.44 -0.938 0 CA-C-O 120.523 0.202 . . . . 72.03 110.524 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.554 ' HA ' HG21 ' A' ' 134' ' ' ILE . 9.9 tt0 -54.45 -50.63 67.23 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.319 0.489 . . . . 43.34 112.319 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.493 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.6 p80 -64.31 -26.56 68.54 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 121.068 -0.253 . . . . 74.13 110.97 -176.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.433 ' CD2' HD21 ' A' ' 171' ' ' ASN . 39.1 m80 -68.46 -61.49 1.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.623 -0.262 . . . . 54.5 110.649 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.408 HD21 ' O ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -55.89 -50.79 69.69 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.131 -0.486 . . . . 61.33 110.434 178.013 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -53.46 -49.77 66.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.73 -0.668 . . . . 74.34 111.425 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.69 -28.18 68.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.676 0.274 . . . . 71.22 111.713 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -88.49 -34.86 17.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.83 0.347 . . . . 74.21 111.214 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 36.9 m-85 -92.22 -17.7 24.46 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.441 0.534 . . . . 60.31 112.441 -173.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -22.01 66.25 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.13 0.491 . . . . 72.32 110.993 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -64.15 -35.85 82.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.75 -0.659 . . . . 74.54 110.752 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.438 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 41.8 m-85 -80.93 -21.07 40.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.009 -0.541 . . . . 73.31 111.12 -176.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.744 ' HA3' ' HG ' ' A' ' 158' ' ' SER . . . 166.78 -167.4 39.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.016 -1.087 . . . . 53.23 113.066 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -79.18 120.97 24.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.447 0.642 . . . . 74.23 111.231 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.457 HG21 HD12 ' A' ' 134' ' ' ILE . 45.6 mt -94.28 133.74 34.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.318 -0.855 . . . . 73.4 110.039 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.488 ' HG3' ' N ' ' A' ' 154' ' ' ASP . 20.0 mt-10 -78.03 -70.01 0.51 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.203 -0.453 . . . . 74.13 110.635 176.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.4 m -143.54 154.89 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.663 -0.244 . . . . 63.43 110.542 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.63 ' CD1' HG12 ' A' ' 151' ' ' VAL . 24.9 mm -107.34 112.69 41.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.574 -0.528 . . . . 62.55 109.574 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 89.6 mt-10 -92.63 99.85 12.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.155 0.502 . . . . 72.44 110.416 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.542 HD13 ' H ' ' A' ' 118' ' ' GLU . 31.8 mt -83.91 108.19 16.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.985 -0.552 . . . . 74.23 109.652 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.5 tpp . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 121.65 0.738 . . . . 73.33 109.887 179.455 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 31.2 p90 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.615 0.245 . . . . 72.51 111.096 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.32 173.28 11.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.462 -0.336 . . . . 74.02 110.741 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.494 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 88.3 m-85 -133.87 148.35 51.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.111 -0.495 . . . . 73.12 110.373 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.63 HG12 ' CD1' ' A' ' 134' ' ' ILE . 55.8 t -127.17 110.94 23.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.189 -0.46 . . . . 74.03 110.072 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.592 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 25.0 m -89.35 126.71 35.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.282 -0.417 . . . . 64.33 110.533 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.487 ' CD2' HG22 ' A' ' 159' ' ' VAL . 96.6 m-85 -108.37 149.12 29.12 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.237 -0.283 . . . . 75.41 110.237 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.488 ' N ' ' HG3' ' A' ' 132' ' ' GLU . 18.2 t70 -63.65 -29.07 70.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 70.43 111.439 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -132.21 147.63 52.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.289 -0.414 . . . . 64.32 110.616 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -21.1 61.81 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.812 -0.44 . . . . 73.01 109.812 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -58.42 -50.01 75.22 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.86 -0.609 . . . . 74.21 110.765 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.744 ' HG ' ' HA3' ' A' ' 129' ' ' GLY . 9.9 m -60.66 -29.1 69.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 72.34 110.957 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 105' ' ' LYS . 20.9 t -74.29 -37.35 45.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.487 -0.779 . . . . 75.15 111.081 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.424 ' HA ' HG21 ' A' ' 163' ' ' VAL . 25.8 t70 -60.97 -38.91 87.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.361 -0.381 . . . . 72.0 112.025 -172.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.438 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 4.0 mttt -66.01 -18.56 65.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.207 0.527 . . . . 73.25 110.825 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.424 ' CG2' HG13 ' A' ' 177' ' ' VAL . 93.2 mt -98.84 -49.86 11.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.494 -0.775 . . . . 75.11 111.067 -176.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.567 ' HB ' ' HD2' ' A' ' 179' ' ' LYS . 24.7 m -67.36 -18.35 23.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.693 0.627 . . . . 73.41 112.693 -174.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.0 pp -69.46 -29.33 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.054 0.454 . . . . 72.32 111.063 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -108.23 144.62 35.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.04 -0.527 . . . . 74.52 109.887 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.604 ' HE3' ' OE2' ' A' ' 176' ' ' GLU . 84.3 tttt -93.64 -64.27 1.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.818 0.342 . . . . 74.43 111.167 -177.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.557 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 21.8 m-85 -83.17 106.83 15.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.076 0.465 . . . . 74.31 111.223 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -106.7 170.06 8.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.68 -0.691 . . . . 63.31 110.323 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.7 m -114.57 95.74 5.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.518 -0.31 . . . . 74.12 110.52 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 171' ' ' ASN . 6.7 p -122.75 137.72 55.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.629 -0.508 . . . . 74.32 109.629 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.433 HD21 ' CD2' ' A' ' 120' ' ' HIS . 26.0 t-20 69.73 1.93 3.61 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.641 0.734 . . . . 75.43 110.496 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.9 13.53 57.71 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.539 -0.624 . . . . 72.33 111.539 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -122.88 145.12 48.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.071 -0.344 . . . . 74.11 110.071 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.488 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 9.0 t30 -80.64 105.99 12.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.108 -0.496 . . . . 73.22 110.214 176.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 25.4 m -115.39 165.85 12.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.106 -0.497 . . . . 72.2 110.294 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.604 ' OE2' ' HE3' ' A' ' 166' ' ' LYS . 20.6 tt0 -99.04 134.51 41.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.949 0.404 . . . . 71.2 110.755 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 83.9 t -126.53 130.47 71.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.903 -0.59 . . . . 75.42 110.521 176.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.44 ' HD3' ' OE2' ' A' ' 176' ' ' GLU . 19.8 mtm-85 -133.58 177.89 7.35 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.075 -0.713 . . . . 75.15 109.075 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.567 ' HD2' ' HB ' ' A' ' 163' ' ' VAL . 0.3 OUTLIER -72.06 128.9 37.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.941 -0.763 . . . . 71.45 108.941 173.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -84.37 86.04 7.31 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.446 -0.502 . . . . 54.35 110.88 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.438 HD21 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -80.61 135.44 36.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.198 -0.667 . . . . 73.44 109.198 175.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.8 m -49.9 136.15 18.74 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.537 0.523 . . . . 61.11 111.091 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.67 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.8 pttp -63.65 -24.66 67.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.69 0.281 . . . . 73.04 110.809 -178.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -60.98 -41.06 95.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.195 0.522 . . . . 74.42 109.94 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -84.9 -35.87 21.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.507 -0.77 . . . . 75.33 110.709 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.67 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 12.7 ptm . . . . . 0 C--N 1.333 -0.152 0 CA-C-O 120.755 0.312 . . . . 74.11 110.22 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.519 HG23 ' HB3' ' A' ' 179' ' ' LYS . 2.7 t . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.836 -0.431 . . . . 74.21 109.836 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.729 ' HA ' HG22 ' A' ' 159' ' ' VAL . 7.0 mtmt -122.48 24.15 9.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.379 0.609 . . . . 73.4 110.332 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.515 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.8 ttpt -159.42 135.08 8.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.407 -0.815 . . . . 74.34 109.454 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.532 HG12 ' HB ' ' A' ' 151' ' ' VAL . 6.1 pt -106.44 160.6 5.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.806 0.336 . . . . 74.01 111.064 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 58.9 t80 -107.07 119.35 39.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.784 -0.644 . . . . 72.24 110.171 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.409 HG12 HD13 ' A' ' 121' ' ' LEU . 43.0 t -101.3 103.16 14.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.945 0.403 . . . . 72.32 110.357 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.749 0 N-CA-C 111.284 -0.726 . . . . 64.44 111.284 178.135 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.606 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 13.1 pt-20 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.826 0.346 . . . . 75.14 111.515 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.527 ' HA ' HG23 ' A' ' 134' ' ' ILE . 13.7 tt0 -59.18 -45.88 89.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.01 -0.541 . . . . 75.4 111.555 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.424 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -60.23 -27.54 67.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.324 -0.398 . . . . 60.44 110.715 -178.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.606 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 30.0 m80 -72.48 -60.75 2.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.56 -0.291 . . . . 71.04 111.017 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.409 HD13 HG12 ' A' ' 109' ' ' VAL . 0.9 OUTLIER -57.57 -49.22 77.09 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.983 0.421 . . . . 71.11 110.251 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.74 -44.68 81.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.811 -0.631 . . . . 73.53 111.144 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.21 -31.11 68.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 75.52 111.411 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.405 ' CD1' HG21 ' A' ' 170' ' ' VAL . 78.7 t80 -86.97 -49.32 7.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.984 0.421 . . . . 73.14 111.09 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.497 ' CD1' HG22 ' A' ' 151' ' ' VAL . 65.3 m-85 -78.24 -14.01 59.61 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.579 0.585 . . . . 72.03 112.579 -171.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -25.23 67.72 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.68 0.252 . . . . 62.24 111.68 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -72.78 -19.33 61.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.949 0.404 . . . . 62.51 110.615 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.425 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 88.7 m-85 -83.86 -35.19 24.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.11 -0.495 . . . . 73.22 110.485 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.41 -167.67 38.36 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.438 -0.887 . . . . 72.53 112.556 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -77.59 122.68 25.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.206 0.526 . . . . 74.11 111.173 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.468 HG21 HD12 ' A' ' 134' ' ' ILE . 42.0 mt -97.41 131.15 44.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.604 -0.725 . . . . 75.31 110.504 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.407 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 7.2 mm-40 -78.01 -72.28 0.37 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.652 -0.704 . . . . 75.22 110.566 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.7 m -145.49 147.29 18.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.524 -0.307 . . . . 74.21 110.725 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.623 ' CD1' HG13 ' A' ' 151' ' ' VAL . 30.3 mm -102.83 107.71 22.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.888 -0.412 . . . . 73.41 109.888 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 38.1 mt-10 -85.96 103.2 14.45 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.792 -0.447 . . . . 72.44 109.792 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 23.9 mt -78.81 -11.24 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.089 0.471 . . . . 73.14 110.328 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.0 tpp . . . . . 0 C--O 1.233 0.233 0 CA-C-O 121.945 0.879 . . . . 72.23 110.651 -177.778 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.9 p90 . . . . . 0 C--O 1.232 0.152 0 N-CA-C 110.406 -0.22 . . . . 74.13 110.406 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -128.43 165.41 20.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.332 0.587 . . . . 62.34 111.443 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.506 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 66.0 m-85 -132.06 136.28 47.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.442 -0.799 . . . . 73.41 109.757 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.623 HG13 ' CD1' ' A' ' 134' ' ' ILE . 38.9 t -111.34 104.82 17.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.864 -0.421 . . . . 74.04 109.864 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.515 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 7.5 m -83.79 125.87 32.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 75.41 110.065 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.533 ' CD2' HG21 ' A' ' 159' ' ' VAL . 98.7 m-85 -109.5 151.55 26.59 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.074 -0.343 . . . . 75.35 110.074 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.407 ' HB2' ' HG2' ' A' ' 132' ' ' GLU . 26.6 t70 -78.53 -6.38 55.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.209 0.528 . . . . 74.15 111.163 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 159' ' ' VAL . 5.6 t70 -140.19 145.68 37.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.174 -0.466 . . . . 74.14 110.31 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -79.21 -18.44 52.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.148 -0.478 . . . . 73.13 110.56 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -73.07 -38.56 66.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.205 0.526 . . . . 71.01 110.064 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.2 m -64.65 -28.66 69.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.518 -0.765 . . . . 64.23 110.371 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.729 HG22 ' HA ' ' A' ' 105' ' ' LYS . 22.7 t -76.78 -36.56 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.66 -0.7 . . . . 75.04 110.201 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.29 -31.09 70.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.732 -0.667 . . . . 73.03 111.387 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.425 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 13.0 mmtp -65.1 -27.57 68.84 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.47 0.652 . . . . 73.14 110.021 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.505 HG23 HD13 ' A' ' 107' ' ' ILE . 90.4 mt -100.23 -50.18 10.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.949 -1.023 . . . . 73.53 111.828 -168.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.598 ' HB ' ' HG3' ' A' ' 179' ' ' LYS . 28.1 m -65.73 -16.76 21.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.448 0.536 . . . . 74.22 112.448 -173.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -74.48 -26.83 20.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.965 0.412 . . . . 65.35 110.781 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -100.42 146.2 27.3 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.695 -0.684 . . . . 71.2 109.2 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -100.63 -66.06 0.93 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.762 0.315 . . . . 62.4 110.598 -177.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 19.7 m-85 -82.49 101.85 10.97 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.131 0.491 . . . . 73.13 111.11 -177.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -98.0 -172.8 2.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.721 -0.672 . . . . 74.13 109.593 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 61.4 m -141.64 106.63 4.94 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.222 0.534 . . . . 74.55 110.821 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.405 HG21 ' CD1' ' A' ' 124' ' ' TYR . 39.2 t -121.18 135.32 61.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.631 -0.713 . . . . 72.21 109.739 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.9 t30 71.47 -4.62 1.81 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.277 0.56 . . . . 75.45 111.393 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 109.19 4.87 30.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.954 -0.641 . . . . 70.2 111.752 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -114.63 131.61 56.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.917 0.389 . . . . 72.45 110.326 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.64 103.15 4.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.896 -0.593 . . . . 71.13 109.585 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 14.9 p -103.8 176.96 4.98 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.162 -0.472 . . . . 62.31 110.77 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -118.34 120.38 37.44 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.083 0.468 . . . . 74.42 110.117 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 87.1 t -113.35 135.09 54.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.898 -0.592 . . . . 72.02 111.045 -175.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -129.12 179.67 5.63 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.553 -0.749 . . . . 73.4 109.742 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.598 ' HG3' ' HB ' ' A' ' 163' ' ' VAL . 0.6 OUTLIER -77.67 122.07 24.84 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.918 -1.141 . . . . 71.53 107.918 172.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.459 ' HB3' ' C ' ' A' ' 107' ' ' ILE . . . -77.12 89.8 3.63 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.513 -0.475 . . . . 63.01 111.199 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.516 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.3 pt? -81.35 138.96 35.6 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.805 -0.813 . . . . 73.04 108.805 175.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.1 m -54.15 145.9 16.19 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.085 -0.339 . . . . 65.4 110.085 -178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.739 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.4 pttp -61.92 -17.51 57.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.921 0.391 . . . . 64.14 110.31 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -67.67 -51.98 43.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.377 0.608 . . . . 74.21 109.738 170.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -64.96 -41.64 95.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.309 -0.86 . . . . 75.02 110.553 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.739 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 16.4 ptm . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 115.946 -0.57 . . . . 73.15 110.692 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.7 t . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 110.183 -0.303 . . . . 72.23 110.183 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.615 ' HA ' HG23 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -116.84 -3.75 11.64 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.244 0.461 . . . . 72.13 112.244 -177.602 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.593 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 26.0 ttpt -135.31 138.59 43.58 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.015 -0.365 . . . . 65.43 110.015 177.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.459 ' CG2' HG13 ' A' ' 159' ' ' VAL . 2.1 pp -106.35 154.35 7.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.984 0.421 . . . . 74.31 110.759 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.421 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 62.4 t80 -102.23 127.21 49.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.586 -0.734 . . . . 74.34 109.996 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.49 HG23 ' HG ' ' A' ' 121' ' ' LEU . 46.7 t -102.31 110.03 27.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.88 0.372 . . . . 74.12 110.581 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.92 0 N-CA-C 110.957 -0.857 . . . . 71.11 110.957 175.46 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.453 ' CG ' ' HD2' ' A' ' 119' ' ' HIS . 12.2 pt-20 . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 120.725 0.298 . . . . 73.3 110.972 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.552 ' H ' HD13 ' A' ' 136' ' ' ILE . 8.5 tt0 -58.19 -46.41 85.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.877 -0.601 . . . . 73.35 112.347 -173.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.453 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 0.8 OUTLIER -62.41 -28.98 70.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.699 0.285 . . . . 74.44 110.673 -178.217 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.431 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 32.3 m80 -68.05 -56.37 9.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.355 -0.384 . . . . 73.13 110.791 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.49 ' HG ' HG23 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -60.79 -51.63 68.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.282 -0.417 . . . . 73.44 110.558 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.416 ' HB2' HG13 ' A' ' 134' ' ' ILE . 0.6 OUTLIER -55.06 -49.56 71.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 75.24 111.648 -177.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -59.15 -30.14 67.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 55.3 111.218 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.447 ' CD1' HG22 ' A' ' 170' ' ' VAL . 76.6 t80 -85.25 -47.92 9.6 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.814 -0.354 . . . . 64.1 111.111 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.512 ' CD1' HG22 ' A' ' 151' ' ' VAL . 42.8 m-85 -77.48 -18.15 57.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.373 0.508 . . . . 64.14 112.373 -172.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.55 -24.51 67.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.804 0.335 . . . . 74.33 111.618 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 124' ' ' TYR . 7.0 pt20 -76.19 -14.71 60.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.108 0.48 . . . . 65.13 110.202 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -87.72 -25.52 23.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 75.14 110.319 178.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.496 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 165.22 -151.17 19.82 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 119.912 -1.137 . . . . 44.13 113.689 175.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.54 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 20.4 tptm -91.23 117.07 29.33 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.394 0.616 . . . . 71.43 111.279 -172.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.446 HG12 ' CE1' ' A' ' 153' ' ' PHE . 38.2 mt -99.81 138.8 23.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.325 -0.852 . . . . 75.23 110.69 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 154' ' ' ASP . 21.8 mt-10 -82.59 -75.38 0.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.021 -0.536 . . . . 73.14 110.341 172.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 m -143.97 152.4 15.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.616 -0.72 . . . . 71.54 110.079 -178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.618 ' CD1' HG13 ' A' ' 151' ' ' VAL . 22.7 mm -100.84 138.23 25.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.907 -0.775 . . . . 72.13 108.907 175.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 44.7 mt-10 -117.94 97.94 6.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.815 0.34 . . . . 72.33 110.743 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.552 HD13 ' H ' ' A' ' 118' ' ' GLU . 8.5 mt -76.21 105.51 5.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.066 -1.087 . . . . 73.15 108.066 172.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 10.4 tpt . . . . . 0 C--N 1.319 -0.726 0 CA-C-O 121.855 0.836 . . . . 71.5 111.272 -171.586 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 33.0 p90 . . . . . 0 C--O 1.233 0.216 0 CA-C-O 121.269 0.556 . . . . 72.42 111.841 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -135.26 171.9 13.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.514 -0.766 . . . . 74.34 110.274 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.454 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 70.1 m-85 -136.64 152.09 50.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.355 -0.384 . . . . 73.42 110.115 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.618 HG13 ' CD1' ' A' ' 134' ' ' ILE . 62.1 t -128.49 110.48 21.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.133 -0.485 . . . . 72.32 109.88 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.593 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 97.0 m -86.17 125.02 33.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.109 -0.496 . . . . 73.42 110.085 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.446 ' CE1' HG12 ' A' ' 131' ' ' ILE . 97.0 m-85 -106.06 146.79 29.68 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.871 0.367 . . . . 64.43 110.346 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.54 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 21.4 t0 -78.32 -19.13 54.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.535 0.683 . . . . 73.23 109.633 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -128.89 132.71 47.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.222 -0.899 . . . . 52.34 109.694 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.54 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.2 p-80 -73.96 -14.01 60.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.203 -0.453 . . . . 71.14 110.474 177.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -66.33 -40.84 90.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.195 0.522 . . . . 64.13 110.025 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.614 ' HA ' ' HE3' ' A' ' 161' ' ' LYS . 4.6 m -66.76 -28.54 68.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.419 -0.81 . . . . 71.32 110.986 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.615 HG23 ' HA ' ' A' ' 105' ' ' LYS . 18.7 t -72.57 -35.11 49.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.722 -0.672 . . . . 63.05 111.22 -176.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -56.74 -51.47 68.73 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.084 -0.507 . . . . 71.13 111.897 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.614 ' HE3' ' HA ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -65.16 -14.08 59.72 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.996 0.369 . . . . 72.21 111.996 -178.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 94.5 mt -93.7 -48.27 13.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 120.661 0.267 . . . . 74.0 110.926 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.452 HG13 HG11 ' A' ' 159' ' ' VAL . 35.6 m -69.69 -19.42 22.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.343 0.497 . . . . 63.12 112.343 -175.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.39 -30.72 49.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.78 0.324 . . . . 71.22 111.529 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.494 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 14.0 pt20 -113.49 145.99 40.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.389 -0.369 . . . . 74.35 110.17 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.527 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 77.0 tttt -91.27 -60.09 1.98 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.051 -0.522 . . . . 75.32 110.513 -178.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.555 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 7.9 m-30 -72.47 110.53 6.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.259 0.552 . . . . 75.44 111.234 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.571 ' CD2' ' HB ' ' A' ' 177' ' ' VAL . 37.7 m-70 -110.85 170.92 7.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.303 -0.862 . . . . 64.34 109.583 173.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.7 m -119.41 96.04 5.04 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.841 0.353 . . . . 70.0 110.384 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.461 HG13 HD12 ' A' ' 121' ' ' LEU . 47.5 t -117.2 130.89 71.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.324 -0.398 . . . . 75.11 110.126 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.4 t30 59.7 31.49 20.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.509 0.671 . . . . 73.34 110.477 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 70.57 19.28 76.27 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.925 -0.58 . . . . 63.44 112.211 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -122.84 129.7 51.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.85 0.357 . . . . 71.22 110.617 -177.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -73.28 112.1 9.03 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.472 -0.566 . . . . 73.1 109.472 174.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 18.9 p -121.65 173.55 7.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.814 0.34 . . . . 75.51 111.382 -174.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.527 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 10.8 tt0 -108.41 116.92 32.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.838 -0.619 . . . . 75.11 110.064 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.571 ' HB ' ' CD2' ' A' ' 168' ' ' HIS . 59.4 t -120.26 134.68 62.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.233 -0.44 . . . . 73.14 110.493 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -150.54 -177.98 6.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.858 -0.61 . . . . 75.51 110.294 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -63.78 133.23 53.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.961 -0.385 . . . . 62.04 109.961 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.418 ' HB2' ' C ' ' A' ' 107' ' ' ILE . . . -88.3 86.67 7.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.192 0.52 . . . . 73.22 110.538 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.674 HD22 ' H ' ' A' ' 181' ' ' LEU . 2.3 pt? -80.8 127.55 32.65 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.764 -0.828 . . . . 72.3 108.764 174.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.5 t -56.02 156.66 5.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.105 -0.498 . . . . 72.22 110.548 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.898 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.3 pttp -63.73 -15.13 57.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.293 0.568 . . . . 63.52 109.83 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . 0.421 ' HA ' ' OE1' ' A' ' 184' ' ' GLN . 6.6 tp60 -71.7 -38.02 70.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.566 -0.743 . . . . 74.31 109.823 172.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -87.22 -41.34 13.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.483 -0.78 . . . . 74.32 111.116 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.898 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.7 ptm . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 116.263 -0.426 . . . . 75.32 110.72 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 159' ' ' VAL . 9.6 p . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 110.273 -0.269 . . . . 74.33 110.273 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.427 ' HE2' ' HB3' ' A' ' 156' ' ' HIS . 0.0 OUTLIER -105.59 -0.85 25.35 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.931 0.396 . . . . 54.3 110.903 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.62 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 24.0 ttpt -133.98 136.69 44.3 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.107 0.479 . . . . 73.52 110.807 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.488 HG12 ' HB ' ' A' ' 151' ' ' VAL . 9.2 pt -107.95 162.57 6.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.132 -0.485 . . . . 71.5 110.642 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 61.6 t80 -110.23 118.05 35.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.846 -0.616 . . . . 64.5 110.078 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 30.6 t -106.84 103.04 14.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.506 -0.553 . . . . 73.33 109.506 175.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.627 0 C-N-CA 120.656 -0.783 . . . . 72.34 112.364 -178.224 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 . . . . . 0 C--O 1.234 0.284 0 CA-C-O 121.253 0.549 . . . . 71.31 112.1 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.592 ' HG2' ' CG1' ' A' ' 134' ' ' ILE . 2.8 tm-20 -60.41 -47.14 87.37 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.181 -0.918 . . . . 74.34 111.475 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -30.8 71.85 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.883 -0.327 . . . . 75.53 110.524 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -66.68 -59.62 3.42 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.943 0.401 . . . . 64.42 110.611 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.481 ' HA ' HG22 ' A' ' 170' ' ' VAL . 8.5 mp -60.0 -47.94 83.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.769 -0.651 . . . . 55.53 111.359 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.472 ' HG3' HD11 ' A' ' 131' ' ' ILE . 3.1 ttp180 -62.06 -41.78 98.51 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.062 -0.255 . . . . 54.12 111.359 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -57.24 -30.42 64.61 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.339 0.59 . . . . 71.41 111.061 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -88.43 -47.04 8.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.788 -0.642 . . . . 74.04 111.156 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -80.11 -12.12 59.7 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.528 0.566 . . . . 73.51 112.528 -173.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.67 -24.8 66.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.84 0.352 . . . . 71.24 111.568 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -72.57 -20.7 61.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.321 -0.4 . . . . 72.24 110.451 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.45 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 89.0 m-85 -82.15 -38.82 24.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.048 -0.524 . . . . 73.45 110.023 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.44 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 176.86 -168.47 40.42 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.229 -0.986 . . . . 75.33 113.277 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.523 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 40.1 tptt -74.33 116.41 14.96 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.405 0.621 . . . . 71.34 111.4 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.48 HG12 ' CE1' ' A' ' 153' ' ' PHE . 33.0 mt -92.53 140.51 16.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.324 -0.853 . . . . 74.33 110.542 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -86.91 -72.46 0.51 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.09 -0.504 . . . . 70.31 110.405 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.72 140.41 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 73.44 111.325 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.633 ' CD1' HG11 ' A' ' 151' ' ' VAL . 21.3 mm -95.1 101.61 12.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.611 -0.514 . . . . 72.33 109.611 174.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -84.67 94.74 8.71 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.939 -0.393 . . . . 60.52 109.939 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.484 HD11 ' H ' ' A' ' 118' ' ' GLU . 7.1 mt -73.05 100.91 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.005 -1.109 . . . . 63.15 108.005 175.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 10.7 tpt . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.381 0.61 . . . . 73.14 110.494 -173.476 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 31.7 p90 . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 110.32 -0.252 . . . . 73.3 110.32 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.4 165.15 28.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.961 0.41 . . . . 54.32 110.952 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.549 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 65.9 m-85 -126.26 123.72 38.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.753 -0.658 . . . . 62.14 110.006 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.633 HG11 ' CD1' ' A' ' 134' ' ' ILE . 48.9 t -98.75 107.44 20.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 110.017 -0.364 . . . . 74.42 110.017 -179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.62 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 25.3 m -86.8 124.43 33.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.118 -0.492 . . . . 38.12 110.151 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.646 ' CD2' HG13 ' A' ' 159' ' ' VAL . 97.6 m-85 -104.92 157.63 17.08 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.916 -0.402 . . . . 74.22 109.916 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.523 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 16.0 t70 -69.59 -29.81 67.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.03 -0.532 . . . . 65.14 110.557 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -132.45 147.38 52.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.57 -0.741 . . . . 74.02 110.923 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.664 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.3 p-80 -75.45 -12.81 60.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.181 -0.463 . . . . 74.04 110.732 177.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -60.84 -49.83 75.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.173 0.511 . . . . 73.12 110.153 174.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.44 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 14.6 m -66.56 -22.14 66.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.377 -0.829 . . . . 71.21 112.373 -173.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 156' ' ' HIS . 4.1 m -81.49 -25.84 10.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.935 -0.306 . . . . 71.44 111.453 -176.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.543 ' HA ' HG21 ' A' ' 163' ' ' VAL . 36.1 t70 -70.31 -39.88 74.54 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.983 -0.287 . . . . 75.13 111.342 -171.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.45 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.6 mptp? -62.21 -14.63 40.07 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.372 0.606 . . . . 72.13 110.586 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.464 HG23 HD11 ' A' ' 107' ' ' ILE . 94.5 mt -98.38 -49.21 11.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.455 -0.793 . . . . 73.35 110.886 -176.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.543 HG21 ' HA ' ' A' ' 160' ' ' ASP . 23.5 m -72.93 -15.57 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.104 -0.498 . . . . 75.41 112.078 -175.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.2 pp -64.68 -26.81 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.696 0.284 . . . . 72.33 111.572 178.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -116.0 -178.94 3.52 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.407 -0.59 . . . . 70.22 109.407 171.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.44 ' HE3' ' OE1' ' A' ' 176' ' ' GLU . 83.5 tttt -120.48 -67.79 0.95 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.655 0.264 . . . . 70.54 111.226 -173.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 11.1 m-30 -71.69 107.54 4.57 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.088 0.47 . . . . 73.45 111.401 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.439 ' CE1' HG21 ' A' ' 162' ' ' ILE . 32.9 m-70 -104.89 151.58 23.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.624 -0.716 . . . . 72.23 109.837 174.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 21.8 m -109.87 84.73 1.98 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.045 0.45 . . . . 73.41 110.424 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.481 HG22 ' HA ' ' A' ' 121' ' ' LEU . 4.1 p -102.57 132.86 47.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.892 -0.595 . . . . 75.44 109.719 178.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 170' ' ' VAL . 4.6 t30 71.92 -14.79 0.49 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.106 0.479 . . . . 72.45 110.544 -176.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 114.97 -3.08 22.76 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.905 -0.878 . . . . 61.13 110.905 -173.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.489 ' O ' ' HA ' ' A' ' 169' ' ' THR . 58.5 t-80 -93.97 148.7 21.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.303 -0.448 . . . . 63.22 110.286 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -94.24 102.78 14.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.999 0.428 . . . . 73.55 110.151 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 29.4 m -114.47 154.1 28.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.131 -0.486 . . . . 73.53 111.201 -175.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.492 ' OE2' ' HD3' ' A' ' 178' ' ' ARG . 20.5 tt0 -91.53 119.55 31.56 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.664 -0.495 . . . . 75.31 109.664 175.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 48.4 t -117.63 138.99 46.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.955 -0.566 . . . . 75.42 110.659 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.492 ' HD3' ' OE2' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -159.02 171.86 19.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.417 -0.81 . . . . 74.22 109.675 -177.658 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.55 ' HB3' ' HZ2' ' A' ' 179' ' ' LYS . 8.6 mtpm? -63.26 122.1 15.33 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.104 -0.332 . . . . 73.44 110.104 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -74.89 91.25 2.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.985 0.422 . . . . 73.51 110.686 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.483 HD22 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -80.9 139.52 35.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.489 -0.56 . . . . 73.34 109.489 177.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.5 m -50.88 130.66 25.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.167 -0.469 . . . . 73.13 110.755 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.773 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.0 pttp -64.34 -23.24 67.23 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.843 0.354 . . . . 71.2 110.664 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.86 -37.14 86.28 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.484 -0.562 . . . . 65.14 109.484 176.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -88.16 -34.75 17.73 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.705 -0.679 . . . . 73.43 111.049 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.773 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 6.5 ptp . . . . . 0 C--N 1.333 -0.145 0 N-CA-C 109.632 -0.506 . . . . 75.11 109.632 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.405 0 CA-C-O 121.692 0.758 . . . . 75.44 112.824 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.546 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 2.4 mtmt -129.53 12.83 5.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.723 -0.671 . . . . 74.1 110.012 175.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.493 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 30.6 ttpt -144.23 137.26 27.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.295 -0.866 . . . . 72.34 109.379 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pp -107.59 153.6 8.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.35 -0.387 . . . . 73.23 110.537 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.536 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 75.6 t80 -105.0 125.29 50.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.28 -0.418 . . . . 72.45 110.881 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.9 t -105.94 107.32 22.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.468 -0.333 . . . . 74.1 110.394 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 C-N-CA 120.78 -0.724 . . . . 73.32 112.585 -179.401 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.467 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 12.0 pt-20 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.652 0.263 . . . . 74.25 110.737 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.537 ' HG3' ' HB ' ' A' ' 134' ' ' ILE . 7.2 tt0 -59.62 -46.43 89.01 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.044 -0.526 . . . . 73.54 112.355 -176.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.435 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -65.0 -32.99 74.99 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.811 -0.355 . . . . 71.4 110.601 -176.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.467 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 38.6 m80 -61.8 -52.73 62.99 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.912 0.387 . . . . 71.31 110.709 178.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.409 HD21 HG21 ' A' ' 170' ' ' VAL . 70.3 mt -62.99 -47.91 81.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.625 -0.716 . . . . 73.13 110.288 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -56.17 -49.33 74.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.798 -0.637 . . . . 75.11 110.651 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -56.71 -32.66 65.72 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.179 0.514 . . . . 74.23 111.62 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -85.16 -40.8 16.31 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.035 -0.53 . . . . 73.33 111.104 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.498 ' CD1' HG23 ' A' ' 151' ' ' VAL . 57.1 m-85 -88.63 -18.02 28.86 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.78 0.659 . . . . 64.53 112.78 -173.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.4 ' N ' HD12 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -66.35 -21.52 66.25 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.142 0.496 . . . . 74.25 110.928 -179.448 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -70.08 -22.14 63.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.673 -0.694 . . . . 64.51 110.477 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.477 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 28.9 m-85 -86.74 -33.25 20.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.957 -0.565 . . . . 74.45 110.674 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 176.93 -170.38 43.07 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.285 -0.959 . . . . 45.42 113.151 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -75.17 124.02 26.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 122.924 0.49 . . . . 75.44 111.49 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.465 HG12 ' CE1' ' A' ' 153' ' ' PHE . 44.2 mt -100.31 137.31 28.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.876 -0.602 . . . . 62.32 111.149 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.14 -74.41 0.34 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.383 -0.826 . . . . 73.54 110.359 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.81 159.09 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.655 -0.498 . . . . 61.32 109.655 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.607 ' CD1' HG12 ' A' ' 151' ' ' VAL . 29.3 mm -112.41 104.45 17.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.928 0.394 . . . . 70.03 109.948 174.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.4 ' C ' ' H ' ' A' ' 137' ' ' MET . 46.5 mt-10 -89.61 101.64 14.32 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.959 -0.386 . . . . 72.41 109.959 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.3 mt -81.18 12.6 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.349 0.595 . . . . 74.12 109.84 -179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.693 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.36 0 CA-C-N 115.143 -0.935 . . . . 63.44 109.702 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.693 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 42.9 p90 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.601 0.239 . . . . 72.42 110.402 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.86 165.13 23.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.976 0.417 . . . . 61.23 111.206 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.479 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 43.7 m-85 -132.47 135.5 46.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.699 -0.682 . . . . 73.32 109.467 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.607 HG12 ' CD1' ' A' ' 134' ' ' ILE . 43.4 t -110.85 108.42 25.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.55 -0.537 . . . . 71.44 109.55 177.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.493 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 3.9 m -85.88 128.48 34.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.055 -0.52 . . . . 74.3 110.301 -178.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.577 ' CD2' HG11 ' A' ' 159' ' ' VAL . 94.7 m-85 -111.75 151.41 29.0 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.916 -0.401 . . . . 74.31 109.916 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -78.87 -6.56 56.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.249 0.547 . . . . 74.11 110.854 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.75 149.64 43.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.182 -0.463 . . . . 55.44 110.245 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.546 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.0 p-80 -89.48 -2.64 58.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.928 0.394 . . . . 71.52 110.897 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -75.04 -39.08 61.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.359 0.6 . . . . 75.31 109.476 173.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.4 m -64.9 -30.31 71.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.513 -0.767 . . . . 63.03 111.789 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.577 HG11 ' CD2' ' A' ' 153' ' ' PHE . 14.1 m -78.87 -20.81 12.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.634 -0.257 . . . . 71.33 111.68 -176.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.05 -46.14 75.27 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 120.596 0.236 . . . . 71.23 110.46 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.477 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.4 mptp? -59.29 -20.08 51.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.364 0.602 . . . . 63.3 111.038 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.402 ' CG2' HG13 ' A' ' 177' ' ' VAL . 79.5 mt -94.1 -49.07 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.529 -0.76 . . . . 75.35 111.206 -175.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.573 ' HB ' ' HE3' ' A' ' 179' ' ' LYS . 25.9 m -80.59 -10.72 12.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 112.287 0.477 . . . . 74.52 112.287 -173.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 165' ' ' GLN . 2.6 pp -68.82 -31.35 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.998 0.428 . . . . 71.42 110.961 176.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.516 ' N ' HD13 ' A' ' 164' ' ' ILE . 14.5 pt20 -101.15 -162.0 0.9 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.116 -0.698 . . . . 74.21 109.116 172.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.517 ' HE3' ' HG3' ' A' ' 176' ' ' GLU . 44.3 tttt -134.67 -68.67 0.53 Allowed 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.811 -0.356 . . . . 73.12 111.568 -174.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.503 ' CD1' ' HG2' ' A' ' 166' ' ' LYS . 97.2 m-85 -88.32 113.41 23.89 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.133 0.492 . . . . 74.23 111.544 -175.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -105.35 147.36 28.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.57 -0.741 . . . . 73.43 110.248 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 47.2 m -100.73 98.92 9.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.075 0.464 . . . . 64.52 110.745 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.409 HG21 HD21 ' A' ' 121' ' ' LEU . 4.7 p -118.19 130.97 72.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.076 -0.511 . . . . 75.04 109.833 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.8 t30 64.67 15.73 9.91 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.643 0.735 . . . . 72.1 110.279 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.85 8.78 75.63 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.765 -0.731 . . . . 62.42 112.225 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -110.03 124.67 51.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.719 0.295 . . . . 72.54 110.367 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -81.42 105.3 12.48 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.427 -0.583 . . . . 70.22 109.427 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 10.5 m -118.15 154.31 32.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.926 -0.579 . . . . 53.25 110.589 -172.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.517 ' HG3' ' HE3' ' A' ' 166' ' ' LYS . 30.1 tt0 -88.73 126.0 35.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.001 0.429 . . . . 73.41 110.153 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 97.8 t -112.23 129.43 67.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.343 0.592 . . . . 73.54 111.034 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -119.0 179.58 4.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.24 -0.891 . . . . 75.13 110.083 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.573 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 9.6 mptt -81.69 126.52 31.88 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.327 -1.36 . . . . 72.13 107.327 168.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.88 83.95 6.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.055 0.455 . . . . 70.41 111.505 -174.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.552 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.6 pt? -84.04 140.79 31.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.88 -0.6 . . . . 72.43 109.444 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 46.4 t -50.15 142.14 10.17 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.423 0.452 . . . . 74.11 111.179 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.754 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.5 pttp -62.09 -20.05 63.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.188 -0.46 . . . . 75.01 111.29 -178.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -54.31 14.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.886 -0.783 . . . . 61.52 108.886 174.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.9 -32.15 72.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.747 -0.66 . . . . 75.31 111.564 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.754 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 21.7 ptm . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 120.779 0.323 . . . . 75.42 110.523 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.512 HG21 HG12 ' A' ' 159' ' ' VAL . 6.6 m . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 109.798 -0.445 . . . . 63.24 109.798 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.753 ' HA ' HG23 ' A' ' 159' ' ' VAL . 14.0 mtmt -118.17 22.72 12.02 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.599 0.714 . . . . 74.21 109.46 177.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.692 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 42.0 tttt -149.88 129.5 13.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.802 -1.09 . . . . 73.24 109.361 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.495 HG12 ' HB ' ' A' ' 151' ' ' VAL . 7.9 pt -106.03 163.04 4.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.0 0.429 . . . . 75.02 111.225 -177.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -109.59 118.76 37.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.526 -0.761 . . . . 75.23 109.567 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.493 HG13 HD13 ' A' ' 121' ' ' LEU . 37.3 t -102.59 103.36 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.881 0.372 . . . . 72.44 110.757 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.422 ' O ' ' HB2' ' A' ' 175' ' ' CYS . . . . . . . . 0 N--CA 1.442 -0.954 0 N-CA-C 110.898 -0.881 . . . . 55.14 110.898 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.541 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 11.5 pt-20 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.919 0.39 . . . . 62.44 111.605 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.582 ' H ' HD13 ' A' ' 136' ' ' ILE . 14.2 tt0 -53.42 -49.71 66.75 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.427 -0.806 . . . . 64.54 112.212 -174.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.446 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 0.8 OUTLIER -63.39 -31.44 72.6 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.1 -0.24 . . . . 75.42 110.678 -176.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.541 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 35.7 m80 -67.06 -56.81 8.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.476 -0.329 . . . . 73.41 110.376 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.493 HD13 HG13 ' A' ' 109' ' ' VAL . 0.5 OUTLIER -61.05 -49.55 76.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.48 . . . . 75.45 110.928 -178.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.494 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 1.5 tpp180 -58.08 -45.32 87.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.273 -0.422 . . . . 75.44 111.197 -177.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -56.61 -37.11 70.22 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.096 0.474 . . . . 74.34 111.44 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -84.96 -39.85 17.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.271 -0.422 . . . . 75.25 111.257 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -86.69 -17.5 33.57 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.47 0.545 . . . . 74.4 112.47 -172.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -21.7 65.58 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.334 0.588 . . . . 72.34 110.697 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -70.22 -24.82 63.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.336 -0.847 . . . . 72.02 110.406 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.438 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 31.0 m-85 -83.46 -32.06 26.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.951 -0.568 . . . . 74.3 110.139 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.7 177.78 43.17 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.162 -0.775 . . . . 73.43 111.162 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -67.25 133.88 50.55 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.656 0.741 . . . . 73.1 110.478 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 122' ' ' ARG . 46.6 mt -100.24 141.92 16.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 115.288 -0.869 . . . . 64.4 110.446 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -78.46 -70.63 0.48 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.081 -0.509 . . . . 70.31 110.419 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.3 m -148.08 157.04 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.456 -0.338 . . . . 61.11 110.659 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.608 ' CD1' HG11 ' A' ' 151' ' ' VAL . 12.9 mm -109.96 108.93 26.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.572 -0.899 . . . . 71.55 108.572 174.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -95.08 95.97 8.93 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.204 0.526 . . . . 74.13 110.519 -175.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.582 HD13 ' H ' ' A' ' 118' ' ' GLU . 20.6 mt -74.81 99.06 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.702 -0.851 . . . . 75.11 108.702 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 C--N 1.325 -0.485 0 CA-C-O 121.287 0.565 . . . . 65.31 110.488 -174.385 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.7 p90 . . . . . 0 C--O 1.234 0.253 0 CA-C-O 120.947 0.403 . . . . 75.43 110.924 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.05 175.16 9.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.009 -0.541 . . . . 72.34 110.366 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.692 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 85.3 m-85 -132.03 152.06 51.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.351 -0.386 . . . . 74.54 110.333 -176.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.608 HG11 ' CD1' ' A' ' 134' ' ' ILE . 44.6 t -134.91 114.61 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.076 -0.713 . . . . 63.33 109.076 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.463 ' OG1' ' HD2' ' A' ' 106' ' ' LYS . 42.5 m -98.23 132.12 44.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.929 0.395 . . . . 75.44 110.558 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.471 ' CD2' HG22 ' A' ' 159' ' ' VAL . 91.2 m-85 -112.14 155.26 24.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.075 -0.511 . . . . 74.51 110.282 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -76.53 -23.82 53.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.244 0.545 . . . . 73.55 110.536 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.418 ' O ' HG21 ' A' ' 159' ' ' VAL . 9.5 t0 -131.47 138.88 49.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.587 -0.733 . . . . 73.15 109.73 -178.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.52 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.3 p-80 -75.83 -9.91 58.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.908 0.385 . . . . 75.4 110.605 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -66.61 -48.54 69.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 74.4 110.218 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.539 ' HA ' ' HZ3' ' A' ' 161' ' ' LYS . 42.2 t -58.97 -37.16 76.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.611 . . . . 74.24 110.228 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.753 HG23 ' HA ' ' A' ' 105' ' ' LYS . 18.5 t -65.58 -36.99 78.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.451 -0.795 . . . . 71.05 111.017 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -55.45 -48.2 74.86 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.173 -0.467 . . . . 64.32 111.814 -176.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.539 ' HZ3' ' HA ' ' A' ' 158' ' ' SER . 4.0 mptt -60.19 -19.13 52.7 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.201 0.524 . . . . 74.33 111.063 -177.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.472 HG21 HD11 ' A' ' 107' ' ' ILE . 84.0 mt -99.84 -47.34 11.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.527 -0.76 . . . . 75.31 111.366 -175.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.462 HG11 HG11 ' A' ' 159' ' ' VAL . 28.9 m -71.26 -11.17 14.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.438 0.532 . . . . 74.54 112.438 -174.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.79 -24.29 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.909 0.385 . . . . 74.51 111.21 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -106.04 142.33 35.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.07 -0.514 . . . . 74.21 110.538 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.51 ' HG3' ' HG2' ' A' ' 176' ' ' GLU . 85.5 tttt -89.78 -67.3 0.85 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.005 -0.543 . . . . 64.12 111.199 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.588 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 22.8 m-85 -81.04 100.43 8.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.186 -0.461 . . . . 70.03 111.688 -177.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -101.51 153.38 19.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.944 -0.571 . . . . 74.34 109.79 174.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 23.9 m -106.38 96.23 6.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.982 0.42 . . . . 74.35 110.67 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.5 ' C ' ' H ' ' A' ' 172' ' ' GLY . 47.1 t -105.3 133.2 50.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.57 -0.53 . . . . 70.02 109.57 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.4 t30 70.48 -19.25 0.22 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.128 0.571 . . . . 71.0 111.728 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 128.52 -6.03 6.64 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.181 -0.533 . . . . 71.25 111.833 -177.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -112.62 151.18 30.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.038 0.447 . . . . 73.11 110.399 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 66.0 t30 -82.86 124.83 30.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.753 -0.658 . . . . 72.01 110.374 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 23.5 p -119.42 -171.86 2.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.955 -0.566 . . . . 74.21 110.253 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.51 ' HG2' ' HG3' ' A' ' 166' ' ' LYS . 0.9 OUTLIER -139.1 116.07 10.92 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.468 -0.567 . . . . 74.42 109.468 -176.531 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 93.4 t -116.41 140.15 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.018 -0.537 . . . . 73.53 112.062 -171.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -134.29 -178.83 5.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.69 -0.686 . . . . 74.43 109.801 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.42 ' HE3' ' CG2' ' A' ' 163' ' ' VAL . 11.9 mptt -75.01 128.43 35.54 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.267 -1.012 . . . . 74.24 108.267 168.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.405 ' HB1' ' C ' ' A' ' 107' ' ' ILE . . . -74.04 97.83 2.95 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.582 -0.447 . . . . 73.21 110.773 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.607 HD22 ' H ' ' A' ' 181' ' ' LEU . 2.7 pt? -106.6 149.18 27.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.936 -0.574 . . . . 73.13 110.204 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.5 t -49.62 139.63 12.27 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.579 0.55 . . . . 73.34 111.187 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.735 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 17.8 pttp -65.49 -12.7 55.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.135 0.493 . . . . 74.13 110.732 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -74.99 -52.92 9.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.857 -0.611 . . . . 72.44 109.94 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -73.38 -32.17 64.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.453 -0.794 . . . . 71.23 111.265 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.735 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.3 ptm . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.394 -0.367 . . . . 64.31 110.876 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 120.969 0.414 . . . . 73.33 110.176 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.583 ' HA ' HG23 ' A' ' 159' ' ' VAL . 15.2 mtmt -120.34 21.93 11.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.036 -0.529 . . . . 73.34 110.765 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.545 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.3 ttpt -153.89 142.49 20.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.327 -0.397 . . . . 71.55 109.944 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.543 ' CG2' HG13 ' A' ' 159' ' ' VAL . 4.0 pt -113.43 157.41 14.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.939 0.4 . . . . 70.25 110.915 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 66.7 t80 -105.61 119.89 40.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.608 -0.724 . . . . 72.13 109.932 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.0 t -101.1 108.89 24.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.796 0.331 . . . . 75.31 110.68 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.57 0 C-N-CA 121.165 -0.54 . . . . 74.2 112.331 -179.222 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.939 0.399 . . . . 64.03 111.438 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.652 ' HG3' HG13 ' A' ' 134' ' ' ILE . 15.1 tt0 -57.77 -49.87 75.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.64 -0.709 . . . . 75.23 112.429 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -33.53 69.9 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 121.046 -0.262 . . . . 65.42 110.504 -175.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -64.47 -53.36 49.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.08 -0.509 . . . . 65.35 110.552 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.474 HD12 HG12 ' A' ' 170' ' ' VAL . 9.3 mp -66.02 -49.62 67.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.727 -0.67 . . . . 75.31 111.193 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.5 -48.46 81.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.196 -0.456 . . . . 73.14 111.456 -176.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.3 -30.5 69.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.126 0.489 . . . . 64.51 110.832 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.474 ' CD1' HG22 ' A' ' 170' ' ' VAL . 50.8 t80 -81.64 -46.89 13.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.914 -0.584 . . . . 74.44 111.247 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -83.55 -16.89 43.72 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.725 0.639 . . . . 75.44 112.725 -173.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -23.9 67.38 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.989 0.423 . . . . 74.04 111.233 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -67.08 -25.02 66.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.821 -0.627 . . . . 71.33 110.508 178.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.483 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 45.7 m-85 -84.07 -34.25 24.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.968 -0.56 . . . . 74.42 110.477 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.95 -170.69 43.85 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.145 -1.026 . . . . 51.35 113.133 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -72.9 120.1 18.05 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.639 0.733 . . . . 73.05 112.092 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.467 HG23 HD13 ' A' ' 134' ' ' ILE . 41.1 mt -94.98 134.48 32.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.937 -1.029 . . . . 74.51 110.201 176.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.41 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 6.7 mm-40 -82.99 -67.42 0.79 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.032 -0.531 . . . . 63.31 110.717 178.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.0 m -146.53 152.62 13.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 72.22 110.259 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.652 HG13 ' HG3' ' A' ' 118' ' ' GLU . 33.5 mm -105.83 112.72 40.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.616 -0.513 . . . . 74.44 109.616 176.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -93.12 94.45 8.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.07 0.462 . . . . 74.01 110.212 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.0 mt -80.99 88.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.714 -0.847 . . . . 71.05 108.714 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.8 tpp . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 121.585 0.707 . . . . 63.33 110.864 -175.974 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.8 p90 . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.669 0.271 . . . . 65.5 110.486 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.91 163.39 33.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.332 -0.395 . . . . 74.31 110.405 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.453 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 50.2 m-85 -124.41 135.56 53.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.289 -0.414 . . . . 73.14 110.212 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.6 HG13 ' CD1' ' A' ' 134' ' ' ILE . 23.7 t -108.63 109.24 27.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.852 -0.425 . . . . 73.11 109.852 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.545 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 15.3 m -87.68 125.4 34.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.391 -0.368 . . . . 71.45 110.562 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.401 ' CE1' HG12 ' A' ' 131' ' ' ILE . 90.4 m-85 -109.84 154.41 23.06 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.703 -0.48 . . . . 74.14 109.703 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.41 ' HB2' ' HG2' ' A' ' 132' ' ' GLU . 23.9 t70 -77.57 -22.27 51.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.599 0.714 . . . . 61.13 110.213 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' ' 157' ' ' ASP . 25.7 t70 -123.31 135.09 54.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.113 -0.949 . . . . 64.02 111.236 -171.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.52 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.4 p-80 -84.2 0.19 49.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 74.33 112.006 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.429 ' HB2' ' OD2' ' A' ' 155' ' ' ASP . 54.3 m-20 -98.08 -29.25 13.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.97 -0.752 . . . . 71.03 108.97 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.418 ' HA ' ' HE3' ' A' ' 161' ' ' LYS . 42.4 t -58.8 -32.8 69.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.551 -0.749 . . . . 64.44 109.704 170.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.583 HG23 ' HA ' ' A' ' 105' ' ' LYS . 21.7 t -74.18 -29.77 25.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.355 -0.838 . . . . 64.21 110.434 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.03 -47.74 84.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 74.31 111.726 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.483 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -60.89 -18.65 57.59 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.324 0.583 . . . . 74.02 110.906 -178.313 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.529 HG23 HD13 ' A' ' 107' ' ' ILE . 80.5 mt -95.76 -52.33 9.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.451 -0.795 . . . . 72.13 111.158 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.538 ' HB ' ' HE3' ' A' ' 179' ' ' LYS . 26.4 m -74.77 -10.75 13.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.715 0.635 . . . . 74.34 112.715 -173.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.4 pp -68.61 -32.92 57.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.836 0.35 . . . . 74.15 111.052 176.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.467 ' N ' HD12 ' A' ' 164' ' ' ILE . 13.7 pt20 -107.51 -174.35 2.51 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.337 -0.616 . . . . 74.33 109.337 176.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.62 ' HE3' ' OE1' ' A' ' 176' ' ' GLU . 82.5 tttt -123.52 -56.52 1.69 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.933 0.397 . . . . 73.25 111.063 -174.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.582 ' HB3' ' OD1' ' A' ' 174' ' ' ASN . 21.8 m-30 -79.93 113.0 17.77 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.93 -0.577 . . . . 75.24 111.62 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -116.66 143.75 45.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.575 -0.739 . . . . 72.15 110.555 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 76.3 m -95.7 101.53 13.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.042 0.448 . . . . 71.03 111.202 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.474 HG12 HD12 ' A' ' 121' ' ' LEU . 42.4 t -118.62 127.96 75.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.285 -0.635 . . . . 75.22 109.285 177.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 58.5 t30 63.21 21.65 12.95 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.83 0.824 . . . . 73.4 110.112 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.58 -1.27 88.97 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.656 -0.702 . . . . 74.41 112.684 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -103.26 145.56 29.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.919 0.39 . . . . 75.32 110.541 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.582 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 64.5 t30 -88.87 106.58 18.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.907 -0.588 . . . . 73.15 110.072 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 12.0 p -116.55 159.86 21.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.088 -0.506 . . . . 65.35 110.993 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.62 ' OE1' ' HE3' ' A' ' 166' ' ' LYS . 14.5 tt0 -95.47 130.88 42.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.101 -0.5 . . . . 71.41 109.915 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 3.0 m -118.88 142.97 31.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.126 0.488 . . . . 72.44 110.135 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -130.53 177.68 7.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.157 -0.474 . . . . 72.33 110.199 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.538 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 10.1 mptt -75.79 120.01 20.57 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.908 -1.145 . . . . 73.31 107.908 171.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.406 ' HB1' ' C ' ' A' ' 107' ' ' ILE . . . -74.23 93.09 2.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.139 0.495 . . . . 74.2 111.66 -176.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.653 HD22 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -95.94 144.59 26.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.755 -0.657 . . . . 75.44 109.655 175.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.508 ' HB3' ' HG3' ' A' ' 185' ' ' GLU . 30.6 t -50.28 143.34 8.74 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.405 0.44 . . . . 72.32 111.593 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -60.23 -23.54 64.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.762 -0.654 . . . . 73.31 110.182 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -73.76 -42.88 60.44 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.656 -0.702 . . . . 72.21 110.124 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.508 ' HG3' ' HB3' ' A' ' 182' ' ' SER . 37.9 mt-10 -78.85 -32.48 46.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.654 -0.703 . . . . 73.41 111.295 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 18.7 ptm . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.326 -0.397 . . . . 72.24 110.666 -177.351 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.442 HG11 HG12 ' A' ' 159' ' ' VAL . 14.6 p . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 120.84 0.352 . . . . 63.42 111.266 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.734 ' HA ' HG21 ' A' ' 159' ' ' VAL . 12.1 mtmt -123.07 -1.41 8.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 75.01 111.865 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.603 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 27.0 ttpt -130.45 137.42 49.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.846 0.355 . . . . 71.24 110.171 175.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.575 ' CG2' HG13 ' A' ' 159' ' ' VAL . 10.8 pt -108.36 163.97 5.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.949 0.404 . . . . 74.55 111.258 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.46 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 75.0 t80 -112.67 120.19 40.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.567 -0.742 . . . . 74.44 109.452 176.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.4 t -105.9 115.45 47.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.947 0.403 . . . . 74.34 110.919 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.746 0 N-CA-C 111.65 -0.58 . . . . 45.23 111.65 177.512 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.532 0.273 0 CA-C-O 120.931 0.396 . . . . 75.33 110.978 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.557 ' HA ' HG23 ' A' ' 134' ' ' ILE . 10.7 tt0 -57.68 -51.8 68.05 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.522 -0.763 . . . . 75.05 112.266 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.67 -33.97 76.15 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 120.921 -0.312 . . . . 72.31 110.619 -173.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -60.88 -56.19 24.07 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.281 -0.418 . . . . 63.55 110.314 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.532 HD22 HG13 ' A' ' 170' ' ' VAL . 59.2 mt -59.31 -54.75 43.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.435 -0.802 . . . . 72.54 111.191 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -55.36 -46.64 76.43 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.1 -0.5 . . . . 71.43 111.412 -177.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.65 -35.3 65.79 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.996 0.427 . . . . 73.04 111.436 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -84.31 -44.4 13.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.378 -0.374 . . . . 75.32 111.191 -178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -81.39 -16.88 50.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.387 0.514 . . . . 71.13 112.387 -172.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -24.03 67.4 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.998 0.427 . . . . 64.12 110.951 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -66.76 -28.29 68.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.832 -0.622 . . . . 73.04 110.234 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.434 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 69.3 m-85 -80.78 -34.58 34.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.642 -0.708 . . . . 73.45 110.948 -177.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 171.7 -164.28 36.98 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.964 -1.112 . . . . 75.43 113.118 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -75.85 118.7 18.92 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.512 0.673 . . . . 72.03 111.959 -176.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.458 HG12 ' CE1' ' A' ' 153' ' ' PHE . 36.2 mt -95.22 139.96 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.19 -0.914 . . . . 54.22 110.355 177.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 9.0 mm-40 -84.61 -76.28 0.31 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.132 -0.485 . . . . 74.33 110.011 176.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.02 158.36 26.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.008 -0.542 . . . . 74.33 110.136 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.589 ' CD1' HG13 ' A' ' 151' ' ' VAL . 23.4 mm -107.35 112.46 40.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.139 -0.689 . . . . 75.52 109.139 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -97.58 92.02 5.71 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.348 0.594 . . . . 72.34 110.68 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.7 mt -73.66 128.54 36.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.324 -0.991 . . . . 75.43 108.324 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.636 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.489 0 N-CA-C 109.265 -0.643 . . . . 61.45 109.265 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.636 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 42.4 p90 . . . . . 0 C--O 1.234 0.282 0 CA-C-O 120.865 0.364 . . . . 74.44 110.773 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.449 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -149.14 165.33 32.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.415 -0.357 . . . . 74.32 110.99 -177.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.46 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 53.7 m-85 -124.04 143.2 50.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 71.41 109.934 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.589 HG13 ' CD1' ' A' ' 134' ' ' ILE . 44.1 t -117.56 112.54 39.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.875 -0.417 . . . . 75.54 109.875 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.603 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 16.6 m -89.83 125.08 35.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.226 -0.443 . . . . 74.04 110.434 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.474 ' CD2' HG23 ' A' ' 159' ' ' VAL . 88.3 m-85 -108.63 152.24 25.06 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.432 -0.581 . . . . 73.53 109.432 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.436 ' HB2' ' HG2' ' A' ' 132' ' ' GLU . 28.4 t70 -81.3 -18.93 44.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.113 0.959 . . . . 54.12 109.07 176.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.522 ' OD2' ' HB3' ' A' ' 157' ' ' ASP . 26.0 t70 -116.05 126.16 53.41 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.227 -1.351 . . . . 74.43 110.548 -175.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.541 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.6 p-80 -78.81 -8.49 58.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.222 -0.445 . . . . 71.33 111.363 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.522 ' HB3' ' OD2' ' A' ' 155' ' ' ASP . 18.5 t70 -89.03 -36.26 15.9 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.308 -0.627 . . . . 74.23 109.308 -176.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.0 t -54.44 -40.79 68.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.315 -0.857 . . . . 52.11 109.713 168.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.734 HG21 ' HA ' ' A' ' 105' ' ' LYS . 11.3 t -67.75 -33.96 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.516 -0.766 . . . . 74.44 110.443 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -64.25 -28.85 70.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 73.42 110.752 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.434 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 20.9 mmtp -70.07 -24.36 63.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.621 0.724 . . . . 74.15 109.893 177.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.469 HG23 ' CE1' ' A' ' 168' ' ' HIS . 87.3 mt -99.71 -48.4 11.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.009 -0.996 . . . . 65.54 111.917 -169.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.488 HG12 HG11 ' A' ' 159' ' ' VAL . 31.6 m -73.05 -7.76 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 112.769 0.655 . . . . 73.43 112.769 -173.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.514 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.3 pp -78.45 -33.81 17.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.911 -0.316 . . . . 74.24 111.479 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.514 ' N ' HD12 ' A' ' 164' ' ' ILE . 12.8 pt20 -108.47 171.34 7.47 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.493 -0.558 . . . . 70.2 109.493 176.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.524 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 86.3 tttt -111.61 -59.38 1.99 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.831 0.348 . . . . 72.14 111.181 -174.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.587 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 19.8 m-30 -77.32 99.16 5.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.272 0.558 . . . . 63.54 112.042 -176.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.469 ' CE1' HG23 ' A' ' 162' ' ' ILE . 49.0 m-70 -98.61 159.19 15.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.551 -0.75 . . . . 74.11 110.009 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.9 m -104.67 83.77 2.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.927 0.394 . . . . 74.33 110.956 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.532 HG13 HD22 ' A' ' 121' ' ' LEU . 21.9 t -106.93 131.85 55.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.952 -0.388 . . . . 74.51 109.952 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.505 ' HB3' ' HD2' ' A' ' 173' ' ' HIS . 31.1 t-20 67.07 13.52 9.48 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.756 0.789 . . . . 73.11 109.776 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.05 17.69 71.53 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.758 -0.656 . . . . 74.01 112.072 -177.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . 0.505 ' HD2' ' HB3' ' A' ' 171' ' ' ASN . 86.9 m-70 -117.28 160.25 21.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.074 0.464 . . . . 72.55 110.553 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -87.2 105.98 17.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.703 -0.68 . . . . 71.41 109.449 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 66.8 m -114.15 158.43 21.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.151 -0.477 . . . . 75.34 111.02 -175.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.524 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 9.5 tt0 -103.16 125.74 50.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.15 -0.477 . . . . 74.33 110.152 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.409 HG13 ' CG2' ' A' ' 162' ' ' ILE . 78.5 t -123.06 135.16 64.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.308 0.575 . . . . 73.24 110.896 177.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 -139.9 165.56 26.99 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.346 -0.843 . . . . 71.42 108.993 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.421 ' HB2' HG13 ' A' ' 104' ' ' VAL . 11.5 ptmm? -72.04 126.21 29.19 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.544 -0.462 . . . . 75.1 110.038 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -72.3 129.29 38.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.859 -0.61 . . . . 70.13 111.239 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.71 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.5 pt? -124.7 143.96 50.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.437 -0.801 . . . . 75.54 109.025 174.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 m -49.3 137.91 13.59 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.445 0.466 . . . . 70.25 111.246 -177.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.843 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.1 pttp -61.84 -25.63 67.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.17 0.51 . . . . 72.23 110.094 178.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -59.06 -41.48 88.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.34 -0.846 . . . . 73.11 110.762 172.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -93.11 -35.89 12.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.58 -0.736 . . . . 74.03 111.38 -172.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.843 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 23.9 ptm . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 120.753 0.311 . . . . 74.21 110.385 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.474 ' O ' HG22 ' A' ' 159' ' ' VAL . 4.1 p . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 110.323 -0.251 . . . . 65.31 110.323 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.525 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 2.5 mtmt -122.24 16.81 10.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.389 0.614 . . . . 74.43 110.547 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.556 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 24.8 ttpt -152.78 136.52 16.15 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.339 -0.846 . . . . 62.44 109.742 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.517 HG12 ' HB ' ' A' ' 151' ' ' VAL . 9.1 pt -103.93 162.7 4.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.904 0.383 . . . . 73.43 110.732 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.463 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 59.7 t80 -110.63 110.63 21.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.762 -0.653 . . . . 74.11 110.363 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.1 t -98.25 91.86 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.132 -0.692 . . . . 74.55 109.132 176.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 C-N-CA 120.669 -0.777 . . . . 52.13 112.928 -174.659 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.215 0.531 . . . . 74.53 112.143 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.579 ' HA ' HG22 ' A' ' 134' ' ' ILE . 21.1 tt0 -58.13 -48.73 79.34 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.881 -1.054 . . . . 74.04 111.926 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -34.94 75.19 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.089 -0.244 . . . . 72.03 110.554 -177.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -64.4 -57.31 9.65 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.085 0.469 . . . . 75.44 110.453 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.549 HD22 HG11 ' A' ' 170' ' ' VAL . 79.4 mt -59.93 -52.4 65.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.306 -0.861 . . . . 72.32 110.848 -176.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.52 -44.09 93.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.007 -0.542 . . . . 74.44 111.419 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -63.16 -22.75 67.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.042 0.448 . . . . 73.51 110.938 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.408 ' CD1' HG22 ' A' ' 170' ' ' VAL . 85.9 t80 -89.83 -51.78 5.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.251 -0.432 . . . . 74.04 110.85 176.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.404 ' HA ' ' HD2' ' A' ' 128' ' ' TYR . 52.2 m-85 -74.49 -14.7 60.86 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.38 0.511 . . . . 74.34 112.38 -172.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -22.34 65.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.837 0.31 . . . . 74.25 111.837 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -74.66 -21.82 59.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 71.24 110.582 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.452 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 86.6 m-85 -86.04 -21.79 27.56 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.501 -0.318 . . . . 73.44 110.279 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 163.18 -167.69 37.6 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 119.822 -1.18 . . . . 44.51 113.373 174.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.529 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 37.7 tptt -75.74 117.09 17.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.633 0.73 . . . . 72.25 111.09 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.484 HG22 HD12 ' A' ' 134' ' ' ILE . 40.1 mt -93.69 133.78 33.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.023 -0.989 . . . . 73.42 110.557 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -82.2 -75.17 0.31 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.925 -0.58 . . . . 74.44 110.765 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.54 155.57 36.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.797 -0.446 . . . . 75.31 109.797 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.626 ' CD1' HG12 ' A' ' 151' ' ' VAL . 27.8 mm -113.01 123.08 68.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.493 -0.558 . . . . 74.13 109.493 173.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.3 96.13 6.31 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.017 0.437 . . . . 72.1 110.644 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.54 HD12 ' H ' ' A' ' 118' ' ' GLU . 7.9 mt -80.19 120.46 31.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.036 -1.098 . . . . 73.21 108.036 173.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.579 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 76.1 mmm . . . . . 0 CA--C 1.509 -0.615 0 C-N-CA 119.926 -0.71 . . . . 75.23 109.964 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.579 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 24.5 p90 . . . . . 0 C--O 1.235 0.298 0 CA-C-O 121.071 0.463 . . . . 73.23 111.853 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.53 165.52 27.34 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.173 -0.467 . . . . 74.21 110.938 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.54 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 69.1 m-85 -123.73 142.34 51.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.1 -0.5 . . . . 74.23 110.317 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.626 HG12 ' CD1' ' A' ' 134' ' ' ILE . 55.6 t -116.42 108.49 25.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.04 -0.527 . . . . 74.42 109.784 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.556 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 8.7 m -86.35 127.61 34.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.142 -0.481 . . . . 74.03 110.475 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.531 ' CD2' HG13 ' A' ' 159' ' ' VAL . 96.4 m-85 -110.47 153.5 24.96 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.936 0.398 . . . . 74.42 110.555 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.529 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 19.4 t70 -76.69 -15.26 59.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.905 -0.589 . . . . 71.22 110.606 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -136.15 139.85 43.2 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.809 -0.632 . . . . 72.34 110.609 -174.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.525 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.4 p-80 -83.99 -0.29 51.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.979 0.418 . . . . 70.51 111.018 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -80.44 -40.97 25.32 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.417 0.627 . . . . 74.11 109.48 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.696 ' HA ' ' HZ3' ' A' ' 161' ' ' LYS . 1.4 m -61.17 -33.64 73.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.121 -0.945 . . . . 75.31 111.538 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.531 HG13 ' CD2' ' A' ' 153' ' ' PHE . 15.3 m -72.85 -27.92 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 74.0 111.396 -177.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . 0.479 ' HA ' HG23 ' A' ' 163' ' ' VAL . 35.6 t70 -65.53 -42.12 92.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.608 -0.269 . . . . 61.21 110.993 -173.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.696 ' HZ3' ' HA ' ' A' ' 158' ' ' SER . 4.9 mttt -58.86 -22.33 58.9 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.196 0.522 . . . . 71.52 110.807 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.472 HG23 HD11 ' A' ' 107' ' ' ILE . 79.6 mt -92.86 -49.37 12.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.397 -0.82 . . . . 51.5 110.939 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 179' ' ' LYS . 30.3 m -77.83 -7.73 10.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.898 0.703 . . . . 75.33 112.898 -174.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -72.84 -28.87 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.967 0.413 . . . . 75.43 110.561 174.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.42 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 11.9 pt20 -108.06 -171.17 1.81 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.172 -0.677 . . . . 74.43 109.172 172.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -130.3 -61.85 0.96 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.781 -0.368 . . . . 63.33 111.537 -174.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -82.6 115.51 21.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.949 0.404 . . . . 72.22 110.721 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.434 ' CE1' HG21 ' A' ' 162' ' ' ILE . 21.3 m-70 -110.15 140.04 44.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.702 -0.681 . . . . 72.04 110.655 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 34.3 m -88.85 87.72 7.34 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.047 -0.524 . . . . 71.53 110.354 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.549 HG11 HD22 ' A' ' 121' ' ' LEU . 33.0 t -106.07 131.07 56.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.597 -0.52 . . . . 74.25 109.597 178.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 63.46 20.83 12.47 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.879 0.847 . . . . 74.23 109.546 -177.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.08 -5.74 70.24 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.383 -0.826 . . . . 71.53 112.191 -176.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -96.46 151.24 19.75 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.207 -0.294 . . . . 73.41 110.207 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -86.78 99.49 11.83 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.008 -0.367 . . . . 71.41 110.008 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 58.5 m -110.46 128.85 55.8 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.363 -0.38 . . . . 72.44 110.979 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -76.72 123.52 26.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.173 -0.467 . . . . 74.14 110.534 178.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 1.1 m -119.31 151.75 21.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.185 -0.461 . . . . 72.12 110.354 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -138.23 -173.92 3.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.716 -0.846 . . . . 74.43 108.716 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.537 ' HB3' HG13 ' A' ' 163' ' ' VAL . 19.4 ptmt -91.07 132.88 35.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.253 -0.647 . . . . 75.22 109.253 170.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -82.15 114.36 20.62 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.101 0.408 . . . . 73.54 112.101 -173.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.574 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.6 pt? -102.66 144.62 30.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.076 -0.713 . . . . 72.01 109.076 173.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 m -52.86 133.13 37.7 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.312 0.383 . . . . 61.33 111.252 -176.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.741 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 39.0 pttt -62.35 -30.25 71.04 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 109.828 -0.434 . . . . 75.31 109.828 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -59.99 -41.26 91.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.517 -0.765 . . . . 65.31 110.358 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -85.26 -39.16 18.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.645 -0.707 . . . . 75.01 111.257 -175.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.741 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 25.3 ptm . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 73.53 110.49 -178.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.4 t . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.391 0.138 . . . . 73.13 111.266 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.711 ' HA ' HG22 ' A' ' 159' ' ' VAL . 24.1 mtmt 69.45 12.27 8.22 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.163 -0.472 . . . . 74.1 112.206 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.561 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 27.9 ttpt -157.23 133.91 10.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.593 -0.521 . . . . 64.33 109.593 173.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.495 HD13 HG23 ' A' ' 162' ' ' ILE . 4.7 pt -108.42 158.49 8.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.106 0.479 . . . . 75.11 111.023 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 69.4 t80 -105.3 121.11 43.19 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.246 -0.888 . . . . 72.42 109.899 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . 0.406 HG13 HD13 ' A' ' 121' ' ' LEU . 41.9 t -108.43 111.56 36.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.44 -0.345 . . . . 74.22 110.405 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 121.02 -0.61 . . . . 51.45 112.241 -178.925 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.414 ' O ' HD23 ' A' ' 121' ' ' LEU . 10.9 pt-20 . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 120.46 0.171 . . . . 61.55 110.812 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.539 ' HG3' ' CG1' ' A' ' 134' ' ' ILE . 15.9 tt0 -49.47 -52.43 29.22 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.028 -0.533 . . . . 75.24 112.056 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.49 -29.29 70.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.525 -0.307 . . . . 74.23 110.663 -174.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -69.42 -56.46 7.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.533 -0.303 . . . . 64.54 110.918 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -57.19 -49.07 77.15 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.969 0.414 . . . . 71.43 109.951 177.47 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 122' ' ' ARG . 0.7 OUTLIER -55.03 -49.94 70.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.725 -0.671 . . . . 74.25 111.03 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -53.29 -32.71 50.04 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.169 0.509 . . . . 73.4 111.8 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -89.88 -39.09 13.27 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.077 -0.511 . . . . 74.35 111.578 -177.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.446 ' CD1' HG23 ' A' ' 151' ' ' VAL . 56.4 m-85 -89.14 -14.35 36.37 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.358 0.503 . . . . 71.04 112.358 -173.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -20.47 66.16 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.413 0.625 . . . . 72.32 110.013 176.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -71.58 -23.64 61.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.996 -1.002 . . . . 75.1 110.755 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -87.17 -32.64 19.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.086 -0.506 . . . . 75.42 111.099 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.33 -152.35 16.69 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.829 -1.177 . . . . 73.51 113.7 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.436 ' HA ' ' HE3' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -87.97 113.95 24.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.421 0.629 . . . . 73.44 111.547 -175.656 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.3 mt -94.24 138.25 21.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.041 -0.982 . . . . 72.44 110.187 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -78.04 -74.58 0.26 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.483 -0.562 . . . . 72.53 109.483 172.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.6 m -146.57 165.48 7.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.917 -0.583 . . . . 74.14 109.816 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.594 ' CD1' HG12 ' A' ' 151' ' ' VAL . 19.6 mm -109.59 109.45 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.274 -0.639 . . . . 73.45 109.274 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -88.14 98.57 11.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.312 0.577 . . . . 63.12 110.231 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.514 HD13 ' H ' ' A' ' 118' ' ' GLU . 35.8 mt -78.48 116.26 21.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.637 -0.71 . . . . 74.51 109.571 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.756 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.585 0 CA-C-O 121.078 0.466 . . . . 70.43 109.809 -178.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.756 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 21.4 p90 . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 120.849 0.357 . . . . 71.42 110.477 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.49 174.23 10.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.757 -0.656 . . . . 72.1 110.069 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.517 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 82.2 m-85 -133.33 139.55 46.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.914 0.387 . . . . 74.34 110.095 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.594 HG12 ' CD1' ' A' ' 134' ' ' ILE . 26.3 t -114.02 106.61 21.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.598 -0.519 . . . . 73.25 109.598 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.561 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 17.7 m -85.28 124.11 31.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.23 -0.441 . . . . 74.1 110.313 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.438 ' CD2' HG21 ' A' ' 159' ' ' VAL . 97.5 m-85 -107.91 145.09 34.24 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.833 -0.432 . . . . 74.42 109.833 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -74.87 -21.32 59.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.688 0.756 . . . . 72.04 109.486 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.487 ' OD1' ' HB3' ' A' ' 157' ' ' ASP . 18.7 t70 -118.99 128.52 54.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.801 -1.09 . . . . 71.41 110.871 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.548 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 3.2 p-80 -76.23 -9.59 58.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.996 -0.547 . . . . 64.3 111.268 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.487 ' HB3' ' OD1' ' A' ' 155' ' ' ASP . 32.8 t70 -85.3 -39.84 17.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.207 0.527 . . . . 60.45 109.642 -176.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.4 t -57.68 -34.6 69.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.627 -0.715 . . . . 61.22 110.526 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.711 HG22 ' HA ' ' A' ' 105' ' ' LYS . 16.9 t -66.84 -35.54 74.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.004 -0.544 . . . . 73.43 110.134 178.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.12 -31.7 72.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.525 -0.761 . . . . 74.23 111.362 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 35.3 mmtt -71.36 -19.48 62.28 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.306 0.574 . . . . 71.32 110.184 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.495 HG23 HD13 ' A' ' 107' ' ' ILE . 86.8 mt -102.22 -48.88 10.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.262 -0.881 . . . . 74.33 111.433 -171.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.536 ' HB ' ' HG3' ' A' ' 179' ' ' LYS . 33.6 m -67.85 -19.25 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.216 0.451 . . . . 73.23 112.216 -174.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.4 pp -69.34 -25.44 29.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.096 0.474 . . . . 71.51 110.774 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.549 ' HB3' ' NE2' ' A' ' 168' ' ' HIS . 21.9 tt0 -106.96 159.62 16.14 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.414 -0.812 . . . . 73.34 109.114 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.527 ' HE2' ' CE2' ' A' ' 167' ' ' TYR . 80.6 tttt -109.66 -64.3 1.27 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.87 0.367 . . . . 75.43 110.762 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.527 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 22.9 m-85 -77.03 113.17 14.45 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.049 0.452 . . . . 73.33 110.829 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.549 ' NE2' ' HB3' ' A' ' 165' ' ' GLN . 36.0 m-70 -121.7 132.53 54.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.549 -0.75 . . . . 71.02 110.019 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 174' ' ' ASN . 55.2 m -90.45 102.56 15.29 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.062 0.458 . . . . 74.22 110.951 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.21 136.58 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.899 -0.591 . . . . 72.24 109.881 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 59.29 25.5 14.14 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.511 0.672 . . . . 70.25 110.718 -175.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 77.57 7.61 87.16 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.766 -0.73 . . . . 61.31 112.555 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -116.02 123.62 48.43 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.718 -0.475 . . . . 71.34 109.718 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 169' ' ' THR . 64.1 t30 -74.73 102.63 4.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.214 -0.448 . . . . 70.22 110.071 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 35.5 m -107.76 169.99 8.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.158 -0.474 . . . . 75.44 110.709 -175.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -103.0 122.22 44.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.232 -0.44 . . . . 64.35 109.948 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.0 OUTLIER -120.36 151.67 23.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.263 -0.643 . . . . 72.23 109.263 176.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -161.62 -171.67 3.03 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.835 -0.621 . . . . 73.21 109.758 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.651 ' H ' ' HD2' ' A' ' 179' ' ' LYS . 7.7 mptt -74.43 122.16 22.56 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.874 -0.417 . . . . 71.33 109.874 -177.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.427 ' HB2' ' C ' ' A' ' 107' ' ' ILE . . . -81.28 90.85 6.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.942 0.401 . . . . 75.12 111.321 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.611 HD21 ' H ' ' A' ' 181' ' ' LEU . 2.5 pt? -88.76 134.95 33.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.259 -0.645 . . . . 71.4 109.259 174.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.4 m -51.91 144.47 11.55 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.567 0.542 . . . . 75.14 111.309 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.656 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 32.1 pttt -57.71 -29.78 64.99 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.227 0.537 . . . . 62.14 110.114 177.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -58.04 -47.78 82.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.416 -0.811 . . . . 73.52 110.713 173.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -82.31 -37.66 25.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.122 -0.945 . . . . 71.43 111.275 -173.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.656 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.7 ptm . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.494 -0.321 . . . . 71.1 110.638 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . 0.41 HG11 HG13 ' A' ' 159' ' ' VAL . 12.5 p . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.74 0.305 . . . . 64.44 111.089 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.781 ' HA ' HG22 ' A' ' 159' ' ' VAL . 21.7 mtmt -122.91 6.32 9.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 65.14 111.662 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.611 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.6 ttpt -139.55 139.95 36.98 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.967 -0.383 . . . . 73.44 109.967 174.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.535 HG12 ' HB ' ' A' ' 151' ' ' VAL . 5.5 pt -109.25 160.78 7.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.94 0.4 . . . . 75.4 111.157 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.476 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 62.7 t80 -110.82 127.79 55.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.571 -0.741 . . . . 74.32 109.681 177.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 45.8 t -108.83 117.72 54.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.966 0.412 . . . . 73.13 110.855 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 111.042 -0.823 . . . . 70.44 111.042 177.196 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.517 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 10.6 pt-20 . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 112.466 0.543 . . . . 74.34 112.466 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.568 ' CG ' ' HB ' ' A' ' 134' ' ' ILE . 2.6 tm-20 -61.63 -47.44 85.37 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.536 -0.756 . . . . 75.22 111.826 -173.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.471 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.0 p80 -63.6 -33.43 75.6 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.632 -0.427 . . . . 75.3 110.573 -177.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . 0.517 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 35.6 m80 -63.75 -59.36 4.67 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.232 0.539 . . . . 73.13 111.085 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.535 HD13 HG12 ' A' ' 170' ' ' VAL . 4.5 mp -59.41 -48.14 82.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.276 -0.875 . . . . 75.45 110.938 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.439 ' HG3' HD12 ' A' ' 131' ' ' ILE . 6.2 ttp180 -63.68 -38.97 93.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.147 -0.479 . . . . 74.04 111.414 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -58.99 -31.15 68.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.088 0.471 . . . . 75.2 110.987 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.585 ' CD1' HG22 ' A' ' 170' ' ' VAL . 59.4 t80 -93.03 -48.15 6.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.897 -0.592 . . . . 71.11 111.525 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.411 ' HA ' ' HD2' ' A' ' 128' ' ' TYR . 43.6 m-85 -76.07 -11.82 60.01 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.519 0.563 . . . . 72.21 112.519 -172.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.48 -25.16 67.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.674 0.273 . . . . 75.5 111.506 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -73.9 -23.11 59.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.017 0.437 . . . . 70.0 110.65 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.411 ' HD2' ' HA ' ' A' ' 125' ' ' PHE . 91.0 m-85 -81.42 -29.14 33.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 74.13 110.561 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.419 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 168.59 -156.4 27.78 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.085 -1.055 . . . . 75.12 113.223 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.465 ' HA ' ' HE3' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -86.17 114.91 23.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.359 0.599 . . . . 73.44 110.994 -177.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.439 HD12 ' HG3' ' A' ' 122' ' ' ARG . 27.4 mt -89.14 135.01 26.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.355 -0.839 . . . . 71.22 110.068 176.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.5 ' HG3' ' N ' ' A' ' 154' ' ' ASP . 29.2 mt-10 -78.61 -69.22 0.58 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.84 -0.429 . . . . 64.42 109.84 174.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.1 m -148.56 157.27 7.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.971 -0.559 . . . . 75.41 110.085 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.604 ' CD1' HG13 ' A' ' 151' ' ' VAL . 22.9 mm -104.71 107.63 22.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.571 -0.529 . . . . 71.42 109.571 175.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -90.68 91.7 8.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.842 -0.617 . . . . 72.45 110.449 -174.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.512 HD11 ' H ' ' A' ' 118' ' ' GLU . 21.3 mt -74.94 121.51 26.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.858 -0.793 . . . . 74.41 108.858 176.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.604 ' HA ' ' HE1' ' A' ' 137' ' ' MET . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 N-CA-C 108.767 -0.827 . . . . 75.44 108.767 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.587 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 18.1 p90 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.82 0.343 . . . . 73.34 111.175 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.03 162.2 36.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.984 0.421 . . . . 74.03 111.3 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.476 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 49.6 m-85 -125.96 146.02 50.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.947 -0.57 . . . . 65.42 109.905 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.604 HG13 ' CD1' ' A' ' 134' ' ' ILE . 39.1 t -118.65 111.74 35.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 110.12 -0.326 . . . . 71.03 110.12 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.611 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 19.5 m -89.69 126.71 35.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.116 -0.493 . . . . 75.0 110.683 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.496 ' CD2' HG21 ' A' ' 159' ' ' VAL . 97.8 m-85 -110.97 145.95 37.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.435 -0.348 . . . . 72.42 110.306 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.5 ' N ' ' HG3' ' A' ' 132' ' ' GLU . 9.4 t70 -65.52 -29.93 70.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 73.11 110.747 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 159' ' ' VAL . 6.1 t70 -125.72 142.83 51.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.863 -0.608 . . . . 73.32 110.497 -174.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.457 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.4 p-80 -75.75 -16.99 60.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.098 -0.501 . . . . 74.53 110.909 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.53 -38.01 68.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.999 0.428 . . . . 73.13 109.983 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.419 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 13.6 m -64.84 -28.98 69.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.734 -0.666 . . . . 73.41 110.19 177.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.781 HG22 ' HA ' ' A' ' 105' ' ' LYS . 14.8 t -76.04 -34.67 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.444 -0.798 . . . . 75.11 110.516 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -52.18 -56.18 16.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.549 -0.75 . . . . 72.43 112.397 -176.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -9.7 29.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.753 0.311 . . . . 72.14 111.834 -176.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.422 HG21 ' CE1' ' A' ' 168' ' ' HIS . 84.4 mt -96.46 -50.11 11.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.391 -0.368 . . . . 74.43 111.019 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.463 HG13 HG12 ' A' ' 159' ' ' VAL . 34.6 m -72.13 -19.1 19.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.422 0.527 . . . . 71.43 112.422 -174.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.5 pp -68.86 -30.3 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 72.11 111.495 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.476 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 16.9 pt20 -106.06 167.78 9.57 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.613 -0.514 . . . . 72.23 109.613 175.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.516 ' HE3' ' OE1' ' A' ' 176' ' ' GLU . 83.8 tttt -109.18 -58.78 1.98 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.996 0.427 . . . . 73.55 110.662 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.633 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 21.4 m-85 -78.34 118.3 20.39 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.878 -0.601 . . . . 72.35 111.27 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.476 ' NE2' ' HG3' ' A' ' 165' ' ' GLN . 38.3 m-70 -118.07 151.54 37.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.25 -0.886 . . . . 73.23 110.046 177.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 m -93.81 84.99 4.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.991 0.424 . . . . 65.52 110.769 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.585 HG22 ' CD1' ' A' ' 124' ' ' TYR . 11.2 t -113.77 137.1 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.874 -0.417 . . . . 72.22 109.874 -178.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 57.2 t30 61.32 24.54 14.63 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.716 0.769 . . . . 61.41 109.889 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 69.47 25.0 75.91 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.573 -0.74 . . . . 73.14 112.208 -177.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -131.62 150.07 52.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.871 0.367 . . . . 64.33 110.556 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 8.9 t30 -85.1 97.66 9.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.987 -0.551 . . . . 64.22 110.047 176.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . 0.633 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 46.2 m -105.67 177.47 4.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.278 -0.419 . . . . 71.34 111.042 -176.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.516 ' OE1' ' HE3' ' A' ' 166' ' ' LYS . 12.6 tt0 -112.54 136.43 52.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.292 -0.413 . . . . 74.3 110.66 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.418 HG13 HG22 ' A' ' 162' ' ' ILE . 70.6 t -127.48 138.14 55.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.146 -0.479 . . . . 62.34 111.105 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -130.22 175.86 8.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 73.14 110.129 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.415 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 11.4 mptt -76.52 121.31 22.95 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.432 -0.951 . . . . 72.42 108.432 171.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.486 ' HB1' ' C ' ' A' ' 107' ' ' ILE . . . -79.96 100.04 7.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.105 0.479 . . . . 74.31 111.911 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.691 HD21 ' H ' ' A' ' 181' ' ' LEU . 2.2 pt? -99.29 141.18 32.4 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.822 -0.806 . . . . 74.31 108.822 172.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.529 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 51.8 m -59.64 156.15 14.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.632 0.254 . . . . 74.23 111.337 -173.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.477 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.8 pttp -65.74 -25.74 67.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.962 0.411 . . . . 71.32 110.832 -175.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -36.63 59.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.282 0.563 . . . . 55.41 110.112 175.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.529 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 48.7 mt-10 -75.95 -42.96 46.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.792 -0.64 . . . . 75.3 110.595 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.687 ' HB3' ' HG ' ' A' ' 181' ' ' LEU . 22.5 ptm . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 116.134 -0.484 . . . . 75.14 110.387 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 109.229 -0.656 . . . . 73.13 109.229 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -119.88 19.32 12.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.402 0.62 . . . . 63.31 110.677 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.586 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 6.7 ttpm? -157.88 138.91 13.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.32 -0.854 . . . . 74.22 109.603 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.52 HD13 HG23 ' A' ' 162' ' ' ILE . 15.6 pt -107.14 165.27 4.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.096 0.474 . . . . 71.21 110.873 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 38.4 t80 -114.38 116.28 28.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.524 -0.762 . . . . 73.34 109.877 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 44.8 t -105.09 111.92 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.993 -0.373 . . . . 71.5 109.993 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.851 0 C-N-CA 120.608 -0.806 . . . . 74.1 112.385 -178.653 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.44 ' CG ' ' HD2' ' A' ' 119' ' ' HIS . 11.4 pt-20 . . . . . 0 CA--C 1.534 0.342 0 N-CA-C 110.344 -0.243 . . . . 75.4 110.344 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.586 ' HG3' ' CG1' ' A' ' 134' ' ' ILE . 12.2 tt0 -54.75 -49.85 69.85 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.413 0.523 . . . . 72.33 112.413 -175.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.44 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.4 p80 -65.2 -29.07 69.85 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.794 -0.362 . . . . 73.24 110.675 -174.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -65.44 -52.59 52.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.004 0.43 . . . . 73.35 110.759 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.52 -46.87 77.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 73.33 110.423 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.74 -48.49 79.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.103 -0.498 . . . . 75.45 111.309 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.36 -31.15 67.34 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.11 0.481 . . . . 52.24 111.116 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.455 ' CD1' HG22 ' A' ' 170' ' ' VAL . 31.2 t80 -83.88 -42.1 16.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.956 -0.565 . . . . 70.22 111.337 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -88.44 -16.43 32.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.645 0.609 . . . . 71.13 112.645 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -22.2 66.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.08 0.467 . . . . 75.13 110.874 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -70.14 -26.71 64.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.752 -0.658 . . . . 74.03 110.349 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' TYR . . . . . 0.471 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 57.6 m-85 -81.64 -38.56 25.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.646 -0.706 . . . . 74.4 111.272 -176.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -174.64 -155.84 13.0 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.118 -1.039 . . . . 63.33 112.888 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -91.86 119.17 31.4 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.42 0.628 . . . . 62.4 111.179 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.469 HG12 ' CE1' ' A' ' 153' ' ' PHE . 41.3 mt -95.86 137.79 23.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.262 -0.881 . . . . 71.24 110.103 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 154' ' ' ASP . 18.0 mt-10 -84.06 -73.34 0.42 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.334 -0.394 . . . . 75.03 110.533 174.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.1 m -143.29 163.25 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.082 -0.508 . . . . 74.34 110.072 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.586 ' CG1' ' HG3' ' A' ' 118' ' ' GLU . 26.7 mm -111.68 108.67 26.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.101 0.477 . . . . 75.11 109.843 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 30.5 mm-40 -84.69 91.43 7.93 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.608 -0.723 . . . . 70.05 110.466 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.541 HD11 ' CB ' ' A' ' 118' ' ' GLU . 16.9 mt -81.79 108.18 14.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.999 -0.741 . . . . 74.43 108.999 176.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' MET . . . . . 0.565 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.405 0 N-CA-C 108.773 -0.825 . . . . 73.55 108.773 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.565 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 11.2 p90 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 121.028 0.442 . . . . 74.52 111.627 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.35 156.85 46.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 62.22 110.734 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PHE . . . . . 0.528 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 49.2 m-85 -121.59 125.4 46.65 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.025 -0.534 . . . . 72.1 110.061 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.563 HG12 ' CD1' ' A' ' 134' ' ' ILE . 30.9 t -100.08 109.07 24.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 110.076 -0.342 . . . . 74.15 110.076 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' THR . . . . . 0.586 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 27.7 m -85.56 125.16 32.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.18 -0.464 . . . . 73.33 110.32 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.545 ' CD2' HG11 ' A' ' 159' ' ' VAL . 98.0 m-85 -109.41 149.93 28.81 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.539 -0.541 . . . . 74.1 109.539 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 132' ' ' GLU . 20.9 t70 -68.73 -26.73 65.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.033 0.444 . . . . 71.32 110.912 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -129.95 150.7 51.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.286 -0.416 . . . . 70.31 111.184 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' HIS . . . . . 0.567 ' O ' HG21 ' A' ' 159' ' ' VAL . 2.5 p-80 -83.28 -6.59 59.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.847 -0.615 . . . . 73.43 110.855 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -72.53 -40.71 66.54 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.654 -0.498 . . . . 63.33 109.654 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.7 m -63.92 -31.54 72.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.636 -0.711 . . . . 73.33 111.506 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.567 HG21 ' O ' ' A' ' 156' ' ' HIS . 5.7 m -78.03 -23.15 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 121.054 -0.258 . . . . 64.2 111.285 -175.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.79 -45.23 90.65 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 116.657 -0.247 . . . . 72.21 111.306 -173.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' LYS . . . . . 0.471 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.0 OUTLIER -62.03 -18.76 61.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.175 0.512 . . . . 72.24 110.68 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ILE . . . . . 0.52 HG23 HD13 ' A' ' 107' ' ' ILE . 72.3 mt -97.71 -54.69 6.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.618 -0.719 . . . . 75.45 111.527 -174.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.451 ' HB ' ' HG2' ' A' ' 179' ' ' LYS . 33.6 m -66.13 -19.83 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.452 0.538 . . . . 62.43 112.452 -172.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.426 HD11 ' HB2' ' A' ' 165' ' ' GLN . 2.6 pp -69.12 -24.75 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.32 0.581 . . . . 75.21 110.707 176.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLN . . . . . 0.477 ' HB3' ' NE2' ' A' ' 168' ' ' HIS . 23.0 tt0 -108.52 140.85 41.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.177 -0.919 . . . . 74.12 109.626 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.548 ' HE3' ' OE1' ' A' ' 176' ' ' GLU . 82.4 tttt -93.77 -61.69 1.5 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.794 0.33 . . . . 64.2 110.776 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -74.04 114.58 12.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.139 -0.482 . . . . 72.33 110.905 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.477 ' NE2' ' HB3' ' A' ' 165' ' ' GLN . 30.3 m-70 -120.99 162.25 20.23 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.642 -0.708 . . . . 72.42 109.257 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 11.7 m -118.09 102.27 8.89 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.468 -0.493 . . . . 75.15 111.218 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.455 HG22 ' CD1' ' A' ' 124' ' ' TYR . 47.5 t -111.51 130.0 65.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.813 -0.63 . . . . 65.54 109.508 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 62.54 23.59 14.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.609 0.718 . . . . 73.34 110.445 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 78.24 11.06 85.72 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.896 -0.669 . . . . 39.05 112.488 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -111.68 135.43 52.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.901 0.381 . . . . 71.11 110.521 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.88 114.91 13.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.922 -0.581 . . . . 75.25 110.441 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.32 169.16 13.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.964 0.411 . . . . 72.3 110.953 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.548 ' OE1' ' HE3' ' A' ' 166' ' ' LYS . 15.1 tt0 -108.85 127.37 53.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.896 -0.593 . . . . 71.02 109.548 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.6 m -117.88 144.9 24.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.391 -0.524 . . . . 73.01 110.543 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -132.75 -179.36 5.42 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.056 -0.52 . . . . 75.2 109.818 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.451 ' HG2' ' HB ' ' A' ' 163' ' ' VAL . 38.4 mtpt -81.2 119.09 23.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.964 -1.125 . . . . 74.13 107.964 170.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -70.17 95.06 0.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.902 0.382 . . . . 74.25 111.513 -175.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.568 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.5 pt? -92.98 144.96 24.74 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.368 -0.604 . . . . 73.33 109.368 175.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.423 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 7.5 m -53.83 142.54 23.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.141 -0.481 . . . . 60.22 110.96 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.67 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 18.8 pttp -59.88 -22.66 62.63 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.048 0.451 . . . . 74.24 110.524 177.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -64.26 -52.96 56.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.666 . . . . 75.24 110.275 171.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' GLU . . . . . 0.423 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 35.7 mt-10 -68.42 -41.35 80.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.38 -0.827 . . . . 63.23 111.021 -176.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' MET . . . . . 0.67 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 20.7 ptm . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.891 -0.595 . . . . 73.24 111.163 -175.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.805 -0.443 . . . . 72.15 109.805 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -105.14 -21.58 13.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.137 -0.483 . . . . 71.31 111.131 -173.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 61.72 95.26 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.254 0 O-C-N 123.686 0.616 . . . . 72.52 109.713 -169.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.451 ' HB3' HD11 ' A' ' 181' ' ' LEU . 32.2 Cg_exo -58.81 102.37 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.142 2.561 . . . . 62.3 112.625 -175.006 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.44 55.05 22.82 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.806 -0.711 . . . . 63.31 111.669 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.18 -36.16 82.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.973 0.416 . . . . 74.43 111.019 -177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -79.68 -4.87 53.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.887 -0.597 . . . . 72.41 110.712 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.5 mt -101.68 144.88 29.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.99 -0.55 . . . . 75.43 110.49 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.8 p -84.01 126.63 33.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.266 -0.424 . . . . 73.34 110.178 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.454 ' O ' HG22 ' A' ' 159' ' ' VAL . 9.1 p -118.64 155.01 20.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.881 -0.414 . . . . 74.34 109.881 -177.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -128.56 18.69 6.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.168 0.509 . . . . 75.24 111.291 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.57 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 23.6 ttpt -151.15 131.69 13.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.814 -0.63 . . . . 75.3 109.608 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.486 HG13 ' HB ' ' A' ' 151' ' ' VAL . 2.1 pp -106.43 153.55 7.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.21 -0.45 . . . . 72.12 110.397 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.515 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 81.9 t80 -103.25 130.53 50.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.978 -0.555 . . . . 74.13 110.276 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.7 t -111.09 110.17 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.294 -0.412 . . . . 72.34 110.436 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -121.72 165.22 14.67 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.205 -0.758 . . . . 61.15 111.205 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.513 ' H ' " C5'" ' B' ' 2' ' ' ' C' . . . 81.31 10.37 84.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.747 -0.739 . . . . 62.01 112.786 178.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.626 HG13 " H5'" ' B' ' 1' ' ' ' U' . 16.9 pt -71.11 89.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.473 0.654 . . . . 75.14 111.22 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -79.01 -30.15 44.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.103 -0.499 . . . . 75.53 110.08 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -83.19 151.62 25.6 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.971 -0.558 . . . . 74.33 109.901 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -68.61 90.22 0.39 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.484 0.659 . . . . 73.34 110.155 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.2 m -101.87 136.23 42.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.162 -0.926 . . . . 73.02 110.204 -177.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.418 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 8.1 pt-20 -125.79 -168.86 1.91 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.863 0.363 . . . . 71.11 110.854 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.54 ' HA ' HG23 ' A' ' 134' ' ' ILE . 13.3 tt0 -56.29 -50.25 71.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.449 -0.796 . . . . 75.03 112.41 -178.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.53 -33.65 76.41 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.877 -0.329 . . . . 74.13 110.665 -174.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.445 ' CD2' HD21 ' A' ' 171' ' ' ASN . 40.9 m80 -63.0 -53.64 50.86 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.012 0.434 . . . . 70.12 110.631 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.527 HD22 HG11 ' A' ' 170' ' ' VAL . 97.6 mt -62.25 -48.59 79.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.523 -0.762 . . . . 74.32 110.937 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -59.47 -40.88 88.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.252 -0.431 . . . . 74.3 110.985 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -59.47 -30.39 68.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.99 0.424 . . . . 72.32 111.278 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -88.92 -47.37 8.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.408 -0.36 . . . . 72.44 111.346 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -77.54 -14.63 59.62 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.308 0.484 . . . . 75.32 112.308 -172.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -65.3 -24.02 67.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.747 0.308 . . . . 75.22 111.414 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -65.24 -25.73 67.8 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.221 0.534 . . . . 74.35 110.641 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.469 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 88.5 m-85 -86.01 -37.84 18.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.675 -0.693 . . . . 64.22 111.148 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 177.44 -166.77 37.43 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.012 -1.089 . . . . 60.01 113.422 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.52 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 38.3 tptt -75.78 118.78 18.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.4 0.619 . . . . 74.24 111.464 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.46 HG23 HD13 ' A' ' 134' ' ' ILE . 34.3 mt -97.49 139.93 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.378 -0.828 . . . . 72.14 110.41 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.509 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 6.7 mm-40 -89.12 -71.2 0.61 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.317 -0.401 . . . . 52.4 111.237 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.47 157.42 27.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.645 0.259 . . . . 71.43 110.57 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.57 ' CD1' HG11 ' A' ' 151' ' ' VAL . 17.7 mm -113.02 111.64 37.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.174 -0.676 . . . . 71.11 109.174 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.541 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 22.4 mm-40 -90.27 95.0 9.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.988 -0.551 . . . . 74.33 110.786 -175.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.499 HD13 ' H ' ' A' ' 118' ' ' GLU . 11.1 mt -80.69 87.35 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.01 -1.107 . . . . 73.44 108.01 173.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.534 ' HE1' " C4'" ' B' ' 4' ' ' ' G' . 11.2 tpt -68.41 103.48 1.65 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.581 0.705 . . . . 73.31 111.252 -170.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.0 p -77.64 160.82 28.26 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.053 -0.976 . . . . 64.22 110.886 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.512 ' HA ' ' HD2' ' A' ' 146' ' ' ARG . 25.6 t70 -65.86 135.99 55.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.672 -0.695 . . . . 55.15 110.137 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.569 ' HG2' ' C6 ' ' B' ' 5' ' ' ' U' . 0.0 OUTLIER -86.26 5.48 34.2 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.786 -0.643 . . . . 74.24 111.846 -176.437 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -111.11 -57.98 0.48 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.935 -0.65 . . . . 51.45 111.786 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 t -91.31 -28.57 17.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.95 0.405 . . . . 71.01 110.957 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.61 53.63 4.26 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.405 -0.902 . . . . 71.32 111.319 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -131.7 170.47 14.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.901 -0.777 . . . . 75.21 108.901 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -69.69 103.93 2.27 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.243 -0.651 . . . . 71.21 109.243 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.512 ' HD2' ' HA ' ' A' ' 139' ' ' ASP . 52.4 ttt180 -67.46 -25.97 66.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.575 -0.739 . . . . 74.14 112.215 -168.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.93 ' HA3' " H2'" ' B' ' 1' ' ' ' U' . . . 134.19 -11.82 4.72 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.018 -1.086 . . . . 64.32 113.139 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.591 ' CE2' " H4'" ' B' ' 3' ' ' ' A' . 40.6 p90 -139.24 160.5 39.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.818 0.309 . . . . 74.3 111.004 -177.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -144.42 165.78 26.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.994 -0.548 . . . . 72.23 110.193 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.541 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 42.2 m-85 -129.64 150.67 50.86 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.947 -0.39 . . . . 61.31 109.947 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.57 HG11 ' CD1' ' A' ' 134' ' ' ILE . 59.0 t -122.9 112.38 33.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.981 -0.377 . . . . 74.12 109.981 176.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.57 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 26.1 m -88.08 127.52 35.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.027 -0.533 . . . . 74.12 110.591 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.506 ' CD2' HG13 ' A' ' 159' ' ' VAL . 92.4 m-85 -109.59 152.24 25.77 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.143 -0.317 . . . . 62.32 110.143 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.52 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 31.9 t70 -75.34 -18.31 60.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.225 0.536 . . . . 71.04 110.547 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.459 ' OD2' ' HB3' ' A' ' 157' ' ' ASP . 24.0 t70 -132.61 153.21 51.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.618 -0.719 . . . . 75.04 111.123 -177.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.4 ' O ' HG21 ' A' ' 159' ' ' VAL . 2.1 p-80 -95.53 5.03 52.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.26 -0.427 . . . . 74.11 111.883 -178.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.459 ' HB3' ' OD2' ' A' ' 155' ' ' ASP . 13.2 t70 -91.81 -37.23 13.07 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.506 -0.553 . . . . 73.12 109.506 171.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.5 m -58.6 -27.59 64.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.749 -0.66 . . . . 64.51 110.901 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.506 HG13 ' CD2' ' A' ' 153' ' ' PHE . 13.0 m -80.42 -20.99 11.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 75.34 111.367 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.35 -38.4 71.63 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.691 0.281 . . . . 71.41 110.672 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.469 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.1 mptp? -65.03 -19.22 65.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.302 0.572 . . . . 74.2 110.68 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 81.9 mt -96.78 -53.62 7.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.573 -0.739 . . . . 75.23 111.227 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.496 ' HB ' ' HG2' ' A' ' 179' ' ' LYS . 35.3 m -64.56 -20.82 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.586 0.587 . . . . 75.15 112.586 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.74 -28.41 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 74.45 111.072 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -105.16 142.19 35.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.004 -0.544 . . . . 71.32 109.655 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.444 ' CE ' ' HG3' ' A' ' 176' ' ' GLU . 87.4 tttt -87.04 -71.39 0.56 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 121.033 -0.267 . . . . 75.3 110.997 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.605 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 3.7 m-85 -79.19 116.62 19.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.207 0.527 . . . . 74.32 111.971 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -117.51 140.63 49.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.19 -0.914 . . . . 63.31 109.492 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 174' ' ' ASN . 57.4 m -92.37 109.28 20.66 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.089 0.471 . . . . 63.44 111.232 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.527 HG11 HD22 ' A' ' 121' ' ' LEU . 43.3 t -120.06 136.27 57.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.928 -0.578 . . . . 72.11 109.464 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.445 HD21 ' CD2' ' A' ' 120' ' ' HIS . 23.5 t-20 70.57 -12.84 0.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.929 0.491 . . . . 74.43 111.497 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 122.2 -3.62 10.5 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.514 -0.634 . . . . 73.05 111.514 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -112.34 138.68 48.72 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.662 -0.496 . . . . 73.35 109.662 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.445 ' HA ' ' HA ' ' A' ' 169' ' ' THR . 60.0 t30 -88.65 103.8 16.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.755 -0.461 . . . . 74.14 109.755 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 34.0 m -106.77 173.16 6.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.058 -0.519 . . . . 73.13 110.76 -174.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.444 ' HG3' ' CE ' ' A' ' 166' ' ' LYS . 9.0 tt0 -97.58 123.92 41.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.11 0.481 . . . . 74.02 110.756 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 48.4 t -118.84 131.13 72.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.926 -0.579 . . . . 75.11 110.475 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -144.34 173.38 11.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.857 -0.611 . . . . 74.54 109.842 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.496 ' HG2' ' HB ' ' A' ' 163' ' ' VAL . 31.9 mtpt -68.54 125.62 27.07 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.685 -0.487 . . . . 74.53 109.685 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.552 ' HA ' ' C2 ' ' B' ' 3' ' ' ' A' . . . -81.01 89.68 5.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.911 0.386 . . . . 62.41 111.482 -175.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.623 ' H ' HD23 ' A' ' 181' ' ' LEU . 2.3 pt? -86.4 141.99 28.76 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.875 -0.602 . . . . 75.32 109.41 175.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.476 ' HB3' ' HG3' ' A' ' 185' ' ' GLU . 30.0 t -58.0 152.7 15.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.482 -0.326 . . . . 70.4 110.804 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.551 ' CE ' " H3'" ' B' ' 4' ' ' ' G' . 22.1 pttp -60.07 -21.9 62.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.173 0.511 . . . . 72.03 110.368 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.504 ' HA ' ' C4 ' ' B' ' 6' ' ' ' U' . 0.6 OUTLIER -69.49 -49.32 55.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.542 -0.754 . . . . 73.12 109.197 174.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.476 ' HG3' ' HB3' ' A' ' 182' ' ' SER . 30.0 mt-10 -73.38 -37.97 65.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.209 -0.905 . . . . 74.11 111.138 -176.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.51 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 21.7 ptm -63.6 -23.84 67.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 71.33 111.129 -175.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -75.53 -48.26 23.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.25 0.547 . . . . 64.42 109.767 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.9 m -65.9 -45.68 81.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.483 -0.78 . . . . 52.42 110.861 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.27 -33.94 76.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 75.45 111.559 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 6.1 t -75.96 -40.23 54.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 64.43 110.194 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.9 t -66.8 -39.19 87.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.265 -0.425 . . . . 74.22 110.442 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.457 ' O ' ' HG2' ' A' ' 194' ' ' ARG . 8.6 t -92.74 24.52 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 63.23 110.594 -178.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -61.31 116.51 4.68 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.648 -0.501 . . . . 72.34 109.648 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 192' ' ' SER . 14.7 mmt180 -114.77 141.75 47.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.282 0.563 . . . . 75.2 112.196 -173.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.09 163.23 22.46 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.22 -0.9 . . . . 37.75 111.04 175.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? . . . . . 0 C--O 1.244 0.796 0 CA-C-O 118.434 -0.793 . . . . 70.23 109.524 -178.822 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 1.068 " C3'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.43 -0.654 0 O5'-C5'-C4' 111.69 1.064 . 0.0 '__' . 74.12 . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 1.068 H5'' " C3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.891 0 C4'-C3'-C2' 105.303 2.603 OUTLIER-EPSILON 0.0 OUTLIER alpha 72.12 . . . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.699 ' H8 ' H5'' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.886 0 P-O3'-C3' 122.477 2.315 . 0.0 OUTLIER epsilon-1 74.41 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.551 " H3'" ' CE ' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.427 -0.823 0 C4'-C3'-C2' 103.669 0.969 . 0.0 OUTLIER alpha 75.11 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.685 ' H6 ' ' P ' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.953 0 C4'-C3'-C2' 104.263 1.563 . 0.0 OUTLIER gamma 74.35 . . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.504 ' C4 ' ' HA ' ' A' ' 184' ' ' GLN . . . . . . . . 0 O5'--C5' 1.426 -0.876 0 C3'-C2'-C1' 100.676 -0.916 . 0.0 OUTLIER gamma 73.24 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 109.916 -0.401 . . . . 74.02 109.916 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -84.8 -38.7 19.25 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.485 -0.561 . . . . 74.32 109.485 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -123.95 96.1 43.13 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.537 -0.756 . . . . 75.21 109.03 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -84.34 37.49 0.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.225 2.616 . . . . 72.33 113.291 -169.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 158.01 60.37 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.784 -0.722 . . . . 64.12 111.668 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.86 -31.98 70.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.873 0.368 . . . . 73.02 111.021 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -88.3 8.85 25.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.564 . . . . 73.32 110.805 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.9 mt -114.77 149.87 36.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.252 -0.431 . . . . 71.43 110.732 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.5 p -93.04 117.39 30.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.059 -0.518 . . . . 74.35 110.815 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.523 HG13 ' HB3' ' A' ' 179' ' ' LYS . 11.5 p -111.71 143.31 21.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.656 -0.498 . . . . 73.23 109.656 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.469 ' HE3' ' N ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -104.49 -6.34 20.73 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.736 0.303 . . . . 73.25 111.81 -175.038 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.712 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.0 ttpt -133.99 140.73 46.91 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.86 -0.422 . . . . 74.21 109.86 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.603 ' CG2' HG13 ' A' ' 159' ' ' VAL . 4.9 pt -108.07 158.03 8.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.991 0.424 . . . . 75.42 110.973 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.445 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 46.8 t80 -107.72 121.61 45.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.469 -0.787 . . . . 73.54 109.296 177.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.7 t -105.21 102.46 13.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.864 0.364 . . . . 74.24 110.902 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.494 ' HA2' H5'' ' B' ' 2' ' ' ' C' . . . -112.37 -177.6 19.88 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.849 -0.9 . . . . 61.44 110.849 175.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.424 ' H ' ' H6 ' ' B' ' 2' ' ' ' C' . . . 61.84 34.83 90.09 Favored Glycine 0 C--O 1.226 -0.352 0 C-N-CA 120.83 -0.7 . . . . 73.14 112.631 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.583 HD12 ' O ' ' A' ' 147' ' ' GLY . 31.7 pt -102.87 -171.77 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.87 0.366 . . . . 73.11 111.319 -176.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.666 ' HG3' ' H ' ' A' ' 114' ' ' GLU . 1.1 tpmt? -91.2 177.02 6.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.166 -0.47 . . . . 54.43 109.736 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.666 ' H ' ' HG3' ' A' ' 113' ' ' LYS . 10.9 mp0 -64.52 -44.62 90.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.061 0.458 . . . . 63.33 110.531 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -104.79 100.36 9.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.89 -0.595 . . . . 75.11 110.602 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.7 m -145.6 120.87 10.22 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.092 -0.707 . . . . 73.35 109.092 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.425 ' CG ' ' HD2' ' A' ' 119' ' ' HIS . 11.5 pt-20 -120.1 -170.79 2.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.48 -0.327 . . . . 64.2 111.363 -173.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.553 ' HA ' HG21 ' A' ' 134' ' ' ILE . 10.9 tt0 -58.96 -45.46 90.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 75.14 112.242 -174.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.425 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -64.22 -30.33 71.39 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 120.491 -0.484 . . . . 74.4 110.176 -176.42 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 34.3 m80 -64.38 -56.6 13.28 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.471 -0.331 . . . . 73.22 110.529 178.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.446 HD11 HG12 ' A' ' 170' ' ' VAL . 1.7 mm? -60.32 -51.9 67.54 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.233 -0.439 . . . . 73.44 110.737 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -58.29 -53.51 57.47 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.847 -0.615 . . . . 70.3 111.439 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.73 -28.34 63.79 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.066 0.46 . . . . 73.11 111.843 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -86.24 -43.16 13.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.939 0.4 . . . . 75.12 111.299 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.416 ' CD1' HG23 ' A' ' 151' ' ' VAL . 41.8 m-85 -86.84 -15.5 38.96 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.718 0.636 . . . . 72.1 112.718 -172.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -22.22 66.23 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.342 0.591 . . . . 71.4 110.352 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -69.28 -19.11 63.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.264 -0.88 . . . . 74.25 110.479 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.422 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 66.7 m-85 -90.63 -34.8 15.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.873 -0.603 . . . . 75.3 110.819 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 174.82 -168.02 40.46 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.072 -1.061 . . . . 74.25 113.299 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -74.91 116.78 16.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.528 0.68 . . . . 70.53 111.573 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.438 HG23 HD13 ' A' ' 134' ' ' ILE . 40.8 mt -94.76 139.63 18.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.194 -0.912 . . . . 74.34 110.401 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -84.2 -73.03 0.44 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.889 -0.596 . . . . 74.21 110.67 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.6 m -141.81 152.17 18.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.352 -0.386 . . . . 74.5 110.57 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.597 ' CD1' HG11 ' A' ' 151' ' ' VAL . 31.7 mm -105.22 107.92 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.489 -0.56 . . . . 71.44 109.489 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.452 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 57.7 mt-10 -89.58 96.49 10.72 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.332 0.586 . . . . 64.45 110.611 -176.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.6 mt -80.04 128.28 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.589 -0.732 . . . . 74.41 109.497 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.557 ' HE3' " C4'" ' B' ' 4' ' ' ' G' . 22.1 tpp -78.87 102.91 8.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.352 0.596 . . . . 73.11 110.341 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.581 ' HB ' ' HA2' ' A' ' 143' ' ' GLY . 4.6 p -102.39 168.11 9.53 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.182 -0.917 . . . . 64.1 111.331 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.583 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 16.2 t70 -55.88 140.34 42.93 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.726 -0.472 . . . . 64.52 109.726 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.481 ' HD3' " H2'" ' B' ' 5' ' ' ' U' . 22.4 tpt180 -61.93 -21.2 64.56 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 123.427 0.455 . . . . 73.4 111.68 -172.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -119.36 -49.04 0.33 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.403 -0.904 . . . . 62.13 113.002 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.6 m -88.62 -11.88 44.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.059 0.392 . . . . 60.22 112.059 -172.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.581 ' HA2' ' HB ' ' A' ' 138' ' ' THR . . . 66.57 44.24 90.36 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.84 -0.695 . . . . 74.01 113.002 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.507 ' O ' ' HA ' ' A' ' 138' ' ' THR . 27.8 mtmt -96.29 144.54 26.38 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.807 -0.442 . . . . 75.55 109.807 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -59.97 108.93 0.84 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.096 0.474 . . . . 72.25 109.927 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.02 -63.31 1.39 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.569 -0.741 . . . . 74.11 110.461 -174.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.583 ' O ' HD12 ' A' ' 112' ' ' ILE . . . -170.83 -96.97 0.1 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.539 -0.839 . . . . 52.24 111.95 -175.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.566 ' HB3' " O5'" ' B' ' 2' ' ' ' C' . 41.8 p90 -65.69 164.55 14.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.187 0.517 . . . . 73.44 111.847 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.13 169.16 18.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.793 -0.64 . . . . 63.23 110.333 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.539 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 73.1 m-85 -130.84 145.01 51.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.066 -0.515 . . . . 73.44 110.297 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.597 HG11 ' CD1' ' A' ' 134' ' ' ILE . 15.8 t -120.52 108.33 22.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.738 -0.467 . . . . 63.13 109.738 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.712 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 62.7 m -88.64 123.84 33.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.527 -0.306 . . . . 75.4 110.289 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.517 ' CD2' HG22 ' A' ' 159' ' ' VAL . 90.8 m-85 -105.5 153.3 21.93 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.831 -0.433 . . . . 75.43 109.831 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -69.28 -30.81 69.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.364 0.602 . . . . 71.53 110.334 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.434 ' O ' HG21 ' A' ' 159' ' ' VAL . 5.0 t70 -122.36 145.54 48.16 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.416 -0.811 . . . . 72.23 110.185 -175.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -82.4 -13.58 56.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.291 -0.413 . . . . 71.33 110.907 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.96 -43.87 61.77 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.064 0.459 . . . . 51.43 110.506 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.6 m -63.16 -28.11 69.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.758 -0.655 . . . . 70.13 110.468 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.603 HG13 ' CG2' ' A' ' 107' ' ' ILE . 29.1 t -70.99 -36.61 64.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.722 -0.672 . . . . 75.23 110.185 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.504 ' HA ' HG23 ' A' ' 163' ' ' VAL . 21.0 t70 -59.98 -36.46 77.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.724 -0.671 . . . . 74.53 110.86 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.422 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 38.0 mmtt -60.68 -24.96 66.01 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.545 0.688 . . . . 73.13 110.222 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.509 HG23 HD13 ' A' ' 107' ' ' ILE . 86.3 mt -95.51 -50.39 11.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.142 -0.935 . . . . 71.32 111.338 -173.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.584 ' HB ' ' HG2' ' A' ' 179' ' ' LYS . 19.8 m -68.96 -17.53 22.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.469 0.544 . . . . 72.33 112.469 -173.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.2 pp -68.01 -29.92 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.013 0.375 . . . . 75.12 112.013 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -110.26 174.58 5.8 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.465 -0.568 . . . . 74.12 109.465 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.547 ' HE3' ' HG3' ' A' ' 176' ' ' GLU . 53.2 tttp -114.65 -60.95 1.82 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.75 0.309 . . . . 73.33 111.224 -173.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.537 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 11.8 m-30 -77.06 104.17 7.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.448 0.642 . . . . 73.13 111.249 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.407 ' CE1' HG21 ' A' ' 162' ' ' ILE . 9.2 m-70 -102.27 173.16 6.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.097 -0.956 . . . . 75.51 109.988 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 28.1 m -124.48 98.56 5.79 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.081 0.467 . . . . 74.42 111.076 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.446 HG12 HD11 ' A' ' 121' ' ' LEU . 58.2 t -109.52 131.8 59.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.603 -0.518 . . . . 74.34 109.603 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 63.67 14.94 8.56 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.588 0.709 . . . . 72.41 110.475 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.09 -4.64 81.34 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.851 -0.69 . . . . 62.45 112.413 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.517 ' O ' ' HA ' ' A' ' 169' ' ' THR . 39.6 m80 -98.73 157.37 16.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.814 0.34 . . . . 64.42 110.512 -177.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -84.74 118.48 24.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.059 -0.519 . . . . 74.4 109.724 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 36.8 m -118.38 173.47 6.8 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.833 -0.621 . . . . 73.12 110.305 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.547 ' HG3' ' HE3' ' A' ' 166' ' ' LYS . 1.3 tm-20 -130.24 114.68 15.96 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.571 -0.529 . . . . 63.3 109.571 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 2.3 m -113.71 147.34 17.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.202 0.525 . . . . 72.13 111.671 -171.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.457 ' NH2' ' C2 ' ' B' ' 2' ' ' ' C' . 64.6 mtt180 -134.2 172.09 13.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 73.54 110.643 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.584 ' HG2' ' HB ' ' A' ' 163' ' ' VAL . 28.6 mtpt -77.9 111.52 13.83 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.361 -0.978 . . . . 74.41 108.361 172.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.687 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -72.04 107.67 4.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.287 0.565 . . . . 64.13 112.32 -172.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.622 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.6 pt? -101.24 134.18 44.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.468 -0.787 . . . . 73.43 109.061 173.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.4 m -47.64 135.37 11.57 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.386 0.429 . . . . 72.14 111.535 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.787 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 16.2 pttp -56.93 -32.48 66.01 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.175 -0.466 . . . . 72.21 111.203 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -59.44 -34.4 72.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.888 -0.596 . . . . 75.25 110.458 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -93.0 -37.16 12.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.516 -0.766 . . . . 74.32 110.886 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.787 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 25.3 ptm -63.66 -24.3 67.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.595 -0.275 . . . . 72.45 110.822 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.59 -36.9 79.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.079 0.466 . . . . 65.42 110.269 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 16.1 m -85.55 -36.86 20.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.749 -0.659 . . . . 72.45 110.922 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -70.2 -45.25 66.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.05 -0.523 . . . . 74.33 111.786 -174.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 28.6 m -72.94 122.28 21.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.54 -0.755 . . . . 51.43 111.682 -173.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 61.7 m -89.1 175.53 7.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.989 -0.55 . . . . 62.43 110.171 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 20.0 m -83.01 57.88 4.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.117 0.484 . . . . 72.3 110.545 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.509 ' OE1' ' HD2' ' A' ' 194' ' ' ARG . 6.6 tp-100 -155.27 120.78 4.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.096 -0.502 . . . . 71.53 110.447 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.509 ' H ' ' HD2' ' A' ' 194' ' ' ARG . 0.0 OUTLIER -67.21 111.36 3.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.481 0.658 . . . . 74.32 110.181 177.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 117.17 -29.03 6.95 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.648 -0.705 . . . . 71.41 111.621 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.431 HH11 ' HD2' ' A' ' 196' ' ' ARG . 46.7 mtm180 . . . . . 0 C--O 1.252 1.215 0 CA-C-O 118.072 -0.966 . . . . 71.21 110.337 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 1.073 " H4'" " H5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.739 0 O4'-C4'-C3' 103.283 -1.584 OUTLIER-EPSILON 0.0 '__' . 71.11 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 1.073 " H5'" " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.97 0 C4'-C3'-C2' 105.571 2.871 . 0.0 OUTLIER epsilon-1 75.5 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.687 ' N1 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.426 -0.85 0 C4'-C3'-C2' 104.571 1.871 . 0.0 OUTLIER alpha 73.31 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.565 " C2'" ' HE3' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.425 -0.939 0 C3'-C2'-C1' 100.534 -1.074 . 0.0 OUTLIER alpha 73.01 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.583 ' O4 ' ' HA ' ' A' ' 139' ' ' ASP . . . . . . . . 0 O5'--C5' 1.423 -1.046 0 O4'-C1'-C2' 108.051 1.179 . 0.0 OUTLIER . 74.13 . . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.542 ' C6 ' H5'' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 C3'-C2'-C1' 104.102 2.891 . 0.0 OUTLIER . 74.45 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.3 p . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 110.107 -0.331 . . . . 71.21 110.107 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -79.07 90.86 4.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.104 0.478 . . . . 72.31 110.435 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -115.48 94.17 38.97 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.758 -0.655 . . . . 73.43 110.509 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -89.66 153.85 5.19 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.913 2.408 . . . . 64.22 112.494 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.539 ' HA2' HD11 ' A' ' 102' ' ' LEU . . . 72.19 31.55 63.78 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.919 -0.657 . . . . 53.53 112.865 177.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.95 -27.79 30.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.317 0.58 . . . . 75.44 110.904 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -97.87 20.02 12.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.519 -0.764 . . . . 74.25 110.082 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.539 HD11 ' HA2' ' A' ' 99' ' ' GLY . 44.6 mt -134.16 144.27 48.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.098 -0.501 . . . . 72.25 111.201 -174.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.6 p -84.94 101.4 12.31 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.186 -0.672 . . . . 74.41 109.186 169.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.437 HG13 ' CG ' ' A' ' 179' ' ' LYS . 13.0 p -102.32 142.8 15.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.666 -0.697 . . . . 74.2 110.439 -172.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.747 ' HA ' HG22 ' A' ' 159' ' ' VAL . 25.7 mtmt -119.29 -1.76 10.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.162 -0.472 . . . . 65.1 111.449 -177.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.613 ' HE3' ' O6 ' ' B' ' 4' ' ' ' G' . 28.6 ttpt -124.78 133.9 52.97 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.072 0.463 . . . . 74.44 109.936 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.505 HG12 ' HB ' ' A' ' 151' ' ' VAL . 10.5 pt -107.43 162.99 5.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.908 -0.587 . . . . 61.34 111.036 -178.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 55.9 t80 -113.74 119.28 36.85 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.53 -0.759 . . . . 72.15 109.884 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.3 t -109.85 106.41 20.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.147 -0.479 . . . . 72.35 109.878 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -117.78 159.9 13.96 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.901 -0.666 . . . . 75.41 112.068 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.416 ' HA2' ' P ' ' B' ' 2' ' ' ' C' . . . 83.18 20.05 61.47 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.482 -0.866 . . . . 71.24 112.287 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.578 HG23 ' SG ' ' A' ' 175' ' ' CYS . 18.6 pt -84.52 175.46 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.849 0.357 . . . . 75.2 110.302 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -93.58 162.99 13.73 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.921 -0.4 . . . . 71.24 109.921 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.2 -13.06 62.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.434 . . . . 74.21 110.405 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -77.2 -25.36 51.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 54.23 110.231 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.2 m -74.84 124.63 27.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.778 -0.646 . . . . 74.42 110.993 -175.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.439 ' CG ' ' HD2' ' A' ' 119' ' ' HIS . 12.6 pt-20 -130.84 -170.54 2.37 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.338 -0.392 . . . . 73.4 110.544 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.503 ' HA ' HG23 ' A' ' 134' ' ' ILE . 8.0 tt0 -52.52 -50.63 62.43 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.485 0.55 . . . . 71.43 112.485 -175.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.439 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 1.3 p80 -63.36 -27.23 69.17 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.15 -0.22 . . . . 75.12 110.864 -175.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.511 ' CD2' HD21 ' A' ' 171' ' ' ASN . 35.5 m80 -68.53 -50.03 55.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.829 -0.169 . . . . 74.05 110.726 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.469 HD11 HG13 ' A' ' 170' ' ' VAL . 1.2 mm? -60.4 -51.69 68.42 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.644 -0.502 . . . . 75.32 109.644 175.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -55.21 -50.37 69.58 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.542 -0.753 . . . . 74.24 111.285 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -54.35 -36.12 63.49 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.89 0.376 . . . . 65.21 112.012 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -84.64 -39.93 18.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.384 -0.371 . . . . 74.31 111.15 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.419 ' CD1' HG22 ' A' ' 151' ' ' VAL . 50.9 m-85 -87.26 -17.05 33.43 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.461 0.541 . . . . 72.2 112.461 -173.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -20.82 64.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.836 0.351 . . . . 75.1 111.923 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -77.78 -16.44 58.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.024 0.44 . . . . 72.23 110.562 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.47 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 52.9 m-85 -85.01 -41.28 15.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 73.35 110.279 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.44 ' HA3' ' HB3' ' A' ' 158' ' ' SER . . . -172.21 -170.11 35.71 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.987 -0.625 . . . . 62.3 112.151 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -79.59 122.06 26.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.384 0.612 . . . . 75.41 111.508 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.479 HG21 HD13 ' A' ' 134' ' ' ILE . 43.5 mt -95.84 138.43 21.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.33 -0.85 . . . . 64.4 110.837 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -81.37 -76.65 0.24 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.665 -0.698 . . . . 73.33 110.362 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.2 m -141.48 161.27 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 74.41 110.47 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.608 ' CD1' HG12 ' A' ' 151' ' ' VAL . 23.1 mm -116.42 122.7 70.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 110.03 -0.359 . . . . 75.23 110.03 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -104.46 121.54 43.65 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.79 -0.448 . . . . 74.35 109.79 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.7 mt -95.61 -8.43 9.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.706 0.289 . . . . 72.03 110.797 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.592 ' HE3' " C4'" ' B' ' 4' ' ' ' G' . 8.5 tpp 51.32 67.91 0.88 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 122.113 0.958 . . . . 72.13 110.208 -177.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.51 HG21 ' HA ' ' A' ' 145' ' ' LYS . 7.4 p -80.91 164.38 22.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.549 -1.205 . . . . 53.12 112.025 -174.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.579 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 16.8 t70 -49.04 139.18 10.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.609 -0.723 . . . . 71.32 110.242 173.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.566 ' HD3' ' C6 ' ' B' ' 5' ' ' ' U' . 15.7 tpt180 -71.57 -12.04 61.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.388 -0.369 . . . . 72.35 111.285 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -114.47 -57.74 0.38 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.6 -0.809 . . . . 60.14 112.979 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.533 ' CB ' ' HE3' ' A' ' 144' ' ' LYS . 5.1 m -88.64 -27.69 21.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 70.3 111.802 -171.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.18 41.91 6.07 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.492 -0.861 . . . . 54.43 112.14 -176.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.533 ' HE3' ' CB ' ' A' ' 142' ' ' SER . 27.4 mmtp -77.2 127.43 32.62 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.099 -0.704 . . . . 75.43 109.099 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.51 ' HA ' HG21 ' A' ' 138' ' ' THR . 96.3 mttt -73.82 113.9 11.49 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.064 0.459 . . . . 73.35 109.96 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.503 ' HG2' ' CE2' ' A' ' 148' ' ' PHE . 0.1 OUTLIER -70.24 170.95 10.64 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.262 -0.881 . . . . 75.31 111.877 -171.102 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.566 ' HA3' " O4'" ' B' ' 1' ' ' ' U' . . . -87.66 17.97 41.54 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.975 -0.557 . . . . 72.02 112.587 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.503 ' CE2' ' HG2' ' A' ' 146' ' ' ARG . 48.8 p90 -150.76 141.7 22.94 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.797 -0.816 . . . . 74.15 108.797 173.114 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.52 172.92 12.11 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.089 0.471 . . . . 62.04 111.141 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.411 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 58.4 m-85 -131.78 136.98 47.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.624 -0.716 . . . . 73.23 109.85 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.608 HG12 ' CD1' ' A' ' 134' ' ' ILE . 42.2 t -116.06 110.37 31.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.379 -0.373 . . . . 71.02 110.315 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.596 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 9.0 m -87.05 125.45 34.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.386 -0.37 . . . . 60.31 110.094 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.459 ' CE1' HG12 ' A' ' 131' ' ' ILE . 98.2 m-85 -105.75 150.39 25.57 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.756 0.312 . . . . 74.21 110.175 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -69.73 -22.55 63.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.033 -0.531 . . . . 63.32 111.059 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -136.77 144.86 43.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.896 -0.593 . . . . 73.52 109.711 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.507 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.5 p-80 -75.46 -12.88 60.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.881 0.372 . . . . 73.41 110.293 177.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.93 -46.36 88.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 63.22 110.18 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.44 ' HB3' ' HA3' ' A' ' 129' ' ' GLY . 11.7 m -62.87 -21.64 66.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 74.32 111.08 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.747 HG22 ' HA ' ' A' ' 105' ' ' LYS . 20.2 t -80.75 -29.77 11.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.768 -0.651 . . . . 73.21 111.138 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -36.9 85.34 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.424 -0.353 . . . . 62.21 111.869 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.47 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.5 mptp? -70.24 -16.48 63.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.265 0.555 . . . . 72.5 110.572 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.413 ' CG2' HG13 ' A' ' 177' ' ' VAL . 95.9 mt -100.54 -55.06 6.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.65 -0.705 . . . . 75.12 111.731 -172.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.536 ' HB ' ' HE3' ' A' ' 179' ' ' LYS . 28.9 m -61.07 -21.98 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.903 0.705 . . . . 70.22 112.903 -174.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.4 pp -67.27 -29.57 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.017 0.437 . . . . 63.3 111.095 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -106.23 142.65 35.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.949 -0.569 . . . . 73.52 109.722 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.525 ' HE3' ' HG3' ' A' ' 176' ' ' GLU . 79.2 tttt -92.17 -71.67 0.63 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 121.057 -0.257 . . . . 72.24 111.065 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.489 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 22.7 m-85 -78.59 108.81 12.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.132 0.491 . . . . 71.35 111.307 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -106.38 158.55 16.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 65.32 110.046 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 20.2 m -96.33 100.75 12.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.801 0.334 . . . . 71.5 110.788 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.469 HG13 HD11 ' A' ' 121' ' ' LEU . 46.9 t -116.5 132.61 65.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.622 -0.51 . . . . 71.3 109.622 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.511 HD21 ' CD2' ' A' ' 120' ' ' HIS . 28.1 t-20 63.92 20.43 12.2 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 122.056 0.931 . . . . 71.51 109.834 -177.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 73.39 19.45 79.67 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.558 -0.746 . . . . 63.41 111.624 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -125.22 149.59 47.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.768 -0.456 . . . . 74.12 109.768 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.459 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 9.9 t30 -86.19 117.3 24.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.884 0.373 . . . . 60.52 110.847 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.578 ' SG ' HG23 ' A' ' 112' ' ' ILE . 30.9 m -129.23 158.74 38.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.989 -0.55 . . . . 64.32 110.206 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.525 ' HG3' ' HE3' ' A' ' 166' ' ' LYS . 16.1 tt0 -89.98 135.17 33.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.945 0.402 . . . . 72.42 110.681 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 64.5 t -128.8 132.0 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 115.945 -0.57 . . . . 72.24 110.562 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -150.85 -177.63 6.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.525 -0.761 . . . . 72.25 109.452 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.536 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 9.2 mptt -68.47 130.32 42.54 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.859 -0.336 . . . . 72.13 110.345 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.755 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -86.33 92.85 8.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.864 0.364 . . . . 74.44 111.129 176.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.518 HD21 ' N1 ' ' B' ' 3' ' ' ' A' . 2.6 pt? -81.5 135.23 35.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.568 -0.53 . . . . 64.13 109.568 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.5 m -50.73 142.65 10.92 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.382 0.426 . . . . 75.34 111.387 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.729 ' HE3' " C2'" ' B' ' 4' ' ' ' G' . 8.3 pttp -58.78 -31.69 68.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.064 0.459 . . . . 73.4 110.306 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -65.08 -37.7 88.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.601 -0.727 . . . . 64.11 110.522 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -83.44 -37.17 23.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.551 -0.749 . . . . 62.41 111.09 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.668 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 9.3 ptp -67.5 -22.06 65.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.848 0.356 . . . . 74.13 110.247 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.96 -25.17 66.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.935 -0.575 . . . . 74.22 110.454 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.2 m -93.08 -50.74 5.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.94 -0.573 . . . . 71.41 110.495 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.51 -52.98 55.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.083 -0.508 . . . . 74.44 111.338 -175.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.1 t -91.17 83.88 5.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.062 0.458 . . . . 62.34 110.042 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 79.8 p -156.27 146.0 21.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.876 -0.602 . . . . 72.24 110.075 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 14.7 m -97.19 -63.34 1.14 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.45 -0.341 . . . . 71.21 110.456 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -138.58 116.47 11.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.352 -0.385 . . . . 72.5 110.574 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 35.5 ttm-85 -97.01 -52.57 3.81 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.307 -0.627 . . . . 73.32 109.307 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.96 -177.04 14.68 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.254 -0.884 . . . . 71.34 111.463 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.53 -0.747 . . . . 64.53 109.705 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.566 " O4'" ' HA3' ' A' ' 147' ' ' GLY . . . . . . . . 0 O5'--C5' 1.431 -0.542 0 C3'-C2'-C1' 100.512 -1.098 . 0.0 '__' . 75.45 . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.534 ' H6 ' " O5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.423 -1.088 0 C3'-C2'-C1' 103.328 2.031 . 0.0 OUTLIER . 74.33 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 1.002 " H4'" ' OP1' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -0.98 0 C3'-C2'-C1' 104.26 3.066 OUTLIER-EPSILON 0.0 OUTLIER . 74.54 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 1.002 ' OP1' " H4'" ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.908 0 C4'-C3'-C2' 106.152 3.452 . 0.0 OUTLIER epsilon-1 74.42 . . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.721 ' OP2' " H4'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.046 0 C4'-C3'-C2' 105.796 3.096 OUTLIER-DELTA 0.0 OUTLIER gamma 75.42 . . . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.477 " O5'" ' HE2' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.424 -1.003 0 C4'-C3'-C2' 104.209 1.509 . 0.0 OUTLIER . 73.01 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 110.241 -0.281 . . . . 72.42 110.241 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.589 ' HB3' ' HD3' ' A' ' 178' ' ' ARG . 9.6 mm-40 -88.81 -13.14 40.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.95 0.405 . . . . 74.31 110.692 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -113.61 78.85 3.95 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 74.23 110.195 172.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 96' ' ' GLN . 1.9 Cg_endo -83.4 -1.83 10.35 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.266 2.644 . . . . 60.22 112.632 -175.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.96 56.75 0.71 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.97 -0.633 . . . . 65.23 111.555 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.93 -30.4 63.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.874 0.369 . . . . 62.31 111.157 -177.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.1 p80 -79.41 -14.51 58.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.104 -0.498 . . . . 72.5 110.49 177.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 70.6 mt -86.88 138.28 31.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.976 -0.556 . . . . 72.31 110.367 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.4 p -82.88 96.99 8.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.169 0.509 . . . . 73.5 109.981 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.444 HG13 ' HE3' ' A' ' 179' ' ' LYS . 13.1 p -91.25 134.03 31.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.446 -0.797 . . . . 75.24 110.491 -175.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.524 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 12.2 mtmt -119.0 18.0 13.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.308 0.575 . . . . 74.12 110.776 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.558 ' HE2' ' O6 ' ' B' ' 4' ' ' ' G' . 4.8 ttpm? -146.02 132.6 19.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.532 -0.758 . . . . 74.14 109.48 177.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.532 HG12 ' HB ' ' A' ' 151' ' ' VAL . 13.3 pt -103.64 164.04 3.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.108 0.48 . . . . 71.31 111.059 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.562 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 63.5 t80 -114.07 113.65 25.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.428 -0.805 . . . . 73.34 110.009 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.5 t -104.54 97.95 6.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.114 -0.494 . . . . 74.45 110.034 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.76 142.27 16.05 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.685 -0.769 . . . . 45.34 112.566 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.76 ' N ' " H5'" ' B' ' 2' ' ' ' C' . . . 106.73 25.84 6.08 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.593 -0.813 . . . . 70.42 112.222 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.526 HG23 ' SG ' ' A' ' 175' ' ' CYS . 20.6 pt -100.59 151.17 5.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.981 0.42 . . . . 75.21 110.748 -177.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.62 -154.72 0.59 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.409 -0.589 . . . . 74.12 109.409 177.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -57.15 -23.46 47.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.055 0.455 . . . . 71.22 110.73 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.81 -43.94 77.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.257 -0.883 . . . . 71.24 112.792 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.7 m -109.64 136.32 49.19 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.569 0.581 . . . . 73.41 112.569 -167.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.48 ' O ' HD21 ' A' ' 121' ' ' LEU . 10.6 pt-20 -138.23 -168.58 2.4 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.01 -0.541 . . . . 72.12 109.893 174.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.535 ' HG3' ' HB ' ' A' ' 134' ' ' ILE . 16.4 tt0 -55.2 -50.01 70.48 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.773 0.657 . . . . 71.45 112.773 -174.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.441 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.2 p80 -63.24 -27.29 69.25 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.753 -0.379 . . . . 74.55 110.694 -176.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -70.17 -51.53 30.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.318 -0.401 . . . . 74.21 110.356 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.496 HD12 HG13 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -58.59 -49.29 78.01 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.262 -0.426 . . . . 73.34 110.286 178.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -59.01 -53.62 56.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.745 -0.662 . . . . 71.25 111.717 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -59.99 -29.17 68.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.762 0.315 . . . . 73.34 111.702 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.42 ' CD1' HG22 ' A' ' 170' ' ' VAL . 90.4 t80 -83.09 -43.42 16.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.499 -0.319 . . . . 73.55 110.966 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.426 ' CD1' HG21 ' A' ' 151' ' ' VAL . 46.0 m-85 -87.02 -15.3 39.08 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.729 0.64 . . . . 74.23 112.729 -173.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -22.12 66.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.088 0.471 . . . . 75.54 110.589 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -65.93 -31.06 71.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.761 -0.654 . . . . 70.04 110.082 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -80.85 -27.52 36.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.498 -0.773 . . . . 62.24 111.37 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.07 -166.84 39.75 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.352 -0.928 . . . . 74.31 112.689 177.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -80.68 120.45 24.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.326 0.584 . . . . 74.2 110.959 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.478 HG21 HD13 ' A' ' 134' ' ' ILE . 43.1 mt -93.28 141.38 14.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.46 -0.791 . . . . 70.43 110.572 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.9 -71.19 0.55 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.699 -0.682 . . . . 70.11 110.451 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.3 m -143.5 160.99 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.387 -0.369 . . . . 71.14 110.656 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.594 ' CD1' HG13 ' A' ' 151' ' ' VAL . 18.8 mm -116.41 128.95 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.946 0.403 . . . . 72.01 110.275 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -115.28 115.2 26.26 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.857 -0.61 . . . . 75.53 109.733 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.0 mt -84.04 -11.52 11.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.058 0.456 . . . . 75.11 110.363 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.643 ' HE1' " O4'" ' B' ' 4' ' ' ' G' . 21.4 tpp 54.87 70.41 0.63 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.325 1.059 . . . . 64.31 110.173 -174.021 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.0 p -92.27 152.55 19.76 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.513 -1.222 . . . . 72.21 109.72 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -53.71 119.38 4.86 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.092 -0.706 . . . . 72.54 109.092 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.776 ' HD2' " H3'" ' B' ' 6' ' ' ' U' . 0.0 OUTLIER -77.16 15.53 0.7 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.133 0.42 . . . . 71.44 112.133 -172.403 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -128.91 -45.44 0.19 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.104 -0.57 . . . . 53.03 111.69 173.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.431 ' HB2' ' HG2' ' A' ' 144' ' ' LYS . 32.1 m -90.01 -26.47 20.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.678 0.275 . . . . 75.21 111.522 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.91 50.88 9.88 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 121.106 -0.568 . . . . 72.01 112.414 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.431 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 12.0 ptpt -127.41 143.39 51.22 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.931 -0.396 . . . . 72.21 109.931 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.426 ' HD3' ' H ' ' A' ' 145' ' ' LYS . 3.6 mppt? -64.47 131.62 47.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.687 0.279 . . . . 75.54 110.754 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -84.38 -26.24 28.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 75.31 111.055 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.517 ' C ' " H5'" ' B' ' 1' ' ' ' U' . . . 120.11 -6.07 12.13 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.133 -1.032 . . . . 72.25 113.541 175.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.433 ' O ' ' HB3' ' A' ' 137' ' ' MET . 38.3 p90 -135.2 135.75 41.25 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 122.424 -0.457 . . . . 73.15 109.856 174.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.53 169.45 10.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.192 0.52 . . . . 72.14 111.055 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -135.49 128.89 32.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.541 -0.754 . . . . 74.54 109.574 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.594 HG13 ' CD1' ' A' ' 134' ' ' ILE . 29.7 t -108.82 110.24 31.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.755 -0.461 . . . . 74.51 109.755 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.412 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 16.4 m -86.47 125.35 33.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.451 -0.34 . . . . 75.42 110.272 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.549 ' CD2' HG13 ' A' ' 159' ' ' VAL . 97.1 m-85 -108.79 156.52 19.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.804 0.335 . . . . 73.14 110.279 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.21 -24.08 63.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.879 -0.6 . . . . 75.04 110.861 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -133.95 150.12 51.28 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.078 -0.51 . . . . 74.34 111.188 -173.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.541 ' O ' HG23 ' A' ' 159' ' ' VAL . 2.5 p-80 -88.57 -5.13 58.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.053 -0.521 . . . . 75.42 110.723 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -73.39 -42.72 61.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.16 0.505 . . . . 72.12 110.119 174.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 m -63.85 -33.13 75.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.528 -0.76 . . . . 75.12 111.428 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.549 HG13 ' CD2' ' A' ' 153' ' ' PHE . 4.7 m -72.82 -22.24 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.501 -0.318 . . . . 74.35 110.987 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.4 ' HA ' HG22 ' A' ' 163' ' ' VAL . 33.2 t70 -63.84 -44.97 91.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.4 . . . . 74.15 111.395 -174.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -8.28 31.91 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.178 0.513 . . . . 71.54 110.508 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.488 HG23 HD12 ' A' ' 107' ' ' ILE . 69.6 mt -100.83 -50.04 10.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.665 -0.698 . . . . 72.34 110.688 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.4 HG22 ' HA ' ' A' ' 160' ' ' ASP . 27.0 m -73.37 -15.43 17.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.675 -0.693 . . . . 74.22 112.77 -175.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.91 -30.05 46.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 64.52 110.979 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.412 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 15.5 pt20 -105.52 -173.37 2.28 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.684 -0.487 . . . . 72.41 109.684 173.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.497 ' HE3' ' HG3' ' A' ' 176' ' ' GLU . 46.6 tttp -127.42 -69.37 0.75 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.706 0.288 . . . . 64.43 110.56 -176.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -70.89 120.28 16.25 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.912 0.387 . . . . 73.21 110.681 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.434 ' CE1' HG21 ' A' ' 162' ' ' ILE . 28.1 m-70 -116.62 141.56 48.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.812 -0.631 . . . . 75.32 110.006 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.5 m -93.52 81.96 4.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.249 0.547 . . . . 75.24 110.585 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.496 HG13 HD12 ' A' ' 121' ' ' LEU . 22.0 t -96.33 122.15 47.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.875 -0.602 . . . . 74.44 109.744 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.9 t30 63.39 16.37 9.48 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.866 0.841 . . . . 75.43 110.248 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 87.5 -3.55 86.35 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.955 -0.641 . . . . 60.1 111.866 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -88.77 150.42 22.95 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.611 -0.514 . . . . 75.21 109.611 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -97.34 103.51 15.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.871 0.367 . . . . 75.24 110.442 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.526 ' SG ' HG23 ' A' ' 112' ' ' ILE . 31.2 m -116.74 155.08 29.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.153 -0.476 . . . . 65.14 110.436 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.497 ' HG3' ' HE3' ' A' ' 166' ' ' LYS . 11.4 tt0 -94.3 125.46 38.96 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.718 -0.475 . . . . 71.43 109.718 177.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.562 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 51.1 t -121.39 134.38 64.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.106 0.479 . . . . 74.54 111.258 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.589 ' HD3' ' HB3' ' A' ' 96' ' ' GLN . 2.3 ptt180 -146.21 -176.97 5.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.46 -0.791 . . . . 73.3 108.911 174.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.444 ' HE3' HG13 ' A' ' 104' ' ' VAL . 2.5 ptpp? -75.32 126.93 32.03 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.532 -0.467 . . . . 72.51 110.756 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.703 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -79.61 101.66 8.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.963 -0.562 . . . . 64.13 111.07 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.629 HD21 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -94.24 138.45 32.23 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.01 -0.737 . . . . 73.34 109.01 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.461 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 4.3 m -50.97 140.32 15.74 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.55 0.531 . . . . 74.32 110.773 -176.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.764 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.7 pttp -62.57 -22.63 66.5 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.876 0.369 . . . . 75.21 110.856 -177.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -66.79 -42.3 86.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.868 -0.606 . . . . 73.34 109.728 173.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.461 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 35.1 mt-10 -77.1 -38.45 52.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.757 -0.656 . . . . 71.22 110.664 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.764 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 19.8 ptm -68.23 -17.22 64.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.354 -0.385 . . . . 74.35 110.791 -177.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -67.79 -32.2 72.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.293 0.568 . . . . 65.04 109.776 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.0 t -83.16 -36.0 25.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.402 -0.817 . . . . 62.45 109.788 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.16 -38.46 91.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.564 -0.744 . . . . 72.25 111.191 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 69.3 m -76.25 112.45 12.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.262 -0.881 . . . . 73.43 111.192 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.7 m -81.78 -19.53 41.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.833 -0.621 . . . . 73.32 109.757 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 11.4 p -86.78 116.93 25.19 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.68 -0.691 . . . . 72.4 110.074 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -85.11 156.02 21.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.055 -0.52 . . . . 75.2 110.828 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -81.73 -44.45 17.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.728 -0.841 . . . . 71.5 108.728 174.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.51 -175.63 29.38 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.806 -1.088 . . . . 74.21 113.191 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? . . . . . 0 C--O 1.245 0.846 0 N-CA-C 108.29 -1.004 . . . . 75.34 108.29 175.632 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 1.057 " C4'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.732 0 C3'-C2'-C1' 99.926 -1.749 . 0.0 '__' . 73.52 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 1.057 H5'' " C4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.901 0 O4'-C4'-C3' 103.438 -1.473 . 0.0 OUTLIER '7D dist 6p' 74.24 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.703 ' N1 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.424 -1.002 0 O4'-C4'-C3' 103.481 -1.442 . 0.0 OUTLIER . 75.03 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.643 " O4'" ' HE1' ' A' ' 137' ' ' MET . . . . . . . . 0 O5'--C5' 1.423 -1.04 0 C4'-C3'-C2' 104.599 1.899 . 0.0 OUTLIER alpha 73.11 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 1.06 " H4'" " H5'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.419 -1.312 0 C3'-C2'-C1' 102.938 1.598 . 0.0 OUTLIER gamma 72.54 . . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 1.06 " H5'" " H4'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.06 0 O4'-C1'-C2' 107.908 1.077 . 0.0 OUTLIER gamma 74.13 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.476 0.871 0 CA-C-O 121.198 0.523 . . . . 64.53 110.28 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.616 ' NE2' ' HG2' ' A' ' 178' ' ' ARG . 6.0 pt20 -118.65 100.38 7.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.799 -0.637 . . . . 75.1 110.277 178.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.809 ' HD3' ' HB1' ' A' ' 100' ' ' ALA . 5.5 ppt_? -147.69 149.43 33.64 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.62 -0.718 . . . . 73.42 111.173 -174.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_endo -87.7 -81.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.555 2.17 . . . . 75.01 110.265 167.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.07 103.13 2.68 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.879 -0.889 . . . . 72.0 110.879 172.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.809 ' HB1' ' HD3' ' A' ' 97' ' ' ARG . . . -80.24 -19.2 47.41 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 73.33 111.168 -175.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -83.46 -9.02 59.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.131 -0.486 . . . . 74.43 110.479 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 84.8 mt -81.77 123.91 29.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.877 -0.601 . . . . 72.31 109.577 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.7 p -77.46 97.78 5.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.542 0.687 . . . . 75.25 111.583 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.462 ' O ' HG21 ' A' ' 159' ' ' VAL . 12.8 p -90.62 144.51 8.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.991 -1.004 . . . . 73.41 109.598 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.54 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 19.8 mtmt -121.37 9.04 10.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.171 0.51 . . . . 73.15 111.578 -176.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.625 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 28.6 ttpt -138.58 135.97 35.52 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.915 -0.584 . . . . 74.55 109.466 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.514 HD13 HG23 ' A' ' 162' ' ' ILE . 6.7 pt -107.31 159.28 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.943 0.402 . . . . 74.53 110.638 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.513 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 57.1 t80 -108.43 115.18 29.63 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.847 -0.615 . . . . 63.55 109.847 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.7 t -102.77 103.48 15.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.796 -0.446 . . . . 74.03 109.796 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.87 161.95 12.54 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.858 -0.61 . . . . 71.22 111.974 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.456 ' HA2' ' OP2' ' B' ' 2' ' ' ' C' . . . 73.28 30.28 62.95 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.55 -0.833 . . . . 73.42 112.285 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.442 ' HA ' ' SG ' ' A' ' 175' ' ' CYS . 40.2 pt -95.58 -179.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.059 0.457 . . . . 72.22 110.765 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.857 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -98.68 159.96 14.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.843 -0.799 . . . . 74.22 108.843 178.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.584 ' OE2' ' HG3' ' A' ' 113' ' ' LYS . 0.6 OUTLIER -76.18 -6.04 49.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.093 0.473 . . . . 72.24 110.196 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -82.62 -34.33 27.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.69 -0.686 . . . . 73.42 110.084 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.8 m -67.09 129.96 41.57 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.704 -0.68 . . . . 75.44 111.173 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.502 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 11.9 pt-20 -134.7 -162.0 1.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.767 0.318 . . . . 71.22 111.644 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.672 ' HG2' ' CG1' ' A' ' 134' ' ' ILE . 3.1 tm-20 -55.28 -54.75 39.56 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.634 -0.712 . . . . 60.53 111.714 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.414 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.3 p80 -63.2 -31.02 72.07 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.961 -0.296 . . . . 74.24 111.089 -175.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.502 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 65.3 m80 -63.46 -60.32 3.52 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.261 0.553 . . . . 73.11 110.539 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.528 ' HA ' HG21 ' A' ' 170' ' ' VAL . 89.0 mt -61.41 -44.13 97.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.337 -0.847 . . . . 63.12 110.602 -177.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.526 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.5 OUTLIER -60.21 -42.63 95.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.674 -0.694 . . . . 70.52 110.846 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -58.1 -32.9 68.54 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.271 0.557 . . . . 75.43 111.438 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -88.2 -43.46 11.6 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.708 -0.678 . . . . 71.03 111.668 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 43.1 m-85 -83.74 -15.03 50.12 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.596 0.591 . . . . 73.21 112.596 -173.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.8 -19.45 65.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.115 0.484 . . . . 55.14 111.394 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -69.56 -25.15 63.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.867 -0.606 . . . . 74.32 110.441 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.454 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 80.2 m-85 -86.44 -32.06 21.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.898 -0.592 . . . . 74.12 110.368 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.601 ' HA3' ' HB3' ' A' ' 158' ' ' SER . . . -178.95 179.16 48.93 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.123 -0.791 . . . . 53.51 111.123 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -78.67 131.93 36.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.68 0.753 . . . . 74.35 109.846 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 122' ' ' ARG . 50.2 mt -98.85 137.21 27.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.317 -0.856 . . . . 75.32 110.984 -176.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -81.35 -70.44 0.54 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.819 -0.628 . . . . 71.22 110.757 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.31 159.69 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.523 -0.308 . . . . 73.12 110.72 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.672 ' CG1' ' HG2' ' A' ' 118' ' ' GLU . 18.8 mm -117.13 109.34 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.802 -0.444 . . . . 73.05 109.802 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -85.24 95.77 9.29 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.202 -0.666 . . . . 74.53 109.202 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.491 HG22 ' HE3' ' A' ' 145' ' ' LYS . 18.8 mt -73.15 -15.84 17.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.133 0.492 . . . . 74.45 110.58 -176.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.662 ' HE1' " O4'" ' B' ' 4' ' ' ' G' . 19.7 tpp 61.0 70.78 0.59 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.023 0.916 . . . . 74.44 110.872 178.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 p -90.87 142.5 27.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.821 -1.081 . . . . 73.14 110.658 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -50.35 141.48 11.74 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.572 0.545 . . . . 75.42 111.108 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.472 ' H ' ' HD3' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -81.04 -1.94 46.07 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.543 -0.753 . . . . 73.23 111.327 -173.559 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -111.51 -55.26 0.49 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.876 -0.678 . . . . 73.13 112.326 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.2 m -95.81 -21.2 18.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.94 0.348 . . . . 75.13 111.94 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.79 34.16 35.4 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.52 -0.848 . . . . 71.2 112.0 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -101.02 141.15 34.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.815 0.341 . . . . 75.23 110.41 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.491 ' HE3' HG22 ' A' ' 136' ' ' ILE . 45.3 mtpt -73.64 123.28 23.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.924 -0.58 . . . . 74.04 110.65 -173.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.429 ' NH2' " H4'" ' B' ' 4' ' ' ' G' . 41.4 mtm180 -77.61 -4.25 44.97 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.383 0.882 . . . . 74.24 113.383 -171.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.501 ' HA3' HO5' ' B' ' 1' ' ' ' U' . . . 98.19 4.04 57.61 Favored Glycine 0 CA--C 1.516 0.115 0 C-N-CA 120.311 -0.947 . . . . 55.02 113.446 173.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -144.56 143.64 30.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.448 -0.575 . . . . 75.4 109.448 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -133.07 158.28 43.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.036 0.446 . . . . 62.34 111.201 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -119.58 122.85 42.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.904 -0.589 . . . . 73.14 109.768 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.614 HG12 ' CD1' ' A' ' 134' ' ' ILE . 61.7 t -99.92 109.86 25.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.569 0.223 . . . . 73.2 110.567 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.625 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 19.1 m -88.63 126.8 35.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.313 -0.403 . . . . 74.1 110.858 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.546 ' CD2' HG13 ' A' ' 159' ' ' VAL . 89.1 m-85 -108.64 154.35 22.11 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.514 -0.55 . . . . 65.42 109.514 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.27 -33.49 73.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.947 -0.76 . . . . 61.51 108.947 174.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -112.96 143.91 43.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.602 -1.181 . . . . 74.52 111.543 -172.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.619 ' O ' HG23 ' A' ' 159' ' ' VAL . 2.9 p-80 -88.87 -12.72 41.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.716 -0.674 . . . . 71.22 110.178 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.62 -36.31 73.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.364 0.602 . . . . 74.52 109.605 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.603 ' HA ' ' HE2' ' A' ' 161' ' ' LYS . 13.0 m -75.67 -19.69 58.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.199 -0.909 . . . . 72.34 111.687 -175.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.619 HG23 ' O ' ' A' ' 156' ' ' HIS . 4.0 m -81.54 -22.31 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.758 0.313 . . . . 70.52 110.833 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.436 ' HA ' HG21 ' A' ' 163' ' ' VAL . 27.8 t70 -68.23 -40.53 82.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.342 -0.39 . . . . 73.11 111.429 -172.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.603 ' HE2' ' HA ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -62.63 -19.08 63.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.327 0.584 . . . . 65.13 110.247 178.565 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.514 HG23 HD13 ' A' ' 107' ' ' ILE . 90.4 mt -94.66 -55.2 6.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.412 -0.813 . . . . 73.43 111.23 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.769 HG22 ' HZ1' ' A' ' 179' ' ' LYS . 27.5 m -66.28 -14.62 17.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.645 0.609 . . . . 72.41 112.645 -173.1 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.426 HD13 ' N ' ' A' ' 165' ' ' GLN . 2.6 pp -72.51 -28.67 28.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.901 0.381 . . . . 73.32 110.817 176.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.473 ' HB3' ' NE2' ' A' ' 168' ' ' HIS . 5.9 tt0 -101.97 148.82 24.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.436 -0.579 . . . . 71.2 109.436 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.636 ' HE2' ' CE2' ' A' ' 167' ' ' TYR . 83.7 tttt -93.83 -61.21 1.58 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.828 0.346 . . . . 74.4 111.014 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.636 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 22.1 m-85 -82.51 108.6 16.04 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.188 0.518 . . . . 74.53 111.382 -176.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.473 ' NE2' ' HB3' ' A' ' 165' ' ' GLN . 27.5 m-70 -111.49 142.04 44.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.556 -0.747 . . . . 75.54 110.4 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.6 m -103.1 104.92 15.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.15 0.5 . . . . 73.31 111.096 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.528 HG21 ' HA ' ' A' ' 121' ' ' LEU . 6.3 p -130.17 140.89 47.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.782 -0.645 . . . . 74.32 109.403 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.14 -15.48 0.6 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.569 0.7 . . . . 74.32 109.459 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.464 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 113.34 2.22 24.65 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.64 -0.984 . . . . 54.23 110.64 -173.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -109.48 134.24 52.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.311 -0.444 . . . . 73.53 109.818 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -86.28 106.19 17.18 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.443 -0.577 . . . . 70.33 109.443 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 63.9 m -115.99 -177.86 3.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.986 -0.552 . . . . 70.54 110.797 -175.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.596 ' OE2' ' HE3' ' A' ' 166' ' ' LYS . 14.3 tt0 -111.31 132.64 54.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.625 -0.261 . . . . 74.2 110.593 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.7 m -121.86 144.46 31.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.082 0.468 . . . . 64.34 110.495 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.616 ' HG2' ' NE2' ' A' ' 96' ' ' GLN . 51.3 mtt180 -135.33 173.72 11.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.118 -0.492 . . . . 73.44 110.215 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.769 ' HZ1' HG22 ' A' ' 163' ' ' VAL . 66.4 mttm -70.09 119.03 13.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.645 -1.243 . . . . 75.43 107.645 167.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.553 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -75.87 93.05 3.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.111 0.482 . . . . 73.35 111.674 -175.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.616 HD22 ' H ' ' A' ' 181' ' ' LEU . 2.4 pt? -90.73 138.3 31.69 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.935 -0.765 . . . . 75.2 108.935 173.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.426 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 12.7 m -56.43 151.83 12.53 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.136 0.273 . . . . 74.22 110.64 -176.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.778 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.1 pttp -59.14 -28.38 66.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.353 0.597 . . . . 75.23 109.7 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -60.51 -42.36 96.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.977 -1.011 . . . . 74.24 110.628 173.191 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.426 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 32.7 mt-10 -85.68 -35.21 21.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.395 -0.82 . . . . 72.1 110.768 -174.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.778 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.6 ptm -72.22 -16.05 61.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.513 . . . . 63.01 110.587 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.24 -26.7 60.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 71.01 110.13 173.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 43.4 m -88.82 -45.31 9.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.82 -0.627 . . . . 72.22 110.681 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.8 -37.09 85.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 74.22 111.336 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 35.1 t -113.52 131.68 55.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.942 0.401 . . . . 73.11 110.437 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 24.3 m -114.19 -34.74 5.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.997 -0.547 . . . . 64.54 110.407 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 13.1 t -158.95 -163.52 1.25 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.772 -0.455 . . . . 71.42 109.772 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -91.81 -13.5 31.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.219 0.533 . . . . 63.44 109.701 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -101.52 123.92 46.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.519 -0.764 . . . . 74.53 109.803 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 90.06 -84.81 1.36 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.021 -0.831 . . . . 70.34 111.021 -176.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.492 -0.766 . . . . 72.1 109.674 176.329 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.947 H5'' " H4'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.665 0 C4'-C3'-C2' 103.754 1.054 . 0.0 '__' . 72.12 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.947 " H4'" H5'' ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.977 0 C3'-C2'-C1' 103.18 1.866 . 0.0 OUTLIER . 75.24 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.613 " H2'" ' SD ' ' A' ' 186' ' ' MET . . . . . . . . 0 O5'--C5' 1.425 -0.967 0 O4'-C4'-C3' 103.363 -1.527 . 0.0 OUTLIER . 74.13 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.662 " O4'" ' HE1' ' A' ' 137' ' ' MET . . . . . . . . 0 O5'--C5' 1.424 -1.024 0 C3'-C2'-C1' 98.72 -3.089 . 0.0 OUTLIER alpha 73.51 . . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 1.018 ' C6 ' " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.99 0 C4'-C3'-C2' 105.23 2.53 OUTLIER-DELTA 0.0 OUTLIER . 73.03 . . . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.835 0 C4'-C3'-C2' 103.416 0.716 . 0.0 OUTLIER . 73.52 . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.8 m . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 120.847 0.356 . . . . 61.35 110.949 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -96.36 141.04 30.15 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.831 -0.433 . . . . 75.31 109.831 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.808 ' HG3' ' HB2' ' A' ' 100' ' ' ALA . 11.7 ptm180 -69.45 129.31 91.72 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.417 -0.957 . . . . 72.54 108.417 171.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.671 ' HG2' ' HB2' ' A' ' 179' ' ' LYS . 15.0 Cg_endo -57.46 97.81 0.08 OUTLIER 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.219 2.612 . . . . 70.41 113.652 -167.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.421 ' HA3' HD13 ' A' ' 102' ' ' LEU . . . 55.56 64.09 4.69 Favored Glycine 0 C--O 1.224 -0.473 0 CA-C-N 115.415 -0.811 . . . . 65.53 112.835 176.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.808 ' HB2' ' HG3' ' A' ' 97' ' ' ARG . . . -70.74 -25.53 62.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.998 0.428 . . . . 73.24 110.8 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -84.93 0.66 50.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.901 -0.59 . . . . 72.25 110.247 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.421 HD13 ' HA3' ' A' ' 99' ' ' GLY . 51.6 mt -107.32 126.44 52.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.552 -0.749 . . . . 74.33 109.922 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.0 p -66.46 112.55 4.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 74.14 110.719 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.447 ' O ' HG22 ' A' ' 159' ' ' VAL . 8.7 p -104.54 136.63 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.298 -0.41 . . . . 71.55 109.918 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.444 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 19.3 mtmt -122.32 20.13 10.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.324 0.583 . . . . 71.3 110.991 -177.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.601 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 30.0 ttpt -150.85 136.94 18.36 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.377 -0.829 . . . . 73.23 108.973 174.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.527 HD12 HG21 ' A' ' 162' ' ' ILE . 2.7 pt -110.12 153.95 11.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.937 0.399 . . . . 74.52 110.342 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.576 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 74.0 t80 -100.89 120.74 40.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.736 -0.665 . . . . 73.25 110.012 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.429 HG11 HD12 ' A' ' 121' ' ' LEU . 47.0 t -107.6 113.67 44.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.753 0.311 . . . . 73.51 110.411 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.05 155.56 20.33 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.657 -0.782 . . . . 73.02 112.598 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.468 ' H ' " H5'" ' B' ' 2' ' ' ' C' . . . 88.32 24.59 33.55 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.058 -0.591 . . . . 73.01 112.897 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.9 pt -81.61 69.18 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.432 0.634 . . . . 72.3 111.599 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -49.41 -57.09 7.58 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.105 -0.952 . . . . 74.31 113.004 -173.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.92 29.25 0.33 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.653 0.612 . . . . 71.13 112.653 -170.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.538 ' CG ' ' HZ2' ' A' ' 145' ' ' LYS . 34.1 t70 66.63 98.41 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.618 0.723 . . . . 64.25 112.046 175.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.459 HG23 ' CB ' ' A' ' 120' ' ' HIS . 86.0 m -113.87 138.49 50.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.515 -0.766 . . . . 71.4 110.1 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.539 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 10.2 pt-20 -125.99 -170.85 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.415 -0.178 . . . . 71.21 110.862 -177.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.558 ' H ' HD13 ' A' ' 136' ' ' ILE . 19.1 tt0 -55.87 -53.19 59.78 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.58 0.585 . . . . 74.54 112.58 -174.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.475 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.0 p80 -59.09 -30.51 68.15 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.071 -0.251 . . . . 74.34 110.581 -175.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.539 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 41.9 m80 -64.91 -55.95 16.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.157 -0.474 . . . . 71.33 110.327 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.479 HD21 ' O ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -61.24 -48.07 83.13 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.296 -0.411 . . . . 72.13 110.689 -179.408 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.403 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 3.1 tpp180 -61.65 -48.98 78.39 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.263 -0.426 . . . . 73.23 111.49 -176.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.55 -31.52 68.04 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.31 0.576 . . . . 64.45 110.958 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.403 ' HE1' ' HB3' ' A' ' 168' ' ' HIS . 38.8 t80 -86.83 -44.21 11.9 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.834 -0.621 . . . . 74.0 111.305 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.409 ' CD1' HG21 ' A' ' 151' ' ' VAL . 47.2 m-85 -86.16 -13.84 45.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.054 0.761 . . . . 72.31 113.054 -172.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.51 -22.27 65.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.047 0.451 . . . . 74.4 110.839 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -66.6 -25.8 66.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.731 -0.668 . . . . 61.35 110.463 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.452 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 72.1 m-85 -84.88 -30.24 24.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.663 -0.699 . . . . 75.42 110.851 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.431 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 175.93 -174.8 47.14 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.717 -0.754 . . . . 75.13 111.881 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.436 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 20.1 ptmt -79.11 129.55 34.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.811 0.815 . . . . 74.23 109.976 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.47 HG23 HD12 ' A' ' 134' ' ' ILE . 48.1 mt -98.94 142.56 14.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.246 -0.888 . . . . 73.41 110.528 -176.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -85.89 -75.63 0.37 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.953 -0.567 . . . . 72.33 110.159 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.6 m -139.35 155.56 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.327 -0.397 . . . . 71.52 110.611 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.592 ' CD1' HG12 ' A' ' 151' ' ' VAL . 24.0 mm -110.87 107.8 23.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.25 -0.648 . . . . 74.33 109.25 175.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.46 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 88.0 mt-10 -91.2 97.54 11.19 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.098 0.475 . . . . 73.2 110.955 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.558 HD13 ' H ' ' A' ' 118' ' ' GLU . 32.3 mt -81.1 103.75 8.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.313 -0.625 . . . . 75.13 109.313 176.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.638 ' HE3' " O4'" ' B' ' 4' ' ' ' G' . 24.6 tpp -67.41 122.92 19.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.425 0.631 . . . . 71.25 110.668 -177.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.7 p -108.53 163.91 12.81 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.103 -0.953 . . . . 75.13 111.509 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.677 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 22.9 t70 -57.68 139.51 53.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.45 -0.796 . . . . 73.13 109.822 175.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.583 ' HD3' " H2'" ' B' ' 5' ' ' ' U' . 9.5 tpt180 -65.26 -23.18 66.98 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.094 -0.503 . . . . 72.41 111.288 -172.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -108.16 -54.28 0.63 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.557 -0.83 . . . . 45.43 113.059 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.8 t -84.46 -19.56 33.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 71.31 110.979 -173.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.33 30.41 69.3 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.606 -0.806 . . . . 73.4 111.898 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -95.93 162.17 13.69 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.334 -0.617 . . . . 75.51 109.334 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.538 ' HZ2' ' CG ' ' A' ' 115' ' ' ASP . 53.9 mtpt -65.17 115.12 5.19 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.028 0.442 . . . . 63.51 110.796 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 23.6 tpt180 -66.79 -58.05 5.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.537 -0.756 . . . . 74.42 112.252 -173.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.787 ' HA3' " H2'" ' B' ' 1' ' ' ' U' . . . 158.95 -17.73 0.26 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.985 -1.102 . . . . 43.23 112.654 -175.048 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.712 ' HB3' " H4'" ' B' ' 2' ' ' ' C' . 35.4 p90 -136.68 158.23 44.92 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 122.69 -0.3 . . . . 73.34 110.245 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.96 169.48 17.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.212 -0.449 . . . . 72.35 110.764 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.557 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 66.6 m-85 -130.79 137.35 49.4 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.016 -0.538 . . . . 73.11 110.011 -177.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.592 HG12 ' CD1' ' A' ' 134' ' ' ILE . 18.7 t -112.27 107.13 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.811 -0.441 . . . . 75.14 109.811 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.601 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 18.4 m -86.94 126.03 34.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.323 -0.399 . . . . 70.33 110.359 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -109.41 152.1 25.8 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.776 -0.453 . . . . 71.53 109.776 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.436 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 26.9 t70 -75.45 -22.54 57.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.404 0.621 . . . . 74.12 109.735 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -124.84 139.52 53.77 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.327 -0.851 . . . . 73.54 110.441 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.587 ' O ' HG21 ' A' ' 159' ' ' VAL . 3.8 p-80 -81.63 -5.65 58.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.345 0.593 . . . . 70.13 109.955 175.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.43 -44.11 83.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.751 -0.659 . . . . 71.15 109.991 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.431 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 3.3 m -60.15 -39.25 85.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.17 -0.923 . . . . 73.12 111.729 -177.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.587 HG21 ' O ' ' A' ' 156' ' ' HIS . 6.5 m -70.86 -25.91 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.391 -0.368 . . . . 74.52 111.452 -174.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -69.44 -22.32 63.66 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.578 0.214 . . . . 74.44 111.578 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.452 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 0.5 OUTLIER -89.32 -1.35 58.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.389 0.614 . . . . 64.4 109.644 177.142 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.527 HG21 HD12 ' A' ' 107' ' ' ILE . 92.5 mt -108.53 -54.6 5.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.432 -0.803 . . . . 63.03 110.782 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.499 HG13 ' HG2' ' A' ' 179' ' ' LYS . 23.9 m -71.75 -3.55 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.851 -0.613 . . . . 74.54 112.589 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.515 HD11 ' N ' ' A' ' 165' ' ' GLN . 2.1 pp -74.39 -30.71 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.73 0.3 . . . . 74.32 111.227 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.515 ' N ' HD11 ' A' ' 164' ' ' ILE . 12.0 pt20 -114.34 176.54 5.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.916 -0.402 . . . . 73.44 109.916 173.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.548 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 79.8 tttt -113.24 -59.46 2.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.566 -0.288 . . . . 71.2 111.631 -174.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.544 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 21.0 m-85 -78.19 107.75 11.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.127 0.489 . . . . 71.23 111.083 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.403 ' HB3' ' HE1' ' A' ' 124' ' ' TYR . 16.5 m-70 -107.47 135.63 48.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.635 -0.711 . . . . 73.41 110.536 178.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.7 m -93.55 97.45 10.51 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.797 -0.638 . . . . 73.4 111.233 -175.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.99 139.44 50.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.994 -0.743 . . . . 73.31 108.994 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 71.43 -7.19 1.23 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.292 0.568 . . . . 71.31 110.275 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 108.04 -0.29 33.61 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.57 -0.612 . . . . 62.35 111.57 -176.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -115.93 146.57 41.97 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.178 -0.305 . . . . 72.32 110.178 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -90.3 104.86 17.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.981 0.896 . . . . 65.13 110.496 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 25.8 p -95.37 172.22 8.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.315 -0.857 . . . . 74.31 110.017 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.548 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 38.0 tt0 -107.99 121.39 44.71 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.85 -0.426 . . . . 75.4 109.85 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.576 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 2.8 m -109.86 145.78 16.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.983 0.42 . . . . 62.42 110.558 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -135.39 170.77 15.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.112 -0.495 . . . . 74.53 110.147 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.671 ' HB2' ' HG2' ' A' ' 98' ' ' PRO . 8.1 mtpm? -73.42 114.4 11.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.458 -0.941 . . . . 73.11 108.458 169.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.76 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -72.11 97.57 1.95 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.262 0.553 . . . . 62.22 111.735 -175.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.685 HD22 ' H ' ' A' ' 181' ' ' LEU . 2.3 pt? -96.75 138.3 34.51 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.488 -0.778 . . . . 72.2 109.133 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.493 ' HB3' ' HG2' ' A' ' 185' ' ' GLU . 36.3 t -49.89 145.36 5.57 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.279 0.362 . . . . 63.23 110.959 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.636 ' HE2' ' OP1' ' B' ' 5' ' ' ' U' . 22.4 pttp -62.64 -23.51 67.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.152 0.501 . . . . 75.02 109.908 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -73.75 -41.4 62.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.507 -0.77 . . . . 63.42 109.487 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.493 ' HG2' ' HB3' ' A' ' 182' ' ' SER . 56.1 mm-40 -73.44 -40.85 63.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.321 -0.854 . . . . 75.3 110.943 -177.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.609 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 12.5 ptp -64.12 -24.35 67.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.784 0.326 . . . . 72.24 110.734 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -80.0 -30.15 39.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.052 0.453 . . . . 75.4 110.312 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 21.8 t -87.45 -38.09 16.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.573 -0.739 . . . . 62.51 110.829 -178.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -79.09 -40.88 30.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.108 0.48 . . . . 44.54 110.674 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.2 m -108.52 96.87 6.64 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.901 -0.591 . . . . 62.14 110.36 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.5 m -121.42 152.46 39.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.569 -0.53 . . . . 64.31 109.569 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.1 p -59.38 125.3 23.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.255 0.55 . . . . 75.44 111.192 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -91.78 131.01 37.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.551 -0.75 . . . . 62.42 110.261 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -151.36 29.64 0.63 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.823 0.821 . . . . 75.21 109.809 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -70.21 -31.68 69.0 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.495 -0.775 . . . . 63.22 112.27 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.753 -0.641 . . . . 74.01 110.319 178.105 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.983 " H3'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.424 -1.031 0 C1'-O4'-C4' 106.957 -2.936 OUTLIER-EPSILON 0.0 '__' . 73.41 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.983 H5'' " H3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.868 0 C4'-C3'-C2' 105.777 3.077 . 0.0 OUTLIER epsilon-1 72.34 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.76 ' N1 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.424 -0.99 0 C4'-C3'-C2' 104.772 2.072 . 0.0 OUTLIER gamma 75.54 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.638 " O4'" ' HE3' ' A' ' 137' ' ' MET . . . . . . . . 0 O5'--C5' 1.424 -1.015 0 C3'-C2'-C1' 99.547 -2.17 . 0.0 OUTLIER alpha 73.24 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.677 ' O4 ' ' HA ' ' A' ' 139' ' ' ASP . . . . . . . . 0 O5'--C5' 1.426 -0.855 0 O4'-C4'-C3' 103.749 -1.251 . 0.0 OUTLIER gamma 73.11 . . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.591 ' H6 ' " O5'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.852 0 O4'-C1'-C2' 107.26 0.614 . 0.101 4b . 64.52 . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.432 0.158 . . . . 65.43 110.612 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 56.66 4.81 0.17 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.019 1.328 . . . . 71.14 113.518 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -122.01 85.95 46.19 Favored Pre-proline 0 C--N 1.326 -0.423 0 O-C-N 122.018 -0.426 . . . . 74.52 110.611 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.478 ' HG2' HD22 ' A' ' 181' ' ' LEU . 15.9 Cg_exo -69.1 -63.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.374 2.049 . . . . 75.11 110.763 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.85 93.58 1.12 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.999 -0.841 . . . . 62.2 110.999 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.477 ' HA ' ' HZ1' ' A' ' 179' ' ' LYS . . . -87.15 -41.11 14.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.07 0.462 . . . . 74.22 110.746 -179.148 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -91.65 13.9 16.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.658 -0.701 . . . . 73.1 110.534 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -113.11 139.77 48.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.7 -0.682 . . . . 74.22 110.285 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.508 HG22 ' HB2' ' A' ' 156' ' ' HIS . 0.2 OUTLIER -90.72 118.81 30.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.807 -0.442 . . . . 75.5 109.807 178.658 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.505 HG22 ' HB3' ' A' ' 179' ' ' LYS . 2.1 t -112.0 153.63 13.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.24 -0.437 . . . . 73.32 110.365 -172.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.626 ' HA ' HG22 ' A' ' 159' ' ' VAL . 4.8 mtmt -118.33 9.04 12.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.886 0.374 . . . . 74.54 111.345 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.584 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.9 ttpt -147.02 138.4 24.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.88 0.372 . . . . 72.14 110.068 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.559 ' CG2' HG12 ' A' ' 159' ' ' VAL . 7.4 pt -109.18 162.42 6.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.208 -0.451 . . . . 71.04 111.203 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.442 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 54.3 t80 -109.14 121.28 44.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.747 -0.661 . . . . 73.33 109.912 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.1 t -105.05 104.71 17.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.899 0.38 . . . . 54.41 110.694 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -121.91 178.75 16.35 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.321 -0.712 . . . . 63.15 111.321 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.489 ' HA2' " O5'" ' B' ' 1' ' ' ' U' . . . 70.23 19.5 75.86 Favored Glycine 0 C--O 1.229 -0.164 0 C-N-CA 120.635 -0.793 . . . . 72.33 112.289 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.694 ' O ' " H2'" ' B' ' 1' ' ' ' U' . 27.6 pt -96.47 -167.72 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.753 0.311 . . . . 62.22 111.074 -177.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.434 ' HA ' " H2'" ' B' ' 1' ' ' ' U' . 47.8 pttt -120.88 163.36 18.31 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.105 -0.498 . . . . 74.05 110.14 174.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.21 -27.79 68.68 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.581 0.551 . . . . 73.42 112.256 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.48 -31.04 71.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.588 -0.278 . . . . 63.25 111.593 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.461 ' HB ' HD12 ' A' ' 112' ' ' ILE . 1.0 OUTLIER -61.54 144.37 54.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 72.45 111.166 -175.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.413 ' CG ' ' HD2' ' A' ' 119' ' ' HIS . 11.2 pt-20 -158.32 -165.94 1.81 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.823 0.344 . . . . 70.04 111.71 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.546 ' HA ' HG21 ' A' ' 134' ' ' ILE . 21.5 tt0 -51.69 -56.58 12.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.282 -0.872 . . . . 65.42 112.318 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.413 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.0 p80 -61.83 -31.05 71.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.352 -0.386 . . . . 65.33 111.065 -174.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -67.6 -59.38 3.39 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.25 0.548 . . . . 73.45 110.064 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.541 HD21 HG13 ' A' ' 170' ' ' VAL . 68.8 mt -57.2 -49.58 75.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.066 -0.97 . . . . 73.42 110.973 -177.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.429 ' HG3' HD12 ' A' ' 131' ' ' ILE . 4.7 ttp180 -62.03 -37.79 86.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 74.43 111.38 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.17 -29.61 68.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.982 0.42 . . . . 64.3 110.872 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -91.67 -46.98 7.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.045 -0.525 . . . . 75.34 111.622 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -77.2 -14.01 59.85 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.595 0.591 . . . . 74.41 112.595 -172.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.83 -22.16 66.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.11 0.481 . . . . 64.22 110.912 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.81 -30.89 71.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.712 -0.676 . . . . 75.34 110.858 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.423 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 76.6 m-85 -82.48 -31.04 29.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.129 -0.487 . . . . 74.54 111.253 -175.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.577 ' HA3' ' HB3' ' A' ' 158' ' ' SER . . . 172.66 -170.91 43.98 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.822 -1.18 . . . . 62.3 113.381 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -75.86 114.19 14.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.526 0.679 . . . . 74.21 111.342 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.461 HG23 HD12 ' A' ' 134' ' ' ILE . 35.3 mt -87.27 142.18 13.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.15 -0.932 . . . . 75.41 110.039 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -86.66 -74.68 0.42 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.106 -0.497 . . . . 73.13 110.315 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.1 m -143.86 152.37 16.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.135 -0.484 . . . . 61.4 110.079 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.597 ' CD1' HG11 ' A' ' 151' ' ' VAL . 16.2 mm -103.47 105.63 18.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.867 -0.79 . . . . 64.24 108.867 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -85.42 94.7 9.05 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.052 -0.522 . . . . 75.33 110.247 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.537 HD11 ' H ' ' A' ' 118' ' ' GLU . 31.5 mt -80.79 119.94 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.653 -0.703 . . . . 73.33 109.802 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.561 ' HE3' " C4'" ' B' ' 4' ' ' ' G' . 21.4 tpp -73.68 94.94 2.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.709 0.766 . . . . 75.42 109.434 176.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 145' ' ' LYS . 16.7 p -81.85 165.37 20.9 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.871 -1.059 . . . . 71.52 111.118 -176.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.776 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 31.4 t70 -53.73 133.34 42.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.071 -0.513 . . . . 64.43 109.954 177.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.524 ' HD3' " H2'" ' B' ' 5' ' ' ' U' . 11.8 tpt180 -71.16 -9.23 57.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.777 0.322 . . . . 75.32 111.56 -171.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -106.92 -53.08 0.71 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.423 -0.894 . . . . 70.14 112.718 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.5 t -102.9 -11.35 18.3 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.695 -0.297 . . . . 74.21 111.618 -174.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.507 ' HA2' ' HB ' ' A' ' 138' ' ' THR . . . 60.12 53.22 47.51 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 120.607 -0.806 . . . . 65.25 112.103 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -122.51 34.91 5.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.777 0.322 . . . . 74.43 111.708 -173.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 138' ' ' THR . 56.5 mtpt 68.56 123.08 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.525 -0.761 . . . . 75.13 111.724 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.487 ' HD2' ' C4 ' ' B' ' 5' ' ' ' U' . 68.2 ttt-85 -93.72 -52.73 4.33 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.738 -0.385 . . . . 75.44 110.302 173.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.49 ' O ' HD13 ' A' ' 112' ' ' ILE . . . 174.53 -85.3 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.695 -0.764 . . . . 65.41 112.154 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.74 ' HB3' H5'' ' B' ' 2' ' ' ' C' . 47.9 p90 -65.29 158.1 27.25 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.077 0.465 . . . . 74.35 111.384 -175.283 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.94 166.88 26.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.857 -0.611 . . . . 72.14 110.824 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.416 ' HE2' ' N3 ' ' B' ' 3' ' ' ' A' . 55.1 m-85 -122.38 131.42 53.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.949 -0.569 . . . . 74.21 109.707 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.597 HG11 ' CD1' ' A' ' 134' ' ' ILE . 47.7 t -104.56 109.66 28.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.776 0.322 . . . . 75.51 110.324 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.584 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 12.3 m -88.02 129.51 35.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.894 -0.593 . . . . 71.41 110.175 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.499 ' CD2' HG21 ' A' ' 159' ' ' VAL . 97.8 m-85 -111.58 150.61 29.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.821 -0.437 . . . . 74.1 109.821 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.49 -13.01 60.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.575 0.703 . . . . 54.33 110.235 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -129.41 147.63 51.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.312 -0.858 . . . . 75.23 109.969 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.508 ' HB2' HG22 ' A' ' 103' ' ' THR . 2.0 p-80 -85.57 -15.41 42.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.074 0.464 . . . . 73.24 110.441 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -71.73 -39.67 69.92 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.079 -0.509 . . . . 44.31 110.047 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.577 ' HB3' ' HA3' ' A' ' 129' ' ' GLY . 0.8 OUTLIER -59.94 -35.29 74.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.619 -0.719 . . . . 75.42 110.1 178.438 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.626 HG22 ' HA ' ' A' ' 105' ' ' LYS . 22.0 t -70.22 -35.86 65.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.04 -0.982 . . . . 73.05 110.816 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.35 -38.75 92.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.897 -0.592 . . . . 74.12 112.289 -171.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.423 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -66.25 -22.15 66.31 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.337 0.589 . . . . 73.22 110.316 178.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.463 HG23 HD13 ' A' ' 107' ' ' ILE . 96.0 mt -93.59 -49.3 12.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.377 -0.829 . . . . 75.13 111.478 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.552 ' HB ' ' HE2' ' A' ' 179' ' ' LYS . 34.8 m -69.37 -14.94 19.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.591 0.589 . . . . 72.15 112.591 -173.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -75.73 -27.73 18.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.173 0.511 . . . . 72.44 110.664 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -103.36 143.84 32.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.773 -0.649 . . . . 61.43 110.158 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.637 ' HE2' ' CE2' ' A' ' 167' ' ' TYR . 83.0 tttt -91.85 -64.25 1.14 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.865 0.364 . . . . 75.11 110.714 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.637 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 15.5 m-30 -84.27 105.22 14.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.423 0.63 . . . . 75.35 112.216 -175.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -106.24 149.79 26.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.959 -1.018 . . . . 74.51 109.424 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 53.5 m -102.6 103.12 13.41 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.956 0.408 . . . . 74.31 110.975 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.541 HG13 HD21 ' A' ' 121' ' ' LEU . 31.3 t -116.8 131.38 69.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.06 -0.518 . . . . 73.44 109.85 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.7 t30 59.53 27.27 16.41 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.482 0.658 . . . . 74.14 110.401 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 76.02 5.59 80.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.854 -0.689 . . . . 72.32 112.386 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.405 ' HB2' ' HE2' ' A' ' 113' ' ' LYS . 61.4 t60 -109.11 133.09 53.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.787 0.327 . . . . 74.43 110.127 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.431 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 10.7 t30 -77.9 122.6 25.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.29 -0.414 . . . . 72.23 109.91 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.625 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 24.2 p -126.33 165.61 18.69 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.442 -0.345 . . . . 75.3 110.943 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.53 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 15.7 tt0 -108.58 118.85 37.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.998 -0.546 . . . . 72.32 110.017 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 86.9 t -110.82 132.87 58.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.17 0.51 . . . . 71.32 111.297 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -127.01 177.91 6.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.549 -0.75 . . . . 74.25 109.823 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.552 ' HE2' ' HB ' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -77.59 123.64 26.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.405 -0.961 . . . . 74.24 108.405 170.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.562 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -75.3 92.87 2.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.147 0.499 . . . . 72.35 112.089 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.588 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.5 pt? -88.13 131.24 34.78 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.537 -0.912 . . . . 74.51 108.537 171.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.5 m -58.31 153.8 14.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.476 -0.329 . . . . 73.34 110.938 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.619 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.4 pttp -63.45 -14.8 54.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.091 0.472 . . . . 75.12 111.238 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 11.4 tm0? -78.57 -43.51 26.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.099 -0.704 . . . . 61.5 109.099 173.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -73.0 -41.88 63.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.32 -0.854 . . . . 73.31 110.958 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.619 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 21.1 ptm -65.6 -21.04 66.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 72.43 110.442 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -71.57 -21.15 61.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.859 -0.61 . . . . 72.3 110.199 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.3 m -94.76 -8.98 36.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.759 -0.655 . . . . 71.3 110.182 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -93.74 -45.45 7.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.863 -0.608 . . . . 72.24 110.793 -178.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.2 t -92.64 84.82 5.1 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.187 0.517 . . . . 74.14 109.844 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 55.2 m -157.97 173.06 17.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.496 -0.774 . . . . 73.44 109.338 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 49.2 m -66.16 -19.86 65.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.116 0.484 . . . . 62.43 110.632 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -123.43 101.76 7.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.987 -0.551 . . . . 72.12 109.945 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.488 ' H ' ' HD2' ' A' ' 194' ' ' ARG . 0.7 OUTLIER -107.46 20.59 18.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.939 -0.573 . . . . 75.32 110.225 -178.406 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 113.24 -69.92 0.23 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.697 -0.961 . . . . 74.32 110.697 -174.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 80.3 mmt-85 . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.337 -0.839 . . . . 72.24 109.062 171.884 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.889 " H4'" " C5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.813 0 O4'-C1'-C2' 108.017 1.155 OUTLIER-EPSILON 0.0 '__' . 73.55 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.889 " C5'" " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.819 0 P-O3'-C3' 122.159 2.049 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 75.22 . . . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.759 ' OP1' " H4'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 C3'-C2'-C1' 103.497 2.219 . 0.0 OUTLIER epsilon-1 75.44 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.823 ' OP1' " H4'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.896 0 C3'-C2'-C1' 100.496 -1.115 . 0.0 OUTLIER alpha 75.3 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.823 " H4'" ' OP1' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.856 0 O4'-C4'-C3' 103.755 -1.246 . 0.0 OUTLIER gamma 72.42 . . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.96 0 C4'-C3'-C2' 106.067 3.367 . 0.0 OUTLIER gamma 75.3 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 164' ' ' ILE . 24.9 t . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.777 -0.453 . . . . 74.54 109.777 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.772 ' HG3' ' HA ' ' A' ' 178' ' ' ARG . 39.1 mm-40 -64.66 154.18 37.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 74.43 111.35 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -84.6 -49.99 0.6 Allowed Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 113.071 0.767 . . . . 73.42 113.071 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.26 102.4 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 121.821 1.681 . . . . 72.53 112.518 -174.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.31 49.87 42.68 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.854 -0.689 . . . . 64.44 111.968 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 1.019 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . . . -64.6 -40.15 95.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.761 0.315 . . . . 74.54 111.302 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -81.29 -5.64 58.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.059 -0.519 . . . . 72.31 110.777 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.77 143.68 26.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.137 -0.483 . . . . 71.15 111.227 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.2 p -80.83 100.35 8.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.458 -0.792 . . . . 74.11 110.355 175.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.47 HG23 ' HB3' ' A' ' 179' ' ' LYS . 38.9 t -92.18 145.2 7.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.649 -0.705 . . . . 74.13 110.032 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.541 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 6.4 mtmt -115.79 -3.96 12.18 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.132 0.419 . . . . 65.23 112.132 -178.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.568 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.8 ttpt -135.46 134.11 39.24 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.028 -0.36 . . . . 75.14 110.028 175.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.666 HG22 HG13 ' A' ' 159' ' ' VAL . 3.3 pt -104.45 155.3 6.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.064 0.459 . . . . 75.12 110.745 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.418 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 41.8 t80 -104.83 122.93 46.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.551 -0.75 . . . . 74.3 109.785 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.43 HG11 HG23 ' A' ' 112' ' ' ILE . 3.2 t -110.65 98.59 7.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.432 -0.581 . . . . 75.13 109.432 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.485 ' O ' " H5'" ' B' ' 2' ' ' ' C' . . . -91.42 -48.02 3.36 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.674 -0.774 . . . . 62.13 113.185 -173.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.563 ' O ' ' HA ' ' A' ' 175' ' ' CYS . . . -80.28 63.77 4.09 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.627 -0.797 . . . . 61.13 113.406 -174.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.599 HG21 ' SG ' ' A' ' 175' ' ' CYS . 32.8 pt -115.28 -175.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.954 0.377 . . . . 75.43 110.637 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -124.42 172.37 9.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.099 -0.5 . . . . 64.53 109.989 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.7 -18.6 65.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 63.42 111.013 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -72.39 -28.08 62.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.941 -0.572 . . . . 74.32 110.494 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.0 m -77.78 124.47 28.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.969 -0.56 . . . . 74.54 111.384 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.413 ' O ' HD21 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -127.72 -168.5 1.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.225 -0.443 . . . . 71.41 110.157 178.261 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.53 ' HG3' ' HB ' ' A' ' 134' ' ' ILE . 12.7 tt0 -55.79 -49.95 71.79 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 112.294 0.479 . . . . 65.14 112.294 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.53 -29.86 69.39 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 120.752 -0.379 . . . . 72.3 110.25 -175.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.526 ' CD2' HD21 ' A' ' 171' ' ' ASN . 37.2 m80 -65.56 -55.87 15.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.374 -0.376 . . . . 73.43 111.009 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.413 HD21 ' O ' ' A' ' 117' ' ' GLU . 1.0 OUTLIER -59.38 -47.71 84.4 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.944 0.402 . . . . 74.32 110.472 179.531 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.31 -46.32 90.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.042 -0.526 . . . . 72.44 111.385 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -57.18 -32.01 66.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.106 0.479 . . . . 50.41 111.602 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.425 ' CE1' ' HB3' ' A' ' 168' ' ' HIS . 50.6 t80 -90.63 -44.1 9.74 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.182 -0.463 . . . . 73.52 111.411 -177.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -82.77 -12.83 57.21 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.674 0.62 . . . . 70.34 112.674 -172.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -61.47 -27.25 68.44 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.68 0.276 . . . . 75.35 111.556 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -74.82 -14.96 60.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.906 0.384 . . . . 74.31 110.903 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -90.0 -26.63 20.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.312 -0.403 . . . . 64.12 110.868 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.488 ' HA3' ' CB ' ' A' ' 158' ' ' SER . . . 169.56 -170.97 43.02 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.508 -0.853 . . . . 63.23 112.533 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -75.86 122.27 23.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.28 0.562 . . . . 64.02 111.18 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.462 HG21 HD13 ' A' ' 134' ' ' ILE . 46.7 mt -95.59 137.9 22.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.415 -0.811 . . . . 74.34 110.296 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.428 ' HG2' ' N ' ' A' ' 154' ' ' ASP . 13.5 mm-40 -85.35 -70.57 0.58 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.934 -0.575 . . . . 73.43 110.403 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.22 158.75 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.531 -0.304 . . . . 73.24 110.472 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.598 ' CD1' HG11 ' A' ' 151' ' ' VAL . 23.5 mm -113.73 117.67 56.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.929 -0.397 . . . . 73.33 109.929 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.416 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 59.7 mt-10 -100.49 117.81 35.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.589 -0.522 . . . . 70.1 109.589 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.7 mt -91.65 3.76 7.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.53 0.681 . . . . 72.42 109.255 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.723 ' HE1' " O4'" ' B' ' 4' ' ' ' G' . 8.4 tpp 52.03 50.51 18.37 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 114.857 -1.065 . . . . 72.05 109.588 -175.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 2.7 p -66.42 141.88 57.78 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.039 -0.982 . . . . 75.21 110.449 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -46.65 121.43 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.559 0.537 . . . . 71.2 110.213 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.524 ' H ' ' NE ' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -73.56 2.48 7.85 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.14 -0.482 . . . . 73.21 111.981 -173.327 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -107.65 -43.96 1.28 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.846 -0.692 . . . . 72.13 112.548 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.9 t -116.3 -19.99 9.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.106 0.453 . . . . 61.01 112.024 -176.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.02 56.09 2.13 Favored Glycine 0 CA--C 1.517 0.183 0 C-N-CA 120.673 -0.775 . . . . 75.3 111.965 -177.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 138' ' ' THR . 0.0 OUTLIER -112.07 124.31 52.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.235 -0.283 . . . . 65.21 110.235 -175.12 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -61.02 130.59 47.18 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.079 0.466 . . . . 73.3 111.731 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.456 ' HG3' ' H ' ' A' ' 147' ' ' GLY . 25.4 tpt180 -84.36 171.76 12.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.484 -0.78 . . . . 74.21 110.018 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.518 ' O ' " H5'" ' B' ' 1' ' ' ' U' . . . -86.18 3.0 87.56 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 121.208 -0.52 . . . . 72.1 112.599 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -142.09 153.35 44.08 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.402 -0.592 . . . . 73.13 109.402 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -136.42 172.11 13.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.214 0.53 . . . . 72.55 111.827 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.538 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 56.5 m-85 -133.32 134.97 44.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.334 -0.848 . . . . 74.52 109.433 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.598 HG11 ' CD1' ' A' ' 134' ' ' ILE . 21.2 t -112.93 108.52 25.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.858 -0.423 . . . . 72.23 109.858 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.568 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 6.7 m -88.14 127.19 35.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.168 -0.469 . . . . 75.3 110.461 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.49 ' CD2' HG21 ' A' ' 159' ' ' VAL . 86.8 m-85 -111.81 151.33 29.16 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.923 -0.399 . . . . 74.54 109.923 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.428 ' N ' ' HG2' ' A' ' 132' ' ' GLU . 28.1 t70 -76.91 -14.66 59.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.776 0.798 . . . . 74.14 110.042 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.424 ' OD1' ' HB3' ' A' ' 157' ' ' ASP . 37.0 t70 -123.93 133.32 53.75 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.002 -0.999 . . . . 51.22 111.043 -173.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.541 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.1 p-80 -85.11 -2.07 57.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.3 -0.409 . . . . 60.03 111.357 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.424 ' HB3' ' OD1' ' A' ' 155' ' ' ASP . 22.1 t70 -94.56 -37.05 11.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.183 0.516 . . . . 44.04 109.614 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.84 ' HA ' ' HE3' ' A' ' 161' ' ' LYS . 18.5 m -57.36 -32.03 66.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.482 -0.781 . . . . 64.52 110.482 175.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.666 HG13 HG22 ' A' ' 107' ' ' ILE . 46.9 t -70.83 -29.11 36.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.462 -0.79 . . . . 74.41 110.873 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -65.64 -45.57 82.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.907 -0.588 . . . . 72.32 111.608 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.84 ' HE3' ' HA ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -65.99 -12.6 56.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.119 0.485 . . . . 75.43 111.148 178.072 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.49 HG21 HD13 ' A' ' 107' ' ' ILE . 96.9 mt -93.3 -51.8 10.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.036 -0.529 . . . . 75.32 110.84 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.459 HG13 HG11 ' A' ' 159' ' ' VAL . 25.7 m -68.25 -15.75 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.516 0.562 . . . . 61.24 112.516 -174.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 95' ' ' SER . 2.7 pp -73.82 -27.26 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.976 0.417 . . . . 73.5 110.574 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -102.76 150.09 23.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.092 -0.707 . . . . 72.42 109.092 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.507 ' HE2' ' HG3' ' A' ' 176' ' ' GLU . 86.6 tttt -100.16 -59.6 1.68 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.794 -0.362 . . . . 72.13 111.1 -176.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -88.19 113.43 23.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.404 0.621 . . . . 74.13 111.177 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.425 ' HB3' ' CE1' ' A' ' 124' ' ' TYR . 32.7 m-70 -109.24 139.4 44.22 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.153 -0.931 . . . . 74.11 110.219 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.2 m -92.58 101.48 13.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.123 0.487 . . . . 71.42 111.124 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.431 ' O ' ' HB3' ' A' ' 171' ' ' ASN . 4.2 p -134.15 140.02 47.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.956 -0.565 . . . . 74.23 109.728 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.526 HD21 ' CD2' ' A' ' 120' ' ' HIS . 24.7 t-20 71.71 1.16 3.78 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.729 0.776 . . . . 60.54 110.042 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.67 8.32 63.93 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.478 -0.783 . . . . 50.43 111.556 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -117.9 154.52 31.74 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.094 -0.336 . . . . 71.04 110.094 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -83.31 98.71 9.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.101 0.477 . . . . 72.23 110.341 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.599 ' SG ' HG21 ' A' ' 112' ' ' ILE . 78.6 m -101.22 123.66 45.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.817 -0.629 . . . . 74.4 111.07 -176.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.507 ' HG3' ' HE2' ' A' ' 166' ' ' LYS . 3.8 tm-20 -83.7 122.92 29.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.518 -0.764 . . . . 73.12 109.738 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.418 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.4 m -118.74 148.77 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.202 -0.454 . . . . 73.23 111.189 -171.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.772 ' HA ' ' HG3' ' A' ' 96' ' ' GLN . 75.8 mtt180 -139.59 173.4 11.57 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.036 0.446 . . . . 71.13 111.503 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 1.019 ' HE3' ' HA ' ' A' ' 100' ' ' ALA . 47.9 mttm -71.73 117.56 13.47 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.08 -1.081 . . . . 72.4 108.08 166.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.544 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -76.98 93.6 3.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.076 0.465 . . . . 72.3 111.862 -175.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.578 HD23 ' N1 ' ' B' ' 3' ' ' ' A' . 2.7 pt? -91.37 131.84 36.59 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.696 -0.853 . . . . 71.15 108.696 170.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.6 m -53.97 148.56 10.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.449 -0.341 . . . . 71.44 110.857 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.914 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.0 pttp -61.74 -26.54 68.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.288 0.566 . . . . 74.43 109.625 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -56.52 -38.6 72.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.994 -1.003 . . . . 73.3 110.525 172.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -95.17 -38.4 10.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.454 -0.794 . . . . 73.12 110.974 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.914 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 23.1 ptm -66.05 -20.05 66.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 72.44 110.792 -177.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -77.65 -22.6 50.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.097 -0.501 . . . . 70.22 110.595 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 18.7 m -97.11 -41.93 8.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 73.51 110.43 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -66.13 -38.77 89.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 61.41 110.855 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.9 t -117.06 113.87 22.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.003 -0.544 . . . . 71.42 110.269 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.6 t -64.3 108.78 1.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.023 -0.535 . . . . 75.21 109.673 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 14.3 m -112.11 125.38 54.04 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.138 0.495 . . . . 73.41 110.783 -175.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -114.34 89.37 3.08 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.889 -0.782 . . . . 75.11 108.889 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -90.54 -28.94 18.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.948 -0.569 . . . . 75.31 110.015 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 80.8 -52.54 4.45 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.891 -0.595 . . . . 72.15 112.366 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.225 -0.893 . . . . 74.44 109.694 179.711 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.973 " C4'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.433 -0.462 0 O5'-C5'-C4' 111.559 0.971 . 0.0 '__' . 74.13 . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.973 H5'' " C4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.974 0 C3'-C2'-C1' 104.309 3.121 OUTLIER-EPSILON 0.0 OUTLIER zeta-1 72.34 . . . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.694 ' H8 ' H5'' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.995 0 O4'-C4'-C3' 103.573 -1.377 . 0.0 OUTLIER epsilon-1 75.14 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.723 " O4'" ' HE1' ' A' ' 137' ' ' MET . . . . . . . . 0 O5'--C5' 1.424 -0.974 0 C4'-C3'-C2' 104.314 1.614 . 0.0 OUTLIER alpha 75.22 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.524 H5'' ' HD3' ' A' ' 140' ' ' ARG . . . . . . . . 0 O5'--C5' 1.422 -1.104 0 C3'-C2'-C1' 102.806 1.451 . 0.0 OUTLIER gamma 73.33 . . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.983 0 C4'-C3'-C2' 104.138 1.438 . 0.0 OUTLIER gamma 73.43 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 109.907 -0.405 . . . . 73.1 109.907 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 97' ' ' ARG . 15.2 mm100 -111.12 -5.58 14.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.713 -0.221 . . . . 70.41 111.124 -175.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.515 ' HB3' ' HB3' ' A' ' 100' ' ' ALA . 9.2 mmt180 68.75 107.49 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.206 0 O-C-N 123.744 0.653 . . . . 64.54 110.658 -176.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.504 ' O ' ' HB2' ' A' ' 179' ' ' LYS . 7.4 Cg_exo -71.55 120.36 6.88 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.0 2.467 . . . . 62.43 111.821 -175.365 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.44 ' HA2' HD11 ' A' ' 102' ' ' LEU . . . 70.94 32.22 66.44 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.011 -0.614 . . . . 63.22 112.499 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.546 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . . . -77.94 -7.92 57.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.175 0.512 . . . . 73.33 111.168 -178.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -116.63 11.9 14.84 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.856 -0.611 . . . . 73.3 110.115 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.44 HD11 ' HA2' ' A' ' 99' ' ' GLY . 62.5 mt -118.74 148.24 43.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.974 -0.557 . . . . 72.54 111.405 -172.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.7 p -81.06 100.08 8.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.232 -0.655 . . . . 74.33 109.232 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 179' ' ' LYS . 31.9 t -102.49 138.39 26.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.785 -0.643 . . . . 52.44 110.138 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.663 ' HA ' HG23 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -110.33 -9.74 14.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.885 0.374 . . . . 61.45 110.501 -179.058 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.592 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 32.2 ttpt -126.18 135.57 51.79 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.065 0.46 . . . . 71.43 110.397 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.538 ' CG2' HG13 ' A' ' 159' ' ' VAL . 7.5 pt -104.61 161.28 4.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.163 0.506 . . . . 74.32 111.544 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.5 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 67.8 t80 -108.21 115.64 30.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.157 -0.929 . . . . 64.34 109.802 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.416 HG11 ' CG2' ' A' ' 112' ' ' ILE . 5.2 t -104.24 106.33 20.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.134 -0.321 . . . . 71.23 110.134 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.36 155.34 16.12 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.948 -0.644 . . . . 61.13 112.524 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.88 56.31 17.16 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.059 -0.591 . . . . 37.76 112.57 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.445 HG22 ' SG ' ' A' ' 175' ' ' CYS . 32.2 pt -111.36 -172.42 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.861 0.362 . . . . 74.54 110.969 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -92.18 170.74 9.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.099 -0.5 . . . . 73.12 110.019 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -74.24 -42.12 60.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 121.105 -0.238 . . . . 75.34 110.422 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -83.81 65.42 8.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.9 0.857 . . . . 71.24 109.241 173.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.6 m -146.33 100.49 3.37 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.665 -1.152 . . . . 73.15 108.574 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.493 ' CG ' ' HD2' ' A' ' 119' ' ' HIS . 12.0 pt-20 -121.15 -163.61 1.05 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.034 -0.985 . . . . 72.03 110.524 -171.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.554 ' HA ' HG21 ' A' ' 134' ' ' ILE . 9.9 tt0 -54.45 -50.63 67.23 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.319 0.489 . . . . 43.34 112.319 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.493 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.6 p80 -64.31 -26.56 68.54 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 121.068 -0.253 . . . . 74.13 110.97 -176.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.433 ' CD2' HD21 ' A' ' 171' ' ' ASN . 39.1 m80 -68.46 -61.49 1.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.623 -0.262 . . . . 54.5 110.649 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.408 HD21 ' O ' ' A' ' 117' ' ' GLU . 0.6 OUTLIER -55.89 -50.79 69.69 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.131 -0.486 . . . . 61.33 110.434 178.013 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -53.46 -49.77 66.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.73 -0.668 . . . . 74.34 111.425 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.69 -28.18 68.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.676 0.274 . . . . 71.22 111.713 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -88.49 -34.86 17.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.83 0.347 . . . . 74.21 111.214 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.432 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 36.9 m-85 -92.22 -17.7 24.46 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.441 0.534 . . . . 60.31 112.441 -173.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -22.01 66.25 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.13 0.491 . . . . 72.32 110.993 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -64.15 -35.85 82.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.75 -0.659 . . . . 74.54 110.752 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.438 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 41.8 m-85 -80.93 -21.07 40.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.009 -0.541 . . . . 73.31 111.12 -176.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.744 ' HA3' ' HG ' ' A' ' 158' ' ' SER . . . 166.78 -167.4 39.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.016 -1.087 . . . . 53.23 113.066 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -79.18 120.97 24.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.447 0.642 . . . . 74.23 111.231 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.457 HG21 HD12 ' A' ' 134' ' ' ILE . 45.6 mt -94.28 133.74 34.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.318 -0.855 . . . . 73.4 110.039 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.488 ' HG3' ' N ' ' A' ' 154' ' ' ASP . 20.0 mt-10 -78.03 -70.01 0.51 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.203 -0.453 . . . . 74.13 110.635 176.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.4 m -143.54 154.89 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.663 -0.244 . . . . 63.43 110.542 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.63 ' CD1' HG12 ' A' ' 151' ' ' VAL . 24.9 mm -107.34 112.69 41.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.574 -0.528 . . . . 62.55 109.574 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 89.6 mt-10 -92.63 99.85 12.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.155 0.502 . . . . 72.44 110.416 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.542 HD13 ' H ' ' A' ' 118' ' ' GLU . 31.8 mt -83.91 108.19 16.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.985 -0.552 . . . . 74.23 109.652 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.729 ' HG3' ' HB3' ' A' ' 146' ' ' ARG . 24.5 tpp -69.13 108.45 3.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.65 0.738 . . . . 73.33 109.887 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.516 HG23 ' O ' ' A' ' 144' ' ' LYS . 5.0 p -103.35 176.62 5.09 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.104 -0.953 . . . . 74.52 111.514 -174.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.641 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 19.9 t70 -64.34 138.78 58.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.585 -0.734 . . . . 72.02 109.559 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -66.46 -21.97 66.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.4 -0.364 . . . . 74.22 111.193 -174.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -108.8 -57.14 0.55 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.537 -0.84 . . . . 72.52 112.522 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 26.8 t -83.82 -20.54 33.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.797 0.332 . . . . 64.43 111.035 -174.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 68.63 35.25 80.36 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.726 -0.749 . . . . 72.45 112.381 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.677 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 39.4 pttt -93.25 -76.79 0.46 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.581 -0.155 . . . . 74.44 110.581 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.677 ' H ' ' HG3' ' A' ' 144' ' ' LYS . 26.3 mtpt -157.15 137.04 12.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.469 0.307 . . . . 64.1 110.386 174.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.729 ' HB3' ' HG3' ' A' ' 137' ' ' MET . 31.3 tpt180 -90.51 -26.79 19.59 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.563 -0.903 . . . . 70.01 108.563 170.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.667 ' C ' H5'' ' B' ' 1' ' ' ' U' . . . 136.97 -74.78 0.41 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.195 -0.911 . . . . 74.32 111.915 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.484 ' HB3' " H5'" ' B' ' 2' ' ' ' C' . 31.2 p90 -78.5 168.15 20.21 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 122.405 0.282 . . . . 72.51 111.096 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.32 173.28 11.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.462 -0.336 . . . . 74.02 110.741 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.494 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 88.3 m-85 -133.87 148.35 51.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.111 -0.495 . . . . 73.12 110.373 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.63 HG12 ' CD1' ' A' ' 134' ' ' ILE . 55.8 t -127.17 110.94 23.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.189 -0.46 . . . . 74.03 110.072 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.592 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 25.0 m -89.35 126.71 35.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.282 -0.417 . . . . 64.33 110.533 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.487 ' CD2' HG22 ' A' ' 159' ' ' VAL . 96.6 m-85 -108.37 149.12 29.12 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.237 -0.283 . . . . 75.41 110.237 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.488 ' N ' ' HG3' ' A' ' 132' ' ' GLU . 18.2 t70 -63.65 -29.07 70.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 70.43 111.439 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -132.21 147.63 52.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.289 -0.414 . . . . 64.32 110.616 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -21.1 61.81 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.812 -0.44 . . . . 73.01 109.812 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -58.42 -50.01 75.22 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.86 -0.609 . . . . 74.21 110.765 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.744 ' HG ' ' HA3' ' A' ' 129' ' ' GLY . 9.9 m -60.66 -29.1 69.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 72.34 110.957 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.663 HG23 ' HA ' ' A' ' 105' ' ' LYS . 20.9 t -74.29 -37.35 45.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.487 -0.779 . . . . 75.15 111.081 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.424 ' HA ' HG21 ' A' ' 163' ' ' VAL . 25.8 t70 -60.97 -38.91 87.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.361 -0.381 . . . . 72.0 112.025 -172.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.438 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 4.0 mttt -66.01 -18.56 65.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.207 0.527 . . . . 73.25 110.825 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.424 ' CG2' HG13 ' A' ' 177' ' ' VAL . 93.2 mt -98.84 -49.86 11.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.494 -0.775 . . . . 75.11 111.067 -176.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.567 ' HB ' ' HD2' ' A' ' 179' ' ' LYS . 24.7 m -67.36 -18.35 23.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.693 0.627 . . . . 73.41 112.693 -174.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.0 pp -69.46 -29.33 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.054 0.454 . . . . 72.32 111.063 177.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -108.23 144.62 35.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.04 -0.527 . . . . 74.52 109.887 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.604 ' HE3' ' OE2' ' A' ' 176' ' ' GLU . 84.3 tttt -93.64 -64.27 1.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.818 0.342 . . . . 74.43 111.167 -177.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.557 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 21.8 m-85 -83.17 106.83 15.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.076 0.465 . . . . 74.31 111.223 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -106.7 170.06 8.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.68 -0.691 . . . . 63.31 110.323 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.7 m -114.57 95.74 5.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.518 -0.31 . . . . 74.12 110.52 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.405 ' O ' ' HB3' ' A' ' 171' ' ' ASN . 6.7 p -122.75 137.72 55.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.629 -0.508 . . . . 74.32 109.629 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.433 HD21 ' CD2' ' A' ' 120' ' ' HIS . 26.0 t-20 69.73 1.93 3.61 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.641 0.734 . . . . 75.43 110.496 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.9 13.53 57.71 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.539 -0.624 . . . . 72.33 111.539 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -122.88 145.12 48.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.071 -0.344 . . . . 74.11 110.071 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.488 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 9.0 t30 -80.64 105.99 12.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.108 -0.496 . . . . 73.22 110.214 176.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.445 ' SG ' HG22 ' A' ' 112' ' ' ILE . 25.4 m -115.39 165.85 12.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.106 -0.497 . . . . 72.2 110.294 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.604 ' OE2' ' HE3' ' A' ' 166' ' ' LYS . 20.6 tt0 -99.04 134.51 41.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.949 0.404 . . . . 71.2 110.755 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 83.9 t -126.53 130.47 71.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.903 -0.59 . . . . 75.42 110.521 176.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.44 ' HD3' ' OE2' ' A' ' 176' ' ' GLU . 19.8 mtm-85 -133.58 177.89 7.35 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.075 -0.713 . . . . 75.15 109.075 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.567 ' HD2' ' HB ' ' A' ' 163' ' ' VAL . 0.3 OUTLIER -72.06 128.9 37.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.941 -0.763 . . . . 71.45 108.941 173.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.746 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -84.37 86.04 7.31 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.446 -0.502 . . . . 54.35 110.88 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.581 HD21 ' N1 ' ' B' ' 3' ' ' ' A' . 2.6 pt? -80.61 135.44 36.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.198 -0.667 . . . . 73.44 109.198 175.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.8 m -49.9 136.15 18.74 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.537 0.523 . . . . 61.11 111.091 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.67 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.8 pttp -63.65 -24.66 67.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.69 0.281 . . . . 73.04 110.809 -178.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -60.98 -41.06 95.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.195 0.522 . . . . 74.42 109.94 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -84.9 -35.87 21.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.507 -0.77 . . . . 75.33 110.709 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.67 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 12.7 ptm -65.22 -20.89 66.65 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.755 0.312 . . . . 74.11 110.22 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.86 -42.73 60.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 72.43 110.289 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.2 m -71.56 -31.2 66.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.388 0.614 . . . . 65.44 110.034 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -82.17 -6.99 59.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.424 -0.807 . . . . 75.11 111.224 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' SER . . . . . 0.419 ' HB2' ' O ' ' A' ' 186' ' ' MET . 23.0 t -79.6 79.67 6.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.599 0.714 . . . . 74.55 110.577 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 43.5 m -152.56 25.99 0.58 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.961 -1.018 . . . . 75.53 108.497 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 33.1 m -79.52 80.47 5.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.876 -1.056 . . . . 71.22 110.631 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -115.56 11.68 15.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.574 -0.739 . . . . 74.4 109.755 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -93.75 2.47 56.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.941 -0.572 . . . . 72.33 110.674 -175.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -84.86 47.46 3.86 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.935 -0.65 . . . . 75.51 111.992 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 . . . . . 0 C--O 1.245 0.84 0 CA-C-O 118.548 -0.739 . . . . 75.14 109.613 -178.56 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.907 " H3'" " C5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.726 0 C4'-C3'-C2' 104.958 2.258 . 0.0 '__' . 73.54 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.907 " C5'" " H3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.845 0 C4'-C3'-C2' 105.367 2.667 . 0.0 OUTLIER zeta-1 75.43 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.746 ' N1 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.424 -0.982 0 O4'-C4'-C3' 103.342 -1.542 . 0.0 OUTLIER . 75.54 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.605 " C4'" H5'' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.947 0 C3'-C2'-C1' 99.94 -1.733 . 0.0 OUTLIER alpha 73.42 . . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.673 ' C4 ' ' HD3' ' A' ' 146' ' ' ARG . . . . . . . . 0 O5'--C5' 1.426 -0.897 0 O4'-C4'-C3' 103.373 -1.519 OUTLIER-EPSILON 0.0 OUTLIER gamma 75.45 . . . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.518 ' H5 ' " H1'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.98 0 C4'-C3'-C2' 103.589 0.889 . 0.0 OUTLIER epsilon-1 73.45 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.7 p . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.368 0.128 . . . . 60.13 110.71 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.851 ' HG2' ' HG2' ' A' ' 193' ' ' GLN . 77.9 mt-30 59.61 23.6 12.35 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.86 0.464 . . . . 62.33 111.442 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.471 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 13.7 mtp180 -118.65 143.88 34.34 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 63.33 111.603 -175.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.735 ' HA ' HD12 ' A' ' 181' ' ' LEU . 2.0 Cg_endo -86.06 -168.72 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.651 2.901 . . . . 70.52 111.524 172.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.67 80.57 1.04 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.653 -0.784 . . . . 74.52 111.263 173.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.6 -30.59 70.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.933 0.346 . . . . 74.5 111.933 -175.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -88.74 9.4 24.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.405 -0.361 . . . . 74.25 111.236 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -104.8 151.88 23.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.37 -0.377 . . . . 74.43 110.529 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 p -79.71 97.17 6.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.304 0.573 . . . . 65.43 110.814 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.519 HG23 ' HB3' ' A' ' 179' ' ' LYS . 2.7 t -92.39 148.71 4.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.575 -0.739 . . . . 74.21 109.836 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.729 ' HA ' HG22 ' A' ' 159' ' ' VAL . 7.0 mtmt -122.48 24.15 9.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.379 0.609 . . . . 73.4 110.332 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.515 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.8 ttpt -159.42 135.08 8.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.407 -0.815 . . . . 74.34 109.454 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.532 HG12 ' HB ' ' A' ' 151' ' ' VAL . 6.1 pt -106.44 160.6 5.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.806 0.336 . . . . 74.01 111.064 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.43 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 58.9 t80 -107.07 119.35 39.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.784 -0.644 . . . . 72.24 110.171 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.409 HG12 HD13 ' A' ' 121' ' ' LEU . 43.0 t -101.3 103.16 14.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.945 0.403 . . . . 72.32 110.357 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.68 178.45 16.63 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.284 -0.726 . . . . 64.44 111.284 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.775 ' H ' H5'' ' B' ' 2' ' ' ' C' . . . 68.73 26.13 74.7 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.645 -0.788 . . . . 63.02 112.928 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.569 ' O ' " H3'" ' B' ' 1' ' ' ' U' . 28.4 pt -85.45 -163.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.255 -0.646 . . . . 75.11 109.255 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -140.08 -67.33 0.43 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.335 -0.546 . . . . 72.14 110.875 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -88.9 168.9 12.03 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.778 -0.646 . . . . 75.22 110.431 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.13 105.56 0.61 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.18 0.514 . . . . 64.11 110.732 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.6 m -101.74 117.04 34.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.428 -0.805 . . . . 72.2 109.454 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.606 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 13.1 pt-20 -97.96 -177.33 3.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.826 0.346 . . . . 75.14 111.515 -172.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.527 ' HA ' HG23 ' A' ' 134' ' ' ILE . 13.7 tt0 -59.18 -45.88 89.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.01 -0.541 . . . . 75.4 111.555 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.424 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -60.23 -27.54 67.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.324 -0.398 . . . . 60.44 110.715 -178.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.606 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 30.0 m80 -72.48 -60.75 2.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.56 -0.291 . . . . 71.04 111.017 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.409 HD13 HG12 ' A' ' 109' ' ' VAL . 0.9 OUTLIER -57.57 -49.22 77.09 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.983 0.421 . . . . 71.11 110.251 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -56.74 -44.68 81.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.811 -0.631 . . . . 73.53 111.144 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.21 -31.11 68.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 75.52 111.411 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.405 ' CD1' HG21 ' A' ' 170' ' ' VAL . 78.7 t80 -86.97 -49.32 7.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.984 0.421 . . . . 73.14 111.09 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.497 ' CD1' HG22 ' A' ' 151' ' ' VAL . 65.3 m-85 -78.24 -14.01 59.61 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.579 0.585 . . . . 72.03 112.579 -171.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -25.23 67.72 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.68 0.252 . . . . 62.24 111.68 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -72.78 -19.33 61.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.949 0.404 . . . . 62.51 110.615 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.425 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 88.7 m-85 -83.86 -35.19 24.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.11 -0.495 . . . . 73.22 110.485 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.41 -167.67 38.36 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.438 -0.887 . . . . 72.53 112.556 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -77.59 122.68 25.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.206 0.526 . . . . 74.11 111.173 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.468 HG21 HD12 ' A' ' 134' ' ' ILE . 42.0 mt -97.41 131.15 44.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.604 -0.725 . . . . 75.31 110.504 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.407 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 7.2 mm-40 -78.01 -72.28 0.37 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.652 -0.704 . . . . 75.22 110.566 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.7 m -145.49 147.29 18.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.524 -0.307 . . . . 74.21 110.725 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.623 ' CD1' HG13 ' A' ' 151' ' ' VAL . 30.3 mm -102.83 107.71 22.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.888 -0.412 . . . . 73.41 109.888 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.506 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 38.1 mt-10 -85.96 103.2 14.45 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.792 -0.447 . . . . 72.44 109.792 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.5 HG21 ' HG2' ' A' ' 145' ' ' LYS . 23.9 mt -78.81 -11.24 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.089 0.471 . . . . 73.14 110.328 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.641 ' HE3' " C4'" ' B' ' 4' ' ' ' G' . 14.0 tpp 62.31 96.99 0.03 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.945 0.879 . . . . 72.23 110.651 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 5.1 p -101.63 151.08 22.43 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.963 -1.017 . . . . 72.15 110.69 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.662 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 17.6 t70 -52.4 142.21 17.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.585 -0.734 . . . . 72.33 110.525 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.411 ' HD3' ' C6 ' ' B' ' 5' ' ' ' U' . 15.8 tpt180 -65.43 -20.69 66.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.66 -0.7 . . . . 73.41 111.783 -171.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -122.52 -44.19 0.36 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.491 -0.862 . . . . 44.44 113.063 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.549 ' HB2' ' HG2' ' A' ' 144' ' ' LYS . 19.8 m -80.46 -21.85 41.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.787 0.327 . . . . 51.33 111.155 -175.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.84 33.54 80.2 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.062 -0.589 . . . . 54.33 112.385 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.549 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 14.0 ptpt -106.13 146.76 29.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.098 -0.334 . . . . 63.32 110.098 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . 0.5 ' HG2' HG21 ' A' ' 136' ' ' ILE . 16.9 mtpt -58.41 124.05 18.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.699 0.285 . . . . 72.33 110.528 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.413 ' HD2' ' O4 ' ' B' ' 5' ' ' ' U' . 69.1 ttt180 -81.12 -55.58 4.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.925 -0.579 . . . . 74.22 111.663 -173.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 168.43 -77.32 0.11 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.461 -0.876 . . . . 71.11 112.253 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.504 ' CE2' " H4'" ' B' ' 3' ' ' ' A' . 45.9 p90 -71.36 145.53 49.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.406 -0.22 . . . . 74.13 110.406 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -128.43 165.41 20.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.332 0.587 . . . . 62.34 111.443 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.506 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 66.0 m-85 -132.06 136.28 47.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.442 -0.799 . . . . 73.41 109.757 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.623 HG13 ' CD1' ' A' ' 134' ' ' ILE . 38.9 t -111.34 104.82 17.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.864 -0.421 . . . . 74.04 109.864 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.515 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 7.5 m -83.79 125.87 32.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 75.41 110.065 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.533 ' CD2' HG21 ' A' ' 159' ' ' VAL . 98.7 m-85 -109.5 151.55 26.59 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.074 -0.343 . . . . 75.35 110.074 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.407 ' HB2' ' HG2' ' A' ' 132' ' ' GLU . 26.6 t70 -78.53 -6.38 55.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.209 0.528 . . . . 74.15 111.163 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 159' ' ' VAL . 5.6 t70 -140.19 145.68 37.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.174 -0.466 . . . . 74.14 110.31 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -79.21 -18.44 52.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.148 -0.478 . . . . 73.13 110.56 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -73.07 -38.56 66.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.205 0.526 . . . . 71.01 110.064 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.2 m -64.65 -28.66 69.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.518 -0.765 . . . . 64.23 110.371 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.729 HG22 ' HA ' ' A' ' 105' ' ' LYS . 22.7 t -76.78 -36.56 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.66 -0.7 . . . . 75.04 110.201 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.29 -31.09 70.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.732 -0.667 . . . . 73.03 111.387 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.425 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 13.0 mmtp -65.1 -27.57 68.84 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.47 0.652 . . . . 73.14 110.021 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.505 HG23 HD13 ' A' ' 107' ' ' ILE . 90.4 mt -100.23 -50.18 10.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.949 -1.023 . . . . 73.53 111.828 -168.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.598 ' HB ' ' HG3' ' A' ' 179' ' ' LYS . 28.1 m -65.73 -16.76 21.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.448 0.536 . . . . 74.22 112.448 -173.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -74.48 -26.83 20.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.965 0.412 . . . . 65.35 110.781 176.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -100.42 146.2 27.3 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.695 -0.684 . . . . 71.2 109.2 175.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -100.63 -66.06 0.93 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.762 0.315 . . . . 62.4 110.598 -177.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.482 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 19.7 m-85 -82.49 101.85 10.97 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.131 0.491 . . . . 73.13 111.11 -177.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -98.0 -172.8 2.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.721 -0.672 . . . . 74.13 109.593 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 61.4 m -141.64 106.63 4.94 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.222 0.534 . . . . 74.55 110.821 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.405 HG21 ' CD1' ' A' ' 124' ' ' TYR . 39.2 t -121.18 135.32 61.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.631 -0.713 . . . . 72.21 109.739 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.9 t30 71.47 -4.62 1.81 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.277 0.56 . . . . 75.45 111.393 177.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 109.19 4.87 30.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.954 -0.641 . . . . 70.2 111.752 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.467 ' CD2' ' HA ' ' A' ' 112' ' ' ILE . 80.3 t60 -114.63 131.61 56.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.917 0.389 . . . . 72.45 110.326 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.64 103.15 4.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.896 -0.593 . . . . 71.13 109.585 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 14.9 p -103.8 176.96 4.98 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.162 -0.472 . . . . 62.31 110.77 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -118.34 120.38 37.44 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.083 0.468 . . . . 74.42 110.117 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 87.1 t -113.35 135.09 54.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.898 -0.592 . . . . 72.02 111.045 -175.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -129.12 179.67 5.63 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.553 -0.749 . . . . 73.4 109.742 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.598 ' HG3' ' HB ' ' A' ' 163' ' ' VAL . 0.6 OUTLIER -77.67 122.07 24.84 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.918 -1.141 . . . . 71.53 107.918 172.391 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.537 ' HA ' ' C2 ' ' B' ' 3' ' ' ' A' . . . -77.12 89.8 3.63 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.513 -0.475 . . . . 63.01 111.199 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.735 HD12 ' HA ' ' A' ' 98' ' ' PRO . 2.3 pt? -81.35 138.96 35.6 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.805 -0.813 . . . . 73.04 108.805 175.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.1 m -54.15 145.9 16.19 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.085 -0.339 . . . . 65.4 110.085 -178.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.739 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.4 pttp -61.92 -17.51 57.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.921 0.391 . . . . 64.14 110.31 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -67.67 -51.98 43.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.377 0.608 . . . . 74.21 109.738 170.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -64.96 -41.64 95.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.309 -0.86 . . . . 75.02 110.553 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.739 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 16.4 ptm -72.76 -13.17 61.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.946 -0.57 . . . . 73.15 110.692 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -86.27 -11.26 52.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.031 0.443 . . . . 44.11 110.334 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 16.0 m -111.57 -46.07 3.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.888 -0.596 . . . . 53.24 111.37 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -90.88 -38.22 13.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.002 0.429 . . . . 64.34 111.782 -176.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.8 m -107.75 31.51 5.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.235 -0.439 . . . . 74.01 110.651 -175.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.8 m -62.24 -28.8 69.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.922 -0.581 . . . . 65.22 111.415 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 30.4 m -97.76 75.64 2.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.218 0.532 . . . . 63.44 111.341 -178.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . 0.851 ' HG2' ' HG2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -136.87 95.47 3.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.389 -0.967 . . . . 75.32 108.389 173.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -87.12 103.19 15.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.909 0.385 . . . . 72.32 111.178 -174.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -87.64 -10.82 69.52 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.198 -0.761 . . . . 55.01 111.198 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.7 tpm_? . . . . . 0 C--O 1.245 0.82 0 CA-C-O 118.395 -0.812 . . . . 73.13 110.089 178.579 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.954 " H4'" " C5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.43 -0.6 0 C4'-C3'-C2' 105.212 2.512 OUTLIER-EPSILON 0.0 '__' . 75.54 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.954 " C5'" " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.053 0 C4'-C3'-C2' 106.123 3.423 . 0.0 OUTLIER epsilon-1 75.42 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.537 ' C2 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.425 -0.955 0 C3'-C2'-C1' 103.189 1.876 . 0.0 OUTLIER alpha 75.22 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.641 " C4'" ' HE3' ' A' ' 137' ' ' MET . . . . . . . . 0 O5'--C5' 1.423 -1.043 0 C3'-C2'-C1' 99.722 -1.975 . 0.0 OUTLIER alpha 75.41 . . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.72 ' C6 ' " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.059 0 C4'-C3'-C2' 105.777 3.077 OUTLIER-DELTA 0.0 OUTLIER . 74.2 . . . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.583 ' H6 ' " O5'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 P-O3'-C3' 118.933 -0.639 . 0.0 OUTLIER gamma 75.43 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.8 t . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.635 -0.506 . . . . 45.03 109.635 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.556 ' O ' ' HD3' ' A' ' 98' ' ' PRO . 73.1 mt-30 71.94 -46.75 0.65 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.573 0.749 . . . . 75.43 111.702 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.65 ' HB3' ' HB3' ' A' ' 100' ' ' ALA . 12.5 mmt180 -110.63 87.64 6.83 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.726 -0.216 . . . . 74.02 110.519 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.556 ' HD3' ' O ' ' A' ' 96' ' ' GLN . 6.1 Cg_exo -74.77 -39.18 1.41 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.637 2.225 . . . . 64.34 111.597 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.444 ' HA3' HD11 ' A' ' 102' ' ' LEU . . . -140.88 67.49 0.49 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.379 -0.828 . . . . 73.52 111.47 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.788 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . . . -74.82 -33.37 62.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.956 0.408 . . . . 62.11 110.833 -178.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -83.3 -2.63 56.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.857 -0.61 . . . . 74.15 110.338 177.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.444 HD11 ' HA3' ' A' ' 99' ' ' GLY . 68.6 mt -99.5 177.61 5.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.702 -0.681 . . . . 75.32 109.62 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.53 HG21 ' HB2' ' A' ' 156' ' ' HIS . 0.5 OUTLIER -118.13 129.51 55.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.167 0.508 . . . . 75.14 111.165 -177.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.11 148.58 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.883 -0.599 . . . . 72.23 110.183 -175.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.615 ' HA ' HG23 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -116.84 -3.75 11.64 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.244 0.461 . . . . 72.13 112.244 -177.602 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.593 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 26.0 ttpt -135.31 138.59 43.58 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.015 -0.365 . . . . 65.43 110.015 177.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.459 ' CG2' HG13 ' A' ' 159' ' ' VAL . 2.1 pp -106.35 154.35 7.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.984 0.421 . . . . 74.31 110.759 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.421 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 62.4 t80 -102.23 127.21 49.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.586 -0.734 . . . . 74.34 109.996 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.49 HG23 ' HG ' ' A' ' 121' ' ' LEU . 46.7 t -102.31 110.03 27.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.88 0.372 . . . . 74.12 110.581 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.85 -174.23 13.64 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.957 -0.857 . . . . 71.11 110.957 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.38 16.91 67.86 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.219 -0.515 . . . . 63.24 113.313 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.625 ' O ' " H3'" ' B' ' 1' ' ' ' U' . 18.1 pt -91.58 173.38 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 117.115 0.458 . . . . 73.04 109.869 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -145.8 -48.32 0.22 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.002 -0.279 . . . . 75.12 110.742 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -74.91 165.85 24.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 73.41 110.523 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.93 103.67 0.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 64.02 110.207 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.6 m -113.05 116.76 30.42 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.645 -0.707 . . . . 72.45 109.948 -176.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.453 ' CG ' ' HD2' ' A' ' 119' ' ' HIS . 12.2 pt-20 -113.71 -171.95 1.99 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.359 -0.382 . . . . 73.3 110.972 -175.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.552 ' H ' HD13 ' A' ' 136' ' ' ILE . 8.5 tt0 -58.19 -46.41 85.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.877 -0.601 . . . . 73.35 112.347 -173.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.453 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 0.8 OUTLIER -62.41 -28.98 70.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.699 0.285 . . . . 74.44 110.673 -178.217 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.431 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 32.3 m80 -68.05 -56.37 9.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.355 -0.384 . . . . 73.13 110.791 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.49 ' HG ' HG23 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -60.79 -51.63 68.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.282 -0.417 . . . . 73.44 110.558 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.416 ' HB2' HG13 ' A' ' 134' ' ' ILE . 0.6 OUTLIER -55.06 -49.56 71.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 75.24 111.648 -177.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -59.15 -30.14 67.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 55.3 111.218 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.447 ' CD1' HG22 ' A' ' 170' ' ' VAL . 76.6 t80 -85.25 -47.92 9.6 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.814 -0.354 . . . . 64.1 111.111 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.512 ' CD1' HG22 ' A' ' 151' ' ' VAL . 42.8 m-85 -77.48 -18.15 57.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.373 0.508 . . . . 64.14 112.373 -172.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.55 -24.51 67.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.804 0.335 . . . . 74.33 111.618 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 124' ' ' TYR . 7.0 pt20 -76.19 -14.71 60.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.108 0.48 . . . . 65.13 110.202 178.304 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -87.72 -25.52 23.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 75.14 110.319 178.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.496 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 165.22 -151.17 19.82 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 119.912 -1.137 . . . . 44.13 113.689 175.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.54 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 20.4 tptm -91.23 117.07 29.33 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.394 0.616 . . . . 71.43 111.279 -172.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.446 HG12 ' CE1' ' A' ' 153' ' ' PHE . 38.2 mt -99.81 138.8 23.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.325 -0.852 . . . . 75.23 110.69 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.41 ' HG3' ' N ' ' A' ' 154' ' ' ASP . 21.8 mt-10 -82.59 -75.38 0.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.021 -0.536 . . . . 73.14 110.341 172.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 m -143.97 152.4 15.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.616 -0.72 . . . . 71.54 110.079 -178.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.618 ' CD1' HG13 ' A' ' 151' ' ' VAL . 22.7 mm -100.84 138.23 25.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.907 -0.775 . . . . 72.13 108.907 175.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.454 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 44.7 mt-10 -117.94 97.94 6.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.815 0.34 . . . . 72.33 110.743 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.552 HD13 ' H ' ' A' ' 118' ' ' GLU . 8.5 mt -76.21 105.51 5.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.066 -1.087 . . . . 73.15 108.066 172.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.616 ' HE3' " C4'" ' B' ' 4' ' ' ' G' . 10.4 tpt -79.94 98.46 7.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.855 0.836 . . . . 71.5 111.272 -171.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 7.5 p -89.72 -170.28 2.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.002 -0.999 . . . . 64.22 110.339 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -88.68 129.47 35.51 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.53 -0.544 . . . . 74.22 109.53 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 22.1 tpt180 -62.29 -19.15 62.97 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.421 0.45 . . . . 71.31 111.984 -177.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -105.6 -53.45 0.77 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.343 -0.932 . . . . 72.15 112.73 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.533 ' HB2' ' HG2' ' A' ' 144' ' ' LYS . 43.1 m -86.19 -16.95 36.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.872 0.323 . . . . 72.55 111.872 -173.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.29 36.76 92.15 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.972 -0.632 . . . . 73.51 112.489 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.533 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 13.1 ptpt -114.1 146.29 40.46 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.771 -0.455 . . . . 73.43 109.771 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -63.15 118.83 8.47 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.729 -0.389 . . . . 75.31 110.201 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -86.6 3.22 45.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.168 0.508 . . . . 74.4 110.598 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.438 ' HA3' " H1'" ' B' ' 1' ' ' ' U' . . . 109.1 -65.94 0.24 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.943 -0.646 . . . . 64.22 112.799 174.723 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.501 ' HA ' ' OP2' ' B' ' 2' ' ' ' C' . 33.0 p90 -75.82 150.6 37.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.269 0.556 . . . . 72.42 111.841 -173.692 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -135.26 171.9 13.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.514 -0.766 . . . . 74.34 110.274 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.454 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 70.1 m-85 -136.64 152.09 50.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.355 -0.384 . . . . 73.42 110.115 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.618 HG13 ' CD1' ' A' ' 134' ' ' ILE . 62.1 t -128.49 110.48 21.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.133 -0.485 . . . . 72.32 109.88 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.593 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 97.0 m -86.17 125.02 33.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.109 -0.496 . . . . 73.42 110.085 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.446 ' CE1' HG12 ' A' ' 131' ' ' ILE . 97.0 m-85 -106.06 146.79 29.68 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.871 0.367 . . . . 64.43 110.346 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.54 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 21.4 t0 -78.32 -19.13 54.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.535 0.683 . . . . 73.23 109.633 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -128.89 132.71 47.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.222 -0.899 . . . . 52.34 109.694 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.54 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.2 p-80 -73.96 -14.01 60.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.203 -0.453 . . . . 71.14 110.474 177.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -66.33 -40.84 90.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.195 0.522 . . . . 64.13 110.025 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.614 ' HA ' ' HE3' ' A' ' 161' ' ' LYS . 4.6 m -66.76 -28.54 68.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.419 -0.81 . . . . 71.32 110.986 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.615 HG23 ' HA ' ' A' ' 105' ' ' LYS . 18.7 t -72.57 -35.11 49.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.722 -0.672 . . . . 63.05 111.22 -176.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -56.74 -51.47 68.73 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.084 -0.507 . . . . 71.13 111.897 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.614 ' HE3' ' HA ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -65.16 -14.08 59.72 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.996 0.369 . . . . 72.21 111.996 -178.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 94.5 mt -93.7 -48.27 13.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 120.661 0.267 . . . . 74.0 110.926 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.452 HG13 HG11 ' A' ' 159' ' ' VAL . 35.6 m -69.69 -19.42 22.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.343 0.497 . . . . 63.12 112.343 -175.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.39 -30.72 49.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.78 0.324 . . . . 71.22 111.529 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.494 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 14.0 pt20 -113.49 145.99 40.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.389 -0.369 . . . . 74.35 110.17 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.527 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 77.0 tttt -91.27 -60.09 1.98 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.051 -0.522 . . . . 75.32 110.513 -178.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.555 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 7.9 m-30 -72.47 110.53 6.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.259 0.552 . . . . 75.44 111.234 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.571 ' CD2' ' HB ' ' A' ' 177' ' ' VAL . 37.7 m-70 -110.85 170.92 7.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.303 -0.862 . . . . 64.34 109.583 173.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.7 m -119.41 96.04 5.04 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.841 0.353 . . . . 70.0 110.384 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.461 HG13 HD12 ' A' ' 121' ' ' LEU . 47.5 t -117.2 130.89 71.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.324 -0.398 . . . . 75.11 110.126 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.4 t30 59.7 31.49 20.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.509 0.671 . . . . 73.34 110.477 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 70.57 19.28 76.27 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.925 -0.58 . . . . 63.44 112.211 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.458 ' CD2' ' HA ' ' A' ' 112' ' ' ILE . 67.9 t60 -122.84 129.7 51.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.85 0.357 . . . . 71.22 110.617 -177.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -73.28 112.1 9.03 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.472 -0.566 . . . . 73.1 109.472 174.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 18.9 p -121.65 173.55 7.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.814 0.34 . . . . 75.51 111.382 -174.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.527 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 10.8 tt0 -108.41 116.92 32.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.838 -0.619 . . . . 75.11 110.064 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.571 ' HB ' ' CD2' ' A' ' 168' ' ' HIS . 59.4 t -120.26 134.68 62.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.233 -0.44 . . . . 73.14 110.493 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -150.54 -177.98 6.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.858 -0.61 . . . . 75.51 110.294 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.788 ' HE3' ' HA ' ' A' ' 100' ' ' ALA . 55.2 mttm -63.78 133.23 53.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.961 -0.385 . . . . 62.04 109.961 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.482 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -88.3 86.67 7.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.192 0.52 . . . . 73.22 110.538 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.674 HD22 ' H ' ' A' ' 181' ' ' LEU . 2.3 pt? -80.8 127.55 32.65 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.764 -0.828 . . . . 72.3 108.764 174.377 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.5 t -56.02 156.66 5.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.105 -0.498 . . . . 72.22 110.548 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.898 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.3 pttp -63.73 -15.13 57.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.293 0.568 . . . . 63.52 109.83 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . 0.421 ' HA ' ' OE1' ' A' ' 184' ' ' GLN . 6.6 tp60 -71.7 -38.02 70.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.566 -0.743 . . . . 74.31 109.823 172.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -87.22 -41.34 13.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.483 -0.78 . . . . 74.32 111.116 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.898 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.7 ptm -70.66 -16.24 62.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.263 -0.426 . . . . 75.32 110.72 -177.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -71.34 -24.66 62.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.375 0.607 . . . . 73.11 109.721 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.5 m -93.38 -35.17 13.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.103 -0.953 . . . . 53.01 110.459 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -76.55 -50.26 14.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.86 -0.609 . . . . 74.4 111.446 -176.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.6 m -78.04 108.97 11.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.94 -0.573 . . . . 71.32 110.697 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.3 m -66.08 -32.47 73.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.866 -0.606 . . . . 73.24 111.065 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 37.0 m -62.78 -25.84 68.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.813 0.34 . . . . 61.45 111.264 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -63.76 -24.7 67.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.213 0.53 . . . . 71.54 110.349 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -108.76 14.56 24.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.344 0.593 . . . . 73.41 109.675 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -89.62 -69.74 1.24 Allowed Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.667 -0.697 . . . . 71.4 111.918 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.658 ' H ' ' HD3' ' A' ' 196' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.546 -0.74 . . . . 72.34 109.555 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.985 " H4'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.694 0 O5'-C5'-C4' 111.277 0.769 OUTLIER-EPSILON 0.0 '__' . 75.44 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.985 H5'' " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.422 -1.131 0 C4'-C3'-C2' 105.699 2.999 . 0.0 OUTLIER epsilon-1 75.3 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.634 ' H8 ' H5'' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.423 -1.07 0 O4'-C4'-C3' 103.135 -1.689 . 0.0 OUTLIER . 75.43 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.616 " C4'" ' HE3' ' A' ' 137' ' ' MET . . . . . . . . 0 O5'--C5' 1.424 -0.969 0 C4'-C3'-C2' 104.998 2.298 . 0.0 OUTLIER alpha 72.34 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.608 " H3'" HO2' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.42 -1.246 0 O4'-C1'-C2' 108.16 1.257 . 0.0 OUTLIER gamma 73.45 . . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.981 0 C4'-C3'-C2' 103.439 0.739 . 0.01 2u . 75.14 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 109.691 -0.485 . . . . 75.02 109.691 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.87 -65.85 0.89 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.757 -0.201 . . . . 72.5 110.961 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.481 ' HD2' ' HA ' ' A' ' 164' ' ' ILE . 42.9 mtp180 53.28 69.84 2.09 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 116.14 -0.482 . . . . 75.11 110.858 -174.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.498 ' HG2' ' HB2' ' A' ' 179' ' ' LYS . 28.9 Cg_endo -63.72 120.14 7.43 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.66 2.24 . . . . 75.01 112.416 -177.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.29 60.06 6.27 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.099 -0.8 . . . . 63.33 111.099 -177.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.26 -21.81 62.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.666 0.269 . . . . 74.0 111.605 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -83.05 -1.33 52.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.424 0.631 . . . . 75.24 110.287 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 66.4 mt -105.97 108.62 20.22 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.546 -0.752 . . . . 75.14 109.764 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.0 p -62.04 114.14 3.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.338 0.589 . . . . 74.24 110.504 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.459 ' O ' HG23 ' A' ' 159' ' ' VAL . 9.6 p -107.1 136.38 42.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.771 -0.649 . . . . 74.33 110.273 -173.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.427 ' HE2' ' HB3' ' A' ' 156' ' ' HIS . 0.0 OUTLIER -105.59 -0.85 25.35 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.931 0.396 . . . . 54.3 110.903 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.62 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 24.0 ttpt -133.98 136.69 44.3 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.107 0.479 . . . . 73.52 110.807 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.488 HG12 ' HB ' ' A' ' 151' ' ' VAL . 9.2 pt -107.95 162.57 6.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.132 -0.485 . . . . 71.5 110.642 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 61.6 t80 -110.23 118.05 35.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.846 -0.616 . . . . 64.5 110.078 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 30.6 t -106.84 103.04 14.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.506 -0.553 . . . . 73.33 109.506 175.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -117.77 136.27 12.33 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.656 -0.783 . . . . 72.34 112.364 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.534 ' N ' " H5'" ' B' ' 2' ' ' ' C' . . . 131.27 -12.63 5.49 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.134 -1.032 . . . . 55.01 112.929 176.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.918 HD11 ' HA ' ' A' ' 148' ' ' PHE . 0.1 OUTLIER -68.2 91.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 122.091 0.948 . . . . 74.13 111.239 -179.006 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -94.83 4.01 54.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.789 -1.096 . . . . 75.15 109.966 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -121.83 -174.28 2.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.383 -0.826 . . . . 75.42 109.679 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.39 107.18 4.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.229 0.537 . . . . 54.4 110.899 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.8 m -144.32 128.69 17.9 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.679 -0.691 . . . . 63.02 109.274 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -125.52 -166.17 1.51 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.253 0.549 . . . . 71.31 112.1 -173.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.592 ' HG2' ' CG1' ' A' ' 134' ' ' ILE . 2.8 tm-20 -60.41 -47.14 87.37 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.181 -0.918 . . . . 74.34 111.475 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -30.8 71.85 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.883 -0.327 . . . . 75.53 110.524 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -66.68 -59.62 3.42 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.943 0.401 . . . . 64.42 110.611 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.481 ' HA ' HG22 ' A' ' 170' ' ' VAL . 8.5 mp -60.0 -47.94 83.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.769 -0.651 . . . . 55.53 111.359 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.472 ' HG3' HD11 ' A' ' 131' ' ' ILE . 3.1 ttp180 -62.06 -41.78 98.51 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.062 -0.255 . . . . 54.12 111.359 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -57.24 -30.42 64.61 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.339 0.59 . . . . 71.41 111.061 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -88.43 -47.04 8.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.788 -0.642 . . . . 74.04 111.156 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -80.11 -12.12 59.7 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.528 0.566 . . . . 73.51 112.528 -173.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.67 -24.8 66.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.84 0.352 . . . . 71.24 111.568 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -72.57 -20.7 61.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.321 -0.4 . . . . 72.24 110.451 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.45 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 89.0 m-85 -82.15 -38.82 24.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.048 -0.524 . . . . 73.45 110.023 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.44 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 176.86 -168.47 40.42 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.229 -0.986 . . . . 75.33 113.277 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.523 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 40.1 tptt -74.33 116.41 14.96 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.405 0.621 . . . . 71.34 111.4 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.48 HG12 ' CE1' ' A' ' 153' ' ' PHE . 33.0 mt -92.53 140.51 16.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.324 -0.853 . . . . 74.33 110.542 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -86.91 -72.46 0.51 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.09 -0.504 . . . . 70.31 110.405 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.72 140.41 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 73.44 111.325 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.633 ' CD1' HG11 ' A' ' 151' ' ' VAL . 21.3 mm -95.1 101.61 12.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.611 -0.514 . . . . 72.33 109.611 174.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -84.67 94.74 8.71 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.939 -0.393 . . . . 60.52 109.939 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.484 HD11 ' H ' ' A' ' 118' ' ' GLU . 7.1 mt -73.05 100.91 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.005 -1.109 . . . . 63.15 108.005 175.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.573 ' HE3' " H4'" ' B' ' 4' ' ' ' G' . 10.7 tpt -61.38 108.89 1.01 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.381 0.61 . . . . 73.14 110.494 -173.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.6 p -121.78 158.82 27.99 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.018 -0.992 . . . . 73.51 110.257 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.79 ' HA ' ' C4 ' ' B' ' 5' ' ' ' U' . 19.0 t0 -56.73 136.48 55.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.255 -0.429 . . . . 73.23 110.889 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.448 ' HD2' " C1'" ' B' ' 5' ' ' ' U' . 0.2 OUTLIER -71.95 -12.27 61.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.663 -0.699 . . . . 74.13 111.011 -175.216 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.95 -60.15 0.51 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.609 -0.805 . . . . 72.21 112.328 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.569 ' HB2' ' HG2' ' A' ' 144' ' ' LYS . 2.2 m -79.49 -25.02 41.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.944 0.402 . . . . 72.21 111.194 -174.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.91 38.21 60.34 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.019 -0.61 . . . . 74.14 112.456 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.569 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 12.7 ptpt -108.67 152.35 24.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.918 -0.401 . . . . 73.24 109.918 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -62.33 135.34 57.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 74.05 111.394 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 14.8 tpt180 -87.04 -5.61 59.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.932 -0.577 . . . . 74.4 110.314 178.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.782 ' O ' " H5'" ' B' ' 1' ' ' ' U' . . . 101.94 -6.93 54.62 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.867 -0.683 . . . . 75.34 112.925 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.918 ' HA ' HD11 ' A' ' 112' ' ' ILE . 31.7 p90 -145.03 164.06 32.32 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 122.514 -0.404 . . . . 73.3 110.32 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.4 165.15 28.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.961 0.41 . . . . 54.32 110.952 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.549 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 65.9 m-85 -126.26 123.72 38.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.753 -0.658 . . . . 62.14 110.006 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.633 HG11 ' CD1' ' A' ' 134' ' ' ILE . 48.9 t -98.75 107.44 20.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 110.017 -0.364 . . . . 74.42 110.017 -179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.62 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 25.3 m -86.8 124.43 33.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.118 -0.492 . . . . 38.12 110.151 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.646 ' CD2' HG13 ' A' ' 159' ' ' VAL . 97.6 m-85 -104.92 157.63 17.08 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.916 -0.402 . . . . 74.22 109.916 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.523 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 16.0 t70 -69.59 -29.81 67.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.03 -0.532 . . . . 65.14 110.557 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -132.45 147.38 52.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.57 -0.741 . . . . 74.02 110.923 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.664 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.3 p-80 -75.45 -12.81 60.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.181 -0.463 . . . . 74.04 110.732 177.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -60.84 -49.83 75.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.173 0.511 . . . . 73.12 110.153 174.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.44 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 14.6 m -66.56 -22.14 66.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.377 -0.829 . . . . 71.21 112.373 -173.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.664 HG22 ' O ' ' A' ' 156' ' ' HIS . 4.1 m -81.49 -25.84 10.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.935 -0.306 . . . . 71.44 111.453 -176.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.543 ' HA ' HG21 ' A' ' 163' ' ' VAL . 36.1 t70 -70.31 -39.88 74.54 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.983 -0.287 . . . . 75.13 111.342 -171.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.45 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.6 mptp? -62.21 -14.63 40.07 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.372 0.606 . . . . 72.13 110.586 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.464 HG23 HD11 ' A' ' 107' ' ' ILE . 94.5 mt -98.38 -49.21 11.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.455 -0.793 . . . . 73.35 110.886 -176.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.543 HG21 ' HA ' ' A' ' 160' ' ' ASP . 23.5 m -72.93 -15.57 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.104 -0.498 . . . . 75.41 112.078 -175.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.481 ' HA ' ' HD2' ' A' ' 97' ' ' ARG . 2.2 pp -64.68 -26.81 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.696 0.284 . . . . 72.33 111.572 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -116.0 -178.94 3.52 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.407 -0.59 . . . . 70.22 109.407 171.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.44 ' HE3' ' OE1' ' A' ' 176' ' ' GLU . 83.5 tttt -120.48 -67.79 0.95 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.655 0.264 . . . . 70.54 111.226 -173.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 11.1 m-30 -71.69 107.54 4.57 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.088 0.47 . . . . 73.45 111.401 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.439 ' CE1' HG21 ' A' ' 162' ' ' ILE . 32.9 m-70 -104.89 151.58 23.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.624 -0.716 . . . . 72.23 109.837 174.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.489 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 21.8 m -109.87 84.73 1.98 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.045 0.45 . . . . 73.41 110.424 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.481 HG22 ' HA ' ' A' ' 121' ' ' LEU . 4.1 p -102.57 132.86 47.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.892 -0.595 . . . . 75.44 109.719 178.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 170' ' ' VAL . 4.6 t30 71.92 -14.79 0.49 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.106 0.479 . . . . 72.45 110.544 -176.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.475 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 114.97 -3.08 22.76 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.905 -0.878 . . . . 61.13 110.905 -173.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.489 ' O ' ' HA ' ' A' ' 169' ' ' THR . 58.5 t-80 -93.97 148.7 21.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.303 -0.448 . . . . 63.22 110.286 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -94.24 102.78 14.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.999 0.428 . . . . 73.55 110.151 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.433 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 29.4 m -114.47 154.1 28.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.131 -0.486 . . . . 73.53 111.201 -175.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.492 ' OE2' ' HD3' ' A' ' 178' ' ' ARG . 20.5 tt0 -91.53 119.55 31.56 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.664 -0.495 . . . . 75.31 109.664 175.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 48.4 t -117.63 138.99 46.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.955 -0.566 . . . . 75.42 110.659 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.492 ' HD3' ' OE2' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -159.02 171.86 19.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.417 -0.81 . . . . 74.22 109.675 -177.658 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.55 ' HB3' ' HZ2' ' A' ' 179' ' ' LYS . 8.6 mtpm? -63.26 122.1 15.33 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.104 -0.332 . . . . 73.44 110.104 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.747 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -74.89 91.25 2.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.985 0.422 . . . . 73.51 110.686 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.514 HD22 ' N1 ' ' B' ' 3' ' ' ' A' . 2.6 pt? -80.9 139.52 35.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.489 -0.56 . . . . 73.34 109.489 177.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.5 m -50.88 130.66 25.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.167 -0.469 . . . . 73.13 110.755 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.773 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.0 pttp -64.34 -23.24 67.23 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.843 0.354 . . . . 71.2 110.664 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.86 -37.14 86.28 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.484 -0.562 . . . . 65.14 109.484 176.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -88.16 -34.75 17.73 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.705 -0.679 . . . . 73.43 111.049 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.773 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 6.5 ptp -63.64 -28.04 69.64 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.632 -0.506 . . . . 75.11 109.632 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . 0.555 ' HA ' ' HB2' ' A' ' 192' ' ' SER . . . -65.47 -33.07 75.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.882 -0.599 . . . . 73.21 110.336 177.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.6 m -98.05 7.82 45.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.576 -0.738 . . . . 72.12 111.192 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -123.16 -50.51 1.91 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.038 0.446 . . . . 73.24 111.385 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.8 m -103.81 15.21 29.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.289 -0.414 . . . . 75.34 110.637 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.6 m 61.29 28.54 18.04 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.009 -0.541 . . . . 74.42 111.218 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.555 ' HB2' ' HA ' ' A' ' 187' ' ' ALA . 14.0 m -66.23 111.08 3.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.099 -0.501 . . . . 74.1 110.635 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -140.76 -44.71 0.39 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.347 0.594 . . . . 74.43 109.707 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -99.33 153.72 18.75 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.405 -0.816 . . . . 73.15 110.664 -175.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -82.18 86.29 1.44 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.922 -0.656 . . . . 72.24 112.191 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.622 ' HA ' ' HE ' ' A' ' 196' ' ' ARG . 1.4 tpm_? . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.385 -0.817 . . . . 74.33 109.595 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 1.07 " C4'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.66 0 C4'-C3'-C2' 104.832 2.132 . 0.0 '__' . 75.11 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 1.07 H5'' " C4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.9 0 C3'-C2'-C1' 103.84 2.601 . 0.0 OUTLIER zeta-1 64.55 . . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.809 " H4'" ' OP1' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -0.992 0 C3'-C2'-C1' 103.636 2.373 OUTLIER-EPSILON 0.0 OUTLIER alpha 72.53 . . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.809 ' OP1' " H4'" ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.863 0 C4'-C3'-C2' 106.034 3.334 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 75.42 . . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.79 ' C4 ' ' HA ' ' A' ' 139' ' ' ASP . . . . . . . . 0 O5'--C5' 1.423 -1.043 0 C1'-O4'-C4' 106.843 -3.063 OUTLIER-DELTA 0.0 OUTLIER gamma 74.44 . . . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.864 0 C3'-C2'-C1' 100.557 -1.047 . 0.0 OUTLIER . 74.22 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 120.696 0.284 . . . . 60.21 111.141 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.544 ' O ' ' HD3' ' A' ' 98' ' ' PRO . 5.6 tp-100 -104.11 -15.05 15.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.799 0.333 . . . . 73.34 111.044 -174.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -106.11 94.06 8.82 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.981 -0.377 . . . . 64.52 109.981 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 96' ' ' GLN . 56.4 Cg_endo -99.34 97.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 123.366 2.711 . . . . 72.33 112.494 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.11 19.62 69.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.672 -0.775 . . . . 52.14 112.436 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.5 -11.32 59.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.261 0.553 . . . . 71.42 110.373 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -86.34 2.3 47.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.406 -0.816 . . . . 75.32 110.308 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 84.3 mt -111.11 162.02 15.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.807 -0.633 . . . . 75.1 110.057 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.1 m -80.95 -43.31 19.93 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.159 -0.682 . . . . 73.14 109.159 176.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 67.38 145.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 124.455 1.097 . . . . 75.44 112.824 172.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.546 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 2.4 mtmt -129.53 12.83 5.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.723 -0.671 . . . . 74.1 110.012 175.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.493 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 30.6 ttpt -144.23 137.26 27.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.295 -0.866 . . . . 72.34 109.379 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pp -107.59 153.6 8.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.35 -0.387 . . . . 73.23 110.537 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.536 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 75.6 t80 -105.0 125.29 50.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.28 -0.418 . . . . 72.45 110.881 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.9 t -105.94 107.32 22.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.468 -0.333 . . . . 74.1 110.394 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.532 ' HA2' " H5'" ' B' ' 2' ' ' ' C' . . . -120.92 114.9 2.73 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.78 -0.724 . . . . 73.32 112.585 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 124.43 29.63 1.07 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.613 -0.804 . . . . 50.1 113.015 175.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.538 HG12 " O5'" ' B' ' 1' ' ' ' U' . 40.1 pt -91.51 -165.76 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 117.073 0.436 . . . . 73.35 111.484 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.403 ' HA ' ' O2 ' ' B' ' 1' ' ' ' U' . 13.6 tmtt? -131.13 159.63 37.07 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.152 -1.055 . . . . 74.15 108.152 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.14 -17.69 54.15 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.657 0.614 . . . . 75.1 112.657 -174.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -70.34 -38.16 74.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.877 0.37 . . . . 63.04 111.134 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.4 m -64.63 138.32 58.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.818 -0.628 . . . . 70.13 110.753 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.467 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 12.0 pt-20 -136.53 -168.66 2.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.449 -0.341 . . . . 74.25 110.737 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.537 ' HG3' ' HB ' ' A' ' 134' ' ' ILE . 7.2 tt0 -59.62 -46.43 89.01 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.044 -0.526 . . . . 73.54 112.355 -176.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.435 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -65.0 -32.99 74.99 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.811 -0.355 . . . . 71.4 110.601 -176.631 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.467 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 38.6 m80 -61.8 -52.73 62.99 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.912 0.387 . . . . 71.31 110.709 178.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.409 HD21 HG21 ' A' ' 170' ' ' VAL . 70.3 mt -62.99 -47.91 81.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.625 -0.716 . . . . 73.13 110.288 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -56.17 -49.33 74.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.798 -0.637 . . . . 75.11 110.651 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -56.71 -32.66 65.72 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.179 0.514 . . . . 74.23 111.62 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -85.16 -40.8 16.31 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.035 -0.53 . . . . 73.33 111.104 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.498 ' CD1' HG23 ' A' ' 151' ' ' VAL . 57.1 m-85 -88.63 -18.02 28.86 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.78 0.659 . . . . 64.53 112.78 -173.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.4 ' N ' HD12 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -66.35 -21.52 66.25 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.142 0.496 . . . . 74.25 110.928 -179.448 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -70.08 -22.14 63.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.673 -0.694 . . . . 64.51 110.477 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.477 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 28.9 m-85 -86.74 -33.25 20.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.957 -0.565 . . . . 74.45 110.674 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 176.93 -170.38 43.07 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.285 -0.959 . . . . 45.42 113.151 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -75.17 124.02 26.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 122.924 0.49 . . . . 75.44 111.49 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.465 HG12 ' CE1' ' A' ' 153' ' ' PHE . 44.2 mt -100.31 137.31 28.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.876 -0.602 . . . . 62.32 111.149 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.14 -74.41 0.34 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.383 -0.826 . . . . 73.54 110.359 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.81 159.09 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.655 -0.498 . . . . 61.32 109.655 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.607 ' CD1' HG12 ' A' ' 151' ' ' VAL . 29.3 mm -112.41 104.45 17.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.928 0.394 . . . . 70.03 109.948 174.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.4 ' C ' ' H ' ' A' ' 137' ' ' MET . 46.5 mt-10 -89.61 101.64 14.32 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.959 -0.386 . . . . 72.41 109.959 179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.767 ' HB ' HG23 ' A' ' 138' ' ' THR . 4.3 mt -81.18 12.6 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.349 0.595 . . . . 74.12 109.84 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.693 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER 59.44 26.23 15.12 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.143 -0.935 . . . . 63.44 109.702 -174.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.767 HG23 ' HB ' ' A' ' 136' ' ' ILE . 1.4 p -64.5 146.55 54.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.841 -1.072 . . . . 74.44 111.05 -178.186 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.427 ' HB3' ' HG2' ' A' ' 144' ' ' LYS . 22.7 t70 -47.2 130.56 12.93 Favored 'General case' 0 CA--C 1.515 -0.369 0 O-C-N 123.482 0.489 . . . . 74.24 110.053 177.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.591 ' HD2' H5'' ' B' ' 5' ' ' ' U' . 0.0 OUTLIER -84.7 12.66 6.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.992 -0.549 . . . . 74.23 110.947 -170.566 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -118.44 -50.99 0.32 Allowed Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.643 -0.708 . . . . 51.21 111.946 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.479 ' HB2' ' HE2' ' A' ' 144' ' ' LYS . 50.9 m -111.14 -13.13 14.07 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.397 0.517 . . . . 73.41 112.397 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.14 70.35 1.3 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.331 -0.938 . . . . 65.34 112.183 -176.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.677 ' O ' ' HA ' ' A' ' 138' ' ' THR . 62.6 mmtt -110.67 135.49 51.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.763 -0.458 . . . . 74.32 109.763 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -69.86 115.11 8.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.923 0.392 . . . . 70.31 110.913 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.473 ' HB3' ' HB3' ' A' ' 137' ' ' MET . 68.8 ttt180 -83.6 -54.98 4.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.992 -0.549 . . . . 74.23 111.107 -178.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.617 ' C ' H5'' ' B' ' 1' ' ' ' U' . . . 161.16 -93.07 0.12 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.693 -0.765 . . . . 61.13 111.934 -177.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.693 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 42.9 p90 -61.57 145.16 52.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.601 0.239 . . . . 72.42 110.402 177.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.86 165.13 23.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.976 0.417 . . . . 61.23 111.206 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.479 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 43.7 m-85 -132.47 135.5 46.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.699 -0.682 . . . . 73.32 109.467 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.607 HG12 ' CD1' ' A' ' 134' ' ' ILE . 43.4 t -110.85 108.42 25.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.55 -0.537 . . . . 71.44 109.55 177.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.493 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 3.9 m -85.88 128.48 34.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.055 -0.52 . . . . 74.3 110.301 -178.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.577 ' CD2' HG11 ' A' ' 159' ' ' VAL . 94.7 m-85 -111.75 151.41 29.0 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.916 -0.401 . . . . 74.31 109.916 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -78.87 -6.56 56.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.249 0.547 . . . . 74.11 110.854 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.75 149.64 43.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.182 -0.463 . . . . 55.44 110.245 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.546 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.0 p-80 -89.48 -2.64 58.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.928 0.394 . . . . 71.52 110.897 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -75.04 -39.08 61.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.359 0.6 . . . . 75.31 109.476 173.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.4 m -64.9 -30.31 71.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.513 -0.767 . . . . 63.03 111.789 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.577 HG11 ' CD2' ' A' ' 153' ' ' PHE . 14.1 m -78.87 -20.81 12.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.634 -0.257 . . . . 71.33 111.68 -176.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.05 -46.14 75.27 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 120.596 0.236 . . . . 71.23 110.46 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.477 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.4 mptp? -59.29 -20.08 51.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.364 0.602 . . . . 63.3 111.038 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.402 ' CG2' HG13 ' A' ' 177' ' ' VAL . 79.5 mt -94.1 -49.07 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.529 -0.76 . . . . 75.35 111.206 -175.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.573 ' HB ' ' HE3' ' A' ' 179' ' ' LYS . 25.9 m -80.59 -10.72 12.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 112.287 0.477 . . . . 74.52 112.287 -173.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.516 HD13 ' N ' ' A' ' 165' ' ' GLN . 2.6 pp -68.82 -31.35 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.998 0.428 . . . . 71.42 110.961 176.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.516 ' N ' HD13 ' A' ' 164' ' ' ILE . 14.5 pt20 -101.15 -162.0 0.9 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.116 -0.698 . . . . 74.21 109.116 172.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.517 ' HE3' ' HG3' ' A' ' 176' ' ' GLU . 44.3 tttt -134.67 -68.67 0.53 Allowed 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.811 -0.356 . . . . 73.12 111.568 -174.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.503 ' CD1' ' HG2' ' A' ' 166' ' ' LYS . 97.2 m-85 -88.32 113.41 23.89 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.133 0.492 . . . . 74.23 111.544 -175.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -105.35 147.36 28.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.57 -0.741 . . . . 73.43 110.248 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 47.2 m -100.73 98.92 9.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.075 0.464 . . . . 64.52 110.745 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.409 HG21 HD21 ' A' ' 121' ' ' LEU . 4.7 p -118.19 130.97 72.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.076 -0.511 . . . . 75.04 109.833 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.8 t30 64.67 15.73 9.91 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.643 0.735 . . . . 72.1 110.279 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.85 8.78 75.63 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.765 -0.731 . . . . 62.42 112.225 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -110.03 124.67 51.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.719 0.295 . . . . 72.54 110.367 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -81.42 105.3 12.48 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.427 -0.583 . . . . 70.22 109.427 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.5 ' SG ' HG21 ' A' ' 112' ' ' ILE . 10.5 m -118.15 154.31 32.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.926 -0.579 . . . . 53.25 110.589 -172.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.517 ' HG3' ' HE3' ' A' ' 166' ' ' LYS . 30.1 tt0 -88.73 126.0 35.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.001 0.429 . . . . 73.41 110.153 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 97.8 t -112.23 129.43 67.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.343 0.592 . . . . 73.54 111.034 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.421 ' HB3' ' HG2' ' A' ' 98' ' ' PRO . 80.7 mtt180 -119.0 179.58 4.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.24 -0.891 . . . . 75.13 110.083 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.573 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 9.6 mptt -81.69 126.52 31.88 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.327 -1.36 . . . . 72.13 107.327 168.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.675 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -80.88 83.95 6.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.055 0.455 . . . . 70.41 111.505 -174.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.562 HD22 ' N1 ' ' B' ' 3' ' ' ' A' . 2.6 pt? -84.04 140.79 31.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.88 -0.6 . . . . 72.43 109.444 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 46.4 t -50.15 142.14 10.17 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.423 0.452 . . . . 74.11 111.179 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.754 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.5 pttp -62.09 -20.05 63.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.188 -0.46 . . . . 75.01 111.29 -178.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -54.31 14.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.886 -0.783 . . . . 61.52 108.886 174.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.9 -32.15 72.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.747 -0.66 . . . . 75.31 111.564 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.754 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 21.7 ptm -72.84 -17.24 61.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.779 0.323 . . . . 75.42 110.523 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.43 -39.83 62.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.531 -0.544 . . . . 73.23 109.531 173.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 m -70.93 -35.0 72.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.584 -0.735 . . . . 74.24 109.949 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -70.31 -20.28 63.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.514 -0.766 . . . . 65.42 110.763 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 34.7 t -76.44 87.17 3.19 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.273 0.559 . . . . 64.24 109.994 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 48.1 m -140.53 117.71 11.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.602 -0.726 . . . . 63.42 109.895 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.7 t 67.49 26.4 8.23 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.741 -0.663 . . . . 62.13 110.582 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -88.47 153.69 20.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 72.14 110.155 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -108.22 119.84 40.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.833 0.349 . . . . 74.12 110.261 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 91.49 -136.84 13.51 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.758 -0.734 . . . . 74.35 111.975 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.501 -0.761 . . . . 73.02 110.088 179.754 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.928 " H3'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.673 0 C4'-C3'-C2' 105.259 2.559 . 0.0 '__' . 74.34 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.928 H5'' " H3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.879 0 C4'-C3'-C2' 104.851 2.151 . 0.0 OUTLIER . 73.54 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.675 ' N1 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.426 -0.882 0 O4'-C1'-C2' 108.391 1.422 . 0.0 OUTLIER gamma 72.12 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.573 " H3'" ' HD3' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.424 -1.026 0 C4'-C3'-C2' 104.043 1.343 . 0.0 OUTLIER alpha 74.43 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.591 H5'' ' HD2' ' A' ' 140' ' ' ARG . . . . . . . . 0 O5'--C5' 1.422 -1.122 0 O4'-C1'-C2' 108.2 1.285 . 0.0 OUTLIER gamma 75.32 . . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.592 ' C6 ' H5'' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.012 0 C4'-C3'-C2' 105.999 3.299 . 0.0 OUTLIER gamma 74.42 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.74 -0.467 . . . . 63.3 109.74 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.653 ' NE2' ' HG2' ' A' ' 178' ' ' ARG . 46.5 tp60 -79.54 -26.83 41.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.37 0.605 . . . . 72.44 109.772 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -114.05 84.16 8.65 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.557 -0.747 . . . . 73.31 110.471 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 96' ' ' GLN . 4.9 Cg_exo -80.74 -65.23 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.604 2.203 . . . . 70.44 111.585 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.21 97.63 0.92 Allowed Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.342 -0.703 . . . . 71.51 111.342 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -95.9 -35.85 11.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.088 0.471 . . . . 72.42 110.66 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -73.81 -19.74 60.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.776 -0.647 . . . . 72.23 110.243 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 77.7 mt -80.09 111.99 16.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.623 -0.717 . . . . 74.13 110.183 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.8 p -73.66 98.06 2.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.331 0.586 . . . . 73.05 110.477 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.512 HG21 HG12 ' A' ' 159' ' ' VAL . 6.6 m -93.52 152.46 3.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.869 -0.605 . . . . 63.24 109.798 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.753 ' HA ' HG23 ' A' ' 159' ' ' VAL . 14.0 mtmt -118.17 22.72 12.02 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.599 0.714 . . . . 74.21 109.46 177.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.692 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 42.0 tttt -149.88 129.5 13.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.802 -1.09 . . . . 73.24 109.361 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.495 HG12 ' HB ' ' A' ' 151' ' ' VAL . 7.9 pt -106.03 163.04 4.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.0 0.429 . . . . 75.02 111.225 -177.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -109.59 118.76 37.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.526 -0.761 . . . . 75.23 109.567 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.493 HG13 HD13 ' A' ' 121' ' ' LEU . 37.3 t -102.59 103.36 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.881 0.372 . . . . 72.44 110.757 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.489 ' HA2' H5'' ' B' ' 2' ' ' ' C' . . . -119.69 -167.9 13.74 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.898 -0.881 . . . . 55.14 110.898 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.484 ' HA2' ' C5 ' ' B' ' 2' ' ' ' C' . . . 71.21 5.48 59.1 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.785 -0.721 . . . . 61.44 113.042 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.625 HD12 ' O ' ' A' ' 147' ' ' GLY . 23.8 pt -87.38 122.02 38.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.27 0.557 . . . . 72.5 110.551 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -88.31 -27.64 21.56 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.079 -0.51 . . . . 75.51 110.631 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -98.48 154.89 17.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.037 -0.529 . . . . 73.15 109.81 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -63.1 91.56 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.053 0.454 . . . . 72.41 109.804 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.439 ' HB ' HD11 ' A' ' 112' ' ' ILE . 9.7 m -90.28 118.13 29.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.73 -0.668 . . . . 73.04 109.638 -178.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.541 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 11.5 pt-20 -109.86 -174.08 2.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.919 0.39 . . . . 62.44 111.605 -172.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.582 ' H ' HD13 ' A' ' 136' ' ' ILE . 14.2 tt0 -53.42 -49.71 66.75 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.427 -0.806 . . . . 64.54 112.212 -174.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.446 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 0.8 OUTLIER -63.39 -31.44 72.6 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.1 -0.24 . . . . 75.42 110.678 -176.534 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.541 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 35.7 m80 -67.06 -56.81 8.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.476 -0.329 . . . . 73.41 110.376 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.493 HD13 HG13 ' A' ' 109' ' ' VAL . 0.5 OUTLIER -61.05 -49.55 76.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.48 . . . . 75.45 110.928 -178.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.494 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 1.5 tpp180 -58.08 -45.32 87.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.273 -0.422 . . . . 75.44 111.197 -177.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -56.61 -37.11 70.22 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.096 0.474 . . . . 74.34 111.44 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -84.96 -39.85 17.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.271 -0.422 . . . . 75.25 111.257 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -86.69 -17.5 33.57 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.47 0.545 . . . . 74.4 112.47 -172.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -21.7 65.58 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.334 0.588 . . . . 72.34 110.697 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -70.22 -24.82 63.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.336 -0.847 . . . . 72.02 110.406 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.438 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 31.0 m-85 -83.46 -32.06 26.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.951 -0.568 . . . . 74.3 110.139 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.7 177.78 43.17 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.162 -0.775 . . . . 73.43 111.162 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -67.25 133.88 50.55 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.656 0.741 . . . . 73.1 110.478 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.494 ' CD1' ' HA ' ' A' ' 122' ' ' ARG . 46.6 mt -100.24 141.92 16.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 115.288 -0.869 . . . . 64.4 110.446 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -78.46 -70.63 0.48 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.081 -0.509 . . . . 70.31 110.419 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.3 m -148.08 157.04 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.456 -0.338 . . . . 61.11 110.659 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.608 ' CD1' HG11 ' A' ' 151' ' ' VAL . 12.9 mm -109.96 108.93 26.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.572 -0.899 . . . . 71.55 108.572 174.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -95.08 95.97 8.93 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.204 0.526 . . . . 74.13 110.519 -175.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.582 HD13 ' H ' ' A' ' 118' ' ' GLU . 20.6 mt -74.81 99.06 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.702 -0.851 . . . . 75.11 108.702 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.555 ' HE2' " C4'" ' B' ' 4' ' ' ' G' . 12.8 tpt -67.29 108.94 2.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.287 0.565 . . . . 65.31 110.488 -174.385 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.8 p -86.5 166.77 15.22 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.654 -0.703 . . . . 73.51 111.754 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.6 t0 -76.85 153.09 35.15 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.021 -0.99 . . . . 63.41 110.567 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.494 ' HG3' ' C2 ' ' B' ' 5' ' ' ' U' . 0.0 OUTLIER -92.89 0.9 57.5 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.806 -0.634 . . . . 74.22 110.535 -178.735 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.66 -62.37 0.52 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 121.009 -0.615 . . . . 71.43 112.213 177.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.531 ' HB2' ' HD2' ' A' ' 144' ' ' LYS . 21.2 m -87.56 -17.59 31.66 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.532 -0.393 . . . . 63.32 111.225 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.38 33.03 72.19 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.576 -1.01 . . . . 42.25 110.576 -174.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.531 ' HD2' ' HB2' ' A' ' 142' ' ' SER . 12.9 ptmm? -105.15 171.66 7.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.737 -0.731 . . . . 73.43 109.731 -172.327 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -69.08 99.19 1.07 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.171 -0.677 . . . . 75.42 109.171 174.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.62 HH12 H5'' ' B' ' 5' ' ' ' U' . 65.0 ttt180 -58.24 -46.11 86.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.139 -0.937 . . . . 74.14 111.886 -172.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.625 ' O ' HD12 ' A' ' 112' ' ' ILE . . . 166.96 -78.75 0.11 Allowed Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 110.973 -0.851 . . . . 62.2 110.973 -177.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -76.52 163.54 26.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.947 0.403 . . . . 75.43 110.924 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.05 175.16 9.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.009 -0.541 . . . . 72.34 110.366 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.692 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 85.3 m-85 -132.03 152.06 51.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.351 -0.386 . . . . 74.54 110.333 -176.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.608 HG11 ' CD1' ' A' ' 134' ' ' ILE . 44.6 t -134.91 114.61 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.076 -0.713 . . . . 63.33 109.076 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.463 ' OG1' ' HD2' ' A' ' 106' ' ' LYS . 42.5 m -98.23 132.12 44.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.929 0.395 . . . . 75.44 110.558 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.471 ' CD2' HG22 ' A' ' 159' ' ' VAL . 91.2 m-85 -112.14 155.26 24.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.075 -0.511 . . . . 74.51 110.282 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -76.53 -23.82 53.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.244 0.545 . . . . 73.55 110.536 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.418 ' O ' HG21 ' A' ' 159' ' ' VAL . 9.5 t0 -131.47 138.88 49.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.587 -0.733 . . . . 73.15 109.73 -178.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.52 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.3 p-80 -75.83 -9.91 58.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.908 0.385 . . . . 75.4 110.605 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -66.61 -48.54 69.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 74.4 110.218 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.539 ' HA ' ' HZ3' ' A' ' 161' ' ' LYS . 42.2 t -58.97 -37.16 76.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.611 . . . . 74.24 110.228 176.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.753 HG23 ' HA ' ' A' ' 105' ' ' LYS . 18.5 t -65.58 -36.99 78.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.451 -0.795 . . . . 71.05 111.017 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -55.45 -48.2 74.86 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.173 -0.467 . . . . 64.32 111.814 -176.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.539 ' HZ3' ' HA ' ' A' ' 158' ' ' SER . 4.0 mptt -60.19 -19.13 52.7 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.201 0.524 . . . . 74.33 111.063 -177.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.472 HG21 HD11 ' A' ' 107' ' ' ILE . 84.0 mt -99.84 -47.34 11.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.527 -0.76 . . . . 75.31 111.366 -175.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.462 HG11 HG11 ' A' ' 159' ' ' VAL . 28.9 m -71.26 -11.17 14.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.438 0.532 . . . . 74.54 112.438 -174.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.79 -24.29 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.909 0.385 . . . . 74.51 111.21 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -106.04 142.33 35.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.07 -0.514 . . . . 74.21 110.538 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.51 ' HG3' ' HG2' ' A' ' 176' ' ' GLU . 85.5 tttt -89.78 -67.3 0.85 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.005 -0.543 . . . . 64.12 111.199 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.588 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 22.8 m-85 -81.04 100.43 8.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.186 -0.461 . . . . 70.03 111.688 -177.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -101.51 153.38 19.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.944 -0.571 . . . . 74.34 109.79 174.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 23.9 m -106.38 96.23 6.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.982 0.42 . . . . 74.35 110.67 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.5 ' C ' ' H ' ' A' ' 172' ' ' GLY . 47.1 t -105.3 133.2 50.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.57 -0.53 . . . . 70.02 109.57 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.4 t30 70.48 -19.25 0.22 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.128 0.571 . . . . 71.0 111.728 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.5 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 128.52 -6.03 6.64 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.181 -0.533 . . . . 71.25 111.833 -177.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -112.62 151.18 30.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.038 0.447 . . . . 73.11 110.399 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 66.0 t30 -82.86 124.83 30.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.753 -0.658 . . . . 72.01 110.374 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 23.5 p -119.42 -171.86 2.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.955 -0.566 . . . . 74.21 110.253 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.51 ' HG2' ' HG3' ' A' ' 166' ' ' LYS . 0.9 OUTLIER -139.1 116.07 10.92 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.468 -0.567 . . . . 74.42 109.468 -176.531 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 93.4 t -116.41 140.15 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.018 -0.537 . . . . 73.53 112.062 -171.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.699 ' HD2' ' H61' ' B' ' 3' ' ' ' A' . 43.7 mtt180 -134.29 -178.83 5.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.69 -0.686 . . . . 74.43 109.801 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.42 ' HE3' ' CG2' ' A' ' 163' ' ' VAL . 11.9 mptt -75.01 128.43 35.54 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.267 -1.012 . . . . 74.24 108.267 168.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.546 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -74.04 97.83 2.95 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.582 -0.447 . . . . 73.21 110.773 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.607 HD22 ' H ' ' A' ' 181' ' ' LEU . 2.7 pt? -106.6 149.18 27.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.936 -0.574 . . . . 73.13 110.204 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.5 t -49.62 139.63 12.27 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.579 0.55 . . . . 73.34 111.187 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.735 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 17.8 pttp -65.49 -12.7 55.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.135 0.493 . . . . 74.13 110.732 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -74.99 -52.92 9.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.857 -0.611 . . . . 72.44 109.94 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -73.38 -32.17 64.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.453 -0.794 . . . . 71.23 111.265 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.735 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.3 ptm -65.18 -24.53 67.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.394 -0.367 . . . . 64.31 110.876 -177.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.68 -38.19 76.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.99 0.424 . . . . 61.43 110.074 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.8 m -77.78 -33.01 52.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.676 -0.693 . . . . 71.24 110.643 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -77.76 -42.68 33.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 73.21 111.234 -177.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 33.6 m -90.06 -63.3 1.3 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.935 -0.575 . . . . 75.22 111.095 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 49.9 m 61.24 28.73 18.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.133 -0.485 . . . . 63.41 111.115 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 13.8 t -119.76 97.68 5.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.313 -0.625 . . . . 74.5 109.313 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -87.69 126.5 35.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.946 -0.57 . . . . 70.13 110.537 -177.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -62.69 94.03 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.603 -0.726 . . . . 75.44 110.859 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -163.3 21.05 0.16 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.407 -0.677 . . . . 41.03 111.407 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.176 -0.916 . . . . 75.51 109.167 -177.629 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.984 " H4'" " C5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.789 0 O4'-C4'-C3' 103.631 -1.335 OUTLIER-EPSILON 0.0 '__' . 74.51 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.984 " C5'" " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.021 0 C4'-C3'-C2' 104.37 1.67 . 0.0 OUTLIER epsilon-1 74.32 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.699 ' H61' ' HD2' ' A' ' 178' ' ' ARG . . . . . . . . 0 O5'--C5' 1.426 -0.889 0 O4'-C1'-C2' 108.101 1.215 . 0.0 OUTLIER . 74.42 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.575 " H3'" ' CE ' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.426 -0.87 0 C3'-C2'-C1' 99.82 -1.867 . 0.0 OUTLIER . 73.43 . . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.657 ' H6 ' ' P ' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.947 0 C4'-C3'-C2' 106.459 3.759 OUTLIER-DELTA 0.0 OUTLIER gamma 74.33 . . . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.446 ' H6 ' " O5'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.946 0 C3'-C2'-C1' 100.828 -0.747 . 0.01 4p . 63.31 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.476 0.866 0 CA-C-O 120.919 0.39 . . . . 71.02 110.232 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -110.21 145.03 38.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.398 -0.365 . . . . 73.41 110.398 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.486 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 0.0 OUTLIER -148.32 137.59 12.13 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.901 -0.59 . . . . 72.11 109.695 179.498 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 97' ' ' ARG . 4.0 Cg_exo -76.22 146.45 28.45 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.941 2.428 . . . . 74.03 112.605 -172.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.406 ' HA2' HD13 ' A' ' 102' ' ' LEU . . . 78.13 -26.67 2.11 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 116.036 -0.529 . . . . 36.83 113.996 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.613 ' HB2' ' HE2' ' A' ' 179' ' ' LYS . . . -72.83 -25.3 61.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.997 0.399 . . . . 74.12 111.955 -174.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -91.92 12.78 20.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.271 0.557 . . . . 74.42 110.156 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.406 HD13 ' HA2' ' A' ' 99' ' ' GLY . 23.1 mt -129.24 -176.31 3.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.385 -0.825 . . . . 73.54 109.709 -177.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.4 p -102.86 95.37 6.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.482 0.658 . . . . 72.32 109.531 170.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 12.4 p -98.69 132.74 43.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.634 -0.712 . . . . 73.33 110.176 -176.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.583 ' HA ' HG23 ' A' ' 159' ' ' VAL . 15.2 mtmt -120.34 21.93 11.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.036 -0.529 . . . . 73.34 110.765 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.545 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.3 ttpt -153.89 142.49 20.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.327 -0.397 . . . . 71.55 109.944 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.543 ' CG2' HG13 ' A' ' 159' ' ' VAL . 4.0 pt -113.43 157.41 14.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.939 0.4 . . . . 70.25 110.915 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.478 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 66.7 t80 -105.61 119.89 40.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.608 -0.724 . . . . 72.13 109.932 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.0 t -101.1 108.89 24.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.796 0.331 . . . . 75.31 110.68 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.451 ' HA2' " H5'" ' B' ' 2' ' ' ' C' . . . -128.42 112.35 1.41 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.165 -0.54 . . . . 74.2 112.331 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.38 14.16 1.24 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.445 -0.884 . . . . 61.32 113.197 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.835 HD13 ' HB ' ' A' ' 116' ' ' THR . 9.0 pt -80.78 87.68 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.387 0.613 . . . . 74.52 110.311 177.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -61.25 -30.82 70.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.461 -0.79 . . . . 73.41 112.147 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -93.64 162.58 13.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.347 -0.388 . . . . 61.21 110.292 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -58.69 108.13 0.6 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 71.21 110.082 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.835 ' HB ' HD13 ' A' ' 112' ' ' ILE . 27.1 m -125.58 131.98 52.62 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.809 -0.632 . . . . 72.32 110.138 -175.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.14 -168.66 1.71 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.939 0.399 . . . . 64.03 111.438 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.652 ' HG3' HG13 ' A' ' 134' ' ' ILE . 15.1 tt0 -57.77 -49.87 75.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.64 -0.709 . . . . 75.23 112.429 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -33.53 69.9 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 121.046 -0.262 . . . . 65.42 110.504 -175.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -64.47 -53.36 49.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.08 -0.509 . . . . 65.35 110.552 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.474 HD12 HG12 ' A' ' 170' ' ' VAL . 9.3 mp -66.02 -49.62 67.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.727 -0.67 . . . . 75.31 111.193 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.5 -48.46 81.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.196 -0.456 . . . . 73.14 111.456 -176.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.3 -30.5 69.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.126 0.489 . . . . 64.51 110.832 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.474 ' CD1' HG22 ' A' ' 170' ' ' VAL . 50.8 t80 -81.64 -46.89 13.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.914 -0.584 . . . . 74.44 111.247 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -83.55 -16.89 43.72 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.725 0.639 . . . . 75.44 112.725 -173.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -23.9 67.38 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.989 0.423 . . . . 74.04 111.233 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -67.08 -25.02 66.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.821 -0.627 . . . . 71.33 110.508 178.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.483 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 45.7 m-85 -84.07 -34.25 24.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.968 -0.56 . . . . 74.42 110.477 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.95 -170.69 43.85 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.145 -1.026 . . . . 51.35 113.133 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -72.9 120.1 18.05 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.639 0.733 . . . . 73.05 112.092 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.467 HG23 HD13 ' A' ' 134' ' ' ILE . 41.1 mt -94.98 134.48 32.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.937 -1.029 . . . . 74.51 110.201 176.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.41 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 6.7 mm-40 -82.99 -67.42 0.79 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.032 -0.531 . . . . 63.31 110.717 178.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.0 m -146.53 152.62 13.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 72.22 110.259 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.652 HG13 ' HG3' ' A' ' 118' ' ' GLU . 33.5 mm -105.83 112.72 40.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.616 -0.513 . . . . 74.44 109.616 176.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -93.12 94.45 8.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.07 0.462 . . . . 74.01 110.212 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.0 mt -80.99 88.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.714 -0.847 . . . . 71.05 108.714 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.573 ' HE1' " C4'" ' B' ' 4' ' ' ' G' . 26.8 tpp -60.93 112.82 2.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.585 0.707 . . . . 63.33 110.864 -175.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -88.26 169.98 11.4 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.854 -1.066 . . . . 61.15 110.81 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.89 126.2 26.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.245 -0.65 . . . . 75.22 109.245 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.621 ' HD3' ' C2 ' ' B' ' 5' ' ' ' U' . 4.3 ppt_? -84.14 17.55 2.45 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.244 0.545 . . . . 74.41 111.211 -172.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -126.69 -53.16 0.15 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.545 -0.752 . . . . 63.11 111.706 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.8 m -97.36 -13.35 21.92 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.252 0.464 . . . . 72.41 112.252 -177.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.52 45.93 50.92 Favored Glycine 0 CA--C 1.516 0.131 0 C-N-CA 120.527 -0.845 . . . . 73.1 112.819 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -121.74 159.4 26.71 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.217 -0.66 . . . . 71.34 109.217 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -56.56 107.51 0.39 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.117 0.484 . . . . 73.01 110.452 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -72.2 -66.65 0.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.368 -0.833 . . . . 64.0 112.005 -169.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.668 ' C ' H5'' ' B' ' 1' ' ' ' U' . . . 172.28 -66.28 0.13 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.339 -0.934 . . . . 64.54 111.991 -177.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.551 ' CZ ' " H4'" ' B' ' 3' ' ' ' A' . 45.8 p90 -85.06 154.81 21.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.669 0.271 . . . . 65.5 110.486 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.91 163.39 33.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.332 -0.395 . . . . 74.31 110.405 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.453 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 50.2 m-85 -124.41 135.56 53.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.289 -0.414 . . . . 73.14 110.212 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.6 HG13 ' CD1' ' A' ' 134' ' ' ILE . 23.7 t -108.63 109.24 27.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.852 -0.425 . . . . 73.11 109.852 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.545 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 15.3 m -87.68 125.4 34.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.391 -0.368 . . . . 71.45 110.562 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.401 ' CE1' HG12 ' A' ' 131' ' ' ILE . 90.4 m-85 -109.84 154.41 23.06 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.703 -0.48 . . . . 74.14 109.703 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.41 ' HB2' ' HG2' ' A' ' 132' ' ' GLU . 23.9 t70 -77.57 -22.27 51.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.599 0.714 . . . . 61.13 110.213 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.429 ' OD2' ' HB2' ' A' ' 157' ' ' ASP . 25.7 t70 -123.31 135.09 54.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.113 -0.949 . . . . 64.02 111.236 -171.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.52 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.4 p-80 -84.2 0.19 49.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 74.33 112.006 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.429 ' HB2' ' OD2' ' A' ' 155' ' ' ASP . 54.3 m-20 -98.08 -29.25 13.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.97 -0.752 . . . . 71.03 108.97 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.418 ' HA ' ' HE3' ' A' ' 161' ' ' LYS . 42.4 t -58.8 -32.8 69.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.551 -0.749 . . . . 64.44 109.704 170.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.583 HG23 ' HA ' ' A' ' 105' ' ' LYS . 21.7 t -74.18 -29.77 25.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.355 -0.838 . . . . 64.21 110.434 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.03 -47.74 84.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 74.31 111.726 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.483 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -60.89 -18.65 57.59 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.324 0.583 . . . . 74.02 110.906 -178.313 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.529 HG23 HD13 ' A' ' 107' ' ' ILE . 80.5 mt -95.76 -52.33 9.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.451 -0.795 . . . . 72.13 111.158 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.538 ' HB ' ' HE3' ' A' ' 179' ' ' LYS . 26.4 m -74.77 -10.75 13.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.715 0.635 . . . . 74.34 112.715 -173.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.467 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.4 pp -68.61 -32.92 57.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.836 0.35 . . . . 74.15 111.052 176.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.467 ' N ' HD12 ' A' ' 164' ' ' ILE . 13.7 pt20 -107.51 -174.35 2.51 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.337 -0.616 . . . . 74.33 109.337 176.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.62 ' HE3' ' OE1' ' A' ' 176' ' ' GLU . 82.5 tttt -123.52 -56.52 1.69 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.933 0.397 . . . . 73.25 111.063 -174.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.582 ' HB3' ' OD1' ' A' ' 174' ' ' ASN . 21.8 m-30 -79.93 113.0 17.77 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.93 -0.577 . . . . 75.24 111.62 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -116.66 143.75 45.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.575 -0.739 . . . . 72.15 110.555 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 76.3 m -95.7 101.53 13.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.042 0.448 . . . . 71.03 111.202 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.474 HG12 HD12 ' A' ' 121' ' ' LEU . 42.4 t -118.62 127.96 75.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.285 -0.635 . . . . 75.22 109.285 177.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 58.5 t30 63.21 21.65 12.95 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.83 0.824 . . . . 73.4 110.112 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.58 -1.27 88.97 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.656 -0.702 . . . . 74.41 112.684 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -103.26 145.56 29.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.919 0.39 . . . . 75.32 110.541 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.582 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 64.5 t30 -88.87 106.58 18.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.907 -0.588 . . . . 73.15 110.072 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 12.0 p -116.55 159.86 21.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.088 -0.506 . . . . 65.35 110.993 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.62 ' OE1' ' HE3' ' A' ' 166' ' ' LYS . 14.5 tt0 -95.47 130.88 42.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.101 -0.5 . . . . 71.41 109.915 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 3.0 m -118.88 142.97 31.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.126 0.488 . . . . 72.44 110.135 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -130.53 177.68 7.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.157 -0.474 . . . . 72.33 110.199 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.613 ' HE2' ' HB2' ' A' ' 100' ' ' ALA . 10.1 mptt -75.79 120.01 20.57 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.908 -1.145 . . . . 73.31 107.908 171.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.535 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -74.23 93.09 2.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.139 0.495 . . . . 74.2 111.66 -176.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.653 HD22 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -95.94 144.59 26.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.755 -0.657 . . . . 75.44 109.655 175.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.508 ' HB3' ' HG3' ' A' ' 185' ' ' GLU . 30.6 t -50.28 143.34 8.74 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.405 0.44 . . . . 72.32 111.593 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.824 ' HB2' " H5'" ' B' ' 6' ' ' ' U' . 21.5 pttp -60.23 -23.54 64.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.762 -0.654 . . . . 73.31 110.182 175.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -73.76 -42.88 60.44 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.656 -0.702 . . . . 72.21 110.124 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.508 ' HG3' ' HB3' ' A' ' 182' ' ' SER . 37.9 mt-10 -78.85 -32.48 46.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.654 -0.703 . . . . 73.41 111.295 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 18.7 ptm -65.93 -26.0 67.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.326 -0.397 . . . . 72.24 110.666 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.96 -42.27 57.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.006 0.432 . . . . 64.54 110.267 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.5 t -69.64 -32.6 71.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.786 -0.643 . . . . 70.42 110.319 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -69.12 -31.4 70.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.218 0.532 . . . . 75.05 110.821 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 46.3 m -96.25 35.51 1.45 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.59 -0.732 . . . . 74.15 111.281 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.7 m -90.03 3.88 51.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 73.14 110.657 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 28.2 t -98.73 102.4 14.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.224 -0.444 . . . . 75.14 110.535 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -111.18 118.76 36.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.138 -0.483 . . . . 73.05 109.969 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -91.29 122.72 34.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.106 -0.497 . . . . 61.33 110.283 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.48 -125.74 9.55 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.922 -0.656 . . . . 65.02 112.142 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.419 ' HA ' ' HD3' ' A' ' 196' ' ' ARG . 9.2 mmt180 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.384 -0.817 . . . . 75.5 110.502 -179.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.831 " H3'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.831 0 C4'-C3'-C2' 103.99 1.29 . 0.0 '__' . 71.21 . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.831 H5'' " H3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.848 0 C4'-C3'-C2' 104.095 1.395 . 0.0 OUTLIER . 74.14 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.584 ' N1 ' HD22 ' A' ' 181' ' ' LEU . . . . . . . . 0 O5'--C5' 1.423 -1.038 0 C4'-C3'-C2' 103.883 1.183 . 0.0 OUTLIER . 73.21 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.67 " O5'" H5'' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.892 0 C3'-C2'-C1' 99.651 -2.055 . 0.0 OUTLIER alpha 75.53 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.67 H5'' " O5'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.839 0 O4'-C1'-C2' 108.34 1.385 . 0.0 OUTLIER . 74.12 . . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.824 " H5'" ' HB2' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.425 -0.913 0 C3'-C2'-C1' 103.731 2.479 . 0.0 OUTLIER . 74.43 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 110.379 -0.23 . . . . 74.14 110.379 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.479 ' HG2' ' HD3' ' A' ' 98' ' ' PRO . 61.3 tt0 -59.4 119.55 7.66 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.021 0.438 . . . . 70.33 110.906 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -149.94 79.28 7.79 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.774 -0.648 . . . . 72.11 110.639 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.479 ' HD3' ' HG2' ' A' ' 96' ' ' GLN . 17.1 Cg_exo -66.53 -54.27 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.632 2.221 . . . . 70.42 110.57 176.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.77 78.35 0.48 Allowed Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.734 -0.946 . . . . 50.34 110.734 172.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.19 -25.16 36.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.203 0.525 . . . . 64.11 110.48 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -70.96 -21.52 62.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.679 -0.692 . . . . 61.21 109.724 175.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.9 mt -82.76 107.31 15.29 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.405 -0.816 . . . . 75.33 109.858 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.494 HG21 ' HB2' ' A' ' 156' ' ' HIS . 1.8 m -63.96 130.85 45.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.083 -0.508 . . . . 75.31 109.65 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.442 HG11 HG12 ' A' ' 159' ' ' VAL . 14.6 p -114.74 147.18 18.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.149 -0.478 . . . . 63.42 111.266 -168.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.734 ' HA ' HG21 ' A' ' 159' ' ' VAL . 12.1 mtmt -123.07 -1.41 8.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 75.01 111.865 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.603 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 27.0 ttpt -130.45 137.42 49.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.846 0.355 . . . . 71.24 110.171 175.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.575 ' CG2' HG13 ' A' ' 159' ' ' VAL . 10.8 pt -108.36 163.97 5.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.949 0.404 . . . . 74.55 111.258 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.46 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 75.0 t80 -112.67 120.19 40.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.567 -0.742 . . . . 74.44 109.452 176.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.4 t -105.9 115.45 47.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.947 0.403 . . . . 74.34 110.919 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.86 171.53 18.5 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.65 -0.58 . . . . 45.23 111.65 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.519 ' H ' H5'' ' B' ' 2' ' ' ' C' . . . 66.97 36.95 91.76 Favored Glycine 0 N--CA 1.454 -0.119 0 C-N-CA 120.675 -0.774 . . . . 53.12 112.186 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.657 ' CD1' " H3'" ' B' ' 1' ' ' ' U' . 0.2 OUTLIER -94.62 -167.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.613 0.244 . . . . 71.14 110.828 -177.51 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -109.29 163.1 13.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.042 -0.355 . . . . 62.05 110.042 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.33 -34.36 46.92 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.386 0.675 . . . . 73.5 112.094 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -93.87 -3.64 51.45 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.466 0.543 . . . . 73.21 112.466 -173.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.7 m -69.14 115.85 8.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.019 0.437 . . . . 65.34 111.418 -172.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.31 -161.13 0.94 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.592 -0.731 . . . . 75.33 110.978 -177.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.557 ' HA ' HG23 ' A' ' 134' ' ' ILE . 10.7 tt0 -57.68 -51.8 68.05 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.522 -0.763 . . . . 75.05 112.266 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.67 -33.97 76.15 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 120.921 -0.312 . . . . 72.31 110.619 -173.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -60.88 -56.19 24.07 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.281 -0.418 . . . . 63.55 110.314 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.532 HD22 HG13 ' A' ' 170' ' ' VAL . 59.2 mt -59.31 -54.75 43.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.435 -0.802 . . . . 72.54 111.191 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -55.36 -46.64 76.43 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.1 -0.5 . . . . 71.43 111.412 -177.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.65 -35.3 65.79 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.996 0.427 . . . . 73.04 111.436 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -84.31 -44.4 13.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.378 -0.374 . . . . 75.32 111.191 -178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -81.39 -16.88 50.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.387 0.514 . . . . 71.13 112.387 -172.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -24.03 67.4 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.998 0.427 . . . . 64.12 110.951 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -66.76 -28.29 68.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.832 -0.622 . . . . 73.04 110.234 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.434 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 69.3 m-85 -80.78 -34.58 34.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.642 -0.708 . . . . 73.45 110.948 -177.45 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 171.7 -164.28 36.98 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.964 -1.112 . . . . 75.43 113.118 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -75.85 118.7 18.92 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.512 0.673 . . . . 72.03 111.959 -176.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.458 HG12 ' CE1' ' A' ' 153' ' ' PHE . 36.2 mt -95.22 139.96 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.19 -0.914 . . . . 54.22 110.355 177.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.436 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 9.0 mm-40 -84.61 -76.28 0.31 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.132 -0.485 . . . . 74.33 110.011 176.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.02 158.36 26.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.008 -0.542 . . . . 74.33 110.136 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.589 ' CD1' HG13 ' A' ' 151' ' ' VAL . 23.4 mm -107.35 112.46 40.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.139 -0.689 . . . . 75.52 109.139 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -97.58 92.02 5.71 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.348 0.594 . . . . 72.34 110.68 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.7 mt -73.66 128.54 36.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.324 -0.991 . . . . 75.43 108.324 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.636 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -71.36 96.91 1.52 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.265 -0.643 . . . . 61.45 109.265 -179.115 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 3.3 p -114.72 154.16 28.98 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.664 -0.698 . . . . 74.42 110.889 -178.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.652 ' HA ' ' C4 ' ' B' ' 5' ' ' ' U' . 33.0 t70 -56.93 142.44 41.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.082 -0.508 . . . . 72.25 110.917 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.01 -15.36 61.09 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.858 -0.61 . . . . 64.42 111.486 -175.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.61 -56.76 0.81 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.699 -0.762 . . . . 72.33 112.815 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.3 t -101.13 -8.23 22.45 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.652 -0.322 . . . . 71.52 111.536 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.87 43.61 91.07 Favored Glycine 0 N--CA 1.454 -0.107 0 C-N-CA 120.58 -0.819 . . . . 62.41 112.214 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 138' ' ' THR . 2.9 mtpt -93.08 141.97 27.81 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.869 -0.419 . . . . 72.24 109.869 -177.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -65.82 109.84 2.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.091 0.472 . . . . 73.33 110.934 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -70.35 -30.66 67.66 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.671 -0.695 . . . . 73.42 110.216 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 140.08 -79.0 0.29 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.738 -0.665 . . . . 36.09 112.127 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.636 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 42.4 p90 -69.94 165.16 22.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.865 0.364 . . . . 74.44 110.773 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.449 ' HB1' HD11 ' A' ' 121' ' ' LEU . . . -149.14 165.33 32.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.415 -0.357 . . . . 74.32 110.99 -177.4 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.46 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 53.7 m-85 -124.04 143.2 50.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 71.41 109.934 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.589 HG13 ' CD1' ' A' ' 134' ' ' ILE . 44.1 t -117.56 112.54 39.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.875 -0.417 . . . . 75.54 109.875 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.603 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 16.6 m -89.83 125.08 35.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.226 -0.443 . . . . 74.04 110.434 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.474 ' CD2' HG23 ' A' ' 159' ' ' VAL . 88.3 m-85 -108.63 152.24 25.06 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.432 -0.581 . . . . 73.53 109.432 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.436 ' HB2' ' HG2' ' A' ' 132' ' ' GLU . 28.4 t70 -81.3 -18.93 44.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.113 0.959 . . . . 54.12 109.07 176.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.522 ' OD2' ' HB3' ' A' ' 157' ' ' ASP . 26.0 t70 -116.05 126.16 53.41 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.227 -1.351 . . . . 74.43 110.548 -175.149 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.541 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.6 p-80 -78.81 -8.49 58.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.222 -0.445 . . . . 71.33 111.363 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.522 ' HB3' ' OD2' ' A' ' 155' ' ' ASP . 18.5 t70 -89.03 -36.26 15.9 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.308 -0.627 . . . . 74.23 109.308 -176.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.0 t -54.44 -40.79 68.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.315 -0.857 . . . . 52.11 109.713 168.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.734 HG21 ' HA ' ' A' ' 105' ' ' LYS . 11.3 t -67.75 -33.96 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.516 -0.766 . . . . 74.44 110.443 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -64.25 -28.85 70.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 73.42 110.752 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.434 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 20.9 mmtp -70.07 -24.36 63.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.621 0.724 . . . . 74.15 109.893 177.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.469 HG23 ' CE1' ' A' ' 168' ' ' HIS . 87.3 mt -99.71 -48.4 11.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.009 -0.996 . . . . 65.54 111.917 -169.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.488 HG12 HG11 ' A' ' 159' ' ' VAL . 31.6 m -73.05 -7.76 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 112.769 0.655 . . . . 73.43 112.769 -173.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.514 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.3 pp -78.45 -33.81 17.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.911 -0.316 . . . . 74.24 111.479 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.514 ' N ' HD12 ' A' ' 164' ' ' ILE . 12.8 pt20 -108.47 171.34 7.47 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.493 -0.558 . . . . 70.2 109.493 176.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.524 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 86.3 tttt -111.61 -59.38 1.99 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.831 0.348 . . . . 72.14 111.181 -174.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.587 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 19.8 m-30 -77.32 99.16 5.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.272 0.558 . . . . 63.54 112.042 -176.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.469 ' CE1' HG23 ' A' ' 162' ' ' ILE . 49.0 m-70 -98.61 159.19 15.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.551 -0.75 . . . . 74.11 110.009 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.9 m -104.67 83.77 2.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.927 0.394 . . . . 74.33 110.956 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.532 HG13 HD22 ' A' ' 121' ' ' LEU . 21.9 t -106.93 131.85 55.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.952 -0.388 . . . . 74.51 109.952 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.505 ' HB3' ' HD2' ' A' ' 173' ' ' HIS . 31.1 t-20 67.07 13.52 9.48 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.756 0.789 . . . . 73.11 109.776 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.05 17.69 71.53 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.758 -0.656 . . . . 74.01 112.072 -177.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . 0.505 ' HD2' ' HB3' ' A' ' 171' ' ' ASN . 86.9 m-70 -117.28 160.25 21.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.074 0.464 . . . . 72.55 110.553 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -87.2 105.98 17.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.703 -0.68 . . . . 71.41 109.449 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.587 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 66.8 m -114.15 158.43 21.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.151 -0.477 . . . . 75.34 111.02 -175.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.524 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 9.5 tt0 -103.16 125.74 50.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.15 -0.477 . . . . 74.33 110.152 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.409 HG13 ' CG2' ' A' ' 162' ' ' ILE . 78.5 t -123.06 135.16 64.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.308 0.575 . . . . 73.24 110.896 177.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.47 ' HD2' ' OE1' ' A' ' 96' ' ' GLN . 2.8 ptt180 -139.9 165.56 26.99 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.346 -0.843 . . . . 71.42 108.993 176.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.421 ' HB2' HG13 ' A' ' 104' ' ' VAL . 11.5 ptmm? -72.04 126.21 29.19 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.544 -0.462 . . . . 75.1 110.038 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.687 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -72.3 129.29 38.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.859 -0.61 . . . . 70.13 111.239 -176.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.71 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.5 pt? -124.7 143.96 50.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.437 -0.801 . . . . 75.54 109.025 174.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 m -49.3 137.91 13.59 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.445 0.466 . . . . 70.25 111.246 -177.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.843 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.1 pttp -61.84 -25.63 67.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.17 0.51 . . . . 72.23 110.094 178.194 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -59.06 -41.48 88.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.34 -0.846 . . . . 73.11 110.762 172.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -93.11 -35.89 12.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.58 -0.736 . . . . 74.03 111.38 -172.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.843 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 23.9 ptm -67.42 -22.59 65.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.753 0.311 . . . . 74.21 110.385 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.77 -39.35 90.93 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.7 -0.481 . . . . 74.24 109.7 175.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 16.0 m -70.64 -38.4 73.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.706 -0.679 . . . . 71.12 110.333 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.01 -34.73 79.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 70.22 110.729 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.7 t -75.24 -37.46 61.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.959 -0.564 . . . . 61.35 110.022 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 49.0 m -70.27 171.48 9.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.928 -0.578 . . . . 73.42 110.283 176.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 195' ' ' GLY . 14.7 m -96.71 88.6 4.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.932 0.396 . . . . 74.3 110.542 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -83.96 -46.77 11.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.024 0.44 . . . . 73.32 110.241 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -87.39 -42.29 12.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.091 -0.504 . . . . 72.34 110.183 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 192' ' ' SER . . . 168.87 -76.25 0.11 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.635 -0.793 . . . . 52.04 112.328 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.686 -0.673 . . . . 74.2 110.161 -177.884 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.657 " H3'" ' CD1' ' A' ' 112' ' ' ILE . . . . . . . . 0 O5'--C5' 1.423 -1.074 0 C3'-C2'-C1' 100.405 -1.216 . 0.0 '__' . 74.53 . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.653 ' OP2' " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.96 0 C3'-C2'-C1' 100.806 -0.771 . 0.0 OUTLIER . 73.45 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.687 ' N1 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.426 -0.864 0 O4'-C1'-C2' 108.051 1.18 . 0.0 OUTLIER . 74.31 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.629 " O5'" ' HD3' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.424 -0.993 0 C3'-C2'-C1' 100.547 -1.059 . 0.0 OUTLIER alpha 74.14 . . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.929 ' C6 ' " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.97 0 C3'-C2'-C1' 103.722 2.469 OUTLIER-DELTA 0.0 OUTLIER . 75.43 . . . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.507 " O5'" " H4'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.923 0 C3'-C2'-C1' 100.343 -1.285 . 0.0 OUTLIER . 75.44 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 121.102 0.477 . . . . 71.44 110.948 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -84.63 128.4 34.58 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.016 -0.735 . . . . 74.4 109.016 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 97' ' ' ARG . 46.8 mtm105 58.86 96.11 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.292 0 O-C-N 123.874 0.734 . . . . 75.23 110.85 -172.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.614 ' HG2' ' O ' ' A' ' 179' ' ' LYS . 34.9 Cg_exo -64.57 -169.49 0.12 Allowed 'Trans proline' 0 N--CA 1.472 0.212 0 C-N-CA 123.27 2.646 . . . . 74.53 113.463 -179.342 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -56.58 98.86 0.07 OUTLIER Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.647 -0.706 . . . . 63.23 112.552 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.456 ' HA ' ' HZ1' ' A' ' 179' ' ' LYS . . . -76.94 -14.38 59.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.318 0.58 . . . . 63.1 110.499 -178.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -83.34 -6.29 59.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.453 -0.794 . . . . 73.54 110.391 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.5 mt -101.06 130.85 47.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.901 -0.591 . . . . 71.11 110.52 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.91 104.09 3.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.17 0.51 . . . . 65.22 110.349 175.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.474 ' O ' HG22 ' A' ' 159' ' ' VAL . 4.1 p -89.56 144.76 8.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.866 -0.607 . . . . 65.31 110.323 -176.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.525 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 2.5 mtmt -122.24 16.81 10.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.389 0.614 . . . . 74.43 110.547 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.556 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 24.8 ttpt -152.78 136.52 16.15 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.339 -0.846 . . . . 62.44 109.742 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.517 HG12 ' HB ' ' A' ' 151' ' ' VAL . 9.1 pt -103.93 162.7 4.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.904 0.383 . . . . 73.43 110.732 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.463 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 59.7 t80 -110.63 110.63 21.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.762 -0.653 . . . . 74.11 110.363 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.1 t -98.25 91.86 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.132 -0.692 . . . . 74.55 109.132 176.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.684 ' O ' " H5'" ' B' ' 2' ' ' ' C' . . . -106.64 -38.99 2.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.669 -0.777 . . . . 52.13 112.928 -174.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.627 ' HA3' ' HB3' ' A' ' 176' ' ' GLU . . . -79.54 59.43 4.4 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.589 -0.815 . . . . 75.44 113.229 -174.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.474 HG23 ' SG ' ' A' ' 175' ' ' CYS . 44.9 pt -110.97 169.87 3.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 110.123 -0.325 . . . . 75.22 110.123 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.445 ' HA ' ' O2 ' ' B' ' 1' ' ' ' U' . 49.6 mttm -138.35 -48.72 0.54 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.337 -0.392 . . . . 74.32 111.175 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.75 173.58 8.2 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.193 -0.458 . . . . 73.52 111.011 -176.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.27 97.36 0.54 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.956 -0.565 . . . . 74.11 110.052 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.1 m -117.8 120.48 38.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.346 -0.843 . . . . 53.43 109.393 -178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.61 -169.37 1.49 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.215 0.531 . . . . 74.53 112.143 -173.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.579 ' HA ' HG22 ' A' ' 134' ' ' ILE . 21.1 tt0 -58.13 -48.73 79.34 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.881 -1.054 . . . . 74.04 111.926 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -34.94 75.19 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.089 -0.244 . . . . 72.03 110.554 -177.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -64.4 -57.31 9.65 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.085 0.469 . . . . 75.44 110.453 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.549 HD22 HG11 ' A' ' 170' ' ' VAL . 79.4 mt -59.93 -52.4 65.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.306 -0.861 . . . . 72.32 110.848 -176.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.52 -44.09 93.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.007 -0.542 . . . . 74.44 111.419 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -63.16 -22.75 67.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.042 0.448 . . . . 73.51 110.938 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.408 ' CD1' HG22 ' A' ' 170' ' ' VAL . 85.9 t80 -89.83 -51.78 5.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.251 -0.432 . . . . 74.04 110.85 176.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.404 ' HA ' ' HD2' ' A' ' 128' ' ' TYR . 52.2 m-85 -74.49 -14.7 60.86 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.38 0.511 . . . . 74.34 112.38 -172.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -22.34 65.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.837 0.31 . . . . 74.25 111.837 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -74.66 -21.82 59.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 71.24 110.582 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.452 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 86.6 m-85 -86.04 -21.79 27.56 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.501 -0.318 . . . . 73.44 110.279 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 163.18 -167.69 37.6 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 119.822 -1.18 . . . . 44.51 113.373 174.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.529 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 37.7 tptt -75.74 117.09 17.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.633 0.73 . . . . 72.25 111.09 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.484 HG22 HD12 ' A' ' 134' ' ' ILE . 40.1 mt -93.69 133.78 33.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.023 -0.989 . . . . 73.42 110.557 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -82.2 -75.17 0.31 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.925 -0.58 . . . . 74.44 110.765 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.54 155.57 36.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.797 -0.446 . . . . 75.31 109.797 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.626 ' CD1' HG12 ' A' ' 151' ' ' VAL . 27.8 mm -113.01 123.08 68.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.493 -0.558 . . . . 74.13 109.493 173.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.3 96.13 6.31 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.017 0.437 . . . . 72.1 110.644 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.54 HD12 ' H ' ' A' ' 118' ' ' GLU . 7.9 mt -80.19 120.46 31.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.036 -1.098 . . . . 73.21 108.036 173.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.579 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 76.1 mmm -74.15 94.39 2.43 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 119.926 -0.71 . . . . 75.23 109.964 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.2 p -99.56 173.71 6.6 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.704 -1.135 . . . . 70.52 109.983 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.749 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 22.1 t70 -60.61 138.6 58.03 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.349 -0.612 . . . . 65.43 109.349 173.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.401 ' HD3' " H2'" ' B' ' 5' ' ' ' U' . 5.1 tpt180 -72.04 -2.38 18.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.006 0.431 . . . . 70.21 111.214 -172.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -128.67 -49.47 0.14 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.032 -0.604 . . . . 73.0 112.852 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.51 ' HB2' ' HG2' ' A' ' 144' ' ' LYS . 24.5 m -83.51 -18.93 36.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.745 0.307 . . . . 61.13 111.61 -175.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.76 32.54 78.19 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.765 -0.731 . . . . 55.03 112.855 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.51 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 8.3 ptpt -105.6 139.62 39.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.76 -0.459 . . . . 72.44 109.76 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -52.89 130.05 32.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 74.41 112.028 -172.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -91.04 -32.1 16.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.258 -0.645 . . . . 72.32 109.258 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.672 ' HA3' " O5'" ' B' ' 1' ' ' ' U' . . . 154.68 -101.91 0.21 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.508 -0.769 . . . . 73.41 112.283 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.634 ' N ' " H5'" ' B' ' 1' ' ' ' U' . 24.5 p90 -57.22 157.64 6.05 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.921 0.488 . . . . 73.23 111.853 -175.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.53 165.52 27.34 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.173 -0.467 . . . . 74.21 110.938 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.54 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 69.1 m-85 -123.73 142.34 51.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.1 -0.5 . . . . 74.23 110.317 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.626 HG12 ' CD1' ' A' ' 134' ' ' ILE . 55.6 t -116.42 108.49 25.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.04 -0.527 . . . . 74.42 109.784 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.556 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 8.7 m -86.35 127.61 34.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.142 -0.481 . . . . 74.03 110.475 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.531 ' CD2' HG13 ' A' ' 159' ' ' VAL . 96.4 m-85 -110.47 153.5 24.96 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.936 0.398 . . . . 74.42 110.555 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.529 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 19.4 t70 -76.69 -15.26 59.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.905 -0.589 . . . . 71.22 110.606 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -136.15 139.85 43.2 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.809 -0.632 . . . . 72.34 110.609 -174.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.525 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.4 p-80 -83.99 -0.29 51.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.979 0.418 . . . . 70.51 111.018 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -80.44 -40.97 25.32 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.417 0.627 . . . . 74.11 109.48 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.696 ' HA ' ' HZ3' ' A' ' 161' ' ' LYS . 1.4 m -61.17 -33.64 73.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.121 -0.945 . . . . 75.31 111.538 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.531 HG13 ' CD2' ' A' ' 153' ' ' PHE . 15.3 m -72.85 -27.92 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 74.0 111.396 -177.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . 0.479 ' HA ' HG23 ' A' ' 163' ' ' VAL . 35.6 t70 -65.53 -42.12 92.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.608 -0.269 . . . . 61.21 110.993 -173.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.696 ' HZ3' ' HA ' ' A' ' 158' ' ' SER . 4.9 mttt -58.86 -22.33 58.9 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.196 0.522 . . . . 71.52 110.807 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.472 HG23 HD11 ' A' ' 107' ' ' ILE . 79.6 mt -92.86 -49.37 12.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.397 -0.82 . . . . 51.5 110.939 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 179' ' ' LYS . 30.3 m -77.83 -7.73 10.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.898 0.703 . . . . 75.33 112.898 -174.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -72.84 -28.87 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.967 0.413 . . . . 75.43 110.561 174.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.42 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 11.9 pt20 -108.06 -171.17 1.81 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.172 -0.677 . . . . 74.43 109.172 172.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -130.3 -61.85 0.96 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.781 -0.368 . . . . 63.33 111.537 -174.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -82.6 115.51 21.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.949 0.404 . . . . 72.22 110.721 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.434 ' CE1' HG21 ' A' ' 162' ' ' ILE . 21.3 m-70 -110.15 140.04 44.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.702 -0.681 . . . . 72.04 110.655 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 34.3 m -88.85 87.72 7.34 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.047 -0.524 . . . . 71.53 110.354 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.549 HG11 HD22 ' A' ' 121' ' ' LEU . 33.0 t -106.07 131.07 56.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.597 -0.52 . . . . 74.25 109.597 178.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 63.46 20.83 12.47 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.879 0.847 . . . . 74.23 109.546 -177.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.08 -5.74 70.24 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.383 -0.826 . . . . 71.53 112.191 -176.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -96.46 151.24 19.75 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.207 -0.294 . . . . 73.41 110.207 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -86.78 99.49 11.83 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.008 -0.367 . . . . 71.41 110.008 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 58.5 m -110.46 128.85 55.8 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.363 -0.38 . . . . 72.44 110.979 -177.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.627 ' HB3' ' HA3' ' A' ' 111' ' ' GLY . 28.4 tt0 -76.72 123.52 26.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.173 -0.467 . . . . 74.14 110.534 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 1.1 m -119.31 151.75 21.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.185 -0.461 . . . . 72.12 110.354 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -138.23 -173.92 3.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.716 -0.846 . . . . 74.43 108.716 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.614 ' O ' ' HG2' ' A' ' 98' ' ' PRO . 19.4 ptmt -91.07 132.88 35.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.253 -0.647 . . . . 75.22 109.253 170.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -82.15 114.36 20.62 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.101 0.408 . . . . 73.54 112.101 -173.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.574 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.6 pt? -102.66 144.62 30.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.076 -0.713 . . . . 72.01 109.076 173.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 m -52.86 133.13 37.7 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.312 0.383 . . . . 61.33 111.252 -176.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.741 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 39.0 pttt -62.35 -30.25 71.04 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 109.828 -0.434 . . . . 75.31 109.828 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -59.99 -41.26 91.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.517 -0.765 . . . . 65.31 110.358 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -85.26 -39.16 18.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.645 -0.707 . . . . 75.01 111.257 -175.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.741 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 25.3 ptm -68.14 -21.33 64.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 73.53 110.49 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.75 -43.08 63.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 64.33 109.864 175.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 18.8 m -69.41 -31.49 69.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.912 -0.586 . . . . 70.43 110.479 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -66.24 -46.53 76.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.395 0.616 . . . . 73.43 110.326 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 64.6 m -69.51 -53.99 16.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.19 -0.913 . . . . 74.14 110.894 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 28.5 m -111.16 88.3 2.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.124 0.488 . . . . 70.41 110.363 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.1 m -89.74 95.49 10.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.856 -0.611 . . . . 62.33 110.605 -178.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -83.95 136.93 33.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.979 -0.555 . . . . 72.1 109.576 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -101.68 24.43 9.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.005 0.431 . . . . 65.43 110.291 -174.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 94.17 -74.15 1.09 Allowed Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.09 -0.804 . . . . 64.33 111.09 -174.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.727 -0.654 . . . . 70.42 109.431 175.9 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 1.0 " C4'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.725 0 C4'-C3'-C2' 104.199 1.499 . 0.0 '__' . 75.55 . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 1.0 H5'' " C4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.006 0 C3'-C2'-C1' 104.404 3.227 OUTLIER-DELTA 0.0 OUTLIER alpha 75.13 . . . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.565 ' N1 ' HD22 ' A' ' 181' ' ' LEU . . . . . . . . 0 O5'--C5' 1.424 -1.03 0 C4'-C3'-C2' 104.545 1.845 . 0.0 OUTLIER . 75.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.627 ' H21' ' HB3' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.424 -1.01 0 C3'-C2'-C1' 98.582 -3.243 . 0.0 OUTLIER alpha 75.21 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.906 " H3'" " H5'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.422 -1.135 0 O4'-C1'-C2' 107.797 0.998 . 0.0 OUTLIER zeta-1 71.44 . . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.906 " H5'" " H3'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.887 0 C3'-C2'-C1' 100.765 -0.817 . 0.0 OUTLIER . 72.52 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 59.2 m . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 110.313 -0.254 . . . . 75.43 110.313 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 65.28 19.92 11.78 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.296 0.639 . . . . 72.25 111.401 177.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -135.69 78.11 50.13 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.96 0.41 . . . . 74.24 110.578 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -91.47 46.35 0.54 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.144 2.563 . . . . 70.3 111.912 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.79 -28.26 5.53 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.961 -0.856 . . . . 61.22 110.961 -173.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.481 ' HB1' ' HB3' ' A' ' 181' ' ' LEU . . . -85.91 96.47 9.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.656 -0.498 . . . . 64.05 109.656 172.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . 0.764 ' HA ' ' HG2' ' A' ' 179' ' ' LYS . 8.5 p80 -173.14 8.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.523 -0.762 . . . . 74.2 110.01 177.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.2 mt -102.22 -140.09 0.35 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.315 -0.857 . . . . 74.54 109.641 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.2 p -74.16 96.66 2.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.915 0.388 . . . . 75.43 110.307 174.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.4 t -103.31 -46.74 10.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.364 -0.38 . . . . 73.13 111.266 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.711 ' HA ' HG22 ' A' ' 159' ' ' VAL . 24.1 mtmt 69.45 12.27 8.22 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.163 -0.472 . . . . 74.1 112.206 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.561 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 27.9 ttpt -157.23 133.91 10.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.593 -0.521 . . . . 64.33 109.593 173.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.495 HD13 HG23 ' A' ' 162' ' ' ILE . 4.7 pt -108.42 158.49 8.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.106 0.479 . . . . 75.11 111.023 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 69.4 t80 -105.3 121.11 43.19 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.246 -0.888 . . . . 72.42 109.899 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . 0.473 HG12 ' CG2' ' A' ' 112' ' ' ILE . 41.9 t -108.43 111.56 36.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.44 -0.345 . . . . 74.22 110.405 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.53 162.05 20.75 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.02 -0.61 . . . . 51.45 112.241 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.43 62.81 5.22 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.948 -0.644 . . . . 71.25 111.59 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.558 ' H ' " C5'" ' B' ' 1' ' ' ' U' . 17.6 pt -111.71 -170.23 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.339 0.59 . . . . 74.22 112.475 -169.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.447 ' HB3' ' OG1' ' A' ' 116' ' ' THR . 44.4 tttm -96.46 153.45 17.83 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.014 -0.993 . . . . 75.24 109.763 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -47.2 -67.51 0.27 Allowed 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.485 0.491 . . . . 62.12 111.249 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -87.48 80.59 8.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.316 0.579 . . . . 41.54 110.139 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.447 ' OG1' ' HB3' ' A' ' 113' ' ' LYS . 62.3 m -140.64 106.87 5.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.125 -0.943 . . . . 72.05 109.356 173.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.414 ' O ' HD23 ' A' ' 121' ' ' LEU . 10.9 pt-20 -123.22 -162.9 1.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.706 -0.679 . . . . 61.55 110.812 -174.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.539 ' HG3' ' CG1' ' A' ' 134' ' ' ILE . 15.9 tt0 -49.47 -52.43 29.22 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.028 -0.533 . . . . 75.24 112.056 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.49 -29.29 70.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.525 -0.307 . . . . 74.23 110.663 -174.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -69.42 -56.46 7.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.533 -0.303 . . . . 64.54 110.918 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -57.19 -49.07 77.15 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.969 0.414 . . . . 71.43 109.951 177.47 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 122' ' ' ARG . 0.7 OUTLIER -55.03 -49.94 70.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.725 -0.671 . . . . 74.25 111.03 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -53.29 -32.71 50.04 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.169 0.509 . . . . 73.4 111.8 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -89.88 -39.09 13.27 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.077 -0.511 . . . . 74.35 111.578 -177.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.446 ' CD1' HG23 ' A' ' 151' ' ' VAL . 56.4 m-85 -89.14 -14.35 36.37 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.358 0.503 . . . . 71.04 112.358 -173.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.12 -20.47 66.16 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.413 0.625 . . . . 72.32 110.013 176.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -71.58 -23.64 61.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.996 -1.002 . . . . 75.1 110.755 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -87.17 -32.64 19.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.086 -0.506 . . . . 75.42 111.099 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.33 -152.35 16.69 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.829 -1.177 . . . . 73.51 113.7 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.436 ' HA ' ' HE3' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -87.97 113.95 24.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.421 0.629 . . . . 73.44 111.547 -175.656 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 34.3 mt -94.24 138.25 21.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.041 -0.982 . . . . 72.44 110.187 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -78.04 -74.58 0.26 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.483 -0.562 . . . . 72.53 109.483 172.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.6 m -146.57 165.48 7.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.917 -0.583 . . . . 74.14 109.816 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.594 ' CD1' HG12 ' A' ' 151' ' ' VAL . 19.6 mm -109.59 109.45 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.274 -0.639 . . . . 73.45 109.274 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.5 mt-10 -88.14 98.57 11.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.312 0.577 . . . . 63.12 110.231 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.514 HD13 ' H ' ' A' ' 118' ' ' GLU . 35.8 mt -78.48 116.26 21.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.637 -0.71 . . . . 74.51 109.571 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.756 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -77.05 98.67 5.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.078 0.466 . . . . 70.43 109.809 -178.632 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 p -90.74 144.06 26.11 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.896 -0.593 . . . . 63.33 110.97 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -59.55 141.07 55.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.228 -0.896 . . . . 71.31 110.524 178.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.426 ' H ' ' HD3' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -96.06 14.68 22.97 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.07 -0.513 . . . . 61.01 110.961 -174.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -120.28 -45.8 0.39 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.97 -0.633 . . . . 62.23 111.717 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.1 t -100.86 -34.35 9.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.878 0.37 . . . . 63.31 111.035 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.67 54.32 2.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.64 -0.791 . . . . 45.03 111.526 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -134.19 159.86 39.6 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.595 -0.52 . . . . 74.4 109.595 -176.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -60.47 113.56 2.49 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.344 -0.614 . . . . 62.02 109.344 174.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 21.9 ttt-85 -82.38 6.33 17.44 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.516 0.561 . . . . 72.2 112.516 -167.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 1.048 ' HA3' " H2'" ' B' ' 1' ' ' ' U' . . . 106.74 -11.44 41.92 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.139 -1.029 . . . . 74.53 112.964 176.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.756 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 21.4 p90 -141.92 150.76 41.91 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 122.485 -0.42 . . . . 71.42 110.477 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.49 174.23 10.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.757 -0.656 . . . . 72.1 110.069 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.517 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 82.2 m-85 -133.33 139.55 46.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.914 0.387 . . . . 74.34 110.095 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.594 HG12 ' CD1' ' A' ' 134' ' ' ILE . 26.3 t -114.02 106.61 21.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.598 -0.519 . . . . 73.25 109.598 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.561 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 17.7 m -85.28 124.11 31.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.23 -0.441 . . . . 74.1 110.313 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.438 ' CD2' HG21 ' A' ' 159' ' ' VAL . 97.5 m-85 -107.91 145.09 34.24 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.833 -0.432 . . . . 74.42 109.833 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -74.87 -21.32 59.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.688 0.756 . . . . 72.04 109.486 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.487 ' OD1' ' HB3' ' A' ' 157' ' ' ASP . 18.7 t70 -118.99 128.52 54.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.801 -1.09 . . . . 71.41 110.871 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.548 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 3.2 p-80 -76.23 -9.59 58.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.996 -0.547 . . . . 64.3 111.268 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.487 ' HB3' ' OD1' ' A' ' 155' ' ' ASP . 32.8 t70 -85.3 -39.84 17.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.207 0.527 . . . . 60.45 109.642 -176.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.4 t -57.68 -34.6 69.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.627 -0.715 . . . . 61.22 110.526 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.711 HG22 ' HA ' ' A' ' 105' ' ' LYS . 16.9 t -66.84 -35.54 74.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.004 -0.544 . . . . 73.43 110.134 178.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.12 -31.7 72.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.525 -0.761 . . . . 74.23 111.362 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 35.3 mmtt -71.36 -19.48 62.28 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.306 0.574 . . . . 71.32 110.184 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.495 HG23 HD13 ' A' ' 107' ' ' ILE . 86.8 mt -102.22 -48.88 10.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.262 -0.881 . . . . 74.33 111.433 -171.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.536 ' HB ' ' HG3' ' A' ' 179' ' ' LYS . 33.6 m -67.85 -19.25 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.216 0.451 . . . . 73.23 112.216 -174.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.4 pp -69.34 -25.44 29.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.096 0.474 . . . . 71.51 110.774 176.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.549 ' HB3' ' NE2' ' A' ' 168' ' ' HIS . 21.9 tt0 -106.96 159.62 16.14 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.414 -0.812 . . . . 73.34 109.114 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.527 ' HE2' ' CE2' ' A' ' 167' ' ' TYR . 80.6 tttt -109.66 -64.3 1.27 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.87 0.367 . . . . 75.43 110.762 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.527 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 22.9 m-85 -77.03 113.17 14.45 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.049 0.452 . . . . 73.33 110.829 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.549 ' NE2' ' HB3' ' A' ' 165' ' ' GLN . 36.0 m-70 -121.7 132.53 54.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.549 -0.75 . . . . 71.02 110.019 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' THR . . . . . 0.408 ' HA ' ' HA ' ' A' ' 174' ' ' ASN . 55.2 m -90.45 102.56 15.29 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.062 0.458 . . . . 74.22 110.951 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.21 136.58 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.899 -0.591 . . . . 72.24 109.881 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 59.29 25.5 14.14 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.511 0.672 . . . . 70.25 110.718 -175.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 77.57 7.61 87.16 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.766 -0.73 . . . . 61.31 112.555 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -116.02 123.62 48.43 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.718 -0.475 . . . . 71.34 109.718 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 169' ' ' THR . 64.1 t30 -74.73 102.63 4.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.214 -0.448 . . . . 70.22 110.071 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' ' 112' ' ' ILE . 35.5 m -107.76 169.99 8.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.158 -0.474 . . . . 75.44 110.709 -175.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -103.0 122.22 44.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.232 -0.44 . . . . 64.35 109.948 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.0 OUTLIER -120.36 151.67 23.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.263 -0.643 . . . . 72.23 109.263 176.646 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -161.62 -171.67 3.03 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.835 -0.621 . . . . 73.21 109.758 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.764 ' HG2' ' HA ' ' A' ' 101' ' ' HIS . 7.7 mptt -74.43 122.16 22.56 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.874 -0.417 . . . . 71.33 109.874 -177.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.654 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -81.28 90.85 6.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.942 0.401 . . . . 75.12 111.321 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.611 HD21 ' H ' ' A' ' 181' ' ' LEU . 2.5 pt? -88.76 134.95 33.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.259 -0.645 . . . . 71.4 109.259 174.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.4 m -51.91 144.47 11.55 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.567 0.542 . . . . 75.14 111.309 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.757 ' NZ ' " H3'" ' B' ' 5' ' ' ' U' . 32.1 pttt -57.71 -29.78 64.99 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.227 0.537 . . . . 62.14 110.114 177.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -58.04 -47.78 82.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.416 -0.811 . . . . 73.52 110.713 173.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -82.31 -37.66 25.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.122 -0.945 . . . . 71.43 111.275 -173.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.656 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.7 ptm -64.17 -24.42 67.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.494 -0.321 . . . . 71.1 110.638 -178.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.11 -30.05 63.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.011 0.434 . . . . 72.04 110.599 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.4 m -88.95 -45.86 9.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.03 -0.532 . . . . 72.53 110.65 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -73.02 -54.22 9.14 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.117 -0.492 . . . . 75.33 111.392 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 7.8 t -83.39 93.57 7.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.402 0.62 . . . . 64.53 109.769 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.3 t -165.14 145.21 7.02 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.281 -0.872 . . . . 74.4 109.193 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 16.9 m -69.18 120.93 15.78 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.195 -0.669 . . . . 62.54 109.195 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -59.72 119.08 6.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.558 0.694 . . . . 74.11 110.654 -177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -94.02 -24.7 17.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.349 -0.841 . . . . 75.21 109.449 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 93.61 -103.88 3.09 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.429 -0.805 . . . . 65.22 112.502 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 8.4 mtm-85 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.451 -0.785 . . . . 71.13 110.452 -174.284 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 1.048 " H2'" ' HA3' ' A' ' 147' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.914 0 C4'-C3'-C2' 105.509 2.809 . 0.0 '__' . 74.54 . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.967 H5'' " H3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.812 0 C4'-C3'-C2' 105.955 3.255 . 0.0 OUTLIER . 75.44 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.654 ' N1 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.427 -0.834 0 O4'-C1'-C2' 108.279 1.342 . 0.0 OUTLIER gamma 75.22 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.592 " H4'" ' SD ' ' A' ' 137' ' ' MET . . . . . . . . 0 O5'--C5' 1.424 -0.973 0 C3'-C2'-C1' 99.954 -1.717 . 0.0 OUTLIER alpha 75.33 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.757 " H3'" ' NZ ' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.424 -0.988 0 O4'-C4'-C3' 103.772 -1.234 . 0.0 OUTLIER gamma 74.22 . . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.665 " C5'" ' HZ3' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.423 -1.054 0 O4'-C1'-C2' 107.703 0.931 . 0.0 OUTLIER zeta-1 74.43 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 111.518 0.192 . . . . 74.45 111.518 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.497 ' NE2' ' HG2' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -92.72 157.49 16.42 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.968 0.413 . . . . 65.41 111.121 -174.177 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -144.74 82.89 9.92 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.377 -0.374 . . . . 72.22 111.163 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -89.9 0.9 5.59 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.876 2.384 . . . . 74.22 112.269 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.49 53.09 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.985 -0.846 . . . . 71.31 110.985 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.55 -13.12 49.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.241 0.543 . . . . 73.52 110.27 -177.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 1.9 p80 -76.71 -6.18 51.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.404 -0.816 . . . . 71.44 110.264 175.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.3 mt -114.02 145.56 41.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.569 -0.741 . . . . 75.34 109.99 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.06 119.68 24.79 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.057 -0.72 . . . . 75.52 109.057 174.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . 0.41 HG11 HG13 ' A' ' 159' ' ' VAL . 12.5 p -111.3 144.09 19.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.728 -0.669 . . . . 64.44 111.089 -168.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.781 ' HA ' HG22 ' A' ' 159' ' ' VAL . 21.7 mtmt -122.91 6.32 9.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 65.14 111.662 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.611 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.6 ttpt -139.55 139.95 36.98 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.967 -0.383 . . . . 73.44 109.967 174.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.535 HG12 ' HB ' ' A' ' 151' ' ' VAL . 5.5 pt -109.25 160.78 7.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.94 0.4 . . . . 75.4 111.157 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.476 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 62.7 t80 -110.82 127.79 55.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.571 -0.741 . . . . 74.32 109.681 177.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 45.8 t -108.83 117.72 54.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.966 0.412 . . . . 73.13 110.855 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -130.97 171.08 21.08 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.042 -0.823 . . . . 70.44 111.042 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 68.66 31.69 73.68 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.102 -0.571 . . . . 74.23 113.401 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.745 HD11 ' HB ' ' A' ' 116' ' ' THR . 18.8 pt -87.17 -21.87 7.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.783 0.291 . . . . 74.11 110.707 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.712 ' HG3' ' O ' ' A' ' 112' ' ' ILE . 0.0 OUTLIER 58.97 -51.73 0.06 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.851 1.66 . . . . 71.12 114.028 179.029 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.522 ' HG3' ' H ' ' A' ' 115' ' ' ASP . 2.9 tp10 -95.79 171.11 8.86 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.314 -0.625 . . . . 63.54 109.314 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.522 ' H ' ' HG3' ' A' ' 114' ' ' GLU . 3.3 p-10 -65.71 121.23 14.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.543 0.687 . . . . 63.42 110.183 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.745 ' HB ' HD11 ' A' ' 112' ' ' ILE . 23.0 m -134.8 123.36 23.44 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.311 -0.859 . . . . 73.12 108.799 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.517 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 10.6 pt-20 -119.99 -164.26 1.06 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.466 0.543 . . . . 74.34 112.466 -167.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.568 ' CG ' ' HB ' ' A' ' 134' ' ' ILE . 2.6 tm-20 -61.63 -47.44 85.37 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.536 -0.756 . . . . 75.22 111.826 -173.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.471 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.0 p80 -63.6 -33.43 75.6 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.632 -0.427 . . . . 75.3 110.573 -177.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . 0.517 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 35.6 m80 -63.75 -59.36 4.67 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.232 0.539 . . . . 73.13 111.085 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.535 HD13 HG12 ' A' ' 170' ' ' VAL . 4.5 mp -59.41 -48.14 82.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.276 -0.875 . . . . 75.45 110.938 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.439 ' HG3' HD12 ' A' ' 131' ' ' ILE . 6.2 ttp180 -63.68 -38.97 93.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.147 -0.479 . . . . 74.04 111.414 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -58.99 -31.15 68.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.088 0.471 . . . . 75.2 110.987 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.585 ' CD1' HG22 ' A' ' 170' ' ' VAL . 59.4 t80 -93.03 -48.15 6.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.897 -0.592 . . . . 71.11 111.525 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.411 ' HA ' ' HD2' ' A' ' 128' ' ' TYR . 43.6 m-85 -76.07 -11.82 60.01 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.519 0.563 . . . . 72.21 112.519 -172.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.48 -25.16 67.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.674 0.273 . . . . 75.5 111.506 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -73.9 -23.11 59.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.017 0.437 . . . . 70.0 110.65 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.411 ' HD2' ' HA ' ' A' ' 125' ' ' PHE . 91.0 m-85 -81.42 -29.14 33.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 74.13 110.561 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.419 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 168.59 -156.4 27.78 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.085 -1.055 . . . . 75.12 113.223 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.465 ' HA ' ' HE3' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -86.17 114.91 23.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.359 0.599 . . . . 73.44 110.994 -177.501 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.439 HD12 ' HG3' ' A' ' 122' ' ' ARG . 27.4 mt -89.14 135.01 26.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.355 -0.839 . . . . 71.22 110.068 176.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.5 ' HG3' ' N ' ' A' ' 154' ' ' ASP . 29.2 mt-10 -78.61 -69.22 0.58 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.84 -0.429 . . . . 64.42 109.84 174.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.1 m -148.56 157.27 7.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.971 -0.559 . . . . 75.41 110.085 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.604 ' CD1' HG13 ' A' ' 151' ' ' VAL . 22.9 mm -104.71 107.63 22.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.571 -0.529 . . . . 71.42 109.571 175.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -90.68 91.7 8.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.842 -0.617 . . . . 72.45 110.449 -174.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.512 HD11 ' H ' ' A' ' 118' ' ' GLU . 21.3 mt -74.94 121.51 26.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.858 -0.793 . . . . 74.41 108.858 176.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.604 ' HA ' ' HE1' ' A' ' 137' ' ' MET . 0.0 OUTLIER -61.99 103.09 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.767 -0.827 . . . . 75.44 108.767 178.76 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.2 159.97 28.93 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.741 -0.663 . . . . 74.32 110.797 -174.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.625 ' HA ' ' C5 ' ' B' ' 5' ' ' ' U' . 34.1 t70 -60.48 141.74 56.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.039 -0.528 . . . . 72.33 110.744 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.459 ' NH1' " H1'" ' B' ' 5' ' ' ' U' . 0.0 OUTLIER -69.18 -17.0 63.76 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.607 -0.724 . . . . 70.15 111.46 -174.211 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -111.96 -58.23 0.45 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.523 -0.846 . . . . 73.43 112.86 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.0 m -82.96 -15.4 51.44 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.742 -0.269 . . . . 65.23 111.522 -174.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.87 29.35 74.87 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.78 -0.724 . . . . 61.44 112.208 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -85.77 143.03 28.54 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.854 -0.425 . . . . 74.22 109.854 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -66.3 114.54 5.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.209 -0.451 . . . . 73.41 111.072 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -68.82 -40.96 79.22 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.653 -0.703 . . . . 75.24 110.652 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 158.05 -72.28 0.24 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.644 -0.788 . . . . 53.24 112.608 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.748 ' HA ' ' OP2' ' B' ' 2' ' ' ' C' . 18.1 p90 -82.58 165.74 19.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.82 0.343 . . . . 73.34 111.175 -178.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.03 162.2 36.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.984 0.421 . . . . 74.03 111.3 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.476 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 49.6 m-85 -125.96 146.02 50.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.947 -0.57 . . . . 65.42 109.905 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.604 HG13 ' CD1' ' A' ' 134' ' ' ILE . 39.1 t -118.65 111.74 35.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 110.12 -0.326 . . . . 71.03 110.12 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.611 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 19.5 m -89.69 126.71 35.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.116 -0.493 . . . . 75.0 110.683 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.496 ' CD2' HG21 ' A' ' 159' ' ' VAL . 97.8 m-85 -110.97 145.95 37.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.435 -0.348 . . . . 72.42 110.306 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.5 ' N ' ' HG3' ' A' ' 132' ' ' GLU . 9.4 t70 -65.52 -29.93 70.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 73.11 110.747 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . 0.415 ' O ' HG23 ' A' ' 159' ' ' VAL . 6.1 t70 -125.72 142.83 51.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.863 -0.608 . . . . 73.32 110.497 -174.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.457 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.4 p-80 -75.75 -16.99 60.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.098 -0.501 . . . . 74.53 110.909 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.53 -38.01 68.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.999 0.428 . . . . 73.13 109.983 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.419 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 13.6 m -64.84 -28.98 69.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.734 -0.666 . . . . 73.41 110.19 177.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.781 HG22 ' HA ' ' A' ' 105' ' ' LYS . 14.8 t -76.04 -34.67 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.444 -0.798 . . . . 75.11 110.516 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -52.18 -56.18 16.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.549 -0.75 . . . . 72.43 112.397 -176.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -9.7 29.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.753 0.311 . . . . 72.14 111.834 -176.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.422 HG21 ' CE1' ' A' ' 168' ' ' HIS . 84.4 mt -96.46 -50.11 11.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.391 -0.368 . . . . 74.43 111.019 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.463 HG13 HG12 ' A' ' 159' ' ' VAL . 34.6 m -72.13 -19.1 19.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.422 0.527 . . . . 71.43 112.422 -174.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.5 pp -68.86 -30.3 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 72.11 111.495 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.476 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 16.9 pt20 -106.06 167.78 9.57 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.613 -0.514 . . . . 72.23 109.613 175.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.516 ' HE3' ' OE1' ' A' ' 176' ' ' GLU . 83.8 tttt -109.18 -58.78 1.98 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.996 0.427 . . . . 73.55 110.662 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.633 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 21.4 m-85 -78.34 118.3 20.39 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.878 -0.601 . . . . 72.35 111.27 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.476 ' NE2' ' HG3' ' A' ' 165' ' ' GLN . 38.3 m-70 -118.07 151.54 37.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.25 -0.886 . . . . 73.23 110.046 177.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 m -93.81 84.99 4.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.991 0.424 . . . . 65.52 110.769 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.585 HG22 ' CD1' ' A' ' 124' ' ' TYR . 11.2 t -113.77 137.1 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.874 -0.417 . . . . 72.22 109.874 -178.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 57.2 t30 61.32 24.54 14.63 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.716 0.769 . . . . 61.41 109.889 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 69.47 25.0 75.91 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.573 -0.74 . . . . 73.14 112.208 -177.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -131.62 150.07 52.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.871 0.367 . . . . 64.33 110.556 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . 0.44 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 8.9 t30 -85.1 97.66 9.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.987 -0.551 . . . . 64.22 110.047 176.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . 0.633 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 46.2 m -105.67 177.47 4.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.278 -0.419 . . . . 71.34 111.042 -176.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.516 ' OE1' ' HE3' ' A' ' 166' ' ' LYS . 12.6 tt0 -112.54 136.43 52.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.292 -0.413 . . . . 74.3 110.66 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.418 HG13 HG22 ' A' ' 162' ' ' ILE . 70.6 t -127.48 138.14 55.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.146 -0.479 . . . . 62.34 111.105 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.497 ' HG2' ' NE2' ' A' ' 96' ' ' GLN . 60.2 mtt180 -130.22 175.86 8.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 73.14 110.129 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.415 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 11.4 mptt -76.52 121.31 22.95 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.432 -0.951 . . . . 72.42 108.432 171.015 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.743 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -79.96 100.04 7.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.105 0.479 . . . . 74.31 111.911 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.691 HD21 ' H ' ' A' ' 181' ' ' LEU . 2.2 pt? -99.29 141.18 32.4 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.822 -0.806 . . . . 74.31 108.822 172.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.529 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 51.8 m -59.64 156.15 14.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.632 0.254 . . . . 74.23 111.337 -173.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.477 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.8 pttp -65.74 -25.74 67.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.962 0.411 . . . . 71.32 110.832 -175.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -36.63 59.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.282 0.563 . . . . 55.41 110.112 175.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.529 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 48.7 mt-10 -75.95 -42.96 46.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.792 -0.64 . . . . 75.3 110.595 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.687 ' HB3' ' HG ' ' A' ' 181' ' ' LEU . 22.5 ptm -67.16 -23.29 65.77 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.134 -0.484 . . . . 75.14 110.387 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -79.82 -16.75 54.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.377 0.608 . . . . 72.21 110.088 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.0 m -101.75 3.78 39.89 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.471 -0.786 . . . . 74.2 110.329 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.76 -60.92 0.96 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.047 -0.524 . . . . 64.4 111.038 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.1 m -84.38 111.28 19.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.213 -0.449 . . . . 73.33 110.358 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.0 t -138.37 159.99 40.66 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.9 -0.408 . . . . 44.43 109.9 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.2 p -60.98 121.05 11.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.284 -0.416 . . . . 70.13 111.171 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 68.0 17.79 9.53 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.592 -0.731 . . . . 70.22 111.653 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -109.27 94.37 5.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.092 0.473 . . . . 60.11 109.753 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 90.2 -64.72 2.94 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.975 -0.631 . . . . 64.31 112.449 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 46.8 mtp85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.417 -0.801 . . . . 71.24 110.701 -177.987 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 1.043 " H4'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.666 0 O5'-C5'-C4' 111.267 0.762 . 0.0 '__' . 75.34 . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 1.043 H5'' " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.422 -1.102 0 C4'-C3'-C2' 105.639 2.939 OUTLIER-EPSILON 0.0 OUTLIER alpha 74.51 . . . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.838 ' H8 ' H5'' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 P-O3'-C3' 121.661 1.634 . 0.0 OUTLIER epsilon-1 73.33 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.507 ' O6 ' ' HE3' ' A' ' 106' ' ' LYS . . . . . . . . 0 O5'--C5' 1.425 -0.941 0 C3'-C2'-C1' 100.42 -1.2 . 0.0 OUTLIER alpha 74.22 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.835 ' C6 ' " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.079 0 C3'-C2'-C1' 103.534 2.26 . 0.0 OUTLIER . 71.43 . . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.576 ' OP2' " H4'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 O4'-C1'-C2' 107.593 0.852 . 0.0 OUTLIER . 74.44 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.771 -0.455 . . . . 74.12 109.771 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLN . . . . . 0.66 ' NE2' ' HG2' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -107.85 19.26 20.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.045 0.45 . . . . 75.24 110.784 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -99.88 104.73 30.38 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.784 -0.643 . . . . 75.54 110.177 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . 0.491 ' HG3' HD22 ' A' ' 181' ' ' LEU . 74.2 Cg_endo -85.57 127.6 3.27 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.475 2.117 . . . . 75.41 111.991 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.511 ' HA3' HD13 ' A' ' 102' ' ' LEU . . . 60.5 68.43 1.68 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.164 -0.541 . . . . 54.31 112.473 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.08 -30.45 68.76 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.733 0.272 . . . . 74.14 111.733 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -85.37 -12.21 52.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.932 0.396 . . . . 71.43 110.82 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.511 HD13 ' HA3' ' A' ' 99' ' ' GLY . 83.2 mt -82.86 148.36 27.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.169 -0.468 . . . . 73.2 110.782 -177.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.1 p -89.32 106.0 18.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.016 0.436 . . . . 72.24 111.357 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 p -98.16 147.45 6.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.229 -0.656 . . . . 73.13 109.229 177.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -119.88 19.32 12.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.402 0.62 . . . . 63.31 110.677 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.586 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 6.7 ttpm? -157.88 138.91 13.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.32 -0.854 . . . . 74.22 109.603 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.52 HD13 HG23 ' A' ' 162' ' ' ILE . 15.6 pt -107.14 165.27 4.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.096 0.474 . . . . 71.21 110.873 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 38.4 t80 -114.38 116.28 28.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.524 -0.762 . . . . 73.34 109.877 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 44.8 t -105.09 111.92 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.993 -0.373 . . . . 71.5 109.993 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.693 ' HA2' " H5'" ' B' ' 2' ' ' ' C' . . . -123.45 156.39 17.73 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.608 -0.806 . . . . 74.1 112.385 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . 0.78 ' HA2' " H4'" ' B' ' 1' ' ' ' U' . . . 78.66 46.16 8.89 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.987 -0.625 . . . . 75.34 112.723 178.459 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.471 ' H ' HD11 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -116.02 -179.84 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.659 0.266 . . . . 75.23 110.427 178.162 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.444 ' HE2' ' OE1' ' A' ' 114' ' ' GLU . 14.4 mmmm -98.3 169.43 9.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.779 0.323 . . . . 73.14 110.951 -177.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.444 ' OE1' ' HE2' ' A' ' 113' ' ' LYS . 0.8 OUTLIER -77.74 -6.74 55.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.117 0.484 . . . . 72.22 110.521 178.848 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.17 -29.23 61.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.93 -0.577 . . . . 71.4 109.643 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.1 m -79.51 133.95 36.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.021 -0.99 . . . . 73.1 111.479 -173.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.44 ' CG ' ' HD2' ' A' ' 119' ' ' HIS . 11.4 pt-20 -140.95 -166.46 2.16 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.998 -0.547 . . . . 75.4 110.344 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.586 ' HG3' ' CG1' ' A' ' 134' ' ' ILE . 12.2 tt0 -54.75 -49.85 69.85 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.413 0.523 . . . . 72.33 112.413 -175.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.44 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.4 p80 -65.2 -29.07 69.85 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.794 -0.362 . . . . 73.24 110.675 -174.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -65.44 -52.59 52.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.004 0.43 . . . . 73.35 110.759 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.52 -46.87 77.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 73.33 110.423 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.74 -48.49 79.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.103 -0.498 . . . . 75.45 111.309 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.36 -31.15 67.34 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.11 0.481 . . . . 52.24 111.116 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.455 ' CD1' HG22 ' A' ' 170' ' ' VAL . 31.2 t80 -83.88 -42.1 16.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.956 -0.565 . . . . 70.22 111.337 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -88.44 -16.43 32.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.645 0.609 . . . . 71.13 112.645 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -22.2 66.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.08 0.467 . . . . 75.13 110.874 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -70.14 -26.71 64.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.752 -0.658 . . . . 74.03 110.349 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' TYR . . . . . 0.471 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 57.6 m-85 -81.64 -38.56 25.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.646 -0.706 . . . . 74.4 111.272 -176.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -174.64 -155.84 13.0 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.118 -1.039 . . . . 63.33 112.888 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -91.86 119.17 31.4 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.42 0.628 . . . . 62.4 111.179 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.469 HG12 ' CE1' ' A' ' 153' ' ' PHE . 41.3 mt -95.86 137.79 23.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.262 -0.881 . . . . 71.24 110.103 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLU . . . . . 0.456 ' HG3' ' N ' ' A' ' 154' ' ' ASP . 18.0 mt-10 -84.06 -73.34 0.42 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.334 -0.394 . . . . 75.03 110.533 174.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.1 m -143.29 163.25 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.082 -0.508 . . . . 74.34 110.072 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.586 ' CG1' ' HG3' ' A' ' 118' ' ' GLU . 26.7 mm -111.68 108.67 26.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.101 0.477 . . . . 75.11 109.843 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.528 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 30.5 mm-40 -84.69 91.43 7.93 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.608 -0.723 . . . . 70.05 110.466 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.541 HD11 ' CB ' ' A' ' 118' ' ' GLU . 16.9 mt -81.79 108.18 14.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.999 -0.741 . . . . 74.43 108.999 176.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' MET . . . . . 0.565 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -57.25 112.57 1.42 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.773 -0.825 . . . . 73.55 108.773 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.76 153.04 38.78 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.011 0.434 . . . . 74.42 111.733 -174.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.483 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 14.1 t70 -54.49 136.38 44.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.013 -0.994 . . . . 71.21 110.399 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.73 -9.94 59.17 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.763 -0.653 . . . . 74.3 112.456 -172.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -128.29 -42.05 0.26 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.994 -1.098 . . . . 72.34 113.363 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.558 ' OG ' ' HE3' ' A' ' 144' ' ' LYS . 27.1 t -89.24 -17.0 29.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.745 0.307 . . . . 63.34 111.086 -177.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 68.82 31.75 73.25 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.994 -0.622 . . . . 71.51 113.111 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.558 ' HE3' ' OG ' ' A' ' 142' ' ' SER . 13.7 ptpt -109.15 148.41 30.94 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.39 -0.596 . . . . 72.52 109.39 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -55.95 129.09 38.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.385 0.612 . . . . 75.23 111.849 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -78.35 -25.84 46.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.0 -1.0 . . . . 75.02 110.693 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 145.85 -91.47 0.15 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.771 -0.65 . . . . 54.42 111.719 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.71 ' HB3' " C5'" ' B' ' 2' ' ' ' C' . 11.2 p90 -70.72 162.28 29.34 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.028 0.531 . . . . 74.52 111.627 -177.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.35 156.85 46.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 62.22 110.734 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.528 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 49.2 m-85 -121.59 125.4 46.65 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.025 -0.534 . . . . 72.1 110.061 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.563 HG12 ' CD1' ' A' ' 134' ' ' ILE . 30.9 t -100.08 109.07 24.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 110.076 -0.342 . . . . 74.15 110.076 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' THR . . . . . 0.586 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 27.7 m -85.56 125.16 32.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.18 -0.464 . . . . 73.33 110.32 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.545 ' CD2' HG11 ' A' ' 159' ' ' VAL . 98.0 m-85 -109.41 149.93 28.81 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.539 -0.541 . . . . 74.1 109.539 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.456 ' N ' ' HG3' ' A' ' 132' ' ' GLU . 20.9 t70 -68.73 -26.73 65.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.033 0.444 . . . . 71.32 110.912 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -129.95 150.7 51.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.286 -0.416 . . . . 70.31 111.184 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.567 ' O ' HG21 ' A' ' 159' ' ' VAL . 2.5 p-80 -83.28 -6.59 59.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.847 -0.615 . . . . 73.43 110.855 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -72.53 -40.71 66.54 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.654 -0.498 . . . . 63.33 109.654 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.7 m -63.92 -31.54 72.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.636 -0.711 . . . . 73.33 111.506 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.567 HG21 ' O ' ' A' ' 156' ' ' HIS . 5.7 m -78.03 -23.15 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 121.054 -0.258 . . . . 64.2 111.285 -175.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.79 -45.23 90.65 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 116.657 -0.247 . . . . 72.21 111.306 -173.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' LYS . . . . . 0.471 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.0 OUTLIER -62.03 -18.76 61.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.175 0.512 . . . . 72.24 110.68 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . 0.52 HG23 HD13 ' A' ' 107' ' ' ILE . 72.3 mt -97.71 -54.69 6.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.618 -0.719 . . . . 75.45 111.527 -174.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.451 ' HB ' ' HG2' ' A' ' 179' ' ' LYS . 33.6 m -66.13 -19.83 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.452 0.538 . . . . 62.43 112.452 -172.67 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.426 HD11 ' HB2' ' A' ' 165' ' ' GLN . 2.6 pp -69.12 -24.75 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.32 0.581 . . . . 75.21 110.707 176.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLN . . . . . 0.477 ' HB3' ' NE2' ' A' ' 168' ' ' HIS . 23.0 tt0 -108.52 140.85 41.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.177 -0.919 . . . . 74.12 109.626 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.548 ' HE3' ' OE1' ' A' ' 176' ' ' GLU . 82.4 tttt -93.77 -61.69 1.5 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.794 0.33 . . . . 64.2 110.776 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -74.04 114.58 12.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.139 -0.482 . . . . 72.33 110.905 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.477 ' NE2' ' HB3' ' A' ' 165' ' ' GLN . 30.3 m-70 -120.99 162.25 20.23 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.642 -0.708 . . . . 72.42 109.257 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 11.7 m -118.09 102.27 8.89 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.468 -0.493 . . . . 75.15 111.218 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.455 HG22 ' CD1' ' A' ' 124' ' ' TYR . 47.5 t -111.51 130.0 65.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.813 -0.63 . . . . 65.54 109.508 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 62.54 23.59 14.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.609 0.718 . . . . 73.34 110.445 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 78.24 11.06 85.72 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.896 -0.669 . . . . 39.05 112.488 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -111.68 135.43 52.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.901 0.381 . . . . 71.11 110.521 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.88 114.91 13.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.922 -0.581 . . . . 75.25 110.441 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.32 169.16 13.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.964 0.411 . . . . 72.3 110.953 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.548 ' OE1' ' HE3' ' A' ' 166' ' ' LYS . 15.1 tt0 -108.85 127.37 53.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.896 -0.593 . . . . 71.02 109.548 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.6 m -117.88 144.9 24.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.391 -0.524 . . . . 73.01 110.543 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.66 ' HG2' ' NE2' ' A' ' 96' ' ' GLN . 66.5 mtt180 -132.75 -179.36 5.42 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.056 -0.52 . . . . 75.2 109.818 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.451 ' HG2' ' HB ' ' A' ' 163' ' ' VAL . 38.4 mtpt -81.2 119.09 23.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.964 -1.125 . . . . 74.13 107.964 170.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.621 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -70.17 95.06 0.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.902 0.382 . . . . 74.25 111.513 -175.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.568 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.5 pt? -92.98 144.96 24.74 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.368 -0.604 . . . . 73.33 109.368 175.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.423 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 7.5 m -53.83 142.54 23.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.141 -0.481 . . . . 60.22 110.96 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.67 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 18.8 pttp -59.88 -22.66 62.63 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.048 0.451 . . . . 74.24 110.524 177.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -64.26 -52.96 56.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.666 . . . . 75.24 110.275 171.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' GLU . . . . . 0.423 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 35.7 mt-10 -68.42 -41.35 80.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.38 -0.827 . . . . 63.23 111.021 -176.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' MET . . . . . 0.67 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 20.7 ptm -68.24 -16.56 64.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.891 -0.595 . . . . 73.24 111.163 -175.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.79 -36.55 62.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.197 0.522 . . . . 75.4 109.868 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.8 t -73.17 -32.26 64.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.426 -0.806 . . . . 74.12 110.051 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -74.74 -24.73 58.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.917 -0.583 . . . . 74.11 110.922 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 46.6 t -71.86 131.44 43.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.928 -0.578 . . . . 74.25 110.372 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 10.5 t -148.11 97.55 2.8 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.601 -0.518 . . . . 63.54 109.601 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.4 p -81.7 -67.9 0.74 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.151 -0.477 . . . . 73.44 110.817 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -108.88 105.21 14.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.453 -0.573 . . . . 73.45 109.453 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -93.95 153.85 17.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.066 -0.515 . . . . 73.3 111.523 -174.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 81.57 -64.31 4.21 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.708 -0.678 . . . . 73.45 112.007 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 196' ' ' ARG . 11.6 tpp85 . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.127 -0.94 . . . . 75.15 109.244 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' ' U' . . . . . 0.78 " H4'" ' HA2' ' A' ' 111' ' ' GLY . . . . . . . . 0 O5'--C5' 1.429 -0.663 0 C4'-C3'-C2' 104.405 1.705 OUTLIER-EPSILON 0.0 '__' . 75.14 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ' C' . . . . . 0.753 " H4'" ' OP2' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.892 0 C4'-C3'-C2' 104.884 2.184 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 74.41 . . . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ' A' . . . . . 0.753 ' OP2' " H4'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.425 -0.907 0 O4'-C4'-C3' 103.635 -1.332 . 0.0 OUTLIER epsilon-1 73.45 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ' G' . . . . . 0.517 " C4'" ' HE1' ' A' ' 137' ' ' MET . . . . . . . . 0 O5'--C5' 1.425 -0.953 0 C3'-C2'-C1' 99.118 -2.646 . 0.0 OUTLIER alpha 73.5 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ' U' . . . . . 0.77 " H3'" ' OP1' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.915 0 O4'-C4'-C3' 103.732 -1.263 . 0.0 OUTLIER gamma 75.21 . . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' ' U' . . . . . 0.493 ' C6 ' H5'' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.998 0 C4'-C3'-C2' 105.959 3.259 . 0.0 OUTLIER . 73.32 . . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.472 ' O ' HG21 ' A' ' 159' ' ' VAL . 9.1 p . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 109.881 -0.414 . . . . 64.340000000000003 109.881 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -128.56 18.69 6.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.168 0.509 . . . . 75.239999999999995 111.291 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.584 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 23.6 ttpt -151.15 131.69 13.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.814 -0.63 . . . . 75.299999999999997 109.608 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.509 HG13 ' HB ' ' A' ' 151' ' ' VAL . 2.1 pp -106.43 153.55 7.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.21 -0.45 . . . . 72.120000000000005 110.397 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.516 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 81.9 t80 -103.25 130.53 50.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.978 -0.555 . . . . 74.129999999999995 110.276 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.7 t -111.09 110.17 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.294 -0.412 . . . . 72.340000000000003 110.436 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.688 0 N-CA-C 111.205 -0.758 . . . . 61.149999999999999 111.205 177.098 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.67 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 8.1 pt-20 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.863 0.363 . . . . 71.109999999999999 110.854 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.695 ' HA ' HG21 ' A' ' 134' ' ' ILE . 13.3 tt0 -56.29 -50.25 71.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.449 -0.796 . . . . 75.030000000000001 112.41 -178.09 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -65.53 -33.65 76.41 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.877 -0.329 . . . . 74.129999999999995 110.665 -174.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.67 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 40.9 m80 -63.0 -53.64 50.86 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.012 0.434 . . . . 70.120000000000005 110.631 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.584 HD23 HG11 ' A' ' 170' ' ' VAL . 97.6 mt -62.25 -48.59 79.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.523 -0.762 . . . . 74.319999999999993 110.937 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -59.47 -40.88 88.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.252 -0.431 . . . . 73.109999999999999 110.985 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -59.47 -30.39 68.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.99 0.424 . . . . 72.319999999999993 111.278 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -88.92 -47.37 8.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.408 -0.36 . . . . 65.109999999999999 111.346 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.408 ' CD1' HG21 ' A' ' 151' ' ' VAL . 53.1 m-85 -77.54 -14.63 59.62 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.308 0.484 . . . . 75.319999999999993 112.308 -172.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -65.3 -24.02 67.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.747 0.308 . . . . 75.219999999999999 111.414 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -65.24 -25.73 67.8 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.221 0.534 . . . . 74.329999999999998 110.641 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.495 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 88.5 m-85 -86.01 -37.84 18.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.675 -0.693 . . . . 61.229999999999997 111.148 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 177.44 -166.77 37.43 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.012 -1.089 . . . . 60.009999999999998 113.422 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.569 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 38.3 tptt -75.78 118.78 18.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.4 0.619 . . . . 63.340000000000003 111.464 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.505 HG21 HD11 ' A' ' 134' ' ' ILE . 34.3 mt -97.49 139.93 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.378 -0.828 . . . . 72.140000000000001 110.41 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 6.7 mm-40 -89.12 -71.2 0.61 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.317 -0.401 . . . . 52.399999999999999 111.237 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.47 157.42 27.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.645 0.259 . . . . 64.400000000000006 110.57 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.695 HG21 ' HA ' ' A' ' 118' ' ' GLU . 17.7 mm -113.02 111.64 37.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.174 -0.676 . . . . 71.109999999999999 109.174 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 22.4 mm-40 -90.27 95.0 9.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.988 -0.551 . . . . 74.329999999999998 110.786 -175.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.565 HD11 ' H ' ' A' ' 118' ' ' GLU . 11.1 mt -80.69 87.35 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.01 -1.107 . . . . 65.209999999999994 108.01 173.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 11.2 tpt . . . . . 0 C--N 1.325 -0.465 0 CA-C-O 121.581 0.705 . . . . 72.420000000000002 111.252 -170.582 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 40.6 p90 . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.72 0.295 . . . . 72.129999999999995 111.004 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -144.42 165.78 26.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.994 -0.548 . . . . 72.230000000000004 110.193 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.562 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 42.2 m-85 -129.64 150.67 50.86 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.947 -0.39 . . . . 61.310000000000002 109.947 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.57 HG13 ' CD1' ' A' ' 134' ' ' ILE . 59.0 t -122.9 112.38 33.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.981 -0.377 . . . . 63.310000000000002 109.981 176.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.584 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 26.1 m -88.08 127.52 35.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.027 -0.533 . . . . 74.120000000000005 110.591 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.514 ' CD2' HG12 ' A' ' 159' ' ' VAL . 92.4 m-85 -109.59 152.24 25.77 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.143 -0.317 . . . . 52.409999999999997 110.143 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.569 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 31.9 t70 -75.34 -18.31 60.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.225 0.536 . . . . 71.040000000000006 110.547 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 157' ' ' ASP . 24.0 t70 -132.61 153.21 51.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.618 -0.719 . . . . 75.040000000000006 111.123 -177.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.41 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.1 p-80 -95.53 5.03 52.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.26 -0.427 . . . . 74.109999999999999 111.883 -178.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.477 ' HB3' ' OD2' ' A' ' 155' ' ' ASP . 13.2 t70 -91.81 -37.23 13.07 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.506 -0.553 . . . . 73.120000000000005 109.506 171.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.5 m -58.6 -27.59 64.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.749 -0.66 . . . . 64.510000000000005 110.901 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.514 HG12 ' CD2' ' A' ' 153' ' ' PHE . 13.0 m -80.42 -20.99 11.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 75.340000000000003 111.367 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.35 -38.4 71.63 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.691 0.281 . . . . 71.409999999999997 110.672 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.495 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.1 mptp? -65.03 -19.22 65.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.302 0.572 . . . . 74.200000000000003 110.68 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 81.9 mt -96.78 -53.62 7.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.573 -0.739 . . . . 75.230000000000004 111.227 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.518 ' HB ' ' HG2' ' A' ' 179' ' ' LYS . 35.3 m -64.56 -20.82 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.586 0.587 . . . . 61.119999999999997 112.586 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.74 -28.41 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 74.329999999999998 111.072 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -105.16 142.19 35.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.004 -0.544 . . . . 71.319999999999993 109.655 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.441 ' CE ' ' HG3' ' A' ' 176' ' ' GLU . 87.4 tttt -87.04 -71.39 0.56 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 121.033 -0.267 . . . . 75.299999999999997 110.997 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.62 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 3.7 m-85 -79.19 116.62 19.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.207 0.527 . . . . 72.409999999999997 111.971 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -117.51 140.63 49.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.19 -0.914 . . . . 63.310000000000002 109.492 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 174' ' ' ASN . 57.4 m -92.37 109.28 20.66 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.089 0.471 . . . . 62.420000000000002 111.232 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.584 HG11 HD23 ' A' ' 121' ' ' LEU . 43.3 t -120.06 136.27 57.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.928 -0.578 . . . . 72.109999999999999 109.464 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.1 t30 70.57 -12.84 0.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.929 0.491 . . . . 73.319999999999993 111.497 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 122.2 -3.62 10.5 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.514 -0.634 . . . . 73.049999999999997 111.514 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -112.34 138.68 48.72 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.662 -0.496 . . . . 73.349999999999994 109.662 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 169' ' ' THR . 60.0 t30 -88.65 103.8 16.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.755 -0.461 . . . . 74.140000000000001 109.755 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 34.0 m -106.77 173.16 6.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.058 -0.519 . . . . 60.530000000000001 110.76 -174.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.441 ' HG3' ' CE ' ' A' ' 166' ' ' LYS . 9.0 tt0 -97.58 123.92 41.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.11 0.481 . . . . 74.019999999999996 110.756 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 48.4 t -118.84 131.13 72.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.926 -0.579 . . . . 71.120000000000005 110.475 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -144.34 173.38 11.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.857 -0.611 . . . . 74.540000000000006 109.842 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.518 ' HG2' ' HB ' ' A' ' 163' ' ' VAL . 31.9 mtpt -68.54 125.62 27.07 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.685 -0.487 . . . . 74.530000000000001 109.685 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -81.01 89.68 5.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.911 0.386 . . . . 62.409999999999997 111.482 -175.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.693 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.3 pt? -86.4 141.99 28.76 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.875 -0.602 . . . . 73.230000000000004 109.41 175.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.473 ' HB3' ' HG3' ' A' ' 185' ' ' GLU . 30.0 t -58.0 152.7 15.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.482 -0.326 . . . . 70.400000000000006 110.804 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.51 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 22.1 pttp -60.07 -21.9 62.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.173 0.511 . . . . 72.030000000000001 110.368 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -49.32 55.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.542 -0.754 . . . . 71.230000000000004 109.197 174.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.473 ' HG3' ' HB3' ' A' ' 182' ' ' SER . 30.0 mt-10 -73.38 -37.97 65.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.209 -0.905 . . . . 74.109999999999999 111.138 -176.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.51 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 21.7 ptm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 71.319999999999993 111.129 -175.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.628 HG13 HG11 ' A' ' 159' ' ' VAL . 11.5 p . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 109.656 -0.498 . . . . 73.230000000000004 109.656 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.484 ' N ' ' HE3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -104.49 -6.34 20.73 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.736 0.303 . . . . 73.25 111.81 -175.038 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.725 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.0 ttpt -133.99 140.73 46.91 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.86 -0.422 . . . . 72.450000000000003 109.86 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.615 ' CG2' HG13 ' A' ' 159' ' ' VAL . 4.9 pt -108.07 158.03 8.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.991 0.424 . . . . 63.439999999999998 110.973 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.445 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 46.8 t80 -107.72 121.61 45.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.469 -0.787 . . . . 73.540000000000006 109.296 177.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.7 t -105.21 102.46 13.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.864 0.364 . . . . 74.239999999999995 110.902 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 110.849 -0.9 . . . . 61.439999999999998 110.849 175.655 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.713 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 11.5 pt-20 . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.754 0.312 . . . . 64.200000000000003 111.363 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.738 ' HA ' HG21 ' A' ' 134' ' ' ILE . 10.9 tt0 -58.96 -45.46 90.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 75.140000000000001 112.242 -174.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -64.22 -30.33 71.39 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 120.491 -0.484 . . . . 74.129999999999995 110.176 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.713 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 34.3 m80 -64.38 -56.6 13.28 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.471 -0.331 . . . . 73.219999999999999 110.529 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.534 HD13 HG11 ' A' ' 170' ' ' VAL . 1.7 mm? -60.32 -51.9 67.54 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.233 -0.439 . . . . 73.439999999999998 110.737 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -58.29 -53.51 57.47 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.847 -0.615 . . . . 65.439999999999998 111.439 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.73 -28.34 63.79 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.066 0.46 . . . . 73.109999999999999 111.843 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -86.24 -43.16 13.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.939 0.4 . . . . 62.030000000000001 111.299 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.428 ' CD1' HG21 ' A' ' 151' ' ' VAL . 41.8 m-85 -86.84 -15.5 38.96 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.718 0.636 . . . . 45.219999999999999 112.718 -172.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -22.22 66.23 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.342 0.591 . . . . 71.400000000000006 110.352 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -69.28 -19.11 63.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.264 -0.88 . . . . 74.25 110.479 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.446 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 66.7 m-85 -90.63 -34.8 15.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.873 -0.603 . . . . 75.299999999999997 110.819 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 174.82 -168.02 40.46 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.072 -1.061 . . . . 74.25 113.299 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -74.91 116.78 16.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.528 0.68 . . . . 64.209999999999994 111.573 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.482 HG21 HD11 ' A' ' 134' ' ' ILE . 40.8 mt -94.76 139.63 18.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.194 -0.912 . . . . 73.310000000000002 110.401 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -84.2 -73.03 0.44 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.889 -0.596 . . . . 74.209999999999994 110.67 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.6 m -141.81 152.17 18.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.352 -0.386 . . . . 74.5 110.57 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.738 HG21 ' HA ' ' A' ' 118' ' ' GLU . 31.7 mm -105.22 107.92 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.489 -0.56 . . . . 71.439999999999998 109.489 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 57.7 mt-10 -89.58 96.49 10.72 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.332 0.586 . . . . 64.450000000000003 110.611 -176.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.6 mt -80.04 128.28 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.589 -0.732 . . . . 74.219999999999999 109.497 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.441 ' HB3' ' O ' ' A' ' 148' ' ' PHE . 22.1 tpp . . . . . 0 C--N 1.324 -0.517 0 CA-C-O 121.352 0.596 . . . . 73.109999999999999 110.341 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 137' ' ' MET . 41.8 p90 . . . . . 0 C--O 1.234 0.254 0 CA-C-O 121.187 0.517 . . . . 73.340000000000003 111.847 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.13 169.16 18.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.793 -0.64 . . . . 63.229999999999997 110.333 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.557 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 73.1 m-85 -130.84 145.01 51.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.066 -0.515 . . . . 73.439999999999998 110.297 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.608 HG13 ' CD1' ' A' ' 134' ' ' ILE . 15.8 t -120.52 108.33 22.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.738 -0.467 . . . . 54.210000000000001 109.738 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.725 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 62.7 m -88.64 123.84 33.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.527 -0.306 . . . . 62.329999999999998 110.289 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.527 ' CD2' HG22 ' A' ' 159' ' ' VAL . 90.8 m-85 -105.5 153.3 21.93 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.831 -0.433 . . . . 75.430000000000007 109.831 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -69.28 -30.81 69.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.364 0.602 . . . . 71.530000000000001 110.334 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.443 ' O ' HG23 ' A' ' 159' ' ' VAL . 5.0 t70 -122.36 145.54 48.16 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.416 -0.811 . . . . 72.230000000000004 110.185 -175.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -82.4 -13.58 56.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.291 -0.413 . . . . 71.329999999999998 110.907 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.96 -43.87 61.77 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.064 0.459 . . . . 51.43 110.506 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.6 m -63.16 -28.11 69.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.758 -0.655 . . . . 70.129999999999995 110.468 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.628 HG11 HG13 ' A' ' 104' ' ' VAL . 29.1 t -70.99 -36.61 64.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.722 -0.672 . . . . 75.230000000000004 110.185 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.524 ' HA ' HG22 ' A' ' 163' ' ' VAL . 21.0 t70 -59.98 -36.46 77.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.724 -0.671 . . . . 74.530000000000001 110.86 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.446 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 38.0 mmtt -60.68 -24.96 66.01 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.545 0.688 . . . . 73.129999999999995 110.222 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.544 HG21 HD13 ' A' ' 107' ' ' ILE . 86.3 mt -95.51 -50.39 11.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.142 -0.935 . . . . 63.119999999999997 111.338 -173.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.609 ' HB ' ' HG2' ' A' ' 179' ' ' LYS . 19.8 m -68.96 -17.53 22.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.469 0.544 . . . . 54.409999999999997 112.469 -173.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.469 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.2 pp -68.01 -29.92 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.013 0.375 . . . . 71.239999999999995 112.013 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -110.26 174.58 5.8 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.465 -0.568 . . . . 74.120000000000005 109.465 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.573 ' HE3' ' HG3' ' A' ' 176' ' ' GLU . 53.2 tttp -114.65 -60.95 1.82 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.75 0.309 . . . . 73.329999999999998 111.224 -173.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 11.8 m-30 -77.06 104.17 7.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.448 0.642 . . . . 73.049999999999997 111.249 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.409 ' CE1' HG23 ' A' ' 162' ' ' ILE . 9.2 m-70 -102.27 173.16 6.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.097 -0.956 . . . . 75.510000000000005 109.988 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 28.1 m -124.48 98.56 5.79 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.081 0.467 . . . . 74.420000000000002 111.076 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.534 HG11 HD13 ' A' ' 121' ' ' LEU . 58.2 t -109.52 131.8 59.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.603 -0.518 . . . . 74.340000000000003 109.603 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 65.3 t30 63.67 14.94 8.56 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.588 0.709 . . . . 72.219999999999999 110.475 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.09 -4.64 81.34 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.851 -0.69 . . . . 62.450000000000003 112.413 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.522 ' O ' ' HA ' ' A' ' 169' ' ' THR . 39.6 m80 -98.73 157.37 16.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.814 0.34 . . . . 64.420000000000002 110.512 -177.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -84.74 118.48 24.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.059 -0.519 . . . . 74.400000000000006 109.724 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 36.8 m -118.38 173.47 6.8 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.833 -0.621 . . . . 64.209999999999994 110.305 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.573 ' HG3' ' HE3' ' A' ' 166' ' ' LYS . 1.3 tm-20 -130.24 114.68 15.96 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.571 -0.529 . . . . 63.299999999999997 109.571 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 2.3 m -113.71 147.34 17.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.202 0.525 . . . . 63.409999999999997 111.671 -171.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -134.2 172.09 13.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 73.109999999999999 110.643 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.609 ' HG2' ' HB ' ' A' ' 163' ' ' VAL . 28.6 mtpt -77.9 111.52 13.83 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.361 -0.978 . . . . 72.109999999999999 108.361 172.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -72.04 107.67 4.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.287 0.565 . . . . 64.129999999999995 112.32 -172.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -101.24 134.18 44.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.468 -0.787 . . . . 73.430000000000007 109.061 173.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.4 m -47.64 135.37 11.57 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.386 0.429 . . . . 63.43 111.535 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.8 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 16.2 pttp -56.93 -32.48 66.01 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.175 -0.466 . . . . 72.209999999999994 111.203 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -59.44 -34.4 72.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.888 -0.596 . . . . 71.310000000000002 110.458 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -93.0 -37.16 12.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.516 -0.766 . . . . 74.319999999999993 110.886 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.8 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 25.3 ptm . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.595 -0.275 . . . . 72.450000000000003 110.822 -177.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.442 HG11 ' CG ' ' A' ' 179' ' ' LYS . 13.0 p . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 120.755 0.312 . . . . 74.200000000000003 110.439 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.775 ' HA ' HG21 ' A' ' 159' ' ' VAL . 25.7 mtmt -119.29 -1.76 10.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.162 -0.472 . . . . 64.340000000000003 111.449 -177.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.613 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 28.6 ttpt -124.78 133.9 52.97 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.072 0.463 . . . . 74.439999999999998 109.936 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.529 HG12 ' HB ' ' A' ' 151' ' ' VAL . 10.5 pt -107.43 162.99 5.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.908 -0.587 . . . . 55.119999999999997 111.036 -178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 55.9 t80 -113.74 119.28 36.85 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.53 -0.759 . . . . 72.150000000000006 109.884 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.3 t -109.85 106.41 20.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.147 -0.479 . . . . 65.439999999999998 109.878 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.678 0 C-N-CA 120.901 -0.666 . . . . 75.409999999999997 112.068 -178.311 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.684 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 12.6 pt-20 . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 110.544 -0.169 . . . . 73.400000000000006 110.544 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.596 ' HA ' HG21 ' A' ' 134' ' ' ILE . 8.0 tt0 -52.52 -50.63 62.43 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.485 0.55 . . . . 71.430000000000007 112.485 -175.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -63.36 -27.23 69.17 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.15 -0.22 . . . . 75.120000000000005 110.864 -175.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.684 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 35.5 m80 -68.53 -50.03 55.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.829 -0.169 . . . . 71.040000000000006 110.726 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.495 HD13 HG11 ' A' ' 170' ' ' VAL . 1.2 mm? -60.4 -51.69 68.42 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.644 -0.502 . . . . 75.319999999999993 109.644 175.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -55.21 -50.37 69.58 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.542 -0.753 . . . . 74.239999999999995 111.285 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -54.35 -36.12 63.49 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.89 0.376 . . . . 65.209999999999994 112.012 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -84.64 -39.93 18.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.384 -0.371 . . . . 74.310000000000002 111.15 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.428 ' CD1' HG21 ' A' ' 151' ' ' VAL . 50.9 m-85 -87.26 -17.05 33.43 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.461 0.541 . . . . 72.200000000000003 112.461 -173.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -20.82 64.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.836 0.351 . . . . 73.140000000000001 111.923 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -77.78 -16.44 58.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.024 0.44 . . . . 72.230000000000004 110.562 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.5 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 52.9 m-85 -85.01 -41.28 15.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 73.349999999999994 110.279 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' A' ' 158' ' ' SER . . . -172.21 -170.11 35.71 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.987 -0.625 . . . . 62.299999999999997 112.151 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -79.59 122.06 26.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.384 0.612 . . . . 71.099999999999994 111.508 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.529 HG21 HD11 ' A' ' 134' ' ' ILE . 43.5 mt -95.84 138.43 21.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.33 -0.85 . . . . 50.340000000000003 110.837 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -81.37 -76.65 0.24 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.665 -0.698 . . . . 73.329999999999998 110.362 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.2 m -141.48 161.27 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 71.409999999999997 110.47 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.613 ' CD1' HG13 ' A' ' 151' ' ' VAL . 23.1 mm -116.42 122.7 70.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 110.03 -0.359 . . . . 75.230000000000004 110.03 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -104.46 121.54 43.65 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.79 -0.448 . . . . 71.310000000000002 109.79 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.7 mt -95.61 -8.43 9.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.706 0.289 . . . . 72.030000000000001 110.797 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.5 tpp . . . . . 0 C--O 1.235 0.31 0 CA-C-O 122.113 0.958 . . . . 65.319999999999993 110.208 -177.737 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.8 p90 . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.797 -0.816 . . . . 71.420000000000002 108.797 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.52 172.92 12.11 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.089 0.471 . . . . 61.420000000000002 111.141 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.411 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 58.4 m-85 -131.78 136.98 47.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.624 -0.716 . . . . 62.219999999999999 109.85 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.613 HG13 ' CD1' ' A' ' 134' ' ' ILE . 42.2 t -116.06 110.37 31.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.379 -0.373 . . . . 71.019999999999996 110.315 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.613 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 9.0 m -87.05 125.45 34.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.386 -0.37 . . . . 60.310000000000002 110.094 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.464 ' CE1' HG12 ' A' ' 131' ' ' ILE . 98.2 m-85 -105.75 150.39 25.57 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.756 0.312 . . . . 71.439999999999998 110.175 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -69.73 -22.55 63.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.033 -0.531 . . . . 63.32 111.059 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -136.77 144.86 43.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.896 -0.593 . . . . 73.519999999999996 109.711 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.538 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.5 p-80 -75.46 -12.88 60.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.881 0.372 . . . . 70.019999999999996 110.293 177.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.93 -46.36 88.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 61.219999999999999 110.18 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.44 ' CB ' ' HA3' ' A' ' 129' ' ' GLY . 11.7 m -62.87 -21.64 66.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 74.319999999999993 111.08 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.775 HG21 ' HA ' ' A' ' 105' ' ' LYS . 20.2 t -80.75 -29.77 11.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.768 -0.651 . . . . 73.209999999999994 111.138 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -36.9 85.34 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.424 -0.353 . . . . 62.210000000000001 111.869 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.5 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.5 mptp? -70.24 -16.48 63.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.265 0.555 . . . . 65.040000000000006 110.572 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.439 ' CG2' HG11 ' A' ' 177' ' ' VAL . 95.9 mt -100.54 -55.06 6.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.65 -0.705 . . . . 55.210000000000001 111.731 -172.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.526 ' HB ' ' HE3' ' A' ' 179' ' ' LYS . 28.9 m -61.07 -21.98 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.903 0.705 . . . . 64.109999999999999 112.903 -174.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.437 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.4 pp -67.27 -29.57 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.017 0.437 . . . . 63.299999999999997 111.095 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -106.23 142.65 35.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.949 -0.569 . . . . 65.209999999999994 109.722 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.543 ' HE3' ' HG3' ' A' ' 176' ' ' GLU . 79.2 tttt -92.17 -71.67 0.63 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 121.057 -0.257 . . . . 72.239999999999995 111.065 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.501 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 22.7 m-85 -78.59 108.81 12.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.132 0.491 . . . . 42.210000000000001 111.307 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -106.38 158.55 16.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 65.319999999999993 110.046 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 20.2 m -96.33 100.75 12.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.801 0.334 . . . . 71.5 110.788 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.495 HG11 HD13 ' A' ' 121' ' ' LEU . 46.9 t -116.5 132.61 65.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.622 -0.51 . . . . 71.299999999999997 109.622 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.3 t30 63.92 20.43 12.2 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 122.056 0.931 . . . . 71.510000000000005 109.834 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 73.39 19.45 79.67 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.558 -0.746 . . . . 63.409999999999997 111.624 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -125.22 149.59 47.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.768 -0.456 . . . . 74.120000000000005 109.768 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.474 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 9.9 t30 -86.19 117.3 24.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.884 0.373 . . . . 60.520000000000003 110.847 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 30.9 m -129.23 158.74 38.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.989 -0.55 . . . . 63.25 110.206 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.543 ' HG3' ' HE3' ' A' ' 166' ' ' LYS . 16.1 tt0 -89.98 135.17 33.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.945 0.402 . . . . 72.420000000000002 110.681 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 64.5 t -128.8 132.0 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 115.945 -0.57 . . . . 70.230000000000004 110.562 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -150.85 -177.63 6.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.525 -0.761 . . . . 70.349999999999994 109.452 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.526 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 9.2 mptt -68.47 130.32 42.54 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.859 -0.336 . . . . 72.129999999999995 110.345 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -86.33 92.85 8.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.864 0.364 . . . . 73.299999999999997 111.129 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.564 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -81.5 135.23 35.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.568 -0.53 . . . . 62.530000000000001 109.568 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.5 m -50.73 142.65 10.92 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.382 0.426 . . . . 75.340000000000003 111.387 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.667 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 8.3 pttp -58.78 -31.69 68.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.064 0.459 . . . . 60.420000000000002 110.306 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -65.08 -37.7 88.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.601 -0.727 . . . . 60.310000000000002 110.522 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -83.44 -37.17 23.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.551 -0.749 . . . . 53.539999999999999 111.09 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.667 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 9.3 ptp . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.848 0.356 . . . . 71.040000000000006 110.247 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 106' ' ' LYS . 13.1 p . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 120.855 0.359 . . . . 75.230000000000004 110.491 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.537 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 12.2 mtmt -119.0 18.0 13.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.308 0.575 . . . . 73.010000000000005 110.776 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.48 ' H ' HG22 ' A' ' 104' ' ' VAL . 4.8 ttpm? -146.02 132.6 19.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.532 -0.758 . . . . 54.420000000000002 109.48 177.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.555 HG12 ' HB ' ' A' ' 151' ' ' VAL . 13.3 pt -103.64 164.04 3.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.108 0.48 . . . . 60.549999999999997 111.059 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 63.5 t80 -114.07 113.65 25.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.428 -0.805 . . . . 73.340000000000003 110.009 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.5 t -104.54 97.95 6.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.114 -0.494 . . . . 74.450000000000003 110.034 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.661 0 C-N-CA 120.685 -0.769 . . . . 45.340000000000003 112.566 -176.392 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.716 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 10.6 pt-20 . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 109.893 -0.41 . . . . 63.409999999999997 109.893 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.614 ' HA ' HG21 ' A' ' 134' ' ' ILE . 16.4 tt0 -55.2 -50.01 70.48 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.773 0.657 . . . . 71.450000000000003 112.773 -174.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.425 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.2 p80 -63.24 -27.29 69.25 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.753 -0.379 . . . . 74.549999999999997 110.694 -176.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.716 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 38.6 m80 -70.17 -51.53 30.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.318 -0.401 . . . . 70.329999999999998 110.356 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.562 HD13 HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -58.59 -49.29 78.01 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.262 -0.426 . . . . 53.229999999999997 110.286 178.122 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -59.01 -53.62 56.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.745 -0.662 . . . . 71.25 111.717 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -59.99 -29.17 68.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.762 0.315 . . . . 73.340000000000003 111.702 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.431 ' CD1' HG22 ' A' ' 170' ' ' VAL . 90.4 t80 -83.09 -43.42 16.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.499 -0.319 . . . . 72.340000000000003 110.966 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.435 ' CD1' HG21 ' A' ' 151' ' ' VAL . 46.0 m-85 -87.02 -15.3 39.08 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.729 0.64 . . . . 74.230000000000004 112.729 -173.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -22.12 66.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.088 0.471 . . . . 72.420000000000002 110.589 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -65.93 -31.06 71.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.761 -0.654 . . . . 64.439999999999998 110.082 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -80.85 -27.52 36.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.498 -0.773 . . . . 62.240000000000002 111.37 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.07 -166.84 39.75 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.352 -0.928 . . . . 74.310000000000002 112.689 177.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -80.68 120.45 24.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.326 0.584 . . . . 74.129999999999995 110.959 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.553 HG21 HD11 ' A' ' 134' ' ' ILE . 43.1 mt -93.28 141.38 14.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.46 -0.791 . . . . 70.430000000000007 110.572 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.9 -71.19 0.55 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.699 -0.682 . . . . 70.109999999999999 110.451 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.3 m -143.5 160.99 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.387 -0.369 . . . . 61.439999999999998 110.656 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.614 HG21 ' HA ' ' A' ' 118' ' ' GLU . 18.8 mm -116.41 128.95 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.946 0.403 . . . . 63.32 110.275 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -115.28 115.2 26.26 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.857 -0.61 . . . . 75.530000000000001 109.733 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.0 mt -84.04 -11.52 11.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.058 0.456 . . . . 75.109999999999999 110.363 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.447 ' HB3' ' O ' ' A' ' 148' ' ' PHE . 21.4 tpp . . . . . 0 C--O 1.237 0.43 0 CA-C-O 122.325 1.059 . . . . 64.310000000000002 110.173 -174.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.447 ' O ' ' HB3' ' A' ' 137' ' ' MET . 38.3 p90 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.856 -0.424 . . . . 73.150000000000006 109.856 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.53 169.45 10.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.192 0.52 . . . . 72.140000000000001 111.055 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -135.49 128.89 32.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.541 -0.754 . . . . 74.409999999999997 109.574 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.604 HG13 ' CD1' ' A' ' 134' ' ' ILE . 29.7 t -108.82 110.24 31.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.755 -0.461 . . . . 73.219999999999999 109.755 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.431 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 16.4 m -86.47 125.35 33.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.451 -0.34 . . . . 74.129999999999995 110.272 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.555 ' CD2' HG12 ' A' ' 159' ' ' VAL . 97.1 m-85 -108.79 156.52 19.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.804 0.335 . . . . 73.140000000000001 110.279 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.21 -24.08 63.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.879 -0.6 . . . . 75.040000000000006 110.861 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -133.95 150.12 51.28 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.078 -0.51 . . . . 74.340000000000003 111.188 -173.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.55 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.5 p-80 -88.57 -5.13 58.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.053 -0.521 . . . . 75.420000000000002 110.723 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -73.39 -42.72 61.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.16 0.505 . . . . 71.319999999999993 110.119 174.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 m -63.85 -33.13 75.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.528 -0.76 . . . . 34.409999999999997 111.428 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.555 HG12 ' CD2' ' A' ' 153' ' ' PHE . 4.7 m -72.82 -22.24 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.501 -0.318 . . . . 74.349999999999994 110.987 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.416 ' HA ' HG22 ' A' ' 163' ' ' VAL . 33.2 t70 -63.84 -44.97 91.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.4 . . . . 74.150000000000006 111.395 -174.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -8.28 31.91 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.178 0.513 . . . . 71.540000000000006 110.508 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.507 HG21 HD13 ' A' ' 107' ' ' ILE . 69.6 mt -100.83 -50.04 10.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.665 -0.698 . . . . 64.519999999999996 110.688 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.416 HG22 ' HA ' ' A' ' 160' ' ' ASP . 27.0 m -73.37 -15.43 17.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.675 -0.693 . . . . 73.150000000000006 112.77 -175.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.5 pp -67.91 -30.05 46.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 53.439999999999998 110.979 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.423 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 15.5 pt20 -105.52 -173.37 2.28 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.684 -0.487 . . . . 72.409999999999997 109.684 173.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.471 ' HE3' ' HG3' ' A' ' 176' ' ' GLU . 46.6 tttp -127.42 -69.37 0.75 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.706 0.288 . . . . 62.009999999999998 110.56 -176.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -70.89 120.28 16.25 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.912 0.387 . . . . 71.310000000000002 110.681 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.44 ' CE1' HG23 ' A' ' 162' ' ' ILE . 28.1 m-70 -116.62 141.56 48.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.812 -0.631 . . . . 75.319999999999993 110.006 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.5 m -93.52 81.96 4.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.249 0.547 . . . . 75.239999999999995 110.585 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.562 HG11 HD13 ' A' ' 121' ' ' LEU . 22.0 t -96.33 122.15 47.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.875 -0.602 . . . . 72.400000000000006 109.744 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.9 t30 63.39 16.37 9.48 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.866 0.841 . . . . 75.430000000000007 110.248 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 87.5 -3.55 86.35 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.955 -0.641 . . . . 21.129999999999999 111.866 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -88.77 150.42 22.95 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.611 -0.514 . . . . 75.209999999999994 109.611 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -97.34 103.51 15.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.871 0.367 . . . . 75.239999999999995 110.442 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 31.2 m -116.74 155.08 29.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.153 -0.476 . . . . 65.140000000000001 110.436 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.471 ' HG3' ' HE3' ' A' ' 166' ' ' LYS . 11.4 tt0 -94.3 125.46 38.96 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.718 -0.475 . . . . 62.130000000000003 109.718 177.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 51.1 t -121.39 134.38 64.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.106 0.479 . . . . 74.310000000000002 111.258 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -146.21 -176.97 5.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.46 -0.791 . . . . 73.299999999999997 108.911 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.423 ' HE3' HG11 ' A' ' 104' ' ' VAL . 2.5 ptpp? -75.32 126.93 32.03 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.532 -0.467 . . . . 64.010000000000005 110.756 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -79.61 101.66 8.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.963 -0.562 . . . . 33.409999999999997 111.07 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.712 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -94.24 138.45 32.23 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.01 -0.737 . . . . 64.239999999999995 109.01 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.456 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 4.3 m -50.97 140.32 15.74 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.55 0.531 . . . . 74.319999999999993 110.773 -176.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.764 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.7 pttp -62.57 -22.63 66.5 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.876 0.369 . . . . 74.25 110.856 -177.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -66.79 -42.3 86.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.868 -0.606 . . . . 73.340000000000003 109.728 173.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.456 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 35.1 mt-10 -77.1 -38.45 52.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.757 -0.656 . . . . 71.219999999999999 110.664 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.764 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 19.8 ptm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.354 -0.385 . . . . 74.349999999999994 110.791 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.485 HG22 ' H ' ' A' ' 106' ' ' LYS . 12.8 p . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 109.598 -0.519 . . . . 54.539999999999999 109.598 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.574 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 19.8 mtmt -121.37 9.04 10.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.171 0.51 . . . . 73.150000000000006 111.578 -176.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.638 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 28.6 ttpt -138.58 135.97 35.52 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.915 -0.584 . . . . 63.009999999999998 109.466 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.594 HD13 HG21 ' A' ' 162' ' ' ILE . 6.7 pt -107.31 159.28 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.943 0.402 . . . . 74.530000000000001 110.638 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 57.1 t80 -108.43 115.18 29.63 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.847 -0.615 . . . . 63.549999999999997 109.847 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.7 t -102.77 103.48 15.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.796 -0.446 . . . . 74.030000000000001 109.796 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.839 0 CA-C-N 115.858 -0.61 . . . . 23.309999999999999 111.974 -177.219 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.512 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 11.9 pt-20 . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.767 0.318 . . . . 71.219999999999999 111.644 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.686 ' HG2' ' CG1' ' A' ' 134' ' ' ILE . 3.1 tm-20 -55.28 -54.75 39.56 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.634 -0.712 . . . . 60.530000000000001 111.714 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -63.2 -31.02 72.07 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.961 -0.296 . . . . 74.239999999999995 111.089 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.512 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 65.3 m80 -63.46 -60.32 3.52 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.261 0.553 . . . . 73.109999999999999 110.539 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.538 ' HA ' HG21 ' A' ' 170' ' ' VAL . 89.0 mt -61.41 -44.13 97.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.337 -0.847 . . . . 54.310000000000002 110.602 -177.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.547 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.5 OUTLIER -60.21 -42.63 95.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.674 -0.694 . . . . 65.019999999999996 110.846 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -58.1 -32.9 68.54 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.271 0.557 . . . . 75.430000000000007 111.438 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -88.2 -43.46 11.6 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.708 -0.678 . . . . 64.109999999999999 111.668 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 43.1 m-85 -83.74 -15.03 50.12 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.596 0.591 . . . . 73.209999999999994 112.596 -173.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.8 -19.45 65.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.115 0.484 . . . . 45.509999999999998 111.394 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -69.56 -25.15 63.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.867 -0.606 . . . . 70.25 110.441 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.48 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 80.2 m-85 -86.44 -32.06 21.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.898 -0.592 . . . . 70.299999999999997 110.368 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.594 ' HA3' ' HB3' ' A' ' 158' ' ' SER . . . -178.95 179.16 48.93 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.123 -0.791 . . . . 53.509999999999998 111.123 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -78.67 131.93 36.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.68 0.753 . . . . 74.340000000000003 109.846 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.628 HG21 HD11 ' A' ' 134' ' ' ILE . 50.2 mt -98.85 137.21 27.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.317 -0.856 . . . . 75.319999999999993 110.984 -176.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -81.35 -70.44 0.54 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.819 -0.628 . . . . 63.350000000000001 110.757 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.31 159.69 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.523 -0.308 . . . . 61.439999999999998 110.72 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.686 ' CG1' ' HG2' ' A' ' 118' ' ' GLU . 18.8 mm -117.13 109.34 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.802 -0.444 . . . . 44.439999999999998 109.802 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -85.24 95.77 9.29 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.202 -0.666 . . . . 62.149999999999999 109.202 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.8 mt -73.15 -15.84 17.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.133 0.492 . . . . 61.340000000000003 110.58 -176.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 19.7 tpp . . . . . 0 C--O 1.236 0.394 0 CA-C-O 122.023 0.916 . . . . 52.439999999999998 110.872 178.186 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.1 p90 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 109.448 -0.575 . . . . 74.299999999999997 109.448 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -133.07 158.28 43.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.036 0.446 . . . . 62.340000000000003 111.201 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -119.58 122.85 42.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.904 -0.589 . . . . 73.140000000000001 109.768 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.619 HG13 ' CD1' ' A' ' 134' ' ' ILE . 61.7 t -99.92 109.86 25.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.569 0.223 . . . . 61.32 110.567 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.638 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 19.1 m -88.63 126.8 35.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.313 -0.403 . . . . 74.099999999999994 110.858 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.555 ' CD2' HG12 ' A' ' 159' ' ' VAL . 89.1 m-85 -108.64 154.35 22.11 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.514 -0.55 . . . . 64.439999999999998 109.514 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.27 -33.49 73.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.947 -0.76 . . . . 61.509999999999998 108.947 174.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -112.96 143.91 43.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.602 -1.181 . . . . 74.519999999999996 111.543 -172.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.63 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.9 p-80 -88.87 -12.72 41.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.716 -0.674 . . . . 71.219999999999999 110.178 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.62 -36.31 73.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.364 0.602 . . . . 74.519999999999996 109.605 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.595 ' HA ' ' HE2' ' A' ' 161' ' ' LYS . 13.0 m -75.67 -19.69 58.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.199 -0.909 . . . . 72.340000000000003 111.687 -175.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.63 HG22 ' O ' ' A' ' 156' ' ' HIS . 4.0 m -81.54 -22.31 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.758 0.313 . . . . 70.519999999999996 110.833 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.451 ' HA ' HG22 ' A' ' 163' ' ' VAL . 27.8 t70 -68.23 -40.53 82.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.342 -0.39 . . . . 73.109999999999999 111.429 -172.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.595 ' HE2' ' HA ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -62.63 -19.08 63.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.327 0.584 . . . . 62.340000000000003 110.247 178.565 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.594 HG21 HD13 ' A' ' 107' ' ' ILE . 90.4 mt -94.66 -55.2 6.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.412 -0.813 . . . . 65.030000000000001 111.23 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.451 HG22 ' HA ' ' A' ' 160' ' ' ASP . 27.5 m -66.28 -14.62 17.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.645 0.609 . . . . 72.409999999999997 112.645 -173.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.428 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.6 pp -72.51 -28.67 28.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.901 0.381 . . . . 73.319999999999993 110.817 176.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.486 ' HB3' ' NE2' ' A' ' 168' ' ' HIS . 39.4 tt0 -101.97 148.82 24.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.436 -0.579 . . . . 71.200000000000003 109.436 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.641 ' HE2' ' CE2' ' A' ' 167' ' ' TYR . 83.7 tttt -93.83 -61.21 1.58 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.828 0.346 . . . . 70.430000000000007 111.014 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.641 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 22.1 m-85 -82.51 108.6 16.04 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.188 0.518 . . . . 64.420000000000002 111.382 -176.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.486 ' NE2' ' HB3' ' A' ' 165' ' ' GLN . 27.5 m-70 -111.49 142.04 44.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.556 -0.747 . . . . 75.540000000000006 110.4 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.6 m -103.1 104.92 15.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.15 0.5 . . . . 73.310000000000002 111.096 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.538 HG21 ' HA ' ' A' ' 121' ' ' LEU . 6.3 p -130.17 140.89 47.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.782 -0.645 . . . . 73.319999999999993 109.403 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.14 -15.48 0.6 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.569 0.7 . . . . 74.319999999999993 109.459 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 113.34 2.22 24.65 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.64 -0.984 . . . . 54.229999999999997 110.64 -173.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -109.48 134.24 52.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.311 -0.444 . . . . 73.530000000000001 109.818 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -86.28 106.19 17.18 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.443 -0.577 . . . . 52.140000000000001 109.443 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 63.9 m -115.99 -177.86 3.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.986 -0.552 . . . . 55.109999999999999 110.797 -175.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.612 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 14.3 tt0 -111.31 132.64 54.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.625 -0.261 . . . . 74.200000000000003 110.593 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.7 m -121.86 144.46 31.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.082 0.468 . . . . 63.219999999999999 110.495 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -135.33 173.72 11.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.118 -0.492 . . . . 60.420000000000002 110.215 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.435 ' NZ ' HG21 ' A' ' 163' ' ' VAL . 66.4 mttm -70.09 119.03 13.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.645 -1.243 . . . . 75.430000000000007 107.645 167.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' A' ' 107' ' ' ILE . . . -75.87 93.05 3.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.111 0.482 . . . . 73.349999999999994 111.674 -175.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.695 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.4 pt? -90.73 138.3 31.69 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.935 -0.765 . . . . 75.200000000000003 108.935 173.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.427 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 12.7 m -56.43 151.83 12.53 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.136 0.273 . . . . 74.219999999999999 110.64 -176.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.77 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.1 pttp -59.14 -28.38 66.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.353 0.597 . . . . 75.230000000000004 109.7 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -60.51 -42.36 96.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.977 -1.011 . . . . 44.0 110.628 173.191 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 32.7 mt-10 -85.68 -35.21 21.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.395 -0.82 . . . . 72.099999999999994 110.768 -174.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.77 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.6 ptm . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.513 . . . . 43.100000000000001 110.587 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.459 HG22 ' H ' ' A' ' 106' ' ' LYS . 8.7 p . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 109.918 -0.401 . . . . 61.32 109.918 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 19.3 mtmt -122.32 20.13 10.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.324 0.583 . . . . 71.299999999999997 110.991 -177.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.62 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 30.0 ttpt -150.85 136.94 18.36 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.377 -0.829 . . . . 73.230000000000004 108.973 174.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.551 HD13 HG21 ' A' ' 162' ' ' ILE . 2.7 pt -110.12 153.95 11.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.937 0.399 . . . . 61.0 110.342 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 74.0 t80 -100.89 120.74 40.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.736 -0.665 . . . . 73.129999999999995 110.012 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.462 HG11 HD11 ' A' ' 121' ' ' LEU . 47.0 t -107.6 113.67 44.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.753 0.311 . . . . 73.510000000000005 110.411 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.529 0 C-N-CA 120.657 -0.782 . . . . 73.019999999999996 112.598 -179.379 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.606 ' HG2' ' HD1' ' A' ' 120' ' ' HIS . 10.2 pt-20 . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.326 0.107 . . . . 71.209999999999994 110.862 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.758 ' HA ' HG21 ' A' ' 134' ' ' ILE . 19.1 tt0 -55.87 -53.19 59.78 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.58 0.585 . . . . 74.540000000000006 112.58 -174.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -59.09 -30.51 68.15 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.071 -0.251 . . . . 74.340000000000003 110.581 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.606 ' HD1' ' HG2' ' A' ' 117' ' ' GLU . 41.9 m80 -64.91 -55.95 16.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.157 -0.474 . . . . 71.329999999999998 110.327 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -61.24 -48.07 83.13 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.296 -0.411 . . . . 62.450000000000003 110.689 -179.408 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.418 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 3.1 tpp180 -61.65 -48.98 78.39 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.263 -0.426 . . . . 73.230000000000004 111.49 -176.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.55 -31.52 68.04 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.31 0.576 . . . . 64.450000000000003 110.958 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.407 ' HE1' ' HB3' ' A' ' 168' ' ' HIS . 38.8 t80 -86.83 -44.21 11.9 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.834 -0.621 . . . . 74.0 111.305 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.418 ' CD1' HG21 ' A' ' 151' ' ' VAL . 47.2 m-85 -86.16 -13.84 45.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.054 0.761 . . . . 71.209999999999994 113.054 -172.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.51 -22.27 65.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.047 0.451 . . . . 74.400000000000006 110.839 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -66.6 -25.8 66.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.731 -0.668 . . . . 61.350000000000001 110.463 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.467 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 72.1 m-85 -84.88 -30.24 24.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.663 -0.699 . . . . 70.129999999999995 110.851 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.438 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 175.93 -174.8 47.14 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.717 -0.754 . . . . 75.129999999999995 111.881 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 20.1 ptmt -79.11 129.55 34.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.811 0.815 . . . . 74.230000000000004 109.976 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.55 HG21 HD11 ' A' ' 134' ' ' ILE . 48.1 mt -98.94 142.56 14.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.246 -0.888 . . . . 62.299999999999997 110.528 -176.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -85.89 -75.63 0.37 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.953 -0.567 . . . . 72.329999999999998 110.159 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.6 m -139.35 155.56 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.327 -0.397 . . . . 71.140000000000001 110.611 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.758 HG21 ' HA ' ' A' ' 118' ' ' GLU . 24.0 mm -110.87 107.8 23.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.25 -0.648 . . . . 63.420000000000002 109.25 175.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 88.0 mt-10 -91.2 97.54 11.19 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.098 0.475 . . . . 73.200000000000003 110.955 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.615 HD11 ' H ' ' A' ' 118' ' ' GLU . 32.3 mt -81.1 103.75 8.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.313 -0.625 . . . . 62.310000000000002 109.313 176.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.6 tpp . . . . . 0 C--N 1.326 -0.441 0 CA-C-O 121.425 0.631 . . . . 71.25 110.668 -177.795 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 35.4 p90 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.245 -0.28 . . . . 73.340000000000003 110.245 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.96 169.48 17.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.212 -0.449 . . . . 72.349999999999994 110.764 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.578 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 66.6 m-85 -130.79 137.35 49.4 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.016 -0.538 . . . . 72.239999999999995 110.011 -177.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.602 HG13 ' CD1' ' A' ' 134' ' ' ILE . 18.7 t -112.27 107.13 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.811 -0.441 . . . . 75.140000000000001 109.811 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.62 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 18.4 m -86.94 126.03 34.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.323 -0.399 . . . . 70.329999999999998 110.359 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -109.41 152.1 25.8 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.776 -0.453 . . . . 70.239999999999995 109.776 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.475 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 26.9 t70 -75.45 -22.54 57.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.404 0.621 . . . . 74.120000000000005 109.735 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -124.84 139.52 53.77 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.327 -0.851 . . . . 73.540000000000006 110.441 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.59 ' O ' HG22 ' A' ' 159' ' ' VAL . 3.8 p-80 -81.63 -5.65 58.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.345 0.593 . . . . 64.140000000000001 109.955 175.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.43 -44.11 83.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.751 -0.659 . . . . 71.150000000000006 109.991 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.438 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 3.3 m -60.15 -39.25 85.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.17 -0.923 . . . . 73.120000000000005 111.729 -177.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 156' ' ' HIS . 6.5 m -70.86 -25.91 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.391 -0.368 . . . . 73.319999999999993 111.452 -174.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -69.44 -22.32 63.66 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.578 0.214 . . . . 74.439999999999998 111.578 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.467 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 0.5 OUTLIER -89.32 -1.35 58.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.389 0.614 . . . . 61.030000000000001 109.644 177.142 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.551 HG21 HD13 ' A' ' 107' ' ' ILE . 92.5 mt -108.53 -54.6 5.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.432 -0.803 . . . . 63.030000000000001 110.782 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.519 HG11 ' HG2' ' A' ' 179' ' ' LYS . 23.9 m -71.75 -3.55 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.851 -0.613 . . . . 54.240000000000002 112.589 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.1 pp -74.39 -30.71 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.73 0.3 . . . . 70.5 111.227 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.525 ' N ' HD12 ' A' ' 164' ' ' ILE . 4.0 pt20 -114.34 176.54 5.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.916 -0.402 . . . . 73.439999999999998 109.916 173.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.591 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 79.8 tttt -113.24 -59.46 2.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.566 -0.288 . . . . 61.350000000000001 111.631 -174.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 21.0 m-85 -78.19 107.75 11.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.127 0.489 . . . . 71.230000000000004 111.083 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.407 ' HB3' ' HE1' ' A' ' 124' ' ' TYR . 16.5 m-70 -107.47 135.63 48.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.635 -0.711 . . . . 73.409999999999997 110.536 178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.7 m -93.55 97.45 10.51 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.797 -0.638 . . . . 73.400000000000006 111.233 -175.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.99 139.44 50.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.994 -0.743 . . . . 73.310000000000002 108.994 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 71.43 -7.19 1.23 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.292 0.568 . . . . 61.43 110.275 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 108.04 -0.29 33.61 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.57 -0.612 . . . . 62.350000000000001 111.57 -176.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -115.93 146.57 41.97 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.178 -0.305 . . . . 72.319999999999993 110.178 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -90.3 104.86 17.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.981 0.896 . . . . 55.200000000000003 110.496 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 25.8 p -95.37 172.22 8.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.315 -0.857 . . . . 74.310000000000002 110.017 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.591 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 38.0 tt0 -107.99 121.39 44.71 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.85 -0.426 . . . . 75.400000000000006 109.85 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 2.8 m -109.86 145.78 16.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.983 0.42 . . . . 62.420000000000002 110.558 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -135.39 170.77 15.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.112 -0.495 . . . . 74.530000000000001 110.147 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.519 ' HG2' HG11 ' A' ' 163' ' ' VAL . 8.1 mtpm? -73.42 114.4 11.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.458 -0.941 . . . . 52.450000000000003 108.458 169.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -72.11 97.57 1.95 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.262 0.553 . . . . 62.219999999999999 111.735 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.748 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.3 pt? -96.75 138.3 34.51 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.488 -0.778 . . . . 32.240000000000002 109.133 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.522 ' HB3' ' HG2' ' A' ' 185' ' ' GLU . 36.3 t -49.89 145.36 5.57 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.279 0.362 . . . . 40.310000000000002 110.959 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.606 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 22.4 pttp -62.64 -23.51 67.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.152 0.501 . . . . 75.019999999999996 109.908 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -73.75 -41.4 62.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.507 -0.77 . . . . 41.119999999999997 109.487 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.522 ' HG2' ' HB3' ' A' ' 182' ' ' SER . 56.1 mm-40 -73.44 -40.85 63.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.321 -0.854 . . . . 75.299999999999997 110.943 -177.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.606 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 12.5 ptp . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 120.784 0.326 . . . . 72.239999999999995 110.734 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.52 HG21 ' HB3' ' A' ' 179' ' ' LYS . 2.1 t . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 110.365 -0.235 . . . . 73.319999999999993 110.365 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.649 ' HA ' HG21 ' A' ' 159' ' ' VAL . 4.8 mtmt -118.33 9.04 12.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.886 0.374 . . . . 62.020000000000003 111.345 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.601 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.9 ttpt -147.02 138.4 24.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.88 0.372 . . . . 72.140000000000001 110.068 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.571 ' CG2' HG13 ' A' ' 159' ' ' VAL . 7.4 pt -109.18 162.42 6.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.208 -0.451 . . . . 62.240000000000002 111.203 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 54.3 t80 -109.14 121.28 44.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.747 -0.661 . . . . 54.210000000000001 109.912 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.1 t -105.05 104.71 17.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.899 0.38 . . . . 54.409999999999997 110.694 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.518 0 N-CA-C 111.321 -0.712 . . . . 63.149999999999999 111.321 178.242 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.686 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 11.2 pt-20 . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 120.823 0.344 . . . . 70.040000000000006 111.71 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.744 ' HA ' HG21 ' A' ' 134' ' ' ILE . 21.5 tt0 -51.69 -56.58 12.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.282 -0.872 . . . . 63.130000000000003 112.318 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.402 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.0 p80 -61.83 -31.05 71.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.352 -0.386 . . . . 65.329999999999998 111.065 -174.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.686 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 41.3 m80 -67.6 -59.38 3.39 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.25 0.548 . . . . 65.209999999999994 110.064 177.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.655 HD23 HG11 ' A' ' 170' ' ' VAL . 68.8 mt -57.2 -49.58 75.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.066 -0.97 . . . . 73.420000000000002 110.973 -177.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.424 ' HG3' HD12 ' A' ' 131' ' ' ILE . 4.7 ttp180 -62.03 -37.79 86.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 74.430000000000007 111.38 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.17 -29.61 68.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.982 0.42 . . . . 64.299999999999997 110.872 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.405 ' CD1' HG22 ' A' ' 170' ' ' VAL . 83.2 t80 -91.67 -46.98 7.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.045 -0.525 . . . . 72.340000000000003 111.622 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -77.2 -14.01 59.85 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.595 0.591 . . . . 55.509999999999998 112.595 -172.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.83 -22.16 66.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.11 0.481 . . . . 64.219999999999999 110.912 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.81 -30.89 71.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.712 -0.676 . . . . 75.340000000000003 110.858 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.439 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 76.6 m-85 -82.48 -31.04 29.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.129 -0.487 . . . . 74.329999999999998 111.253 -175.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 158' ' ' SER . . . 172.66 -170.91 43.98 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.822 -1.18 . . . . 62.299999999999997 113.381 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -75.86 114.19 14.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.526 0.679 . . . . 74.209999999999994 111.342 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.517 HG21 HD11 ' A' ' 134' ' ' ILE . 35.3 mt -87.27 142.18 13.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.15 -0.932 . . . . 75.409999999999997 110.039 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -86.66 -74.68 0.42 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.106 -0.497 . . . . 73.129999999999995 110.315 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.1 m -143.86 152.37 16.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.135 -0.484 . . . . 32.539999999999999 110.079 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.744 HG21 ' HA ' ' A' ' 118' ' ' GLU . 16.2 mm -103.47 105.63 18.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.867 -0.79 . . . . 54.409999999999997 108.867 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -85.42 94.7 9.05 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.052 -0.522 . . . . 75.329999999999998 110.247 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.609 HD11 ' H ' ' A' ' 118' ' ' GLU . 31.5 mt -80.79 119.94 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.653 -0.703 . . . . 73.329999999999998 109.802 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 21.4 tpp . . . . . 0 C--N 1.322 -0.608 0 CA-C-O 121.709 0.766 . . . . 75.420000000000002 109.434 176.545 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 47.9 p90 . . . . . 0 C--O 1.236 0.379 0 CA-C-O 121.077 0.465 . . . . 71.140000000000001 111.384 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.94 166.88 26.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.857 -0.611 . . . . 72.140000000000001 110.824 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -122.38 131.42 53.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.949 -0.569 . . . . 73.219999999999999 109.707 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.599 HG13 ' CD1' ' A' ' 134' ' ' ILE . 47.7 t -104.56 109.66 28.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.776 0.322 . . . . 73.329999999999998 110.324 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.601 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 12.3 m -88.02 129.51 35.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.894 -0.593 . . . . 51.420000000000002 110.175 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.508 ' CD2' HG22 ' A' ' 159' ' ' VAL . 97.8 m-85 -111.58 150.61 29.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.821 -0.437 . . . . 74.099999999999994 109.821 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.49 -13.01 60.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.575 0.703 . . . . 54.329999999999998 110.235 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -129.41 147.63 51.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.312 -0.858 . . . . 75.230000000000004 109.969 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -85.57 -15.41 42.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.074 0.464 . . . . 71.430000000000007 110.441 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -71.73 -39.67 69.92 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.079 -0.509 . . . . 44.310000000000002 110.047 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.557 ' HB3' ' HA3' ' A' ' 129' ' ' GLY . 0.8 OUTLIER -59.94 -35.29 74.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.619 -0.719 . . . . 75.420000000000002 110.1 178.438 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 105' ' ' LYS . 22.0 t -70.22 -35.86 65.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.04 -0.982 . . . . 50.210000000000001 110.816 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.35 -38.75 92.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.897 -0.592 . . . . 74.120000000000005 112.289 -171.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.439 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -66.25 -22.15 66.31 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.337 0.589 . . . . 73.219999999999999 110.316 178.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.493 HG21 HD13 ' A' ' 107' ' ' ILE . 96.0 mt -93.59 -49.3 12.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.377 -0.829 . . . . 73.150000000000006 111.478 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.552 ' HB ' ' HE2' ' A' ' 179' ' ' LYS . 34.8 m -69.37 -14.94 19.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.591 0.589 . . . . 72.150000000000006 112.591 -173.12 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -75.73 -27.73 18.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.173 0.511 . . . . 72.439999999999998 110.664 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -103.36 143.84 32.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.773 -0.649 . . . . 60.340000000000003 110.158 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.641 ' HE2' ' CE2' ' A' ' 167' ' ' TYR . 83.0 tttt -91.85 -64.25 1.14 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.865 0.364 . . . . 75.109999999999999 110.714 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.641 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 15.5 m-30 -84.27 105.22 14.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.423 0.63 . . . . 75.349999999999994 112.216 -175.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -106.24 149.79 26.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.959 -1.018 . . . . 74.219999999999999 109.424 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 53.5 m -102.6 103.12 13.41 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.956 0.408 . . . . 61.399999999999999 110.975 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.655 HG11 HD23 ' A' ' 121' ' ' LEU . 31.3 t -116.8 131.38 69.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.06 -0.518 . . . . 73.439999999999998 109.85 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.7 t30 59.53 27.27 16.41 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.482 0.658 . . . . 73.519999999999996 110.401 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 76.02 5.59 80.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.854 -0.689 . . . . 72.319999999999993 112.386 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -109.11 133.09 53.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.787 0.327 . . . . 74.430000000000007 110.127 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.435 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 10.7 t30 -77.9 122.6 25.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.29 -0.414 . . . . 52.340000000000003 109.91 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 24.2 p -126.33 165.61 18.69 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.442 -0.345 . . . . 75.299999999999997 110.943 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.571 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 15.7 tt0 -108.58 118.85 37.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.998 -0.546 . . . . 72.319999999999993 110.017 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.449 HG11 HG22 ' A' ' 162' ' ' ILE . 86.9 t -110.82 132.87 58.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.17 0.51 . . . . 65.420000000000002 111.297 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -127.01 177.91 6.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.549 -0.75 . . . . 73.5 109.823 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.552 ' HE2' ' HB ' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -77.59 123.64 26.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.405 -0.961 . . . . 74.239999999999995 108.405 170.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.411 ' HB2' ' C ' ' A' ' 107' ' ' ILE . . . -75.3 92.87 2.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.147 0.499 . . . . 72.140000000000001 112.089 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.587 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.5 pt? -88.13 131.24 34.78 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.537 -0.912 . . . . 74.510000000000005 108.537 171.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.5 m -58.31 153.8 14.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.476 -0.329 . . . . 73.340000000000003 110.938 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.621 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.4 pttp -63.45 -14.8 54.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.091 0.472 . . . . 74.109999999999999 111.238 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 11.4 tm0? -78.57 -43.51 26.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.099 -0.704 . . . . 61.5 109.099 173.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -73.0 -41.88 63.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.32 -0.854 . . . . 64.230000000000004 110.958 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.621 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 21.1 ptm . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 63.509999999999998 110.442 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 179' ' ' LYS . 38.9 t . . . . . 0 N--CA 1.455 -0.202 0 N-CA-C 110.032 -0.358 . . . . 74.129999999999995 110.032 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.577 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 6.4 mtmt -115.79 -3.96 12.18 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.132 0.419 . . . . 62.009999999999998 112.132 -178.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.585 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.8 ttpt -135.46 134.11 39.24 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.028 -0.36 . . . . 74.319999999999993 110.028 175.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.674 HG22 HG13 ' A' ' 159' ' ' VAL . 3.3 pt -104.45 155.3 6.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.064 0.459 . . . . 75.120000000000005 110.745 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 41.8 t80 -104.83 122.93 46.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.551 -0.75 . . . . 74.299999999999997 109.785 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.2 t -110.65 98.59 7.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.432 -0.581 . . . . 74.430000000000007 109.432 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.674 -0.774 . . . . 62.130000000000003 113.185 -173.492 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.704 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 110.157 -0.312 . . . . 71.409999999999997 110.157 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.641 ' HA ' HG21 ' A' ' 134' ' ' ILE . 12.7 tt0 -55.79 -49.95 71.79 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 112.294 0.479 . . . . 65.140000000000001 112.294 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -60.53 -29.86 69.39 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 120.752 -0.379 . . . . 72.299999999999997 110.25 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.704 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 37.2 m80 -65.56 -55.87 15.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.374 -0.376 . . . . 61.43 111.009 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.38 -47.71 84.4 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.944 0.402 . . . . 74.319999999999993 110.472 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.31 -46.32 90.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.042 -0.526 . . . . 72.439999999999998 111.385 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -57.18 -32.01 66.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.106 0.479 . . . . 50.409999999999997 111.602 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.432 ' CE1' ' HB3' ' A' ' 168' ' ' HIS . 50.6 t80 -90.63 -44.1 9.74 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.182 -0.463 . . . . 73.519999999999996 111.411 -177.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -82.77 -12.83 57.21 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.674 0.62 . . . . 63.119999999999997 112.674 -172.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -61.47 -27.25 68.44 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.68 0.276 . . . . 75.349999999999994 111.556 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -74.82 -14.96 60.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.906 0.384 . . . . 74.310000000000002 110.903 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -90.0 -26.63 20.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.312 -0.403 . . . . 64.120000000000005 110.868 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' A' ' 158' ' ' SER . . . 169.56 -170.97 43.02 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.508 -0.853 . . . . 63.229999999999997 112.533 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -75.86 122.27 23.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.28 0.562 . . . . 55.219999999999999 111.18 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.532 HG21 HD11 ' A' ' 134' ' ' ILE . 46.7 mt -95.59 137.9 22.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.415 -0.811 . . . . 74.340000000000003 110.296 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.455 ' HG2' ' N ' ' A' ' 154' ' ' ASP . 13.5 mm-40 -85.35 -70.57 0.58 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.934 -0.575 . . . . 73.430000000000007 110.403 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.22 158.75 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.531 -0.304 . . . . 73.239999999999995 110.472 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.641 HG21 ' HA ' ' A' ' 118' ' ' GLU . 23.5 mm -113.73 117.67 56.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.929 -0.397 . . . . 73.329999999999998 109.929 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 59.7 mt-10 -100.49 117.81 35.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.589 -0.522 . . . . 64.340000000000003 109.589 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.7 mt -91.65 3.76 7.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.53 0.681 . . . . 60.240000000000002 109.255 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.4 tpp . . . . . 0 C--O 1.232 0.174 0 CA-C-N 114.857 -1.065 . . . . 72.049999999999997 109.588 -175.894 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 29.0 p90 . . . . . 0 C--O 1.234 0.268 0 N-CA-C 109.402 -0.592 . . . . 65.439999999999998 109.402 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -136.42 172.11 13.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.214 0.53 . . . . 70.129999999999995 111.827 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.552 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 56.5 m-85 -133.32 134.97 44.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.334 -0.848 . . . . 74.519999999999996 109.433 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.61 HG13 ' CD1' ' A' ' 134' ' ' ILE . 21.2 t -112.93 108.52 25.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.858 -0.423 . . . . 72.230000000000004 109.858 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.585 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 6.7 m -88.14 127.19 35.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.168 -0.469 . . . . 75.299999999999997 110.461 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.497 ' CD2' HG22 ' A' ' 159' ' ' VAL . 86.8 m-85 -111.81 151.33 29.16 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.923 -0.399 . . . . 61.149999999999999 109.923 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.455 ' N ' ' HG2' ' A' ' 132' ' ' GLU . 28.1 t70 -76.91 -14.66 59.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.776 0.798 . . . . 74.140000000000001 110.042 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.43 ' OD1' ' HB3' ' A' ' 157' ' ' ASP . 37.0 t70 -123.93 133.32 53.75 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.002 -0.999 . . . . 32.399999999999999 111.043 -173.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.577 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 3.3 p80 -85.11 -2.07 57.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.3 -0.409 . . . . 60.030000000000001 111.357 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.43 ' HB3' ' OD1' ' A' ' 155' ' ' ASP . 22.1 t70 -94.56 -37.05 11.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.183 0.516 . . . . 34.020000000000003 109.614 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.852 ' HA ' ' HE3' ' A' ' 161' ' ' LYS . 18.5 m -57.36 -32.03 66.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.482 -0.781 . . . . 64.519999999999996 110.482 175.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.674 HG13 HG22 ' A' ' 107' ' ' ILE . 46.9 t -70.83 -29.11 36.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.462 -0.79 . . . . 64.5 110.873 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -65.64 -45.57 82.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.907 -0.588 . . . . 72.319999999999993 111.608 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.852 ' HE3' ' HA ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -65.99 -12.6 56.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.119 0.485 . . . . 61.210000000000001 111.148 178.072 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.515 HG21 HD13 ' A' ' 107' ' ' ILE . 96.9 mt -93.3 -51.8 10.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.036 -0.529 . . . . 72.540000000000006 110.84 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 25.7 m -68.25 -15.75 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.516 0.562 . . . . 52.130000000000003 112.516 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.7 pp -73.82 -27.26 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.976 0.417 . . . . 73.209999999999994 110.574 177.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -102.76 150.09 23.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.092 -0.707 . . . . 72.420000000000002 109.092 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.546 ' HE2' ' HG3' ' A' ' 176' ' ' GLU . 86.6 tttt -100.16 -59.6 1.68 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.794 -0.362 . . . . 71.040000000000006 111.1 -176.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -88.19 113.43 23.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.404 0.621 . . . . 72.299999999999997 111.177 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.432 ' HB3' ' CE1' ' A' ' 124' ' ' TYR . 32.7 m-70 -109.24 139.4 44.22 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.153 -0.931 . . . . 74.109999999999999 110.219 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.2 m -92.58 101.48 13.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.123 0.487 . . . . 71.049999999999997 111.124 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 171' ' ' ASN . 4.2 p -134.15 140.02 47.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.956 -0.565 . . . . 61.009999999999998 109.728 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 170' ' ' VAL . 6.7 t30 71.71 1.16 3.78 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.729 0.776 . . . . 60.539999999999999 110.042 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.67 8.32 63.93 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.478 -0.783 . . . . 50.43 111.556 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -117.9 154.52 31.74 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.094 -0.336 . . . . 71.040000000000006 110.094 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -83.31 98.71 9.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.101 0.477 . . . . 72.230000000000004 110.341 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 78.6 m -101.22 123.66 45.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.817 -0.629 . . . . 74.400000000000006 111.07 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.546 ' HG3' ' HE2' ' A' ' 166' ' ' LYS . 3.8 tm-20 -83.7 122.92 29.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.518 -0.764 . . . . 73.120000000000005 109.738 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.4 m -118.74 148.77 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.202 -0.454 . . . . 70.329999999999998 111.189 -171.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -139.59 173.4 11.57 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.036 0.446 . . . . 60.109999999999999 111.503 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.473 ' HB3' HG21 ' A' ' 104' ' ' VAL . 47.9 mttm -71.73 117.56 13.47 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.08 -1.081 . . . . 72.400000000000006 108.08 166.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -76.98 93.6 3.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.076 0.465 . . . . 72.299999999999997 111.862 -175.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.643 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.7 pt? -91.37 131.84 36.59 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.696 -0.853 . . . . 51.210000000000001 108.696 170.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.6 m -53.97 148.56 10.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.449 -0.341 . . . . 71.439999999999998 110.857 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.901 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.0 pttp -61.74 -26.54 68.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.288 0.566 . . . . 74.430000000000007 109.625 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -56.52 -38.6 72.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.994 -1.003 . . . . 73.299999999999997 110.525 172.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -95.17 -38.4 10.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.454 -0.794 . . . . 73.120000000000005 110.974 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.901 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 23.1 ptm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 72.439999999999998 110.792 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.471 HG21 ' HB3' ' A' ' 179' ' ' LYS . 31.9 t . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 110.138 -0.319 . . . . 52.439999999999998 110.138 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.667 ' HA ' HG21 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -110.33 -9.74 14.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.885 0.374 . . . . 40.130000000000003 110.501 -179.058 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.607 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 32.2 ttpt -126.18 135.57 51.79 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.065 0.46 . . . . 65.430000000000007 110.397 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.547 ' CG2' HG13 ' A' ' 159' ' ' VAL . 7.5 pt -104.61 161.28 4.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.163 0.506 . . . . 72.200000000000003 111.544 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 67.8 t80 -108.21 115.64 30.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.157 -0.929 . . . . 64.340000000000003 109.802 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.2 t -104.24 106.33 20.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.134 -0.321 . . . . 70.420000000000002 110.134 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.474 0 C-N-CA 120.948 -0.644 . . . . 61.130000000000003 112.524 -176.393 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.702 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 12.0 pt-20 . . . . . 0 N--CA 1.44 -0.938 0 CA-C-O 120.523 0.202 . . . . 72.030000000000001 110.524 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.73 ' HA ' HG21 ' A' ' 134' ' ' ILE . 9.9 tt0 -54.45 -50.63 67.23 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.319 0.489 . . . . 43.340000000000003 112.319 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -64.31 -26.56 68.54 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 121.068 -0.253 . . . . 74.129999999999995 110.97 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.702 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 39.1 m80 -68.46 -61.49 1.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.623 -0.262 . . . . 54.5 110.649 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.89 -50.79 69.69 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.131 -0.486 . . . . 52.439999999999998 110.434 178.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -53.46 -49.77 66.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.73 -0.668 . . . . 73.400000000000006 111.425 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.69 -28.18 68.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.676 0.274 . . . . 71.219999999999999 111.713 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -88.49 -34.86 17.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.83 0.347 . . . . 74.209999999999994 111.214 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 36.9 m-85 -92.22 -17.7 24.46 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.441 0.534 . . . . 60.310000000000002 112.441 -173.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -22.01 66.25 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.13 0.491 . . . . 72.319999999999993 110.993 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -64.15 -35.85 82.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.75 -0.659 . . . . 70.120000000000005 110.752 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.459 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 41.8 m-85 -80.93 -21.07 40.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.009 -0.541 . . . . 72.230000000000004 111.12 -176.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.54 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 166.78 -167.4 39.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.016 -1.087 . . . . 53.229999999999997 113.066 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -79.18 120.97 24.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.447 0.642 . . . . 74.230000000000004 111.231 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.534 HG21 HD11 ' A' ' 134' ' ' ILE . 45.6 mt -94.28 133.74 34.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.318 -0.855 . . . . 73.400000000000006 110.039 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 154' ' ' ASP . 20.0 mt-10 -78.03 -70.01 0.51 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 110.635 176.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.4 m -143.54 154.89 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.663 -0.244 . . . . 63.43 110.542 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.73 HG21 ' HA ' ' A' ' 118' ' ' GLU . 24.9 mm -107.34 112.69 41.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.574 -0.528 . . . . 62.549999999999997 109.574 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 89.6 mt-10 -92.63 99.85 12.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.155 0.502 . . . . 70.150000000000006 110.416 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.598 HD11 ' H ' ' A' ' 118' ' ' GLU . 31.8 mt -83.91 108.19 16.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.985 -0.552 . . . . 65.209999999999994 109.652 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.5 tpp . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 121.65 0.738 . . . . 73.329999999999998 109.887 179.455 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 31.2 p90 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.615 0.245 . . . . 72.510000000000005 111.096 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.32 173.28 11.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.462 -0.336 . . . . 72.040000000000006 110.741 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.521 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 88.3 m-85 -133.87 148.35 51.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.111 -0.495 . . . . 73.120000000000005 110.373 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.63 HG13 ' CD1' ' A' ' 134' ' ' ILE . 55.8 t -127.17 110.94 23.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.189 -0.46 . . . . 74.030000000000001 110.072 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.607 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 25.0 m -89.35 126.71 35.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.282 -0.417 . . . . 51.43 110.533 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.495 ' CD2' HG22 ' A' ' 159' ' ' VAL . 96.6 m-85 -108.37 149.12 29.12 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.237 -0.283 . . . . 75.409999999999997 110.237 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.505 ' N ' ' HG3' ' A' ' 132' ' ' GLU . 18.2 t70 -63.65 -29.07 70.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 70.430000000000007 111.439 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -132.21 147.63 52.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.289 -0.414 . . . . 64.319999999999993 110.616 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -21.1 61.81 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.812 -0.44 . . . . 73.010000000000005 109.812 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -58.42 -50.01 75.22 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.86 -0.609 . . . . 74.209999999999994 110.765 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.54 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 9.9 m -60.66 -29.1 69.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 72.340000000000003 110.957 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.667 HG21 ' HA ' ' A' ' 105' ' ' LYS . 20.9 t -74.29 -37.35 45.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.487 -0.779 . . . . 74.519999999999996 111.081 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.442 ' HA ' HG22 ' A' ' 163' ' ' VAL . 25.8 t70 -60.97 -38.91 87.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.361 -0.381 . . . . 72.0 112.025 -172.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.459 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 4.0 mttt -66.01 -18.56 65.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.207 0.527 . . . . 73.25 110.825 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.471 ' CG2' HG11 ' A' ' 177' ' ' VAL . 93.2 mt -98.84 -49.86 11.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.494 -0.775 . . . . 75.109999999999999 111.067 -176.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.566 ' HB ' ' HD2' ' A' ' 179' ' ' LYS . 24.7 m -67.36 -18.35 23.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.693 0.627 . . . . 73.409999999999997 112.693 -174.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.406 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.0 pp -69.46 -29.33 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.054 0.454 . . . . 60.329999999999998 111.063 177.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -108.23 144.62 35.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.04 -0.527 . . . . 74.519999999999996 109.887 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.613 ' HE3' ' OE2' ' A' ' 176' ' ' GLU . 84.3 tttt -93.64 -64.27 1.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.818 0.342 . . . . 74.430000000000007 111.167 -177.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.563 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 21.8 m-85 -83.17 106.83 15.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.076 0.465 . . . . 74.310000000000002 111.223 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -106.7 170.06 8.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.68 -0.691 . . . . 63.310000000000002 110.323 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.7 m -114.57 95.74 5.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.518 -0.31 . . . . 70.109999999999999 110.52 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 171' ' ' ASN . 6.7 p -122.75 137.72 55.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.629 -0.508 . . . . 71.420000000000002 109.629 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' A' ' 170' ' ' VAL . 7.8 t30 69.73 1.93 3.61 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.641 0.734 . . . . 75.430000000000007 110.496 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.9 13.53 57.71 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.539 -0.624 . . . . 72.329999999999998 111.539 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -122.88 145.12 48.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.071 -0.344 . . . . 74.109999999999999 110.071 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.501 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 9.0 t30 -80.64 105.99 12.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.108 -0.496 . . . . 73.219999999999999 110.214 176.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 25.4 m -115.39 165.85 12.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.106 -0.497 . . . . 72.200000000000003 110.294 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.613 ' OE2' ' HE3' ' A' ' 166' ' ' LYS . 20.6 tt0 -99.04 134.51 41.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.949 0.404 . . . . 71.200000000000003 110.755 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 83.9 t -126.53 130.47 71.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.903 -0.59 . . . . 75.420000000000002 110.521 176.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.44 ' HD3' ' OE2' ' A' ' 176' ' ' GLU . 19.8 mtm-85 -133.58 177.89 7.35 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.075 -0.713 . . . . 74.420000000000002 109.075 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.566 ' HD2' ' HB ' ' A' ' 163' ' ' VAL . 0.3 OUTLIER -72.06 128.9 37.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.941 -0.763 . . . . 64.530000000000001 108.941 173.156 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -84.37 86.04 7.31 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.446 -0.502 . . . . 54.350000000000001 110.88 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -80.61 135.44 36.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.198 -0.667 . . . . 71.310000000000002 109.198 175.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.8 m -49.9 136.15 18.74 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.537 0.523 . . . . 45.340000000000003 111.091 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.662 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.8 pttp -63.65 -24.66 67.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.69 0.281 . . . . 73.040000000000006 110.809 -178.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -60.98 -41.06 95.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.195 0.522 . . . . 74.420000000000002 109.94 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -84.9 -35.87 21.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.507 -0.77 . . . . 74.310000000000002 110.709 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.662 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 12.7 ptm . . . . . 0 C--N 1.333 -0.152 0 CA-C-O 120.755 0.312 . . . . 74.109999999999999 110.22 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.539 HG21 ' HB3' ' A' ' 179' ' ' LYS . 2.7 t . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.836 -0.431 . . . . 74.209999999999994 109.836 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.738 ' HA ' HG21 ' A' ' 159' ' ' VAL . 7.0 mtmt -122.48 24.15 9.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.379 0.609 . . . . 73.400000000000006 110.332 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.531 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.8 ttpt -159.42 135.08 8.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.407 -0.815 . . . . 74.340000000000003 109.454 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.556 HG12 ' HB ' ' A' ' 151' ' ' VAL . 6.1 pt -106.44 160.6 5.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.806 0.336 . . . . 72.109999999999999 111.064 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 58.9 t80 -107.07 119.35 39.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.784 -0.644 . . . . 64.340000000000003 110.171 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 121' ' ' LEU . 43.0 t -101.3 103.16 14.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.945 0.403 . . . . 72.319999999999993 110.357 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.749 0 N-CA-C 111.284 -0.726 . . . . 63.439999999999998 111.284 178.135 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.62 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 13.1 pt-20 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.826 0.346 . . . . 75.140000000000001 111.515 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.645 ' HA ' HG21 ' A' ' 134' ' ' ILE . 13.7 tt0 -59.18 -45.88 89.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.01 -0.541 . . . . 75.400000000000006 111.555 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.23 -27.54 67.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.324 -0.398 . . . . 44.210000000000001 110.715 -178.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.62 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 30.0 m80 -72.48 -60.75 2.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.56 -0.291 . . . . 64.209999999999994 111.017 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.43 HD13 HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -57.57 -49.22 77.09 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.983 0.421 . . . . 71.109999999999999 110.251 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.408 ' HD3' HD12 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -56.74 -44.68 81.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.811 -0.631 . . . . 73.25 111.144 -178.739 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.21 -31.11 68.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 73.129999999999995 111.411 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.412 ' CD1' HG22 ' A' ' 170' ' ' VAL . 78.7 t80 -86.97 -49.32 7.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.984 0.421 . . . . 73.140000000000001 111.09 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.506 ' CD1' HG21 ' A' ' 151' ' ' VAL . 65.3 m-85 -78.24 -14.01 59.61 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.579 0.585 . . . . 62.43 112.579 -171.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -25.23 67.72 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.68 0.252 . . . . 60.119999999999997 111.68 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -72.78 -19.33 61.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.949 0.404 . . . . 62.509999999999998 110.615 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.448 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 88.7 m-85 -83.86 -35.19 24.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.11 -0.495 . . . . 73.219999999999999 110.485 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.41 -167.67 38.36 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.438 -0.887 . . . . 72.530000000000001 112.556 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -77.59 122.68 25.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.206 0.526 . . . . 74.109999999999999 111.173 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.542 HG21 HD11 ' A' ' 134' ' ' ILE . 42.0 mt -97.41 131.15 44.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.604 -0.725 . . . . 61.32 110.504 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.416 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 7.2 mm-40 -78.01 -72.28 0.37 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.652 -0.704 . . . . 75.219999999999999 110.566 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.7 m -145.49 147.29 18.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.524 -0.307 . . . . 64.129999999999995 110.725 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.645 HG21 ' HA ' ' A' ' 118' ' ' GLU . 30.3 mm -102.83 107.71 22.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.888 -0.412 . . . . 72.409999999999997 109.888 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 38.1 mt-10 -85.96 103.2 14.45 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.792 -0.447 . . . . 72.439999999999998 109.792 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 23.9 mt -78.81 -11.24 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.089 0.471 . . . . 72.25 110.328 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.0 tpp . . . . . 0 C--O 1.233 0.233 0 CA-C-O 121.945 0.879 . . . . 72.230000000000004 110.651 -177.778 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.9 p90 . . . . . 0 C--O 1.232 0.152 0 N-CA-C 110.406 -0.22 . . . . 64.25 110.406 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -128.43 165.41 20.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.332 0.587 . . . . 54.130000000000003 111.443 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.511 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 66.0 m-85 -132.06 136.28 47.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.442 -0.799 . . . . 73.409999999999997 109.757 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.631 HG13 ' CD1' ' A' ' 134' ' ' ILE . 38.9 t -111.34 104.82 17.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.864 -0.421 . . . . 64.319999999999993 109.864 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.531 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 7.5 m -83.79 125.87 32.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 75.409999999999997 110.065 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.541 ' CD2' HG22 ' A' ' 159' ' ' VAL . 98.7 m-85 -109.5 151.55 26.59 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.074 -0.343 . . . . 64.040000000000006 110.074 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.416 ' HB2' ' HG2' ' A' ' 132' ' ' GLU . 26.6 t70 -78.53 -6.38 55.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.209 0.528 . . . . 74.150000000000006 111.163 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.444 ' O ' HG23 ' A' ' 159' ' ' VAL . 5.6 t70 -140.19 145.68 37.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.174 -0.466 . . . . 74.140000000000001 110.31 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -79.21 -18.44 52.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.148 -0.478 . . . . 65.120000000000005 110.56 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -73.07 -38.56 66.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.205 0.526 . . . . 71.010000000000005 110.064 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.2 m -64.65 -28.66 69.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.518 -0.765 . . . . 52.450000000000003 110.371 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.738 HG21 ' HA ' ' A' ' 105' ' ' LYS . 22.7 t -76.78 -36.56 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.66 -0.7 . . . . 74.310000000000002 110.201 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.29 -31.09 70.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.732 -0.667 . . . . 73.030000000000001 111.387 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.448 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 13.0 mmtp -65.1 -27.57 68.84 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.47 0.652 . . . . 54.439999999999998 110.021 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.54 HG21 HD13 ' A' ' 107' ' ' ILE . 90.4 mt -100.23 -50.18 10.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.949 -1.023 . . . . 73.530000000000001 111.828 -168.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.607 ' HB ' ' HG3' ' A' ' 179' ' ' LYS . 28.1 m -65.73 -16.76 21.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.448 0.536 . . . . 70.340000000000003 112.448 -173.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.5 pp -74.48 -26.83 20.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.965 0.412 . . . . 65.349999999999994 110.781 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.407 ' N ' HD12 ' A' ' 164' ' ' ILE . 35.0 tt0 -100.42 146.2 27.3 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.695 -0.684 . . . . 71.200000000000003 109.2 175.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -100.63 -66.06 0.93 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.762 0.315 . . . . 62.399999999999999 110.598 -177.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 19.7 m-85 -82.49 101.85 10.97 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.131 0.491 . . . . 62.399999999999999 111.11 -177.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -98.0 -172.8 2.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.721 -0.672 . . . . 74.129999999999995 109.593 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 61.4 m -141.64 106.63 4.94 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.222 0.534 . . . . 54.130000000000003 110.821 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.43 HG11 HD13 ' A' ' 121' ' ' LEU . 39.2 t -121.18 135.32 61.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.631 -0.713 . . . . 62.32 109.739 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 170' ' ' VAL . 7.9 t30 71.47 -4.62 1.81 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.277 0.56 . . . . 75.450000000000003 111.393 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 109.19 4.87 30.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.954 -0.641 . . . . 70.200000000000003 111.752 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -114.63 131.61 56.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.917 0.389 . . . . 63.539999999999999 110.326 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -74.64 103.15 4.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.896 -0.593 . . . . 71.129999999999995 109.585 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 14.9 p -103.8 176.96 4.98 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.162 -0.472 . . . . 62.310000000000002 110.77 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -118.34 120.38 37.44 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.083 0.468 . . . . 74.109999999999999 110.117 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 87.1 t -113.35 135.09 54.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.898 -0.592 . . . . 72.019999999999996 111.045 -175.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -129.12 179.67 5.63 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.553 -0.749 . . . . 73.400000000000006 109.742 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.607 ' HG3' ' HB ' ' A' ' 163' ' ' VAL . 0.6 OUTLIER -77.67 122.07 24.84 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.918 -1.141 . . . . 70.109999999999999 107.918 172.391 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.439 ' HB2' ' C ' ' A' ' 107' ' ' ILE . . . -77.12 89.8 3.63 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.513 -0.475 . . . . 63.009999999999998 111.199 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.518 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.3 pt? -81.35 138.96 35.6 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.805 -0.813 . . . . 53.200000000000003 108.805 175.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.1 m -54.15 145.9 16.19 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.085 -0.339 . . . . 52.039999999999999 110.085 -178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.74 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.4 pttp -61.92 -17.51 57.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.921 0.391 . . . . 64.140000000000001 110.31 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -67.67 -51.98 43.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.377 0.608 . . . . 74.209999999999994 109.738 170.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -64.96 -41.64 95.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.309 -0.86 . . . . 75.019999999999996 110.553 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.74 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 16.4 ptm . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 115.946 -0.57 . . . . 64.120000000000005 110.692 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.456 HG12 ' H ' ' A' ' 106' ' ' LYS . 39.7 t . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 110.183 -0.303 . . . . 70.409999999999997 110.183 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.641 ' HA ' HG21 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -116.84 -3.75 11.64 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.244 0.461 . . . . 62.439999999999998 112.244 -177.602 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.607 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 26.0 ttpt -135.31 138.59 43.58 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.015 -0.365 . . . . 63.109999999999999 110.015 177.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.48 HG13 ' HB ' ' A' ' 151' ' ' VAL . 2.1 pp -106.35 154.35 7.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.984 0.421 . . . . 74.310000000000002 110.759 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.421 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 62.4 t80 -102.23 127.21 49.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.586 -0.734 . . . . 71.140000000000001 109.996 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.505 HG21 ' HG ' ' A' ' 121' ' ' LEU . 46.7 t -102.31 110.03 27.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.88 0.372 . . . . 72.540000000000006 110.581 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.92 0 N-CA-C 110.957 -0.857 . . . . 71.109999999999999 110.957 175.46 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.739 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 12.2 pt-20 . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 120.725 0.298 . . . . 63.219999999999999 110.972 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.604 ' H ' HD11 ' A' ' 136' ' ' ILE . 8.5 tt0 -58.19 -46.41 85.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.877 -0.601 . . . . 73.349999999999994 112.347 -173.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -62.41 -28.98 70.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.699 0.285 . . . . 74.409999999999997 110.673 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.739 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 32.3 m80 -68.05 -56.37 9.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.355 -0.384 . . . . 73.129999999999995 110.791 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.505 ' HG ' HG21 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -60.79 -51.63 68.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.282 -0.417 . . . . 62.219999999999999 110.558 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.438 ' HB2' HG13 ' A' ' 134' ' ' ILE . 0.6 OUTLIER -55.06 -49.56 71.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 75.239999999999995 111.648 -177.803 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -59.15 -30.14 67.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 55.299999999999997 111.218 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.456 ' CD1' HG22 ' A' ' 170' ' ' VAL . 76.6 t80 -85.25 -47.92 9.6 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.814 -0.354 . . . . 64.099999999999994 111.111 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.521 ' CD1' HG21 ' A' ' 151' ' ' VAL . 42.8 m-85 -77.48 -18.15 57.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.373 0.508 . . . . 64.140000000000001 112.373 -172.217 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.55 -24.51 67.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.804 0.335 . . . . 62.43 111.618 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -76.19 -14.71 60.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.108 0.48 . . . . 54.340000000000003 110.202 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -87.72 -25.52 23.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 75.140000000000001 110.319 178.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.501 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 165.22 -151.17 19.82 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 119.912 -1.137 . . . . 44.130000000000003 113.689 175.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.614 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 20.4 tptm -91.23 117.07 29.33 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.394 0.616 . . . . 62.420000000000002 111.279 -172.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.454 HG12 ' CE1' ' A' ' 153' ' ' PHE . 38.2 mt -99.81 138.8 23.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.325 -0.852 . . . . 75.140000000000001 110.69 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.427 ' HG3' ' CA ' ' A' ' 154' ' ' ASP . 21.8 mt-10 -82.59 -75.38 0.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.021 -0.536 . . . . 73.140000000000001 110.341 172.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 m -143.97 152.4 15.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.616 -0.72 . . . . 71.540000000000006 110.079 -178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.609 ' CD1' HG13 ' A' ' 151' ' ' VAL . 22.7 mm -100.84 138.23 25.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.907 -0.775 . . . . 72.129999999999995 108.907 175.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 44.7 mt-10 -117.94 97.94 6.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.815 0.34 . . . . 72.329999999999998 110.743 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.604 HD11 ' H ' ' A' ' 118' ' ' GLU . 8.5 mt -76.21 105.51 5.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.066 -1.087 . . . . 71.420000000000002 108.066 172.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 10.4 tpt . . . . . 0 C--N 1.319 -0.726 0 CA-C-O 121.855 0.836 . . . . 53.32 111.272 -171.586 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 33.0 p90 . . . . . 0 C--O 1.233 0.216 0 CA-C-O 121.269 0.556 . . . . 72.420000000000002 111.841 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -135.26 171.9 13.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.514 -0.766 . . . . 54.409999999999997 110.274 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 70.1 m-85 -136.64 152.09 50.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.355 -0.384 . . . . 73.329999999999998 110.115 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.609 HG13 ' CD1' ' A' ' 134' ' ' ILE . 62.1 t -128.49 110.48 21.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.133 -0.485 . . . . 71.430000000000007 109.88 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.607 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 97.0 m -86.17 125.02 33.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.109 -0.496 . . . . 73.420000000000002 110.085 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.454 ' CE1' HG12 ' A' ' 131' ' ' ILE . 97.0 m-85 -106.06 146.79 29.68 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.871 0.367 . . . . 64.430000000000007 110.346 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.614 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 21.4 t0 -78.32 -19.13 54.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.535 0.683 . . . . 73.230000000000004 109.633 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -128.89 132.71 47.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.222 -0.899 . . . . 52.119999999999997 109.694 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.569 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 5.1 p80 -73.96 -14.01 60.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.203 -0.453 . . . . 55.409999999999997 110.474 177.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -66.33 -40.84 90.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.195 0.522 . . . . 64.129999999999995 110.025 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.644 ' HA ' ' HE3' ' A' ' 161' ' ' LYS . 4.6 m -66.76 -28.54 68.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.419 -0.81 . . . . 52.149999999999999 110.986 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 105' ' ' LYS . 18.7 t -72.57 -35.11 49.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.722 -0.672 . . . . 62.039999999999999 111.22 -176.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -56.74 -51.47 68.73 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.084 -0.507 . . . . 71.129999999999995 111.897 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.644 ' HE3' ' HA ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -65.16 -14.08 59.72 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.996 0.369 . . . . 70.239999999999995 111.996 -178.323 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 94.5 mt -93.7 -48.27 13.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 120.661 0.267 . . . . 72.030000000000001 110.926 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.405 HG13 HG12 ' A' ' 159' ' ' VAL . 35.6 m -69.69 -19.42 22.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.343 0.497 . . . . 61.229999999999997 112.343 -175.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.39 -30.72 49.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.78 0.324 . . . . 63.340000000000003 111.529 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.506 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 14.0 pt20 -113.49 145.99 40.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.389 -0.369 . . . . 74.349999999999994 110.17 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.569 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 77.0 tttt -91.27 -60.09 1.98 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.051 -0.522 . . . . 73.120000000000005 110.513 -178.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.566 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 7.9 m-30 -72.47 110.53 6.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.259 0.552 . . . . 75.439999999999998 111.234 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.577 ' CD2' ' HB ' ' A' ' 177' ' ' VAL . 37.7 m-70 -110.85 170.92 7.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.303 -0.862 . . . . 64.340000000000003 109.583 173.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.7 m -119.41 96.04 5.04 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.841 0.353 . . . . 52.549999999999997 110.384 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.486 HG11 HD13 ' A' ' 121' ' ' LEU . 47.5 t -117.2 130.89 71.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.324 -0.398 . . . . 72.340000000000003 110.126 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.4 t30 59.7 31.49 20.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.509 0.671 . . . . 73.340000000000003 110.477 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 70.57 19.28 76.27 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.925 -0.58 . . . . 63.439999999999998 112.211 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -122.84 129.7 51.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.85 0.357 . . . . 71.200000000000003 110.617 -177.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.28 112.1 9.03 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.472 -0.566 . . . . 73.099999999999994 109.472 174.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 18.9 p -121.65 173.55 7.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.814 0.34 . . . . 75.510000000000005 111.382 -174.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.569 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 10.8 tt0 -108.41 116.92 32.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.838 -0.619 . . . . 75.109999999999999 110.064 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.577 ' HB ' ' CD2' ' A' ' 168' ' ' HIS . 59.4 t -120.26 134.68 62.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.233 -0.44 . . . . 71.510000000000005 110.493 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -150.54 -177.98 6.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.858 -0.61 . . . . 75.510000000000005 110.294 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -63.78 133.23 53.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.961 -0.385 . . . . 62.030000000000001 109.961 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.41 ' HB2' ' C ' ' A' ' 107' ' ' ILE . . . -88.3 86.67 7.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.192 0.52 . . . . 73.030000000000001 110.538 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.734 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.3 pt? -80.8 127.55 32.65 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.764 -0.828 . . . . 72.299999999999997 108.764 174.377 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.5 t -56.02 156.66 5.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.105 -0.498 . . . . 62.43 110.548 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.897 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.3 pttp -63.73 -15.13 57.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.293 0.568 . . . . 63.520000000000003 109.83 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 184' ' ' GLN . 6.6 tp60 -71.7 -38.02 70.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.566 -0.743 . . . . 74.310000000000002 109.823 172.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -87.22 -41.34 13.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.483 -0.78 . . . . 74.319999999999993 111.116 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.897 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.7 ptm . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 116.263 -0.426 . . . . 72.150000000000006 110.72 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.499 HG22 ' H ' ' A' ' 106' ' ' LYS . 9.6 p . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 110.273 -0.269 . . . . 74.329999999999998 110.273 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 156' ' ' HIS . 0.0 OUTLIER -105.59 -0.85 25.35 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.931 0.396 . . . . 54.299999999999997 110.903 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.636 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 24.0 ttpt -133.98 136.69 44.3 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.107 0.479 . . . . 73.519999999999996 110.807 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.505 HG12 ' HB ' ' A' ' 151' ' ' VAL . 9.2 pt -107.95 162.57 6.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.132 -0.485 . . . . 71.5 110.642 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 61.6 t80 -110.23 118.05 35.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.846 -0.616 . . . . 61.030000000000001 110.078 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 30.6 t -106.84 103.04 14.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.506 -0.553 . . . . 73.299999999999997 109.506 175.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.627 0 C-N-CA 120.656 -0.783 . . . . 72.340000000000003 112.364 -178.224 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.599 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 1.8 pt-20 . . . . . 0 C--O 1.234 0.284 0 CA-C-O 121.253 0.549 . . . . 61.439999999999998 112.1 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.609 ' HG2' ' CG1' ' A' ' 134' ' ' ILE . 2.8 tm-20 -60.41 -47.14 87.37 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.181 -0.918 . . . . 74.340000000000003 111.475 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.96 -30.8 71.85 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.883 -0.327 . . . . 75.530000000000001 110.524 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.599 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 43.6 m80 -66.68 -59.62 3.42 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.943 0.401 . . . . 64.420000000000002 110.611 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.524 ' HA ' HG21 ' A' ' 170' ' ' VAL . 8.5 mp -60.0 -47.94 83.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.769 -0.651 . . . . 43.409999999999997 111.359 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.472 ' HG3' HD12 ' A' ' 131' ' ' ILE . 3.1 ttp180 -62.06 -41.78 98.51 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.062 -0.255 . . . . 42.549999999999997 111.359 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -57.24 -30.42 64.61 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.339 0.59 . . . . 71.409999999999997 111.061 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -88.43 -47.04 8.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.788 -0.642 . . . . 73.099999999999994 111.156 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.408 ' HA ' ' HD2' ' A' ' 128' ' ' TYR . 51.8 m-85 -80.11 -12.12 59.7 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.528 0.566 . . . . 61.509999999999998 112.528 -173.25 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.67 -24.8 66.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.84 0.352 . . . . 71.239999999999995 111.568 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -72.57 -20.7 61.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.321 -0.4 . . . . 72.239999999999995 110.451 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.474 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 89.0 m-85 -82.15 -38.82 24.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.048 -0.524 . . . . 73.450000000000003 110.023 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.447 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 176.86 -168.47 40.42 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.229 -0.986 . . . . 75.329999999999998 113.277 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.566 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 40.1 tptt -74.33 116.41 14.96 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.405 0.621 . . . . 71.219999999999999 111.4 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.504 HG21 HD11 ' A' ' 134' ' ' ILE . 33.0 mt -92.53 140.51 16.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.324 -0.853 . . . . 74.329999999999998 110.542 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -86.91 -72.46 0.51 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.09 -0.504 . . . . 70.310000000000002 110.405 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.72 140.41 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 73.439999999999998 111.325 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.627 ' CD1' HG13 ' A' ' 151' ' ' VAL . 21.3 mm -95.1 101.61 12.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.611 -0.514 . . . . 63.450000000000003 109.611 174.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -84.67 94.74 8.71 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.939 -0.393 . . . . 60.520000000000003 109.939 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.538 HD11 ' H ' ' A' ' 118' ' ' GLU . 7.1 mt -73.05 100.91 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.005 -1.109 . . . . 63.149999999999999 108.005 175.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 10.7 tpt . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.381 0.61 . . . . 73.140000000000001 110.494 -173.476 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 31.7 p90 . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 110.32 -0.252 . . . . 64.439999999999998 110.32 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.4 165.15 28.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.961 0.41 . . . . 53.109999999999999 110.952 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.564 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 65.9 m-85 -126.26 123.72 38.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.753 -0.658 . . . . 60.229999999999997 110.006 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.627 HG13 ' CD1' ' A' ' 134' ' ' ILE . 48.9 t -98.75 107.44 20.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 110.017 -0.364 . . . . 74.420000000000002 110.017 -179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.636 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 25.3 m -86.8 124.43 33.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.118 -0.492 . . . . 34.329999999999998 110.151 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.655 ' CD2' HG12 ' A' ' 159' ' ' VAL . 97.6 m-85 -104.92 157.63 17.08 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.916 -0.402 . . . . 65.420000000000002 109.916 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.566 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 16.0 t70 -69.59 -29.81 67.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.03 -0.532 . . . . 65.140000000000001 110.557 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -132.45 147.38 52.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.57 -0.741 . . . . 74.019999999999996 110.923 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.673 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.3 p-80 -75.45 -12.81 60.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.181 -0.463 . . . . 74.040000000000006 110.732 177.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -60.84 -49.83 75.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.173 0.511 . . . . 73.120000000000005 110.153 174.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.447 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 14.6 m -66.56 -22.14 66.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.377 -0.829 . . . . 71.209999999999994 112.373 -173.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 156' ' ' HIS . 4.1 m -81.49 -25.84 10.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.935 -0.306 . . . . 71.439999999999998 111.453 -176.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.566 ' HA ' HG22 ' A' ' 163' ' ' VAL . 36.1 t70 -70.31 -39.88 74.54 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.983 -0.287 . . . . 75.129999999999995 111.342 -171.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.485 ' HD2' ' H ' ' A' ' 161' ' ' LYS . 1.6 mptp? -62.21 -14.63 40.07 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.372 0.606 . . . . 71.239999999999995 110.586 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.5 HG21 HD13 ' A' ' 107' ' ' ILE . 94.5 mt -98.38 -49.21 11.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.455 -0.793 . . . . 70.340000000000003 110.886 -176.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.566 HG22 ' HA ' ' A' ' 160' ' ' ASP . 23.5 m -72.93 -15.57 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.104 -0.498 . . . . 75.409999999999997 112.078 -175.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.441 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.2 pp -64.68 -26.81 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.696 0.284 . . . . 72.329999999999998 111.572 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -116.0 -178.94 3.52 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.407 -0.59 . . . . 70.219999999999999 109.407 171.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.455 ' HE3' ' OE1' ' A' ' 176' ' ' GLU . 83.5 tttt -120.48 -67.79 0.95 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.655 0.264 . . . . 70.540000000000006 111.226 -173.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 11.1 m-30 -71.69 107.54 4.57 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.088 0.47 . . . . 63.020000000000003 111.401 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.432 ' CE1' HG23 ' A' ' 162' ' ' ILE . 32.9 m-70 -104.89 151.58 23.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.624 -0.716 . . . . 72.230000000000004 109.837 174.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 21.8 m -109.87 84.73 1.98 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.045 0.45 . . . . 73.230000000000004 110.424 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.524 HG21 ' HA ' ' A' ' 121' ' ' LEU . 4.1 p -102.57 132.86 47.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.892 -0.595 . . . . 70.450000000000003 109.719 178.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 170' ' ' VAL . 4.6 t30 71.92 -14.79 0.49 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.106 0.479 . . . . 72.450000000000003 110.544 -176.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 114.97 -3.08 22.76 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.905 -0.878 . . . . 61.130000000000003 110.905 -173.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' HIS . . . . . 0.491 ' O ' ' HA ' ' A' ' 169' ' ' THR . 58.5 t-80 -93.97 148.7 21.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.303 -0.448 . . . . 63.219999999999999 110.286 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -94.24 102.78 14.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.999 0.428 . . . . 73.549999999999997 110.151 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 29.4 m -114.47 154.1 28.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.131 -0.486 . . . . 73.530000000000001 111.201 -175.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.51 ' OE2' ' HD3' ' A' ' 178' ' ' ARG . 20.5 tt0 -91.53 119.55 31.56 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.664 -0.495 . . . . 73.549999999999997 109.664 175.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 48.4 t -117.63 138.99 46.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.955 -0.566 . . . . 71.409999999999997 110.659 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.51 ' HD3' ' OE2' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -159.02 171.86 19.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.417 -0.81 . . . . 74.219999999999999 109.675 -177.658 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.485 ' HG2' HG11 ' A' ' 163' ' ' VAL . 8.6 mtpm? -63.26 122.1 15.33 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.104 -0.332 . . . . 73.200000000000003 110.104 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -74.89 91.25 2.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.985 0.422 . . . . 73.510000000000005 110.686 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.56 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -80.9 139.52 35.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.489 -0.56 . . . . 73.340000000000003 109.489 177.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.5 m -50.88 130.66 25.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.167 -0.469 . . . . 73.129999999999995 110.755 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.774 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.0 pttp -64.34 -23.24 67.23 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.843 0.354 . . . . 71.200000000000003 110.664 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.86 -37.14 86.28 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.484 -0.562 . . . . 65.140000000000001 109.484 176.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -88.16 -34.75 17.73 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.705 -0.679 . . . . 73.430000000000007 111.049 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.774 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 6.5 ptp . . . . . 0 C--N 1.333 -0.145 0 N-CA-C 109.632 -0.506 . . . . 75.109999999999999 109.632 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.405 0 CA-C-O 121.692 0.758 . . . . 75.439999999999998 112.824 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.56 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 2.4 mtmt -129.53 12.83 5.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.723 -0.671 . . . . 70.120000000000005 110.012 175.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.509 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 30.6 ttpt -144.23 137.26 27.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.295 -0.866 . . . . 72.340000000000003 109.379 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pp -107.59 153.6 8.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.35 -0.387 . . . . 71.530000000000001 110.537 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 75.6 t80 -105.0 125.29 50.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.28 -0.418 . . . . 72.450000000000003 110.881 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.9 t -105.94 107.32 22.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.468 -0.333 . . . . 74.099999999999994 110.394 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 C-N-CA 120.78 -0.724 . . . . 73.319999999999993 112.585 -179.401 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.571 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 12.0 pt-20 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.652 0.263 . . . . 74.25 110.737 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.63 ' HA ' HG21 ' A' ' 134' ' ' ILE . 7.2 tt0 -59.62 -46.43 89.01 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.044 -0.526 . . . . 73.540000000000006 112.355 -176.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -65.0 -32.99 74.99 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.811 -0.355 . . . . 71.400000000000006 110.601 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.571 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 38.6 m80 -61.8 -52.73 62.99 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.912 0.387 . . . . 71.310000000000002 110.709 178.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.447 HD23 HG21 ' A' ' 170' ' ' VAL . 70.3 mt -62.99 -47.91 81.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.625 -0.716 . . . . 73.129999999999995 110.288 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -56.17 -49.33 74.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.798 -0.637 . . . . 73.150000000000006 110.651 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -56.71 -32.66 65.72 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.179 0.514 . . . . 74.230000000000004 111.62 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -85.16 -40.8 16.31 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.035 -0.53 . . . . 73.319999999999993 111.104 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.508 ' CD1' HG21 ' A' ' 151' ' ' VAL . 57.1 m-85 -88.63 -18.02 28.86 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.78 0.659 . . . . 64.319999999999993 112.78 -173.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.4 ' N ' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -66.35 -21.52 66.25 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.142 0.496 . . . . 74.25 110.928 -179.448 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -70.08 -22.14 63.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.673 -0.694 . . . . 61.229999999999997 110.477 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.508 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 28.9 m-85 -86.74 -33.25 20.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.957 -0.565 . . . . 74.450000000000003 110.674 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 176.93 -170.38 43.07 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.285 -0.959 . . . . 45.420000000000002 113.151 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -75.17 124.02 26.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 122.924 0.49 . . . . 73.329999999999998 111.49 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.488 HG21 HD11 ' A' ' 134' ' ' ILE . 44.2 mt -100.31 137.31 28.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.876 -0.602 . . . . 62.32 111.149 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.14 -74.41 0.34 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.383 -0.826 . . . . 64.109999999999999 110.359 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.81 159.09 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.655 -0.498 . . . . 55.009999999999998 109.655 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.63 HG21 ' HA ' ' A' ' 118' ' ' GLU . 29.3 mm -112.41 104.45 17.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.928 0.394 . . . . 64.439999999999998 109.948 174.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -89.61 101.64 14.32 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.959 -0.386 . . . . 72.409999999999997 109.959 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.401 ' H ' HG13 ' A' ' 136' ' ' ILE . 4.3 mt -81.18 12.6 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.349 0.595 . . . . 74.120000000000005 109.84 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.714 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.36 0 CA-C-N 115.143 -0.935 . . . . 53.219999999999999 109.702 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.714 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 42.9 p90 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.601 0.239 . . . . 72.420000000000002 110.402 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.86 165.13 23.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.976 0.417 . . . . 61.229999999999997 111.206 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.48 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 43.7 m-85 -132.47 135.5 46.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.699 -0.682 . . . . 72.430000000000007 109.467 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.61 HG13 ' CD1' ' A' ' 134' ' ' ILE . 43.4 t -110.85 108.42 25.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.55 -0.537 . . . . 50.43 109.55 177.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.509 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 3.9 m -85.88 128.48 34.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.055 -0.52 . . . . 74.299999999999997 110.301 -178.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.587 ' CD2' HG12 ' A' ' 159' ' ' VAL . 94.7 m-85 -111.75 151.41 29.0 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.916 -0.401 . . . . 74.310000000000002 109.916 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -78.87 -6.56 56.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.249 0.547 . . . . 73.409999999999997 110.854 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.75 149.64 43.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.182 -0.463 . . . . 51.299999999999997 110.245 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.56 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.0 p-80 -89.48 -2.64 58.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.928 0.394 . . . . 71.519999999999996 110.897 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -75.04 -39.08 61.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.359 0.6 . . . . 64.150000000000006 109.476 173.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.4 m -64.9 -30.31 71.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.513 -0.767 . . . . 61.229999999999997 111.789 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.587 HG12 ' CD2' ' A' ' 153' ' ' PHE . 14.1 m -78.87 -20.81 12.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.634 -0.257 . . . . 54.149999999999999 111.68 -176.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.05 -46.14 75.27 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 120.596 0.236 . . . . 71.230000000000004 110.46 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.508 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.4 mptp? -59.29 -20.08 51.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.364 0.602 . . . . 63.299999999999997 111.038 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.437 HG22 HG11 ' A' ' 177' ' ' VAL . 79.5 mt -94.1 -49.07 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.529 -0.76 . . . . 71.400000000000006 111.206 -175.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.578 ' HB ' ' HE3' ' A' ' 179' ' ' LYS . 25.9 m -80.59 -10.72 12.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 112.287 0.477 . . . . 64.0 112.287 -173.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.6 pp -68.82 -31.35 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.998 0.428 . . . . 71.420000000000002 110.961 176.704 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.522 ' N ' HD12 ' A' ' 164' ' ' ILE . 14.5 pt20 -101.15 -162.0 0.9 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.116 -0.698 . . . . 65.140000000000001 109.116 172.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.518 ' HE3' ' CD ' ' A' ' 176' ' ' GLU . 44.3 tttt -134.67 -68.67 0.53 Allowed 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.811 -0.356 . . . . 62.43 111.568 -174.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 97.2 m-85 -88.32 113.41 23.89 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.133 0.492 . . . . 74.230000000000004 111.544 -175.633 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -105.35 147.36 28.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.57 -0.741 . . . . 73.430000000000007 110.248 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 47.2 m -100.73 98.92 9.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.075 0.464 . . . . 54.329999999999998 110.745 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.447 HG21 HD23 ' A' ' 121' ' ' LEU . 4.7 p -118.19 130.97 72.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.076 -0.511 . . . . 45.240000000000002 109.833 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.8 t30 64.67 15.73 9.91 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.643 0.735 . . . . 71.109999999999999 110.279 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.85 8.78 75.63 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.765 -0.731 . . . . 62.420000000000002 112.225 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -110.03 124.67 51.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.719 0.295 . . . . 72.540000000000006 110.367 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -81.42 105.3 12.48 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.427 -0.583 . . . . 70.219999999999999 109.427 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 10.5 m -118.15 154.31 32.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.926 -0.579 . . . . 53.25 110.589 -172.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.518 ' CD ' ' HE3' ' A' ' 166' ' ' LYS . 30.1 tt0 -88.73 126.0 35.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.001 0.429 . . . . 73.230000000000004 110.153 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 97.8 t -112.23 129.43 67.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.343 0.592 . . . . 73.540000000000006 111.034 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -119.0 179.58 4.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.24 -0.891 . . . . 75.129999999999995 110.083 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.578 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 9.6 mptt -81.69 126.52 31.88 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.327 -1.36 . . . . 71.209999999999994 107.327 168.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.88 83.95 6.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.055 0.455 . . . . 43.109999999999999 111.505 -174.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.587 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -84.04 140.79 31.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.88 -0.6 . . . . 72.430000000000007 109.444 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 46.4 t -50.15 142.14 10.17 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.423 0.452 . . . . 74.109999999999999 111.179 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.758 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.5 pttp -62.09 -20.05 63.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.188 -0.46 . . . . 74.349999999999994 111.29 -178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -54.31 14.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.886 -0.783 . . . . 61.520000000000003 108.886 174.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.9 -32.15 72.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.747 -0.66 . . . . 75.310000000000002 111.564 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.758 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 21.7 ptm . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 120.779 0.323 . . . . 75.420000000000002 110.523 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.609 HG23 HG11 ' A' ' 159' ' ' VAL . 6.6 m . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 109.798 -0.445 . . . . 61.520000000000003 109.798 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.772 ' HA ' HG21 ' A' ' 159' ' ' VAL . 14.0 mtmt -118.17 22.72 12.02 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.599 0.714 . . . . 73.530000000000001 109.46 177.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.727 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 42.0 tttt -149.88 129.5 13.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.802 -1.09 . . . . 65.540000000000006 109.361 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.527 HD13 HG21 ' A' ' 162' ' ' ILE . 7.9 pt -106.03 163.04 4.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.0 0.429 . . . . 75.019999999999996 111.225 -177.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -109.59 118.76 37.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.526 -0.761 . . . . 75.230000000000004 109.567 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.596 HG11 HD11 ' A' ' 121' ' ' LEU . 37.3 t -102.59 103.36 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.881 0.372 . . . . 65.219999999999999 110.757 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 175' ' ' CYS . . . . . . . . 0 N--CA 1.442 -0.954 0 N-CA-C 110.898 -0.881 . . . . 34.219999999999999 110.898 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.674 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 11.5 pt-20 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.919 0.39 . . . . 62.439999999999998 111.605 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.701 ' HA ' HG21 ' A' ' 134' ' ' ILE . 14.2 tt0 -53.42 -49.71 66.75 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.427 -0.806 . . . . 64.540000000000006 112.212 -174.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -63.39 -31.44 72.6 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.1 -0.24 . . . . 42.299999999999997 110.678 -176.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.674 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 35.7 m80 -67.06 -56.81 8.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.476 -0.329 . . . . 73.409999999999997 110.376 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.596 HD11 HG11 ' A' ' 109' ' ' VAL . 0.5 OUTLIER -61.05 -49.55 76.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.48 . . . . 60.020000000000003 110.928 -178.451 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.509 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 1.5 tpp180 -58.08 -45.32 87.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.273 -0.422 . . . . 75.439999999999998 111.197 -177.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -56.61 -37.11 70.22 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.096 0.474 . . . . 70.010000000000005 111.44 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -84.96 -39.85 17.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.271 -0.422 . . . . 75.209999999999994 111.257 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -86.69 -17.5 33.57 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.47 0.545 . . . . 73.239999999999995 112.47 -172.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -21.7 65.58 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.334 0.588 . . . . 72.340000000000003 110.697 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -70.22 -24.82 63.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.336 -0.847 . . . . 72.019999999999996 110.406 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.462 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 31.0 m-85 -83.46 -32.06 26.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.951 -0.568 . . . . 74.299999999999997 110.139 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.7 177.78 43.17 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.162 -0.775 . . . . 73.430000000000007 111.162 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -67.25 133.88 50.55 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.656 0.741 . . . . 73.099999999999994 110.478 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 122' ' ' ARG . 46.6 mt -100.24 141.92 16.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 115.288 -0.869 . . . . 52.299999999999997 110.446 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -78.46 -70.63 0.48 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.081 -0.509 . . . . 70.310000000000002 110.419 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.3 m -148.08 157.04 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.456 -0.338 . . . . 23.32 110.659 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.701 HG21 ' HA ' ' A' ' 118' ' ' GLU . 12.9 mm -109.96 108.93 26.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.572 -0.899 . . . . 71.409999999999997 108.572 174.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -95.08 95.97 8.93 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.204 0.526 . . . . 74.129999999999995 110.519 -175.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.638 HD11 ' H ' ' A' ' 118' ' ' GLU . 20.6 mt -74.81 99.06 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.702 -0.851 . . . . 74.340000000000003 108.702 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 C--N 1.325 -0.485 0 CA-C-O 121.287 0.565 . . . . 65.310000000000002 110.488 -174.385 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.7 p90 . . . . . 0 C--O 1.234 0.253 0 CA-C-O 120.947 0.403 . . . . 75.430000000000007 110.924 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.05 175.16 9.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.009 -0.541 . . . . 72.340000000000003 110.366 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.727 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 85.3 m-85 -132.03 152.06 51.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.351 -0.386 . . . . 71.530000000000001 110.333 -176.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.608 HG13 ' CD1' ' A' ' 134' ' ' ILE . 44.6 t -134.91 114.61 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.076 -0.713 . . . . 55.539999999999999 109.076 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.476 ' OG1' ' HD2' ' A' ' 106' ' ' LYS . 42.5 m -98.23 132.12 44.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.929 0.395 . . . . 75.439999999999998 110.558 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.481 ' CD2' HG22 ' A' ' 159' ' ' VAL . 91.2 m-85 -112.14 155.26 24.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.075 -0.511 . . . . 74.510000000000005 110.282 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -76.53 -23.82 53.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.244 0.545 . . . . 73.549999999999997 110.536 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.427 ' O ' HG23 ' A' ' 159' ' ' VAL . 9.5 t0 -131.47 138.88 49.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.587 -0.733 . . . . 73.150000000000006 109.73 -178.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.539 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.3 p-80 -75.83 -9.91 58.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.908 0.385 . . . . 64.049999999999997 110.605 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -66.61 -48.54 69.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 74.400000000000006 110.218 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 42.2 t -58.97 -37.16 76.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.611 . . . . 74.239999999999995 110.228 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.772 HG21 ' HA ' ' A' ' 105' ' ' LYS . 18.5 t -65.58 -36.99 78.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.451 -0.795 . . . . 71.049999999999997 111.017 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -55.45 -48.2 74.86 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.173 -0.467 . . . . 64.319999999999993 111.814 -176.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.462 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 4.0 mptt -60.19 -19.13 52.7 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.201 0.524 . . . . 65.329999999999998 111.063 -177.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.527 HG21 HD13 ' A' ' 107' ' ' ILE . 84.0 mt -99.84 -47.34 11.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.527 -0.76 . . . . 75.310000000000002 111.366 -175.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.422 ' CG2' ' HE3' ' A' ' 179' ' ' LYS . 28.9 m -71.26 -11.17 14.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.438 0.532 . . . . 74.540000000000006 112.438 -174.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.79 -24.29 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.909 0.385 . . . . 74.510000000000005 111.21 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -106.04 142.33 35.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.07 -0.514 . . . . 74.209999999999994 110.538 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.55 ' HG3' ' HG2' ' A' ' 176' ' ' GLU . 85.5 tttt -89.78 -67.3 0.85 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.005 -0.543 . . . . 64.0 111.199 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.596 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 22.8 m-85 -81.04 100.43 8.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.186 -0.461 . . . . 70.030000000000001 111.688 -177.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -101.51 153.38 19.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.944 -0.571 . . . . 74.340000000000003 109.79 174.258 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 23.9 m -106.38 96.23 6.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.982 0.42 . . . . 72.400000000000006 110.67 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' A' ' 172' ' ' GLY . 47.1 t -105.3 133.2 50.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.57 -0.53 . . . . 70.019999999999996 109.57 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.4 t30 70.48 -19.25 0.22 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.128 0.571 . . . . 71.0 111.728 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 128.52 -6.03 6.64 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.181 -0.533 . . . . 63.229999999999997 111.833 -177.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -112.62 151.18 30.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.038 0.447 . . . . 73.010000000000005 110.399 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.487 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 66.0 t30 -82.86 124.83 30.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.753 -0.658 . . . . 72.010000000000005 110.374 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 23.5 p -119.42 -171.86 2.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.955 -0.566 . . . . 40.329999999999998 110.253 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.55 ' HG2' ' HG3' ' A' ' 166' ' ' LYS . 0.9 OUTLIER -139.1 116.07 10.92 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.468 -0.567 . . . . 74.420000000000002 109.468 -176.531 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 93.4 t -116.41 140.15 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.018 -0.537 . . . . 54.240000000000002 112.062 -171.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -134.29 -178.83 5.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.69 -0.686 . . . . 74.430000000000007 109.801 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.422 ' HE3' ' CG2' ' A' ' 163' ' ' VAL . 11.9 mptt -75.01 128.43 35.54 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.267 -1.012 . . . . 74.239999999999995 108.267 168.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -74.04 97.83 2.95 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.582 -0.447 . . . . 73.209999999999994 110.773 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.7 pt? -106.6 149.18 27.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.936 -0.574 . . . . 64.109999999999999 110.204 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.5 t -49.62 139.63 12.27 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.579 0.55 . . . . 73.340000000000003 111.187 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.729 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 17.8 pttp -65.49 -12.7 55.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.135 0.493 . . . . 73.450000000000003 110.732 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -74.99 -52.92 9.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.857 -0.611 . . . . 72.439999999999998 109.94 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -73.38 -32.17 64.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.453 -0.794 . . . . 71.230000000000004 111.265 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.729 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.3 ptm . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.394 -0.367 . . . . 63.210000000000001 110.876 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 106' ' ' LYS . 12.4 p . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 120.969 0.414 . . . . 71.530000000000001 110.176 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.601 ' HA ' HG21 ' A' ' 159' ' ' VAL . 15.2 mtmt -120.34 21.93 11.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.036 -0.529 . . . . 73.340000000000003 110.765 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.565 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.3 ttpt -153.89 142.49 20.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.327 -0.397 . . . . 71.030000000000001 109.944 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.561 HD13 HG21 ' A' ' 162' ' ' ILE . 4.0 pt -113.43 157.41 14.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.939 0.4 . . . . 53.200000000000003 110.915 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 66.7 t80 -105.61 119.89 40.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.608 -0.724 . . . . 72.129999999999995 109.932 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.0 t -101.1 108.89 24.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.796 0.331 . . . . 75.310000000000002 110.68 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.57 0 C-N-CA 121.165 -0.54 . . . . 61.409999999999997 112.331 -179.222 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.643 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.939 0.399 . . . . 64.030000000000001 111.438 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.691 ' HG3' HG13 ' A' ' 134' ' ' ILE . 15.1 tt0 -57.77 -49.87 75.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.64 -0.709 . . . . 75.230000000000004 112.429 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -33.53 69.9 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 121.046 -0.262 . . . . 64.219999999999999 110.504 -175.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.643 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 41.8 m80 -64.47 -53.36 49.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.08 -0.509 . . . . 65.349999999999994 110.552 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.541 HD12 HG11 ' A' ' 170' ' ' VAL . 9.3 mp -66.02 -49.62 67.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.727 -0.67 . . . . 75.310000000000002 111.193 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.5 -48.46 81.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.196 -0.456 . . . . 73.140000000000001 111.456 -176.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.3 -30.5 69.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.126 0.489 . . . . 64.510000000000005 110.832 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.483 ' CD1' HG22 ' A' ' 170' ' ' VAL . 50.8 t80 -81.64 -46.89 13.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.914 -0.584 . . . . 74.439999999999998 111.247 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -83.55 -16.89 43.72 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.725 0.639 . . . . 75.439999999999998 112.725 -173.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -23.9 67.38 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.989 0.423 . . . . 74.040000000000006 111.233 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -67.08 -25.02 66.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.821 -0.627 . . . . 54.530000000000001 110.508 178.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.509 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 45.7 m-85 -84.07 -34.25 24.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.968 -0.56 . . . . 74.420000000000002 110.477 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.95 -170.69 43.85 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.145 -1.026 . . . . 51.350000000000001 113.133 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -72.9 120.1 18.05 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.639 0.733 . . . . 73.049999999999997 112.092 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.539 HG21 HD11 ' A' ' 134' ' ' ILE . 41.1 mt -94.98 134.48 32.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.937 -1.029 . . . . 74.409999999999997 110.201 176.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 6.7 mm-40 -82.99 -67.42 0.79 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.032 -0.531 . . . . 63.310000000000002 110.717 178.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.0 m -146.53 152.62 13.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 72.219999999999999 110.259 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.691 HG13 ' HG3' ' A' ' 118' ' ' GLU . 33.5 mm -105.83 112.72 40.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.616 -0.513 . . . . 65.25 109.616 176.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -93.12 94.45 8.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.07 0.462 . . . . 74.010000000000005 110.212 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.0 mt -80.99 88.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.714 -0.847 . . . . 53.130000000000003 108.714 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.8 tpp . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 121.585 0.707 . . . . 63.329999999999998 110.864 -175.974 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.8 p90 . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.669 0.271 . . . . 51.530000000000001 110.486 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.91 163.39 33.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.332 -0.395 . . . . 74.310000000000002 110.405 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.453 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 50.2 m-85 -124.41 135.56 53.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.289 -0.414 . . . . 73.140000000000001 110.212 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.61 HG13 ' CD1' ' A' ' 134' ' ' ILE . 23.7 t -108.63 109.24 27.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.852 -0.425 . . . . 62.200000000000003 109.852 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.565 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 15.3 m -87.68 125.4 34.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.391 -0.368 . . . . 71.450000000000003 110.562 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.413 ' CE1' HG12 ' A' ' 131' ' ' ILE . 90.4 m-85 -109.84 154.41 23.06 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.703 -0.48 . . . . 74.140000000000001 109.703 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.426 ' HB2' ' HG2' ' A' ' 132' ' ' GLU . 23.9 t70 -77.57 -22.27 51.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.599 0.714 . . . . 43.409999999999997 110.213 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 157' ' ' ASP . 25.7 t70 -123.31 135.09 54.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.113 -0.949 . . . . 64.019999999999996 111.236 -171.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.554 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.4 p-80 -84.2 0.19 49.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 112.006 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.428 ' HB2' ' OD2' ' A' ' 155' ' ' ASP . 54.3 m-20 -98.08 -29.25 13.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.97 -0.752 . . . . 71.030000000000001 108.97 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.43 ' HA ' ' HE3' ' A' ' 161' ' ' LYS . 42.4 t -58.8 -32.8 69.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.551 -0.749 . . . . 64.439999999999998 109.704 170.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 105' ' ' LYS . 21.7 t -74.18 -29.77 25.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.355 -0.838 . . . . 64.140000000000001 110.434 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.03 -47.74 84.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 74.310000000000002 111.726 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.509 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -60.89 -18.65 57.59 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.324 0.583 . . . . 74.019999999999996 110.906 -178.313 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.561 HG21 HD13 ' A' ' 107' ' ' ILE . 80.5 mt -95.76 -52.33 9.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.451 -0.795 . . . . 54.229999999999997 111.158 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.534 ' HB ' ' HE3' ' A' ' 179' ' ' LYS . 26.4 m -74.77 -10.75 13.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.715 0.635 . . . . 71.420000000000002 112.715 -173.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.4 pp -68.61 -32.92 57.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.836 0.35 . . . . 72.319999999999993 111.052 176.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.475 ' N ' HD12 ' A' ' 164' ' ' ILE . 3.7 pt20 -107.51 -174.35 2.51 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.337 -0.616 . . . . 73.519999999999996 109.337 176.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.633 ' HE3' ' OE1' ' A' ' 176' ' ' GLU . 82.5 tttt -123.52 -56.52 1.69 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.933 0.397 . . . . 71.120000000000005 111.063 -174.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.586 ' HB3' ' OD1' ' A' ' 174' ' ' ASN . 21.8 m-30 -79.93 113.0 17.77 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.93 -0.577 . . . . 75.219999999999999 111.62 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -116.66 143.75 45.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.575 -0.739 . . . . 72.150000000000006 110.555 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 76.3 m -95.7 101.53 13.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.042 0.448 . . . . 64.140000000000001 111.202 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.541 HG11 HD12 ' A' ' 121' ' ' LEU . 42.4 t -118.62 127.96 75.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.285 -0.635 . . . . 63.32 109.285 177.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 58.5 t30 63.21 21.65 12.95 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.83 0.824 . . . . 73.400000000000006 110.112 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.58 -1.27 88.97 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.656 -0.702 . . . . 74.409999999999997 112.684 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -103.26 145.56 29.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.919 0.39 . . . . 71.430000000000007 110.541 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.586 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 64.5 t30 -88.87 106.58 18.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.907 -0.588 . . . . 73.150000000000006 110.072 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 12.0 p -116.55 159.86 21.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.088 -0.506 . . . . 61.039999999999999 110.993 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.633 ' OE1' ' HE3' ' A' ' 166' ' ' LYS . 14.5 tt0 -95.47 130.88 42.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.101 -0.5 . . . . 71.409999999999997 109.915 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 3.0 m -118.88 142.97 31.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.126 0.488 . . . . 61.409999999999997 110.135 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -130.53 177.68 7.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.157 -0.474 . . . . 72.329999999999998 110.199 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.534 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 10.1 mptt -75.79 120.01 20.57 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.908 -1.145 . . . . 51.140000000000001 107.908 171.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -74.23 93.09 2.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.139 0.495 . . . . 45.210000000000001 111.66 -176.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.731 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -95.94 144.59 26.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.755 -0.657 . . . . 75.439999999999998 109.655 175.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.501 ' HB3' ' HG3' ' A' ' 185' ' ' GLU . 30.6 t -50.28 143.34 8.74 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.405 0.44 . . . . 72.319999999999993 111.593 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -60.23 -23.54 64.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.762 -0.654 . . . . 51.119999999999997 110.182 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -73.76 -42.88 60.44 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.656 -0.702 . . . . 72.209999999999994 110.124 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 182' ' ' SER . 37.9 mt-10 -78.85 -32.48 46.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.654 -0.703 . . . . 72.519999999999996 111.295 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 18.7 ptm . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.326 -0.397 . . . . 54.329999999999998 110.666 -177.351 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.558 HG13 HG11 ' A' ' 159' ' ' VAL . 14.6 p . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 120.84 0.352 . . . . 40.119999999999997 111.266 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.762 ' HA ' HG21 ' A' ' 159' ' ' VAL . 12.1 mtmt -123.07 -1.41 8.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 74.140000000000001 111.865 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.622 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 27.0 ttpt -130.45 137.42 49.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.846 0.355 . . . . 71.140000000000001 110.171 175.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.577 ' CG2' HG13 ' A' ' 159' ' ' VAL . 10.8 pt -108.36 163.97 5.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.949 0.404 . . . . 74.549999999999997 111.258 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.461 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 75.0 t80 -112.67 120.19 40.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.567 -0.742 . . . . 74.439999999999998 109.452 176.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.4 t -105.9 115.45 47.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.947 0.403 . . . . 74.340000000000003 110.919 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.746 0 N-CA-C 111.65 -0.58 . . . . 44.109999999999999 111.65 177.512 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.452 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 0.9 OUTLIER . . . . . 0 CA--C 1.532 0.273 0 CA-C-O 120.931 0.396 . . . . 75.329999999999998 110.978 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.723 ' HA ' HG21 ' A' ' 134' ' ' ILE . 10.7 tt0 -57.68 -51.8 68.05 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.522 -0.763 . . . . 75.049999999999997 112.266 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -62.67 -33.97 76.15 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 120.921 -0.312 . . . . 72.310000000000002 110.619 -173.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.452 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 62.5 m80 -60.88 -56.19 24.07 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.281 -0.418 . . . . 63.549999999999997 110.314 177.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.575 HD23 HG11 ' A' ' 170' ' ' VAL . 59.2 mt -59.31 -54.75 43.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.435 -0.802 . . . . 72.540000000000006 111.191 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -55.36 -46.64 76.43 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.1 -0.5 . . . . 71.430000000000007 111.412 -177.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.65 -35.3 65.79 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.996 0.427 . . . . 73.040000000000006 111.436 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -84.31 -44.4 13.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.378 -0.374 . . . . 72.019999999999996 111.191 -178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -81.39 -16.88 50.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.387 0.514 . . . . 71.129999999999995 112.387 -172.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -24.03 67.4 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.998 0.427 . . . . 64.120000000000005 110.951 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -66.76 -28.29 68.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.832 -0.622 . . . . 73.040000000000006 110.234 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.464 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 69.3 m-85 -80.78 -34.58 34.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.642 -0.708 . . . . 72.420000000000002 110.948 -177.45 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 171.7 -164.28 36.98 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.964 -1.112 . . . . 75.430000000000007 113.118 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -75.85 118.7 18.92 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.512 0.673 . . . . 72.030000000000001 111.959 -176.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.481 HG21 HD11 ' A' ' 134' ' ' ILE . 36.2 mt -95.22 139.96 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.19 -0.914 . . . . 40.130000000000003 110.355 177.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.448 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 9.0 mm-40 -84.61 -76.28 0.31 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.132 -0.485 . . . . 74.329999999999998 110.011 176.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.02 158.36 26.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.008 -0.542 . . . . 74.329999999999998 110.136 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.723 HG21 ' HA ' ' A' ' 118' ' ' GLU . 23.4 mm -107.35 112.46 40.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.139 -0.689 . . . . 75.519999999999996 109.139 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -97.58 92.02 5.71 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.348 0.594 . . . . 72.340000000000003 110.68 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.7 mt -73.66 128.54 36.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.324 -0.991 . . . . 71.319999999999993 108.324 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.647 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.489 0 N-CA-C 109.265 -0.643 . . . . 60.009999999999998 109.265 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.647 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 42.4 p90 . . . . . 0 C--O 1.234 0.282 0 CA-C-O 120.865 0.364 . . . . 54.530000000000001 110.773 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.461 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -149.14 165.33 32.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.415 -0.357 . . . . 74.319999999999993 110.99 -177.4 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.461 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 53.7 m-85 -124.04 143.2 50.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 71.409999999999997 109.934 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.585 HG13 ' CD1' ' A' ' 134' ' ' ILE . 44.1 t -117.56 112.54 39.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.875 -0.417 . . . . 75.540000000000006 109.875 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.622 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 16.6 m -89.83 125.08 35.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.226 -0.443 . . . . 73.439999999999998 110.434 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.484 ' CD2' HG22 ' A' ' 159' ' ' VAL . 88.3 m-85 -108.63 152.24 25.06 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.432 -0.581 . . . . 61.5 109.432 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.448 ' HB2' ' HG2' ' A' ' 132' ' ' GLU . 28.4 t70 -81.3 -18.93 44.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.113 0.959 . . . . 54.119999999999997 109.07 176.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.526 ' OD2' ' HB3' ' A' ' 157' ' ' ASP . 26.0 t70 -116.05 126.16 53.41 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.227 -1.351 . . . . 74.430000000000007 110.548 -175.149 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.575 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 7.0 p80 -78.81 -8.49 58.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.222 -0.445 . . . . 54.210000000000001 111.363 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.526 ' HB3' ' OD2' ' A' ' 155' ' ' ASP . 18.5 t70 -89.03 -36.26 15.9 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.308 -0.627 . . . . 71.420000000000002 109.308 -176.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.0 t -54.44 -40.79 68.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.315 -0.857 . . . . 50.43 109.713 168.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.762 HG21 ' HA ' ' A' ' 105' ' ' LYS . 11.3 t -67.75 -33.96 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.516 -0.766 . . . . 61.420000000000002 110.443 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -64.25 -28.85 70.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 73.420000000000002 110.752 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.464 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 20.9 mmtp -70.07 -24.36 63.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.621 0.724 . . . . 64.439999999999998 109.893 177.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.482 HG23 ' CE1' ' A' ' 168' ' ' HIS . 87.3 mt -99.71 -48.4 11.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.009 -0.996 . . . . 65.540000000000006 111.917 -169.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.421 HG13 HG12 ' A' ' 159' ' ' VAL . 31.6 m -73.05 -7.76 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 112.769 0.655 . . . . 71.209999999999994 112.769 -173.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.3 pp -78.45 -33.81 17.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.911 -0.316 . . . . 72.010000000000005 111.479 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.525 ' N ' HD12 ' A' ' 164' ' ' ILE . 12.8 pt20 -108.47 171.34 7.47 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.493 -0.558 . . . . 53.509999999999998 109.493 176.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.565 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 86.3 tttt -111.61 -59.38 1.99 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.831 0.348 . . . . 72.140000000000001 111.181 -174.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.602 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 19.8 m-30 -77.32 99.16 5.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.272 0.558 . . . . 63.539999999999999 112.042 -176.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.482 ' CE1' HG23 ' A' ' 162' ' ' ILE . 49.0 m-70 -98.61 159.19 15.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.551 -0.75 . . . . 72.510000000000005 110.009 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.9 m -104.67 83.77 2.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.927 0.394 . . . . 74.329999999999998 110.956 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.575 HG11 HD23 ' A' ' 121' ' ' LEU . 21.9 t -106.93 131.85 55.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.952 -0.388 . . . . 74.510000000000005 109.952 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 67.07 13.52 9.48 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.756 0.789 . . . . 73.109999999999999 109.776 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.05 17.69 71.53 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.758 -0.656 . . . . 74.010000000000005 112.072 -177.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -117.28 160.25 21.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.074 0.464 . . . . 72.549999999999997 110.553 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -87.2 105.98 17.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.703 -0.68 . . . . 71.409999999999997 109.449 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 66.8 m -114.15 158.43 21.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.151 -0.477 . . . . 75.340000000000003 111.02 -175.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.565 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 9.5 tt0 -103.16 125.74 50.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.15 -0.477 . . . . 74.329999999999998 110.152 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.435 HG11 ' CG2' ' A' ' 162' ' ' ILE . 78.5 t -123.06 135.16 64.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.308 0.575 . . . . 73.239999999999995 110.896 177.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 -139.9 165.56 26.99 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.346 -0.843 . . . . 71.420000000000002 108.993 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.46 ' HB2' HG11 ' A' ' 104' ' ' VAL . 11.5 ptmm? -72.04 126.21 29.19 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.544 -0.462 . . . . 75.099999999999994 110.038 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -72.3 129.29 38.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.859 -0.61 . . . . 50.130000000000003 111.239 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.708 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.5 pt? -124.7 143.96 50.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.437 -0.801 . . . . 75.540000000000006 109.025 174.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 m -49.3 137.91 13.59 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.445 0.466 . . . . 70.25 111.246 -177.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.854 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.1 pttp -61.84 -25.63 67.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.17 0.51 . . . . 70.230000000000004 110.094 178.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -59.06 -41.48 88.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.34 -0.846 . . . . 73.109999999999999 110.762 172.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -93.11 -35.89 12.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.58 -0.736 . . . . 63.009999999999998 111.38 -172.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.854 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 23.9 ptm . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 120.753 0.311 . . . . 72.510000000000005 110.385 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.485 ' O ' HG21 ' A' ' 159' ' ' VAL . 4.1 p . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 110.323 -0.251 . . . . 65.310000000000002 110.323 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.548 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 2.5 mtmt -122.24 16.81 10.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.389 0.614 . . . . 62.450000000000003 110.547 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.576 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 24.8 ttpt -152.78 136.52 16.15 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.339 -0.846 . . . . 62.439999999999998 109.742 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.546 HG12 ' HB ' ' A' ' 151' ' ' VAL . 9.1 pt -103.93 162.7 4.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.904 0.383 . . . . 64.420000000000002 110.732 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.465 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 59.7 t80 -110.63 110.63 21.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.762 -0.653 . . . . 74.109999999999999 110.363 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.1 t -98.25 91.86 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.132 -0.692 . . . . 74.549999999999997 109.132 176.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 C-N-CA 120.669 -0.777 . . . . 52.130000000000003 112.928 -174.659 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.647 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.215 0.531 . . . . 74.530000000000001 112.143 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.73 ' HA ' HG21 ' A' ' 134' ' ' ILE . 21.1 tt0 -58.13 -48.73 79.34 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.881 -1.054 . . . . 74.040000000000006 111.926 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -34.94 75.19 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.089 -0.244 . . . . 63.420000000000002 110.554 -177.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.647 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 44.0 m80 -64.4 -57.31 9.65 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.085 0.469 . . . . 75.439999999999998 110.453 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.599 HD23 HG11 ' A' ' 170' ' ' VAL . 79.4 mt -59.93 -52.4 65.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.306 -0.861 . . . . 52.409999999999997 110.848 -176.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.52 -44.09 93.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.007 -0.542 . . . . 74.439999999999998 111.419 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -63.16 -22.75 67.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.042 0.448 . . . . 73.239999999999995 110.938 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.417 ' CD1' HG22 ' A' ' 170' ' ' VAL . 85.9 t80 -89.83 -51.78 5.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.251 -0.432 . . . . 63.399999999999999 110.85 176.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.431 ' HA ' ' HD2' ' A' ' 128' ' ' TYR . 52.2 m-85 -74.49 -14.7 60.86 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.38 0.511 . . . . 74.340000000000003 112.38 -172.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -22.34 65.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.837 0.31 . . . . 74.25 111.837 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -74.66 -21.82 59.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 71.239999999999995 110.582 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.473 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 86.6 m-85 -86.04 -21.79 27.56 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.501 -0.318 . . . . 73.439999999999998 110.279 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 163.18 -167.69 37.6 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 119.822 -1.18 . . . . 44.509999999999998 113.373 174.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.567 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 37.7 tptt -75.74 117.09 17.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.633 0.73 . . . . 71.040000000000006 111.09 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.552 HG21 HD11 ' A' ' 134' ' ' ILE . 40.1 mt -93.69 133.78 33.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.023 -0.989 . . . . 73.420000000000002 110.557 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -82.2 -75.17 0.31 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.925 -0.58 . . . . 74.439999999999998 110.765 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.54 155.57 36.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.797 -0.446 . . . . 52.200000000000003 109.797 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.73 HG21 ' HA ' ' A' ' 118' ' ' GLU . 27.8 mm -113.01 123.08 68.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.493 -0.558 . . . . 74.129999999999995 109.493 173.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.3 96.13 6.31 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.017 0.437 . . . . 72.099999999999994 110.644 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.61 HD11 ' H ' ' A' ' 118' ' ' GLU . 7.9 mt -80.19 120.46 31.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.036 -1.098 . . . . 73.030000000000001 108.036 173.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.601 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 76.1 mmm . . . . . 0 CA--C 1.509 -0.615 0 C-N-CA 119.926 -0.71 . . . . 73.530000000000001 109.964 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.601 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 24.5 p90 . . . . . 0 C--O 1.235 0.298 0 CA-C-O 121.071 0.463 . . . . 73.230000000000004 111.853 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.53 165.52 27.34 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.173 -0.467 . . . . 60.420000000000002 110.938 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.552 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 69.1 m-85 -123.73 142.34 51.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.1 -0.5 . . . . 71.140000000000001 110.317 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.634 HG13 ' CD1' ' A' ' 134' ' ' ILE . 55.6 t -116.42 108.49 25.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.04 -0.527 . . . . 70.030000000000001 109.784 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.576 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 8.7 m -86.35 127.61 34.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.142 -0.481 . . . . 74.030000000000001 110.475 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.541 ' CD2' HG12 ' A' ' 159' ' ' VAL . 96.4 m-85 -110.47 153.5 24.96 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.936 0.398 . . . . 74.420000000000002 110.555 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.567 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 19.4 t70 -76.69 -15.26 59.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.905 -0.589 . . . . 71.219999999999999 110.606 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -136.15 139.85 43.2 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.809 -0.632 . . . . 72.340000000000003 110.609 -174.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.548 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.4 p-80 -83.99 -0.29 51.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.979 0.418 . . . . 70.510000000000005 111.018 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -80.44 -40.97 25.32 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.417 0.627 . . . . 74.109999999999999 109.48 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.4 m -61.17 -33.64 73.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.121 -0.945 . . . . 52.049999999999997 111.538 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.541 HG12 ' CD2' ' A' ' 153' ' ' PHE . 15.3 m -72.85 -27.92 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 50.020000000000003 111.396 -177.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ASP . . . . . 0.495 ' HA ' HG22 ' A' ' 163' ' ' VAL . 35.6 t70 -65.53 -42.12 92.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.608 -0.269 . . . . 61.210000000000001 110.993 -173.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.473 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 4.9 mttt -58.86 -22.33 58.9 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.196 0.522 . . . . 71.519999999999996 110.807 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.522 HG21 HD13 ' A' ' 107' ' ' ILE . 79.6 mt -92.86 -49.37 12.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.397 -0.82 . . . . 51.5 110.939 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' ' 179' ' ' LYS . 30.3 m -77.83 -7.73 10.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.898 0.703 . . . . 63.130000000000003 112.898 -174.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.409 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.5 pp -72.84 -28.87 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.967 0.413 . . . . 75.430000000000007 110.561 174.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.432 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 11.9 pt20 -108.06 -171.17 1.81 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.172 -0.677 . . . . 72.040000000000006 109.172 172.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.41 ' HG2' ' HG3' ' A' ' 176' ' ' GLU . 87.6 tttt -130.3 -61.85 0.96 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.781 -0.368 . . . . 63.329999999999998 111.537 -174.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -82.6 115.51 21.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.949 0.404 . . . . 64.319999999999993 110.721 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.442 ' CE1' HG23 ' A' ' 162' ' ' ILE . 21.3 m-70 -110.15 140.04 44.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.702 -0.681 . . . . 72.040000000000006 110.655 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 34.3 m -88.85 87.72 7.34 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.047 -0.524 . . . . 71.530000000000001 110.354 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.599 HG11 HD23 ' A' ' 121' ' ' LEU . 33.0 t -106.07 131.07 56.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.597 -0.52 . . . . 74.25 109.597 178.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 61.9 t30 63.46 20.83 12.47 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.879 0.847 . . . . 62.450000000000003 109.546 -177.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.08 -5.74 70.24 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.383 -0.826 . . . . 71.530000000000001 112.191 -176.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -96.46 151.24 19.75 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.207 -0.294 . . . . 73.409999999999997 110.207 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -86.78 99.49 11.83 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.008 -0.367 . . . . 71.409999999999997 110.008 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 58.5 m -110.46 128.85 55.8 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.363 -0.38 . . . . 72.439999999999998 110.979 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.41 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 28.4 tt0 -76.72 123.52 26.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.173 -0.467 . . . . 74.140000000000001 110.534 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 1.1 m -119.31 151.75 21.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.185 -0.461 . . . . 55.32 110.354 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -138.23 -173.92 3.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.716 -0.846 . . . . 74.430000000000007 108.716 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.551 ' HB3' HG11 ' A' ' 163' ' ' VAL . 19.4 ptmt -91.07 132.88 35.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.253 -0.647 . . . . 75.040000000000006 109.253 170.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -82.15 114.36 20.62 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.101 0.408 . . . . 51.039999999999999 112.101 -173.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.576 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -102.66 144.62 30.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.076 -0.713 . . . . 61.119999999999997 109.076 173.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 m -52.86 133.13 37.7 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.312 0.383 . . . . 61.329999999999998 111.252 -176.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.743 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 39.0 pttt -62.35 -30.25 71.04 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 109.828 -0.434 . . . . 75.310000000000002 109.828 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -59.99 -41.26 91.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.517 -0.765 . . . . 63.039999999999999 110.358 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -85.26 -39.16 18.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.645 -0.707 . . . . 75.010000000000005 111.257 -175.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.743 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 25.3 ptm . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 73.530000000000001 110.49 -178.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.4 t . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.391 0.138 . . . . 31.120000000000001 111.266 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.725 ' HA ' HG21 ' A' ' 159' ' ' VAL . 24.1 mtmt 69.45 12.27 8.22 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.163 -0.472 . . . . 74.099999999999994 112.206 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.58 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 27.9 ttpt -157.23 133.91 10.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.593 -0.521 . . . . 64.329999999999998 109.593 173.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.528 HD13 HG21 ' A' ' 162' ' ' ILE . 4.7 pt -108.42 158.49 8.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.106 0.479 . . . . 75.109999999999999 111.023 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 69.4 t80 -105.3 121.11 43.19 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.246 -0.888 . . . . 65.340000000000003 109.899 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' VAL . . . . . 0.455 HG11 HD11 ' A' ' 121' ' ' LEU . 41.9 t -108.43 111.56 36.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.44 -0.345 . . . . 73.230000000000004 110.405 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 121.02 -0.61 . . . . 51.450000000000003 112.241 -178.925 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.654 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 10.9 pt-20 . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 120.46 0.171 . . . . 61.549999999999997 110.812 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.635 ' HA ' HG21 ' A' ' 134' ' ' ILE . 15.9 tt0 -49.47 -52.43 29.22 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.028 -0.533 . . . . 75.239999999999995 112.056 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.49 -29.29 70.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.525 -0.307 . . . . 71.040000000000006 110.663 -174.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.654 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 57.9 m80 -69.42 -56.46 7.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.533 -0.303 . . . . 64.540000000000006 110.918 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.455 HD11 HG11 ' A' ' 109' ' ' VAL . 0.7 OUTLIER -57.19 -49.07 77.15 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.969 0.414 . . . . 71.430000000000007 109.951 177.47 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 122' ' ' ARG . 0.7 OUTLIER -55.03 -49.94 70.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.725 -0.671 . . . . 53.340000000000003 111.03 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -53.29 -32.71 50.04 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.169 0.509 . . . . 73.400000000000006 111.8 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -89.88 -39.09 13.27 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.077 -0.511 . . . . 74.349999999999994 111.578 -177.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.457 ' CD1' HG21 ' A' ' 151' ' ' VAL . 56.4 m-85 -89.14 -14.35 36.37 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.358 0.503 . . . . 53.219999999999999 112.358 -173.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.407 ' N ' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -66.12 -20.47 66.16 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.413 0.625 . . . . 72.319999999999993 110.013 176.039 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -71.58 -23.64 61.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.996 -1.002 . . . . 54.049999999999997 110.755 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -87.17 -32.64 19.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.086 -0.506 . . . . 75.420000000000002 111.099 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.33 -152.35 16.69 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.829 -1.177 . . . . 63.530000000000001 113.7 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.464 ' HA ' ' HE3' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -87.97 113.95 24.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.421 0.629 . . . . 73.439999999999998 111.547 -175.656 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.407 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 34.3 mt -94.24 138.25 21.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.041 -0.982 . . . . 72.439999999999998 110.187 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -78.04 -74.58 0.26 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.483 -0.562 . . . . 72.530000000000001 109.483 172.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.6 m -146.57 165.48 7.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.917 -0.583 . . . . 64.109999999999999 109.816 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.635 HG21 ' HA ' ' A' ' 118' ' ' GLU . 19.6 mm -109.59 109.45 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.274 -0.639 . . . . 73.450000000000003 109.274 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 59.5 mt-10 -88.14 98.57 11.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.312 0.577 . . . . 63.119999999999997 110.231 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.57 HD11 ' H ' ' A' ' 118' ' ' GLU . 35.8 mt -78.48 116.26 21.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.637 -0.71 . . . . 64.239999999999995 109.571 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.765 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.585 0 CA-C-O 121.078 0.466 . . . . 64.439999999999998 109.809 -178.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.765 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 21.4 p90 . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 120.849 0.357 . . . . 64.310000000000002 110.477 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.49 174.23 10.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.757 -0.656 . . . . 72.099999999999994 110.069 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.518 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 82.2 m-85 -133.33 139.55 46.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.914 0.387 . . . . 63.119999999999997 110.095 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.605 HG13 ' CD1' ' A' ' 134' ' ' ILE . 26.3 t -114.02 106.61 21.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.598 -0.519 . . . . 73.25 109.598 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.58 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 17.7 m -85.28 124.11 31.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.23 -0.441 . . . . 72.329999999999998 110.313 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.447 ' CD2' HG22 ' A' ' 159' ' ' VAL . 97.5 m-85 -107.91 145.09 34.24 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.833 -0.432 . . . . 65.219999999999999 109.833 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -74.87 -21.32 59.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.688 0.756 . . . . 72.040000000000006 109.486 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.494 ' OD1' ' HB3' ' A' ' 157' ' ' ASP . 18.7 t70 -118.99 128.52 54.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.801 -1.09 . . . . 71.409999999999997 110.871 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.58 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 3.2 p-80 -76.23 -9.59 58.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.996 -0.547 . . . . 64.299999999999997 111.268 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.494 ' HB3' ' OD1' ' A' ' 155' ' ' ASP . 32.8 t70 -85.3 -39.84 17.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.207 0.527 . . . . 60.450000000000003 109.642 -176.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.4 t -57.68 -34.6 69.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.627 -0.715 . . . . 61.219999999999999 110.526 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.725 HG21 ' HA ' ' A' ' 105' ' ' LYS . 16.9 t -66.84 -35.54 74.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.004 -0.544 . . . . 72.239999999999995 110.134 178.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.12 -31.7 72.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.525 -0.761 . . . . 74.230000000000004 111.362 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 35.3 mmtt -71.36 -19.48 62.28 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.306 0.574 . . . . 71.319999999999993 110.184 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.528 HG21 HD13 ' A' ' 107' ' ' ILE . 86.8 mt -102.22 -48.88 10.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.262 -0.881 . . . . 74.329999999999998 111.433 -171.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.536 ' HB ' ' HG3' ' A' ' 179' ' ' LYS . 33.6 m -67.85 -19.25 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.216 0.451 . . . . 71.420000000000002 112.216 -174.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.423 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.4 pp -69.34 -25.44 29.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.096 0.474 . . . . 71.109999999999999 110.774 176.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.556 ' HB3' ' NE2' ' A' ' 168' ' ' HIS . 21.9 tt0 -106.96 159.62 16.14 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.414 -0.812 . . . . 73.340000000000003 109.114 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.522 ' HE2' ' CE2' ' A' ' 167' ' ' TYR . 80.6 tttt -109.66 -64.3 1.27 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.87 0.367 . . . . 72.109999999999999 110.762 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.522 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 22.9 m-85 -77.03 113.17 14.45 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.049 0.452 . . . . 73.329999999999998 110.829 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.556 ' NE2' ' HB3' ' A' ' 165' ' ' GLN . 36.0 m-70 -121.7 132.53 54.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.549 -0.75 . . . . 71.019999999999996 110.019 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 174' ' ' ASN . 55.2 m -90.45 102.56 15.29 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.062 0.458 . . . . 74.219999999999999 110.951 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.21 136.58 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.899 -0.591 . . . . 71.5 109.881 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 65.1 t30 59.29 25.5 14.14 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.511 0.672 . . . . 70.25 110.718 -175.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 77.57 7.61 87.16 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.766 -0.73 . . . . 61.310000000000002 112.555 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -116.02 123.62 48.43 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.718 -0.475 . . . . 64.430000000000007 109.718 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 169' ' ' THR . 64.1 t30 -74.73 102.63 4.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.214 -0.448 . . . . 55.439999999999998 110.071 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 35.5 m -107.76 169.99 8.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.158 -0.474 . . . . 62.310000000000002 110.709 -175.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -103.0 122.22 44.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.232 -0.44 . . . . 61.219999999999999 109.948 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.0 OUTLIER -120.36 151.67 23.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.263 -0.643 . . . . 72.230000000000004 109.263 176.646 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -161.62 -171.67 3.03 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.835 -0.621 . . . . 63.100000000000001 109.758 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.718 ' HD2' ' H ' ' A' ' 179' ' ' LYS . 7.7 mptt -74.43 122.16 22.56 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.874 -0.417 . . . . 63.130000000000003 109.874 -177.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.405 ' HB2' ' C ' ' A' ' 107' ' ' ILE . . . -81.28 90.85 6.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.942 0.401 . . . . 54.310000000000002 111.321 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.692 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.5 pt? -88.76 134.95 33.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.259 -0.645 . . . . 71.400000000000006 109.259 174.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.4 m -51.91 144.47 11.55 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.567 0.542 . . . . 75.140000000000001 111.309 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.648 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 32.1 pttt -57.71 -29.78 64.99 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.227 0.537 . . . . 62.140000000000001 110.114 177.527 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -58.04 -47.78 82.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.416 -0.811 . . . . 73.519999999999996 110.713 173.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -82.31 -37.66 25.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.122 -0.945 . . . . 63.350000000000001 111.275 -173.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.648 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.7 ptm . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.494 -0.321 . . . . 71.099999999999994 110.638 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 106' ' ' LYS . 12.5 p . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.74 0.305 . . . . 62.130000000000003 111.089 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.812 ' HA ' HG21 ' A' ' 159' ' ' VAL . 21.7 mtmt -122.91 6.32 9.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 64.129999999999995 111.662 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.631 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.6 ttpt -139.55 139.95 36.98 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.967 -0.383 . . . . 64.25 109.967 174.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.563 HG12 ' HB ' ' A' ' 151' ' ' VAL . 5.5 pt -109.25 160.78 7.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.94 0.4 . . . . 75.400000000000006 111.157 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.477 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 62.7 t80 -110.82 127.79 55.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.571 -0.741 . . . . 74.040000000000006 109.681 177.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 45.8 t -108.83 117.72 54.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.966 0.412 . . . . 73.129999999999995 110.855 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 111.042 -0.823 . . . . 70.439999999999998 111.042 177.196 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.674 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 10.6 pt-20 . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 112.466 0.543 . . . . 74.340000000000003 112.466 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.717 ' HA ' HG21 ' A' ' 134' ' ' ILE . 2.6 tm-20 -61.63 -47.44 85.37 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.536 -0.756 . . . . 75.219999999999999 111.826 -173.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -63.6 -33.43 75.6 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.632 -0.427 . . . . 74.329999999999998 110.573 -177.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.674 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 35.6 m80 -63.75 -59.36 4.67 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.232 0.539 . . . . 72.400000000000006 111.085 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.634 HD12 HG11 ' A' ' 170' ' ' VAL . 4.5 mp -59.41 -48.14 82.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.276 -0.875 . . . . 75.450000000000003 110.938 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.437 ' HG3' HD12 ' A' ' 131' ' ' ILE . 6.2 ttp180 -63.68 -38.97 93.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.147 -0.479 . . . . 72.049999999999997 111.414 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -58.99 -31.15 68.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.088 0.471 . . . . 75.200000000000003 110.987 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.594 ' CD1' HG22 ' A' ' 170' ' ' VAL . 59.4 t80 -93.03 -48.15 6.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.897 -0.592 . . . . 62.43 111.525 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.438 ' HA ' ' HD2' ' A' ' 128' ' ' TYR . 43.6 m-85 -76.07 -11.82 60.01 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.519 0.563 . . . . 72.209999999999994 112.519 -172.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.48 -25.16 67.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.674 0.273 . . . . 75.5 111.506 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -73.9 -23.11 59.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.017 0.437 . . . . 70.0 110.65 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.438 ' HD2' ' HA ' ' A' ' 125' ' ' PHE . 91.0 m-85 -81.42 -29.14 33.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 74.129999999999995 110.561 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.428 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 168.59 -156.4 27.78 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.085 -1.055 . . . . 75.120000000000005 113.223 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.492 ' HA ' ' HE3' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -86.17 114.91 23.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.359 0.599 . . . . 73.439999999999998 110.994 -177.501 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.49 HG21 HD11 ' A' ' 134' ' ' ILE . 27.4 mt -89.14 135.01 26.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.355 -0.839 . . . . 71.219999999999999 110.068 176.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 154' ' ' ASP . 29.2 mt-10 -78.61 -69.22 0.58 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.84 -0.429 . . . . 64.420000000000002 109.84 174.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.1 m -148.56 157.27 7.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.971 -0.559 . . . . 74.5 110.085 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.717 HG21 ' HA ' ' A' ' 118' ' ' GLU . 22.9 mm -104.71 107.63 22.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.571 -0.529 . . . . 71.420000000000002 109.571 175.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -90.68 91.7 8.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.842 -0.617 . . . . 72.450000000000003 110.449 -174.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.567 HD11 ' H ' ' A' ' 118' ' ' GLU . 21.3 mt -74.94 121.51 26.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.858 -0.793 . . . . 74.409999999999997 108.858 176.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.6 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 N-CA-C 108.767 -0.827 . . . . 73.209999999999994 108.767 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.6 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 18.1 p90 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.82 0.343 . . . . 73.340000000000003 111.175 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.03 162.2 36.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.984 0.421 . . . . 60.140000000000001 111.3 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.477 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 49.6 m-85 -125.96 146.02 50.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.947 -0.57 . . . . 65.420000000000002 109.905 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.608 HG13 ' CD1' ' A' ' 134' ' ' ILE . 39.1 t -118.65 111.74 35.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 110.12 -0.326 . . . . 71.030000000000001 110.12 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.631 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 19.5 m -89.69 126.71 35.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.116 -0.493 . . . . 75.0 110.683 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.507 ' CD2' HG22 ' A' ' 159' ' ' VAL . 97.8 m-85 -110.97 145.95 37.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.435 -0.348 . . . . 62.450000000000003 110.306 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.516 ' N ' ' HG3' ' A' ' 132' ' ' GLU . 9.4 t70 -65.52 -29.93 70.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 73.109999999999999 110.747 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 159' ' ' VAL . 6.1 t70 -125.72 142.83 51.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.863 -0.608 . . . . 73.319999999999993 110.497 -174.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.485 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.4 p-80 -75.75 -16.99 60.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.098 -0.501 . . . . 74.530000000000001 110.909 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.53 -38.01 68.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.999 0.428 . . . . 51.210000000000001 109.983 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.428 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 13.6 m -64.84 -28.98 69.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.734 -0.666 . . . . 62.119999999999997 110.19 177.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.812 HG21 ' HA ' ' A' ' 105' ' ' LYS . 14.8 t -76.04 -34.67 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.444 -0.798 . . . . 75.109999999999999 110.516 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -52.18 -56.18 16.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.549 -0.75 . . . . 72.430000000000007 112.397 -176.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -9.7 29.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.753 0.311 . . . . 72.140000000000001 111.834 -176.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.486 HG22 HG11 ' A' ' 177' ' ' VAL . 84.4 mt -96.46 -50.11 11.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.391 -0.368 . . . . 74.430000000000007 111.019 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.435 HG13 HG12 ' A' ' 159' ' ' VAL . 34.6 m -72.13 -19.1 19.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.422 0.527 . . . . 71.430000000000007 112.422 -174.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.5 pp -68.86 -30.3 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 70.040000000000006 111.495 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.49 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 16.9 pt20 -106.06 167.78 9.57 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.613 -0.514 . . . . 72.230000000000004 109.613 175.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.552 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 83.8 tttt -109.18 -58.78 1.98 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.996 0.427 . . . . 62.140000000000001 110.662 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 21.4 m-85 -78.34 118.3 20.39 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.878 -0.601 . . . . 72.349999999999994 111.27 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.49 ' NE2' ' HG3' ' A' ' 165' ' ' GLN . 38.3 m-70 -118.07 151.54 37.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.25 -0.886 . . . . 62.439999999999998 110.046 177.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 m -93.81 84.99 4.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.991 0.424 . . . . 65.519999999999996 110.769 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.634 HG11 HD12 ' A' ' 121' ' ' LEU . 11.2 t -113.77 137.1 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.874 -0.417 . . . . 70.109999999999999 109.874 -178.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 57.2 t30 61.32 24.54 14.63 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.716 0.769 . . . . 61.409999999999997 109.889 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 69.47 25.0 75.91 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.573 -0.74 . . . . 73.140000000000001 112.208 -177.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -131.62 150.07 52.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.871 0.367 . . . . 64.329999999999998 110.556 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASN . . . . . 0.45 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 8.9 t30 -85.1 97.66 9.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.987 -0.551 . . . . 55.420000000000002 110.047 176.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' CYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 46.2 m -105.67 177.47 4.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.278 -0.419 . . . . 71.340000000000003 111.042 -176.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.552 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 12.6 tt0 -112.54 136.43 52.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.292 -0.413 . . . . 74.109999999999999 110.66 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.486 HG11 HG22 ' A' ' 162' ' ' ILE . 70.6 t -127.48 138.14 55.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.146 -0.479 . . . . 44.310000000000002 111.105 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -130.22 175.86 8.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 73.140000000000001 110.129 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.409 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 11.4 mptt -76.52 121.31 22.95 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.432 -0.951 . . . . 44.130000000000003 108.432 171.015 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.462 ' HB2' ' C ' ' A' ' 107' ' ' ILE . . . -79.96 100.04 7.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.105 0.479 . . . . 72.120000000000005 111.911 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.766 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.2 pt? -99.29 141.18 32.4 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.822 -0.806 . . . . 53.509999999999998 108.822 172.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.53 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 51.8 m -59.64 156.15 14.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.632 0.254 . . . . 74.230000000000004 111.337 -173.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.473 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.8 pttp -65.74 -25.74 67.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.962 0.411 . . . . 71.319999999999993 110.832 -175.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -75.69 -36.63 59.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.282 0.563 . . . . 42.030000000000001 110.112 175.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.53 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 48.7 mt-10 -75.95 -42.96 46.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.792 -0.64 . . . . 64.329999999999998 110.595 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.678 ' HB3' ' HG ' ' A' ' 181' ' ' LEU . 22.5 ptm . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 116.134 -0.484 . . . . 51.240000000000002 110.387 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 109.229 -0.656 . . . . 63.119999999999997 109.229 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -119.88 19.32 12.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.402 0.62 . . . . 63.310000000000002 110.677 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.601 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 6.7 ttpm? -157.88 138.91 13.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.32 -0.854 . . . . 74.219999999999999 109.603 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.579 HD13 HG21 ' A' ' 162' ' ' ILE . 15.6 pt -107.14 165.27 4.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.096 0.474 . . . . 64.510000000000005 110.873 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 38.4 t80 -114.38 116.28 28.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.524 -0.762 . . . . 73.340000000000003 109.877 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 44.8 t -105.09 111.92 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.993 -0.373 . . . . 64.099999999999994 109.993 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.851 0 C-N-CA 120.608 -0.806 . . . . 74.099999999999994 112.385 -178.653 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.668 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 11.4 pt-20 . . . . . 0 CA--C 1.534 0.342 0 N-CA-C 110.344 -0.243 . . . . 63.310000000000002 110.344 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.595 ' HA ' HG21 ' A' ' 134' ' ' ILE . 12.2 tt0 -54.75 -49.85 69.85 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.413 0.523 . . . . 63.130000000000003 112.413 -175.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -65.2 -29.07 69.85 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.794 -0.362 . . . . 73.239999999999995 110.675 -174.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' HIS . . . . . 0.668 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 38.5 m80 -65.44 -52.59 52.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.004 0.43 . . . . 73.349999999999994 110.759 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.52 -46.87 77.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 34.140000000000001 110.423 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.74 -48.49 79.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.103 -0.498 . . . . 75.450000000000003 111.309 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.36 -31.15 67.34 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.11 0.481 . . . . 43.310000000000002 111.116 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.465 ' CD1' HG22 ' A' ' 170' ' ' VAL . 31.2 t80 -83.88 -42.1 16.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.956 -0.565 . . . . 70.219999999999999 111.337 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -88.44 -16.43 32.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.645 0.609 . . . . 63.340000000000003 112.645 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -22.2 66.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.08 0.467 . . . . 64.430000000000007 110.874 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -70.14 -26.71 64.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.752 -0.658 . . . . 65.310000000000002 110.349 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' TYR . . . . . 0.499 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 57.6 m-85 -81.64 -38.56 25.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.646 -0.706 . . . . 74.400000000000006 111.272 -176.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -174.64 -155.84 13.0 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.118 -1.039 . . . . 63.329999999999998 112.888 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -91.86 119.17 31.4 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.42 0.628 . . . . 62.399999999999999 111.179 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.478 HG12 ' CE1' ' A' ' 153' ' ' PHE . 41.3 mt -95.86 137.79 23.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.262 -0.881 . . . . 61.409999999999997 110.103 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 154' ' ' ASP . 18.0 mt-10 -84.06 -73.34 0.42 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.334 -0.394 . . . . 55.329999999999998 110.533 174.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.1 m -143.29 163.25 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.082 -0.508 . . . . 63.240000000000002 110.072 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.595 HG21 ' HA ' ' A' ' 118' ' ' GLU . 26.7 mm -111.68 108.67 26.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.101 0.477 . . . . 72.319999999999993 109.843 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 30.5 mm-40 -84.69 91.43 7.93 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.608 -0.723 . . . . 70.049999999999997 110.466 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.552 HD11 ' CB ' ' A' ' 118' ' ' GLU . 16.9 mt -81.79 108.18 14.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.999 -0.741 . . . . 74.340000000000003 108.999 176.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' MET . . . . . 0.58 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.405 0 N-CA-C 108.773 -0.825 . . . . 73.219999999999999 108.773 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.58 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 11.2 p90 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 121.028 0.442 . . . . 74.409999999999997 111.627 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.35 156.85 46.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 62.219999999999999 110.734 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 49.2 m-85 -121.59 125.4 46.65 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.025 -0.534 . . . . 64.239999999999995 110.061 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.572 HG13 ' CD1' ' A' ' 134' ' ' ILE . 30.9 t -100.08 109.07 24.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 110.076 -0.342 . . . . 74.150000000000006 110.076 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' THR . . . . . 0.601 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 27.7 m -85.56 125.16 32.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.18 -0.464 . . . . 73.329999999999998 110.32 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.554 ' CD2' HG12 ' A' ' 159' ' ' VAL . 98.0 m-85 -109.41 149.93 28.81 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.539 -0.541 . . . . 74.099999999999994 109.539 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.472 ' N ' ' HG3' ' A' ' 132' ' ' GLU . 20.9 t70 -68.73 -26.73 65.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.033 0.444 . . . . 71.319999999999993 110.912 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -129.95 150.7 51.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.286 -0.416 . . . . 70.310000000000002 111.184 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' HIS . . . . . 0.575 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.5 p-80 -83.28 -6.59 59.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.847 -0.615 . . . . 61.5 110.855 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -72.53 -40.71 66.54 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.654 -0.498 . . . . 63.329999999999998 109.654 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.7 m -63.92 -31.54 72.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.636 -0.711 . . . . 73.329999999999998 111.506 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 156' ' ' HIS . 5.7 m -78.03 -23.15 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 121.054 -0.258 . . . . 60.520000000000003 111.285 -175.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.79 -45.23 90.65 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 116.657 -0.247 . . . . 72.209999999999994 111.306 -173.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' LYS . . . . . 0.499 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.0 OUTLIER -62.03 -18.76 61.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.175 0.512 . . . . 72.239999999999995 110.68 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ILE . . . . . 0.579 HG21 HD13 ' A' ' 107' ' ' ILE . 72.3 mt -97.71 -54.69 6.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.618 -0.719 . . . . 75.450000000000003 111.527 -174.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.467 ' HB ' ' HG2' ' A' ' 179' ' ' LYS . 33.6 m -66.13 -19.83 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.452 0.538 . . . . 62.43 112.452 -172.67 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.449 HD12 ' HB2' ' A' ' 165' ' ' GLN . 2.6 pp -69.12 -24.75 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.32 0.581 . . . . 75.209999999999994 110.707 176.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLN . . . . . 0.479 ' HB3' ' NE2' ' A' ' 168' ' ' HIS . 23.0 tt0 -108.52 140.85 41.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.177 -0.919 . . . . 74.120000000000005 109.626 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.563 ' HE3' ' OE1' ' A' ' 176' ' ' GLU . 82.4 tttt -93.77 -61.69 1.5 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.794 0.33 . . . . 64.200000000000003 110.776 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -74.04 114.58 12.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.139 -0.482 . . . . 72.329999999999998 110.905 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.479 ' NE2' ' HB3' ' A' ' 165' ' ' GLN . 30.3 m-70 -120.99 162.25 20.23 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.642 -0.708 . . . . 72.420000000000002 109.257 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 11.7 m -118.09 102.27 8.89 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.468 -0.493 . . . . 75.150000000000006 111.218 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.465 HG22 ' CD1' ' A' ' 124' ' ' TYR . 47.5 t -111.51 130.0 65.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.813 -0.63 . . . . 65.540000000000006 109.508 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 63.9 t30 62.54 23.59 14.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.609 0.718 . . . . 73.340000000000003 110.445 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 78.24 11.06 85.72 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.896 -0.669 . . . . 33.240000000000002 112.488 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -111.68 135.43 52.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.901 0.381 . . . . 70.540000000000006 110.521 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.88 114.91 13.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.922 -0.581 . . . . 42.520000000000003 110.441 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.32 169.16 13.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.964 0.411 . . . . 72.299999999999997 110.953 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.563 ' OE1' ' HE3' ' A' ' 166' ' ' LYS . 15.1 tt0 -108.85 127.37 53.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.896 -0.593 . . . . 71.019999999999996 109.548 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.6 m -117.88 144.9 24.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.391 -0.524 . . . . 73.010000000000005 110.543 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -132.75 -179.36 5.42 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.056 -0.52 . . . . 61.149999999999999 109.818 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.467 ' HG2' ' HB ' ' A' ' 163' ' ' VAL . 38.4 mtpt -81.2 119.09 23.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.964 -1.125 . . . . 72.409999999999997 107.964 170.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -70.17 95.06 0.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.902 0.382 . . . . 74.25 111.513 -175.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.571 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.5 pt? -92.98 144.96 24.74 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.368 -0.604 . . . . 71.549999999999997 109.368 175.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.421 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 7.5 m -53.83 142.54 23.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.141 -0.481 . . . . 52.340000000000003 110.96 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.661 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 18.8 pttp -59.88 -22.66 62.63 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.048 0.451 . . . . 73.140000000000001 110.524 177.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -64.26 -52.96 56.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.666 . . . . 75.239999999999995 110.275 171.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' GLU . . . . . 0.421 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 35.7 mt-10 -68.42 -41.35 80.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.38 -0.827 . . . . 63.229999999999997 111.021 -176.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' MET . . . . . 0.661 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 20.7 ptm . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.891 -0.595 . . . . 55.200000000000003 111.163 -175.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.805 -0.443 . . . . 43.140000000000001 109.805 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -105.14 -21.58 13.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.137 -0.483 . . . . 71.310000000000002 111.131 -173.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' A' ' 100' ' ' ALA . 0.1 OUTLIER 61.72 95.26 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.254 0 O-C-N 123.686 0.616 . . . . 72.109999999999999 109.713 -169.175 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.499 ' HB3' HD13 ' A' ' 181' ' ' LEU . 32.2 Cg_exo -58.81 102.37 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.142 2.561 . . . . 62.299999999999997 112.625 -175.006 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.44 55.05 22.82 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.806 -0.711 . . . . 63.310000000000002 111.669 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 97' ' ' ARG . . . -66.18 -36.16 82.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.973 0.416 . . . . 74.430000000000007 111.019 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 13.5 p-80 -79.68 -4.87 53.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.887 -0.597 . . . . 64.349999999999994 110.712 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.5 mt -101.68 144.88 29.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.99 -0.55 . . . . 75.430000000000007 110.49 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.8 p -84.01 126.63 33.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.266 -0.424 . . . . 41.32 110.178 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.472 ' O ' HG21 ' A' ' 159' ' ' VAL . 9.1 p -118.64 155.01 20.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.881 -0.414 . . . . 64.340000000000003 109.881 -177.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -128.56 18.69 6.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.168 0.509 . . . . 75.239999999999995 111.291 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.584 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 23.6 ttpt -151.15 131.69 13.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.814 -0.63 . . . . 75.299999999999997 109.608 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.509 HG13 ' HB ' ' A' ' 151' ' ' VAL . 2.1 pp -106.43 153.55 7.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.21 -0.45 . . . . 72.120000000000005 110.397 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.516 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 81.9 t80 -103.25 130.53 50.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.978 -0.555 . . . . 74.129999999999995 110.276 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.7 t -111.09 110.17 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.294 -0.412 . . . . 72.340000000000003 110.436 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -121.72 165.22 14.67 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.205 -0.758 . . . . 61.149999999999999 111.205 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.543 ' H ' " C5'" ' B' ' 2' ' ' ' C' . . . 81.31 10.37 84.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.747 -0.739 . . . . 62.009999999999998 112.786 178.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.659 HG13 " H5'" ' B' ' 1' ' ' ' U' . 16.9 pt -71.11 89.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.473 0.654 . . . . 73.129999999999995 111.22 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -79.01 -30.15 44.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.103 -0.499 . . . . 75.530000000000001 110.08 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -83.19 151.62 25.6 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.971 -0.558 . . . . 61.539999999999999 109.901 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -68.61 90.22 0.39 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.484 0.659 . . . . 73.340000000000003 110.155 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.2 m -101.87 136.23 42.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.162 -0.926 . . . . 73.019999999999996 110.204 -177.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.432 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 8.1 pt-20 -125.79 -168.86 1.91 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.863 0.363 . . . . 71.109999999999999 110.854 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.695 ' HA ' HG21 ' A' ' 134' ' ' ILE . 13.3 tt0 -56.29 -50.25 71.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.449 -0.796 . . . . 75.030000000000001 112.41 -178.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -65.53 -33.65 76.41 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.877 -0.329 . . . . 74.129999999999995 110.665 -174.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.432 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 40.9 m80 -63.0 -53.64 50.86 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.012 0.434 . . . . 70.120000000000005 110.631 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.584 HD23 HG11 ' A' ' 170' ' ' VAL . 97.6 mt -62.25 -48.59 79.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.523 -0.762 . . . . 74.319999999999993 110.937 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -59.47 -40.88 88.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.252 -0.431 . . . . 73.109999999999999 110.985 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -59.47 -30.39 68.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.99 0.424 . . . . 72.319999999999993 111.278 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -88.92 -47.37 8.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.408 -0.36 . . . . 65.109999999999999 111.346 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.408 ' CD1' HG21 ' A' ' 151' ' ' VAL . 53.1 m-85 -77.54 -14.63 59.62 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.308 0.484 . . . . 75.319999999999993 112.308 -172.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -65.3 -24.02 67.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.747 0.308 . . . . 75.219999999999999 111.414 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -65.24 -25.73 67.8 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.221 0.534 . . . . 74.329999999999998 110.641 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.495 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 88.5 m-85 -86.01 -37.84 18.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.675 -0.693 . . . . 61.229999999999997 111.148 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 177.44 -166.77 37.43 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.012 -1.089 . . . . 60.009999999999998 113.422 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.569 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 38.3 tptt -75.78 118.78 18.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.4 0.619 . . . . 63.340000000000003 111.464 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.505 HG21 HD11 ' A' ' 134' ' ' ILE . 34.3 mt -97.49 139.93 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.378 -0.828 . . . . 72.140000000000001 110.41 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 6.7 mm-40 -89.12 -71.2 0.61 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.317 -0.401 . . . . 52.399999999999999 111.237 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.47 157.42 27.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.645 0.259 . . . . 64.400000000000006 110.57 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.695 HG21 ' HA ' ' A' ' 118' ' ' GLU . 17.7 mm -113.02 111.64 37.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.174 -0.676 . . . . 71.109999999999999 109.174 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 22.4 mm-40 -90.27 95.0 9.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.988 -0.551 . . . . 74.329999999999998 110.786 -175.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.565 HD11 ' H ' ' A' ' 118' ' ' GLU . 11.1 mt -80.69 87.35 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.01 -1.107 . . . . 65.209999999999994 108.01 173.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 11.2 tpt -68.41 103.48 1.65 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.581 0.705 . . . . 72.420000000000002 111.252 -170.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.0 p -77.64 160.82 28.26 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.053 -0.976 . . . . 64.219999999999999 110.886 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.531 ' HA ' ' HD2' ' A' ' 146' ' ' ARG . 25.6 t70 -65.86 135.99 55.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.672 -0.695 . . . . 55.149999999999999 110.137 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.56 ' HG2' ' C6 ' ' B' ' 5' ' ' ' U' . 0.0 OUTLIER -86.26 5.48 34.2 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.786 -0.643 . . . . 73.140000000000001 111.846 -176.437 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -111.11 -57.98 0.48 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.935 -0.65 . . . . 43.049999999999997 111.786 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 t -91.31 -28.57 17.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.95 0.405 . . . . 71.010000000000005 110.957 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.61 53.63 4.26 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.405 -0.902 . . . . 63.340000000000003 111.319 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -131.7 170.47 14.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.901 -0.777 . . . . 75.209999999999994 108.901 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -69.69 103.93 2.27 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.243 -0.651 . . . . 71.209999999999994 109.243 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.531 ' HD2' ' HA ' ' A' ' 139' ' ' ASP . 52.4 ttt180 -67.46 -25.97 66.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.575 -0.739 . . . . 72.319999999999993 112.215 -168.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.976 ' HA3' " H2'" ' B' ' 1' ' ' ' U' . . . 134.19 -11.82 4.72 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.018 -1.086 . . . . 64.319999999999993 113.139 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.578 ' CE2' " H4'" ' B' ' 3' ' ' ' A' . 40.6 p90 -139.24 160.5 39.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.818 0.309 . . . . 72.129999999999995 111.004 -177.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -144.42 165.78 26.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.994 -0.548 . . . . 72.230000000000004 110.193 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.562 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 42.2 m-85 -129.64 150.67 50.86 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.947 -0.39 . . . . 61.310000000000002 109.947 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.57 HG13 ' CD1' ' A' ' 134' ' ' ILE . 59.0 t -122.9 112.38 33.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.981 -0.377 . . . . 63.310000000000002 109.981 176.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.584 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 26.1 m -88.08 127.52 35.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.027 -0.533 . . . . 74.120000000000005 110.591 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.514 ' CD2' HG12 ' A' ' 159' ' ' VAL . 92.4 m-85 -109.59 152.24 25.77 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.143 -0.317 . . . . 52.409999999999997 110.143 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.569 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 31.9 t70 -75.34 -18.31 60.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.225 0.536 . . . . 71.040000000000006 110.547 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 157' ' ' ASP . 24.0 t70 -132.61 153.21 51.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.618 -0.719 . . . . 75.040000000000006 111.123 -177.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.41 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.1 p-80 -95.53 5.03 52.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.26 -0.427 . . . . 74.109999999999999 111.883 -178.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.477 ' HB3' ' OD2' ' A' ' 155' ' ' ASP . 13.2 t70 -91.81 -37.23 13.07 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.506 -0.553 . . . . 73.120000000000005 109.506 171.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.5 m -58.6 -27.59 64.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.749 -0.66 . . . . 64.510000000000005 110.901 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.514 HG12 ' CD2' ' A' ' 153' ' ' PHE . 13.0 m -80.42 -20.99 11.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 75.340000000000003 111.367 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.35 -38.4 71.63 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.691 0.281 . . . . 71.409999999999997 110.672 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.495 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.1 mptp? -65.03 -19.22 65.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.302 0.572 . . . . 74.200000000000003 110.68 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 81.9 mt -96.78 -53.62 7.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.573 -0.739 . . . . 75.230000000000004 111.227 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.518 ' HB ' ' HG2' ' A' ' 179' ' ' LYS . 35.3 m -64.56 -20.82 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.586 0.587 . . . . 61.119999999999997 112.586 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.74 -28.41 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 74.329999999999998 111.072 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -105.16 142.19 35.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.004 -0.544 . . . . 71.319999999999993 109.655 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.441 ' CE ' ' HG3' ' A' ' 176' ' ' GLU . 87.4 tttt -87.04 -71.39 0.56 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 121.033 -0.267 . . . . 75.299999999999997 110.997 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.62 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 3.7 m-85 -79.19 116.62 19.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.207 0.527 . . . . 72.409999999999997 111.971 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -117.51 140.63 49.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.19 -0.914 . . . . 63.310000000000002 109.492 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 174' ' ' ASN . 57.4 m -92.37 109.28 20.66 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.089 0.471 . . . . 62.420000000000002 111.232 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.584 HG11 HD23 ' A' ' 121' ' ' LEU . 43.3 t -120.06 136.27 57.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.928 -0.578 . . . . 72.109999999999999 109.464 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.1 t30 70.57 -12.84 0.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.929 0.491 . . . . 73.319999999999993 111.497 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 122.2 -3.62 10.5 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.514 -0.634 . . . . 73.049999999999997 111.514 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -112.34 138.68 48.72 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.662 -0.496 . . . . 73.349999999999994 109.662 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 169' ' ' THR . 60.0 t30 -88.65 103.8 16.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.755 -0.461 . . . . 74.140000000000001 109.755 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 34.0 m -106.77 173.16 6.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.058 -0.519 . . . . 60.530000000000001 110.76 -174.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.441 ' HG3' ' CE ' ' A' ' 166' ' ' LYS . 9.0 tt0 -97.58 123.92 41.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.11 0.481 . . . . 74.019999999999996 110.756 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 48.4 t -118.84 131.13 72.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.926 -0.579 . . . . 71.120000000000005 110.475 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -144.34 173.38 11.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.857 -0.611 . . . . 74.540000000000006 109.842 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.518 ' HG2' ' HB ' ' A' ' 163' ' ' VAL . 31.9 mtpt -68.54 125.62 27.07 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.685 -0.487 . . . . 74.530000000000001 109.685 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.556 ' HA ' ' C2 ' ' B' ' 3' ' ' ' A' . . . -81.01 89.68 5.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.911 0.386 . . . . 62.409999999999997 111.482 -175.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.693 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.3 pt? -86.4 141.99 28.76 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.875 -0.602 . . . . 73.230000000000004 109.41 175.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.473 ' HB3' ' HG3' ' A' ' 185' ' ' GLU . 30.0 t -58.0 152.7 15.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.482 -0.326 . . . . 70.400000000000006 110.804 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.565 ' CE ' " H3'" ' B' ' 4' ' ' ' G' . 22.1 pttp -60.07 -21.9 62.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.173 0.511 . . . . 72.030000000000001 110.368 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.499 ' HA ' ' C4 ' ' B' ' 6' ' ' ' U' . 0.6 OUTLIER -69.49 -49.32 55.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.542 -0.754 . . . . 71.230000000000004 109.197 174.425 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.473 ' HG3' ' HB3' ' A' ' 182' ' ' SER . 30.0 mt-10 -73.38 -37.97 65.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.209 -0.905 . . . . 74.109999999999999 111.138 -176.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.51 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 21.7 ptm -63.6 -23.84 67.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 71.319999999999993 111.129 -175.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -75.53 -48.26 23.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.25 0.547 . . . . 64.420000000000002 109.767 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.9 m -65.9 -45.68 81.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.483 -0.78 . . . . 52.420000000000002 110.861 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.27 -33.94 76.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.219999999999999 111.559 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 6.1 t -75.96 -40.23 54.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 64.430000000000007 110.194 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.9 t -66.8 -39.19 87.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.265 -0.425 . . . . 74.219999999999999 110.442 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 194' ' ' ARG . 8.6 t -92.74 24.52 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 53.340000000000003 110.594 -178.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -61.31 116.51 4.68 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.648 -0.501 . . . . 72.340000000000003 109.648 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 192' ' ' SER . 14.7 mmt180 -114.77 141.75 47.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.282 0.563 . . . . 72.420000000000002 112.196 -173.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.09 163.23 22.46 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.22 -0.9 . . . . 23.239999999999998 111.04 175.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? . . . . . 0 C--O 1.244 0.796 0 CA-C-O 118.434 -0.793 . . . . 70.230000000000004 109.524 -178.822 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 1.07 " C3'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.43 -0.654 0 O5'-C5'-C4' 111.69 1.064 . 0.0 '__' . 74.120000000000005 . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 1.07 H5'' " C3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.891 0 C4'-C3'-C2' 105.303 2.603 OUTLIER-EPSILON 0.0 OUTLIER alpha 71.239999999999995 . . . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.691 ' H8 ' H5'' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.886 0 P-O3'-C3' 122.477 2.315 . 0.0 OUTLIER epsilon-1 74.010000000000005 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.565 " H3'" ' CE ' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.427 -0.823 0 C4'-C3'-C2' 103.669 0.969 . 0.0 OUTLIER alpha 75.109999999999999 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.677 ' H6 ' ' P ' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.953 0 C4'-C3'-C2' 104.263 1.563 . 0.0 OUTLIER gamma 74.239999999999995 . . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.499 ' C4 ' ' HA ' ' A' ' 184' ' ' GLN . . . . . . . . 0 O5'--C5' 1.426 -0.876 0 C3'-C2'-C1' 100.676 -0.916 . 0.0 OUTLIER gamma 73.239999999999995 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 109.916 -0.401 . . . . 74.019999999999996 109.916 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -84.8 -38.7 19.25 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.485 -0.561 . . . . 74.219999999999999 109.485 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -123.95 96.1 43.13 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.537 -0.756 . . . . 74.129999999999995 109.03 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.442 ' HG3' HD22 ' A' ' 181' ' ' LEU . 86.4 Cg_endo -84.34 37.49 0.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.225 2.616 . . . . 72.329999999999998 113.291 -169.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 158.01 60.37 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.784 -0.722 . . . . 62.039999999999999 111.668 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.86 -31.98 70.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.873 0.368 . . . . 61.219999999999999 111.021 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -88.3 8.85 25.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.564 . . . . 73.319999999999993 110.805 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.9 mt -114.77 149.87 36.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.252 -0.431 . . . . 63.340000000000003 110.732 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.5 p -93.04 117.39 30.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.059 -0.518 . . . . 73.030000000000001 110.815 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.628 HG13 HG11 ' A' ' 159' ' ' VAL . 11.5 p -111.71 143.31 21.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.656 -0.498 . . . . 73.230000000000004 109.656 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.484 ' N ' ' HE3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -104.49 -6.34 20.73 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.736 0.303 . . . . 73.25 111.81 -175.038 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.725 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.0 ttpt -133.99 140.73 46.91 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.86 -0.422 . . . . 72.450000000000003 109.86 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.615 ' CG2' HG13 ' A' ' 159' ' ' VAL . 4.9 pt -108.07 158.03 8.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.991 0.424 . . . . 63.439999999999998 110.973 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.445 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 46.8 t80 -107.72 121.61 45.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.469 -0.787 . . . . 73.540000000000006 109.296 177.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.7 t -105.21 102.46 13.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.864 0.364 . . . . 74.239999999999995 110.902 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.5 ' HA2' H5'' ' B' ' 2' ' ' ' C' . . . -112.37 -177.6 19.88 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.849 -0.9 . . . . 61.439999999999998 110.849 175.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.451 ' H ' ' H6 ' ' B' ' 2' ' ' ' C' . . . 61.84 34.83 90.09 Favored Glycine 0 C--O 1.226 -0.352 0 C-N-CA 120.83 -0.7 . . . . 73.140000000000001 112.631 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.592 HD11 ' O ' ' A' ' 147' ' ' GLY . 31.7 pt -102.87 -171.77 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.87 0.366 . . . . 73.109999999999999 111.319 -176.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.677 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 1.1 tpmt? -91.2 177.02 6.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.166 -0.47 . . . . 54.43 109.736 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.663 ' H ' ' HG3' ' A' ' 113' ' ' LYS . 10.9 mp0 -64.52 -44.62 90.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.061 0.458 . . . . 63.240000000000002 110.531 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -104.79 100.36 9.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.89 -0.595 . . . . 75.109999999999999 110.602 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.7 m -145.6 120.87 10.22 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.092 -0.707 . . . . 73.099999999999994 109.092 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.407 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 11.5 pt-20 -120.1 -170.79 2.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.48 -0.327 . . . . 64.200000000000003 111.363 -173.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.738 ' HA ' HG21 ' A' ' 134' ' ' ILE . 10.9 tt0 -58.96 -45.46 90.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 75.140000000000001 112.242 -174.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -64.22 -30.33 71.39 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 120.491 -0.484 . . . . 74.129999999999995 110.176 -176.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.407 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 34.3 m80 -64.38 -56.6 13.28 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.471 -0.331 . . . . 73.219999999999999 110.529 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.534 HD13 HG11 ' A' ' 170' ' ' VAL . 1.7 mm? -60.32 -51.9 67.54 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.233 -0.439 . . . . 73.439999999999998 110.737 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -58.29 -53.51 57.47 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.847 -0.615 . . . . 65.439999999999998 111.439 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.73 -28.34 63.79 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.066 0.46 . . . . 73.109999999999999 111.843 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -86.24 -43.16 13.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.939 0.4 . . . . 62.030000000000001 111.299 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.428 ' CD1' HG21 ' A' ' 151' ' ' VAL . 41.8 m-85 -86.84 -15.5 38.96 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.718 0.636 . . . . 45.219999999999999 112.718 -172.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -22.22 66.23 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.342 0.591 . . . . 71.400000000000006 110.352 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -69.28 -19.11 63.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.264 -0.88 . . . . 74.25 110.479 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.446 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 66.7 m-85 -90.63 -34.8 15.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.873 -0.603 . . . . 75.299999999999997 110.819 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 174.82 -168.02 40.46 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.072 -1.061 . . . . 74.25 113.299 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -74.91 116.78 16.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.528 0.68 . . . . 64.209999999999994 111.573 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.482 HG21 HD11 ' A' ' 134' ' ' ILE . 40.8 mt -94.76 139.63 18.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.194 -0.912 . . . . 73.310000000000002 110.401 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -84.2 -73.03 0.44 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.889 -0.596 . . . . 74.209999999999994 110.67 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.6 m -141.81 152.17 18.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.352 -0.386 . . . . 74.5 110.57 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.738 HG21 ' HA ' ' A' ' 118' ' ' GLU . 31.7 mm -105.22 107.92 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.489 -0.56 . . . . 71.439999999999998 109.489 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 57.7 mt-10 -89.58 96.49 10.72 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.332 0.586 . . . . 64.450000000000003 110.611 -176.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.6 mt -80.04 128.28 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.589 -0.732 . . . . 74.219999999999999 109.497 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.497 ' HE1' " O3'" ' B' ' 4' ' ' ' G' . 22.1 tpp -78.87 102.91 8.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.352 0.596 . . . . 73.109999999999999 110.341 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.583 ' HB ' ' HA2' ' A' ' 143' ' ' GLY . 4.6 p -102.39 168.11 9.53 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.182 -0.917 . . . . 64.099999999999994 111.331 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.587 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 16.2 t70 -55.88 140.34 42.93 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.726 -0.472 . . . . 64.519999999999996 109.726 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.53 ' HD3' " H2'" ' B' ' 5' ' ' ' U' . 22.4 tpt180 -61.93 -21.2 64.56 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 123.427 0.455 . . . . 60.109999999999999 111.68 -172.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -119.36 -49.04 0.33 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.403 -0.904 . . . . 62.130000000000003 113.002 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.408 ' HB2' ' HG3' ' A' ' 144' ' ' LYS . 19.6 m -88.62 -11.88 44.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.059 0.392 . . . . 60.219999999999999 112.059 -172.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.583 ' HA2' ' HB ' ' A' ' 138' ' ' THR . . . 66.57 44.24 90.36 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.84 -0.695 . . . . 74.010000000000005 113.002 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.507 ' H ' ' HB3' ' A' ' 139' ' ' ASP . 27.8 mtmt -96.29 144.54 26.38 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.807 -0.442 . . . . 63.32 109.807 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -59.97 108.93 0.84 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.096 0.474 . . . . 42.219999999999999 109.927 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.02 -63.31 1.39 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.569 -0.741 . . . . 74.109999999999999 110.461 -174.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.592 ' O ' HD11 ' A' ' 112' ' ' ILE . . . -170.83 -96.97 0.1 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.539 -0.839 . . . . 52.240000000000002 111.95 -175.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.564 ' HB3' " O5'" ' B' ' 2' ' ' ' C' . 41.8 p90 -65.69 164.55 14.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.187 0.517 . . . . 73.340000000000003 111.847 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.13 169.16 18.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.793 -0.64 . . . . 63.229999999999997 110.333 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.557 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 73.1 m-85 -130.84 145.01 51.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.066 -0.515 . . . . 73.439999999999998 110.297 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.608 HG13 ' CD1' ' A' ' 134' ' ' ILE . 15.8 t -120.52 108.33 22.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.738 -0.467 . . . . 54.210000000000001 109.738 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.725 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 62.7 m -88.64 123.84 33.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.527 -0.306 . . . . 62.329999999999998 110.289 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.527 ' CD2' HG22 ' A' ' 159' ' ' VAL . 90.8 m-85 -105.5 153.3 21.93 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.831 -0.433 . . . . 75.430000000000007 109.831 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -69.28 -30.81 69.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.364 0.602 . . . . 71.530000000000001 110.334 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.443 ' O ' HG23 ' A' ' 159' ' ' VAL . 5.0 t70 -122.36 145.54 48.16 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.416 -0.811 . . . . 72.230000000000004 110.185 -175.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -82.4 -13.58 56.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.291 -0.413 . . . . 71.329999999999998 110.907 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.96 -43.87 61.77 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.064 0.459 . . . . 51.43 110.506 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.6 m -63.16 -28.11 69.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.758 -0.655 . . . . 70.129999999999995 110.468 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.628 HG11 HG13 ' A' ' 104' ' ' VAL . 29.1 t -70.99 -36.61 64.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.722 -0.672 . . . . 75.230000000000004 110.185 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.524 ' HA ' HG22 ' A' ' 163' ' ' VAL . 21.0 t70 -59.98 -36.46 77.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.724 -0.671 . . . . 74.530000000000001 110.86 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.446 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 38.0 mmtt -60.68 -24.96 66.01 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.545 0.688 . . . . 73.129999999999995 110.222 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.544 HG21 HD13 ' A' ' 107' ' ' ILE . 86.3 mt -95.51 -50.39 11.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.142 -0.935 . . . . 63.119999999999997 111.338 -173.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.609 ' HB ' ' HG2' ' A' ' 179' ' ' LYS . 19.8 m -68.96 -17.53 22.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.469 0.544 . . . . 54.409999999999997 112.469 -173.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.469 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.2 pp -68.01 -29.92 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.013 0.375 . . . . 71.239999999999995 112.013 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -110.26 174.58 5.8 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.465 -0.568 . . . . 74.120000000000005 109.465 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.573 ' HE3' ' HG3' ' A' ' 176' ' ' GLU . 53.2 tttp -114.65 -60.95 1.82 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.75 0.309 . . . . 73.329999999999998 111.224 -173.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 11.8 m-30 -77.06 104.17 7.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.448 0.642 . . . . 73.049999999999997 111.249 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.409 ' CE1' HG23 ' A' ' 162' ' ' ILE . 9.2 m-70 -102.27 173.16 6.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.097 -0.956 . . . . 75.510000000000005 109.988 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 28.1 m -124.48 98.56 5.79 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.081 0.467 . . . . 74.420000000000002 111.076 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.534 HG11 HD13 ' A' ' 121' ' ' LEU . 58.2 t -109.52 131.8 59.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.603 -0.518 . . . . 74.340000000000003 109.603 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 65.3 t30 63.67 14.94 8.56 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.588 0.709 . . . . 72.219999999999999 110.475 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.09 -4.64 81.34 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.851 -0.69 . . . . 62.450000000000003 112.413 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.522 ' O ' ' HA ' ' A' ' 169' ' ' THR . 39.6 m80 -98.73 157.37 16.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.814 0.34 . . . . 64.420000000000002 110.512 -177.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -84.74 118.48 24.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.059 -0.519 . . . . 74.400000000000006 109.724 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 36.8 m -118.38 173.47 6.8 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.833 -0.621 . . . . 64.209999999999994 110.305 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.573 ' HG3' ' HE3' ' A' ' 166' ' ' LYS . 1.3 tm-20 -130.24 114.68 15.96 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.571 -0.529 . . . . 63.299999999999997 109.571 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 2.3 m -113.71 147.34 17.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.202 0.525 . . . . 63.409999999999997 111.671 -171.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.457 ' NH2' ' C2 ' ' B' ' 2' ' ' ' C' . 64.6 mtt180 -134.2 172.09 13.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 73.109999999999999 110.643 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.609 ' HG2' ' HB ' ' A' ' 163' ' ' VAL . 28.6 mtpt -77.9 111.52 13.83 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.361 -0.978 . . . . 72.109999999999999 108.361 172.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.701 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -72.04 107.67 4.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.287 0.565 . . . . 64.129999999999995 112.32 -172.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -101.24 134.18 44.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.468 -0.787 . . . . 73.430000000000007 109.061 173.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.4 m -47.64 135.37 11.57 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.386 0.429 . . . . 63.43 111.535 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.8 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 16.2 pttp -56.93 -32.48 66.01 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.175 -0.466 . . . . 72.209999999999994 111.203 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -59.44 -34.4 72.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.888 -0.596 . . . . 71.310000000000002 110.458 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -93.0 -37.16 12.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.516 -0.766 . . . . 74.319999999999993 110.886 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.8 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 25.3 ptm -63.66 -24.3 67.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.595 -0.275 . . . . 72.450000000000003 110.822 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.59 -36.9 79.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.079 0.466 . . . . 61.119999999999997 110.269 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 16.1 m -85.55 -36.86 20.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.749 -0.659 . . . . 55.109999999999999 110.922 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -70.2 -45.25 66.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.05 -0.523 . . . . 74.329999999999998 111.786 -174.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 28.6 m -72.94 122.28 21.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.54 -0.755 . . . . 51.43 111.682 -173.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 61.7 m -89.1 175.53 7.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.989 -0.55 . . . . 62.43 110.171 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 20.0 m -83.01 57.88 4.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.117 0.484 . . . . 72.299999999999997 110.545 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.53 ' OE1' ' HD2' ' A' ' 194' ' ' ARG . 6.6 tp-100 -155.27 120.78 4.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.096 -0.502 . . . . 64.400000000000006 110.447 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.55 ' H ' ' HD2' ' A' ' 194' ' ' ARG . 0.0 OUTLIER -67.21 111.36 3.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.481 0.658 . . . . 60.509999999999998 110.181 177.717 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 117.17 -29.03 6.95 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.648 -0.705 . . . . 71.409999999999997 111.621 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 196' ' ' ARG . 46.7 mtm180 . . . . . 0 C--O 1.252 1.215 0 CA-C-O 118.072 -0.966 . . . . 71.209999999999994 110.337 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 1.011 " H4'" " H5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.739 0 O4'-C4'-C3' 103.283 -1.584 OUTLIER-EPSILON 0.0 '__' . 71.109999999999999 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 1.011 " H5'" " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.97 0 C4'-C3'-C2' 105.571 2.871 . 0.0 OUTLIER epsilon-1 72.310000000000002 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.701 ' N1 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.426 -0.85 0 C4'-C3'-C2' 104.571 1.871 . 0.0 OUTLIER alpha 73.310000000000002 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.569 " C2'" ' HE3' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.425 -0.939 0 C3'-C2'-C1' 100.534 -1.074 . 0.0 OUTLIER alpha 73.010000000000005 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.587 ' O4 ' ' HA ' ' A' ' 139' ' ' ASP . . . . . . . . 0 O5'--C5' 1.423 -1.046 0 O4'-C1'-C2' 108.051 1.179 . 0.0 OUTLIER . 73.540000000000006 . . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.533 " H3'" ' HD2' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 C3'-C2'-C1' 104.102 2.891 . 0.0 OUTLIER . 73.209999999999994 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.3 p . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 110.107 -0.331 . . . . 71.209999999999994 110.107 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -79.07 90.86 4.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.104 0.478 . . . . 65.239999999999995 110.435 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -115.48 94.17 38.97 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.758 -0.655 . . . . 73.430000000000007 110.509 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -89.66 153.85 5.19 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.913 2.408 . . . . 64.219999999999999 112.494 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.565 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 72.19 31.55 63.78 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.919 -0.657 . . . . 52.509999999999998 112.865 177.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.95 -27.79 30.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.317 0.58 . . . . 74.230000000000004 110.904 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -97.87 20.02 12.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.519 -0.764 . . . . 74.25 110.082 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.565 HD12 ' HA2' ' A' ' 99' ' ' GLY . 44.6 mt -134.16 144.27 48.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.098 -0.501 . . . . 52.229999999999997 111.201 -174.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.6 p -84.94 101.4 12.31 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.186 -0.672 . . . . 74.409999999999997 109.186 169.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.442 HG11 ' CG ' ' A' ' 179' ' ' LYS . 13.0 p -102.32 142.8 15.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.666 -0.697 . . . . 74.200000000000003 110.439 -172.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.775 ' HA ' HG21 ' A' ' 159' ' ' VAL . 25.7 mtmt -119.29 -1.76 10.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.162 -0.472 . . . . 64.340000000000003 111.449 -177.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.635 ' HE3' ' O6 ' ' B' ' 4' ' ' ' G' . 28.6 ttpt -124.78 133.9 52.97 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.072 0.463 . . . . 74.439999999999998 109.936 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.529 HG12 ' HB ' ' A' ' 151' ' ' VAL . 10.5 pt -107.43 162.99 5.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.908 -0.587 . . . . 55.119999999999997 111.036 -178.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 55.9 t80 -113.74 119.28 36.85 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.53 -0.759 . . . . 72.150000000000006 109.884 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.3 t -109.85 106.41 20.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.147 -0.479 . . . . 65.439999999999998 109.878 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -117.78 159.9 13.96 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.901 -0.666 . . . . 75.409999999999997 112.068 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.431 ' HA2' ' P ' ' B' ' 2' ' ' ' C' . . . 83.18 20.05 61.47 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.482 -0.866 . . . . 71.239999999999995 112.287 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.586 HG22 ' SG ' ' A' ' 175' ' ' CYS . 18.6 pt -84.52 175.46 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.849 0.357 . . . . 75.200000000000003 110.302 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -93.58 162.99 13.73 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.921 -0.4 . . . . 65.409999999999997 109.921 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.2 -13.06 62.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.434 . . . . 74.209999999999994 110.405 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -77.2 -25.36 51.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 44.299999999999997 110.231 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.2 m -74.84 124.63 27.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.778 -0.646 . . . . 74.420000000000002 110.993 -175.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.403 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 12.6 pt-20 -130.84 -170.54 2.37 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.338 -0.392 . . . . 73.400000000000006 110.544 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.596 ' HA ' HG21 ' A' ' 134' ' ' ILE . 8.0 tt0 -52.52 -50.63 62.43 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.485 0.55 . . . . 71.430000000000007 112.485 -175.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -63.36 -27.23 69.17 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.15 -0.22 . . . . 75.120000000000005 110.864 -175.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.403 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 35.5 m80 -68.53 -50.03 55.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.829 -0.169 . . . . 71.040000000000006 110.726 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.495 HD13 HG11 ' A' ' 170' ' ' VAL . 1.2 mm? -60.4 -51.69 68.42 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.644 -0.502 . . . . 75.319999999999993 109.644 175.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -55.21 -50.37 69.58 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.542 -0.753 . . . . 74.239999999999995 111.285 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -54.35 -36.12 63.49 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.89 0.376 . . . . 65.209999999999994 112.012 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -84.64 -39.93 18.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.384 -0.371 . . . . 74.310000000000002 111.15 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.428 ' CD1' HG21 ' A' ' 151' ' ' VAL . 50.9 m-85 -87.26 -17.05 33.43 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.461 0.541 . . . . 72.200000000000003 112.461 -173.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -20.82 64.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.836 0.351 . . . . 73.140000000000001 111.923 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -77.78 -16.44 58.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.024 0.44 . . . . 72.230000000000004 110.562 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.5 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 52.9 m-85 -85.01 -41.28 15.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 73.349999999999994 110.279 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' A' ' 158' ' ' SER . . . -172.21 -170.11 35.71 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.987 -0.625 . . . . 62.299999999999997 112.151 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -79.59 122.06 26.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.384 0.612 . . . . 71.099999999999994 111.508 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.529 HG21 HD11 ' A' ' 134' ' ' ILE . 43.5 mt -95.84 138.43 21.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.33 -0.85 . . . . 50.340000000000003 110.837 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -81.37 -76.65 0.24 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.665 -0.698 . . . . 73.329999999999998 110.362 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.2 m -141.48 161.27 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 71.409999999999997 110.47 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.613 ' CD1' HG13 ' A' ' 151' ' ' VAL . 23.1 mm -116.42 122.7 70.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 110.03 -0.359 . . . . 75.230000000000004 110.03 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -104.46 121.54 43.65 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.79 -0.448 . . . . 71.310000000000002 109.79 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.7 mt -95.61 -8.43 9.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.706 0.289 . . . . 72.030000000000001 110.797 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.424 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 8.5 tpp 51.32 67.91 0.88 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 122.113 0.958 . . . . 65.319999999999993 110.208 -177.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.518 HG22 ' HA ' ' A' ' 145' ' ' LYS . 7.4 p -80.91 164.38 22.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.549 -1.205 . . . . 53.119999999999997 112.025 -174.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.587 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 16.8 t70 -49.04 139.18 10.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.609 -0.723 . . . . 71.319999999999993 110.242 173.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.571 ' HD3' ' C6 ' ' B' ' 5' ' ' ' U' . 15.7 tpt180 -71.57 -12.04 61.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.388 -0.369 . . . . 72.349999999999994 111.285 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -114.47 -57.74 0.38 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.6 -0.809 . . . . 60.140000000000001 112.979 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.539 ' CB ' ' HE3' ' A' ' 144' ' ' LYS . 5.1 m -88.64 -27.69 21.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 70.299999999999997 111.802 -171.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.18 41.91 6.07 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.492 -0.861 . . . . 54.43 112.14 -176.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.563 ' H ' ' HB3' ' A' ' 139' ' ' ASP . 27.4 mmtp -77.2 127.43 32.62 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.099 -0.704 . . . . 62.340000000000003 109.099 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.518 ' HA ' HG22 ' A' ' 138' ' ' THR . 96.3 mttt -73.82 113.9 11.49 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.064 0.459 . . . . 73.329999999999998 109.96 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.516 ' HG2' ' CE2' ' A' ' 148' ' ' PHE . 0.1 OUTLIER -70.24 170.95 10.64 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.262 -0.881 . . . . 70.239999999999995 111.877 -171.102 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.581 ' HA3' " O4'" ' B' ' 1' ' ' ' U' . . . -87.66 17.97 41.54 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.975 -0.557 . . . . 72.019999999999996 112.587 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.516 ' CE2' ' HG2' ' A' ' 146' ' ' ARG . 48.8 p90 -150.76 141.7 22.94 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.797 -0.816 . . . . 71.420000000000002 108.797 173.114 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.52 172.92 12.11 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.089 0.471 . . . . 61.420000000000002 111.141 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.411 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 58.4 m-85 -131.78 136.98 47.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.624 -0.716 . . . . 62.219999999999999 109.85 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.613 HG13 ' CD1' ' A' ' 134' ' ' ILE . 42.2 t -116.06 110.37 31.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.379 -0.373 . . . . 71.019999999999996 110.315 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.613 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 9.0 m -87.05 125.45 34.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.386 -0.37 . . . . 60.310000000000002 110.094 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.464 ' CE1' HG12 ' A' ' 131' ' ' ILE . 98.2 m-85 -105.75 150.39 25.57 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.756 0.312 . . . . 71.439999999999998 110.175 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -69.73 -22.55 63.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.033 -0.531 . . . . 63.32 111.059 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -136.77 144.86 43.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.896 -0.593 . . . . 73.519999999999996 109.711 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.538 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.5 p-80 -75.46 -12.88 60.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.881 0.372 . . . . 70.019999999999996 110.293 177.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.93 -46.36 88.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 61.219999999999999 110.18 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.44 ' CB ' ' HA3' ' A' ' 129' ' ' GLY . 11.7 m -62.87 -21.64 66.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 74.319999999999993 111.08 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.775 HG21 ' HA ' ' A' ' 105' ' ' LYS . 20.2 t -80.75 -29.77 11.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.768 -0.651 . . . . 73.209999999999994 111.138 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -36.9 85.34 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.424 -0.353 . . . . 62.210000000000001 111.869 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.5 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.5 mptp? -70.24 -16.48 63.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.265 0.555 . . . . 65.040000000000006 110.572 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.439 ' CG2' HG11 ' A' ' 177' ' ' VAL . 95.9 mt -100.54 -55.06 6.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.65 -0.705 . . . . 55.210000000000001 111.731 -172.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.526 ' HB ' ' HE3' ' A' ' 179' ' ' LYS . 28.9 m -61.07 -21.98 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.903 0.705 . . . . 64.109999999999999 112.903 -174.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.437 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.4 pp -67.27 -29.57 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.017 0.437 . . . . 63.299999999999997 111.095 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -106.23 142.65 35.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.949 -0.569 . . . . 65.209999999999994 109.722 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.543 ' HE3' ' HG3' ' A' ' 176' ' ' GLU . 79.2 tttt -92.17 -71.67 0.63 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 121.057 -0.257 . . . . 72.239999999999995 111.065 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.501 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 22.7 m-85 -78.59 108.81 12.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.132 0.491 . . . . 42.210000000000001 111.307 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -106.38 158.55 16.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 65.319999999999993 110.046 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 20.2 m -96.33 100.75 12.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.801 0.334 . . . . 71.5 110.788 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.495 HG11 HD13 ' A' ' 121' ' ' LEU . 46.9 t -116.5 132.61 65.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.622 -0.51 . . . . 71.299999999999997 109.622 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 9.3 t30 63.92 20.43 12.2 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 122.056 0.931 . . . . 71.510000000000005 109.834 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 73.39 19.45 79.67 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.558 -0.746 . . . . 63.409999999999997 111.624 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -125.22 149.59 47.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.768 -0.456 . . . . 74.120000000000005 109.768 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.474 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 9.9 t30 -86.19 117.3 24.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.884 0.373 . . . . 60.520000000000003 110.847 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.586 ' SG ' HG22 ' A' ' 112' ' ' ILE . 30.9 m -129.23 158.74 38.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.989 -0.55 . . . . 63.25 110.206 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.543 ' HG3' ' HE3' ' A' ' 166' ' ' LYS . 16.1 tt0 -89.98 135.17 33.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.945 0.402 . . . . 72.420000000000002 110.681 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 64.5 t -128.8 132.0 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 115.945 -0.57 . . . . 70.230000000000004 110.562 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -150.85 -177.63 6.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.525 -0.761 . . . . 70.349999999999994 109.452 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.526 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 9.2 mptt -68.47 130.32 42.54 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.859 -0.336 . . . . 72.129999999999995 110.345 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.765 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -86.33 92.85 8.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.864 0.364 . . . . 73.299999999999997 111.129 176.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.564 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -81.5 135.23 35.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.568 -0.53 . . . . 62.530000000000001 109.568 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.5 m -50.73 142.65 10.92 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.382 0.426 . . . . 75.340000000000003 111.387 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.744 ' HE3' " C2'" ' B' ' 4' ' ' ' G' . 8.3 pttp -58.78 -31.69 68.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.064 0.459 . . . . 60.420000000000002 110.306 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -65.08 -37.7 88.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.601 -0.727 . . . . 60.310000000000002 110.522 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -83.44 -37.17 23.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.551 -0.749 . . . . 53.539999999999999 111.09 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.667 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 9.3 ptp -67.5 -22.06 65.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.848 0.356 . . . . 71.040000000000006 110.247 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.96 -25.17 66.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.935 -0.575 . . . . 74.219999999999999 110.454 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.2 m -93.08 -50.74 5.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.94 -0.573 . . . . 62.43 110.495 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.51 -52.98 55.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.083 -0.508 . . . . 74.439999999999998 111.338 -175.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.1 t -91.17 83.88 5.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.062 0.458 . . . . 62.340000000000003 110.042 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 79.8 p -156.27 146.0 21.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.876 -0.602 . . . . 71.519999999999996 110.075 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 14.7 m -97.19 -63.34 1.14 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.45 -0.341 . . . . 51.329999999999998 110.456 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -138.58 116.47 11.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.352 -0.385 . . . . 72.5 110.574 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 35.5 ttm-85 -97.01 -52.57 3.81 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.307 -0.627 . . . . 73.319999999999993 109.307 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.96 -177.04 14.68 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.254 -0.884 . . . . 71.340000000000003 111.463 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.53 -0.747 . . . . 64.530000000000001 109.705 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.581 " O4'" ' HA3' ' A' ' 147' ' ' GLY . . . . . . . . 0 O5'--C5' 1.431 -0.542 0 C3'-C2'-C1' 100.512 -1.098 . 0.0 '__' . 73.129999999999995 . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.523 " H4'" H5'' ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.088 0 C3'-C2'-C1' 103.328 2.031 . 0.0 OUTLIER . 71.129999999999995 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.989 ' H8 ' H5'' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.98 0 C3'-C2'-C1' 104.26 3.066 OUTLIER-EPSILON 0.0 OUTLIER . 74.540000000000006 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.97 ' OP1' " H4'" ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.908 0 C4'-C3'-C2' 106.152 3.452 . 0.0 OUTLIER epsilon-1 74.420000000000002 . . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.743 " H4'" ' OP2' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.046 0 C4'-C3'-C2' 105.796 3.096 OUTLIER-DELTA 0.0 OUTLIER gamma 75.420000000000002 . . . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.473 " O5'" ' HE2' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.424 -1.003 0 C4'-C3'-C2' 104.209 1.509 . 0.0 OUTLIER . 64.299999999999997 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 110.241 -0.281 . . . . 72.420000000000002 110.241 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.618 ' HB3' ' HD3' ' A' ' 178' ' ' ARG . 9.6 mm-40 -88.81 -13.14 40.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.95 0.405 . . . . 64.310000000000002 110.692 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -113.61 78.85 3.95 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 73.299999999999997 110.195 172.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 96' ' ' GLN . 1.9 Cg_endo -83.4 -1.83 10.35 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.266 2.644 . . . . 60.219999999999999 112.632 -175.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.96 56.75 0.71 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.97 -0.633 . . . . 65.230000000000004 111.555 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.93 -30.4 63.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.874 0.369 . . . . 62.310000000000002 111.157 -177.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 15.1 p-80 -79.41 -14.51 58.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.104 -0.498 . . . . 72.5 110.49 177.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 70.6 mt -86.88 138.28 31.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.976 -0.556 . . . . 72.310000000000002 110.367 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.4 p -82.88 96.99 8.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.169 0.509 . . . . 72.25 109.981 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 106' ' ' LYS . 13.1 p -91.25 134.03 31.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.446 -0.797 . . . . 75.230000000000004 110.491 -175.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.537 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 12.2 mtmt -119.0 18.0 13.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.308 0.575 . . . . 73.010000000000005 110.776 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.565 ' HE2' ' O6 ' ' B' ' 4' ' ' ' G' . 4.8 ttpm? -146.02 132.6 19.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.532 -0.758 . . . . 54.420000000000002 109.48 177.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.555 HG12 ' HB ' ' A' ' 151' ' ' VAL . 13.3 pt -103.64 164.04 3.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.108 0.48 . . . . 60.549999999999997 111.059 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 63.5 t80 -114.07 113.65 25.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.428 -0.805 . . . . 73.340000000000003 110.009 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.5 t -104.54 97.95 6.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.114 -0.494 . . . . 74.450000000000003 110.034 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.76 142.27 16.05 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.685 -0.769 . . . . 45.340000000000003 112.566 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.763 ' N ' " H5'" ' B' ' 2' ' ' ' C' . . . 106.73 25.84 6.08 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.593 -0.813 . . . . 54.310000000000002 112.222 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.535 HG22 ' SG ' ' A' ' 175' ' ' CYS . 20.6 pt -100.59 151.17 5.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.981 0.42 . . . . 75.209999999999994 110.748 -177.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.402 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 0.5 OUTLIER -119.62 -154.72 0.59 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.409 -0.589 . . . . 74.120000000000005 109.409 177.734 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.402 ' H ' ' HB3' ' A' ' 113' ' ' LYS . 30.7 mm-40 -57.15 -23.46 47.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.055 0.455 . . . . 63.530000000000001 110.73 177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.81 -43.94 77.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.257 -0.883 . . . . 71.239999999999995 112.792 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.7 m -109.64 136.32 49.19 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.569 0.581 . . . . 73.409999999999997 112.569 -167.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' HD22 ' A' ' 121' ' ' LEU . 10.6 pt-20 -138.23 -168.58 2.4 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.01 -0.541 . . . . 63.409999999999997 109.893 174.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.614 ' HA ' HG21 ' A' ' 134' ' ' ILE . 16.4 tt0 -55.2 -50.01 70.48 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.773 0.657 . . . . 71.450000000000003 112.773 -174.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.425 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.2 p80 -63.24 -27.29 69.25 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.753 -0.379 . . . . 74.549999999999997 110.694 -176.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -70.17 -51.53 30.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.318 -0.401 . . . . 70.329999999999998 110.356 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.562 HD13 HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -58.59 -49.29 78.01 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.262 -0.426 . . . . 53.229999999999997 110.286 178.122 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -59.01 -53.62 56.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.745 -0.662 . . . . 71.25 111.717 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -59.99 -29.17 68.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.762 0.315 . . . . 73.340000000000003 111.702 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.431 ' CD1' HG22 ' A' ' 170' ' ' VAL . 90.4 t80 -83.09 -43.42 16.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.499 -0.319 . . . . 72.340000000000003 110.966 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.435 ' CD1' HG21 ' A' ' 151' ' ' VAL . 46.0 m-85 -87.02 -15.3 39.08 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.729 0.64 . . . . 74.230000000000004 112.729 -173.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -22.12 66.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.088 0.471 . . . . 72.420000000000002 110.589 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -65.93 -31.06 71.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.761 -0.654 . . . . 64.439999999999998 110.082 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -80.85 -27.52 36.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.498 -0.773 . . . . 62.240000000000002 111.37 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.07 -166.84 39.75 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.352 -0.928 . . . . 74.310000000000002 112.689 177.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -80.68 120.45 24.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.326 0.584 . . . . 74.129999999999995 110.959 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.553 HG21 HD11 ' A' ' 134' ' ' ILE . 43.1 mt -93.28 141.38 14.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.46 -0.791 . . . . 70.430000000000007 110.572 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.9 -71.19 0.55 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.699 -0.682 . . . . 70.109999999999999 110.451 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.3 m -143.5 160.99 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.387 -0.369 . . . . 61.439999999999998 110.656 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.614 HG21 ' HA ' ' A' ' 118' ' ' GLU . 18.8 mm -116.41 128.95 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.946 0.403 . . . . 63.32 110.275 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -115.28 115.2 26.26 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.857 -0.61 . . . . 75.530000000000001 109.733 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.0 mt -84.04 -11.52 11.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.058 0.456 . . . . 75.109999999999999 110.363 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.447 ' HB3' ' O ' ' A' ' 148' ' ' PHE . 21.4 tpp 54.87 70.41 0.63 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.325 1.059 . . . . 64.310000000000002 110.173 -174.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.0 p -92.27 152.55 19.76 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.513 -1.222 . . . . 72.209999999999994 109.72 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -53.71 119.38 4.86 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.092 -0.706 . . . . 72.540000000000006 109.092 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.808 ' HD2' " H3'" ' B' ' 6' ' ' ' U' . 0.0 OUTLIER -77.16 15.53 0.7 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.133 0.42 . . . . 62.399999999999999 112.133 -172.403 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -128.91 -45.44 0.19 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.104 -0.57 . . . . 53.030000000000001 111.69 173.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.468 ' HB2' ' HG2' ' A' ' 144' ' ' LYS . 32.1 m -90.01 -26.47 20.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.678 0.275 . . . . 75.209999999999994 111.522 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.91 50.88 9.88 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 121.106 -0.568 . . . . 72.010000000000005 112.414 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.468 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 12.0 ptpt -127.41 143.39 51.22 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.931 -0.396 . . . . 72.209999999999994 109.931 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.467 ' HD3' ' H ' ' A' ' 145' ' ' LYS . 3.6 mppt? -64.47 131.62 47.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.687 0.279 . . . . 72.329999999999998 110.754 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -84.38 -26.24 28.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 73.120000000000005 111.055 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.512 ' HA3' " O4'" ' B' ' 1' ' ' ' U' . . . 120.11 -6.07 12.13 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.133 -1.032 . . . . 72.25 113.541 175.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.447 ' O ' ' HB3' ' A' ' 137' ' ' MET . 38.3 p90 -135.2 135.75 41.25 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 122.424 -0.457 . . . . 73.150000000000006 109.856 174.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.53 169.45 10.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.192 0.52 . . . . 72.140000000000001 111.055 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -135.49 128.89 32.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.541 -0.754 . . . . 74.409999999999997 109.574 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.604 HG13 ' CD1' ' A' ' 134' ' ' ILE . 29.7 t -108.82 110.24 31.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.755 -0.461 . . . . 73.219999999999999 109.755 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.431 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 16.4 m -86.47 125.35 33.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.451 -0.34 . . . . 74.129999999999995 110.272 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.555 ' CD2' HG12 ' A' ' 159' ' ' VAL . 97.1 m-85 -108.79 156.52 19.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.804 0.335 . . . . 73.140000000000001 110.279 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.21 -24.08 63.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.879 -0.6 . . . . 75.040000000000006 110.861 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -133.95 150.12 51.28 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.078 -0.51 . . . . 74.340000000000003 111.188 -173.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.55 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.5 p-80 -88.57 -5.13 58.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.053 -0.521 . . . . 75.420000000000002 110.723 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -73.39 -42.72 61.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.16 0.505 . . . . 71.319999999999993 110.119 174.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 m -63.85 -33.13 75.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.528 -0.76 . . . . 34.409999999999997 111.428 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.555 HG12 ' CD2' ' A' ' 153' ' ' PHE . 4.7 m -72.82 -22.24 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.501 -0.318 . . . . 74.349999999999994 110.987 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.416 ' HA ' HG22 ' A' ' 163' ' ' VAL . 33.2 t70 -63.84 -44.97 91.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.4 . . . . 74.150000000000006 111.395 -174.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -8.28 31.91 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.178 0.513 . . . . 71.540000000000006 110.508 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.507 HG21 HD13 ' A' ' 107' ' ' ILE . 69.6 mt -100.83 -50.04 10.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.665 -0.698 . . . . 64.519999999999996 110.688 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.416 HG22 ' HA ' ' A' ' 160' ' ' ASP . 27.0 m -73.37 -15.43 17.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.675 -0.693 . . . . 73.150000000000006 112.77 -175.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.5 pp -67.91 -30.05 46.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 53.439999999999998 110.979 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.423 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 15.5 pt20 -105.52 -173.37 2.28 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.684 -0.487 . . . . 72.409999999999997 109.684 173.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.471 ' HE3' ' HG3' ' A' ' 176' ' ' GLU . 46.6 tttp -127.42 -69.37 0.75 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.706 0.288 . . . . 62.009999999999998 110.56 -176.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -70.89 120.28 16.25 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.912 0.387 . . . . 71.310000000000002 110.681 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.44 ' CE1' HG23 ' A' ' 162' ' ' ILE . 28.1 m-70 -116.62 141.56 48.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.812 -0.631 . . . . 75.319999999999993 110.006 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.5 m -93.52 81.96 4.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.249 0.547 . . . . 75.239999999999995 110.585 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.562 HG11 HD13 ' A' ' 121' ' ' LEU . 22.0 t -96.33 122.15 47.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.875 -0.602 . . . . 72.400000000000006 109.744 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.9 t30 63.39 16.37 9.48 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.866 0.841 . . . . 75.430000000000007 110.248 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 87.5 -3.55 86.35 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.955 -0.641 . . . . 21.129999999999999 111.866 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -88.77 150.42 22.95 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.611 -0.514 . . . . 75.209999999999994 109.611 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -97.34 103.51 15.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.871 0.367 . . . . 75.239999999999995 110.442 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.535 ' SG ' HG22 ' A' ' 112' ' ' ILE . 31.2 m -116.74 155.08 29.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.153 -0.476 . . . . 65.140000000000001 110.436 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.471 ' HG3' ' HE3' ' A' ' 166' ' ' LYS . 11.4 tt0 -94.3 125.46 38.96 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.718 -0.475 . . . . 62.130000000000003 109.718 177.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 51.1 t -121.39 134.38 64.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.106 0.479 . . . . 74.310000000000002 111.258 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.618 ' HD3' ' HB3' ' A' ' 96' ' ' GLN . 2.3 ptt180 -146.21 -176.97 5.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.46 -0.791 . . . . 73.299999999999997 108.911 174.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.423 ' HE3' HG11 ' A' ' 104' ' ' VAL . 2.5 ptpp? -75.32 126.93 32.03 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.532 -0.467 . . . . 64.010000000000005 110.756 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.714 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -79.61 101.66 8.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.963 -0.562 . . . . 33.409999999999997 111.07 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.712 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -94.24 138.45 32.23 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.01 -0.737 . . . . 64.239999999999995 109.01 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.456 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 4.3 m -50.97 140.32 15.74 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.55 0.531 . . . . 74.319999999999993 110.773 -176.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.764 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.7 pttp -62.57 -22.63 66.5 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.876 0.369 . . . . 74.25 110.856 -177.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -66.79 -42.3 86.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.868 -0.606 . . . . 73.340000000000003 109.728 173.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.456 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 35.1 mt-10 -77.1 -38.45 52.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.757 -0.656 . . . . 71.219999999999999 110.664 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.764 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 19.8 ptm -68.23 -17.22 64.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.354 -0.385 . . . . 74.349999999999994 110.791 -177.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -67.79 -32.2 72.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.293 0.568 . . . . 65.040000000000006 109.776 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.0 t -83.16 -36.0 25.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.402 -0.817 . . . . 62.450000000000003 109.788 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' A' ' 186' ' ' MET . . . -64.16 -38.46 91.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.564 -0.744 . . . . 53.420000000000002 111.191 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 69.3 m -76.25 112.45 12.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.262 -0.881 . . . . 73.430000000000007 111.192 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.7 m -81.78 -19.53 41.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.833 -0.621 . . . . 73.319999999999993 109.757 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 11.4 p -86.78 116.93 25.19 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.68 -0.691 . . . . 72.400000000000006 110.074 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -85.11 156.02 21.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.055 -0.52 . . . . 60.109999999999999 110.828 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -81.73 -44.45 17.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.728 -0.841 . . . . 71.5 108.728 174.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.51 -175.63 29.38 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.806 -1.088 . . . . 74.209999999999994 113.191 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? . . . . . 0 C--O 1.245 0.846 0 N-CA-C 108.29 -1.004 . . . . 65.430000000000007 108.29 175.632 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 1.066 " C4'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.732 0 C3'-C2'-C1' 99.926 -1.749 . 0.0 '__' . 73.519999999999996 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 1.066 H5'' " C4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.901 0 O4'-C4'-C3' 103.438 -1.473 . 0.0 OUTLIER '7D dist 6p' 74.209999999999994 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.725 " H2'" ' SD ' ' A' ' 186' ' ' MET . . . . . . . . 0 O5'--C5' 1.424 -1.002 0 O4'-C4'-C3' 103.481 -1.442 . 0.0 OUTLIER . 72.239999999999995 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.583 " H3'" ' HD3' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.423 -1.04 0 C4'-C3'-C2' 104.599 1.899 . 0.0 OUTLIER alpha 73.109999999999999 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 1.061 " H4'" " H5'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.419 -1.312 0 C3'-C2'-C1' 102.938 1.598 . 0.0 OUTLIER gamma 72.540000000000006 . . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 1.061 " H5'" " H4'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.06 0 O4'-C1'-C2' 107.908 1.077 . 0.0 OUTLIER gamma 74.129999999999995 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.476 0.871 0 CA-C-O 121.198 0.523 . . . . 64.530000000000001 110.28 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.483 ' OE1' ' HG2' ' A' ' 178' ' ' ARG . 1.5 pt20 -118.65 100.38 7.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.799 -0.637 . . . . 75.099999999999994 110.277 178.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.765 ' HD3' ' HB2' ' A' ' 100' ' ' ALA . 5.5 ppt_? -147.69 149.43 33.64 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.62 -0.718 . . . . 73.420000000000002 111.173 -174.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 97' ' ' ARG . 5.6 Cg_endo -87.7 -81.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.555 2.17 . . . . 75.010000000000005 110.265 167.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.07 103.13 2.68 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.879 -0.889 . . . . 72.0 110.879 172.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.765 ' HB2' ' HD3' ' A' ' 97' ' ' ARG . . . -80.24 -19.2 47.41 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 70.319999999999993 111.168 -175.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -83.46 -9.02 59.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.131 -0.486 . . . . 74.430000000000007 110.479 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 84.8 mt -81.77 123.91 29.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.877 -0.601 . . . . 53.439999999999998 109.577 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.7 p -77.46 97.78 5.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.542 0.687 . . . . 75.25 111.583 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.485 HG22 ' H ' ' A' ' 106' ' ' LYS . 12.8 p -90.62 144.51 8.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.991 -1.004 . . . . 54.539999999999999 109.598 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.574 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 19.8 mtmt -121.37 9.04 10.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.171 0.51 . . . . 73.150000000000006 111.578 -176.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.638 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 28.6 ttpt -138.58 135.97 35.52 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.915 -0.584 . . . . 63.009999999999998 109.466 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.594 HD13 HG21 ' A' ' 162' ' ' ILE . 6.7 pt -107.31 159.28 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.943 0.402 . . . . 74.530000000000001 110.638 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 57.1 t80 -108.43 115.18 29.63 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.847 -0.615 . . . . 63.549999999999997 109.847 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.7 t -102.77 103.48 15.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.796 -0.446 . . . . 74.030000000000001 109.796 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.87 161.95 12.54 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.858 -0.61 . . . . 23.309999999999999 111.974 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.474 ' HA2' ' OP2' ' B' ' 2' ' ' ' C' . . . 73.28 30.28 62.95 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.55 -0.833 . . . . 73.420000000000002 112.285 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.461 ' HA ' ' SG ' ' A' ' 175' ' ' CYS . 40.2 pt -95.58 -179.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.059 0.457 . . . . 60.009999999999998 110.765 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.874 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -98.68 159.96 14.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.843 -0.799 . . . . 74.219999999999999 108.843 178.474 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.591 ' OE2' ' HG3' ' A' ' 113' ' ' LYS . 0.6 OUTLIER -76.18 -6.04 49.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.093 0.473 . . . . 72.239999999999995 110.196 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -82.62 -34.33 27.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.69 -0.686 . . . . 73.420000000000002 110.084 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.8 m -67.09 129.96 41.57 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.704 -0.68 . . . . 75.439999999999998 111.173 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.512 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 11.9 pt-20 -134.7 -162.0 1.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.767 0.318 . . . . 71.219999999999999 111.644 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.686 ' HG2' ' CG1' ' A' ' 134' ' ' ILE . 3.1 tm-20 -55.28 -54.75 39.56 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.634 -0.712 . . . . 60.530000000000001 111.714 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -63.2 -31.02 72.07 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.961 -0.296 . . . . 74.239999999999995 111.089 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.512 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 65.3 m80 -63.46 -60.32 3.52 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.261 0.553 . . . . 73.109999999999999 110.539 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.538 ' HA ' HG21 ' A' ' 170' ' ' VAL . 89.0 mt -61.41 -44.13 97.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.337 -0.847 . . . . 54.310000000000002 110.602 -177.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.547 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.5 OUTLIER -60.21 -42.63 95.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.674 -0.694 . . . . 65.019999999999996 110.846 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -58.1 -32.9 68.54 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.271 0.557 . . . . 75.430000000000007 111.438 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -88.2 -43.46 11.6 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.708 -0.678 . . . . 64.109999999999999 111.668 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 43.1 m-85 -83.74 -15.03 50.12 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.596 0.591 . . . . 73.209999999999994 112.596 -173.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.8 -19.45 65.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.115 0.484 . . . . 45.509999999999998 111.394 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -69.56 -25.15 63.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.867 -0.606 . . . . 70.25 110.441 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.48 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 80.2 m-85 -86.44 -32.06 21.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.898 -0.592 . . . . 70.299999999999997 110.368 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.594 ' HA3' ' HB3' ' A' ' 158' ' ' SER . . . -178.95 179.16 48.93 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.123 -0.791 . . . . 53.509999999999998 111.123 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -78.67 131.93 36.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.68 0.753 . . . . 74.340000000000003 109.846 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.628 HG21 HD11 ' A' ' 134' ' ' ILE . 50.2 mt -98.85 137.21 27.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.317 -0.856 . . . . 75.319999999999993 110.984 -176.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -81.35 -70.44 0.54 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.819 -0.628 . . . . 63.350000000000001 110.757 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.31 159.69 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.523 -0.308 . . . . 61.439999999999998 110.72 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.686 ' CG1' ' HG2' ' A' ' 118' ' ' GLU . 18.8 mm -117.13 109.34 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.802 -0.444 . . . . 44.439999999999998 109.802 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -85.24 95.77 9.29 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.202 -0.666 . . . . 62.149999999999999 109.202 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.511 HG21 ' HE3' ' A' ' 145' ' ' LYS . 18.8 mt -73.15 -15.84 17.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.133 0.492 . . . . 61.340000000000003 110.58 -176.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 19.7 tpp 61.0 70.78 0.59 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.023 0.916 . . . . 52.439999999999998 110.872 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 p -90.87 142.5 27.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.821 -1.081 . . . . 73.140000000000001 110.658 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -50.35 141.48 11.74 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.572 0.545 . . . . 75.420000000000002 111.108 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.559 ' H ' ' HD3' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -81.04 -1.94 46.07 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.543 -0.753 . . . . 72.340000000000003 111.327 -173.559 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -111.51 -55.26 0.49 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.876 -0.678 . . . . 73.129999999999995 112.326 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.2 m -95.81 -21.2 18.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.94 0.348 . . . . 75.129999999999995 111.94 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.79 34.16 35.4 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.52 -0.848 . . . . 71.200000000000003 112.0 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -101.02 141.15 34.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.815 0.341 . . . . 75.230000000000004 110.41 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.511 ' HE3' HG21 ' A' ' 136' ' ' ILE . 45.3 mtpt -73.64 123.28 23.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.924 -0.58 . . . . 52.32 110.65 -173.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.475 ' NH2' " H4'" ' B' ' 4' ' ' ' G' . 41.4 mtm180 -77.61 -4.25 44.97 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.383 0.882 . . . . 74.239999999999995 113.383 -171.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 98.19 4.04 57.61 Favored Glycine 0 CA--C 1.516 0.115 0 C-N-CA 120.311 -0.947 . . . . 55.020000000000003 113.446 173.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -144.56 143.64 30.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.448 -0.575 . . . . 74.299999999999997 109.448 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -133.07 158.28 43.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.036 0.446 . . . . 62.340000000000003 111.201 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -119.58 122.85 42.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.904 -0.589 . . . . 73.140000000000001 109.768 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.619 HG13 ' CD1' ' A' ' 134' ' ' ILE . 61.7 t -99.92 109.86 25.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.569 0.223 . . . . 61.32 110.567 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.638 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 19.1 m -88.63 126.8 35.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.313 -0.403 . . . . 74.099999999999994 110.858 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.555 ' CD2' HG12 ' A' ' 159' ' ' VAL . 89.1 m-85 -108.64 154.35 22.11 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.514 -0.55 . . . . 64.439999999999998 109.514 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.27 -33.49 73.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.947 -0.76 . . . . 61.509999999999998 108.947 174.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -112.96 143.91 43.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.602 -1.181 . . . . 74.519999999999996 111.543 -172.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.63 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.9 p-80 -88.87 -12.72 41.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.716 -0.674 . . . . 71.219999999999999 110.178 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.62 -36.31 73.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.364 0.602 . . . . 74.519999999999996 109.605 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.595 ' HA ' ' HE2' ' A' ' 161' ' ' LYS . 13.0 m -75.67 -19.69 58.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.199 -0.909 . . . . 72.340000000000003 111.687 -175.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.63 HG22 ' O ' ' A' ' 156' ' ' HIS . 4.0 m -81.54 -22.31 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.758 0.313 . . . . 70.519999999999996 110.833 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.451 ' HA ' HG22 ' A' ' 163' ' ' VAL . 27.8 t70 -68.23 -40.53 82.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.342 -0.39 . . . . 73.109999999999999 111.429 -172.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.595 ' HE2' ' HA ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -62.63 -19.08 63.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.327 0.584 . . . . 62.340000000000003 110.247 178.565 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.594 HG21 HD13 ' A' ' 107' ' ' ILE . 90.4 mt -94.66 -55.2 6.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.412 -0.813 . . . . 65.030000000000001 111.23 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.451 HG22 ' HA ' ' A' ' 160' ' ' ASP . 27.5 m -66.28 -14.62 17.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.645 0.609 . . . . 72.409999999999997 112.645 -173.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.428 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.6 pp -72.51 -28.67 28.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.901 0.381 . . . . 73.319999999999993 110.817 176.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.486 ' HB3' ' NE2' ' A' ' 168' ' ' HIS . 39.4 tt0 -101.97 148.82 24.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.436 -0.579 . . . . 71.200000000000003 109.436 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.641 ' HE2' ' CE2' ' A' ' 167' ' ' TYR . 83.7 tttt -93.83 -61.21 1.58 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.828 0.346 . . . . 70.430000000000007 111.014 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.641 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 22.1 m-85 -82.51 108.6 16.04 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.188 0.518 . . . . 64.420000000000002 111.382 -176.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.486 ' NE2' ' HB3' ' A' ' 165' ' ' GLN . 27.5 m-70 -111.49 142.04 44.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.556 -0.747 . . . . 75.540000000000006 110.4 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.6 m -103.1 104.92 15.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.15 0.5 . . . . 73.310000000000002 111.096 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.538 HG21 ' HA ' ' A' ' 121' ' ' LEU . 6.3 p -130.17 140.89 47.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.782 -0.645 . . . . 73.319999999999993 109.403 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.14 -15.48 0.6 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.569 0.7 . . . . 74.319999999999993 109.459 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 113.34 2.22 24.65 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.64 -0.984 . . . . 54.229999999999997 110.64 -173.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 71.4 m80 -109.48 134.24 52.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.311 -0.444 . . . . 73.530000000000001 109.818 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -86.28 106.19 17.18 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.443 -0.577 . . . . 52.140000000000001 109.443 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 63.9 m -115.99 -177.86 3.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.986 -0.552 . . . . 55.109999999999999 110.797 -175.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.612 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 14.3 tt0 -111.31 132.64 54.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.625 -0.261 . . . . 74.200000000000003 110.593 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.7 m -121.86 144.46 31.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.082 0.468 . . . . 63.219999999999999 110.495 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.483 ' HG2' ' OE1' ' A' ' 96' ' ' GLN . 51.3 mtt180 -135.33 173.72 11.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.118 -0.492 . . . . 60.420000000000002 110.215 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.558 ' HE3' ' HA ' ' A' ' 100' ' ' ALA . 66.4 mttm -70.09 119.03 13.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.645 -1.243 . . . . 75.430000000000007 107.645 167.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.562 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -75.87 93.05 3.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.111 0.482 . . . . 73.349999999999994 111.674 -175.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.695 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.4 pt? -90.73 138.3 31.69 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.935 -0.765 . . . . 75.200000000000003 108.935 173.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.427 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 12.7 m -56.43 151.83 12.53 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.136 0.273 . . . . 74.219999999999999 110.64 -176.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.77 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.1 pttp -59.14 -28.38 66.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.353 0.597 . . . . 75.230000000000004 109.7 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -60.51 -42.36 96.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.977 -1.011 . . . . 44.0 110.628 173.191 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 32.7 mt-10 -85.68 -35.21 21.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.395 -0.82 . . . . 72.099999999999994 110.768 -174.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.77 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.6 ptm -72.22 -16.05 61.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.513 . . . . 43.100000000000001 110.587 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.24 -26.7 60.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 71.010000000000005 110.13 173.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 43.4 m -88.82 -45.31 9.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.82 -0.627 . . . . 72.219999999999999 110.681 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.8 -37.09 85.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 74.219999999999999 111.336 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 35.1 t -113.52 131.68 55.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.942 0.401 . . . . 71.310000000000002 110.437 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 24.3 m -114.19 -34.74 5.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.997 -0.547 . . . . 64.540000000000006 110.407 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 13.1 t -158.95 -163.52 1.25 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.772 -0.455 . . . . 70.099999999999994 109.772 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -91.81 -13.5 31.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.219 0.533 . . . . 63.439999999999998 109.701 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -101.52 123.92 46.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.519 -0.764 . . . . 70.319999999999993 109.803 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 90.06 -84.81 1.36 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.021 -0.831 . . . . 53.340000000000003 111.021 -176.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.492 -0.766 . . . . 72.099999999999994 109.674 176.329 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.954 H5'' " H4'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.665 0 C4'-C3'-C2' 103.754 1.054 . 0.0 '__' . 71.310000000000002 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.954 " H4'" H5'' ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.977 0 C3'-C2'-C1' 103.18 1.866 . 0.0 OUTLIER . 72.150000000000006 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.656 " H2'" ' SD ' ' A' ' 186' ' ' MET . . . . . . . . 0 O5'--C5' 1.425 -0.967 0 O4'-C4'-C3' 103.363 -1.527 . 0.0 OUTLIER . 74.129999999999995 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.475 " H4'" ' NH2' ' A' ' 146' ' ' ARG . . . . . . . . 0 O5'--C5' 1.424 -1.024 0 C3'-C2'-C1' 98.72 -3.089 . 0.0 OUTLIER alpha 73.510000000000005 . . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 1.005 ' C6 ' " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.99 0 C4'-C3'-C2' 105.23 2.53 OUTLIER-DELTA 0.0 OUTLIER . 73.030000000000001 . . . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.835 0 C4'-C3'-C2' 103.416 0.716 . 0.0 OUTLIER . 73.519999999999996 . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.8 m . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 120.847 0.356 . . . . 61.350000000000001 110.949 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -96.36 141.04 30.15 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.831 -0.433 . . . . 75.310000000000002 109.831 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.829 ' HG3' ' HB2' ' A' ' 100' ' ' ALA . 11.7 ptm180 -69.45 129.31 91.72 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.417 -0.957 . . . . 71.200000000000003 108.417 171.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.686 ' HG2' ' HB2' ' A' ' 179' ' ' LYS . 15.0 Cg_endo -57.46 97.81 0.08 OUTLIER 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.219 2.612 . . . . 70.409999999999997 113.652 -167.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.444 ' HA3' HD12 ' A' ' 102' ' ' LEU . . . 55.56 64.09 4.69 Favored Glycine 0 C--O 1.224 -0.473 0 CA-C-N 115.415 -0.811 . . . . 65.530000000000001 112.835 176.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.829 ' HB2' ' HG3' ' A' ' 97' ' ' ARG . . . -70.74 -25.53 62.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.998 0.428 . . . . 63.119999999999997 110.8 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 22.8 p-80 -84.93 0.66 50.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.901 -0.59 . . . . 72.25 110.247 176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.444 HD12 ' HA3' ' A' ' 99' ' ' GLY . 51.6 mt -107.32 126.44 52.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.552 -0.749 . . . . 71.109999999999999 109.922 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.0 p -66.46 112.55 4.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 64.420000000000002 110.719 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.578 ' HB ' ' HZ3' ' A' ' 179' ' ' LYS . 8.7 p -104.54 136.63 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.298 -0.41 . . . . 61.32 109.918 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 19.3 mtmt -122.32 20.13 10.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.324 0.583 . . . . 71.299999999999997 110.991 -177.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.62 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 30.0 ttpt -150.85 136.94 18.36 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.377 -0.829 . . . . 73.230000000000004 108.973 174.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.551 HD13 HG21 ' A' ' 162' ' ' ILE . 2.7 pt -110.12 153.95 11.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.937 0.399 . . . . 61.0 110.342 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 74.0 t80 -100.89 120.74 40.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.736 -0.665 . . . . 73.129999999999995 110.012 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.462 HG11 HD11 ' A' ' 121' ' ' LEU . 47.0 t -107.6 113.67 44.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.753 0.311 . . . . 73.510000000000005 110.411 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.05 155.56 20.33 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.657 -0.782 . . . . 73.019999999999996 112.598 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.461 ' H ' " H5'" ' B' ' 2' ' ' ' C' . . . 88.32 24.59 33.55 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.058 -0.591 . . . . 41.240000000000002 112.897 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.9 pt -81.61 69.18 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.432 0.634 . . . . 71.510000000000005 111.599 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -49.41 -57.09 7.58 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.105 -0.952 . . . . 72.409999999999997 113.004 -173.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.92 29.25 0.33 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.653 0.612 . . . . 71.129999999999995 112.653 -170.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.423 ' CG ' ' HZ3' ' A' ' 145' ' ' LYS . 34.1 t70 66.63 98.41 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.618 0.723 . . . . 64.25 112.046 175.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.468 HG23 ' CB ' ' A' ' 120' ' ' HIS . 86.0 m -113.87 138.49 50.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.515 -0.766 . . . . 71.400000000000006 110.1 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.549 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 10.2 pt-20 -125.99 -170.85 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.415 -0.178 . . . . 71.209999999999994 110.862 -177.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.758 ' HA ' HG21 ' A' ' 134' ' ' ILE . 19.1 tt0 -55.87 -53.19 59.78 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.58 0.585 . . . . 74.540000000000006 112.58 -174.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.4 p-80 -59.09 -30.51 68.15 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.071 -0.251 . . . . 74.340000000000003 110.581 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.549 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 41.9 m80 -64.91 -55.95 16.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.157 -0.474 . . . . 71.329999999999998 110.327 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -61.24 -48.07 83.13 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.296 -0.411 . . . . 62.450000000000003 110.689 -179.408 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.418 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 3.1 tpp180 -61.65 -48.98 78.39 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.263 -0.426 . . . . 73.230000000000004 111.49 -176.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.55 -31.52 68.04 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.31 0.576 . . . . 64.450000000000003 110.958 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.407 ' HE1' ' HB3' ' A' ' 168' ' ' HIS . 38.8 t80 -86.83 -44.21 11.9 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.834 -0.621 . . . . 74.0 111.305 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.418 ' CD1' HG21 ' A' ' 151' ' ' VAL . 47.2 m-85 -86.16 -13.84 45.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.054 0.761 . . . . 71.209999999999994 113.054 -172.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.51 -22.27 65.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.047 0.451 . . . . 74.400000000000006 110.839 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -66.6 -25.8 66.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.731 -0.668 . . . . 61.350000000000001 110.463 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.467 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 72.1 m-85 -84.88 -30.24 24.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.663 -0.699 . . . . 70.129999999999995 110.851 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.438 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 175.93 -174.8 47.14 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.717 -0.754 . . . . 75.129999999999995 111.881 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 20.1 ptmt -79.11 129.55 34.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.811 0.815 . . . . 74.230000000000004 109.976 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.55 HG21 HD11 ' A' ' 134' ' ' ILE . 48.1 mt -98.94 142.56 14.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.246 -0.888 . . . . 62.299999999999997 110.528 -176.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -85.89 -75.63 0.37 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.953 -0.567 . . . . 72.329999999999998 110.159 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.6 m -139.35 155.56 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.327 -0.397 . . . . 71.140000000000001 110.611 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.758 HG21 ' HA ' ' A' ' 118' ' ' GLU . 24.0 mm -110.87 107.8 23.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.25 -0.648 . . . . 63.420000000000002 109.25 175.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 88.0 mt-10 -91.2 97.54 11.19 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.098 0.475 . . . . 73.200000000000003 110.955 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.615 HD11 ' H ' ' A' ' 118' ' ' GLU . 32.3 mt -81.1 103.75 8.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.313 -0.625 . . . . 62.310000000000002 109.313 176.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.6 tpp -67.41 122.92 19.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.425 0.631 . . . . 71.25 110.668 -177.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.7 p -108.53 163.91 12.81 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.103 -0.953 . . . . 72.219999999999999 111.509 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.693 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 22.9 t70 -57.68 139.51 53.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.45 -0.796 . . . . 73.129999999999995 109.822 175.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.635 ' HD3' " H2'" ' B' ' 5' ' ' ' U' . 9.5 tpt180 -65.26 -23.18 66.98 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.094 -0.503 . . . . 71.340000000000003 111.288 -172.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -108.16 -54.28 0.63 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.557 -0.83 . . . . 45.43 113.059 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.8 t -84.46 -19.56 33.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 70.310000000000002 110.979 -173.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.33 30.41 69.3 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.606 -0.806 . . . . 73.400000000000006 111.898 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -95.93 162.17 13.69 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.334 -0.617 . . . . 74.049999999999997 109.334 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.423 ' HZ3' ' CG ' ' A' ' 115' ' ' ASP . 53.9 mtpt -65.17 115.12 5.19 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.028 0.442 . . . . 63.509999999999998 110.796 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.415 ' HD3' ' O4 ' ' B' ' 5' ' ' ' U' . 23.6 tpt180 -66.79 -58.05 5.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.537 -0.756 . . . . 74.420000000000002 112.252 -173.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.787 ' HA3' " H2'" ' B' ' 1' ' ' ' U' . . . 158.95 -17.73 0.26 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.985 -1.102 . . . . 34.43 112.654 -175.048 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.743 ' HB3' " H4'" ' B' ' 2' ' ' ' C' . 35.4 p90 -136.68 158.23 44.92 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 122.69 -0.3 . . . . 73.340000000000003 110.245 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.96 169.48 17.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.212 -0.449 . . . . 72.349999999999994 110.764 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.578 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 66.6 m-85 -130.79 137.35 49.4 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.016 -0.538 . . . . 72.239999999999995 110.011 -177.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.602 HG13 ' CD1' ' A' ' 134' ' ' ILE . 18.7 t -112.27 107.13 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.811 -0.441 . . . . 75.140000000000001 109.811 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.62 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 18.4 m -86.94 126.03 34.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.323 -0.399 . . . . 70.329999999999998 110.359 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -109.41 152.1 25.8 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.776 -0.453 . . . . 70.239999999999995 109.776 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.475 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 26.9 t70 -75.45 -22.54 57.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.404 0.621 . . . . 74.120000000000005 109.735 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -124.84 139.52 53.77 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.327 -0.851 . . . . 73.540000000000006 110.441 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.59 ' O ' HG22 ' A' ' 159' ' ' VAL . 3.8 p-80 -81.63 -5.65 58.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.345 0.593 . . . . 64.140000000000001 109.955 175.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.43 -44.11 83.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.751 -0.659 . . . . 71.150000000000006 109.991 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.438 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 3.3 m -60.15 -39.25 85.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.17 -0.923 . . . . 73.120000000000005 111.729 -177.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 156' ' ' HIS . 6.5 m -70.86 -25.91 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.391 -0.368 . . . . 73.319999999999993 111.452 -174.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -69.44 -22.32 63.66 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.578 0.214 . . . . 74.439999999999998 111.578 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.467 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 0.5 OUTLIER -89.32 -1.35 58.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.389 0.614 . . . . 61.030000000000001 109.644 177.142 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.551 HG21 HD13 ' A' ' 107' ' ' ILE . 92.5 mt -108.53 -54.6 5.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.432 -0.803 . . . . 63.030000000000001 110.782 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.519 HG11 ' HG2' ' A' ' 179' ' ' LYS . 23.9 m -71.75 -3.55 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.851 -0.613 . . . . 54.240000000000002 112.589 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.1 pp -74.39 -30.71 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.73 0.3 . . . . 70.5 111.227 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.525 ' N ' HD12 ' A' ' 164' ' ' ILE . 4.0 pt20 -114.34 176.54 5.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.916 -0.402 . . . . 73.439999999999998 109.916 173.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.591 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 79.8 tttt -113.24 -59.46 2.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.566 -0.288 . . . . 61.350000000000001 111.631 -174.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 21.0 m-85 -78.19 107.75 11.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.127 0.489 . . . . 71.230000000000004 111.083 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.407 ' HB3' ' HE1' ' A' ' 124' ' ' TYR . 16.5 m-70 -107.47 135.63 48.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.635 -0.711 . . . . 73.409999999999997 110.536 178.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.7 m -93.55 97.45 10.51 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.797 -0.638 . . . . 73.400000000000006 111.233 -175.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.99 139.44 50.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.994 -0.743 . . . . 73.310000000000002 108.994 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 71.43 -7.19 1.23 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.292 0.568 . . . . 61.43 110.275 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 108.04 -0.29 33.61 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.57 -0.612 . . . . 62.350000000000001 111.57 -176.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -115.93 146.57 41.97 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.178 -0.305 . . . . 72.319999999999993 110.178 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -90.3 104.86 17.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.981 0.896 . . . . 55.200000000000003 110.496 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 25.8 p -95.37 172.22 8.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.315 -0.857 . . . . 74.310000000000002 110.017 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.591 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 38.0 tt0 -107.99 121.39 44.71 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.85 -0.426 . . . . 75.400000000000006 109.85 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 2.8 m -109.86 145.78 16.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.983 0.42 . . . . 62.420000000000002 110.558 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -135.39 170.77 15.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.112 -0.495 . . . . 74.530000000000001 110.147 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.686 ' HB2' ' HG2' ' A' ' 98' ' ' PRO . 8.1 mtpm? -73.42 114.4 11.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.458 -0.941 . . . . 52.450000000000003 108.458 169.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.771 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -72.11 97.57 1.95 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.262 0.553 . . . . 62.219999999999999 111.735 -175.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.748 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.3 pt? -96.75 138.3 34.51 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.488 -0.778 . . . . 32.240000000000002 109.133 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.522 ' HB3' ' HG2' ' A' ' 185' ' ' GLU . 36.3 t -49.89 145.36 5.57 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.279 0.362 . . . . 40.310000000000002 110.959 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.653 ' HE2' ' OP1' ' B' ' 5' ' ' ' U' . 22.4 pttp -62.64 -23.51 67.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.152 0.501 . . . . 75.019999999999996 109.908 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -73.75 -41.4 62.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.507 -0.77 . . . . 41.119999999999997 109.487 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.522 ' HG2' ' HB3' ' A' ' 182' ' ' SER . 56.1 mm-40 -73.44 -40.85 63.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.321 -0.854 . . . . 75.299999999999997 110.943 -177.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.606 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 12.5 ptp -64.12 -24.35 67.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.784 0.326 . . . . 72.239999999999995 110.734 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -80.0 -30.15 39.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.052 0.453 . . . . 75.400000000000006 110.312 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 21.8 t -87.45 -38.09 16.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.573 -0.739 . . . . 62.509999999999998 110.829 -178.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -79.09 -40.88 30.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.108 0.48 . . . . 44.539999999999999 110.674 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.2 m -108.52 96.87 6.64 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.901 -0.591 . . . . 62.140000000000001 110.36 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.5 m -121.42 152.46 39.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.569 -0.53 . . . . 62.240000000000002 109.569 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.1 p -59.38 125.3 23.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.255 0.55 . . . . 72.140000000000001 111.192 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -91.78 131.01 37.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.551 -0.75 . . . . 62.420000000000002 110.261 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -151.36 29.64 0.63 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.823 0.821 . . . . 75.209999999999994 109.809 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -70.21 -31.68 69.0 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.495 -0.775 . . . . 63.219999999999999 112.27 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.753 -0.641 . . . . 74.010000000000005 110.319 178.105 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 1.001 " H3'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.424 -1.031 0 C1'-O4'-C4' 106.957 -2.936 OUTLIER-EPSILON 0.0 '__' . 72.140000000000001 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 1.001 H5'' " H3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.868 0 C4'-C3'-C2' 105.777 3.077 . 0.0 OUTLIER epsilon-1 72.340000000000003 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.771 ' N1 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.424 -0.99 0 C4'-C3'-C2' 104.772 2.072 . 0.0 OUTLIER gamma 74.239999999999995 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.551 ' OP1' " H4'" ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -1.015 0 C3'-C2'-C1' 99.547 -2.17 . 0.0 OUTLIER alpha 72.409999999999997 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.693 ' O4 ' ' HA ' ' A' ' 139' ' ' ASP . . . . . . . . 0 O5'--C5' 1.426 -0.855 0 O4'-C4'-C3' 103.749 -1.251 . 0.0 OUTLIER gamma 72.519999999999996 . . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.582 ' H6 ' " O5'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.852 0 O4'-C1'-C2' 107.26 0.614 . 0.101 4b . 64.519999999999996 . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.432 0.158 . . . . 64.25 110.612 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 56.66 4.81 0.17 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.019 1.328 . . . . 71.140000000000001 113.518 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -122.01 85.95 46.19 Favored Pre-proline 0 C--N 1.326 -0.423 0 O-C-N 122.018 -0.426 . . . . 71.099999999999994 110.611 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.5 ' HG2' HD22 ' A' ' 181' ' ' LEU . 15.9 Cg_exo -69.1 -63.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.374 2.049 . . . . 75.109999999999999 110.763 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.85 93.58 1.12 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.999 -0.841 . . . . 62.200000000000003 110.999 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.15 -41.11 14.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.07 0.462 . . . . 74.219999999999999 110.746 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -91.65 13.9 16.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.658 -0.701 . . . . 73.099999999999994 110.534 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -113.11 139.77 48.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.7 -0.682 . . . . 74.219999999999999 110.285 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.534 HG22 ' HB2' ' A' ' 156' ' ' HIS . 0.2 OUTLIER -90.72 118.81 30.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.807 -0.442 . . . . 71.010000000000005 109.807 178.658 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.52 HG21 ' HB3' ' A' ' 179' ' ' LYS . 2.1 t -112.0 153.63 13.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.24 -0.437 . . . . 73.319999999999993 110.365 -172.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.649 ' HA ' HG21 ' A' ' 159' ' ' VAL . 4.8 mtmt -118.33 9.04 12.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.886 0.374 . . . . 62.020000000000003 111.345 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.601 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.9 ttpt -147.02 138.4 24.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.88 0.372 . . . . 72.140000000000001 110.068 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.571 ' CG2' HG13 ' A' ' 159' ' ' VAL . 7.4 pt -109.18 162.42 6.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.208 -0.451 . . . . 62.240000000000002 111.203 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 54.3 t80 -109.14 121.28 44.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.747 -0.661 . . . . 54.210000000000001 109.912 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.1 t -105.05 104.71 17.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.899 0.38 . . . . 54.409999999999997 110.694 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -121.91 178.75 16.35 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.321 -0.712 . . . . 63.149999999999999 111.321 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.479 ' HA2' " O5'" ' B' ' 1' ' ' ' U' . . . 70.23 19.5 75.86 Favored Glycine 0 C--O 1.229 -0.164 0 C-N-CA 120.635 -0.793 . . . . 43.25 112.289 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.631 ' O ' " H2'" ' B' ' 1' ' ' ' U' . 27.6 pt -96.47 -167.72 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.753 0.311 . . . . 54.109999999999999 111.074 -177.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.449 ' HA ' " H2'" ' B' ' 1' ' ' ' U' . 47.8 pttt -120.88 163.36 18.31 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.105 -0.498 . . . . 74.049999999999997 110.14 174.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.21 -27.79 68.68 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.581 0.551 . . . . 73.420000000000002 112.256 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.48 -31.04 71.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.588 -0.278 . . . . 62.450000000000003 111.593 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.477 ' HB ' HD12 ' A' ' 112' ' ' ILE . 1.0 OUTLIER -61.54 144.37 54.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 72.450000000000003 111.166 -175.603 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.403 ' HB3' ' NZ ' ' A' ' 145' ' ' LYS . 11.2 pt-20 -158.32 -165.94 1.81 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.823 0.344 . . . . 70.040000000000006 111.71 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.744 ' HA ' HG21 ' A' ' 134' ' ' ILE . 21.5 tt0 -51.69 -56.58 12.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.282 -0.872 . . . . 63.130000000000003 112.318 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.402 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.0 p80 -61.83 -31.05 71.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.352 -0.386 . . . . 65.329999999999998 111.065 -174.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -67.6 -59.38 3.39 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.25 0.548 . . . . 65.209999999999994 110.064 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.655 HD23 HG11 ' A' ' 170' ' ' VAL . 68.8 mt -57.2 -49.58 75.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.066 -0.97 . . . . 73.420000000000002 110.973 -177.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.424 ' HG3' HD12 ' A' ' 131' ' ' ILE . 4.7 ttp180 -62.03 -37.79 86.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 74.430000000000007 111.38 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.17 -29.61 68.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.982 0.42 . . . . 64.299999999999997 110.872 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.405 ' CD1' HG22 ' A' ' 170' ' ' VAL . 83.2 t80 -91.67 -46.98 7.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.045 -0.525 . . . . 72.340000000000003 111.622 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -77.2 -14.01 59.85 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.595 0.591 . . . . 55.509999999999998 112.595 -172.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.83 -22.16 66.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.11 0.481 . . . . 64.219999999999999 110.912 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.81 -30.89 71.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.712 -0.676 . . . . 75.340000000000003 110.858 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.439 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 76.6 m-85 -82.48 -31.04 29.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.129 -0.487 . . . . 74.329999999999998 111.253 -175.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 158' ' ' SER . . . 172.66 -170.91 43.98 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.822 -1.18 . . . . 62.299999999999997 113.381 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -75.86 114.19 14.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.526 0.679 . . . . 74.209999999999994 111.342 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.517 HG21 HD11 ' A' ' 134' ' ' ILE . 35.3 mt -87.27 142.18 13.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.15 -0.932 . . . . 75.409999999999997 110.039 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -86.66 -74.68 0.42 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.106 -0.497 . . . . 73.129999999999995 110.315 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.1 m -143.86 152.37 16.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.135 -0.484 . . . . 32.539999999999999 110.079 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.744 HG21 ' HA ' ' A' ' 118' ' ' GLU . 16.2 mm -103.47 105.63 18.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.867 -0.79 . . . . 54.409999999999997 108.867 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -85.42 94.7 9.05 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.052 -0.522 . . . . 75.329999999999998 110.247 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.609 HD11 ' H ' ' A' ' 118' ' ' GLU . 31.5 mt -80.79 119.94 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.653 -0.703 . . . . 73.329999999999998 109.802 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 21.4 tpp -73.68 94.94 2.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.709 0.766 . . . . 75.420000000000002 109.434 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 145' ' ' LYS . 16.7 p -81.85 165.37 20.9 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.871 -1.059 . . . . 54.439999999999998 111.118 -176.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.779 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 31.4 t70 -53.73 133.34 42.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.071 -0.513 . . . . 64.430000000000007 109.954 177.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.586 ' HD3' " H2'" ' B' ' 5' ' ' ' U' . 11.8 tpt180 -71.16 -9.23 57.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.777 0.322 . . . . 73.439999999999998 111.56 -171.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -106.92 -53.08 0.71 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.423 -0.894 . . . . 70.140000000000001 112.718 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.5 t -102.9 -11.35 18.3 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.695 -0.297 . . . . 74.209999999999994 111.618 -174.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.507 ' HA2' ' HB ' ' A' ' 138' ' ' THR . . . 60.12 53.22 47.51 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 120.607 -0.806 . . . . 65.25 112.103 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.406 ' H ' ' HB3' ' A' ' 139' ' ' ASP . 20.5 pttp -122.51 34.91 5.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.777 0.322 . . . . 50.130000000000003 111.708 -173.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 138' ' ' THR . 56.5 mtpt 68.56 123.08 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.525 -0.761 . . . . 65.109999999999999 111.724 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.508 ' HD2' ' C4 ' ' B' ' 5' ' ' ' U' . 68.2 ttt-85 -93.72 -52.73 4.33 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.738 -0.385 . . . . 72.310000000000002 110.302 173.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.501 ' O ' HD11 ' A' ' 112' ' ' ILE . . . 174.53 -85.3 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.695 -0.764 . . . . 65.409999999999997 112.154 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.748 ' HB3' H5'' ' B' ' 2' ' ' ' C' . 47.9 p90 -65.29 158.1 27.25 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.077 0.465 . . . . 71.140000000000001 111.384 -175.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.94 166.88 26.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.857 -0.611 . . . . 72.140000000000001 110.824 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.417 ' HE2' ' N3 ' ' B' ' 3' ' ' ' A' . 55.1 m-85 -122.38 131.42 53.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.949 -0.569 . . . . 73.219999999999999 109.707 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.599 HG13 ' CD1' ' A' ' 134' ' ' ILE . 47.7 t -104.56 109.66 28.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.776 0.322 . . . . 73.329999999999998 110.324 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.601 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 12.3 m -88.02 129.51 35.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.894 -0.593 . . . . 51.420000000000002 110.175 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.508 ' CD2' HG22 ' A' ' 159' ' ' VAL . 97.8 m-85 -111.58 150.61 29.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.821 -0.437 . . . . 74.099999999999994 109.821 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.49 -13.01 60.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.575 0.703 . . . . 54.329999999999998 110.235 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -129.41 147.63 51.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.312 -0.858 . . . . 75.230000000000004 109.969 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.534 ' HB2' HG22 ' A' ' 103' ' ' THR . 2.9 p80 -85.57 -15.41 42.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.074 0.464 . . . . 71.430000000000007 110.441 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -71.73 -39.67 69.92 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.079 -0.509 . . . . 44.310000000000002 110.047 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.557 ' HB3' ' HA3' ' A' ' 129' ' ' GLY . 0.8 OUTLIER -59.94 -35.29 74.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.619 -0.719 . . . . 75.420000000000002 110.1 178.438 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 105' ' ' LYS . 22.0 t -70.22 -35.86 65.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.04 -0.982 . . . . 50.210000000000001 110.816 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.35 -38.75 92.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.897 -0.592 . . . . 74.120000000000005 112.289 -171.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.439 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -66.25 -22.15 66.31 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.337 0.589 . . . . 73.219999999999999 110.316 178.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.493 HG21 HD13 ' A' ' 107' ' ' ILE . 96.0 mt -93.59 -49.3 12.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.377 -0.829 . . . . 73.150000000000006 111.478 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.552 ' HB ' ' HE2' ' A' ' 179' ' ' LYS . 34.8 m -69.37 -14.94 19.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.591 0.589 . . . . 72.150000000000006 112.591 -173.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -75.73 -27.73 18.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.173 0.511 . . . . 72.439999999999998 110.664 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -103.36 143.84 32.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.773 -0.649 . . . . 60.340000000000003 110.158 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.641 ' HE2' ' CE2' ' A' ' 167' ' ' TYR . 83.0 tttt -91.85 -64.25 1.14 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.865 0.364 . . . . 75.109999999999999 110.714 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.641 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 15.5 m-30 -84.27 105.22 14.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.423 0.63 . . . . 75.349999999999994 112.216 -175.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -106.24 149.79 26.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.959 -1.018 . . . . 74.219999999999999 109.424 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 53.5 m -102.6 103.12 13.41 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.956 0.408 . . . . 61.399999999999999 110.975 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.655 HG11 HD23 ' A' ' 121' ' ' LEU . 31.3 t -116.8 131.38 69.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.06 -0.518 . . . . 73.439999999999998 109.85 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.7 t30 59.53 27.27 16.41 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.482 0.658 . . . . 73.519999999999996 110.401 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 76.02 5.59 80.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.854 -0.689 . . . . 72.319999999999993 112.386 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.416 ' HB2' ' HE2' ' A' ' 113' ' ' LYS . 61.4 t60 -109.11 133.09 53.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.787 0.327 . . . . 74.430000000000007 110.127 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.435 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 10.7 t30 -77.9 122.6 25.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.29 -0.414 . . . . 52.340000000000003 109.91 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 24.2 p -126.33 165.61 18.69 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.442 -0.345 . . . . 75.299999999999997 110.943 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.571 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 15.7 tt0 -108.58 118.85 37.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.998 -0.546 . . . . 72.319999999999993 110.017 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.449 HG11 HG22 ' A' ' 162' ' ' ILE . 86.9 t -110.82 132.87 58.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.17 0.51 . . . . 65.420000000000002 111.297 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -127.01 177.91 6.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.549 -0.75 . . . . 73.5 109.823 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.552 ' HE2' ' HB ' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -77.59 123.64 26.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.405 -0.961 . . . . 74.239999999999995 108.405 170.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.576 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -75.3 92.87 2.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.147 0.499 . . . . 72.140000000000001 112.089 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.587 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.5 pt? -88.13 131.24 34.78 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.537 -0.912 . . . . 74.510000000000005 108.537 171.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.5 m -58.31 153.8 14.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.476 -0.329 . . . . 73.340000000000003 110.938 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.621 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.4 pttp -63.45 -14.8 54.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.091 0.472 . . . . 74.109999999999999 111.238 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 11.4 tm0? -78.57 -43.51 26.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.099 -0.704 . . . . 61.5 109.099 173.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -73.0 -41.88 63.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.32 -0.854 . . . . 64.230000000000004 110.958 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.621 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 21.1 ptm -65.6 -21.04 66.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 63.509999999999998 110.442 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -71.57 -21.15 61.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.859 -0.61 . . . . 64.329999999999998 110.199 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.3 m -94.76 -8.98 36.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.759 -0.655 . . . . 53.130000000000003 110.182 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -93.74 -45.45 7.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.863 -0.608 . . . . 72.239999999999995 110.793 -178.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.2 t -92.64 84.82 5.1 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.187 0.517 . . . . 74.140000000000001 109.844 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 55.2 m -157.97 173.06 17.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.496 -0.774 . . . . 73.439999999999998 109.338 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 49.2 m -66.16 -19.86 65.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.116 0.484 . . . . 55.100000000000001 110.632 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -123.43 101.76 7.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.987 -0.551 . . . . 70.420000000000002 109.945 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.566 ' H ' ' HD2' ' A' ' 194' ' ' ARG . 0.7 OUTLIER -107.46 20.59 18.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.939 -0.573 . . . . 75.319999999999993 110.225 -178.406 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 113.24 -69.92 0.23 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.697 -0.961 . . . . 74.319999999999993 110.697 -174.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 80.3 mmt-85 . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.337 -0.839 . . . . 72.239999999999995 109.062 171.884 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.89 " H4'" " H5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.813 0 O4'-C1'-C2' 108.017 1.155 OUTLIER-EPSILON 0.0 '__' . 73.549999999999997 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.89 " H5'" " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.819 0 P-O3'-C3' 122.159 2.049 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 75.219999999999999 . . . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.736 ' OP1' " H4'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 C3'-C2'-C1' 103.497 2.219 . 0.0 OUTLIER epsilon-1 75.439999999999998 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.839 ' OP1' " H4'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.896 0 C3'-C2'-C1' 100.496 -1.115 . 0.0 OUTLIER alpha 75.299999999999997 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.839 " H4'" ' OP1' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.856 0 O4'-C4'-C3' 103.755 -1.246 . 0.0 OUTLIER gamma 72.420000000000002 . . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.96 0 C4'-C3'-C2' 106.067 3.367 . 0.0 OUTLIER gamma 65.420000000000002 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 164' ' ' ILE . 24.9 t . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.777 -0.453 . . . . 74.540000000000006 109.777 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.773 ' HG3' ' HA ' ' A' ' 178' ' ' ARG . 39.1 mm-40 -64.66 154.18 37.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 73.319999999999993 111.35 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -84.6 -49.99 0.6 Allowed Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 113.071 0.767 . . . . 73.420000000000002 113.071 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.26 102.4 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 121.821 1.681 . . . . 72.319999999999993 112.518 -174.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.31 49.87 42.68 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.854 -0.689 . . . . 64.439999999999998 111.968 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 1.028 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . . . -64.6 -40.15 95.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.761 0.315 . . . . 74.540000000000006 111.302 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -81.29 -5.64 58.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.059 -0.519 . . . . 72.310000000000002 110.777 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.77 143.68 26.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.137 -0.483 . . . . 70.129999999999995 111.227 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.2 p -80.83 100.35 8.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.458 -0.792 . . . . 74.109999999999999 110.355 175.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 179' ' ' LYS . 38.9 t -92.18 145.2 7.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.649 -0.705 . . . . 74.129999999999995 110.032 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.577 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 6.4 mtmt -115.79 -3.96 12.18 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.132 0.419 . . . . 62.009999999999998 112.132 -178.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.585 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.8 ttpt -135.46 134.11 39.24 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.028 -0.36 . . . . 74.319999999999993 110.028 175.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.674 HG22 HG13 ' A' ' 159' ' ' VAL . 3.3 pt -104.45 155.3 6.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.064 0.459 . . . . 75.120000000000005 110.745 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 41.8 t80 -104.83 122.93 46.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.551 -0.75 . . . . 74.299999999999997 109.785 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.434 HG12 HG23 ' A' ' 112' ' ' ILE . 3.2 t -110.65 98.59 7.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.432 -0.581 . . . . 74.430000000000007 109.432 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.493 ' O ' " H5'" ' B' ' 2' ' ' ' C' . . . -91.42 -48.02 3.36 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.674 -0.774 . . . . 62.130000000000003 113.185 -173.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 175' ' ' CYS . . . -80.28 63.77 4.09 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.627 -0.797 . . . . 61.130000000000003 113.406 -174.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.604 HG22 ' SG ' ' A' ' 175' ' ' CYS . 32.8 pt -115.28 -175.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.954 0.377 . . . . 75.430000000000007 110.637 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -124.42 172.37 9.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.099 -0.5 . . . . 54.009999999999998 109.989 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.7 -18.6 65.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 63.420000000000002 111.013 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -72.39 -28.08 62.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.941 -0.572 . . . . 74.319999999999993 110.494 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.0 m -77.78 124.47 28.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.969 -0.56 . . . . 74.540000000000006 111.384 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.72 -168.5 1.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.225 -0.443 . . . . 71.409999999999997 110.157 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.641 ' HA ' HG21 ' A' ' 134' ' ' ILE . 12.7 tt0 -55.79 -49.95 71.79 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 112.294 0.479 . . . . 65.140000000000001 112.294 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -60.53 -29.86 69.39 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 120.752 -0.379 . . . . 72.299999999999997 110.25 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -65.56 -55.87 15.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.374 -0.376 . . . . 61.43 111.009 179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.38 -47.71 84.4 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.944 0.402 . . . . 74.319999999999993 110.472 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.31 -46.32 90.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.042 -0.526 . . . . 72.439999999999998 111.385 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -57.18 -32.01 66.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.106 0.479 . . . . 50.409999999999997 111.602 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.432 ' CE1' ' HB3' ' A' ' 168' ' ' HIS . 50.6 t80 -90.63 -44.1 9.74 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.182 -0.463 . . . . 73.519999999999996 111.411 -177.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -82.77 -12.83 57.21 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.674 0.62 . . . . 63.119999999999997 112.674 -172.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -61.47 -27.25 68.44 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.68 0.276 . . . . 75.349999999999994 111.556 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -74.82 -14.96 60.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.906 0.384 . . . . 74.310000000000002 110.903 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -90.0 -26.63 20.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.312 -0.403 . . . . 64.120000000000005 110.868 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' A' ' 158' ' ' SER . . . 169.56 -170.97 43.02 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.508 -0.853 . . . . 63.229999999999997 112.533 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -75.86 122.27 23.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.28 0.562 . . . . 55.219999999999999 111.18 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.532 HG21 HD11 ' A' ' 134' ' ' ILE . 46.7 mt -95.59 137.9 22.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.415 -0.811 . . . . 74.340000000000003 110.296 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.455 ' HG2' ' N ' ' A' ' 154' ' ' ASP . 13.5 mm-40 -85.35 -70.57 0.58 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.934 -0.575 . . . . 73.430000000000007 110.403 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.22 158.75 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.531 -0.304 . . . . 73.239999999999995 110.472 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.641 HG21 ' HA ' ' A' ' 118' ' ' GLU . 23.5 mm -113.73 117.67 56.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.929 -0.397 . . . . 73.329999999999998 109.929 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 59.7 mt-10 -100.49 117.81 35.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.589 -0.522 . . . . 64.340000000000003 109.589 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.7 mt -91.65 3.76 7.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.53 0.681 . . . . 60.240000000000002 109.255 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 8.4 tpp 52.03 50.51 18.37 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 114.857 -1.065 . . . . 72.049999999999997 109.588 -175.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 2.7 p -66.42 141.88 57.78 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.039 -0.982 . . . . 72.349999999999994 110.449 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.46 ' HB3' ' H ' ' A' ' 144' ' ' LYS . 19.2 t70 -46.65 121.43 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.559 0.537 . . . . 71.200000000000003 110.213 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.581 ' NE ' ' H ' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -73.56 2.48 7.85 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.14 -0.482 . . . . 72.219999999999999 111.981 -173.327 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -107.65 -43.96 1.28 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.846 -0.692 . . . . 72.129999999999995 112.548 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.9 t -116.3 -19.99 9.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.106 0.453 . . . . 52.210000000000001 112.024 -176.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.02 56.09 2.13 Favored Glycine 0 CA--C 1.517 0.183 0 C-N-CA 120.673 -0.775 . . . . 75.299999999999997 111.965 -177.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.46 ' H ' ' HB3' ' A' ' 139' ' ' ASP . 0.0 OUTLIER -112.07 124.31 52.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.235 -0.283 . . . . 63.240000000000002 110.235 -175.12 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -61.02 130.59 47.18 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.079 0.466 . . . . 73.239999999999995 111.731 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 137' ' ' MET . 25.4 tpt180 -84.36 171.76 12.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.484 -0.78 . . . . 74.209999999999994 110.018 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.506 ' O ' " H5'" ' B' ' 1' ' ' ' U' . . . -86.18 3.0 87.56 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 121.208 -0.52 . . . . 54.030000000000001 112.599 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -142.09 153.35 44.08 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.402 -0.592 . . . . 65.439999999999998 109.402 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -136.42 172.11 13.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.214 0.53 . . . . 70.129999999999995 111.827 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.552 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 56.5 m-85 -133.32 134.97 44.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.334 -0.848 . . . . 74.519999999999996 109.433 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.61 HG13 ' CD1' ' A' ' 134' ' ' ILE . 21.2 t -112.93 108.52 25.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.858 -0.423 . . . . 72.230000000000004 109.858 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.585 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 6.7 m -88.14 127.19 35.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.168 -0.469 . . . . 75.299999999999997 110.461 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.497 ' CD2' HG22 ' A' ' 159' ' ' VAL . 86.8 m-85 -111.81 151.33 29.16 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.923 -0.399 . . . . 61.149999999999999 109.923 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.455 ' N ' ' HG2' ' A' ' 132' ' ' GLU . 28.1 t70 -76.91 -14.66 59.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.776 0.798 . . . . 74.140000000000001 110.042 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.43 ' OD1' ' HB3' ' A' ' 157' ' ' ASP . 37.0 t70 -123.93 133.32 53.75 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.002 -0.999 . . . . 32.399999999999999 111.043 -173.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.577 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 3.3 p80 -85.11 -2.07 57.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.3 -0.409 . . . . 60.030000000000001 111.357 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.43 ' HB3' ' OD1' ' A' ' 155' ' ' ASP . 22.1 t70 -94.56 -37.05 11.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.183 0.516 . . . . 34.020000000000003 109.614 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.852 ' HA ' ' HE3' ' A' ' 161' ' ' LYS . 18.5 m -57.36 -32.03 66.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.482 -0.781 . . . . 64.519999999999996 110.482 175.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.674 HG13 HG22 ' A' ' 107' ' ' ILE . 46.9 t -70.83 -29.11 36.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.462 -0.79 . . . . 64.5 110.873 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -65.64 -45.57 82.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.907 -0.588 . . . . 72.319999999999993 111.608 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.852 ' HE3' ' HA ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -65.99 -12.6 56.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.119 0.485 . . . . 61.210000000000001 111.148 178.072 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.515 HG21 HD13 ' A' ' 107' ' ' ILE . 96.9 mt -93.3 -51.8 10.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.036 -0.529 . . . . 72.540000000000006 110.84 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 25.7 m -68.25 -15.75 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.516 0.562 . . . . 52.130000000000003 112.516 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 95' ' ' SER . 2.7 pp -73.82 -27.26 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.976 0.417 . . . . 73.209999999999994 110.574 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 37.1 tt0 -102.76 150.09 23.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.092 -0.707 . . . . 72.420000000000002 109.092 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.546 ' HE2' ' HG3' ' A' ' 176' ' ' GLU . 86.6 tttt -100.16 -59.6 1.68 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.794 -0.362 . . . . 71.040000000000006 111.1 -176.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -88.19 113.43 23.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.404 0.621 . . . . 72.299999999999997 111.177 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.432 ' HB3' ' CE1' ' A' ' 124' ' ' TYR . 32.7 m-70 -109.24 139.4 44.22 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.153 -0.931 . . . . 74.109999999999999 110.219 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.2 m -92.58 101.48 13.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.123 0.487 . . . . 71.049999999999997 111.124 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 171' ' ' ASN . 4.2 p -134.15 140.02 47.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.956 -0.565 . . . . 61.009999999999998 109.728 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.438 ' HB3' ' O ' ' A' ' 170' ' ' VAL . 6.7 t30 71.71 1.16 3.78 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.729 0.776 . . . . 60.539999999999999 110.042 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.67 8.32 63.93 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.478 -0.783 . . . . 50.43 111.556 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -117.9 154.52 31.74 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.094 -0.336 . . . . 71.040000000000006 110.094 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -83.31 98.71 9.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.101 0.477 . . . . 72.230000000000004 110.341 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.604 ' SG ' HG22 ' A' ' 112' ' ' ILE . 78.6 m -101.22 123.66 45.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.817 -0.629 . . . . 74.400000000000006 111.07 -176.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.546 ' HG3' ' HE2' ' A' ' 166' ' ' LYS . 3.8 tm-20 -83.7 122.92 29.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.518 -0.764 . . . . 73.120000000000005 109.738 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.4 m -118.74 148.77 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.202 -0.454 . . . . 70.329999999999998 111.189 -171.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.773 ' HA ' ' HG3' ' A' ' 96' ' ' GLN . 75.8 mtt180 -139.59 173.4 11.57 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.036 0.446 . . . . 60.109999999999999 111.503 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 1.028 ' HE3' ' HA ' ' A' ' 100' ' ' ALA . 47.9 mttm -71.73 117.56 13.47 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.08 -1.081 . . . . 72.400000000000006 108.08 166.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.557 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -76.98 93.6 3.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.076 0.465 . . . . 72.299999999999997 111.862 -175.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.643 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.7 pt? -91.37 131.84 36.59 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.696 -0.853 . . . . 51.210000000000001 108.696 170.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.6 m -53.97 148.56 10.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.449 -0.341 . . . . 71.439999999999998 110.857 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.901 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.0 pttp -61.74 -26.54 68.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.288 0.566 . . . . 74.430000000000007 109.625 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -56.52 -38.6 72.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.994 -1.003 . . . . 73.299999999999997 110.525 172.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -95.17 -38.4 10.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.454 -0.794 . . . . 73.120000000000005 110.974 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.901 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 23.1 ptm -66.05 -20.05 66.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 72.439999999999998 110.792 -177.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -77.65 -22.6 50.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.097 -0.501 . . . . 54.32 110.595 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 18.7 m -97.11 -41.93 8.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 73.510000000000005 110.43 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -66.13 -38.77 89.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 61.409999999999997 110.855 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.9 t -117.06 113.87 22.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.003 -0.544 . . . . 54.520000000000003 110.269 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.6 t -64.3 108.78 1.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.023 -0.535 . . . . 75.209999999999994 109.673 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 14.3 m -112.11 125.38 54.04 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.138 0.495 . . . . 73.409999999999997 110.783 -175.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -114.34 89.37 3.08 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.889 -0.782 . . . . 75.030000000000001 108.889 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -90.54 -28.94 18.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.948 -0.569 . . . . 75.310000000000002 110.015 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 80.8 -52.54 4.45 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.891 -0.595 . . . . 35.32 112.366 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.225 -0.893 . . . . 74.439999999999998 109.694 179.711 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.979 " C4'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.433 -0.462 0 O5'-C5'-C4' 111.559 0.971 . 0.0 '__' . 74.129999999999995 . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.979 H5'' " C4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.974 0 C3'-C2'-C1' 104.309 3.121 OUTLIER-EPSILON 0.0 OUTLIER zeta-1 72.340000000000003 . . . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.686 ' H8 ' H5'' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.995 0 O4'-C4'-C3' 103.573 -1.377 . 0.0 OUTLIER epsilon-1 72.109999999999999 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.552 " H3'" ' HD3' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.424 -0.974 0 C4'-C3'-C2' 104.314 1.614 . 0.0 OUTLIER alpha 73.439999999999998 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.548 H5'' ' HD3' ' A' ' 140' ' ' ARG . . . . . . . . 0 O5'--C5' 1.422 -1.104 0 C3'-C2'-C1' 102.806 1.451 . 0.0 OUTLIER gamma 72.420000000000002 . . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.418 ' C5 ' ' HG3' ' A' ' 140' ' ' ARG . . . . . . . . 0 O5'--C5' 1.424 -0.983 0 C4'-C3'-C2' 104.138 1.438 . 0.0 OUTLIER gamma 73.430000000000007 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 109.907 -0.405 . . . . 73.099999999999994 109.907 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 97' ' ' ARG . 15.2 mm100 -111.12 -5.58 14.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.713 -0.221 . . . . 70.409999999999997 111.124 -175.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 100' ' ' ALA . 9.2 mmt180 68.75 107.49 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.206 0 O-C-N 123.744 0.653 . . . . 64.540000000000006 110.658 -176.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.512 ' O ' ' HB2' ' A' ' 179' ' ' LYS . 7.4 Cg_exo -71.55 120.36 6.88 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.0 2.467 . . . . 34.0 111.821 -175.365 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.457 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 70.94 32.22 66.44 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.011 -0.614 . . . . 63.219999999999999 112.499 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.566 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . . . -77.94 -7.92 57.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.175 0.512 . . . . 71.239999999999995 111.168 -178.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -116.63 11.9 14.84 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.856 -0.611 . . . . 73.299999999999997 110.115 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.457 HD12 ' HA2' ' A' ' 99' ' ' GLY . 62.5 mt -118.74 148.24 43.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.974 -0.557 . . . . 71.150000000000006 111.405 -172.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.7 p -81.06 100.08 8.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.232 -0.655 . . . . 74.329999999999998 109.232 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.471 HG21 ' HB3' ' A' ' 179' ' ' LYS . 31.9 t -102.49 138.39 26.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.785 -0.643 . . . . 52.439999999999998 110.138 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.667 ' HA ' HG21 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -110.33 -9.74 14.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.885 0.374 . . . . 40.130000000000003 110.501 -179.058 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.607 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 32.2 ttpt -126.18 135.57 51.79 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.065 0.46 . . . . 65.430000000000007 110.397 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.547 ' CG2' HG13 ' A' ' 159' ' ' VAL . 7.5 pt -104.61 161.28 4.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.163 0.506 . . . . 72.200000000000003 111.544 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 67.8 t80 -108.21 115.64 30.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.157 -0.929 . . . . 64.340000000000003 109.802 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.422 HG12 ' CG2' ' A' ' 112' ' ' ILE . 5.2 t -104.24 106.33 20.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.134 -0.321 . . . . 70.420000000000002 110.134 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.36 155.34 16.12 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.948 -0.644 . . . . 61.130000000000003 112.524 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.88 56.31 17.16 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.059 -0.591 . . . . 32.140000000000001 112.57 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.456 HG22 ' SG ' ' A' ' 175' ' ' CYS . 32.2 pt -111.36 -172.42 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.861 0.362 . . . . 74.540000000000006 110.969 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -92.18 170.74 9.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.099 -0.5 . . . . 73.120000000000005 110.019 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -74.24 -42.12 60.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 121.105 -0.238 . . . . 75.340000000000003 110.422 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -83.81 65.42 8.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.9 0.857 . . . . 71.239999999999995 109.241 173.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.6 m -146.33 100.49 3.37 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.665 -1.152 . . . . 54.43 108.574 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.415 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 12.0 pt-20 -121.15 -163.61 1.05 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.034 -0.985 . . . . 72.030000000000001 110.524 -171.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.73 ' HA ' HG21 ' A' ' 134' ' ' ILE . 9.9 tt0 -54.45 -50.63 67.23 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.319 0.489 . . . . 43.340000000000003 112.319 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.5 p-80 -64.31 -26.56 68.54 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 121.068 -0.253 . . . . 74.129999999999995 110.97 -176.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.415 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 39.1 m80 -68.46 -61.49 1.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.623 -0.262 . . . . 54.5 110.649 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.89 -50.79 69.69 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.131 -0.486 . . . . 52.439999999999998 110.434 178.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -53.46 -49.77 66.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.73 -0.668 . . . . 73.400000000000006 111.425 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.69 -28.18 68.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.676 0.274 . . . . 71.219999999999999 111.713 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -88.49 -34.86 17.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.83 0.347 . . . . 74.209999999999994 111.214 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 36.9 m-85 -92.22 -17.7 24.46 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.441 0.534 . . . . 60.310000000000002 112.441 -173.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -22.01 66.25 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.13 0.491 . . . . 72.319999999999993 110.993 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -64.15 -35.85 82.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.75 -0.659 . . . . 70.120000000000005 110.752 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.459 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 41.8 m-85 -80.93 -21.07 40.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.009 -0.541 . . . . 72.230000000000004 111.12 -176.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.54 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 166.78 -167.4 39.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.016 -1.087 . . . . 53.229999999999997 113.066 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -79.18 120.97 24.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.447 0.642 . . . . 74.230000000000004 111.231 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.534 HG21 HD11 ' A' ' 134' ' ' ILE . 45.6 mt -94.28 133.74 34.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.318 -0.855 . . . . 73.400000000000006 110.039 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 154' ' ' ASP . 20.0 mt-10 -78.03 -70.01 0.51 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 110.635 176.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.4 m -143.54 154.89 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.663 -0.244 . . . . 63.43 110.542 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.73 HG21 ' HA ' ' A' ' 118' ' ' GLU . 24.9 mm -107.34 112.69 41.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.574 -0.528 . . . . 62.549999999999997 109.574 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 89.6 mt-10 -92.63 99.85 12.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.155 0.502 . . . . 70.150000000000006 110.416 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.598 HD11 ' H ' ' A' ' 118' ' ' GLU . 31.8 mt -83.91 108.19 16.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.985 -0.552 . . . . 65.209999999999994 109.652 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.742 ' HG3' ' HB3' ' A' ' 146' ' ' ARG . 24.5 tpp -69.13 108.45 3.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.65 0.738 . . . . 73.329999999999998 109.887 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 144' ' ' LYS . 5.0 p -103.35 176.62 5.09 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.104 -0.953 . . . . 60.509999999999998 111.514 -174.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.659 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 19.9 t70 -64.34 138.78 58.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.585 -0.734 . . . . 72.019999999999996 109.559 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -66.46 -21.97 66.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.4 -0.364 . . . . 65.219999999999999 111.193 -174.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -108.8 -57.14 0.55 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.537 -0.84 . . . . 72.519999999999996 112.522 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 26.8 t -83.82 -20.54 33.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.797 0.332 . . . . 64.430000000000007 111.035 -174.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 68.63 35.25 80.36 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.726 -0.749 . . . . 72.450000000000003 112.381 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.698 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 39.4 pttt -93.25 -76.79 0.46 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.581 -0.155 . . . . 74.439999999999998 110.581 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.698 ' H ' ' HG3' ' A' ' 144' ' ' LYS . 26.3 mtpt -157.15 137.04 12.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.469 0.307 . . . . 63.350000000000001 110.386 174.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.742 ' HB3' ' HG3' ' A' ' 137' ' ' MET . 31.3 tpt180 -90.51 -26.79 19.59 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.563 -0.903 . . . . 64.329999999999998 108.563 170.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.673 ' C ' H5'' ' B' ' 1' ' ' ' U' . . . 136.97 -74.78 0.41 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.195 -0.911 . . . . 74.319999999999993 111.915 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.48 ' HB3' " H5'" ' B' ' 2' ' ' ' C' . 31.2 p90 -78.5 168.15 20.21 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 122.405 0.282 . . . . 72.510000000000005 111.096 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.32 173.28 11.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.462 -0.336 . . . . 72.040000000000006 110.741 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.521 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 88.3 m-85 -133.87 148.35 51.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.111 -0.495 . . . . 73.120000000000005 110.373 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.63 HG13 ' CD1' ' A' ' 134' ' ' ILE . 55.8 t -127.17 110.94 23.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.189 -0.46 . . . . 74.030000000000001 110.072 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.607 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 25.0 m -89.35 126.71 35.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.282 -0.417 . . . . 51.43 110.533 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.495 ' CD2' HG22 ' A' ' 159' ' ' VAL . 96.6 m-85 -108.37 149.12 29.12 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.237 -0.283 . . . . 75.409999999999997 110.237 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.505 ' N ' ' HG3' ' A' ' 132' ' ' GLU . 18.2 t70 -63.65 -29.07 70.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 70.430000000000007 111.439 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -132.21 147.63 52.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.289 -0.414 . . . . 64.319999999999993 110.616 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -21.1 61.81 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.812 -0.44 . . . . 73.010000000000005 109.812 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -58.42 -50.01 75.22 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.86 -0.609 . . . . 74.209999999999994 110.765 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.54 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 9.9 m -60.66 -29.1 69.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 72.340000000000003 110.957 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.667 HG21 ' HA ' ' A' ' 105' ' ' LYS . 20.9 t -74.29 -37.35 45.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.487 -0.779 . . . . 74.519999999999996 111.081 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.442 ' HA ' HG22 ' A' ' 163' ' ' VAL . 25.8 t70 -60.97 -38.91 87.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.361 -0.381 . . . . 72.0 112.025 -172.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.459 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 4.0 mttt -66.01 -18.56 65.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.207 0.527 . . . . 73.25 110.825 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.471 ' CG2' HG11 ' A' ' 177' ' ' VAL . 93.2 mt -98.84 -49.86 11.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.494 -0.775 . . . . 75.109999999999999 111.067 -176.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.566 ' HB ' ' HD2' ' A' ' 179' ' ' LYS . 24.7 m -67.36 -18.35 23.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.693 0.627 . . . . 73.409999999999997 112.693 -174.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.406 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.0 pp -69.46 -29.33 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.054 0.454 . . . . 60.329999999999998 111.063 177.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -108.23 144.62 35.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.04 -0.527 . . . . 74.519999999999996 109.887 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.613 ' HE3' ' OE2' ' A' ' 176' ' ' GLU . 84.3 tttt -93.64 -64.27 1.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.818 0.342 . . . . 74.430000000000007 111.167 -177.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.563 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 21.8 m-85 -83.17 106.83 15.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.076 0.465 . . . . 74.310000000000002 111.223 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -106.7 170.06 8.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.68 -0.691 . . . . 63.310000000000002 110.323 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.7 m -114.57 95.74 5.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.518 -0.31 . . . . 70.109999999999999 110.52 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 171' ' ' ASN . 6.7 p -122.75 137.72 55.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.629 -0.508 . . . . 71.420000000000002 109.629 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.41 ' HB3' ' O ' ' A' ' 170' ' ' VAL . 7.8 t30 69.73 1.93 3.61 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.641 0.734 . . . . 75.430000000000007 110.496 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.9 13.53 57.71 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.539 -0.624 . . . . 72.329999999999998 111.539 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -122.88 145.12 48.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.071 -0.344 . . . . 74.109999999999999 110.071 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.501 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 9.0 t30 -80.64 105.99 12.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.108 -0.496 . . . . 73.219999999999999 110.214 176.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.456 ' SG ' HG22 ' A' ' 112' ' ' ILE . 25.4 m -115.39 165.85 12.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.106 -0.497 . . . . 72.200000000000003 110.294 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.613 ' OE2' ' HE3' ' A' ' 166' ' ' LYS . 20.6 tt0 -99.04 134.51 41.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.949 0.404 . . . . 71.200000000000003 110.755 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 83.9 t -126.53 130.47 71.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.903 -0.59 . . . . 75.420000000000002 110.521 176.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.44 ' HD3' ' OE2' ' A' ' 176' ' ' GLU . 19.8 mtm-85 -133.58 177.89 7.35 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.075 -0.713 . . . . 74.420000000000002 109.075 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.566 ' HE3' ' HA ' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -72.06 128.9 37.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.941 -0.763 . . . . 64.530000000000001 108.941 173.156 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.755 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -84.37 86.04 7.31 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.446 -0.502 . . . . 54.350000000000001 110.88 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.589 HD23 ' N1 ' ' B' ' 3' ' ' ' A' . 2.6 pt? -80.61 135.44 36.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.198 -0.667 . . . . 71.310000000000002 109.198 175.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.8 m -49.9 136.15 18.74 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.537 0.523 . . . . 45.340000000000003 111.091 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.662 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.8 pttp -63.65 -24.66 67.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.69 0.281 . . . . 73.040000000000006 110.809 -178.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -60.98 -41.06 95.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.195 0.522 . . . . 74.420000000000002 109.94 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -84.9 -35.87 21.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.507 -0.77 . . . . 74.310000000000002 110.709 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.662 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 12.7 ptm -65.22 -20.89 66.65 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.755 0.312 . . . . 74.109999999999999 110.22 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.86 -42.73 60.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 72.430000000000007 110.289 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.2 m -71.56 -31.2 66.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.388 0.614 . . . . 52.109999999999999 110.034 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -82.17 -6.99 59.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.424 -0.807 . . . . 61.039999999999999 111.224 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 186' ' ' MET . 23.0 t -79.6 79.67 6.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.599 0.714 . . . . 74.549999999999997 110.577 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 43.5 m -152.56 25.99 0.58 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.961 -1.018 . . . . 75.530000000000001 108.497 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 33.1 m -79.52 80.47 5.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.876 -1.056 . . . . 60.109999999999999 110.631 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -115.56 11.68 15.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.574 -0.739 . . . . 74.400000000000006 109.755 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -93.75 2.47 56.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.941 -0.572 . . . . 62.109999999999999 110.674 -175.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -84.86 47.46 3.86 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.935 -0.65 . . . . 75.510000000000005 111.992 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 . . . . . 0 C--O 1.245 0.84 0 CA-C-O 118.548 -0.739 . . . . 75.140000000000001 109.613 -178.56 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.908 " H3'" " C5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.726 0 C4'-C3'-C2' 104.958 2.258 . 0.0 '__' . 73.540000000000006 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.908 " C5'" " H3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.845 0 C4'-C3'-C2' 105.367 2.667 . 0.0 OUTLIER zeta-1 75.430000000000007 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.755 ' N1 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.424 -0.982 0 O4'-C4'-C3' 103.342 -1.542 . 0.0 OUTLIER . 74.519999999999996 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.612 " C4'" H5'' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.947 0 C3'-C2'-C1' 99.94 -1.733 . 0.0 OUTLIER alpha 73.420000000000002 . . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.683 ' C4 ' ' HD3' ' A' ' 146' ' ' ARG . . . . . . . . 0 O5'--C5' 1.426 -0.897 0 O4'-C4'-C3' 103.373 -1.519 OUTLIER-EPSILON 0.0 OUTLIER gamma 75.430000000000007 . . . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.53 ' H5 ' " H1'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.98 0 C4'-C3'-C2' 103.589 0.889 . 0.0 OUTLIER epsilon-1 72.409999999999997 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.7 p . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.368 0.128 . . . . 60.130000000000003 110.71 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.883 ' HG2' ' HG2' ' A' ' 193' ' ' GLN . 77.9 mt-30 59.61 23.6 12.35 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.86 0.464 . . . . 62.329999999999998 111.442 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.492 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 13.7 mtp180 -118.65 143.88 34.34 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 63.329999999999998 111.603 -175.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.697 ' HA ' HD13 ' A' ' 181' ' ' LEU . 2.0 Cg_endo -86.06 -168.72 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.651 2.901 . . . . 70.519999999999996 111.524 172.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.67 80.57 1.04 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.653 -0.784 . . . . 74.519999999999996 111.263 173.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.6 -30.59 70.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.933 0.346 . . . . 63.43 111.933 -175.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -88.74 9.4 24.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.405 -0.361 . . . . 74.25 111.236 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -104.8 151.88 23.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.37 -0.377 . . . . 72.030000000000001 110.529 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 p -79.71 97.17 6.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.304 0.573 . . . . 65.430000000000007 110.814 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.539 HG21 ' HB3' ' A' ' 179' ' ' LYS . 2.7 t -92.39 148.71 4.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.575 -0.739 . . . . 74.209999999999994 109.836 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.738 ' HA ' HG21 ' A' ' 159' ' ' VAL . 7.0 mtmt -122.48 24.15 9.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.379 0.609 . . . . 73.400000000000006 110.332 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.531 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.8 ttpt -159.42 135.08 8.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.407 -0.815 . . . . 74.340000000000003 109.454 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.556 HG12 ' HB ' ' A' ' 151' ' ' VAL . 6.1 pt -106.44 160.6 5.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.806 0.336 . . . . 72.109999999999999 111.064 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 58.9 t80 -107.07 119.35 39.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.784 -0.644 . . . . 64.340000000000003 110.171 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 121' ' ' LEU . 43.0 t -101.3 103.16 14.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.945 0.403 . . . . 72.319999999999993 110.357 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.68 178.45 16.63 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.284 -0.726 . . . . 63.439999999999998 111.284 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.784 ' H ' H5'' ' B' ' 2' ' ' ' C' . . . 68.73 26.13 74.7 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.645 -0.788 . . . . 63.020000000000003 112.928 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.58 ' O ' " H3'" ' B' ' 1' ' ' ' U' . 28.4 pt -85.45 -163.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.255 -0.646 . . . . 74.340000000000003 109.255 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -140.08 -67.33 0.43 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.335 -0.546 . . . . 64.040000000000006 110.875 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -88.9 168.9 12.03 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.778 -0.646 . . . . 72.349999999999994 110.431 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.13 105.56 0.61 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.18 0.514 . . . . 64.109999999999999 110.732 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.6 m -101.74 117.04 34.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.428 -0.805 . . . . 72.200000000000003 109.454 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.62 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 13.1 pt-20 -97.96 -177.33 3.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.826 0.346 . . . . 75.140000000000001 111.515 -172.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.645 ' HA ' HG21 ' A' ' 134' ' ' ILE . 13.7 tt0 -59.18 -45.88 89.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.01 -0.541 . . . . 75.400000000000006 111.555 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -60.23 -27.54 67.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.324 -0.398 . . . . 44.210000000000001 110.715 -178.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.62 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 30.0 m80 -72.48 -60.75 2.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.56 -0.291 . . . . 64.209999999999994 111.017 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.43 HD13 HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -57.57 -49.22 77.09 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.983 0.421 . . . . 71.109999999999999 110.251 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.408 ' HD3' HD12 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -56.74 -44.68 81.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.811 -0.631 . . . . 73.25 111.144 -178.739 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.21 -31.11 68.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 73.129999999999995 111.411 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.412 ' CD1' HG22 ' A' ' 170' ' ' VAL . 78.7 t80 -86.97 -49.32 7.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.984 0.421 . . . . 73.140000000000001 111.09 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.506 ' CD1' HG21 ' A' ' 151' ' ' VAL . 65.3 m-85 -78.24 -14.01 59.61 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.579 0.585 . . . . 62.43 112.579 -171.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -25.23 67.72 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.68 0.252 . . . . 60.119999999999997 111.68 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -72.78 -19.33 61.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.949 0.404 . . . . 62.509999999999998 110.615 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.448 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 88.7 m-85 -83.86 -35.19 24.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.11 -0.495 . . . . 73.219999999999999 110.485 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.41 -167.67 38.36 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.438 -0.887 . . . . 72.530000000000001 112.556 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -77.59 122.68 25.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.206 0.526 . . . . 74.109999999999999 111.173 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.542 HG21 HD11 ' A' ' 134' ' ' ILE . 42.0 mt -97.41 131.15 44.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.604 -0.725 . . . . 61.32 110.504 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.416 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 7.2 mm-40 -78.01 -72.28 0.37 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.652 -0.704 . . . . 75.219999999999999 110.566 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.7 m -145.49 147.29 18.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.524 -0.307 . . . . 64.129999999999995 110.725 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.645 HG21 ' HA ' ' A' ' 118' ' ' GLU . 30.3 mm -102.83 107.71 22.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.888 -0.412 . . . . 72.409999999999997 109.888 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 38.1 mt-10 -85.96 103.2 14.45 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.792 -0.447 . . . . 72.439999999999998 109.792 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.612 HG21 ' HG2' ' A' ' 145' ' ' LYS . 23.9 mt -78.81 -11.24 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.089 0.471 . . . . 72.25 110.328 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.602 ' HE1' " O3'" ' B' ' 4' ' ' ' G' . 14.0 tpp 62.31 96.99 0.03 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.945 0.879 . . . . 72.230000000000004 110.651 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 5.1 p -101.63 151.08 22.43 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.963 -1.017 . . . . 72.150000000000006 110.69 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.67 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 17.6 t70 -52.4 142.21 17.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.585 -0.734 . . . . 72.329999999999998 110.525 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.418 ' HD3' ' C6 ' ' B' ' 5' ' ' ' U' . 15.8 tpt180 -65.43 -20.69 66.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.66 -0.7 . . . . 73.329999999999998 111.783 -171.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -122.52 -44.19 0.36 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.491 -0.862 . . . . 44.020000000000003 113.063 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.59 ' HB2' ' HG2' ' A' ' 144' ' ' LYS . 19.8 m -80.46 -21.85 41.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.787 0.327 . . . . 51.329999999999998 111.155 -175.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.84 33.54 80.2 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.062 -0.589 . . . . 51.140000000000001 112.385 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.59 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 14.0 ptpt -106.13 146.76 29.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.098 -0.334 . . . . 63.32 110.098 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LYS . . . . . 0.612 ' HG2' HG21 ' A' ' 136' ' ' ILE . 16.9 mtpt -58.41 124.05 18.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.699 0.285 . . . . 72.329999999999998 110.528 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.428 ' HD2' ' O4 ' ' B' ' 5' ' ' ' U' . 69.1 ttt180 -81.12 -55.58 4.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.925 -0.579 . . . . 74.219999999999999 111.663 -173.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 168.43 -77.32 0.11 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.461 -0.876 . . . . 71.109999999999999 112.253 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.488 ' CE2' " H4'" ' B' ' 3' ' ' ' A' . 45.9 p90 -71.36 145.53 49.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.406 -0.22 . . . . 64.25 110.406 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -128.43 165.41 20.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.332 0.587 . . . . 54.130000000000003 111.443 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.511 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 66.0 m-85 -132.06 136.28 47.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.442 -0.799 . . . . 73.409999999999997 109.757 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.631 HG13 ' CD1' ' A' ' 134' ' ' ILE . 38.9 t -111.34 104.82 17.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.864 -0.421 . . . . 64.319999999999993 109.864 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.531 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 7.5 m -83.79 125.87 32.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 75.409999999999997 110.065 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.541 ' CD2' HG22 ' A' ' 159' ' ' VAL . 98.7 m-85 -109.5 151.55 26.59 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.074 -0.343 . . . . 64.040000000000006 110.074 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.416 ' HB2' ' HG2' ' A' ' 132' ' ' GLU . 26.6 t70 -78.53 -6.38 55.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.209 0.528 . . . . 74.150000000000006 111.163 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.444 ' O ' HG23 ' A' ' 159' ' ' VAL . 5.6 t70 -140.19 145.68 37.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.174 -0.466 . . . . 74.140000000000001 110.31 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -79.21 -18.44 52.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.148 -0.478 . . . . 65.120000000000005 110.56 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -73.07 -38.56 66.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.205 0.526 . . . . 71.010000000000005 110.064 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.2 m -64.65 -28.66 69.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.518 -0.765 . . . . 52.450000000000003 110.371 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.738 HG21 ' HA ' ' A' ' 105' ' ' LYS . 22.7 t -76.78 -36.56 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.66 -0.7 . . . . 74.310000000000002 110.201 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.29 -31.09 70.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.732 -0.667 . . . . 73.030000000000001 111.387 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.448 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 13.0 mmtp -65.1 -27.57 68.84 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.47 0.652 . . . . 54.439999999999998 110.021 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.54 HG21 HD13 ' A' ' 107' ' ' ILE . 90.4 mt -100.23 -50.18 10.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.949 -1.023 . . . . 73.530000000000001 111.828 -168.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.607 ' HB ' ' HG3' ' A' ' 179' ' ' LYS . 28.1 m -65.73 -16.76 21.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.448 0.536 . . . . 70.340000000000003 112.448 -173.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.5 pp -74.48 -26.83 20.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.965 0.412 . . . . 65.349999999999994 110.781 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.407 ' N ' HD12 ' A' ' 164' ' ' ILE . 35.0 tt0 -100.42 146.2 27.3 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.695 -0.684 . . . . 71.200000000000003 109.2 175.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -100.63 -66.06 0.93 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.762 0.315 . . . . 62.399999999999999 110.598 -177.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 19.7 m-85 -82.49 101.85 10.97 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.131 0.491 . . . . 62.399999999999999 111.11 -177.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -98.0 -172.8 2.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.721 -0.672 . . . . 74.129999999999995 109.593 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 61.4 m -141.64 106.63 4.94 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.222 0.534 . . . . 54.130000000000003 110.821 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.43 HG11 HD13 ' A' ' 121' ' ' LEU . 39.2 t -121.18 135.32 61.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.631 -0.713 . . . . 62.32 109.739 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 170' ' ' VAL . 7.9 t30 71.47 -4.62 1.81 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.277 0.56 . . . . 75.450000000000003 111.393 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 109.19 4.87 30.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.954 -0.641 . . . . 70.200000000000003 111.752 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.469 ' CD2' ' HA ' ' A' ' 112' ' ' ILE . 80.3 t60 -114.63 131.61 56.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.917 0.389 . . . . 63.539999999999999 110.326 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -74.64 103.15 4.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.896 -0.593 . . . . 71.129999999999995 109.585 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 14.9 p -103.8 176.96 4.98 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.162 -0.472 . . . . 62.310000000000002 110.77 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -118.34 120.38 37.44 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.083 0.468 . . . . 74.109999999999999 110.117 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 87.1 t -113.35 135.09 54.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.898 -0.592 . . . . 72.019999999999996 111.045 -175.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -129.12 179.67 5.63 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.553 -0.749 . . . . 73.400000000000006 109.742 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.607 ' HG3' ' HB ' ' A' ' 163' ' ' VAL . 0.6 OUTLIER -77.67 122.07 24.84 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.918 -1.141 . . . . 70.109999999999999 107.918 172.391 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.544 ' HA ' ' C2 ' ' B' ' 3' ' ' ' A' . . . -77.12 89.8 3.63 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.513 -0.475 . . . . 63.009999999999998 111.199 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.697 HD13 ' HA ' ' A' ' 98' ' ' PRO . 2.3 pt? -81.35 138.96 35.6 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.805 -0.813 . . . . 53.200000000000003 108.805 175.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.1 m -54.15 145.9 16.19 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.085 -0.339 . . . . 52.039999999999999 110.085 -178.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.74 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.4 pttp -61.92 -17.51 57.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.921 0.391 . . . . 64.140000000000001 110.31 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -67.67 -51.98 43.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.377 0.608 . . . . 74.209999999999994 109.738 170.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -64.96 -41.64 95.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.309 -0.86 . . . . 75.019999999999996 110.553 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.74 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 16.4 ptm -72.76 -13.17 61.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.946 -0.57 . . . . 64.120000000000005 110.692 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -86.27 -11.26 52.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.031 0.443 . . . . 42.43 110.334 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 16.0 m -111.57 -46.07 3.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.888 -0.596 . . . . 50.229999999999997 111.37 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -90.88 -38.22 13.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.002 0.429 . . . . 63.32 111.782 -176.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.8 m -107.75 31.51 5.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.235 -0.439 . . . . 70.209999999999994 110.651 -175.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.8 m -62.24 -28.8 69.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.922 -0.581 . . . . 65.219999999999999 111.415 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 30.4 m -97.76 75.64 2.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.218 0.532 . . . . 63.299999999999997 111.341 -178.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.883 ' HG2' ' HG2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -136.87 95.47 3.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.389 -0.967 . . . . 70.120000000000005 108.389 173.372 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -87.12 103.19 15.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.909 0.385 . . . . 72.319999999999993 111.178 -174.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -87.64 -10.82 69.52 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.198 -0.761 . . . . 55.009999999999998 111.198 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.7 tpm_? . . . . . 0 C--O 1.245 0.82 0 CA-C-O 118.395 -0.812 . . . . 73.120000000000005 110.089 178.579 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.948 " H4'" " C5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.43 -0.6 0 C4'-C3'-C2' 105.212 2.512 OUTLIER-EPSILON 0.0 '__' . 75.540000000000006 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.948 " C5'" " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.053 0 C4'-C3'-C2' 106.123 3.423 . 0.0 OUTLIER epsilon-1 75.420000000000002 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.544 ' C2 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.425 -0.955 0 C3'-C2'-C1' 103.189 1.876 . 0.0 OUTLIER alpha 75.219999999999999 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.602 " O3'" ' HE1' ' A' ' 137' ' ' MET . . . . . . . . 0 O5'--C5' 1.423 -1.043 0 C3'-C2'-C1' 99.722 -1.975 . 0.0 OUTLIER alpha 75.409999999999997 . . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.711 ' C6 ' " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.059 0 C4'-C3'-C2' 105.777 3.077 OUTLIER-DELTA 0.0 OUTLIER . 74.200000000000003 . . . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.576 ' H6 ' " O5'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 P-O3'-C3' 118.933 -0.639 . 0.0 OUTLIER gamma 75.430000000000007 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.8 t . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.635 -0.506 . . . . 42.420000000000002 109.635 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.574 ' O ' ' HD3' ' A' ' 98' ' ' PRO . 73.1 mt-30 71.94 -46.75 0.65 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.573 0.749 . . . . 61.210000000000001 111.702 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.633 ' HB3' ' HB2' ' A' ' 100' ' ' ALA . 12.5 mmt180 -110.63 87.64 6.83 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.726 -0.216 . . . . 74.019999999999996 110.519 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 96' ' ' GLN . 6.1 Cg_exo -74.77 -39.18 1.41 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.637 2.225 . . . . 64.340000000000003 111.597 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.472 ' HA3' HD12 ' A' ' 102' ' ' LEU . . . -140.88 67.49 0.49 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.379 -0.828 . . . . 51.130000000000003 111.47 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.818 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . . . -74.82 -33.37 62.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.956 0.408 . . . . 55.240000000000002 110.833 -178.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -83.3 -2.63 56.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.857 -0.61 . . . . 74.150000000000006 110.338 177.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.472 HD12 ' HA3' ' A' ' 99' ' ' GLY . 68.6 mt -99.5 177.61 5.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.702 -0.681 . . . . 75.319999999999993 109.62 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.57 HG22 ' HB2' ' A' ' 156' ' ' HIS . 0.5 OUTLIER -118.13 129.51 55.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.167 0.508 . . . . 75.140000000000001 111.165 -177.688 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.456 HG12 ' H ' ' A' ' 106' ' ' LYS . 39.7 t -116.11 148.58 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.883 -0.599 . . . . 70.409999999999997 110.183 -175.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.641 ' HA ' HG21 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -116.84 -3.75 11.64 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.244 0.461 . . . . 62.439999999999998 112.244 -177.602 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.607 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 26.0 ttpt -135.31 138.59 43.58 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.015 -0.365 . . . . 63.109999999999999 110.015 177.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.48 HG13 ' HB ' ' A' ' 151' ' ' VAL . 2.1 pp -106.35 154.35 7.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.984 0.421 . . . . 74.310000000000002 110.759 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.421 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 62.4 t80 -102.23 127.21 49.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.586 -0.734 . . . . 71.140000000000001 109.996 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.505 HG21 ' HG ' ' A' ' 121' ' ' LEU . 46.7 t -102.31 110.03 27.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.88 0.372 . . . . 72.540000000000006 110.581 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.85 -174.23 13.64 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.957 -0.857 . . . . 71.109999999999999 110.957 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.38 16.91 67.86 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.219 -0.515 . . . . 63.240000000000002 113.313 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.632 ' O ' " H3'" ' B' ' 1' ' ' ' U' . 18.1 pt -91.58 173.38 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 117.115 0.458 . . . . 72.099999999999994 109.869 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -145.8 -48.32 0.22 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.002 -0.279 . . . . 75.120000000000005 110.742 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -74.91 165.85 24.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 73.409999999999997 110.523 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.93 103.67 0.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 64.019999999999996 110.207 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.6 m -113.05 116.76 30.42 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.645 -0.707 . . . . 64.019999999999996 109.948 -176.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.443 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 12.2 pt-20 -113.71 -171.95 1.99 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.359 -0.382 . . . . 63.219999999999999 110.972 -175.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.604 ' H ' HD11 ' A' ' 136' ' ' ILE . 8.5 tt0 -58.19 -46.41 85.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.877 -0.601 . . . . 73.349999999999994 112.347 -173.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -62.41 -28.98 70.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.699 0.285 . . . . 74.409999999999997 110.673 -178.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.443 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 32.3 m80 -68.05 -56.37 9.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.355 -0.384 . . . . 73.129999999999995 110.791 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.505 ' HG ' HG21 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -60.79 -51.63 68.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.282 -0.417 . . . . 62.219999999999999 110.558 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.438 ' HB2' HG13 ' A' ' 134' ' ' ILE . 0.6 OUTLIER -55.06 -49.56 71.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 75.239999999999995 111.648 -177.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -59.15 -30.14 67.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 55.299999999999997 111.218 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.456 ' CD1' HG22 ' A' ' 170' ' ' VAL . 76.6 t80 -85.25 -47.92 9.6 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.814 -0.354 . . . . 64.099999999999994 111.111 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.521 ' CD1' HG21 ' A' ' 151' ' ' VAL . 42.8 m-85 -77.48 -18.15 57.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.373 0.508 . . . . 64.140000000000001 112.373 -172.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.55 -24.51 67.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.804 0.335 . . . . 62.43 111.618 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -76.19 -14.71 60.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.108 0.48 . . . . 54.340000000000003 110.202 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -87.72 -25.52 23.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 75.140000000000001 110.319 178.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.501 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 165.22 -151.17 19.82 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 119.912 -1.137 . . . . 44.130000000000003 113.689 175.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.614 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 20.4 tptm -91.23 117.07 29.33 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.394 0.616 . . . . 62.420000000000002 111.279 -172.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.454 HG12 ' CE1' ' A' ' 153' ' ' PHE . 38.2 mt -99.81 138.8 23.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.325 -0.852 . . . . 75.140000000000001 110.69 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.427 ' HG3' ' CA ' ' A' ' 154' ' ' ASP . 21.8 mt-10 -82.59 -75.38 0.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.021 -0.536 . . . . 73.140000000000001 110.341 172.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 m -143.97 152.4 15.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.616 -0.72 . . . . 71.540000000000006 110.079 -178.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.609 ' CD1' HG13 ' A' ' 151' ' ' VAL . 22.7 mm -100.84 138.23 25.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.907 -0.775 . . . . 72.129999999999995 108.907 175.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 44.7 mt-10 -117.94 97.94 6.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.815 0.34 . . . . 72.329999999999998 110.743 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.604 HD11 ' H ' ' A' ' 118' ' ' GLU . 8.5 mt -76.21 105.51 5.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.066 -1.087 . . . . 71.420000000000002 108.066 172.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.601 ' HE2' " H4'" ' B' ' 4' ' ' ' G' . 10.4 tpt -79.94 98.46 7.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.855 0.836 . . . . 53.32 111.272 -171.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 7.5 p -89.72 -170.28 2.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.002 -0.999 . . . . 64.219999999999999 110.339 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -88.68 129.47 35.51 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.53 -0.544 . . . . 61.409999999999997 109.53 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.41 ' HD3' ' N1 ' ' B' ' 5' ' ' ' U' . 22.1 tpt180 -62.29 -19.15 62.97 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.421 0.45 . . . . 65.150000000000006 111.984 -177.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -105.6 -53.45 0.77 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.343 -0.932 . . . . 72.150000000000006 112.73 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.568 ' HB2' ' HG2' ' A' ' 144' ' ' LYS . 43.1 m -86.19 -16.95 36.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.872 0.323 . . . . 72.549999999999997 111.872 -173.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.29 36.76 92.15 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.972 -0.632 . . . . 73.510000000000005 112.489 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.568 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 13.1 ptpt -114.1 146.29 40.46 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.771 -0.455 . . . . 72.109999999999999 109.771 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -63.15 118.83 8.47 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.729 -0.389 . . . . 71.310000000000002 110.201 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -86.6 3.22 45.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.168 0.508 . . . . 72.340000000000003 110.598 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.464 ' HA3' " H1'" ' B' ' 1' ' ' ' U' . . . 109.1 -65.94 0.24 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.943 -0.646 . . . . 64.219999999999999 112.799 174.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.505 ' HA ' ' OP2' ' B' ' 2' ' ' ' C' . 33.0 p90 -75.82 150.6 37.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.269 0.556 . . . . 72.420000000000002 111.841 -173.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -135.26 171.9 13.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.514 -0.766 . . . . 54.409999999999997 110.274 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 70.1 m-85 -136.64 152.09 50.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.355 -0.384 . . . . 73.329999999999998 110.115 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.609 HG13 ' CD1' ' A' ' 134' ' ' ILE . 62.1 t -128.49 110.48 21.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.133 -0.485 . . . . 71.430000000000007 109.88 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.607 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 97.0 m -86.17 125.02 33.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.109 -0.496 . . . . 73.420000000000002 110.085 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.454 ' CE1' HG12 ' A' ' 131' ' ' ILE . 97.0 m-85 -106.06 146.79 29.68 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.871 0.367 . . . . 64.430000000000007 110.346 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.614 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 21.4 t0 -78.32 -19.13 54.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.535 0.683 . . . . 73.230000000000004 109.633 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -128.89 132.71 47.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.222 -0.899 . . . . 52.119999999999997 109.694 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.57 ' HB2' HG22 ' A' ' 103' ' ' THR . 5.1 p80 -73.96 -14.01 60.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.203 -0.453 . . . . 55.409999999999997 110.474 177.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -66.33 -40.84 90.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.195 0.522 . . . . 64.129999999999995 110.025 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.644 ' HA ' ' HE3' ' A' ' 161' ' ' LYS . 4.6 m -66.76 -28.54 68.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.419 -0.81 . . . . 52.149999999999999 110.986 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 105' ' ' LYS . 18.7 t -72.57 -35.11 49.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.722 -0.672 . . . . 62.039999999999999 111.22 -176.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -56.74 -51.47 68.73 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.084 -0.507 . . . . 71.129999999999995 111.897 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.644 ' HE3' ' HA ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -65.16 -14.08 59.72 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.996 0.369 . . . . 70.239999999999995 111.996 -178.323 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 94.5 mt -93.7 -48.27 13.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 120.661 0.267 . . . . 72.030000000000001 110.926 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.405 HG13 HG12 ' A' ' 159' ' ' VAL . 35.6 m -69.69 -19.42 22.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.343 0.497 . . . . 61.229999999999997 112.343 -175.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.39 -30.72 49.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.78 0.324 . . . . 63.340000000000003 111.529 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.506 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 14.0 pt20 -113.49 145.99 40.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.389 -0.369 . . . . 74.349999999999994 110.17 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.569 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 77.0 tttt -91.27 -60.09 1.98 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.051 -0.522 . . . . 73.120000000000005 110.513 -178.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.566 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 7.9 m-30 -72.47 110.53 6.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.259 0.552 . . . . 75.439999999999998 111.234 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.577 ' CD2' ' HB ' ' A' ' 177' ' ' VAL . 37.7 m-70 -110.85 170.92 7.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.303 -0.862 . . . . 64.340000000000003 109.583 173.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.7 m -119.41 96.04 5.04 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.841 0.353 . . . . 52.549999999999997 110.384 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.486 HG11 HD13 ' A' ' 121' ' ' LEU . 47.5 t -117.2 130.89 71.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.324 -0.398 . . . . 72.340000000000003 110.126 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.4 t30 59.7 31.49 20.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.509 0.671 . . . . 73.340000000000003 110.477 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 70.57 19.28 76.27 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.925 -0.58 . . . . 63.439999999999998 112.211 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.459 ' CD2' ' HA ' ' A' ' 112' ' ' ILE . 67.9 t60 -122.84 129.7 51.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.85 0.357 . . . . 71.200000000000003 110.617 -177.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -73.28 112.1 9.03 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.472 -0.566 . . . . 73.099999999999994 109.472 174.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 18.9 p -121.65 173.55 7.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.814 0.34 . . . . 75.510000000000005 111.382 -174.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.569 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 10.8 tt0 -108.41 116.92 32.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.838 -0.619 . . . . 75.109999999999999 110.064 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.577 ' HB ' ' CD2' ' A' ' 168' ' ' HIS . 59.4 t -120.26 134.68 62.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.233 -0.44 . . . . 71.510000000000005 110.493 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -150.54 -177.98 6.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.858 -0.61 . . . . 75.510000000000005 110.294 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.818 ' HE3' ' HA ' ' A' ' 100' ' ' ALA . 55.2 mttm -63.78 133.23 53.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.961 -0.385 . . . . 62.030000000000001 109.961 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.488 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -88.3 86.67 7.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.192 0.52 . . . . 73.030000000000001 110.538 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.734 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.3 pt? -80.8 127.55 32.65 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.764 -0.828 . . . . 72.299999999999997 108.764 174.377 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.5 t -56.02 156.66 5.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.105 -0.498 . . . . 62.43 110.548 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.897 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.3 pttp -63.73 -15.13 57.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.293 0.568 . . . . 63.520000000000003 109.83 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 184' ' ' GLN . 6.6 tp60 -71.7 -38.02 70.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.566 -0.743 . . . . 74.310000000000002 109.823 172.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -87.22 -41.34 13.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.483 -0.78 . . . . 74.319999999999993 111.116 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.897 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.7 ptm -70.66 -16.24 62.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.263 -0.426 . . . . 72.150000000000006 110.72 -177.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -71.34 -24.66 62.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.375 0.607 . . . . 73.109999999999999 109.721 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.5 m -93.38 -35.17 13.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.103 -0.953 . . . . 50.25 110.459 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -76.55 -50.26 14.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.86 -0.609 . . . . 74.400000000000006 111.446 -176.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.6 m -78.04 108.97 11.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.94 -0.573 . . . . 71.319999999999993 110.697 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.3 m -66.08 -32.47 73.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.866 -0.606 . . . . 73.239999999999995 111.065 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 37.0 m -62.78 -25.84 68.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.813 0.34 . . . . 61.450000000000003 111.264 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -63.76 -24.7 67.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.213 0.53 . . . . 71.540000000000006 110.349 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -108.76 14.56 24.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.344 0.593 . . . . 72.439999999999998 109.675 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -89.62 -69.74 1.24 Allowed Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.667 -0.697 . . . . 71.400000000000006 111.918 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.754 ' HD3' ' H ' ' A' ' 196' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.546 -0.74 . . . . 72.340000000000003 109.555 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 1.014 " H4'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.694 0 O5'-C5'-C4' 111.277 0.769 OUTLIER-EPSILON 0.0 '__' . 75.439999999999998 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 1.014 H5'' " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.422 -1.131 0 C4'-C3'-C2' 105.699 2.999 . 0.0 OUTLIER epsilon-1 75.299999999999997 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.658 ' H8 ' H5'' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.423 -1.07 0 O4'-C4'-C3' 103.135 -1.689 . 0.0 OUTLIER . 75.129999999999995 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.601 " H4'" ' HE2' ' A' ' 137' ' ' MET . . . . . . . . 0 O5'--C5' 1.424 -0.969 0 C4'-C3'-C2' 104.998 2.298 . 0.0 OUTLIER alpha 72.340000000000003 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.574 ' OP2' ' HE2' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.42 -1.246 0 O4'-C1'-C2' 108.16 1.257 . 0.0 OUTLIER gamma 61.020000000000003 . . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.981 0 C4'-C3'-C2' 103.439 0.739 . 0.01 2u . 75.140000000000001 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 109.691 -0.485 . . . . 61.009999999999998 109.691 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.87 -65.85 0.89 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.757 -0.201 . . . . 72.5 110.961 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.485 ' HD2' ' HA ' ' A' ' 164' ' ' ILE . 42.9 mtp180 53.28 69.84 2.09 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 116.14 -0.482 . . . . 74.519999999999996 110.858 -174.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.508 ' HG2' ' HB2' ' A' ' 179' ' ' LYS . 28.9 Cg_endo -63.72 120.14 7.43 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.66 2.24 . . . . 74.030000000000001 112.416 -177.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.29 60.06 6.27 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.099 -0.8 . . . . 63.329999999999998 111.099 -177.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.26 -21.81 62.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.666 0.269 . . . . 72.230000000000004 111.605 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -83.05 -1.33 52.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.424 0.631 . . . . 75.239999999999995 110.287 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 66.4 mt -105.97 108.62 20.22 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.546 -0.752 . . . . 72.25 109.764 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.0 p -62.04 114.14 3.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.338 0.589 . . . . 71.200000000000003 110.504 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.499 HG22 ' H ' ' A' ' 106' ' ' LYS . 9.6 p -107.1 136.38 42.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.771 -0.649 . . . . 74.329999999999998 110.273 -173.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 156' ' ' HIS . 0.0 OUTLIER -105.59 -0.85 25.35 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.931 0.396 . . . . 54.299999999999997 110.903 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.636 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 24.0 ttpt -133.98 136.69 44.3 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.107 0.479 . . . . 73.519999999999996 110.807 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.505 HG12 ' HB ' ' A' ' 151' ' ' VAL . 9.2 pt -107.95 162.57 6.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.132 -0.485 . . . . 71.5 110.642 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 61.6 t80 -110.23 118.05 35.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.846 -0.616 . . . . 61.030000000000001 110.078 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 30.6 t -106.84 103.04 14.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.506 -0.553 . . . . 73.299999999999997 109.506 175.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -117.77 136.27 12.33 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.656 -0.783 . . . . 72.340000000000003 112.364 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.534 ' N ' " H5'" ' B' ' 2' ' ' ' C' . . . 131.27 -12.63 5.49 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.134 -1.032 . . . . 51.030000000000001 112.929 176.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.921 HD11 ' HA ' ' A' ' 148' ' ' PHE . 0.1 OUTLIER -68.2 91.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 122.091 0.948 . . . . 74.129999999999995 111.239 -179.006 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -94.83 4.01 54.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.789 -1.096 . . . . 75.150000000000006 109.966 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -121.83 -174.28 2.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.383 -0.826 . . . . 75.420000000000002 109.679 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.39 107.18 4.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.229 0.537 . . . . 52.509999999999998 110.899 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.8 m -144.32 128.69 17.9 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.679 -0.691 . . . . 63.020000000000003 109.274 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -125.52 -166.17 1.51 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.253 0.549 . . . . 61.439999999999998 112.1 -173.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.609 ' HG2' ' CG1' ' A' ' 134' ' ' ILE . 2.8 tm-20 -60.41 -47.14 87.37 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.181 -0.918 . . . . 74.340000000000003 111.475 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -62.96 -30.8 71.85 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.883 -0.327 . . . . 75.530000000000001 110.524 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -66.68 -59.62 3.42 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.943 0.401 . . . . 64.420000000000002 110.611 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.524 ' HA ' HG21 ' A' ' 170' ' ' VAL . 8.5 mp -60.0 -47.94 83.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.769 -0.651 . . . . 43.409999999999997 111.359 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.472 ' HG3' HD12 ' A' ' 131' ' ' ILE . 3.1 ttp180 -62.06 -41.78 98.51 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.062 -0.255 . . . . 42.549999999999997 111.359 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -57.24 -30.42 64.61 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.339 0.59 . . . . 71.409999999999997 111.061 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -88.43 -47.04 8.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.788 -0.642 . . . . 73.099999999999994 111.156 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.408 ' HA ' ' HD2' ' A' ' 128' ' ' TYR . 51.8 m-85 -80.11 -12.12 59.7 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.528 0.566 . . . . 61.509999999999998 112.528 -173.25 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.67 -24.8 66.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.84 0.352 . . . . 71.239999999999995 111.568 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -72.57 -20.7 61.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.321 -0.4 . . . . 72.239999999999995 110.451 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.474 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 89.0 m-85 -82.15 -38.82 24.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.048 -0.524 . . . . 73.450000000000003 110.023 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.447 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 176.86 -168.47 40.42 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.229 -0.986 . . . . 75.329999999999998 113.277 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.566 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 40.1 tptt -74.33 116.41 14.96 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.405 0.621 . . . . 71.219999999999999 111.4 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.504 HG21 HD11 ' A' ' 134' ' ' ILE . 33.0 mt -92.53 140.51 16.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.324 -0.853 . . . . 74.329999999999998 110.542 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -86.91 -72.46 0.51 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.09 -0.504 . . . . 70.310000000000002 110.405 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.72 140.41 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 73.439999999999998 111.325 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.627 ' CD1' HG13 ' A' ' 151' ' ' VAL . 21.3 mm -95.1 101.61 12.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.611 -0.514 . . . . 63.450000000000003 109.611 174.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -84.67 94.74 8.71 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.939 -0.393 . . . . 60.520000000000003 109.939 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.538 HD11 ' H ' ' A' ' 118' ' ' GLU . 7.1 mt -73.05 100.91 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.005 -1.109 . . . . 63.149999999999999 108.005 175.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 10.7 tpt -61.38 108.89 1.01 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.381 0.61 . . . . 73.140000000000001 110.494 -173.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.6 p -121.78 158.82 27.99 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.018 -0.992 . . . . 71.319999999999993 110.257 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.8 ' HA ' ' C4 ' ' B' ' 5' ' ' ' U' . 19.0 t0 -56.73 136.48 55.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.255 -0.429 . . . . 73.230000000000004 110.889 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.479 ' HD2' " H1'" ' B' ' 5' ' ' ' U' . 0.2 OUTLIER -71.95 -12.27 61.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.663 -0.699 . . . . 73.310000000000002 111.011 -175.216 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.95 -60.15 0.51 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.609 -0.805 . . . . 72.209999999999994 112.328 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.584 ' HB2' ' HG2' ' A' ' 144' ' ' LYS . 2.2 m -79.49 -25.02 41.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.944 0.402 . . . . 72.209999999999994 111.194 -174.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.91 38.21 60.34 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.019 -0.61 . . . . 74.140000000000001 112.456 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.584 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 12.7 ptpt -108.67 152.35 24.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.918 -0.401 . . . . 73.239999999999995 109.918 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -62.33 135.34 57.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 74.049999999999997 111.394 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 146' ' ' ARG . 14.8 tpt180 -87.04 -5.61 59.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.932 -0.577 . . . . 73.319999999999993 110.314 178.309 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.77 ' O ' " H5'" ' B' ' 1' ' ' ' U' . . . 101.94 -6.93 54.62 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.867 -0.683 . . . . 75.340000000000003 112.925 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.921 ' HA ' HD11 ' A' ' 112' ' ' ILE . 31.7 p90 -145.03 164.06 32.32 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 122.514 -0.404 . . . . 64.439999999999998 110.32 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.4 165.15 28.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.961 0.41 . . . . 53.109999999999999 110.952 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.564 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 65.9 m-85 -126.26 123.72 38.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.753 -0.658 . . . . 60.229999999999997 110.006 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.627 HG13 ' CD1' ' A' ' 134' ' ' ILE . 48.9 t -98.75 107.44 20.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 110.017 -0.364 . . . . 74.420000000000002 110.017 -179.051 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.636 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 25.3 m -86.8 124.43 33.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.118 -0.492 . . . . 34.329999999999998 110.151 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.655 ' CD2' HG12 ' A' ' 159' ' ' VAL . 97.6 m-85 -104.92 157.63 17.08 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.916 -0.402 . . . . 65.420000000000002 109.916 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.566 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 16.0 t70 -69.59 -29.81 67.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.03 -0.532 . . . . 65.140000000000001 110.557 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -132.45 147.38 52.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.57 -0.741 . . . . 74.019999999999996 110.923 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.673 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.3 p-80 -75.45 -12.81 60.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.181 -0.463 . . . . 74.040000000000006 110.732 177.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -60.84 -49.83 75.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.173 0.511 . . . . 73.120000000000005 110.153 174.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.447 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 14.6 m -66.56 -22.14 66.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.377 -0.829 . . . . 71.209999999999994 112.373 -173.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 156' ' ' HIS . 4.1 m -81.49 -25.84 10.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.935 -0.306 . . . . 71.439999999999998 111.453 -176.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.566 ' HA ' HG22 ' A' ' 163' ' ' VAL . 36.1 t70 -70.31 -39.88 74.54 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.983 -0.287 . . . . 75.129999999999995 111.342 -171.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.485 ' HD2' ' H ' ' A' ' 161' ' ' LYS . 1.6 mptp? -62.21 -14.63 40.07 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.372 0.606 . . . . 71.239999999999995 110.586 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.5 HG21 HD13 ' A' ' 107' ' ' ILE . 94.5 mt -98.38 -49.21 11.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.455 -0.793 . . . . 70.340000000000003 110.886 -176.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.566 HG22 ' HA ' ' A' ' 160' ' ' ASP . 23.5 m -72.93 -15.57 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.104 -0.498 . . . . 75.409999999999997 112.078 -175.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.485 ' HA ' ' HD2' ' A' ' 97' ' ' ARG . 2.2 pp -64.68 -26.81 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.696 0.284 . . . . 72.329999999999998 111.572 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -116.0 -178.94 3.52 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.407 -0.59 . . . . 70.219999999999999 109.407 171.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.455 ' HE3' ' OE1' ' A' ' 176' ' ' GLU . 83.5 tttt -120.48 -67.79 0.95 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.655 0.264 . . . . 70.540000000000006 111.226 -173.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 11.1 m-30 -71.69 107.54 4.57 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.088 0.47 . . . . 63.020000000000003 111.401 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.432 ' CE1' HG23 ' A' ' 162' ' ' ILE . 32.9 m-70 -104.89 151.58 23.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.624 -0.716 . . . . 72.230000000000004 109.837 174.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 21.8 m -109.87 84.73 1.98 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.045 0.45 . . . . 73.230000000000004 110.424 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.524 HG21 ' HA ' ' A' ' 121' ' ' LEU . 4.1 p -102.57 132.86 47.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.892 -0.595 . . . . 70.450000000000003 109.719 178.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 170' ' ' VAL . 4.6 t30 71.92 -14.79 0.49 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.106 0.479 . . . . 72.450000000000003 110.544 -176.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 114.97 -3.08 22.76 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.905 -0.878 . . . . 61.130000000000003 110.905 -173.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' HIS . . . . . 0.491 ' O ' ' HA ' ' A' ' 169' ' ' THR . 58.5 t-80 -93.97 148.7 21.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.303 -0.448 . . . . 63.219999999999999 110.286 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -94.24 102.78 14.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.999 0.428 . . . . 73.549999999999997 110.151 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 29.4 m -114.47 154.1 28.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.131 -0.486 . . . . 73.530000000000001 111.201 -175.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.51 ' OE2' ' HD3' ' A' ' 178' ' ' ARG . 20.5 tt0 -91.53 119.55 31.56 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.664 -0.495 . . . . 73.549999999999997 109.664 175.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 48.4 t -117.63 138.99 46.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.955 -0.566 . . . . 71.409999999999997 110.659 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.51 ' HD3' ' OE2' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -159.02 171.86 19.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.417 -0.81 . . . . 74.219999999999999 109.675 -177.658 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.508 ' HB2' ' HG2' ' A' ' 98' ' ' PRO . 8.6 mtpm? -63.26 122.1 15.33 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.104 -0.332 . . . . 73.200000000000003 110.104 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.756 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -74.89 91.25 2.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.985 0.422 . . . . 73.510000000000005 110.686 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.56 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -80.9 139.52 35.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.489 -0.56 . . . . 73.340000000000003 109.489 177.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.5 m -50.88 130.66 25.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.167 -0.469 . . . . 73.129999999999995 110.755 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.774 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.0 pttp -64.34 -23.24 67.23 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.843 0.354 . . . . 71.200000000000003 110.664 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.86 -37.14 86.28 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.484 -0.562 . . . . 65.140000000000001 109.484 176.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -88.16 -34.75 17.73 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.705 -0.679 . . . . 73.430000000000007 111.049 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.774 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 6.5 ptp -63.64 -28.04 69.64 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.632 -0.506 . . . . 75.109999999999999 109.632 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ALA . . . . . 0.541 ' HA ' ' HB2' ' A' ' 192' ' ' SER . . . -65.47 -33.07 75.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.882 -0.599 . . . . 24.109999999999999 110.336 177.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.6 m -98.05 7.82 45.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.576 -0.738 . . . . 44.229999999999997 111.192 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -123.16 -50.51 1.91 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.038 0.446 . . . . 73.239999999999995 111.385 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.8 m -103.81 15.21 29.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.289 -0.414 . . . . 75.340000000000003 110.637 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.6 m 61.29 28.54 18.04 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.009 -0.541 . . . . 74.420000000000002 111.218 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.541 ' HB2' ' HA ' ' A' ' 187' ' ' ALA . 14.0 m -66.23 111.08 3.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.099 -0.501 . . . . 71.540000000000006 110.635 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -140.76 -44.71 0.39 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.347 0.594 . . . . 73.329999999999998 109.707 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -99.33 153.72 18.75 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.405 -0.816 . . . . 72.109999999999999 110.664 -175.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -82.18 86.29 1.44 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.922 -0.656 . . . . 42.229999999999997 112.191 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.66 ' HA ' ' HE ' ' A' ' 196' ' ' ARG . 1.4 tpm_? . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.385 -0.817 . . . . 72.430000000000007 109.595 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 1.077 " C4'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.66 0 C4'-C3'-C2' 104.832 2.132 . 0.0 '__' . 75.109999999999999 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 1.077 H5'' " C4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.9 0 C3'-C2'-C1' 103.84 2.601 . 0.0 OUTLIER zeta-1 64.549999999999997 . . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.791 " H4'" ' OP1' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -0.992 0 C3'-C2'-C1' 103.636 2.373 OUTLIER-EPSILON 0.0 OUTLIER alpha 72.530000000000001 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.791 ' OP1' " H4'" ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.863 0 C4'-C3'-C2' 106.034 3.334 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 75.420000000000002 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.8 ' C4 ' ' HA ' ' A' ' 139' ' ' ASP . . . . . . . . 0 O5'--C5' 1.423 -1.043 0 C1'-O4'-C4' 106.843 -3.063 OUTLIER-DELTA 0.0 OUTLIER gamma 73.409999999999997 . . . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.864 0 C3'-C2'-C1' 100.557 -1.047 . 0.0 OUTLIER . 74.219999999999999 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . 0.612 ' N ' HE21 ' A' ' 193' ' ' GLN . 19.4 m . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 120.696 0.284 . . . . 60.210000000000001 111.141 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.553 ' O ' ' HD3' ' A' ' 98' ' ' PRO . 5.6 tp-100 -104.11 -15.05 15.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.799 0.333 . . . . 73.340000000000003 111.044 -174.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -106.11 94.06 8.82 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.981 -0.377 . . . . 64.519999999999996 109.981 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 96' ' ' GLN . 56.4 Cg_endo -99.34 97.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 123.366 2.711 . . . . 72.329999999999998 112.494 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.11 19.62 69.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.672 -0.775 . . . . 42.009999999999998 112.436 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.5 -11.32 59.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.261 0.553 . . . . 44.0 110.373 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -86.34 2.3 47.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.406 -0.816 . . . . 75.319999999999993 110.308 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 84.3 mt -111.11 162.02 15.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.807 -0.633 . . . . 75.099999999999994 110.057 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.1 m -80.95 -43.31 19.93 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.159 -0.682 . . . . 73.140000000000001 109.159 176.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 67.38 145.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 124.455 1.097 . . . . 75.439999999999998 112.824 172.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.56 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 2.4 mtmt -129.53 12.83 5.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.723 -0.671 . . . . 70.120000000000005 110.012 175.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.509 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 30.6 ttpt -144.23 137.26 27.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.295 -0.866 . . . . 72.340000000000003 109.379 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pp -107.59 153.6 8.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.35 -0.387 . . . . 71.530000000000001 110.537 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 75.6 t80 -105.0 125.29 50.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.28 -0.418 . . . . 72.450000000000003 110.881 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.9 t -105.94 107.32 22.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.468 -0.333 . . . . 74.099999999999994 110.394 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.539 ' HA2' " H5'" ' B' ' 2' ' ' ' C' . . . -120.92 114.9 2.73 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.78 -0.724 . . . . 73.319999999999993 112.585 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 124.43 29.63 1.07 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.613 -0.804 . . . . 50.100000000000001 113.015 175.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.555 HG12 " O5'" ' B' ' 1' ' ' ' U' . 40.1 pt -91.51 -165.76 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 117.073 0.436 . . . . 73.349999999999994 111.484 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.401 ' HD3' ' H ' ' A' ' 115' ' ' ASP . 13.6 tmtt? -131.13 159.63 37.07 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.152 -1.055 . . . . 74.150000000000006 108.152 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.14 -17.69 54.15 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.657 0.614 . . . . 75.099999999999994 112.657 -174.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.401 ' H ' ' HD3' ' A' ' 113' ' ' LYS . 25.4 t70 -70.34 -38.16 74.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.877 0.37 . . . . 61.310000000000002 111.134 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.4 m -64.63 138.32 58.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.818 -0.628 . . . . 70.129999999999995 110.753 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.479 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 12.0 pt-20 -136.53 -168.66 2.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.449 -0.341 . . . . 74.25 110.737 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.63 ' HA ' HG21 ' A' ' 134' ' ' ILE . 7.2 tt0 -59.62 -46.43 89.01 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.044 -0.526 . . . . 73.540000000000006 112.355 -176.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -65.0 -32.99 74.99 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.811 -0.355 . . . . 71.400000000000006 110.601 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.479 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 38.6 m80 -61.8 -52.73 62.99 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.912 0.387 . . . . 71.310000000000002 110.709 178.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.447 HD23 HG21 ' A' ' 170' ' ' VAL . 70.3 mt -62.99 -47.91 81.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.625 -0.716 . . . . 73.129999999999995 110.288 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -56.17 -49.33 74.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.798 -0.637 . . . . 73.150000000000006 110.651 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -56.71 -32.66 65.72 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.179 0.514 . . . . 74.230000000000004 111.62 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -85.16 -40.8 16.31 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.035 -0.53 . . . . 73.319999999999993 111.104 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.508 ' CD1' HG21 ' A' ' 151' ' ' VAL . 57.1 m-85 -88.63 -18.02 28.86 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.78 0.659 . . . . 64.319999999999993 112.78 -173.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.4 ' N ' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -66.35 -21.52 66.25 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.142 0.496 . . . . 74.25 110.928 -179.448 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -70.08 -22.14 63.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.673 -0.694 . . . . 61.229999999999997 110.477 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.508 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 28.9 m-85 -86.74 -33.25 20.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.957 -0.565 . . . . 74.450000000000003 110.674 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 176.93 -170.38 43.07 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.285 -0.959 . . . . 45.420000000000002 113.151 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -75.17 124.02 26.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 122.924 0.49 . . . . 73.329999999999998 111.49 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.488 HG21 HD11 ' A' ' 134' ' ' ILE . 44.2 mt -100.31 137.31 28.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.876 -0.602 . . . . 62.32 111.149 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.14 -74.41 0.34 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.383 -0.826 . . . . 64.109999999999999 110.359 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.81 159.09 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.655 -0.498 . . . . 55.009999999999998 109.655 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.63 HG21 ' HA ' ' A' ' 118' ' ' GLU . 29.3 mm -112.41 104.45 17.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.928 0.394 . . . . 64.439999999999998 109.948 174.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -89.61 101.64 14.32 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.959 -0.386 . . . . 72.409999999999997 109.959 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.795 ' HB ' HG23 ' A' ' 138' ' ' THR . 4.3 mt -81.18 12.6 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.349 0.595 . . . . 74.120000000000005 109.84 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.714 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER 59.44 26.23 15.12 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.143 -0.935 . . . . 53.219999999999999 109.702 -174.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.795 HG23 ' HB ' ' A' ' 136' ' ' ILE . 1.4 p -64.5 146.55 54.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.841 -1.072 . . . . 54.549999999999997 111.05 -178.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 144' ' ' LYS . 22.7 t70 -47.2 130.56 12.93 Favored 'General case' 0 CA--C 1.515 -0.369 0 O-C-N 123.482 0.489 . . . . 74.239999999999995 110.053 177.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.598 ' HD2' H5'' ' B' ' 5' ' ' ' U' . 0.0 OUTLIER -84.7 12.66 6.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.992 -0.549 . . . . 61.020000000000003 110.947 -170.566 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -118.44 -50.99 0.32 Allowed Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.643 -0.708 . . . . 45.32 111.946 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.5 ' HB2' ' HE2' ' A' ' 144' ' ' LYS . 50.9 m -111.14 -13.13 14.07 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.397 0.517 . . . . 73.409999999999997 112.397 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.14 70.35 1.3 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.331 -0.938 . . . . 65.340000000000003 112.183 -176.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 138' ' ' THR . 62.6 mmtt -110.67 135.49 51.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.763 -0.458 . . . . 74.319999999999993 109.763 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -69.86 115.11 8.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.923 0.392 . . . . 70.310000000000002 110.913 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.498 ' HB3' ' HB3' ' A' ' 137' ' ' MET . 68.8 ttt180 -83.6 -54.98 4.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.992 -0.549 . . . . 74.230000000000004 111.107 -178.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.632 ' C ' H5'' ' B' ' 1' ' ' ' U' . . . 161.16 -93.07 0.12 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.693 -0.765 . . . . 61.130000000000003 111.934 -177.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.714 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 42.9 p90 -61.57 145.16 52.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.601 0.239 . . . . 72.420000000000002 110.402 177.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.86 165.13 23.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.976 0.417 . . . . 61.229999999999997 111.206 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.48 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 43.7 m-85 -132.47 135.5 46.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.699 -0.682 . . . . 72.430000000000007 109.467 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.61 HG13 ' CD1' ' A' ' 134' ' ' ILE . 43.4 t -110.85 108.42 25.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.55 -0.537 . . . . 50.43 109.55 177.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.509 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 3.9 m -85.88 128.48 34.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.055 -0.52 . . . . 74.299999999999997 110.301 -178.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.587 ' CD2' HG12 ' A' ' 159' ' ' VAL . 94.7 m-85 -111.75 151.41 29.0 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.916 -0.401 . . . . 74.310000000000002 109.916 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -78.87 -6.56 56.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.249 0.547 . . . . 73.409999999999997 110.854 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.75 149.64 43.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.182 -0.463 . . . . 51.299999999999997 110.245 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.56 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.0 p-80 -89.48 -2.64 58.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.928 0.394 . . . . 71.519999999999996 110.897 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -75.04 -39.08 61.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.359 0.6 . . . . 64.150000000000006 109.476 173.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.4 m -64.9 -30.31 71.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.513 -0.767 . . . . 61.229999999999997 111.789 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.587 HG12 ' CD2' ' A' ' 153' ' ' PHE . 14.1 m -78.87 -20.81 12.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.634 -0.257 . . . . 54.149999999999999 111.68 -176.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.05 -46.14 75.27 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 120.596 0.236 . . . . 71.230000000000004 110.46 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.508 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.4 mptp? -59.29 -20.08 51.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.364 0.602 . . . . 63.299999999999997 111.038 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.437 HG22 HG11 ' A' ' 177' ' ' VAL . 79.5 mt -94.1 -49.07 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.529 -0.76 . . . . 71.400000000000006 111.206 -175.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.578 ' HB ' ' HE3' ' A' ' 179' ' ' LYS . 25.9 m -80.59 -10.72 12.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 112.287 0.477 . . . . 64.0 112.287 -173.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.6 pp -68.82 -31.35 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.998 0.428 . . . . 71.420000000000002 110.961 176.704 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.522 ' N ' HD12 ' A' ' 164' ' ' ILE . 14.5 pt20 -101.15 -162.0 0.9 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.116 -0.698 . . . . 65.140000000000001 109.116 172.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.518 ' HE3' ' CD ' ' A' ' 176' ' ' GLU . 44.3 tttt -134.67 -68.67 0.53 Allowed 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.811 -0.356 . . . . 62.43 111.568 -174.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 97.2 m-85 -88.32 113.41 23.89 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.133 0.492 . . . . 74.230000000000004 111.544 -175.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -105.35 147.36 28.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.57 -0.741 . . . . 73.430000000000007 110.248 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 47.2 m -100.73 98.92 9.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.075 0.464 . . . . 54.329999999999998 110.745 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.447 HG21 HD23 ' A' ' 121' ' ' LEU . 4.7 p -118.19 130.97 72.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.076 -0.511 . . . . 45.240000000000002 109.833 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.8 t30 64.67 15.73 9.91 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.643 0.735 . . . . 71.109999999999999 110.279 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.85 8.78 75.63 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.765 -0.731 . . . . 62.420000000000002 112.225 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -110.03 124.67 51.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.719 0.295 . . . . 72.540000000000006 110.367 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -81.42 105.3 12.48 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.427 -0.583 . . . . 70.219999999999999 109.427 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 10.5 m -118.15 154.31 32.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.926 -0.579 . . . . 53.25 110.589 -172.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.518 ' CD ' ' HE3' ' A' ' 166' ' ' LYS . 30.1 tt0 -88.73 126.0 35.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.001 0.429 . . . . 73.230000000000004 110.153 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 97.8 t -112.23 129.43 67.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.343 0.592 . . . . 73.540000000000006 111.034 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.441 ' HB3' ' HG2' ' A' ' 98' ' ' PRO . 80.7 mtt180 -119.0 179.58 4.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.24 -0.891 . . . . 75.129999999999995 110.083 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.578 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 9.6 mptt -81.69 126.52 31.88 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.327 -1.36 . . . . 71.209999999999994 107.327 168.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.687 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -80.88 83.95 6.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.055 0.455 . . . . 43.109999999999999 111.505 -174.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.587 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -84.04 140.79 31.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.88 -0.6 . . . . 72.430000000000007 109.444 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 46.4 t -50.15 142.14 10.17 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.423 0.452 . . . . 74.109999999999999 111.179 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.758 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.5 pttp -62.09 -20.05 63.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.188 -0.46 . . . . 74.349999999999994 111.29 -178.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -54.31 14.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.886 -0.783 . . . . 61.520000000000003 108.886 174.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.9 -32.15 72.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.747 -0.66 . . . . 75.310000000000002 111.564 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.758 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 21.7 ptm -72.84 -17.24 61.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.779 0.323 . . . . 75.420000000000002 110.523 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.43 -39.83 62.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.531 -0.544 . . . . 73.230000000000004 109.531 173.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 m -70.93 -35.0 72.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.584 -0.735 . . . . 74.239999999999995 109.949 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -70.31 -20.28 63.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.514 -0.766 . . . . 65.420000000000002 110.763 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 34.7 t -76.44 87.17 3.19 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.273 0.559 . . . . 64.239999999999995 109.994 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 48.1 m -140.53 117.71 11.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.602 -0.726 . . . . 55.32 109.895 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.7 t 67.49 26.4 8.23 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.741 -0.663 . . . . 62.130000000000003 110.582 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLN . . . . . 0.612 HE21 ' N ' ' A' ' 95' ' ' SER . 76.8 mt-30 -88.47 153.69 20.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 72.140000000000001 110.155 178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -108.22 119.84 40.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.833 0.349 . . . . 72.239999999999995 110.261 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 91.49 -136.84 13.51 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.758 -0.734 . . . . 74.349999999999994 111.975 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.501 -0.761 . . . . 73.019999999999996 110.088 179.754 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.934 " H3'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.673 0 C4'-C3'-C2' 105.259 2.559 . 0.0 '__' . 72.319999999999993 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.934 H5'' " H3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.879 0 C4'-C3'-C2' 104.851 2.151 . 0.0 OUTLIER . 73.409999999999997 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.687 ' N1 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.426 -0.882 0 O4'-C1'-C2' 108.391 1.422 . 0.0 OUTLIER gamma 72.120000000000005 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.575 " H3'" ' HD3' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.424 -1.026 0 C4'-C3'-C2' 104.043 1.343 . 0.0 OUTLIER alpha 74.209999999999994 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.598 H5'' ' HD2' ' A' ' 140' ' ' ARG . . . . . . . . 0 O5'--C5' 1.422 -1.122 0 O4'-C1'-C2' 108.2 1.285 . 0.0 OUTLIER gamma 75.319999999999993 . . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.6 H5'' ' C6 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.012 0 C4'-C3'-C2' 105.999 3.299 . 0.0 OUTLIER gamma 74.420000000000002 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.74 -0.467 . . . . 63.299999999999997 109.74 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.672 ' NE2' ' HG2' ' A' ' 178' ' ' ARG . 46.5 tp60 -79.54 -26.83 41.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.37 0.605 . . . . 72.439999999999998 109.772 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -114.05 84.16 8.65 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.557 -0.747 . . . . 73.310000000000002 110.471 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 96' ' ' GLN . 4.9 Cg_exo -80.74 -65.23 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.604 2.203 . . . . 60.149999999999999 111.585 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.21 97.63 0.92 Allowed Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.342 -0.703 . . . . 64.540000000000006 111.342 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -95.9 -35.85 11.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.088 0.471 . . . . 72.420000000000002 110.66 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 21.1 p-80 -73.81 -19.74 60.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.776 -0.647 . . . . 65.109999999999999 110.243 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 77.7 mt -80.09 111.99 16.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.623 -0.717 . . . . 72.140000000000001 110.183 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.8 p -73.66 98.06 2.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.331 0.586 . . . . 73.049999999999997 110.477 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.609 HG23 HG11 ' A' ' 159' ' ' VAL . 6.6 m -93.52 152.46 3.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.869 -0.605 . . . . 61.520000000000003 109.798 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.772 ' HA ' HG21 ' A' ' 159' ' ' VAL . 14.0 mtmt -118.17 22.72 12.02 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.599 0.714 . . . . 73.530000000000001 109.46 177.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.727 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 42.0 tttt -149.88 129.5 13.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.802 -1.09 . . . . 65.540000000000006 109.361 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.527 HD13 HG21 ' A' ' 162' ' ' ILE . 7.9 pt -106.03 163.04 4.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.0 0.429 . . . . 75.019999999999996 111.225 -177.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -109.59 118.76 37.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.526 -0.761 . . . . 75.230000000000004 109.567 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.596 HG11 HD11 ' A' ' 121' ' ' LEU . 37.3 t -102.59 103.36 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.881 0.372 . . . . 65.219999999999999 110.757 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.489 ' HA2' H5'' ' B' ' 2' ' ' ' C' . . . -119.69 -167.9 13.74 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.898 -0.881 . . . . 34.219999999999999 110.898 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.501 ' HA2' ' C5 ' ' B' ' 2' ' ' ' C' . . . 71.21 5.48 59.1 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.785 -0.721 . . . . 61.439999999999998 113.042 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.636 HD11 ' O ' ' A' ' 147' ' ' GLY . 23.8 pt -87.38 122.02 38.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.27 0.557 . . . . 55.299999999999997 110.551 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -88.31 -27.64 21.56 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.079 -0.51 . . . . 72.349999999999994 110.631 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -98.48 154.89 17.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.037 -0.529 . . . . 73.150000000000006 109.81 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -63.1 91.56 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.053 0.454 . . . . 72.409999999999997 109.804 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.435 ' HB ' HD12 ' A' ' 112' ' ' ILE . 9.7 m -90.28 118.13 29.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.73 -0.668 . . . . 73.040000000000006 109.638 -178.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.552 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 11.5 pt-20 -109.86 -174.08 2.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.919 0.39 . . . . 62.439999999999998 111.605 -172.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.701 ' HA ' HG21 ' A' ' 134' ' ' ILE . 14.2 tt0 -53.42 -49.71 66.75 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.427 -0.806 . . . . 64.540000000000006 112.212 -174.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -63.39 -31.44 72.6 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.1 -0.24 . . . . 42.299999999999997 110.678 -176.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.552 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 35.7 m80 -67.06 -56.81 8.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.476 -0.329 . . . . 73.409999999999997 110.376 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.596 HD11 HG11 ' A' ' 109' ' ' VAL . 0.5 OUTLIER -61.05 -49.55 76.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.48 . . . . 60.020000000000003 110.928 -178.451 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.509 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 1.5 tpp180 -58.08 -45.32 87.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.273 -0.422 . . . . 75.439999999999998 111.197 -177.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -56.61 -37.11 70.22 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.096 0.474 . . . . 70.010000000000005 111.44 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -84.96 -39.85 17.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.271 -0.422 . . . . 75.209999999999994 111.257 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -86.69 -17.5 33.57 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.47 0.545 . . . . 73.239999999999995 112.47 -172.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -21.7 65.58 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.334 0.588 . . . . 72.340000000000003 110.697 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -70.22 -24.82 63.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.336 -0.847 . . . . 72.019999999999996 110.406 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.462 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 31.0 m-85 -83.46 -32.06 26.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.951 -0.568 . . . . 74.299999999999997 110.139 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.7 177.78 43.17 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.162 -0.775 . . . . 73.430000000000007 111.162 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -67.25 133.88 50.55 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.656 0.741 . . . . 73.099999999999994 110.478 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 122' ' ' ARG . 46.6 mt -100.24 141.92 16.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 115.288 -0.869 . . . . 52.299999999999997 110.446 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -78.46 -70.63 0.48 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.081 -0.509 . . . . 70.310000000000002 110.419 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.3 m -148.08 157.04 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.456 -0.338 . . . . 23.32 110.659 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.701 HG21 ' HA ' ' A' ' 118' ' ' GLU . 12.9 mm -109.96 108.93 26.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.572 -0.899 . . . . 71.409999999999997 108.572 174.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -95.08 95.97 8.93 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.204 0.526 . . . . 74.129999999999995 110.519 -175.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.638 HD11 ' H ' ' A' ' 118' ' ' GLU . 20.6 mt -74.81 99.06 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.702 -0.851 . . . . 74.340000000000003 108.702 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.8 tpt -67.29 108.94 2.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.287 0.565 . . . . 65.310000000000002 110.488 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.8 p -86.5 166.77 15.22 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.654 -0.703 . . . . 73.510000000000005 111.754 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 141' ' ' GLY . 19.6 t0 -76.85 153.09 35.15 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.021 -0.99 . . . . 63.409999999999997 110.567 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.495 ' CD ' ' H ' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -92.89 0.9 57.5 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.806 -0.634 . . . . 74.219999999999999 110.535 -178.735 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.411 ' H ' ' CG ' ' A' ' 139' ' ' ASP . . . -109.66 -62.37 0.52 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 121.009 -0.615 . . . . 41.109999999999999 112.213 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.544 ' HB2' ' HD2' ' A' ' 144' ' ' LYS . 21.2 m -87.56 -17.59 31.66 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.532 -0.393 . . . . 63.32 111.225 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.38 33.03 72.19 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.576 -1.01 . . . . 42.25 110.576 -174.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.544 ' HD2' ' HB2' ' A' ' 142' ' ' SER . 12.9 ptmm? -105.15 171.66 7.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.737 -0.731 . . . . 73.430000000000007 109.731 -172.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -69.08 99.19 1.07 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.171 -0.677 . . . . 71.409999999999997 109.171 174.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.633 HH12 H5'' ' B' ' 5' ' ' ' U' . 65.0 ttt180 -58.24 -46.11 86.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.139 -0.937 . . . . 74.140000000000001 111.886 -172.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.636 ' O ' HD11 ' A' ' 112' ' ' ILE . . . 166.96 -78.75 0.11 Allowed Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 110.973 -0.851 . . . . 62.200000000000003 110.973 -177.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -76.52 163.54 26.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.947 0.403 . . . . 75.430000000000007 110.924 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.05 175.16 9.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.009 -0.541 . . . . 72.340000000000003 110.366 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.727 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 85.3 m-85 -132.03 152.06 51.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.351 -0.386 . . . . 71.530000000000001 110.333 -176.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.608 HG13 ' CD1' ' A' ' 134' ' ' ILE . 44.6 t -134.91 114.61 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.076 -0.713 . . . . 55.539999999999999 109.076 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.476 ' OG1' ' HD2' ' A' ' 106' ' ' LYS . 42.5 m -98.23 132.12 44.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.929 0.395 . . . . 75.439999999999998 110.558 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.481 ' CD2' HG22 ' A' ' 159' ' ' VAL . 91.2 m-85 -112.14 155.26 24.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.075 -0.511 . . . . 74.510000000000005 110.282 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -76.53 -23.82 53.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.244 0.545 . . . . 73.549999999999997 110.536 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.427 ' O ' HG23 ' A' ' 159' ' ' VAL . 9.5 t0 -131.47 138.88 49.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.587 -0.733 . . . . 73.150000000000006 109.73 -178.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.539 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.3 p-80 -75.83 -9.91 58.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.908 0.385 . . . . 64.049999999999997 110.605 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -66.61 -48.54 69.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 74.400000000000006 110.218 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 42.2 t -58.97 -37.16 76.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.611 . . . . 74.239999999999995 110.228 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.772 HG21 ' HA ' ' A' ' 105' ' ' LYS . 18.5 t -65.58 -36.99 78.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.451 -0.795 . . . . 71.049999999999997 111.017 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -55.45 -48.2 74.86 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.173 -0.467 . . . . 64.319999999999993 111.814 -176.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.462 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 4.0 mptt -60.19 -19.13 52.7 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.201 0.524 . . . . 65.329999999999998 111.063 -177.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.527 HG21 HD13 ' A' ' 107' ' ' ILE . 84.0 mt -99.84 -47.34 11.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.527 -0.76 . . . . 75.310000000000002 111.366 -175.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.422 ' CG2' ' HE3' ' A' ' 179' ' ' LYS . 28.9 m -71.26 -11.17 14.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.438 0.532 . . . . 74.540000000000006 112.438 -174.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.79 -24.29 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.909 0.385 . . . . 74.510000000000005 111.21 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -106.04 142.33 35.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.07 -0.514 . . . . 74.209999999999994 110.538 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.55 ' HG3' ' HG2' ' A' ' 176' ' ' GLU . 85.5 tttt -89.78 -67.3 0.85 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.005 -0.543 . . . . 64.0 111.199 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.596 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 22.8 m-85 -81.04 100.43 8.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.186 -0.461 . . . . 70.030000000000001 111.688 -177.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -101.51 153.38 19.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.944 -0.571 . . . . 74.340000000000003 109.79 174.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 23.9 m -106.38 96.23 6.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.982 0.42 . . . . 72.400000000000006 110.67 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' A' ' 172' ' ' GLY . 47.1 t -105.3 133.2 50.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.57 -0.53 . . . . 70.019999999999996 109.57 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.4 t30 70.48 -19.25 0.22 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.128 0.571 . . . . 71.0 111.728 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 128.52 -6.03 6.64 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.181 -0.533 . . . . 63.229999999999997 111.833 -177.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -112.62 151.18 30.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.038 0.447 . . . . 73.010000000000005 110.399 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.487 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 66.0 t30 -82.86 124.83 30.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.753 -0.658 . . . . 72.010000000000005 110.374 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 23.5 p -119.42 -171.86 2.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.955 -0.566 . . . . 40.329999999999998 110.253 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.55 ' HG2' ' HG3' ' A' ' 166' ' ' LYS . 0.9 OUTLIER -139.1 116.07 10.92 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.468 -0.567 . . . . 74.420000000000002 109.468 -176.531 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 93.4 t -116.41 140.15 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.018 -0.537 . . . . 54.240000000000002 112.062 -171.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.728 ' HD2' ' H62' ' B' ' 3' ' ' ' A' . 43.7 mtt180 -134.29 -178.83 5.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.69 -0.686 . . . . 74.430000000000007 109.801 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.422 ' HE3' ' CG2' ' A' ' 163' ' ' VAL . 11.9 mptt -75.01 128.43 35.54 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.267 -1.012 . . . . 74.239999999999995 108.267 168.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.555 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -74.04 97.83 2.95 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.582 -0.447 . . . . 73.209999999999994 110.773 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.7 pt? -106.6 149.18 27.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.936 -0.574 . . . . 64.109999999999999 110.204 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.5 t -49.62 139.63 12.27 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.579 0.55 . . . . 73.340000000000003 111.187 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.729 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 17.8 pttp -65.49 -12.7 55.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.135 0.493 . . . . 73.450000000000003 110.732 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -74.99 -52.92 9.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.857 -0.611 . . . . 72.439999999999998 109.94 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -73.38 -32.17 64.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.453 -0.794 . . . . 71.230000000000004 111.265 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.729 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.3 ptm -65.18 -24.53 67.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.394 -0.367 . . . . 63.210000000000001 110.876 -177.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.68 -38.19 76.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.99 0.424 . . . . 44.43 110.074 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.8 m -77.78 -33.01 52.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.676 -0.693 . . . . 71.239999999999995 110.643 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -77.76 -42.68 33.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 73.209999999999994 111.234 -177.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 33.6 m -90.06 -63.3 1.3 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.935 -0.575 . . . . 75.219999999999999 111.095 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 49.9 m 61.24 28.73 18.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.133 -0.485 . . . . 63.409999999999997 111.115 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 13.8 t -119.76 97.68 5.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.313 -0.625 . . . . 74.5 109.313 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -87.69 126.5 35.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.946 -0.57 . . . . 70.129999999999995 110.537 -177.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -62.69 94.03 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.603 -0.726 . . . . 70.219999999999999 110.859 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -163.3 21.05 0.16 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.407 -0.677 . . . . 41.030000000000001 111.407 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.176 -0.916 . . . . 73.450000000000003 109.167 -177.629 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.995 " H4'" " C5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.789 0 O4'-C4'-C3' 103.631 -1.335 OUTLIER-EPSILON 0.0 '__' . 74.510000000000005 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.995 " C5'" " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.021 0 C4'-C3'-C2' 104.37 1.67 . 0.0 OUTLIER epsilon-1 72.420000000000002 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.728 ' H62' ' HD2' ' A' ' 178' ' ' ARG . . . . . . . . 0 O5'--C5' 1.426 -0.889 0 O4'-C1'-C2' 108.101 1.215 . 0.0 OUTLIER . 74.420000000000002 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.585 " H3'" ' CE ' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.426 -0.87 0 C3'-C2'-C1' 99.82 -1.867 . 0.0 OUTLIER . 73.430000000000007 . . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.647 ' H6 ' ' P ' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.947 0 C4'-C3'-C2' 106.459 3.759 OUTLIER-DELTA 0.0 OUTLIER gamma 71.519999999999996 . . . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.44 ' H6 ' " O5'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.946 0 C3'-C2'-C1' 100.828 -0.747 . 0.01 4p . 63.310000000000002 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.476 0.866 0 CA-C-O 120.919 0.39 . . . . 53.119999999999997 110.232 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -110.21 145.03 38.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.398 -0.365 . . . . 71.349999999999994 110.398 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.496 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 0.0 OUTLIER -148.32 137.59 12.13 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.901 -0.59 . . . . 72.109999999999999 109.695 179.498 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 97' ' ' ARG . 4.0 Cg_exo -76.22 146.45 28.45 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.941 2.428 . . . . 60.130000000000003 112.605 -172.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.414 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 78.13 -26.67 2.11 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 116.036 -0.529 . . . . 31.510000000000002 113.996 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.64 ' HB2' ' HE2' ' A' ' 179' ' ' LYS . . . -72.83 -25.3 61.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.997 0.399 . . . . 65.409999999999997 111.955 -174.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -91.92 12.78 20.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.271 0.557 . . . . 74.420000000000002 110.156 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.414 HD12 ' HA2' ' A' ' 99' ' ' GLY . 23.1 mt -129.24 -176.31 3.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.385 -0.825 . . . . 71.239999999999995 109.709 -177.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.4 p -102.86 95.37 6.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.482 0.658 . . . . 72.319999999999993 109.531 170.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 106' ' ' LYS . 12.4 p -98.69 132.74 43.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.634 -0.712 . . . . 71.530000000000001 110.176 -176.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.601 ' HA ' HG21 ' A' ' 159' ' ' VAL . 15.2 mtmt -120.34 21.93 11.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.036 -0.529 . . . . 73.340000000000003 110.765 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.565 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.3 ttpt -153.89 142.49 20.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.327 -0.397 . . . . 71.030000000000001 109.944 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.561 HD13 HG21 ' A' ' 162' ' ' ILE . 4.0 pt -113.43 157.41 14.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.939 0.4 . . . . 53.200000000000003 110.915 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 66.7 t80 -105.61 119.89 40.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.608 -0.724 . . . . 72.129999999999995 109.932 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.0 t -101.1 108.89 24.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.796 0.331 . . . . 75.310000000000002 110.68 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.464 ' HA2' " H5'" ' B' ' 2' ' ' ' C' . . . -128.42 112.35 1.41 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.165 -0.54 . . . . 61.409999999999997 112.331 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.38 14.16 1.24 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.445 -0.884 . . . . 61.32 113.197 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.851 HD12 ' HB ' ' A' ' 116' ' ' THR . 9.0 pt -80.78 87.68 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.387 0.613 . . . . 74.519999999999996 110.311 177.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -61.25 -30.82 70.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.461 -0.79 . . . . 71.109999999999999 112.147 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -93.64 162.58 13.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.347 -0.388 . . . . 61.210000000000001 110.292 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -58.69 108.13 0.6 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 71.209999999999994 110.082 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.851 ' HB ' HD12 ' A' ' 112' ' ' ILE . 27.1 m -125.58 131.98 52.62 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.809 -0.632 . . . . 72.209999999999994 110.138 -175.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.14 -168.66 1.71 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.939 0.399 . . . . 64.030000000000001 111.438 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.691 ' HG3' HG13 ' A' ' 134' ' ' ILE . 15.1 tt0 -57.77 -49.87 75.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.64 -0.709 . . . . 75.230000000000004 112.429 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -33.53 69.9 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 121.046 -0.262 . . . . 64.219999999999999 110.504 -175.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -64.47 -53.36 49.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.08 -0.509 . . . . 65.349999999999994 110.552 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.541 HD12 HG11 ' A' ' 170' ' ' VAL . 9.3 mp -66.02 -49.62 67.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.727 -0.67 . . . . 75.310000000000002 111.193 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.5 -48.46 81.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.196 -0.456 . . . . 73.140000000000001 111.456 -176.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.3 -30.5 69.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.126 0.489 . . . . 64.510000000000005 110.832 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.483 ' CD1' HG22 ' A' ' 170' ' ' VAL . 50.8 t80 -81.64 -46.89 13.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.914 -0.584 . . . . 74.439999999999998 111.247 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -83.55 -16.89 43.72 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.725 0.639 . . . . 75.439999999999998 112.725 -173.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -23.9 67.38 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.989 0.423 . . . . 74.040000000000006 111.233 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -67.08 -25.02 66.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.821 -0.627 . . . . 54.530000000000001 110.508 178.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.509 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 45.7 m-85 -84.07 -34.25 24.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.968 -0.56 . . . . 74.420000000000002 110.477 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.95 -170.69 43.85 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.145 -1.026 . . . . 51.350000000000001 113.133 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -72.9 120.1 18.05 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.639 0.733 . . . . 73.049999999999997 112.092 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.539 HG21 HD11 ' A' ' 134' ' ' ILE . 41.1 mt -94.98 134.48 32.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.937 -1.029 . . . . 74.409999999999997 110.201 176.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 6.7 mm-40 -82.99 -67.42 0.79 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.032 -0.531 . . . . 63.310000000000002 110.717 178.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.0 m -146.53 152.62 13.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 72.219999999999999 110.259 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.691 HG13 ' HG3' ' A' ' 118' ' ' GLU . 33.5 mm -105.83 112.72 40.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.616 -0.513 . . . . 65.25 109.616 176.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -93.12 94.45 8.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.07 0.462 . . . . 74.010000000000005 110.212 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.0 mt -80.99 88.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.714 -0.847 . . . . 53.130000000000003 108.714 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.8 tpp -60.93 112.82 2.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.585 0.707 . . . . 63.329999999999998 110.864 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -88.26 169.98 11.4 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.854 -1.066 . . . . 61.149999999999999 110.81 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.89 126.2 26.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.245 -0.65 . . . . 75.219999999999999 109.245 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.643 ' HD3' ' C2 ' ' B' ' 5' ' ' ' U' . 4.3 ppt_? -84.14 17.55 2.45 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.244 0.545 . . . . 72.109999999999999 111.211 -172.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -126.69 -53.16 0.15 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.545 -0.752 . . . . 63.109999999999999 111.706 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.8 m -97.36 -13.35 21.92 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.252 0.464 . . . . 72.409999999999997 112.252 -177.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.52 45.93 50.92 Favored Glycine 0 CA--C 1.516 0.131 0 C-N-CA 120.527 -0.845 . . . . 73.099999999999994 112.819 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -121.74 159.4 26.71 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.217 -0.66 . . . . 71.340000000000003 109.217 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -56.56 107.51 0.39 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.117 0.484 . . . . 73.010000000000005 110.452 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -72.2 -66.65 0.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.368 -0.833 . . . . 64.0 112.005 -169.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.674 ' C ' H5'' ' B' ' 1' ' ' ' U' . . . 172.28 -66.28 0.13 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.339 -0.934 . . . . 64.540000000000006 111.991 -177.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.537 ' CZ ' " H4'" ' B' ' 3' ' ' ' A' . 45.8 p90 -85.06 154.81 21.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.669 0.271 . . . . 51.530000000000001 110.486 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.91 163.39 33.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.332 -0.395 . . . . 74.310000000000002 110.405 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.453 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 50.2 m-85 -124.41 135.56 53.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.289 -0.414 . . . . 73.140000000000001 110.212 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.61 HG13 ' CD1' ' A' ' 134' ' ' ILE . 23.7 t -108.63 109.24 27.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.852 -0.425 . . . . 62.200000000000003 109.852 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.565 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 15.3 m -87.68 125.4 34.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.391 -0.368 . . . . 71.450000000000003 110.562 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.413 ' CE1' HG12 ' A' ' 131' ' ' ILE . 90.4 m-85 -109.84 154.41 23.06 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.703 -0.48 . . . . 74.140000000000001 109.703 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.426 ' HB2' ' HG2' ' A' ' 132' ' ' GLU . 23.9 t70 -77.57 -22.27 51.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.599 0.714 . . . . 43.409999999999997 110.213 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 157' ' ' ASP . 25.7 t70 -123.31 135.09 54.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.113 -0.949 . . . . 64.019999999999996 111.236 -171.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.554 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.4 p-80 -84.2 0.19 49.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 112.006 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.428 ' HB2' ' OD2' ' A' ' 155' ' ' ASP . 54.3 m-20 -98.08 -29.25 13.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.97 -0.752 . . . . 71.030000000000001 108.97 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.43 ' HA ' ' HE3' ' A' ' 161' ' ' LYS . 42.4 t -58.8 -32.8 69.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.551 -0.749 . . . . 64.439999999999998 109.704 170.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 105' ' ' LYS . 21.7 t -74.18 -29.77 25.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.355 -0.838 . . . . 64.140000000000001 110.434 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.03 -47.74 84.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 74.310000000000002 111.726 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.509 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -60.89 -18.65 57.59 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.324 0.583 . . . . 74.019999999999996 110.906 -178.313 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.561 HG21 HD13 ' A' ' 107' ' ' ILE . 80.5 mt -95.76 -52.33 9.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.451 -0.795 . . . . 54.229999999999997 111.158 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.534 ' HB ' ' HE3' ' A' ' 179' ' ' LYS . 26.4 m -74.77 -10.75 13.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.715 0.635 . . . . 71.420000000000002 112.715 -173.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.4 pp -68.61 -32.92 57.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.836 0.35 . . . . 72.319999999999993 111.052 176.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.475 ' N ' HD12 ' A' ' 164' ' ' ILE . 3.7 pt20 -107.51 -174.35 2.51 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.337 -0.616 . . . . 73.519999999999996 109.337 176.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.633 ' HE3' ' OE1' ' A' ' 176' ' ' GLU . 82.5 tttt -123.52 -56.52 1.69 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.933 0.397 . . . . 71.120000000000005 111.063 -174.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.586 ' HB3' ' OD1' ' A' ' 174' ' ' ASN . 21.8 m-30 -79.93 113.0 17.77 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.93 -0.577 . . . . 75.219999999999999 111.62 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -116.66 143.75 45.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.575 -0.739 . . . . 72.150000000000006 110.555 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 76.3 m -95.7 101.53 13.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.042 0.448 . . . . 64.140000000000001 111.202 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.541 HG11 HD12 ' A' ' 121' ' ' LEU . 42.4 t -118.62 127.96 75.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.285 -0.635 . . . . 63.32 109.285 177.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 58.5 t30 63.21 21.65 12.95 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.83 0.824 . . . . 73.400000000000006 110.112 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.58 -1.27 88.97 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.656 -0.702 . . . . 74.409999999999997 112.684 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -103.26 145.56 29.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.919 0.39 . . . . 71.430000000000007 110.541 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.586 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 64.5 t30 -88.87 106.58 18.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.907 -0.588 . . . . 73.150000000000006 110.072 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 12.0 p -116.55 159.86 21.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.088 -0.506 . . . . 61.039999999999999 110.993 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.633 ' OE1' ' HE3' ' A' ' 166' ' ' LYS . 14.5 tt0 -95.47 130.88 42.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.101 -0.5 . . . . 71.409999999999997 109.915 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 3.0 m -118.88 142.97 31.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.126 0.488 . . . . 61.409999999999997 110.135 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.419 ' HD2' ' H62' ' B' ' 3' ' ' ' A' . 72.9 mtt180 -130.53 177.68 7.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.157 -0.474 . . . . 72.329999999999998 110.199 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.64 ' HE2' ' HB2' ' A' ' 100' ' ' ALA . 10.1 mptt -75.79 120.01 20.57 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.908 -1.145 . . . . 51.140000000000001 107.908 171.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.574 ' HB1' ' O6 ' ' B' ' 4' ' ' ' G' . . . -74.23 93.09 2.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.139 0.495 . . . . 45.210000000000001 111.66 -176.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.731 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -95.94 144.59 26.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.755 -0.657 . . . . 75.439999999999998 109.655 175.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.501 ' HB3' ' HG3' ' A' ' 185' ' ' GLU . 30.6 t -50.28 143.34 8.74 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.405 0.44 . . . . 72.319999999999993 111.593 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.848 ' HB2' " H5'" ' B' ' 6' ' ' ' U' . 21.5 pttp -60.23 -23.54 64.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.762 -0.654 . . . . 51.119999999999997 110.182 175.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -73.76 -42.88 60.44 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.656 -0.702 . . . . 72.209999999999994 110.124 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 182' ' ' SER . 37.9 mt-10 -78.85 -32.48 46.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.654 -0.703 . . . . 72.519999999999996 111.295 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.403 ' SD ' " H2'" ' B' ' 3' ' ' ' A' . 18.7 ptm -65.93 -26.0 67.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.326 -0.397 . . . . 54.329999999999998 110.666 -177.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.96 -42.27 57.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.006 0.432 . . . . 64.540000000000006 110.267 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.5 t -69.64 -32.6 71.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.786 -0.643 . . . . 70.420000000000002 110.319 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -69.12 -31.4 70.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.218 0.532 . . . . 71.099999999999994 110.821 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 46.3 m -96.25 35.51 1.45 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.59 -0.732 . . . . 53.229999999999997 111.281 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.7 m -90.03 3.88 51.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 72.540000000000006 110.657 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 28.2 t -98.73 102.4 14.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.224 -0.444 . . . . 43.32 110.535 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -111.18 118.76 36.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.138 -0.483 . . . . 73.049999999999997 109.969 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -91.29 122.72 34.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.106 -0.497 . . . . 61.329999999999998 110.283 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.48 -125.74 9.55 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.922 -0.656 . . . . 65.019999999999996 112.142 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.384 -0.817 . . . . 75.409999999999997 110.502 -179.632 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.817 " H3'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.831 0 C4'-C3'-C2' 103.99 1.29 . 0.0 '__' . 71.209999999999994 . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.817 H5'' " H3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.848 0 C4'-C3'-C2' 104.095 1.395 . 0.0 OUTLIER . 74.140000000000001 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.595 ' N1 ' HD23 ' A' ' 181' ' ' LEU . . . . . . . . 0 O5'--C5' 1.423 -1.038 0 C4'-C3'-C2' 103.883 1.183 . 0.0 OUTLIER . 73.209999999999994 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.664 " O5'" H5'' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.892 0 C3'-C2'-C1' 99.651 -2.055 . 0.0 OUTLIER alpha 72.319999999999993 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.664 H5'' " O5'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.839 0 O4'-C1'-C2' 108.34 1.385 . 0.0 OUTLIER . 65.329999999999998 . . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.848 " H5'" ' HB2' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.425 -0.913 0 C3'-C2'-C1' 103.731 2.479 . 0.0 OUTLIER . 74.430000000000007 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 110.379 -0.23 . . . . 74.140000000000001 110.379 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.495 ' HG2' ' HD3' ' A' ' 98' ' ' PRO . 61.3 tt0 -59.4 119.55 7.66 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.021 0.438 . . . . 70.329999999999998 110.906 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -149.94 79.28 7.79 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.774 -0.648 . . . . 72.109999999999999 110.639 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.495 ' HD3' ' HG2' ' A' ' 96' ' ' GLN . 17.1 Cg_exo -66.53 -54.27 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.632 2.221 . . . . 53.420000000000002 110.57 176.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.77 78.35 0.48 Allowed Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.734 -0.946 . . . . 50.340000000000003 110.734 172.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.19 -25.16 36.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.203 0.525 . . . . 64.109999999999999 110.48 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -70.96 -21.52 62.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.679 -0.692 . . . . 61.210000000000001 109.724 175.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.9 mt -82.76 107.31 15.29 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.405 -0.816 . . . . 75.329999999999998 109.858 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.512 HG22 ' HB2' ' A' ' 156' ' ' HIS . 1.8 m -63.96 130.85 45.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.083 -0.508 . . . . 71.430000000000007 109.65 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.558 HG13 HG11 ' A' ' 159' ' ' VAL . 14.6 p -114.74 147.18 18.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.149 -0.478 . . . . 40.119999999999997 111.266 -168.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.762 ' HA ' HG21 ' A' ' 159' ' ' VAL . 12.1 mtmt -123.07 -1.41 8.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 74.140000000000001 111.865 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.622 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 27.0 ttpt -130.45 137.42 49.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.846 0.355 . . . . 71.140000000000001 110.171 175.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.577 ' CG2' HG13 ' A' ' 159' ' ' VAL . 10.8 pt -108.36 163.97 5.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.949 0.404 . . . . 74.549999999999997 111.258 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.461 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 75.0 t80 -112.67 120.19 40.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.567 -0.742 . . . . 74.439999999999998 109.452 176.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.4 t -105.9 115.45 47.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.947 0.403 . . . . 74.340000000000003 110.919 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.86 171.53 18.5 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.65 -0.58 . . . . 44.109999999999999 111.65 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.53 ' H ' H5'' ' B' ' 2' ' ' ' C' . . . 66.97 36.95 91.76 Favored Glycine 0 N--CA 1.454 -0.119 0 C-N-CA 120.675 -0.774 . . . . 53.119999999999997 112.186 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.661 ' CD1' " H3'" ' B' ' 1' ' ' ' U' . 0.2 OUTLIER -94.62 -167.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.613 0.244 . . . . 71.140000000000001 110.828 -177.51 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -109.29 163.1 13.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.042 -0.355 . . . . 62.049999999999997 110.042 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.33 -34.36 46.92 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.386 0.675 . . . . 73.5 112.094 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -93.87 -3.64 51.45 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.466 0.543 . . . . 73.209999999999994 112.466 -173.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.7 m -69.14 115.85 8.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.019 0.437 . . . . 65.340000000000003 111.418 -172.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.408 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 0.9 OUTLIER -123.31 -161.13 0.94 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.592 -0.731 . . . . 75.329999999999998 110.978 -177.515 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.723 ' HA ' HG21 ' A' ' 134' ' ' ILE . 10.7 tt0 -57.68 -51.8 68.05 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.522 -0.763 . . . . 75.049999999999997 112.266 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -62.67 -33.97 76.15 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 120.921 -0.312 . . . . 72.310000000000002 110.619 -173.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -60.88 -56.19 24.07 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.281 -0.418 . . . . 63.549999999999997 110.314 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.575 HD23 HG11 ' A' ' 170' ' ' VAL . 59.2 mt -59.31 -54.75 43.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.435 -0.802 . . . . 72.540000000000006 111.191 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -55.36 -46.64 76.43 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.1 -0.5 . . . . 71.430000000000007 111.412 -177.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.65 -35.3 65.79 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.996 0.427 . . . . 73.040000000000006 111.436 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -84.31 -44.4 13.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.378 -0.374 . . . . 72.019999999999996 111.191 -178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -81.39 -16.88 50.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.387 0.514 . . . . 71.129999999999995 112.387 -172.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -24.03 67.4 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.998 0.427 . . . . 64.120000000000005 110.951 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -66.76 -28.29 68.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.832 -0.622 . . . . 73.040000000000006 110.234 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.464 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 69.3 m-85 -80.78 -34.58 34.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.642 -0.708 . . . . 72.420000000000002 110.948 -177.45 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 171.7 -164.28 36.98 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.964 -1.112 . . . . 75.430000000000007 113.118 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -75.85 118.7 18.92 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.512 0.673 . . . . 72.030000000000001 111.959 -176.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.481 HG21 HD11 ' A' ' 134' ' ' ILE . 36.2 mt -95.22 139.96 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.19 -0.914 . . . . 40.130000000000003 110.355 177.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.448 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 9.0 mm-40 -84.61 -76.28 0.31 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.132 -0.485 . . . . 74.329999999999998 110.011 176.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.02 158.36 26.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.008 -0.542 . . . . 74.329999999999998 110.136 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.723 HG21 ' HA ' ' A' ' 118' ' ' GLU . 23.4 mm -107.35 112.46 40.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.139 -0.689 . . . . 75.519999999999996 109.139 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -97.58 92.02 5.71 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.348 0.594 . . . . 72.340000000000003 110.68 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.7 mt -73.66 128.54 36.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.324 -0.991 . . . . 71.319999999999993 108.324 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.647 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -71.36 96.91 1.52 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.265 -0.643 . . . . 60.009999999999998 109.265 -179.115 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 3.3 p -114.72 154.16 28.98 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.664 -0.698 . . . . 62.229999999999997 110.889 -178.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.665 ' HA ' ' C4 ' ' B' ' 5' ' ' ' U' . 33.0 t70 -56.93 142.44 41.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.082 -0.508 . . . . 72.25 110.917 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.43 ' CD ' ' H ' ' A' ' 140' ' ' ARG . 0.1 OUTLIER -74.01 -15.36 61.09 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.858 -0.61 . . . . 55.049999999999997 111.486 -175.29 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.61 -56.76 0.81 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.699 -0.762 . . . . 72.329999999999998 112.815 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.3 t -101.13 -8.23 22.45 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.652 -0.322 . . . . 71.519999999999996 111.536 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.87 43.61 91.07 Favored Glycine 0 N--CA 1.454 -0.107 0 C-N-CA 120.58 -0.819 . . . . 62.409999999999997 112.214 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.484 ' H ' ' HB3' ' A' ' 139' ' ' ASP . 2.9 mtpt -93.08 141.97 27.81 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.869 -0.419 . . . . 62.32 109.869 -177.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -65.82 109.84 2.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.091 0.472 . . . . 73.329999999999998 110.934 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -70.35 -30.66 67.66 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.671 -0.695 . . . . 61.210000000000001 110.216 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 140.08 -79.0 0.29 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.738 -0.665 . . . . 23.23 112.127 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.647 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 42.4 p90 -69.94 165.16 22.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.865 0.364 . . . . 54.530000000000001 110.773 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.461 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -149.14 165.33 32.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.415 -0.357 . . . . 74.319999999999993 110.99 -177.4 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.461 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 53.7 m-85 -124.04 143.2 50.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 71.409999999999997 109.934 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.585 HG13 ' CD1' ' A' ' 134' ' ' ILE . 44.1 t -117.56 112.54 39.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.875 -0.417 . . . . 75.540000000000006 109.875 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.622 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 16.6 m -89.83 125.08 35.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.226 -0.443 . . . . 73.439999999999998 110.434 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.484 ' CD2' HG22 ' A' ' 159' ' ' VAL . 88.3 m-85 -108.63 152.24 25.06 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.432 -0.581 . . . . 61.5 109.432 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.448 ' HB2' ' HG2' ' A' ' 132' ' ' GLU . 28.4 t70 -81.3 -18.93 44.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.113 0.959 . . . . 54.119999999999997 109.07 176.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.526 ' OD2' ' HB3' ' A' ' 157' ' ' ASP . 26.0 t70 -116.05 126.16 53.41 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.227 -1.351 . . . . 74.430000000000007 110.548 -175.149 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.575 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 7.0 p80 -78.81 -8.49 58.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.222 -0.445 . . . . 54.210000000000001 111.363 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.526 ' HB3' ' OD2' ' A' ' 155' ' ' ASP . 18.5 t70 -89.03 -36.26 15.9 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.308 -0.627 . . . . 71.420000000000002 109.308 -176.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.0 t -54.44 -40.79 68.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.315 -0.857 . . . . 50.43 109.713 168.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.762 HG21 ' HA ' ' A' ' 105' ' ' LYS . 11.3 t -67.75 -33.96 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.516 -0.766 . . . . 61.420000000000002 110.443 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -64.25 -28.85 70.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 73.420000000000002 110.752 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.464 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 20.9 mmtp -70.07 -24.36 63.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.621 0.724 . . . . 64.439999999999998 109.893 177.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.482 HG23 ' CE1' ' A' ' 168' ' ' HIS . 87.3 mt -99.71 -48.4 11.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.009 -0.996 . . . . 65.540000000000006 111.917 -169.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.421 HG13 HG12 ' A' ' 159' ' ' VAL . 31.6 m -73.05 -7.76 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 112.769 0.655 . . . . 71.209999999999994 112.769 -173.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.3 pp -78.45 -33.81 17.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.911 -0.316 . . . . 72.010000000000005 111.479 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.525 ' N ' HD12 ' A' ' 164' ' ' ILE . 12.8 pt20 -108.47 171.34 7.47 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.493 -0.558 . . . . 53.509999999999998 109.493 176.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.565 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 86.3 tttt -111.61 -59.38 1.99 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.831 0.348 . . . . 72.140000000000001 111.181 -174.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.602 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 19.8 m-30 -77.32 99.16 5.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.272 0.558 . . . . 63.539999999999999 112.042 -176.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.482 ' CE1' HG23 ' A' ' 162' ' ' ILE . 49.0 m-70 -98.61 159.19 15.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.551 -0.75 . . . . 72.510000000000005 110.009 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.9 m -104.67 83.77 2.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.927 0.394 . . . . 74.329999999999998 110.956 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.575 HG11 HD23 ' A' ' 121' ' ' LEU . 21.9 t -106.93 131.85 55.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.952 -0.388 . . . . 74.510000000000005 109.952 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 67.07 13.52 9.48 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.756 0.789 . . . . 73.109999999999999 109.776 178.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.05 17.69 71.53 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.758 -0.656 . . . . 74.010000000000005 112.072 -177.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 75.5 m80 -117.28 160.25 21.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.074 0.464 . . . . 72.549999999999997 110.553 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -87.2 105.98 17.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.703 -0.68 . . . . 71.409999999999997 109.449 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 66.8 m -114.15 158.43 21.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.151 -0.477 . . . . 75.340000000000003 111.02 -175.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.565 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 9.5 tt0 -103.16 125.74 50.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.15 -0.477 . . . . 74.329999999999998 110.152 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.435 HG11 ' CG2' ' A' ' 162' ' ' ILE . 78.5 t -123.06 135.16 64.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.308 0.575 . . . . 73.239999999999995 110.896 177.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.485 ' HD2' ' OE1' ' A' ' 96' ' ' GLN . 2.8 ptt180 -139.9 165.56 26.99 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.346 -0.843 . . . . 71.420000000000002 108.993 176.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.46 ' HB2' HG11 ' A' ' 104' ' ' VAL . 11.5 ptmm? -72.04 126.21 29.19 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.544 -0.462 . . . . 75.099999999999994 110.038 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.695 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -72.3 129.29 38.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.859 -0.61 . . . . 50.130000000000003 111.239 -176.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.708 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.5 pt? -124.7 143.96 50.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.437 -0.801 . . . . 75.540000000000006 109.025 174.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 m -49.3 137.91 13.59 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.445 0.466 . . . . 70.25 111.246 -177.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.854 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.1 pttp -61.84 -25.63 67.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.17 0.51 . . . . 70.230000000000004 110.094 178.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 39.7 tt0 -59.06 -41.48 88.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.34 -0.846 . . . . 73.109999999999999 110.762 172.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -93.11 -35.89 12.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.58 -0.736 . . . . 63.009999999999998 111.38 -172.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.854 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 23.9 ptm -67.42 -22.59 65.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.753 0.311 . . . . 72.510000000000005 110.385 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.77 -39.35 90.93 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.7 -0.481 . . . . 74.209999999999994 109.7 175.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 16.0 m -70.64 -38.4 73.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.706 -0.679 . . . . 51.299999999999997 110.333 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.01 -34.73 79.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 45.350000000000001 110.729 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.7 t -75.24 -37.46 61.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.959 -0.564 . . . . 44.049999999999997 110.022 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 49.0 m -70.27 171.48 9.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.928 -0.578 . . . . 72.120000000000005 110.283 176.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 195' ' ' GLY . 14.7 m -96.71 88.6 4.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.932 0.396 . . . . 72.25 110.542 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -83.96 -46.77 11.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.024 0.44 . . . . 73.319999999999993 110.241 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -87.39 -42.29 12.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.091 -0.504 . . . . 72.129999999999995 110.183 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 192' ' ' SER . . . 168.87 -76.25 0.11 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.635 -0.793 . . . . 34.229999999999997 112.328 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.686 -0.673 . . . . 74.200000000000003 110.161 -177.884 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.661 " H3'" ' CD1' ' A' ' 112' ' ' ILE . . . . . . . . 0 O5'--C5' 1.423 -1.074 0 C3'-C2'-C1' 100.405 -1.216 . 0.0 '__' . 74.530000000000001 . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.615 ' OP2' " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.96 0 C3'-C2'-C1' 100.806 -0.771 . 0.0 OUTLIER . 73.450000000000003 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.695 ' N1 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.426 -0.864 0 O4'-C1'-C2' 108.051 1.18 . 0.0 OUTLIER . 74.310000000000002 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.644 " O5'" ' HD3' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.424 -0.993 0 C3'-C2'-C1' 100.547 -1.059 . 0.0 OUTLIER alpha 73.439999999999998 . . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.929 ' C6 ' " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.97 0 C3'-C2'-C1' 103.722 2.469 OUTLIER-DELTA 0.0 OUTLIER . 75.430000000000007 . . . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.464 " O5'" " H4'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.923 0 C3'-C2'-C1' 100.343 -1.285 . 0.0 OUTLIER . 72.030000000000001 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 121.102 0.477 . . . . 63.149999999999999 110.948 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -84.63 128.4 34.58 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.016 -0.735 . . . . 74.400000000000006 109.016 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 97' ' ' ARG . 46.8 mtm105 58.86 96.11 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.292 0 O-C-N 123.874 0.734 . . . . 64.450000000000003 110.85 -172.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.631 ' HG2' ' O ' ' A' ' 179' ' ' LYS . 34.9 Cg_exo -64.57 -169.49 0.12 Allowed 'Trans proline' 0 N--CA 1.472 0.212 0 C-N-CA 123.27 2.646 . . . . 74.530000000000001 113.463 -179.342 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -56.58 98.86 0.07 OUTLIER Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.647 -0.706 . . . . 54.350000000000001 112.552 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.94 -14.38 59.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.318 0.58 . . . . 63.100000000000001 110.499 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -83.34 -6.29 59.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.453 -0.794 . . . . 73.540000000000006 110.391 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.5 mt -101.06 130.85 47.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.901 -0.591 . . . . 71.109999999999999 110.52 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.91 104.09 3.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.17 0.51 . . . . 65.219999999999999 110.349 175.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.485 ' O ' HG21 ' A' ' 159' ' ' VAL . 4.1 p -89.56 144.76 8.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.866 -0.607 . . . . 65.310000000000002 110.323 -176.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.548 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 2.5 mtmt -122.24 16.81 10.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.389 0.614 . . . . 62.450000000000003 110.547 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.576 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 24.8 ttpt -152.78 136.52 16.15 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.339 -0.846 . . . . 62.439999999999998 109.742 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.546 HG12 ' HB ' ' A' ' 151' ' ' VAL . 9.1 pt -103.93 162.7 4.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.904 0.383 . . . . 64.420000000000002 110.732 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.465 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 59.7 t80 -110.63 110.63 21.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.762 -0.653 . . . . 74.109999999999999 110.363 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.1 t -98.25 91.86 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.132 -0.692 . . . . 74.549999999999997 109.132 176.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.691 ' O ' " H5'" ' B' ' 2' ' ' ' C' . . . -106.64 -38.99 2.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.669 -0.777 . . . . 52.130000000000003 112.928 -174.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.647 ' HA3' ' HB3' ' A' ' 176' ' ' GLU . . . -79.54 59.43 4.4 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.589 -0.815 . . . . 75.439999999999998 113.229 -174.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.483 HG22 ' SG ' ' A' ' 175' ' ' CYS . 44.9 pt -110.97 169.87 3.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 110.123 -0.325 . . . . 64.200000000000003 110.123 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.452 ' HA ' ' O2 ' ' B' ' 1' ' ' ' U' . 49.6 mttm -138.35 -48.72 0.54 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.337 -0.392 . . . . 74.319999999999993 111.175 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.75 173.58 8.2 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.193 -0.458 . . . . 73.519999999999996 111.011 -176.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.27 97.36 0.54 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.956 -0.565 . . . . 74.109999999999999 110.052 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.1 m -117.8 120.48 38.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.346 -0.843 . . . . 53.43 109.393 -178.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.61 -169.37 1.49 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.215 0.531 . . . . 74.530000000000001 112.143 -173.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.73 ' HA ' HG21 ' A' ' 134' ' ' ILE . 21.1 tt0 -58.13 -48.73 79.34 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.881 -1.054 . . . . 74.040000000000006 111.926 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -34.94 75.19 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.089 -0.244 . . . . 63.420000000000002 110.554 -177.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -64.4 -57.31 9.65 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.085 0.469 . . . . 75.439999999999998 110.453 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.599 HD23 HG11 ' A' ' 170' ' ' VAL . 79.4 mt -59.93 -52.4 65.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.306 -0.861 . . . . 52.409999999999997 110.848 -176.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.52 -44.09 93.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.007 -0.542 . . . . 74.439999999999998 111.419 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -63.16 -22.75 67.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.042 0.448 . . . . 73.239999999999995 110.938 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.417 ' CD1' HG22 ' A' ' 170' ' ' VAL . 85.9 t80 -89.83 -51.78 5.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.251 -0.432 . . . . 63.399999999999999 110.85 176.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.431 ' HA ' ' HD2' ' A' ' 128' ' ' TYR . 52.2 m-85 -74.49 -14.7 60.86 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.38 0.511 . . . . 74.340000000000003 112.38 -172.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -22.34 65.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.837 0.31 . . . . 74.25 111.837 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -74.66 -21.82 59.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 71.239999999999995 110.582 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.473 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 86.6 m-85 -86.04 -21.79 27.56 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.501 -0.318 . . . . 73.439999999999998 110.279 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 163.18 -167.69 37.6 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 119.822 -1.18 . . . . 44.509999999999998 113.373 174.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.567 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 37.7 tptt -75.74 117.09 17.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.633 0.73 . . . . 71.040000000000006 111.09 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.552 HG21 HD11 ' A' ' 134' ' ' ILE . 40.1 mt -93.69 133.78 33.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.023 -0.989 . . . . 73.420000000000002 110.557 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -82.2 -75.17 0.31 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.925 -0.58 . . . . 74.439999999999998 110.765 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.54 155.57 36.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.797 -0.446 . . . . 52.200000000000003 109.797 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.73 HG21 ' HA ' ' A' ' 118' ' ' GLU . 27.8 mm -113.01 123.08 68.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.493 -0.558 . . . . 74.129999999999995 109.493 173.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.3 96.13 6.31 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.017 0.437 . . . . 72.099999999999994 110.644 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.61 HD11 ' H ' ' A' ' 118' ' ' GLU . 7.9 mt -80.19 120.46 31.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.036 -1.098 . . . . 73.030000000000001 108.036 173.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.601 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 76.1 mmm -74.15 94.39 2.43 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 119.926 -0.71 . . . . 73.530000000000001 109.964 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.2 p -99.56 173.71 6.6 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.704 -1.135 . . . . 53.520000000000003 109.983 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.754 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 22.1 t70 -60.61 138.6 58.03 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.349 -0.612 . . . . 63.240000000000002 109.349 173.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.458 ' HD3' " H2'" ' B' ' 5' ' ' ' U' . 5.1 tpt180 -72.04 -2.38 18.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.006 0.431 . . . . 70.209999999999994 111.214 -172.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -128.67 -49.47 0.14 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.032 -0.604 . . . . 73.0 112.852 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.544 ' HB2' ' HG2' ' A' ' 144' ' ' LYS . 24.5 m -83.51 -18.93 36.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.745 0.307 . . . . 61.020000000000003 111.61 -175.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.76 32.54 78.19 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.765 -0.731 . . . . 55.030000000000001 112.855 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.544 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 8.3 ptpt -105.6 139.62 39.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.76 -0.459 . . . . 72.439999999999998 109.76 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -52.89 130.05 32.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 74.409999999999997 112.028 -172.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -91.04 -32.1 16.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.258 -0.645 . . . . 72.319999999999993 109.258 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.683 ' HA3' " O5'" ' B' ' 1' ' ' ' U' . . . 154.68 -101.91 0.21 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.508 -0.769 . . . . 73.409999999999997 112.283 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.649 ' H ' " H5'" ' B' ' 1' ' ' ' U' . 24.5 p90 -57.22 157.64 6.05 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.921 0.488 . . . . 73.230000000000004 111.853 -175.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.53 165.52 27.34 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.173 -0.467 . . . . 60.420000000000002 110.938 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.552 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 69.1 m-85 -123.73 142.34 51.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.1 -0.5 . . . . 71.140000000000001 110.317 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.634 HG13 ' CD1' ' A' ' 134' ' ' ILE . 55.6 t -116.42 108.49 25.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.04 -0.527 . . . . 70.030000000000001 109.784 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.576 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 8.7 m -86.35 127.61 34.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.142 -0.481 . . . . 74.030000000000001 110.475 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.541 ' CD2' HG12 ' A' ' 159' ' ' VAL . 96.4 m-85 -110.47 153.5 24.96 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.936 0.398 . . . . 74.420000000000002 110.555 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.567 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 19.4 t70 -76.69 -15.26 59.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.905 -0.589 . . . . 71.219999999999999 110.606 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -136.15 139.85 43.2 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.809 -0.632 . . . . 72.340000000000003 110.609 -174.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.548 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.4 p-80 -83.99 -0.29 51.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.979 0.418 . . . . 70.510000000000005 111.018 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -80.44 -40.97 25.32 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.417 0.627 . . . . 74.109999999999999 109.48 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.4 m -61.17 -33.64 73.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.121 -0.945 . . . . 52.049999999999997 111.538 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.541 HG12 ' CD2' ' A' ' 153' ' ' PHE . 15.3 m -72.85 -27.92 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 50.020000000000003 111.396 -177.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ASP . . . . . 0.495 ' HA ' HG22 ' A' ' 163' ' ' VAL . 35.6 t70 -65.53 -42.12 92.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.608 -0.269 . . . . 61.210000000000001 110.993 -173.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.473 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 4.9 mttt -58.86 -22.33 58.9 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.196 0.522 . . . . 71.519999999999996 110.807 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.522 HG21 HD13 ' A' ' 107' ' ' ILE . 79.6 mt -92.86 -49.37 12.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.397 -0.82 . . . . 51.5 110.939 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' ' 179' ' ' LYS . 30.3 m -77.83 -7.73 10.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.898 0.703 . . . . 63.130000000000003 112.898 -174.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.409 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.5 pp -72.84 -28.87 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.967 0.413 . . . . 75.430000000000007 110.561 174.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.432 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 11.9 pt20 -108.06 -171.17 1.81 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.172 -0.677 . . . . 72.040000000000006 109.172 172.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.41 ' HG2' ' HG3' ' A' ' 176' ' ' GLU . 87.6 tttt -130.3 -61.85 0.96 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.781 -0.368 . . . . 63.329999999999998 111.537 -174.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -82.6 115.51 21.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.949 0.404 . . . . 64.319999999999993 110.721 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.442 ' CE1' HG23 ' A' ' 162' ' ' ILE . 21.3 m-70 -110.15 140.04 44.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.702 -0.681 . . . . 72.040000000000006 110.655 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 34.3 m -88.85 87.72 7.34 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.047 -0.524 . . . . 71.530000000000001 110.354 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.599 HG11 HD23 ' A' ' 121' ' ' LEU . 33.0 t -106.07 131.07 56.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.597 -0.52 . . . . 74.25 109.597 178.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 61.9 t30 63.46 20.83 12.47 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.879 0.847 . . . . 62.450000000000003 109.546 -177.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.08 -5.74 70.24 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.383 -0.826 . . . . 71.530000000000001 112.191 -176.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -96.46 151.24 19.75 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.207 -0.294 . . . . 73.409999999999997 110.207 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -86.78 99.49 11.83 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.008 -0.367 . . . . 71.409999999999997 110.008 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 58.5 m -110.46 128.85 55.8 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.363 -0.38 . . . . 72.439999999999998 110.979 -177.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.647 ' HB3' ' HA3' ' A' ' 111' ' ' GLY . 28.4 tt0 -76.72 123.52 26.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.173 -0.467 . . . . 74.140000000000001 110.534 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 1.1 m -119.31 151.75 21.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.185 -0.461 . . . . 55.32 110.354 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -138.23 -173.92 3.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.716 -0.846 . . . . 74.430000000000007 108.716 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.631 ' O ' ' HG2' ' A' ' 98' ' ' PRO . 19.4 ptmt -91.07 132.88 35.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.253 -0.647 . . . . 75.040000000000006 109.253 170.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -82.15 114.36 20.62 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.101 0.408 . . . . 51.039999999999999 112.101 -173.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.576 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -102.66 144.62 30.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.076 -0.713 . . . . 61.119999999999997 109.076 173.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 m -52.86 133.13 37.7 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.312 0.383 . . . . 61.329999999999998 111.252 -176.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.743 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 39.0 pttt -62.35 -30.25 71.04 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 109.828 -0.434 . . . . 75.310000000000002 109.828 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -59.99 -41.26 91.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.517 -0.765 . . . . 63.039999999999999 110.358 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -85.26 -39.16 18.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.645 -0.707 . . . . 75.010000000000005 111.257 -175.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.743 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 25.3 ptm -68.14 -21.33 64.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 73.530000000000001 110.49 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.75 -43.08 63.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 64.310000000000002 109.864 175.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 18.8 m -69.41 -31.49 69.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.912 -0.586 . . . . 42.420000000000002 110.479 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -66.24 -46.53 76.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.395 0.616 . . . . 71.219999999999999 110.326 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 64.6 m -69.51 -53.99 16.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.19 -0.913 . . . . 74.140000000000001 110.894 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 28.5 m -111.16 88.3 2.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.124 0.488 . . . . 35.32 110.363 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.1 m -89.74 95.49 10.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.856 -0.611 . . . . 62.329999999999998 110.605 -178.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -83.95 136.93 33.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.979 -0.555 . . . . 72.099999999999994 109.576 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -101.68 24.43 9.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.005 0.431 . . . . 65.430000000000007 110.291 -174.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 94.17 -74.15 1.09 Allowed Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.09 -0.804 . . . . 64.329999999999998 111.09 -174.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.727 -0.654 . . . . 70.420000000000002 109.431 175.9 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 1.011 " C4'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.725 0 C4'-C3'-C2' 104.199 1.499 . 0.0 '__' . 75.549999999999997 . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 1.011 H5'' " C4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.006 0 C3'-C2'-C1' 104.404 3.227 OUTLIER-DELTA 0.0 OUTLIER alpha 75.129999999999995 . . . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.573 ' N1 ' HD23 ' A' ' 181' ' ' LEU . . . . . . . . 0 O5'--C5' 1.424 -1.03 0 C4'-C3'-C2' 104.545 1.845 . 0.0 OUTLIER . 75.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.649 ' H21' ' HB3' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.424 -1.01 0 C3'-C2'-C1' 98.582 -3.243 . 0.0 OUTLIER alpha 74.450000000000003 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.932 " H3'" " H5'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.422 -1.135 0 O4'-C1'-C2' 107.797 0.998 . 0.0 OUTLIER zeta-1 71.439999999999998 . . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.932 " H5'" " H3'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.887 0 C3'-C2'-C1' 100.765 -0.817 . 0.0 OUTLIER . 65.329999999999998 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 59.2 m . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 110.313 -0.254 . . . . 62.009999999999998 110.313 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 77.1 mm-40 65.28 19.92 11.78 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.296 0.639 . . . . 70.120000000000005 111.401 177.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -135.69 78.11 50.13 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.96 0.41 . . . . 74.239999999999995 110.578 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -91.47 46.35 0.54 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.144 2.563 . . . . 64.420000000000002 111.912 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.79 -28.26 5.53 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.961 -0.856 . . . . 61.219999999999999 110.961 -173.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' A' ' 181' ' ' LEU . . . -85.91 96.47 9.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.656 -0.498 . . . . 64.049999999999997 109.656 172.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' HIS . . . . . 0.766 ' HA ' ' HG2' ' A' ' 179' ' ' LYS . 8.5 p80 -173.14 8.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.523 -0.762 . . . . 74.200000000000003 110.01 177.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.416 ' H ' ' H ' ' A' ' 101' ' ' HIS . 31.2 mt -102.22 -140.09 0.35 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.315 -0.857 . . . . 74.010000000000005 109.641 -177.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.2 p -74.16 96.66 2.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.915 0.388 . . . . 75.430000000000007 110.307 174.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.4 t -103.31 -46.74 10.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.364 -0.38 . . . . 31.120000000000001 111.266 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.725 ' HA ' HG21 ' A' ' 159' ' ' VAL . 24.1 mtmt 69.45 12.27 8.22 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.163 -0.472 . . . . 74.099999999999994 112.206 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.58 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 27.9 ttpt -157.23 133.91 10.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.593 -0.521 . . . . 64.329999999999998 109.593 173.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.528 HD13 HG21 ' A' ' 162' ' ' ILE . 4.7 pt -108.42 158.49 8.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.106 0.479 . . . . 75.109999999999999 111.023 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 69.4 t80 -105.3 121.11 43.19 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.246 -0.888 . . . . 65.340000000000003 109.899 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' VAL . . . . . 0.465 HG12 ' CG2' ' A' ' 112' ' ' ILE . 41.9 t -108.43 111.56 36.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.44 -0.345 . . . . 73.230000000000004 110.405 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.53 162.05 20.75 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.02 -0.61 . . . . 51.450000000000003 112.241 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.43 62.81 5.22 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.948 -0.644 . . . . 71.25 111.59 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.577 ' H ' " C5'" ' B' ' 1' ' ' ' U' . 17.6 pt -111.71 -170.23 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.339 0.59 . . . . 73.409999999999997 112.475 -169.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.451 ' HB3' ' OG1' ' A' ' 116' ' ' THR . 44.4 tttm -96.46 153.45 17.83 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.014 -0.993 . . . . 75.239999999999995 109.763 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -47.2 -67.51 0.27 Allowed 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.485 0.491 . . . . 62.119999999999997 111.249 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -87.48 80.59 8.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.316 0.579 . . . . 33.200000000000003 110.139 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 113' ' ' LYS . 62.3 m -140.64 106.87 5.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.125 -0.943 . . . . 65.420000000000002 109.356 173.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -123.22 -162.9 1.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.706 -0.679 . . . . 61.549999999999997 110.812 -174.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.635 ' HA ' HG21 ' A' ' 134' ' ' ILE . 15.9 tt0 -49.47 -52.43 29.22 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.028 -0.533 . . . . 75.239999999999995 112.056 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.49 -29.29 70.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.525 -0.307 . . . . 71.040000000000006 110.663 -174.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -69.42 -56.46 7.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.533 -0.303 . . . . 64.540000000000006 110.918 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.455 HD11 HG11 ' A' ' 109' ' ' VAL . 0.7 OUTLIER -57.19 -49.07 77.15 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.969 0.414 . . . . 71.430000000000007 109.951 177.47 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 122' ' ' ARG . 0.7 OUTLIER -55.03 -49.94 70.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.725 -0.671 . . . . 53.340000000000003 111.03 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -53.29 -32.71 50.04 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.169 0.509 . . . . 73.400000000000006 111.8 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -89.88 -39.09 13.27 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.077 -0.511 . . . . 74.349999999999994 111.578 -177.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.457 ' CD1' HG21 ' A' ' 151' ' ' VAL . 56.4 m-85 -89.14 -14.35 36.37 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.358 0.503 . . . . 53.219999999999999 112.358 -173.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.407 ' N ' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -66.12 -20.47 66.16 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.413 0.625 . . . . 72.319999999999993 110.013 176.039 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -71.58 -23.64 61.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.996 -1.002 . . . . 54.049999999999997 110.755 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -87.17 -32.64 19.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.086 -0.506 . . . . 75.420000000000002 111.099 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.33 -152.35 16.69 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.829 -1.177 . . . . 63.530000000000001 113.7 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.464 ' HA ' ' HE3' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -87.97 113.95 24.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.421 0.629 . . . . 73.439999999999998 111.547 -175.656 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.407 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 34.3 mt -94.24 138.25 21.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.041 -0.982 . . . . 72.439999999999998 110.187 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -78.04 -74.58 0.26 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.483 -0.562 . . . . 72.530000000000001 109.483 172.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.6 m -146.57 165.48 7.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.917 -0.583 . . . . 64.109999999999999 109.816 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.635 HG21 ' HA ' ' A' ' 118' ' ' GLU . 19.6 mm -109.59 109.45 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.274 -0.639 . . . . 73.450000000000003 109.274 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 59.5 mt-10 -88.14 98.57 11.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.312 0.577 . . . . 63.119999999999997 110.231 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.57 HD11 ' H ' ' A' ' 118' ' ' GLU . 35.8 mt -78.48 116.26 21.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.637 -0.71 . . . . 64.239999999999995 109.571 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.765 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -77.05 98.67 5.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.078 0.466 . . . . 64.439999999999998 109.809 -178.632 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 p -90.74 144.06 26.11 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.896 -0.593 . . . . 63.329999999999998 110.97 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 146' ' ' ARG . 34.5 t70 -59.55 141.07 55.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.228 -0.896 . . . . 71.310000000000002 110.524 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.474 ' H ' ' HD3' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -96.06 14.68 22.97 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.07 -0.513 . . . . 53.149999999999999 110.961 -174.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -120.28 -45.8 0.39 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.97 -0.633 . . . . 62.229999999999997 111.717 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.1 t -100.86 -34.35 9.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.878 0.37 . . . . 63.310000000000002 111.035 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.67 54.32 2.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.64 -0.791 . . . . 45.030000000000001 111.526 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -134.19 159.86 39.6 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.595 -0.52 . . . . 74.400000000000006 109.595 -176.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -60.47 113.56 2.49 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.344 -0.614 . . . . 44.140000000000001 109.344 174.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.459 ' O ' " H2'" ' B' ' 1' ' ' ' U' . 21.9 ttt-85 -82.38 6.33 17.44 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.516 0.561 . . . . 55.409999999999997 112.516 -167.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 1.053 ' HA3' " H2'" ' B' ' 1' ' ' ' U' . . . 106.74 -11.44 41.92 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.139 -1.029 . . . . 74.530000000000001 112.964 176.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.765 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 21.4 p90 -141.92 150.76 41.91 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 122.485 -0.42 . . . . 64.310000000000002 110.477 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.49 174.23 10.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.757 -0.656 . . . . 72.099999999999994 110.069 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.518 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 82.2 m-85 -133.33 139.55 46.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.914 0.387 . . . . 63.119999999999997 110.095 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.605 HG13 ' CD1' ' A' ' 134' ' ' ILE . 26.3 t -114.02 106.61 21.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.598 -0.519 . . . . 73.25 109.598 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.58 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 17.7 m -85.28 124.11 31.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.23 -0.441 . . . . 72.329999999999998 110.313 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.447 ' CD2' HG22 ' A' ' 159' ' ' VAL . 97.5 m-85 -107.91 145.09 34.24 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.833 -0.432 . . . . 65.219999999999999 109.833 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -74.87 -21.32 59.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.688 0.756 . . . . 72.040000000000006 109.486 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.494 ' OD1' ' HB3' ' A' ' 157' ' ' ASP . 18.7 t70 -118.99 128.52 54.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.801 -1.09 . . . . 71.409999999999997 110.871 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.58 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 3.2 p-80 -76.23 -9.59 58.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.996 -0.547 . . . . 64.299999999999997 111.268 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.494 ' HB3' ' OD1' ' A' ' 155' ' ' ASP . 32.8 t70 -85.3 -39.84 17.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.207 0.527 . . . . 60.450000000000003 109.642 -176.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.4 t -57.68 -34.6 69.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.627 -0.715 . . . . 61.219999999999999 110.526 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.725 HG21 ' HA ' ' A' ' 105' ' ' LYS . 16.9 t -66.84 -35.54 74.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.004 -0.544 . . . . 72.239999999999995 110.134 178.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.12 -31.7 72.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.525 -0.761 . . . . 74.230000000000004 111.362 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 35.3 mmtt -71.36 -19.48 62.28 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.306 0.574 . . . . 71.319999999999993 110.184 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.528 HG21 HD13 ' A' ' 107' ' ' ILE . 86.8 mt -102.22 -48.88 10.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.262 -0.881 . . . . 74.329999999999998 111.433 -171.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.536 ' HB ' ' HG3' ' A' ' 179' ' ' LYS . 33.6 m -67.85 -19.25 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.216 0.451 . . . . 71.420000000000002 112.216 -174.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.423 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.4 pp -69.34 -25.44 29.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.096 0.474 . . . . 71.109999999999999 110.774 176.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.556 ' HB3' ' NE2' ' A' ' 168' ' ' HIS . 21.9 tt0 -106.96 159.62 16.14 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.414 -0.812 . . . . 73.340000000000003 109.114 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.522 ' HE2' ' CE2' ' A' ' 167' ' ' TYR . 80.6 tttt -109.66 -64.3 1.27 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.87 0.367 . . . . 72.109999999999999 110.762 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.522 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 22.9 m-85 -77.03 113.17 14.45 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.049 0.452 . . . . 73.329999999999998 110.829 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.556 ' NE2' ' HB3' ' A' ' 165' ' ' GLN . 36.0 m-70 -121.7 132.53 54.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.549 -0.75 . . . . 71.019999999999996 110.019 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 174' ' ' ASN . 55.2 m -90.45 102.56 15.29 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.062 0.458 . . . . 74.219999999999999 110.951 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.21 136.58 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.899 -0.591 . . . . 71.5 109.881 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 59.29 25.5 14.14 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.511 0.672 . . . . 70.25 110.718 -175.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 77.57 7.61 87.16 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.766 -0.73 . . . . 61.310000000000002 112.555 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 51.1 t-80 -116.02 123.62 48.43 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.718 -0.475 . . . . 64.430000000000007 109.718 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 169' ' ' THR . 64.1 t30 -74.73 102.63 4.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.214 -0.448 . . . . 55.439999999999998 110.071 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.509 ' SG ' ' HA ' ' A' ' 112' ' ' ILE . 35.5 m -107.76 169.99 8.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.158 -0.474 . . . . 62.310000000000002 110.709 -175.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -103.0 122.22 44.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.232 -0.44 . . . . 61.219999999999999 109.948 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.0 OUTLIER -120.36 151.67 23.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.263 -0.643 . . . . 72.230000000000004 109.263 176.646 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -161.62 -171.67 3.03 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.835 -0.621 . . . . 63.100000000000001 109.758 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.766 ' HG2' ' HA ' ' A' ' 101' ' ' HIS . 7.7 mptt -74.43 122.16 22.56 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.874 -0.417 . . . . 63.130000000000003 109.874 -177.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.666 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -81.28 90.85 6.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.942 0.401 . . . . 54.310000000000002 111.321 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.692 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.5 pt? -88.76 134.95 33.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.259 -0.645 . . . . 71.400000000000006 109.259 174.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.4 m -51.91 144.47 11.55 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.567 0.542 . . . . 75.140000000000001 111.309 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.753 ' NZ ' " H3'" ' B' ' 5' ' ' ' U' . 32.1 pttt -57.71 -29.78 64.99 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.227 0.537 . . . . 62.140000000000001 110.114 177.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -58.04 -47.78 82.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.416 -0.811 . . . . 73.519999999999996 110.713 173.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -82.31 -37.66 25.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.122 -0.945 . . . . 63.350000000000001 111.275 -173.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.648 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.7 ptm -64.17 -24.42 67.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.494 -0.321 . . . . 71.099999999999994 110.638 -178.067 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.11 -30.05 63.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.011 0.434 . . . . 72.040000000000006 110.599 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.4 m -88.95 -45.86 9.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.03 -0.532 . . . . 72.530000000000001 110.65 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -73.02 -54.22 9.14 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.117 -0.492 . . . . 75.329999999999998 111.392 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 7.8 t -83.39 93.57 7.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.402 0.62 . . . . 63.210000000000001 109.769 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.3 t -165.14 145.21 7.02 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.281 -0.872 . . . . 74.400000000000006 109.193 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 16.9 m -69.18 120.93 15.78 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.195 -0.669 . . . . 62.539999999999999 109.195 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -59.72 119.08 6.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.558 0.694 . . . . 74.109999999999999 110.654 -177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -94.02 -24.7 17.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.349 -0.841 . . . . 61.420000000000002 109.449 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 93.61 -103.88 3.09 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.429 -0.805 . . . . 65.219999999999999 112.502 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 8.4 mtm-85 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.451 -0.785 . . . . 71.129999999999995 110.452 -174.284 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 1.053 " H2'" ' HA3' ' A' ' 147' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.914 0 C4'-C3'-C2' 105.509 2.809 . 0.0 '__' . 74.319999999999993 . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.979 H5'' " H3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.812 0 C4'-C3'-C2' 105.955 3.255 . 0.0 OUTLIER . 71.319999999999993 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.666 ' N1 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.427 -0.834 0 O4'-C1'-C2' 108.279 1.342 . 0.0 OUTLIER gamma 75.219999999999999 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.579 " H4'" ' SD ' ' A' ' 137' ' ' MET . . . . . . . . 0 O5'--C5' 1.424 -0.973 0 C3'-C2'-C1' 99.954 -1.717 . 0.0 OUTLIER alpha 65.209999999999994 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.753 " H3'" ' NZ ' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.424 -0.988 0 O4'-C4'-C3' 103.772 -1.234 . 0.0 OUTLIER gamma 74.219999999999999 . . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.519 " C5'" ' HZ2' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.423 -1.054 0 O4'-C1'-C2' 107.703 0.931 . 0.0 OUTLIER zeta-1 74.040000000000006 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 111.518 0.192 . . . . 52.039999999999999 111.518 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.72 157.49 16.42 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.968 0.413 . . . . 61.049999999999997 111.121 -174.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -144.74 82.89 9.92 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.377 -0.374 . . . . 70.439999999999998 111.163 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -89.9 0.9 5.59 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.876 2.384 . . . . 73.129999999999995 112.269 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.49 53.09 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.985 -0.846 . . . . 71.310000000000002 110.985 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.55 -13.12 49.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.241 0.543 . . . . 73.519999999999996 110.27 -177.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 9.4 p-80 -76.71 -6.18 51.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.404 -0.816 . . . . 71.439999999999998 110.264 175.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.3 mt -114.02 145.56 41.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.569 -0.741 . . . . 75.340000000000003 109.99 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.06 119.68 24.79 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.057 -0.72 . . . . 75.519999999999996 109.057 174.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 106' ' ' LYS . 12.5 p -111.3 144.09 19.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.728 -0.669 . . . . 62.130000000000003 111.089 -168.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.812 ' HA ' HG21 ' A' ' 159' ' ' VAL . 21.7 mtmt -122.91 6.32 9.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 64.129999999999995 111.662 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.631 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.6 ttpt -139.55 139.95 36.98 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.967 -0.383 . . . . 64.25 109.967 174.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.563 HG12 ' HB ' ' A' ' 151' ' ' VAL . 5.5 pt -109.25 160.78 7.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.94 0.4 . . . . 75.400000000000006 111.157 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.477 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 62.7 t80 -110.82 127.79 55.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.571 -0.741 . . . . 74.040000000000006 109.681 177.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 45.8 t -108.83 117.72 54.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.966 0.412 . . . . 73.129999999999995 110.855 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -130.97 171.08 21.08 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.042 -0.823 . . . . 70.439999999999998 111.042 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 68.66 31.69 73.68 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.102 -0.571 . . . . 74.230000000000004 113.401 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.753 HD12 ' HB ' ' A' ' 116' ' ' THR . 18.8 pt -87.17 -21.87 7.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.783 0.291 . . . . 72.120000000000005 110.707 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.709 ' HG3' ' O ' ' A' ' 112' ' ' ILE . 0.0 OUTLIER 58.97 -51.73 0.06 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.851 1.66 . . . . 71.120000000000005 114.028 179.029 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.489 ' HG3' ' H ' ' A' ' 115' ' ' ASP . 2.9 tp10 -95.79 171.11 8.86 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.314 -0.625 . . . . 63.399999999999999 109.314 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.489 ' H ' ' HG3' ' A' ' 114' ' ' GLU . 3.3 p-10 -65.71 121.23 14.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.543 0.687 . . . . 63.420000000000002 110.183 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.753 ' HB ' HD12 ' A' ' 112' ' ' ILE . 23.0 m -134.8 123.36 23.44 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.311 -0.859 . . . . 73.120000000000005 108.799 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.528 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 10.6 pt-20 -119.99 -164.26 1.06 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.466 0.543 . . . . 74.340000000000003 112.466 -167.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.717 ' HA ' HG21 ' A' ' 134' ' ' ILE . 2.6 tm-20 -61.63 -47.44 85.37 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.536 -0.756 . . . . 75.219999999999999 111.826 -173.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 6.5 p-80 -63.6 -33.43 75.6 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.632 -0.427 . . . . 74.329999999999998 110.573 -177.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' HIS . . . . . 0.528 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 35.6 m80 -63.75 -59.36 4.67 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.232 0.539 . . . . 72.400000000000006 111.085 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.634 HD12 HG11 ' A' ' 170' ' ' VAL . 4.5 mp -59.41 -48.14 82.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.276 -0.875 . . . . 75.450000000000003 110.938 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.437 ' HG3' HD12 ' A' ' 131' ' ' ILE . 6.2 ttp180 -63.68 -38.97 93.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.147 -0.479 . . . . 72.049999999999997 111.414 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -58.99 -31.15 68.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.088 0.471 . . . . 75.200000000000003 110.987 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.594 ' CD1' HG22 ' A' ' 170' ' ' VAL . 59.4 t80 -93.03 -48.15 6.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.897 -0.592 . . . . 62.43 111.525 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.438 ' HA ' ' HD2' ' A' ' 128' ' ' TYR . 43.6 m-85 -76.07 -11.82 60.01 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.519 0.563 . . . . 72.209999999999994 112.519 -172.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.48 -25.16 67.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.674 0.273 . . . . 75.5 111.506 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -73.9 -23.11 59.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.017 0.437 . . . . 70.0 110.65 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.438 ' HD2' ' HA ' ' A' ' 125' ' ' PHE . 91.0 m-85 -81.42 -29.14 33.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 74.129999999999995 110.561 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.428 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 168.59 -156.4 27.78 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.085 -1.055 . . . . 75.120000000000005 113.223 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.492 ' HA ' ' HE3' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -86.17 114.91 23.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.359 0.599 . . . . 73.439999999999998 110.994 -177.501 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.49 HG21 HD11 ' A' ' 134' ' ' ILE . 27.4 mt -89.14 135.01 26.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.355 -0.839 . . . . 71.219999999999999 110.068 176.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 154' ' ' ASP . 29.2 mt-10 -78.61 -69.22 0.58 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.84 -0.429 . . . . 64.420000000000002 109.84 174.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.1 m -148.56 157.27 7.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.971 -0.559 . . . . 74.5 110.085 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.717 HG21 ' HA ' ' A' ' 118' ' ' GLU . 22.9 mm -104.71 107.63 22.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.571 -0.529 . . . . 71.420000000000002 109.571 175.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -90.68 91.7 8.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.842 -0.617 . . . . 72.450000000000003 110.449 -174.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.567 HD11 ' H ' ' A' ' 118' ' ' GLU . 21.3 mt -74.94 121.51 26.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.858 -0.793 . . . . 74.409999999999997 108.858 176.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.6 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -61.99 103.09 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.767 -0.827 . . . . 73.209999999999994 108.767 178.76 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.2 159.97 28.93 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.741 -0.663 . . . . 74.319999999999993 110.797 -174.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.635 ' HA ' ' C4 ' ' B' ' 5' ' ' ' U' . 34.1 t70 -60.48 141.74 56.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.039 -0.528 . . . . 72.329999999999998 110.744 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.551 ' NH1' " H1'" ' B' ' 5' ' ' ' U' . 0.0 OUTLIER -69.18 -17.0 63.76 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.607 -0.724 . . . . 65.019999999999996 111.46 -174.211 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -111.96 -58.23 0.45 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.523 -0.846 . . . . 73.430000000000007 112.86 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.0 m -82.96 -15.4 51.44 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.742 -0.269 . . . . 62.100000000000001 111.522 -174.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.87 29.35 74.87 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.78 -0.724 . . . . 61.439999999999998 112.208 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.407 ' HG2' ' HB3' ' A' ' 139' ' ' ASP . 20.3 pttp -85.77 143.03 28.54 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.854 -0.425 . . . . 71.400000000000006 109.854 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -66.3 114.54 5.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.209 -0.451 . . . . 63.149999999999999 111.072 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -68.82 -40.96 79.22 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.653 -0.703 . . . . 75.239999999999995 110.652 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 158.05 -72.28 0.24 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.644 -0.788 . . . . 53.240000000000002 112.608 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.753 ' HA ' ' OP2' ' B' ' 2' ' ' ' C' . 18.1 p90 -82.58 165.74 19.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.82 0.343 . . . . 73.340000000000003 111.175 -178.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.03 162.2 36.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.984 0.421 . . . . 60.140000000000001 111.3 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.477 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 49.6 m-85 -125.96 146.02 50.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.947 -0.57 . . . . 65.420000000000002 109.905 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.608 HG13 ' CD1' ' A' ' 134' ' ' ILE . 39.1 t -118.65 111.74 35.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 110.12 -0.326 . . . . 71.030000000000001 110.12 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.631 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 19.5 m -89.69 126.71 35.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.116 -0.493 . . . . 75.0 110.683 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.507 ' CD2' HG22 ' A' ' 159' ' ' VAL . 97.8 m-85 -110.97 145.95 37.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.435 -0.348 . . . . 62.450000000000003 110.306 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.516 ' N ' ' HG3' ' A' ' 132' ' ' GLU . 9.4 t70 -65.52 -29.93 70.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 73.109999999999999 110.747 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 159' ' ' VAL . 6.1 t70 -125.72 142.83 51.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.863 -0.608 . . . . 73.319999999999993 110.497 -174.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.485 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.4 p-80 -75.75 -16.99 60.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.098 -0.501 . . . . 74.530000000000001 110.909 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.53 -38.01 68.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.999 0.428 . . . . 51.210000000000001 109.983 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.428 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 13.6 m -64.84 -28.98 69.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.734 -0.666 . . . . 62.119999999999997 110.19 177.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.812 HG21 ' HA ' ' A' ' 105' ' ' LYS . 14.8 t -76.04 -34.67 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.444 -0.798 . . . . 75.109999999999999 110.516 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -52.18 -56.18 16.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.549 -0.75 . . . . 72.430000000000007 112.397 -176.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -9.7 29.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.753 0.311 . . . . 72.140000000000001 111.834 -176.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.486 HG22 HG11 ' A' ' 177' ' ' VAL . 84.4 mt -96.46 -50.11 11.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.391 -0.368 . . . . 74.430000000000007 111.019 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.435 HG13 HG12 ' A' ' 159' ' ' VAL . 34.6 m -72.13 -19.1 19.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.422 0.527 . . . . 71.430000000000007 112.422 -174.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.5 pp -68.86 -30.3 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 70.040000000000006 111.495 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.49 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 16.9 pt20 -106.06 167.78 9.57 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.613 -0.514 . . . . 72.230000000000004 109.613 175.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.552 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 83.8 tttt -109.18 -58.78 1.98 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.996 0.427 . . . . 62.140000000000001 110.662 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 21.4 m-85 -78.34 118.3 20.39 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.878 -0.601 . . . . 72.349999999999994 111.27 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.49 ' NE2' ' HG3' ' A' ' 165' ' ' GLN . 38.3 m-70 -118.07 151.54 37.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.25 -0.886 . . . . 62.439999999999998 110.046 177.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 m -93.81 84.99 4.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.991 0.424 . . . . 65.519999999999996 110.769 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.634 HG11 HD12 ' A' ' 121' ' ' LEU . 11.2 t -113.77 137.1 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.874 -0.417 . . . . 70.109999999999999 109.874 -178.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 57.2 t30 61.32 24.54 14.63 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.716 0.769 . . . . 61.409999999999997 109.889 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 69.47 25.0 75.91 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.573 -0.74 . . . . 73.140000000000001 112.208 -177.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -131.62 150.07 52.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.871 0.367 . . . . 64.329999999999998 110.556 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASN . . . . . 0.45 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 8.9 t30 -85.1 97.66 9.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.987 -0.551 . . . . 55.420000000000002 110.047 176.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' CYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 46.2 m -105.67 177.47 4.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.278 -0.419 . . . . 71.340000000000003 111.042 -176.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.552 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 12.6 tt0 -112.54 136.43 52.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.292 -0.413 . . . . 74.109999999999999 110.66 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.486 HG11 HG22 ' A' ' 162' ' ' ILE . 70.6 t -127.48 138.14 55.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.146 -0.479 . . . . 44.310000000000002 111.105 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.417 ' NH2' ' C2 ' ' B' ' 2' ' ' ' C' . 60.2 mtt180 -130.22 175.86 8.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 73.140000000000001 110.129 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.409 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 11.4 mptt -76.52 121.31 22.95 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.432 -0.951 . . . . 44.130000000000003 108.432 171.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.756 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -79.96 100.04 7.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.105 0.479 . . . . 72.120000000000005 111.911 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.766 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.2 pt? -99.29 141.18 32.4 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.822 -0.806 . . . . 53.509999999999998 108.822 172.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.53 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 51.8 m -59.64 156.15 14.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.632 0.254 . . . . 74.230000000000004 111.337 -173.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.473 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.8 pttp -65.74 -25.74 67.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.962 0.411 . . . . 71.319999999999993 110.832 -175.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -75.69 -36.63 59.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.282 0.563 . . . . 42.030000000000001 110.112 175.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.53 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 48.7 mt-10 -75.95 -42.96 46.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.792 -0.64 . . . . 64.329999999999998 110.595 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.678 ' HB3' ' HG ' ' A' ' 181' ' ' LEU . 22.5 ptm -67.16 -23.29 65.77 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.134 -0.484 . . . . 51.240000000000002 110.387 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -79.82 -16.75 54.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.377 0.608 . . . . 64.209999999999994 110.088 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.0 m -101.75 3.78 39.89 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.471 -0.786 . . . . 74.200000000000003 110.329 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.76 -60.92 0.96 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.047 -0.524 . . . . 64.400000000000006 111.038 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.1 m -84.38 111.28 19.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.213 -0.449 . . . . 72.219999999999999 110.358 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.0 t -138.37 159.99 40.66 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.9 -0.408 . . . . 44.43 109.9 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.2 p -60.98 121.05 11.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.284 -0.416 . . . . 70.129999999999995 111.171 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 68.0 17.79 9.53 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.592 -0.731 . . . . 61.420000000000002 111.653 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -109.27 94.37 5.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.092 0.473 . . . . 53.420000000000002 109.753 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 90.2 -64.72 2.94 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.975 -0.631 . . . . 62.130000000000003 112.449 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 46.8 mtp85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.417 -0.801 . . . . 71.239999999999995 110.701 -177.987 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 1.082 " H4'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.666 0 O5'-C5'-C4' 111.267 0.762 . 0.0 '__' . 71.540000000000006 . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 1.082 H5'' " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.422 -1.102 0 C4'-C3'-C2' 105.639 2.939 OUTLIER-EPSILON 0.0 OUTLIER alpha 74.510000000000005 . . . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.845 ' H8 ' H5'' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 P-O3'-C3' 121.661 1.634 . 0.0 OUTLIER epsilon-1 73.329999999999998 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.527 ' O6 ' ' HE3' ' A' ' 106' ' ' LYS . . . . . . . . 0 O5'--C5' 1.425 -0.941 0 C3'-C2'-C1' 100.42 -1.2 . 0.0 OUTLIER alpha 74.219999999999999 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.834 ' C6 ' " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.079 0 C3'-C2'-C1' 103.534 2.26 . 0.0 OUTLIER . 71.430000000000007 . . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.609 " H4'" ' OP2' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 O4'-C1'-C2' 107.593 0.852 . 0.0 OUTLIER . 74.439999999999998 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.771 -0.455 . . . . 74.120000000000005 109.771 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLN . . . . . 0.674 ' NE2' ' HG2' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -107.85 19.26 20.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.045 0.45 . . . . 75.239999999999995 110.784 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -99.88 104.73 30.38 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.784 -0.643 . . . . 74.239999999999995 110.177 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . 0.537 ' HG3' HD22 ' A' ' 181' ' ' LEU . 74.2 Cg_endo -85.57 127.6 3.27 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.475 2.117 . . . . 75.409999999999997 111.991 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.536 ' HA3' HD12 ' A' ' 102' ' ' LEU . . . 60.5 68.43 1.68 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.164 -0.541 . . . . 54.310000000000002 112.473 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.08 -30.45 68.76 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.733 0.272 . . . . 71.510000000000005 111.733 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -85.37 -12.21 52.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.932 0.396 . . . . 71.430000000000007 110.82 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.536 HD12 ' HA3' ' A' ' 99' ' ' GLY . 83.2 mt -82.86 148.36 27.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.169 -0.468 . . . . 63.340000000000003 110.782 -177.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.1 p -89.32 106.0 18.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.016 0.436 . . . . 72.239999999999995 111.357 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 p -98.16 147.45 6.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.229 -0.656 . . . . 63.119999999999997 109.229 177.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -119.88 19.32 12.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.402 0.62 . . . . 63.310000000000002 110.677 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.601 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 6.7 ttpm? -157.88 138.91 13.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.32 -0.854 . . . . 74.219999999999999 109.603 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.579 HD13 HG21 ' A' ' 162' ' ' ILE . 15.6 pt -107.14 165.27 4.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.096 0.474 . . . . 64.510000000000005 110.873 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 38.4 t80 -114.38 116.28 28.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.524 -0.762 . . . . 73.340000000000003 109.877 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 44.8 t -105.09 111.92 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.993 -0.373 . . . . 64.099999999999994 109.993 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.709 ' HA2' " H5'" ' B' ' 2' ' ' ' C' . . . -123.45 156.39 17.73 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.608 -0.806 . . . . 74.099999999999994 112.385 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . 0.805 ' HA2' " H4'" ' B' ' 1' ' ' ' U' . . . 78.66 46.16 8.89 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.987 -0.625 . . . . 65.230000000000004 112.723 178.459 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.527 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -116.02 -179.84 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.659 0.266 . . . . 75.230000000000004 110.427 178.162 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.454 ' HE2' ' OE1' ' A' ' 114' ' ' GLU . 14.4 mmmm -98.3 169.43 9.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.779 0.323 . . . . 73.140000000000001 110.951 -177.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.458 ' H ' ' CD ' ' A' ' 114' ' ' GLU . 0.8 OUTLIER -77.74 -6.74 55.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.117 0.484 . . . . 72.219999999999999 110.521 178.848 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.17 -29.23 61.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.93 -0.577 . . . . 71.400000000000006 109.643 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.1 m -79.51 133.95 36.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.021 -0.99 . . . . 71.109999999999999 111.479 -173.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -140.95 -166.46 2.16 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.998 -0.547 . . . . 63.310000000000002 110.344 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.595 ' HA ' HG21 ' A' ' 134' ' ' ILE . 12.2 tt0 -54.75 -49.85 69.85 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.413 0.523 . . . . 63.130000000000003 112.413 -175.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 8.0 p-80 -65.2 -29.07 69.85 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.794 -0.362 . . . . 73.239999999999995 110.675 -174.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -65.44 -52.59 52.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.004 0.43 . . . . 73.349999999999994 110.759 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.52 -46.87 77.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 34.140000000000001 110.423 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.74 -48.49 79.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.103 -0.498 . . . . 75.450000000000003 111.309 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.36 -31.15 67.34 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.11 0.481 . . . . 43.310000000000002 111.116 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.465 ' CD1' HG22 ' A' ' 170' ' ' VAL . 31.2 t80 -83.88 -42.1 16.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.956 -0.565 . . . . 70.219999999999999 111.337 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -88.44 -16.43 32.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.645 0.609 . . . . 63.340000000000003 112.645 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -22.2 66.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.08 0.467 . . . . 64.430000000000007 110.874 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -70.14 -26.71 64.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.752 -0.658 . . . . 65.310000000000002 110.349 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' TYR . . . . . 0.499 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 57.6 m-85 -81.64 -38.56 25.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.646 -0.706 . . . . 74.400000000000006 111.272 -176.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -174.64 -155.84 13.0 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.118 -1.039 . . . . 63.329999999999998 112.888 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -91.86 119.17 31.4 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.42 0.628 . . . . 62.399999999999999 111.179 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.478 HG12 ' CE1' ' A' ' 153' ' ' PHE . 41.3 mt -95.86 137.79 23.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.262 -0.881 . . . . 61.409999999999997 110.103 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 154' ' ' ASP . 18.0 mt-10 -84.06 -73.34 0.42 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.334 -0.394 . . . . 55.329999999999998 110.533 174.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.1 m -143.29 163.25 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.082 -0.508 . . . . 63.240000000000002 110.072 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.595 HG21 ' HA ' ' A' ' 118' ' ' GLU . 26.7 mm -111.68 108.67 26.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.101 0.477 . . . . 72.319999999999993 109.843 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 30.5 mm-40 -84.69 91.43 7.93 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.608 -0.723 . . . . 70.049999999999997 110.466 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.552 HD11 ' CB ' ' A' ' 118' ' ' GLU . 16.9 mt -81.79 108.18 14.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.999 -0.741 . . . . 74.340000000000003 108.999 176.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' MET . . . . . 0.58 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -57.25 112.57 1.42 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.773 -0.825 . . . . 73.219999999999999 108.773 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.76 153.04 38.78 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.011 0.434 . . . . 74.420000000000002 111.733 -174.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.502 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 14.1 t70 -54.49 136.38 44.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.013 -0.994 . . . . 70.299999999999997 110.399 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.73 -9.94 59.17 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.763 -0.653 . . . . 74.299999999999997 112.456 -172.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -128.29 -42.05 0.26 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.994 -1.098 . . . . 72.340000000000003 113.363 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.559 ' OG ' ' HE3' ' A' ' 144' ' ' LYS . 27.1 t -89.24 -17.0 29.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.745 0.307 . . . . 22.239999999999998 111.086 -177.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 68.82 31.75 73.25 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.994 -0.622 . . . . 71.510000000000005 113.111 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.559 ' HE3' ' OG ' ' A' ' 142' ' ' SER . 13.7 ptpt -109.15 148.41 30.94 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.39 -0.596 . . . . 71.219999999999999 109.39 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -55.95 129.09 38.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.385 0.612 . . . . 75.230000000000004 111.849 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -78.35 -25.84 46.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.0 -1.0 . . . . 75.019999999999996 110.693 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 145.85 -91.47 0.15 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.771 -0.65 . . . . 54.420000000000002 111.719 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.713 ' HB3' " C5'" ' B' ' 2' ' ' ' C' . 11.2 p90 -70.72 162.28 29.34 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.028 0.531 . . . . 74.409999999999997 111.627 -177.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.35 156.85 46.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 62.219999999999999 110.734 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 49.2 m-85 -121.59 125.4 46.65 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.025 -0.534 . . . . 64.239999999999995 110.061 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.572 HG13 ' CD1' ' A' ' 134' ' ' ILE . 30.9 t -100.08 109.07 24.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 110.076 -0.342 . . . . 74.150000000000006 110.076 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' THR . . . . . 0.601 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 27.7 m -85.56 125.16 32.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.18 -0.464 . . . . 73.329999999999998 110.32 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.554 ' CD2' HG12 ' A' ' 159' ' ' VAL . 98.0 m-85 -109.41 149.93 28.81 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.539 -0.541 . . . . 74.099999999999994 109.539 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.472 ' N ' ' HG3' ' A' ' 132' ' ' GLU . 20.9 t70 -68.73 -26.73 65.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.033 0.444 . . . . 71.319999999999993 110.912 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -129.95 150.7 51.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.286 -0.416 . . . . 70.310000000000002 111.184 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.575 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.5 p-80 -83.28 -6.59 59.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.847 -0.615 . . . . 61.5 110.855 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -72.53 -40.71 66.54 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.654 -0.498 . . . . 63.329999999999998 109.654 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.7 m -63.92 -31.54 72.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.636 -0.711 . . . . 73.329999999999998 111.506 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 156' ' ' HIS . 5.7 m -78.03 -23.15 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 121.054 -0.258 . . . . 60.520000000000003 111.285 -175.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.79 -45.23 90.65 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 116.657 -0.247 . . . . 72.209999999999994 111.306 -173.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' LYS . . . . . 0.499 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.0 OUTLIER -62.03 -18.76 61.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.175 0.512 . . . . 72.239999999999995 110.68 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.579 HG21 HD13 ' A' ' 107' ' ' ILE . 72.3 mt -97.71 -54.69 6.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.618 -0.719 . . . . 75.450000000000003 111.527 -174.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.467 ' HB ' ' HG2' ' A' ' 179' ' ' LYS . 33.6 m -66.13 -19.83 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.452 0.538 . . . . 62.43 112.452 -172.67 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.449 HD12 ' HB2' ' A' ' 165' ' ' GLN . 2.6 pp -69.12 -24.75 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.32 0.581 . . . . 75.209999999999994 110.707 176.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLN . . . . . 0.479 ' HB3' ' NE2' ' A' ' 168' ' ' HIS . 23.0 tt0 -108.52 140.85 41.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.177 -0.919 . . . . 74.120000000000005 109.626 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.563 ' HE3' ' OE1' ' A' ' 176' ' ' GLU . 82.4 tttt -93.77 -61.69 1.5 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.794 0.33 . . . . 64.200000000000003 110.776 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -74.04 114.58 12.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.139 -0.482 . . . . 72.329999999999998 110.905 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.479 ' NE2' ' HB3' ' A' ' 165' ' ' GLN . 30.3 m-70 -120.99 162.25 20.23 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.642 -0.708 . . . . 72.420000000000002 109.257 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 11.7 m -118.09 102.27 8.89 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.468 -0.493 . . . . 75.150000000000006 111.218 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.465 HG22 ' CD1' ' A' ' 124' ' ' TYR . 47.5 t -111.51 130.0 65.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.813 -0.63 . . . . 65.540000000000006 109.508 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 63.9 t30 62.54 23.59 14.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.609 0.718 . . . . 73.340000000000003 110.445 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 78.24 11.06 85.72 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.896 -0.669 . . . . 33.240000000000002 112.488 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -111.68 135.43 52.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.901 0.381 . . . . 70.540000000000006 110.521 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.88 114.91 13.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.922 -0.581 . . . . 42.520000000000003 110.441 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.32 169.16 13.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.964 0.411 . . . . 72.299999999999997 110.953 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.563 ' OE1' ' HE3' ' A' ' 166' ' ' LYS . 15.1 tt0 -108.85 127.37 53.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.896 -0.593 . . . . 71.019999999999996 109.548 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.6 m -117.88 144.9 24.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.391 -0.524 . . . . 73.010000000000005 110.543 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.674 ' HG2' ' NE2' ' A' ' 96' ' ' GLN . 66.5 mtt180 -132.75 -179.36 5.42 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.056 -0.52 . . . . 61.149999999999999 109.818 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.467 ' HG2' ' HB ' ' A' ' 163' ' ' VAL . 38.4 mtpt -81.2 119.09 23.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.964 -1.125 . . . . 72.409999999999997 107.964 170.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.635 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -70.17 95.06 0.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.902 0.382 . . . . 74.25 111.513 -175.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.571 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.5 pt? -92.98 144.96 24.74 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.368 -0.604 . . . . 71.549999999999997 109.368 175.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.421 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 7.5 m -53.83 142.54 23.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.141 -0.481 . . . . 52.340000000000003 110.96 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.661 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 18.8 pttp -59.88 -22.66 62.63 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.048 0.451 . . . . 73.140000000000001 110.524 177.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -64.26 -52.96 56.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.666 . . . . 75.239999999999995 110.275 171.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' GLU . . . . . 0.421 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 35.7 mt-10 -68.42 -41.35 80.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.38 -0.827 . . . . 63.229999999999997 111.021 -176.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' MET . . . . . 0.661 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 20.7 ptm -68.24 -16.56 64.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.891 -0.595 . . . . 55.200000000000003 111.163 -175.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.79 -36.55 62.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.197 0.522 . . . . 75.400000000000006 109.868 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.8 t -73.17 -32.26 64.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.426 -0.806 . . . . 74.120000000000005 110.051 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -74.74 -24.73 58.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.917 -0.583 . . . . 74.109999999999999 110.922 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 46.6 t -71.86 131.44 43.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.928 -0.578 . . . . 74.25 110.372 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 10.5 t -148.11 97.55 2.8 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.601 -0.518 . . . . 51.130000000000003 109.601 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.4 p -81.7 -67.9 0.74 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 110.817 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -108.88 105.21 14.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.453 -0.573 . . . . 73.450000000000003 109.453 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -93.95 153.85 17.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.066 -0.515 . . . . 73.200000000000003 111.523 -174.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 81.57 -64.31 4.21 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.708 -0.678 . . . . 73.450000000000003 112.007 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 196' ' ' ARG . 11.6 tpp85 . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.127 -0.94 . . . . 73.0 109.244 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 1' ' ' ' U' . . . . . 0.805 " H4'" ' HA2' ' A' ' 111' ' ' GLY . . . . . . . . 0 O5'--C5' 1.429 -0.663 0 C4'-C3'-C2' 104.405 1.705 OUTLIER-EPSILON 0.0 '__' . 75.140000000000001 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ' C' . . . . . 0.713 ' OP2' " H1'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.892 0 C4'-C3'-C2' 104.884 2.184 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 74.030000000000001 . . . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ' A' . . . . . 0.71 ' OP2' " H4'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.425 -0.907 0 O4'-C4'-C3' 103.635 -1.332 . 0.0 OUTLIER epsilon-1 73.450000000000003 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ' G' . . . . . 0.518 ' O6 ' ' HE2' ' A' ' 106' ' ' LYS . . . . . . . . 0 O5'--C5' 1.425 -0.953 0 C3'-C2'-C1' 99.118 -2.646 . 0.0 OUTLIER alpha 73.5 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ' U' . . . . . 0.752 " H3'" ' OP1' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.915 0 O4'-C4'-C3' 103.732 -1.263 . 0.0 OUTLIER gamma 75.209999999999994 . . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' ' U' . . . . . 0.524 ' OP1' " H4'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.998 0 C4'-C3'-C2' 105.959 3.259 . 0.0 OUTLIER . 73.319999999999993 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.472 ' O ' HG21 ' A' ' 159' ' ' VAL . 9.1 p . . . . . 0 CA--C 1.529 0.164 0 N-CA-C 109.881 -0.414 . . . . 64.340000000000003 109.881 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -128.56 18.69 6.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.168 0.509 . . . . 75.239999999999995 111.291 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.584 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 23.6 ttpt -151.15 131.69 13.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.814 -0.63 . . . . 75.299999999999997 109.608 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.509 HG13 ' HB ' ' A' ' 151' ' ' VAL . 2.1 pp -106.43 153.55 7.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.21 -0.45 . . . . 72.120000000000005 110.397 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.516 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 81.9 t80 -103.25 130.53 50.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.978 -0.555 . . . . 74.129999999999995 110.276 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.7 t -111.09 110.17 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.294 -0.412 . . . . 72.340000000000003 110.436 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.688 0 N-CA-C 111.205 -0.758 . . . . 61.149999999999999 111.205 177.098 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.67 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 8.1 pt-20 . . . . . 0 N--CA 1.453 -0.296 0 CA-C-O 120.863 0.363 . . . . 71.109999999999999 110.854 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.695 ' HA ' HG21 ' A' ' 134' ' ' ILE . 13.3 tt0 -56.29 -50.25 71.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.449 -0.796 . . . . 75.030000000000001 112.41 -178.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.53 -33.65 76.41 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.877 -0.329 . . . . 74.129999999999995 110.665 -174.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.67 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 40.9 m80 -63.0 -53.64 50.86 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.012 0.434 . . . . 70.120000000000005 110.631 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.584 HD23 HG11 ' A' ' 170' ' ' VAL . 97.6 mt -62.25 -48.59 79.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.523 -0.762 . . . . 74.319999999999993 110.937 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -59.47 -40.88 88.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.252 -0.431 . . . . 73.109999999999999 110.985 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -59.47 -30.39 68.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.99 0.424 . . . . 72.319999999999993 111.278 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -88.92 -47.37 8.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.408 -0.36 . . . . 65.109999999999999 111.346 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.408 ' CD1' HG21 ' A' ' 151' ' ' VAL . 53.1 m-85 -77.54 -14.63 59.62 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.308 0.484 . . . . 75.319999999999993 112.308 -172.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -65.3 -24.02 67.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.747 0.308 . . . . 75.219999999999999 111.414 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -65.24 -25.73 67.8 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.221 0.534 . . . . 74.329999999999998 110.641 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.495 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 88.5 m-85 -86.01 -37.84 18.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.675 -0.693 . . . . 61.229999999999997 111.148 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 177.44 -166.77 37.43 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.012 -1.089 . . . . 60.009999999999998 113.422 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.569 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 38.3 tptt -75.78 118.78 18.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.4 0.619 . . . . 63.340000000000003 111.464 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.505 HG21 HD11 ' A' ' 134' ' ' ILE . 34.3 mt -97.49 139.93 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.378 -0.828 . . . . 72.140000000000001 110.41 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 6.7 mm-40 -89.12 -71.2 0.61 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.317 -0.401 . . . . 52.399999999999999 111.237 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.47 157.42 27.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.645 0.259 . . . . 64.400000000000006 110.57 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.695 HG21 ' HA ' ' A' ' 118' ' ' GLU . 17.7 mm -113.02 111.64 37.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.174 -0.676 . . . . 71.109999999999999 109.174 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 22.4 mm-40 -90.27 95.0 9.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.988 -0.551 . . . . 74.329999999999998 110.786 -175.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.565 HD11 ' H ' ' A' ' 118' ' ' GLU . 11.1 mt -80.69 87.35 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.01 -1.107 . . . . 65.209999999999994 108.01 173.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 11.2 tpt . . . . . 0 C--N 1.325 -0.465 0 CA-C-O 121.581 0.705 . . . . 72.420000000000002 111.252 -170.582 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 40.6 p90 . . . . . 0 N--CA 1.454 -0.252 0 CA-C-O 120.72 0.295 . . . . 72.129999999999995 111.004 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -144.42 165.78 26.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.994 -0.548 . . . . 72.230000000000004 110.193 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.562 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 42.2 m-85 -129.64 150.67 50.86 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.947 -0.39 . . . . 61.310000000000002 109.947 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.57 HG13 ' CD1' ' A' ' 134' ' ' ILE . 59.0 t -122.9 112.38 33.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.981 -0.377 . . . . 63.310000000000002 109.981 176.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.584 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 26.1 m -88.08 127.52 35.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.027 -0.533 . . . . 74.120000000000005 110.591 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.514 ' CD2' HG12 ' A' ' 159' ' ' VAL . 92.4 m-85 -109.59 152.24 25.77 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.143 -0.317 . . . . 52.409999999999997 110.143 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.569 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 31.9 t70 -75.34 -18.31 60.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.225 0.536 . . . . 71.040000000000006 110.547 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 157' ' ' ASP . 24.0 t70 -132.61 153.21 51.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.618 -0.719 . . . . 75.040000000000006 111.123 -177.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.41 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.1 p-80 -95.53 5.03 52.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.26 -0.427 . . . . 74.109999999999999 111.883 -178.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.477 ' HB3' ' OD2' ' A' ' 155' ' ' ASP . 13.2 t70 -91.81 -37.23 13.07 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.506 -0.553 . . . . 73.120000000000005 109.506 171.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.5 m -58.6 -27.59 64.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.749 -0.66 . . . . 64.510000000000005 110.901 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.514 HG12 ' CD2' ' A' ' 153' ' ' PHE . 13.0 m -80.42 -20.99 11.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 75.340000000000003 111.367 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.35 -38.4 71.63 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.691 0.281 . . . . 71.409999999999997 110.672 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.495 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.1 mptp? -65.03 -19.22 65.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.302 0.572 . . . . 74.200000000000003 110.68 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 81.9 mt -96.78 -53.62 7.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.573 -0.739 . . . . 75.230000000000004 111.227 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.518 ' HB ' ' HG2' ' A' ' 179' ' ' LYS . 35.3 m -64.56 -20.82 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.586 0.587 . . . . 61.119999999999997 112.586 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.74 -28.41 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 74.329999999999998 111.072 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -105.16 142.19 35.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.004 -0.544 . . . . 71.319999999999993 109.655 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.441 ' CE ' ' HG3' ' A' ' 176' ' ' GLU . 87.4 tttt -87.04 -71.39 0.56 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 121.033 -0.267 . . . . 75.299999999999997 110.997 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.62 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 3.7 m-85 -79.19 116.62 19.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.207 0.527 . . . . 72.409999999999997 111.971 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -117.51 140.63 49.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.19 -0.914 . . . . 63.310000000000002 109.492 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 174' ' ' ASN . 57.4 m -92.37 109.28 20.66 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.089 0.471 . . . . 62.420000000000002 111.232 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.584 HG11 HD23 ' A' ' 121' ' ' LEU . 43.3 t -120.06 136.27 57.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.928 -0.578 . . . . 72.109999999999999 109.464 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.485 HD22 ' CD2' ' A' ' 120' ' ' HIS . 23.5 t-20 70.57 -12.84 0.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.929 0.491 . . . . 73.319999999999993 111.497 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 122.2 -3.62 10.5 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.514 -0.634 . . . . 73.049999999999997 111.514 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -112.34 138.68 48.72 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.662 -0.496 . . . . 73.349999999999994 109.662 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 169' ' ' THR . 60.0 t30 -88.65 103.8 16.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.755 -0.461 . . . . 74.140000000000001 109.755 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 34.0 m -106.77 173.16 6.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.058 -0.519 . . . . 60.530000000000001 110.76 -174.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.441 ' HG3' ' CE ' ' A' ' 166' ' ' LYS . 9.0 tt0 -97.58 123.92 41.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.11 0.481 . . . . 74.019999999999996 110.756 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 48.4 t -118.84 131.13 72.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.926 -0.579 . . . . 71.120000000000005 110.475 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -144.34 173.38 11.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.857 -0.611 . . . . 74.540000000000006 109.842 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.518 ' HG2' ' HB ' ' A' ' 163' ' ' VAL . 31.9 mtpt -68.54 125.62 27.07 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.685 -0.487 . . . . 74.530000000000001 109.685 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -81.01 89.68 5.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.911 0.386 . . . . 62.409999999999997 111.482 -175.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.693 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.3 pt? -86.4 141.99 28.76 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.875 -0.602 . . . . 73.230000000000004 109.41 175.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.473 ' HB3' ' HG3' ' A' ' 185' ' ' GLU . 30.0 t -58.0 152.7 15.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.482 -0.326 . . . . 70.400000000000006 110.804 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.51 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 22.1 pttp -60.07 -21.9 62.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.173 0.511 . . . . 72.030000000000001 110.368 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -69.49 -49.32 55.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.542 -0.754 . . . . 71.230000000000004 109.197 174.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.473 ' HG3' ' HB3' ' A' ' 182' ' ' SER . 30.0 mt-10 -73.38 -37.97 65.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.209 -0.905 . . . . 74.109999999999999 111.138 -176.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.51 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 21.7 ptm . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 71.319999999999993 111.129 -175.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.628 HG13 HG11 ' A' ' 159' ' ' VAL . 11.5 p . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 109.656 -0.498 . . . . 73.230000000000004 109.656 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.484 ' N ' ' HE3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -104.49 -6.34 20.73 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.736 0.303 . . . . 73.25 111.81 -175.038 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.725 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.0 ttpt -133.99 140.73 46.91 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.86 -0.422 . . . . 72.450000000000003 109.86 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.615 ' CG2' HG13 ' A' ' 159' ' ' VAL . 4.9 pt -108.07 158.03 8.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.991 0.424 . . . . 63.439999999999998 110.973 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.445 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 46.8 t80 -107.72 121.61 45.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.469 -0.787 . . . . 73.540000000000006 109.296 177.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.7 t -105.21 102.46 13.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.864 0.364 . . . . 74.239999999999995 110.902 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.664 0 N-CA-C 110.849 -0.9 . . . . 61.439999999999998 110.849 175.655 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.713 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 11.5 pt-20 . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.754 0.312 . . . . 64.200000000000003 111.363 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.738 ' HA ' HG21 ' A' ' 134' ' ' ILE . 10.9 tt0 -58.96 -45.46 90.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 75.140000000000001 112.242 -174.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.419 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -64.22 -30.33 71.39 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 120.491 -0.484 . . . . 74.129999999999995 110.176 -176.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.713 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 34.3 m80 -64.38 -56.6 13.28 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.471 -0.331 . . . . 73.219999999999999 110.529 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.534 HD13 HG11 ' A' ' 170' ' ' VAL . 1.7 mm? -60.32 -51.9 67.54 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.233 -0.439 . . . . 73.439999999999998 110.737 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -58.29 -53.51 57.47 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.847 -0.615 . . . . 65.439999999999998 111.439 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.73 -28.34 63.79 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.066 0.46 . . . . 73.109999999999999 111.843 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -86.24 -43.16 13.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.939 0.4 . . . . 62.030000000000001 111.299 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.428 ' CD1' HG21 ' A' ' 151' ' ' VAL . 41.8 m-85 -86.84 -15.5 38.96 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.718 0.636 . . . . 45.219999999999999 112.718 -172.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -22.22 66.23 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.342 0.591 . . . . 71.400000000000006 110.352 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -69.28 -19.11 63.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.264 -0.88 . . . . 74.25 110.479 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.446 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 66.7 m-85 -90.63 -34.8 15.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.873 -0.603 . . . . 75.299999999999997 110.819 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 174.82 -168.02 40.46 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.072 -1.061 . . . . 74.25 113.299 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -74.91 116.78 16.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.528 0.68 . . . . 64.209999999999994 111.573 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.482 HG21 HD11 ' A' ' 134' ' ' ILE . 40.8 mt -94.76 139.63 18.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.194 -0.912 . . . . 73.310000000000002 110.401 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -84.2 -73.03 0.44 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.889 -0.596 . . . . 74.209999999999994 110.67 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.6 m -141.81 152.17 18.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.352 -0.386 . . . . 74.5 110.57 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.738 HG21 ' HA ' ' A' ' 118' ' ' GLU . 31.7 mm -105.22 107.92 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.489 -0.56 . . . . 71.439999999999998 109.489 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 57.7 mt-10 -89.58 96.49 10.72 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.332 0.586 . . . . 64.450000000000003 110.611 -176.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.6 mt -80.04 128.28 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.589 -0.732 . . . . 74.219999999999999 109.497 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.441 ' HB3' ' O ' ' A' ' 148' ' ' PHE . 22.1 tpp . . . . . 0 C--N 1.324 -0.517 0 CA-C-O 121.352 0.596 . . . . 73.109999999999999 110.341 178.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.441 ' O ' ' HB3' ' A' ' 137' ' ' MET . 41.8 p90 . . . . . 0 C--O 1.234 0.254 0 CA-C-O 121.187 0.517 . . . . 73.340000000000003 111.847 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.13 169.16 18.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.793 -0.64 . . . . 63.229999999999997 110.333 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.557 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 73.1 m-85 -130.84 145.01 51.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.066 -0.515 . . . . 73.439999999999998 110.297 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.608 HG13 ' CD1' ' A' ' 134' ' ' ILE . 15.8 t -120.52 108.33 22.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.738 -0.467 . . . . 54.210000000000001 109.738 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.725 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 62.7 m -88.64 123.84 33.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.527 -0.306 . . . . 62.329999999999998 110.289 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.527 ' CD2' HG22 ' A' ' 159' ' ' VAL . 90.8 m-85 -105.5 153.3 21.93 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.831 -0.433 . . . . 75.430000000000007 109.831 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -69.28 -30.81 69.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.364 0.602 . . . . 71.530000000000001 110.334 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.443 ' O ' HG23 ' A' ' 159' ' ' VAL . 5.0 t70 -122.36 145.54 48.16 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.416 -0.811 . . . . 72.230000000000004 110.185 -175.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -82.4 -13.58 56.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.291 -0.413 . . . . 71.329999999999998 110.907 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.96 -43.87 61.77 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.064 0.459 . . . . 51.43 110.506 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.6 m -63.16 -28.11 69.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.758 -0.655 . . . . 70.129999999999995 110.468 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.628 HG11 HG13 ' A' ' 104' ' ' VAL . 29.1 t -70.99 -36.61 64.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.722 -0.672 . . . . 75.230000000000004 110.185 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.524 ' HA ' HG22 ' A' ' 163' ' ' VAL . 21.0 t70 -59.98 -36.46 77.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.724 -0.671 . . . . 74.530000000000001 110.86 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.446 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 38.0 mmtt -60.68 -24.96 66.01 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.545 0.688 . . . . 73.129999999999995 110.222 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.544 HG21 HD13 ' A' ' 107' ' ' ILE . 86.3 mt -95.51 -50.39 11.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.142 -0.935 . . . . 63.119999999999997 111.338 -173.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.609 ' HB ' ' HG2' ' A' ' 179' ' ' LYS . 19.8 m -68.96 -17.53 22.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.469 0.544 . . . . 54.409999999999997 112.469 -173.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.469 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.2 pp -68.01 -29.92 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.013 0.375 . . . . 71.239999999999995 112.013 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -110.26 174.58 5.8 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.465 -0.568 . . . . 74.120000000000005 109.465 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.573 ' HE3' ' HG3' ' A' ' 176' ' ' GLU . 53.2 tttp -114.65 -60.95 1.82 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.75 0.309 . . . . 73.329999999999998 111.224 -173.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 11.8 m-30 -77.06 104.17 7.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.448 0.642 . . . . 73.049999999999997 111.249 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.409 ' CE1' HG23 ' A' ' 162' ' ' ILE . 9.2 m-70 -102.27 173.16 6.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.097 -0.956 . . . . 75.510000000000005 109.988 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 28.1 m -124.48 98.56 5.79 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.081 0.467 . . . . 74.420000000000002 111.076 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.534 HG11 HD13 ' A' ' 121' ' ' LEU . 58.2 t -109.52 131.8 59.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.603 -0.518 . . . . 74.340000000000003 109.603 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 63.67 14.94 8.56 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.588 0.709 . . . . 72.219999999999999 110.475 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.09 -4.64 81.34 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.851 -0.69 . . . . 62.450000000000003 112.413 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.522 ' O ' ' HA ' ' A' ' 169' ' ' THR . 39.6 m80 -98.73 157.37 16.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.814 0.34 . . . . 64.420000000000002 110.512 -177.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -84.74 118.48 24.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.059 -0.519 . . . . 74.400000000000006 109.724 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 36.8 m -118.38 173.47 6.8 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.833 -0.621 . . . . 64.209999999999994 110.305 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.573 ' HG3' ' HE3' ' A' ' 166' ' ' LYS . 1.3 tm-20 -130.24 114.68 15.96 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.571 -0.529 . . . . 63.299999999999997 109.571 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 2.3 m -113.71 147.34 17.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.202 0.525 . . . . 63.409999999999997 111.671 -171.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -134.2 172.09 13.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 73.109999999999999 110.643 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.609 ' HG2' ' HB ' ' A' ' 163' ' ' VAL . 28.6 mtpt -77.9 111.52 13.83 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.361 -0.978 . . . . 72.109999999999999 108.361 172.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -72.04 107.67 4.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.287 0.565 . . . . 64.129999999999995 112.32 -172.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -101.24 134.18 44.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.468 -0.787 . . . . 73.430000000000007 109.061 173.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.4 m -47.64 135.37 11.57 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.386 0.429 . . . . 63.43 111.535 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.8 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 16.2 pttp -56.93 -32.48 66.01 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.175 -0.466 . . . . 72.209999999999994 111.203 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -59.44 -34.4 72.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.888 -0.596 . . . . 71.310000000000002 110.458 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -93.0 -37.16 12.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.516 -0.766 . . . . 74.319999999999993 110.886 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.8 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 25.3 ptm . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 116.595 -0.275 . . . . 72.450000000000003 110.822 -177.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.442 HG11 ' CG ' ' A' ' 179' ' ' LYS . 13.0 p . . . . . 0 N--CA 1.449 -0.523 0 CA-C-O 120.755 0.312 . . . . 74.200000000000003 110.439 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.775 ' HA ' HG21 ' A' ' 159' ' ' VAL . 25.7 mtmt -119.29 -1.76 10.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.162 -0.472 . . . . 64.340000000000003 111.449 -177.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.613 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 28.6 ttpt -124.78 133.9 52.97 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.072 0.463 . . . . 74.439999999999998 109.936 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.529 HG12 ' HB ' ' A' ' 151' ' ' VAL . 10.5 pt -107.43 162.99 5.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.908 -0.587 . . . . 55.119999999999997 111.036 -178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 55.9 t80 -113.74 119.28 36.85 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.53 -0.759 . . . . 72.150000000000006 109.884 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.3 t -109.85 106.41 20.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.147 -0.479 . . . . 65.439999999999998 109.878 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.678 0 C-N-CA 120.901 -0.666 . . . . 75.409999999999997 112.068 -178.311 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.684 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 12.6 pt-20 . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 110.544 -0.169 . . . . 73.400000000000006 110.544 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.596 ' HA ' HG21 ' A' ' 134' ' ' ILE . 8.0 tt0 -52.52 -50.63 62.43 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.485 0.55 . . . . 71.430000000000007 112.485 -175.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.426 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 1.3 p80 -63.36 -27.23 69.17 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.15 -0.22 . . . . 75.120000000000005 110.864 -175.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.684 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 35.5 m80 -68.53 -50.03 55.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.829 -0.169 . . . . 71.040000000000006 110.726 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.495 HD13 HG11 ' A' ' 170' ' ' VAL . 1.2 mm? -60.4 -51.69 68.42 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.644 -0.502 . . . . 75.319999999999993 109.644 175.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -55.21 -50.37 69.58 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.542 -0.753 . . . . 74.239999999999995 111.285 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -54.35 -36.12 63.49 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.89 0.376 . . . . 65.209999999999994 112.012 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -84.64 -39.93 18.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.384 -0.371 . . . . 74.310000000000002 111.15 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.428 ' CD1' HG21 ' A' ' 151' ' ' VAL . 50.9 m-85 -87.26 -17.05 33.43 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.461 0.541 . . . . 72.200000000000003 112.461 -173.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -20.82 64.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.836 0.351 . . . . 73.140000000000001 111.923 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -77.78 -16.44 58.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.024 0.44 . . . . 72.230000000000004 110.562 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.5 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 52.9 m-85 -85.01 -41.28 15.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 73.349999999999994 110.279 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' A' ' 158' ' ' SER . . . -172.21 -170.11 35.71 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.987 -0.625 . . . . 62.299999999999997 112.151 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -79.59 122.06 26.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.384 0.612 . . . . 71.099999999999994 111.508 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.529 HG21 HD11 ' A' ' 134' ' ' ILE . 43.5 mt -95.84 138.43 21.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.33 -0.85 . . . . 50.340000000000003 110.837 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -81.37 -76.65 0.24 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.665 -0.698 . . . . 73.329999999999998 110.362 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.2 m -141.48 161.27 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 71.409999999999997 110.47 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.613 ' CD1' HG13 ' A' ' 151' ' ' VAL . 23.1 mm -116.42 122.7 70.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 110.03 -0.359 . . . . 75.230000000000004 110.03 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -104.46 121.54 43.65 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.79 -0.448 . . . . 71.310000000000002 109.79 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.7 mt -95.61 -8.43 9.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.706 0.289 . . . . 72.030000000000001 110.797 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.5 tpp . . . . . 0 C--O 1.235 0.31 0 CA-C-O 122.113 0.958 . . . . 65.319999999999993 110.208 -177.737 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.8 p90 . . . . . 0 N--CA 1.45 -0.442 0 N-CA-C 108.797 -0.816 . . . . 71.420000000000002 108.797 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.52 172.92 12.11 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.089 0.471 . . . . 61.420000000000002 111.141 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.411 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 58.4 m-85 -131.78 136.98 47.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.624 -0.716 . . . . 62.219999999999999 109.85 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.613 HG13 ' CD1' ' A' ' 134' ' ' ILE . 42.2 t -116.06 110.37 31.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.379 -0.373 . . . . 71.019999999999996 110.315 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.613 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 9.0 m -87.05 125.45 34.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.386 -0.37 . . . . 60.310000000000002 110.094 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.464 ' CE1' HG12 ' A' ' 131' ' ' ILE . 98.2 m-85 -105.75 150.39 25.57 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.756 0.312 . . . . 71.439999999999998 110.175 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -69.73 -22.55 63.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.033 -0.531 . . . . 63.32 111.059 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -136.77 144.86 43.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.896 -0.593 . . . . 73.519999999999996 109.711 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.538 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.5 p-80 -75.46 -12.88 60.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.881 0.372 . . . . 70.019999999999996 110.293 177.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.93 -46.36 88.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 61.219999999999999 110.18 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.44 ' CB ' ' HA3' ' A' ' 129' ' ' GLY . 11.7 m -62.87 -21.64 66.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 74.319999999999993 111.08 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.775 HG21 ' HA ' ' A' ' 105' ' ' LYS . 20.2 t -80.75 -29.77 11.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.768 -0.651 . . . . 73.209999999999994 111.138 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -36.9 85.34 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.424 -0.353 . . . . 62.210000000000001 111.869 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.5 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.5 mptp? -70.24 -16.48 63.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.265 0.555 . . . . 65.040000000000006 110.572 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.439 ' CG2' HG11 ' A' ' 177' ' ' VAL . 95.9 mt -100.54 -55.06 6.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.65 -0.705 . . . . 55.210000000000001 111.731 -172.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.526 ' HB ' ' HE3' ' A' ' 179' ' ' LYS . 28.9 m -61.07 -21.98 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.903 0.705 . . . . 64.109999999999999 112.903 -174.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.437 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.4 pp -67.27 -29.57 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.017 0.437 . . . . 63.299999999999997 111.095 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -106.23 142.65 35.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.949 -0.569 . . . . 65.209999999999994 109.722 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.543 ' HE3' ' HG3' ' A' ' 176' ' ' GLU . 79.2 tttt -92.17 -71.67 0.63 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 121.057 -0.257 . . . . 72.239999999999995 111.065 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.501 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 22.7 m-85 -78.59 108.81 12.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.132 0.491 . . . . 42.210000000000001 111.307 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -106.38 158.55 16.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 65.319999999999993 110.046 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 20.2 m -96.33 100.75 12.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.801 0.334 . . . . 71.5 110.788 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.495 HG11 HD13 ' A' ' 121' ' ' LEU . 46.9 t -116.5 132.61 65.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.622 -0.51 . . . . 71.299999999999997 109.622 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.552 HD22 ' CD2' ' A' ' 120' ' ' HIS . 28.1 t-20 63.92 20.43 12.2 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 122.056 0.931 . . . . 71.510000000000005 109.834 -177.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 73.39 19.45 79.67 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.558 -0.746 . . . . 63.409999999999997 111.624 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -125.22 149.59 47.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.768 -0.456 . . . . 74.120000000000005 109.768 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.474 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 9.9 t30 -86.19 117.3 24.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.884 0.373 . . . . 60.520000000000003 110.847 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 30.9 m -129.23 158.74 38.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.989 -0.55 . . . . 63.25 110.206 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.543 ' HG3' ' HE3' ' A' ' 166' ' ' LYS . 16.1 tt0 -89.98 135.17 33.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.945 0.402 . . . . 72.420000000000002 110.681 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 64.5 t -128.8 132.0 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 115.945 -0.57 . . . . 70.230000000000004 110.562 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -150.85 -177.63 6.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.525 -0.761 . . . . 70.349999999999994 109.452 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.526 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 9.2 mptt -68.47 130.32 42.54 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.859 -0.336 . . . . 72.129999999999995 110.345 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -86.33 92.85 8.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.864 0.364 . . . . 73.299999999999997 111.129 176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.564 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -81.5 135.23 35.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.568 -0.53 . . . . 62.530000000000001 109.568 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.5 m -50.73 142.65 10.92 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.382 0.426 . . . . 75.340000000000003 111.387 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.667 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 8.3 pttp -58.78 -31.69 68.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.064 0.459 . . . . 60.420000000000002 110.306 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -65.08 -37.7 88.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.601 -0.727 . . . . 60.310000000000002 110.522 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -83.44 -37.17 23.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.551 -0.749 . . . . 53.539999999999999 111.09 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.667 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 9.3 ptp . . . . . 0 C--N 1.33 -0.258 0 CA-C-O 120.848 0.356 . . . . 71.040000000000006 110.247 179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 106' ' ' LYS . 13.1 p . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 120.855 0.359 . . . . 75.230000000000004 110.491 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.537 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 12.2 mtmt -119.0 18.0 13.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.308 0.575 . . . . 73.010000000000005 110.776 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.48 ' H ' HG22 ' A' ' 104' ' ' VAL . 4.8 ttpm? -146.02 132.6 19.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.532 -0.758 . . . . 54.420000000000002 109.48 177.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.555 HG12 ' HB ' ' A' ' 151' ' ' VAL . 13.3 pt -103.64 164.04 3.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.108 0.48 . . . . 60.549999999999997 111.059 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 63.5 t80 -114.07 113.65 25.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.428 -0.805 . . . . 73.340000000000003 110.009 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.5 t -104.54 97.95 6.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.114 -0.494 . . . . 74.450000000000003 110.034 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.661 0 C-N-CA 120.685 -0.769 . . . . 45.340000000000003 112.566 -176.392 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.716 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 10.6 pt-20 . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 109.893 -0.41 . . . . 63.409999999999997 109.893 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.614 ' HA ' HG21 ' A' ' 134' ' ' ILE . 16.4 tt0 -55.2 -50.01 70.48 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.773 0.657 . . . . 71.450000000000003 112.773 -174.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.425 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.2 p80 -63.24 -27.29 69.25 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.753 -0.379 . . . . 74.549999999999997 110.694 -176.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.716 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 38.6 m80 -70.17 -51.53 30.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.318 -0.401 . . . . 70.329999999999998 110.356 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.562 HD13 HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -58.59 -49.29 78.01 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.262 -0.426 . . . . 53.229999999999997 110.286 178.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -59.01 -53.62 56.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.745 -0.662 . . . . 71.25 111.717 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -59.99 -29.17 68.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.762 0.315 . . . . 73.340000000000003 111.702 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.431 ' CD1' HG22 ' A' ' 170' ' ' VAL . 90.4 t80 -83.09 -43.42 16.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.499 -0.319 . . . . 72.340000000000003 110.966 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.435 ' CD1' HG21 ' A' ' 151' ' ' VAL . 46.0 m-85 -87.02 -15.3 39.08 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.729 0.64 . . . . 74.230000000000004 112.729 -173.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -22.12 66.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.088 0.471 . . . . 72.420000000000002 110.589 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -65.93 -31.06 71.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.761 -0.654 . . . . 64.439999999999998 110.082 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -80.85 -27.52 36.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.498 -0.773 . . . . 62.240000000000002 111.37 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.07 -166.84 39.75 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.352 -0.928 . . . . 74.310000000000002 112.689 177.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -80.68 120.45 24.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.326 0.584 . . . . 74.129999999999995 110.959 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.553 HG21 HD11 ' A' ' 134' ' ' ILE . 43.1 mt -93.28 141.38 14.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.46 -0.791 . . . . 70.430000000000007 110.572 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.9 -71.19 0.55 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.699 -0.682 . . . . 70.109999999999999 110.451 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.3 m -143.5 160.99 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.387 -0.369 . . . . 61.439999999999998 110.656 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.614 HG21 ' HA ' ' A' ' 118' ' ' GLU . 18.8 mm -116.41 128.95 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.946 0.403 . . . . 63.32 110.275 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -115.28 115.2 26.26 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.857 -0.61 . . . . 75.530000000000001 109.733 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.0 mt -84.04 -11.52 11.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.058 0.456 . . . . 75.109999999999999 110.363 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.447 ' HB3' ' O ' ' A' ' 148' ' ' PHE . 21.4 tpp . . . . . 0 C--O 1.237 0.43 0 CA-C-O 122.325 1.059 . . . . 64.310000000000002 110.173 -174.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.447 ' O ' ' HB3' ' A' ' 137' ' ' MET . 38.3 p90 . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.856 -0.424 . . . . 73.150000000000006 109.856 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.53 169.45 10.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.192 0.52 . . . . 72.140000000000001 111.055 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -135.49 128.89 32.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.541 -0.754 . . . . 74.409999999999997 109.574 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.604 HG13 ' CD1' ' A' ' 134' ' ' ILE . 29.7 t -108.82 110.24 31.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.755 -0.461 . . . . 73.219999999999999 109.755 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.431 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 16.4 m -86.47 125.35 33.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.451 -0.34 . . . . 74.129999999999995 110.272 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.555 ' CD2' HG12 ' A' ' 159' ' ' VAL . 97.1 m-85 -108.79 156.52 19.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.804 0.335 . . . . 73.140000000000001 110.279 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.21 -24.08 63.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.879 -0.6 . . . . 75.040000000000006 110.861 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -133.95 150.12 51.28 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.078 -0.51 . . . . 74.340000000000003 111.188 -173.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.55 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.5 p-80 -88.57 -5.13 58.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.053 -0.521 . . . . 75.420000000000002 110.723 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -73.39 -42.72 61.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.16 0.505 . . . . 71.319999999999993 110.119 174.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 m -63.85 -33.13 75.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.528 -0.76 . . . . 34.409999999999997 111.428 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.555 HG12 ' CD2' ' A' ' 153' ' ' PHE . 4.7 m -72.82 -22.24 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.501 -0.318 . . . . 74.349999999999994 110.987 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.416 ' HA ' HG22 ' A' ' 163' ' ' VAL . 33.2 t70 -63.84 -44.97 91.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.4 . . . . 74.150000000000006 111.395 -174.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -8.28 31.91 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.178 0.513 . . . . 71.540000000000006 110.508 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.507 HG21 HD13 ' A' ' 107' ' ' ILE . 69.6 mt -100.83 -50.04 10.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.665 -0.698 . . . . 64.519999999999996 110.688 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.416 HG22 ' HA ' ' A' ' 160' ' ' ASP . 27.0 m -73.37 -15.43 17.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.675 -0.693 . . . . 73.150000000000006 112.77 -175.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.5 pp -67.91 -30.05 46.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 53.439999999999998 110.979 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.423 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 15.5 pt20 -105.52 -173.37 2.28 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.684 -0.487 . . . . 72.409999999999997 109.684 173.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.471 ' HE3' ' HG3' ' A' ' 176' ' ' GLU . 46.6 tttp -127.42 -69.37 0.75 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.706 0.288 . . . . 62.009999999999998 110.56 -176.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -70.89 120.28 16.25 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.912 0.387 . . . . 71.310000000000002 110.681 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.44 ' CE1' HG23 ' A' ' 162' ' ' ILE . 28.1 m-70 -116.62 141.56 48.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.812 -0.631 . . . . 75.319999999999993 110.006 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.5 m -93.52 81.96 4.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.249 0.547 . . . . 75.239999999999995 110.585 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.562 HG11 HD13 ' A' ' 121' ' ' LEU . 22.0 t -96.33 122.15 47.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.875 -0.602 . . . . 72.400000000000006 109.744 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.9 t30 63.39 16.37 9.48 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.866 0.841 . . . . 75.430000000000007 110.248 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 87.5 -3.55 86.35 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.955 -0.641 . . . . 21.129999999999999 111.866 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -88.77 150.42 22.95 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.611 -0.514 . . . . 75.209999999999994 109.611 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -97.34 103.51 15.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.871 0.367 . . . . 75.239999999999995 110.442 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 31.2 m -116.74 155.08 29.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.153 -0.476 . . . . 65.140000000000001 110.436 -178.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.471 ' HG3' ' HE3' ' A' ' 166' ' ' LYS . 11.4 tt0 -94.3 125.46 38.96 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.718 -0.475 . . . . 62.130000000000003 109.718 177.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 51.1 t -121.39 134.38 64.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.106 0.479 . . . . 74.310000000000002 111.258 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.3 ptt180 -146.21 -176.97 5.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.46 -0.791 . . . . 73.299999999999997 108.911 174.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.423 ' HE3' HG11 ' A' ' 104' ' ' VAL . 2.5 ptpp? -75.32 126.93 32.03 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.532 -0.467 . . . . 64.010000000000005 110.756 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -79.61 101.66 8.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.963 -0.562 . . . . 33.409999999999997 111.07 -178.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.712 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -94.24 138.45 32.23 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.01 -0.737 . . . . 64.239999999999995 109.01 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.456 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 4.3 m -50.97 140.32 15.74 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.55 0.531 . . . . 74.319999999999993 110.773 -176.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.764 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.7 pttp -62.57 -22.63 66.5 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.876 0.369 . . . . 74.25 110.856 -177.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -66.79 -42.3 86.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.868 -0.606 . . . . 73.340000000000003 109.728 173.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.456 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 35.1 mt-10 -77.1 -38.45 52.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.757 -0.656 . . . . 71.219999999999999 110.664 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.764 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 19.8 ptm . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.354 -0.385 . . . . 74.349999999999994 110.791 -177.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.485 HG22 ' H ' ' A' ' 106' ' ' LYS . 12.8 p . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 109.598 -0.519 . . . . 54.539999999999999 109.598 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.574 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 19.8 mtmt -121.37 9.04 10.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.171 0.51 . . . . 73.150000000000006 111.578 -176.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.638 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 28.6 ttpt -138.58 135.97 35.52 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.915 -0.584 . . . . 63.009999999999998 109.466 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.594 HD13 HG21 ' A' ' 162' ' ' ILE . 6.7 pt -107.31 159.28 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.943 0.402 . . . . 74.530000000000001 110.638 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 57.1 t80 -108.43 115.18 29.63 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.847 -0.615 . . . . 63.549999999999997 109.847 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.7 t -102.77 103.48 15.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.796 -0.446 . . . . 74.030000000000001 109.796 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.839 0 CA-C-N 115.858 -0.61 . . . . 23.309999999999999 111.974 -177.219 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.512 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 11.9 pt-20 . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.767 0.318 . . . . 71.219999999999999 111.644 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.686 ' HG2' ' CG1' ' A' ' 134' ' ' ILE . 3.1 tm-20 -55.28 -54.75 39.56 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.634 -0.712 . . . . 60.530000000000001 111.714 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -63.2 -31.02 72.07 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.961 -0.296 . . . . 74.239999999999995 111.089 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.512 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 65.3 m80 -63.46 -60.32 3.52 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.261 0.553 . . . . 73.109999999999999 110.539 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.538 ' HA ' HG21 ' A' ' 170' ' ' VAL . 89.0 mt -61.41 -44.13 97.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.337 -0.847 . . . . 54.310000000000002 110.602 -177.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.547 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.5 OUTLIER -60.21 -42.63 95.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.674 -0.694 . . . . 65.019999999999996 110.846 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -58.1 -32.9 68.54 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.271 0.557 . . . . 75.430000000000007 111.438 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -88.2 -43.46 11.6 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.708 -0.678 . . . . 64.109999999999999 111.668 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 43.1 m-85 -83.74 -15.03 50.12 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.596 0.591 . . . . 73.209999999999994 112.596 -173.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.8 -19.45 65.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.115 0.484 . . . . 45.509999999999998 111.394 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -69.56 -25.15 63.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.867 -0.606 . . . . 70.25 110.441 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.48 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 80.2 m-85 -86.44 -32.06 21.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.898 -0.592 . . . . 70.299999999999997 110.368 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.594 ' HA3' ' HB3' ' A' ' 158' ' ' SER . . . -178.95 179.16 48.93 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.123 -0.791 . . . . 53.509999999999998 111.123 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -78.67 131.93 36.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.68 0.753 . . . . 74.340000000000003 109.846 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.628 HG21 HD11 ' A' ' 134' ' ' ILE . 50.2 mt -98.85 137.21 27.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.317 -0.856 . . . . 75.319999999999993 110.984 -176.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -81.35 -70.44 0.54 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.819 -0.628 . . . . 63.350000000000001 110.757 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.31 159.69 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.523 -0.308 . . . . 61.439999999999998 110.72 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.686 ' CG1' ' HG2' ' A' ' 118' ' ' GLU . 18.8 mm -117.13 109.34 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.802 -0.444 . . . . 44.439999999999998 109.802 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -85.24 95.77 9.29 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.202 -0.666 . . . . 62.149999999999999 109.202 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 18.8 mt -73.15 -15.84 17.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.133 0.492 . . . . 61.340000000000003 110.58 -176.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 19.7 tpp . . . . . 0 C--O 1.236 0.394 0 CA-C-O 122.023 0.916 . . . . 52.439999999999998 110.872 178.186 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.1 p90 . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 109.448 -0.575 . . . . 74.299999999999997 109.448 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -133.07 158.28 43.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.036 0.446 . . . . 62.340000000000003 111.201 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -119.58 122.85 42.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.904 -0.589 . . . . 73.140000000000001 109.768 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.619 HG13 ' CD1' ' A' ' 134' ' ' ILE . 61.7 t -99.92 109.86 25.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.569 0.223 . . . . 61.32 110.567 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.638 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 19.1 m -88.63 126.8 35.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.313 -0.403 . . . . 74.099999999999994 110.858 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.555 ' CD2' HG12 ' A' ' 159' ' ' VAL . 89.1 m-85 -108.64 154.35 22.11 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.514 -0.55 . . . . 64.439999999999998 109.514 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.27 -33.49 73.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.947 -0.76 . . . . 61.509999999999998 108.947 174.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -112.96 143.91 43.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.602 -1.181 . . . . 74.519999999999996 111.543 -172.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.63 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.9 p-80 -88.87 -12.72 41.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.716 -0.674 . . . . 71.219999999999999 110.178 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.62 -36.31 73.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.364 0.602 . . . . 74.519999999999996 109.605 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.595 ' HA ' ' HE2' ' A' ' 161' ' ' LYS . 13.0 m -75.67 -19.69 58.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.199 -0.909 . . . . 72.340000000000003 111.687 -175.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.63 HG22 ' O ' ' A' ' 156' ' ' HIS . 4.0 m -81.54 -22.31 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.758 0.313 . . . . 70.519999999999996 110.833 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.451 ' HA ' HG22 ' A' ' 163' ' ' VAL . 27.8 t70 -68.23 -40.53 82.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.342 -0.39 . . . . 73.109999999999999 111.429 -172.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.595 ' HE2' ' HA ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -62.63 -19.08 63.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.327 0.584 . . . . 62.340000000000003 110.247 178.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.594 HG21 HD13 ' A' ' 107' ' ' ILE . 90.4 mt -94.66 -55.2 6.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.412 -0.813 . . . . 65.030000000000001 111.23 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.451 HG22 ' HA ' ' A' ' 160' ' ' ASP . 27.5 m -66.28 -14.62 17.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.645 0.609 . . . . 72.409999999999997 112.645 -173.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.428 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.6 pp -72.51 -28.67 28.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.901 0.381 . . . . 73.319999999999993 110.817 176.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.486 ' HB3' ' NE2' ' A' ' 168' ' ' HIS . 5.9 tt0 -101.97 148.82 24.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.436 -0.579 . . . . 71.200000000000003 109.436 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.641 ' HE2' ' CE2' ' A' ' 167' ' ' TYR . 83.7 tttt -93.83 -61.21 1.58 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.828 0.346 . . . . 70.430000000000007 111.014 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.641 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 22.1 m-85 -82.51 108.6 16.04 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.188 0.518 . . . . 64.420000000000002 111.382 -176.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.486 ' NE2' ' HB3' ' A' ' 165' ' ' GLN . 27.5 m-70 -111.49 142.04 44.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.556 -0.747 . . . . 75.540000000000006 110.4 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.6 m -103.1 104.92 15.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.15 0.5 . . . . 73.310000000000002 111.096 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.538 HG21 ' HA ' ' A' ' 121' ' ' LEU . 6.3 p -130.17 140.89 47.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.782 -0.645 . . . . 73.319999999999993 109.403 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.14 -15.48 0.6 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.569 0.7 . . . . 74.319999999999993 109.459 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 113.34 2.22 24.65 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.64 -0.984 . . . . 54.229999999999997 110.64 -173.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -109.48 134.24 52.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.311 -0.444 . . . . 73.530000000000001 109.818 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -86.28 106.19 17.18 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.443 -0.577 . . . . 52.140000000000001 109.443 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 63.9 m -115.99 -177.86 3.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.986 -0.552 . . . . 55.109999999999999 110.797 -175.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.612 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 14.3 tt0 -111.31 132.64 54.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.625 -0.261 . . . . 74.200000000000003 110.593 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.7 m -121.86 144.46 31.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.082 0.468 . . . . 63.219999999999999 110.495 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 51.3 mtt180 -135.33 173.72 11.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.118 -0.492 . . . . 60.420000000000002 110.215 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.435 ' NZ ' HG21 ' A' ' 163' ' ' VAL . 66.4 mttm -70.09 119.03 13.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.645 -1.243 . . . . 75.430000000000007 107.645 167.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' A' ' 107' ' ' ILE . . . -75.87 93.05 3.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.111 0.482 . . . . 73.349999999999994 111.674 -175.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.695 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.4 pt? -90.73 138.3 31.69 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.935 -0.765 . . . . 75.200000000000003 108.935 173.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.427 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 12.7 m -56.43 151.83 12.53 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.136 0.273 . . . . 74.219999999999999 110.64 -176.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.77 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.1 pttp -59.14 -28.38 66.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.353 0.597 . . . . 75.230000000000004 109.7 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -60.51 -42.36 96.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.977 -1.011 . . . . 44.0 110.628 173.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 32.7 mt-10 -85.68 -35.21 21.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.395 -0.82 . . . . 72.099999999999994 110.768 -174.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.77 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.6 ptm . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.513 . . . . 43.100000000000001 110.587 -178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.459 HG22 ' H ' ' A' ' 106' ' ' LYS . 8.7 p . . . . . 0 N--CA 1.448 -0.563 0 N-CA-C 109.918 -0.401 . . . . 61.32 109.918 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 19.3 mtmt -122.32 20.13 10.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.324 0.583 . . . . 71.299999999999997 110.991 -177.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.62 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 30.0 ttpt -150.85 136.94 18.36 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.377 -0.829 . . . . 73.230000000000004 108.973 174.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.551 HD13 HG21 ' A' ' 162' ' ' ILE . 2.7 pt -110.12 153.95 11.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.937 0.399 . . . . 61.0 110.342 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 74.0 t80 -100.89 120.74 40.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.736 -0.665 . . . . 73.129999999999995 110.012 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.462 HG11 HD11 ' A' ' 121' ' ' LEU . 47.0 t -107.6 113.67 44.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.753 0.311 . . . . 73.510000000000005 110.411 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.529 0 C-N-CA 120.657 -0.782 . . . . 73.019999999999996 112.598 -179.379 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.606 ' HG2' ' HD1' ' A' ' 120' ' ' HIS . 10.2 pt-20 . . . . . 0 CA--C 1.528 0.119 0 CA-C-O 120.326 0.107 . . . . 71.209999999999994 110.862 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.758 ' HA ' HG21 ' A' ' 134' ' ' ILE . 19.1 tt0 -55.87 -53.19 59.78 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.58 0.585 . . . . 74.540000000000006 112.58 -174.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.464 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.0 p80 -59.09 -30.51 68.15 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.071 -0.251 . . . . 74.340000000000003 110.581 -175.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.606 ' HD1' ' HG2' ' A' ' 117' ' ' GLU . 41.9 m80 -64.91 -55.95 16.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.157 -0.474 . . . . 71.329999999999998 110.327 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -61.24 -48.07 83.13 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.296 -0.411 . . . . 62.450000000000003 110.689 -179.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.418 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 3.1 tpp180 -61.65 -48.98 78.39 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.263 -0.426 . . . . 73.230000000000004 111.49 -176.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.55 -31.52 68.04 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.31 0.576 . . . . 64.450000000000003 110.958 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.407 ' HE1' ' HB3' ' A' ' 168' ' ' HIS . 38.8 t80 -86.83 -44.21 11.9 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.834 -0.621 . . . . 74.0 111.305 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.418 ' CD1' HG21 ' A' ' 151' ' ' VAL . 47.2 m-85 -86.16 -13.84 45.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.054 0.761 . . . . 71.209999999999994 113.054 -172.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.51 -22.27 65.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.047 0.451 . . . . 74.400000000000006 110.839 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -66.6 -25.8 66.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.731 -0.668 . . . . 61.350000000000001 110.463 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.467 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 72.1 m-85 -84.88 -30.24 24.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.663 -0.699 . . . . 70.129999999999995 110.851 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.438 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 175.93 -174.8 47.14 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.717 -0.754 . . . . 75.129999999999995 111.881 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 20.1 ptmt -79.11 129.55 34.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.811 0.815 . . . . 74.230000000000004 109.976 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.55 HG21 HD11 ' A' ' 134' ' ' ILE . 48.1 mt -98.94 142.56 14.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.246 -0.888 . . . . 62.299999999999997 110.528 -176.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -85.89 -75.63 0.37 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.953 -0.567 . . . . 72.329999999999998 110.159 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.6 m -139.35 155.56 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.327 -0.397 . . . . 71.140000000000001 110.611 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.758 HG21 ' HA ' ' A' ' 118' ' ' GLU . 24.0 mm -110.87 107.8 23.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.25 -0.648 . . . . 63.420000000000002 109.25 175.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 88.0 mt-10 -91.2 97.54 11.19 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.098 0.475 . . . . 73.200000000000003 110.955 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.615 HD11 ' H ' ' A' ' 118' ' ' GLU . 32.3 mt -81.1 103.75 8.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.313 -0.625 . . . . 62.310000000000002 109.313 176.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.6 tpp . . . . . 0 C--N 1.326 -0.441 0 CA-C-O 121.425 0.631 . . . . 71.25 110.668 -177.795 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 35.4 p90 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 110.245 -0.28 . . . . 73.340000000000003 110.245 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.96 169.48 17.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.212 -0.449 . . . . 72.349999999999994 110.764 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.578 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 66.6 m-85 -130.79 137.35 49.4 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.016 -0.538 . . . . 72.239999999999995 110.011 -177.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.602 HG13 ' CD1' ' A' ' 134' ' ' ILE . 18.7 t -112.27 107.13 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.811 -0.441 . . . . 75.140000000000001 109.811 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.62 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 18.4 m -86.94 126.03 34.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.323 -0.399 . . . . 70.329999999999998 110.359 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -109.41 152.1 25.8 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.776 -0.453 . . . . 70.239999999999995 109.776 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.475 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 26.9 t70 -75.45 -22.54 57.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.404 0.621 . . . . 74.120000000000005 109.735 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -124.84 139.52 53.77 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.327 -0.851 . . . . 73.540000000000006 110.441 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.59 ' O ' HG22 ' A' ' 159' ' ' VAL . 3.8 p-80 -81.63 -5.65 58.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.345 0.593 . . . . 64.140000000000001 109.955 175.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.43 -44.11 83.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.751 -0.659 . . . . 71.150000000000006 109.991 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.438 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 3.3 m -60.15 -39.25 85.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.17 -0.923 . . . . 73.120000000000005 111.729 -177.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 156' ' ' HIS . 6.5 m -70.86 -25.91 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.391 -0.368 . . . . 73.319999999999993 111.452 -174.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -69.44 -22.32 63.66 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.578 0.214 . . . . 74.439999999999998 111.578 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.467 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 0.5 OUTLIER -89.32 -1.35 58.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.389 0.614 . . . . 61.030000000000001 109.644 177.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.551 HG21 HD13 ' A' ' 107' ' ' ILE . 92.5 mt -108.53 -54.6 5.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.432 -0.803 . . . . 63.030000000000001 110.782 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.519 HG11 ' HG2' ' A' ' 179' ' ' LYS . 23.9 m -71.75 -3.55 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.851 -0.613 . . . . 54.240000000000002 112.589 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.1 pp -74.39 -30.71 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.73 0.3 . . . . 70.5 111.227 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.525 ' N ' HD12 ' A' ' 164' ' ' ILE . 12.0 pt20 -114.34 176.54 5.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.916 -0.402 . . . . 73.439999999999998 109.916 173.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.591 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 79.8 tttt -113.24 -59.46 2.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.566 -0.288 . . . . 61.350000000000001 111.631 -174.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 21.0 m-85 -78.19 107.75 11.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.127 0.489 . . . . 71.230000000000004 111.083 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.407 ' HB3' ' HE1' ' A' ' 124' ' ' TYR . 16.5 m-70 -107.47 135.63 48.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.635 -0.711 . . . . 73.409999999999997 110.536 178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.7 m -93.55 97.45 10.51 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.797 -0.638 . . . . 73.400000000000006 111.233 -175.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.99 139.44 50.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.994 -0.743 . . . . 73.310000000000002 108.994 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 71.43 -7.19 1.23 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.292 0.568 . . . . 61.43 110.275 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 108.04 -0.29 33.61 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.57 -0.612 . . . . 62.350000000000001 111.57 -176.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -115.93 146.57 41.97 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.178 -0.305 . . . . 72.319999999999993 110.178 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -90.3 104.86 17.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.981 0.896 . . . . 55.200000000000003 110.496 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 25.8 p -95.37 172.22 8.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.315 -0.857 . . . . 74.310000000000002 110.017 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.591 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 38.0 tt0 -107.99 121.39 44.71 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.85 -0.426 . . . . 75.400000000000006 109.85 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 2.8 m -109.86 145.78 16.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.983 0.42 . . . . 62.420000000000002 110.558 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -135.39 170.77 15.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.112 -0.495 . . . . 74.530000000000001 110.147 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.519 ' HG2' HG11 ' A' ' 163' ' ' VAL . 8.1 mtpm? -73.42 114.4 11.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.458 -0.941 . . . . 52.450000000000003 108.458 169.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -72.11 97.57 1.95 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.262 0.553 . . . . 62.219999999999999 111.735 -175.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.748 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.3 pt? -96.75 138.3 34.51 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.488 -0.778 . . . . 32.240000000000002 109.133 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.522 ' HB3' ' HG2' ' A' ' 185' ' ' GLU . 36.3 t -49.89 145.36 5.57 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.279 0.362 . . . . 40.310000000000002 110.959 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.606 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 22.4 pttp -62.64 -23.51 67.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.152 0.501 . . . . 75.019999999999996 109.908 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -73.75 -41.4 62.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.507 -0.77 . . . . 41.119999999999997 109.487 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.522 ' HG2' ' HB3' ' A' ' 182' ' ' SER . 56.1 mm-40 -73.44 -40.85 63.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.321 -0.854 . . . . 75.299999999999997 110.943 -177.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.606 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 12.5 ptp . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 120.784 0.326 . . . . 72.239999999999995 110.734 -178.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.52 HG21 ' HB3' ' A' ' 179' ' ' LYS . 2.1 t . . . . . 0 CA--C 1.529 0.138 0 N-CA-C 110.365 -0.235 . . . . 73.319999999999993 110.365 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.649 ' HA ' HG21 ' A' ' 159' ' ' VAL . 4.8 mtmt -118.33 9.04 12.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.886 0.374 . . . . 62.020000000000003 111.345 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.601 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.9 ttpt -147.02 138.4 24.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.88 0.372 . . . . 72.140000000000001 110.068 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.571 ' CG2' HG13 ' A' ' 159' ' ' VAL . 7.4 pt -109.18 162.42 6.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.208 -0.451 . . . . 62.240000000000002 111.203 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 54.3 t80 -109.14 121.28 44.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.747 -0.661 . . . . 54.210000000000001 109.912 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.1 t -105.05 104.71 17.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.899 0.38 . . . . 54.409999999999997 110.694 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.518 0 N-CA-C 111.321 -0.712 . . . . 63.149999999999999 111.321 178.242 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.686 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 11.2 pt-20 . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 120.823 0.344 . . . . 70.040000000000006 111.71 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.744 ' HA ' HG21 ' A' ' 134' ' ' ILE . 21.5 tt0 -51.69 -56.58 12.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.282 -0.872 . . . . 63.130000000000003 112.318 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.402 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.0 p80 -61.83 -31.05 71.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.352 -0.386 . . . . 65.329999999999998 111.065 -174.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.686 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 41.3 m80 -67.6 -59.38 3.39 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.25 0.548 . . . . 65.209999999999994 110.064 177.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.655 HD23 HG11 ' A' ' 170' ' ' VAL . 68.8 mt -57.2 -49.58 75.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.066 -0.97 . . . . 73.420000000000002 110.973 -177.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.424 ' HG3' HD12 ' A' ' 131' ' ' ILE . 4.7 ttp180 -62.03 -37.79 86.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 74.430000000000007 111.38 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.17 -29.61 68.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.982 0.42 . . . . 64.299999999999997 110.872 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.405 ' CD1' HG22 ' A' ' 170' ' ' VAL . 83.2 t80 -91.67 -46.98 7.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.045 -0.525 . . . . 72.340000000000003 111.622 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -77.2 -14.01 59.85 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.595 0.591 . . . . 55.509999999999998 112.595 -172.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.83 -22.16 66.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.11 0.481 . . . . 64.219999999999999 110.912 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.81 -30.89 71.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.712 -0.676 . . . . 75.340000000000003 110.858 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.439 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 76.6 m-85 -82.48 -31.04 29.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.129 -0.487 . . . . 74.329999999999998 111.253 -175.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 158' ' ' SER . . . 172.66 -170.91 43.98 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.822 -1.18 . . . . 62.299999999999997 113.381 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -75.86 114.19 14.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.526 0.679 . . . . 74.209999999999994 111.342 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.517 HG21 HD11 ' A' ' 134' ' ' ILE . 35.3 mt -87.27 142.18 13.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.15 -0.932 . . . . 75.409999999999997 110.039 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -86.66 -74.68 0.42 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.106 -0.497 . . . . 73.129999999999995 110.315 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.1 m -143.86 152.37 16.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.135 -0.484 . . . . 32.539999999999999 110.079 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.744 HG21 ' HA ' ' A' ' 118' ' ' GLU . 16.2 mm -103.47 105.63 18.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.867 -0.79 . . . . 54.409999999999997 108.867 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -85.42 94.7 9.05 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.052 -0.522 . . . . 75.329999999999998 110.247 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.609 HD11 ' H ' ' A' ' 118' ' ' GLU . 31.5 mt -80.79 119.94 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.653 -0.703 . . . . 73.329999999999998 109.802 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 21.4 tpp . . . . . 0 C--N 1.322 -0.608 0 CA-C-O 121.709 0.766 . . . . 75.420000000000002 109.434 176.545 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 47.9 p90 . . . . . 0 C--O 1.236 0.379 0 CA-C-O 121.077 0.465 . . . . 71.140000000000001 111.384 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.94 166.88 26.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.857 -0.611 . . . . 72.140000000000001 110.824 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -122.38 131.42 53.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.949 -0.569 . . . . 73.219999999999999 109.707 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.599 HG13 ' CD1' ' A' ' 134' ' ' ILE . 47.7 t -104.56 109.66 28.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.776 0.322 . . . . 73.329999999999998 110.324 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.601 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 12.3 m -88.02 129.51 35.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.894 -0.593 . . . . 51.420000000000002 110.175 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.508 ' CD2' HG22 ' A' ' 159' ' ' VAL . 97.8 m-85 -111.58 150.61 29.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.821 -0.437 . . . . 74.099999999999994 109.821 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.49 -13.01 60.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.575 0.703 . . . . 54.329999999999998 110.235 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -129.41 147.63 51.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.312 -0.858 . . . . 75.230000000000004 109.969 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -85.57 -15.41 42.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.074 0.464 . . . . 71.430000000000007 110.441 -179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -71.73 -39.67 69.92 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.079 -0.509 . . . . 44.310000000000002 110.047 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.557 ' HB3' ' HA3' ' A' ' 129' ' ' GLY . 0.8 OUTLIER -59.94 -35.29 74.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.619 -0.719 . . . . 75.420000000000002 110.1 178.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 105' ' ' LYS . 22.0 t -70.22 -35.86 65.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.04 -0.982 . . . . 50.210000000000001 110.816 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.35 -38.75 92.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.897 -0.592 . . . . 74.120000000000005 112.289 -171.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.439 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -66.25 -22.15 66.31 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.337 0.589 . . . . 73.219999999999999 110.316 178.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.493 HG21 HD13 ' A' ' 107' ' ' ILE . 96.0 mt -93.59 -49.3 12.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.377 -0.829 . . . . 73.150000000000006 111.478 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.552 ' HB ' ' HE2' ' A' ' 179' ' ' LYS . 34.8 m -69.37 -14.94 19.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.591 0.589 . . . . 72.150000000000006 112.591 -173.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -75.73 -27.73 18.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.173 0.511 . . . . 72.439999999999998 110.664 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -103.36 143.84 32.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.773 -0.649 . . . . 60.340000000000003 110.158 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.641 ' HE2' ' CE2' ' A' ' 167' ' ' TYR . 83.0 tttt -91.85 -64.25 1.14 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.865 0.364 . . . . 75.109999999999999 110.714 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.641 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 15.5 m-30 -84.27 105.22 14.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.423 0.63 . . . . 75.349999999999994 112.216 -175.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -106.24 149.79 26.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.959 -1.018 . . . . 74.219999999999999 109.424 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 53.5 m -102.6 103.12 13.41 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.956 0.408 . . . . 61.399999999999999 110.975 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.655 HG11 HD23 ' A' ' 121' ' ' LEU . 31.3 t -116.8 131.38 69.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.06 -0.518 . . . . 73.439999999999998 109.85 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.7 t30 59.53 27.27 16.41 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.482 0.658 . . . . 73.519999999999996 110.401 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 76.02 5.59 80.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.854 -0.689 . . . . 72.319999999999993 112.386 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -109.11 133.09 53.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.787 0.327 . . . . 74.430000000000007 110.127 -178.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.435 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 10.7 t30 -77.9 122.6 25.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.29 -0.414 . . . . 52.340000000000003 109.91 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 24.2 p -126.33 165.61 18.69 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.442 -0.345 . . . . 75.299999999999997 110.943 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.571 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 15.7 tt0 -108.58 118.85 37.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.998 -0.546 . . . . 72.319999999999993 110.017 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.449 HG11 HG22 ' A' ' 162' ' ' ILE . 86.9 t -110.82 132.87 58.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.17 0.51 . . . . 65.420000000000002 111.297 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -127.01 177.91 6.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.549 -0.75 . . . . 73.5 109.823 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.552 ' HE2' ' HB ' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -77.59 123.64 26.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.405 -0.961 . . . . 74.239999999999995 108.405 170.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.411 ' HB2' ' C ' ' A' ' 107' ' ' ILE . . . -75.3 92.87 2.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.147 0.499 . . . . 72.140000000000001 112.089 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.587 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.5 pt? -88.13 131.24 34.78 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.537 -0.912 . . . . 74.510000000000005 108.537 171.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.5 m -58.31 153.8 14.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.476 -0.329 . . . . 73.340000000000003 110.938 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.621 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.4 pttp -63.45 -14.8 54.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.091 0.472 . . . . 74.109999999999999 111.238 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 11.4 tm0? -78.57 -43.51 26.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.099 -0.704 . . . . 61.5 109.099 173.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -73.0 -41.88 63.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.32 -0.854 . . . . 64.230000000000004 110.958 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.621 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 21.1 ptm . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 63.509999999999998 110.442 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 179' ' ' LYS . 38.9 t . . . . . 0 N--CA 1.455 -0.202 0 N-CA-C 110.032 -0.358 . . . . 74.129999999999995 110.032 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.577 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 6.4 mtmt -115.79 -3.96 12.18 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.132 0.419 . . . . 62.009999999999998 112.132 -178.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.585 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.8 ttpt -135.46 134.11 39.24 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.028 -0.36 . . . . 74.319999999999993 110.028 175.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.674 HG22 HG13 ' A' ' 159' ' ' VAL . 3.3 pt -104.45 155.3 6.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.064 0.459 . . . . 75.120000000000005 110.745 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 41.8 t80 -104.83 122.93 46.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.551 -0.75 . . . . 74.299999999999997 109.785 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 3.2 t -110.65 98.59 7.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.432 -0.581 . . . . 74.430000000000007 109.432 177.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.35 0 C-N-CA 120.674 -0.774 . . . . 62.130000000000003 113.185 -173.492 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.704 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 0.5 OUTLIER . . . . . 0 N--CA 1.454 -0.261 0 N-CA-C 110.157 -0.312 . . . . 71.409999999999997 110.157 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.641 ' HA ' HG21 ' A' ' 134' ' ' ILE . 12.7 tt0 -55.79 -49.95 71.79 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 112.294 0.479 . . . . 65.140000000000001 112.294 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.53 -29.86 69.39 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 120.752 -0.379 . . . . 72.299999999999997 110.25 -175.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.704 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 37.2 m80 -65.56 -55.87 15.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.374 -0.376 . . . . 61.43 111.009 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.38 -47.71 84.4 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.944 0.402 . . . . 74.319999999999993 110.472 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.31 -46.32 90.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.042 -0.526 . . . . 72.439999999999998 111.385 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -57.18 -32.01 66.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.106 0.479 . . . . 50.409999999999997 111.602 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.432 ' CE1' ' HB3' ' A' ' 168' ' ' HIS . 50.6 t80 -90.63 -44.1 9.74 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.182 -0.463 . . . . 73.519999999999996 111.411 -177.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -82.77 -12.83 57.21 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.674 0.62 . . . . 63.119999999999997 112.674 -172.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -61.47 -27.25 68.44 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.68 0.276 . . . . 75.349999999999994 111.556 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -74.82 -14.96 60.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.906 0.384 . . . . 74.310000000000002 110.903 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -90.0 -26.63 20.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.312 -0.403 . . . . 64.120000000000005 110.868 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' A' ' 158' ' ' SER . . . 169.56 -170.97 43.02 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.508 -0.853 . . . . 63.229999999999997 112.533 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -75.86 122.27 23.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.28 0.562 . . . . 55.219999999999999 111.18 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.532 HG21 HD11 ' A' ' 134' ' ' ILE . 46.7 mt -95.59 137.9 22.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.415 -0.811 . . . . 74.340000000000003 110.296 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.455 ' HG2' ' N ' ' A' ' 154' ' ' ASP . 13.5 mm-40 -85.35 -70.57 0.58 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.934 -0.575 . . . . 73.430000000000007 110.403 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.22 158.75 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.531 -0.304 . . . . 73.239999999999995 110.472 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.641 HG21 ' HA ' ' A' ' 118' ' ' GLU . 23.5 mm -113.73 117.67 56.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.929 -0.397 . . . . 73.329999999999998 109.929 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 59.7 mt-10 -100.49 117.81 35.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.589 -0.522 . . . . 64.340000000000003 109.589 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.7 mt -91.65 3.76 7.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.53 0.681 . . . . 60.240000000000002 109.255 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 8.4 tpp . . . . . 0 C--O 1.232 0.174 0 CA-C-N 114.857 -1.065 . . . . 72.049999999999997 109.588 -175.894 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 29.0 p90 . . . . . 0 C--O 1.234 0.268 0 N-CA-C 109.402 -0.592 . . . . 65.439999999999998 109.402 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -136.42 172.11 13.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.214 0.53 . . . . 70.129999999999995 111.827 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.552 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 56.5 m-85 -133.32 134.97 44.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.334 -0.848 . . . . 74.519999999999996 109.433 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.61 HG13 ' CD1' ' A' ' 134' ' ' ILE . 21.2 t -112.93 108.52 25.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.858 -0.423 . . . . 72.230000000000004 109.858 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.585 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 6.7 m -88.14 127.19 35.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.168 -0.469 . . . . 75.299999999999997 110.461 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.497 ' CD2' HG22 ' A' ' 159' ' ' VAL . 86.8 m-85 -111.81 151.33 29.16 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.923 -0.399 . . . . 61.149999999999999 109.923 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.455 ' N ' ' HG2' ' A' ' 132' ' ' GLU . 28.1 t70 -76.91 -14.66 59.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.776 0.798 . . . . 74.140000000000001 110.042 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.43 ' OD1' ' HB3' ' A' ' 157' ' ' ASP . 37.0 t70 -123.93 133.32 53.75 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.002 -0.999 . . . . 32.399999999999999 111.043 -173.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.577 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.1 p-80 -85.11 -2.07 57.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.3 -0.409 . . . . 60.030000000000001 111.357 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.43 ' HB3' ' OD1' ' A' ' 155' ' ' ASP . 22.1 t70 -94.56 -37.05 11.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.183 0.516 . . . . 34.020000000000003 109.614 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.852 ' HA ' ' HE3' ' A' ' 161' ' ' LYS . 18.5 m -57.36 -32.03 66.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.482 -0.781 . . . . 64.519999999999996 110.482 175.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.674 HG13 HG22 ' A' ' 107' ' ' ILE . 46.9 t -70.83 -29.11 36.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.462 -0.79 . . . . 64.5 110.873 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -65.64 -45.57 82.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.907 -0.588 . . . . 72.319999999999993 111.608 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.852 ' HE3' ' HA ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -65.99 -12.6 56.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.119 0.485 . . . . 61.210000000000001 111.148 178.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.515 HG21 HD13 ' A' ' 107' ' ' ILE . 96.9 mt -93.3 -51.8 10.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.036 -0.529 . . . . 72.540000000000006 110.84 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 25.7 m -68.25 -15.75 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.516 0.562 . . . . 52.130000000000003 112.516 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.7 pp -73.82 -27.26 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.976 0.417 . . . . 73.209999999999994 110.574 177.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -102.76 150.09 23.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.092 -0.707 . . . . 72.420000000000002 109.092 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.546 ' HE2' ' HG3' ' A' ' 176' ' ' GLU . 86.6 tttt -100.16 -59.6 1.68 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.794 -0.362 . . . . 71.040000000000006 111.1 -176.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -88.19 113.43 23.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.404 0.621 . . . . 72.299999999999997 111.177 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.432 ' HB3' ' CE1' ' A' ' 124' ' ' TYR . 32.7 m-70 -109.24 139.4 44.22 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.153 -0.931 . . . . 74.109999999999999 110.219 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.2 m -92.58 101.48 13.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.123 0.487 . . . . 71.049999999999997 111.124 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 171' ' ' ASN . 4.2 p -134.15 140.02 47.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.956 -0.565 . . . . 61.009999999999998 109.728 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.565 HD22 ' CD2' ' A' ' 120' ' ' HIS . 24.7 t-20 71.71 1.16 3.78 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.729 0.776 . . . . 60.539999999999999 110.042 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.67 8.32 63.93 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.478 -0.783 . . . . 50.43 111.556 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -117.9 154.52 31.74 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.094 -0.336 . . . . 71.040000000000006 110.094 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -83.31 98.71 9.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.101 0.477 . . . . 72.230000000000004 110.341 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 78.6 m -101.22 123.66 45.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.817 -0.629 . . . . 74.400000000000006 111.07 -176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.546 ' HG3' ' HE2' ' A' ' 166' ' ' LYS . 3.8 tm-20 -83.7 122.92 29.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.518 -0.764 . . . . 73.120000000000005 109.738 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.4 m -118.74 148.77 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.202 -0.454 . . . . 70.329999999999998 111.189 -171.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -139.59 173.4 11.57 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.036 0.446 . . . . 60.109999999999999 111.503 -178.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.473 ' HB3' HG21 ' A' ' 104' ' ' VAL . 47.9 mttm -71.73 117.56 13.47 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.08 -1.081 . . . . 72.400000000000006 108.08 166.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -76.98 93.6 3.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.076 0.465 . . . . 72.299999999999997 111.862 -175.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.643 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.7 pt? -91.37 131.84 36.59 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.696 -0.853 . . . . 51.210000000000001 108.696 170.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.6 m -53.97 148.56 10.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.449 -0.341 . . . . 71.439999999999998 110.857 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.901 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.0 pttp -61.74 -26.54 68.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.288 0.566 . . . . 74.430000000000007 109.625 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -56.52 -38.6 72.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.994 -1.003 . . . . 73.299999999999997 110.525 172.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -95.17 -38.4 10.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.454 -0.794 . . . . 73.120000000000005 110.974 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.901 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 23.1 ptm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 72.439999999999998 110.792 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.471 HG21 ' HB3' ' A' ' 179' ' ' LYS . 31.9 t . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 110.138 -0.319 . . . . 52.439999999999998 110.138 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.667 ' HA ' HG21 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -110.33 -9.74 14.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.885 0.374 . . . . 40.130000000000003 110.501 -179.058 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.607 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 32.2 ttpt -126.18 135.57 51.79 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.065 0.46 . . . . 65.430000000000007 110.397 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.547 ' CG2' HG13 ' A' ' 159' ' ' VAL . 7.5 pt -104.61 161.28 4.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.163 0.506 . . . . 72.200000000000003 111.544 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 67.8 t80 -108.21 115.64 30.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.157 -0.929 . . . . 64.340000000000003 109.802 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.2 t -104.24 106.33 20.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.134 -0.321 . . . . 70.420000000000002 110.134 178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.474 0 C-N-CA 120.948 -0.644 . . . . 61.130000000000003 112.524 -176.393 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.702 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 12.0 pt-20 . . . . . 0 N--CA 1.44 -0.938 0 CA-C-O 120.523 0.202 . . . . 72.030000000000001 110.524 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.73 ' HA ' HG21 ' A' ' 134' ' ' ILE . 9.9 tt0 -54.45 -50.63 67.23 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.319 0.489 . . . . 43.340000000000003 112.319 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.476 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.6 p80 -64.31 -26.56 68.54 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 121.068 -0.253 . . . . 74.129999999999995 110.97 -176.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.702 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 39.1 m80 -68.46 -61.49 1.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.623 -0.262 . . . . 54.5 110.649 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.89 -50.79 69.69 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.131 -0.486 . . . . 52.439999999999998 110.434 178.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -53.46 -49.77 66.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.73 -0.668 . . . . 73.400000000000006 111.425 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.69 -28.18 68.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.676 0.274 . . . . 71.219999999999999 111.713 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -88.49 -34.86 17.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.83 0.347 . . . . 74.209999999999994 111.214 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 36.9 m-85 -92.22 -17.7 24.46 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.441 0.534 . . . . 60.310000000000002 112.441 -173.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -22.01 66.25 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.13 0.491 . . . . 72.319999999999993 110.993 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -64.15 -35.85 82.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.75 -0.659 . . . . 70.120000000000005 110.752 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.459 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 41.8 m-85 -80.93 -21.07 40.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.009 -0.541 . . . . 72.230000000000004 111.12 -176.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.54 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 166.78 -167.4 39.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.016 -1.087 . . . . 53.229999999999997 113.066 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -79.18 120.97 24.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.447 0.642 . . . . 74.230000000000004 111.231 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.534 HG21 HD11 ' A' ' 134' ' ' ILE . 45.6 mt -94.28 133.74 34.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.318 -0.855 . . . . 73.400000000000006 110.039 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 154' ' ' ASP . 20.0 mt-10 -78.03 -70.01 0.51 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 110.635 176.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.4 m -143.54 154.89 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.663 -0.244 . . . . 63.43 110.542 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.73 HG21 ' HA ' ' A' ' 118' ' ' GLU . 24.9 mm -107.34 112.69 41.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.574 -0.528 . . . . 62.549999999999997 109.574 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 89.6 mt-10 -92.63 99.85 12.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.155 0.502 . . . . 70.150000000000006 110.416 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.598 HD11 ' H ' ' A' ' 118' ' ' GLU . 31.8 mt -83.91 108.19 16.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.985 -0.552 . . . . 65.209999999999994 109.652 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.5 tpp . . . . . 0 C--N 1.323 -0.547 0 CA-C-O 121.65 0.738 . . . . 73.329999999999998 109.887 179.455 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 31.2 p90 . . . . . 0 C--O 1.234 0.276 0 CA-C-O 120.615 0.245 . . . . 72.510000000000005 111.096 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.32 173.28 11.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.462 -0.336 . . . . 72.040000000000006 110.741 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.521 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 88.3 m-85 -133.87 148.35 51.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.111 -0.495 . . . . 73.120000000000005 110.373 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.63 HG13 ' CD1' ' A' ' 134' ' ' ILE . 55.8 t -127.17 110.94 23.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.189 -0.46 . . . . 74.030000000000001 110.072 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.607 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 25.0 m -89.35 126.71 35.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.282 -0.417 . . . . 51.43 110.533 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.495 ' CD2' HG22 ' A' ' 159' ' ' VAL . 96.6 m-85 -108.37 149.12 29.12 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.237 -0.283 . . . . 75.409999999999997 110.237 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.505 ' N ' ' HG3' ' A' ' 132' ' ' GLU . 18.2 t70 -63.65 -29.07 70.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 70.430000000000007 111.439 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -132.21 147.63 52.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.289 -0.414 . . . . 64.319999999999993 110.616 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -21.1 61.81 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.812 -0.44 . . . . 73.010000000000005 109.812 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -58.42 -50.01 75.22 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.86 -0.609 . . . . 74.209999999999994 110.765 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.54 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 9.9 m -60.66 -29.1 69.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 72.340000000000003 110.957 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.667 HG21 ' HA ' ' A' ' 105' ' ' LYS . 20.9 t -74.29 -37.35 45.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.487 -0.779 . . . . 74.519999999999996 111.081 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.442 ' HA ' HG22 ' A' ' 163' ' ' VAL . 25.8 t70 -60.97 -38.91 87.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.361 -0.381 . . . . 72.0 112.025 -172.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.459 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 4.0 mttt -66.01 -18.56 65.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.207 0.527 . . . . 73.25 110.825 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.471 ' CG2' HG11 ' A' ' 177' ' ' VAL . 93.2 mt -98.84 -49.86 11.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.494 -0.775 . . . . 75.109999999999999 111.067 -176.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.566 ' HB ' ' HD2' ' A' ' 179' ' ' LYS . 24.7 m -67.36 -18.35 23.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.693 0.627 . . . . 73.409999999999997 112.693 -174.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.406 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.0 pp -69.46 -29.33 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.054 0.454 . . . . 60.329999999999998 111.063 177.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -108.23 144.62 35.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.04 -0.527 . . . . 74.519999999999996 109.887 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.613 ' HE3' ' OE2' ' A' ' 176' ' ' GLU . 84.3 tttt -93.64 -64.27 1.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.818 0.342 . . . . 74.430000000000007 111.167 -177.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.563 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 21.8 m-85 -83.17 106.83 15.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.076 0.465 . . . . 74.310000000000002 111.223 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -106.7 170.06 8.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.68 -0.691 . . . . 63.310000000000002 110.323 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.7 m -114.57 95.74 5.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.518 -0.31 . . . . 70.109999999999999 110.52 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 171' ' ' ASN . 6.7 p -122.75 137.72 55.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.629 -0.508 . . . . 71.420000000000002 109.629 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.47 HD22 ' CD2' ' A' ' 120' ' ' HIS . 26.0 t-20 69.73 1.93 3.61 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.641 0.734 . . . . 75.430000000000007 110.496 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.9 13.53 57.71 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.539 -0.624 . . . . 72.329999999999998 111.539 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -122.88 145.12 48.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.071 -0.344 . . . . 74.109999999999999 110.071 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.501 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 9.0 t30 -80.64 105.99 12.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.108 -0.496 . . . . 73.219999999999999 110.214 176.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 25.4 m -115.39 165.85 12.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.106 -0.497 . . . . 72.200000000000003 110.294 -178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.613 ' OE2' ' HE3' ' A' ' 166' ' ' LYS . 20.6 tt0 -99.04 134.51 41.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.949 0.404 . . . . 71.200000000000003 110.755 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 83.9 t -126.53 130.47 71.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.903 -0.59 . . . . 75.420000000000002 110.521 176.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.44 ' HD3' ' OE2' ' A' ' 176' ' ' GLU . 19.8 mtm-85 -133.58 177.89 7.35 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.075 -0.713 . . . . 74.420000000000002 109.075 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.566 ' HD2' ' HB ' ' A' ' 163' ' ' VAL . 0.3 OUTLIER -72.06 128.9 37.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.941 -0.763 . . . . 64.530000000000001 108.941 173.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -84.37 86.04 7.31 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.446 -0.502 . . . . 54.350000000000001 110.88 177.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.501 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -80.61 135.44 36.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.198 -0.667 . . . . 71.310000000000002 109.198 175.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.8 m -49.9 136.15 18.74 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.537 0.523 . . . . 45.340000000000003 111.091 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.662 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.8 pttp -63.65 -24.66 67.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.69 0.281 . . . . 73.040000000000006 110.809 -178.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -60.98 -41.06 95.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.195 0.522 . . . . 74.420000000000002 109.94 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -84.9 -35.87 21.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.507 -0.77 . . . . 74.310000000000002 110.709 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.662 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 12.7 ptm . . . . . 0 C--N 1.333 -0.152 0 CA-C-O 120.755 0.312 . . . . 74.109999999999999 110.22 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.539 HG21 ' HB3' ' A' ' 179' ' ' LYS . 2.7 t . . . . . 0 N--CA 1.452 -0.346 0 N-CA-C 109.836 -0.431 . . . . 74.209999999999994 109.836 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.738 ' HA ' HG21 ' A' ' 159' ' ' VAL . 7.0 mtmt -122.48 24.15 9.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.379 0.609 . . . . 73.400000000000006 110.332 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.531 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.8 ttpt -159.42 135.08 8.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.407 -0.815 . . . . 74.340000000000003 109.454 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.556 HG12 ' HB ' ' A' ' 151' ' ' VAL . 6.1 pt -106.44 160.6 5.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.806 0.336 . . . . 72.109999999999999 111.064 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 58.9 t80 -107.07 119.35 39.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.784 -0.644 . . . . 64.340000000000003 110.171 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 121' ' ' LEU . 43.0 t -101.3 103.16 14.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.945 0.403 . . . . 72.319999999999993 110.357 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.749 0 N-CA-C 111.284 -0.726 . . . . 63.439999999999998 111.284 178.135 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.62 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 13.1 pt-20 . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.826 0.346 . . . . 75.140000000000001 111.515 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.645 ' HA ' HG21 ' A' ' 134' ' ' ILE . 13.7 tt0 -59.18 -45.88 89.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.01 -0.541 . . . . 75.400000000000006 111.555 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.419 ' HD2' ' CD ' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -60.23 -27.54 67.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.324 -0.398 . . . . 44.210000000000001 110.715 -178.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.62 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 30.0 m80 -72.48 -60.75 2.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.56 -0.291 . . . . 64.209999999999994 111.017 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.43 HD13 HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -57.57 -49.22 77.09 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.983 0.421 . . . . 71.109999999999999 110.251 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.408 ' HD3' HD12 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -56.74 -44.68 81.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.811 -0.631 . . . . 73.25 111.144 -178.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.21 -31.11 68.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 73.129999999999995 111.411 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.412 ' CD1' HG22 ' A' ' 170' ' ' VAL . 78.7 t80 -86.97 -49.32 7.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.984 0.421 . . . . 73.140000000000001 111.09 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.506 ' CD1' HG21 ' A' ' 151' ' ' VAL . 65.3 m-85 -78.24 -14.01 59.61 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.579 0.585 . . . . 62.43 112.579 -171.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -25.23 67.72 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.68 0.252 . . . . 60.119999999999997 111.68 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -72.78 -19.33 61.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.949 0.404 . . . . 62.509999999999998 110.615 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.448 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 88.7 m-85 -83.86 -35.19 24.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.11 -0.495 . . . . 73.219999999999999 110.485 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.41 -167.67 38.36 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.438 -0.887 . . . . 72.530000000000001 112.556 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -77.59 122.68 25.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.206 0.526 . . . . 74.109999999999999 111.173 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.542 HG21 HD11 ' A' ' 134' ' ' ILE . 42.0 mt -97.41 131.15 44.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.604 -0.725 . . . . 61.32 110.504 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.416 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 7.2 mm-40 -78.01 -72.28 0.37 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.652 -0.704 . . . . 75.219999999999999 110.566 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.7 m -145.49 147.29 18.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.524 -0.307 . . . . 64.129999999999995 110.725 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.645 HG21 ' HA ' ' A' ' 118' ' ' GLU . 30.3 mm -102.83 107.71 22.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.888 -0.412 . . . . 72.409999999999997 109.888 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 38.1 mt-10 -85.96 103.2 14.45 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.792 -0.447 . . . . 72.439999999999998 109.792 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 23.9 mt -78.81 -11.24 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.089 0.471 . . . . 72.25 110.328 -178.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 14.0 tpp . . . . . 0 C--O 1.233 0.233 0 CA-C-O 121.945 0.879 . . . . 72.230000000000004 110.651 -177.778 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.9 p90 . . . . . 0 C--O 1.232 0.152 0 N-CA-C 110.406 -0.22 . . . . 64.25 110.406 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -128.43 165.41 20.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.332 0.587 . . . . 54.130000000000003 111.443 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.511 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 66.0 m-85 -132.06 136.28 47.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.442 -0.799 . . . . 73.409999999999997 109.757 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.631 HG13 ' CD1' ' A' ' 134' ' ' ILE . 38.9 t -111.34 104.82 17.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.864 -0.421 . . . . 64.319999999999993 109.864 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.531 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 7.5 m -83.79 125.87 32.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 75.409999999999997 110.065 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.541 ' CD2' HG22 ' A' ' 159' ' ' VAL . 98.7 m-85 -109.5 151.55 26.59 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.074 -0.343 . . . . 64.040000000000006 110.074 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.416 ' HB2' ' HG2' ' A' ' 132' ' ' GLU . 26.6 t70 -78.53 -6.38 55.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.209 0.528 . . . . 74.150000000000006 111.163 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.444 ' O ' HG23 ' A' ' 159' ' ' VAL . 5.6 t70 -140.19 145.68 37.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.174 -0.466 . . . . 74.140000000000001 110.31 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -79.21 -18.44 52.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.148 -0.478 . . . . 65.120000000000005 110.56 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -73.07 -38.56 66.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.205 0.526 . . . . 71.010000000000005 110.064 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.2 m -64.65 -28.66 69.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.518 -0.765 . . . . 52.450000000000003 110.371 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.738 HG21 ' HA ' ' A' ' 105' ' ' LYS . 22.7 t -76.78 -36.56 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.66 -0.7 . . . . 74.310000000000002 110.201 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.29 -31.09 70.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.732 -0.667 . . . . 73.030000000000001 111.387 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.448 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 13.0 mmtp -65.1 -27.57 68.84 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.47 0.652 . . . . 54.439999999999998 110.021 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.54 HG21 HD13 ' A' ' 107' ' ' ILE . 90.4 mt -100.23 -50.18 10.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.949 -1.023 . . . . 73.530000000000001 111.828 -168.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.607 ' HB ' ' HG3' ' A' ' 179' ' ' LYS . 28.1 m -65.73 -16.76 21.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.448 0.536 . . . . 70.340000000000003 112.448 -173.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.5 pp -74.48 -26.83 20.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.965 0.412 . . . . 65.349999999999994 110.781 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.407 ' N ' HD12 ' A' ' 164' ' ' ILE . 29.0 tt0 -100.42 146.2 27.3 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.695 -0.684 . . . . 71.200000000000003 109.2 175.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -100.63 -66.06 0.93 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.762 0.315 . . . . 62.399999999999999 110.598 -177.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 19.7 m-85 -82.49 101.85 10.97 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.131 0.491 . . . . 62.399999999999999 111.11 -177.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -98.0 -172.8 2.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.721 -0.672 . . . . 74.129999999999995 109.593 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 61.4 m -141.64 106.63 4.94 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.222 0.534 . . . . 54.130000000000003 110.821 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.43 HG11 HD13 ' A' ' 121' ' ' LEU . 39.2 t -121.18 135.32 61.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.631 -0.713 . . . . 62.32 109.739 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 170' ' ' VAL . 7.9 t30 71.47 -4.62 1.81 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.277 0.56 . . . . 75.450000000000003 111.393 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 109.19 4.87 30.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.954 -0.641 . . . . 70.200000000000003 111.752 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 80.3 t60 -114.63 131.61 56.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.917 0.389 . . . . 63.539999999999999 110.326 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.64 103.15 4.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.896 -0.593 . . . . 71.129999999999995 109.585 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 14.9 p -103.8 176.96 4.98 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.162 -0.472 . . . . 62.310000000000002 110.77 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -118.34 120.38 37.44 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.083 0.468 . . . . 74.109999999999999 110.117 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 87.1 t -113.35 135.09 54.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.898 -0.592 . . . . 72.019999999999996 111.045 -175.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -129.12 179.67 5.63 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.553 -0.749 . . . . 73.400000000000006 109.742 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.607 ' HG3' ' HB ' ' A' ' 163' ' ' VAL . 0.6 OUTLIER -77.67 122.07 24.84 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.918 -1.141 . . . . 70.109999999999999 107.918 172.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.439 ' HB2' ' C ' ' A' ' 107' ' ' ILE . . . -77.12 89.8 3.63 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.513 -0.475 . . . . 63.009999999999998 111.199 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.518 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.3 pt? -81.35 138.96 35.6 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.805 -0.813 . . . . 53.200000000000003 108.805 175.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.1 m -54.15 145.9 16.19 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.085 -0.339 . . . . 52.039999999999999 110.085 -178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.74 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.4 pttp -61.92 -17.51 57.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.921 0.391 . . . . 64.140000000000001 110.31 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -67.67 -51.98 43.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.377 0.608 . . . . 74.209999999999994 109.738 170.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -64.96 -41.64 95.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.309 -0.86 . . . . 75.019999999999996 110.553 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.74 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 16.4 ptm . . . . . 0 C--N 1.326 -0.449 0 CA-C-N 115.946 -0.57 . . . . 64.120000000000005 110.692 -177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.456 HG12 ' H ' ' A' ' 106' ' ' LYS . 39.7 t . . . . . 0 CA--C 1.534 0.36 0 N-CA-C 110.183 -0.303 . . . . 70.409999999999997 110.183 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.641 ' HA ' HG21 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -116.84 -3.75 11.64 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.244 0.461 . . . . 62.439999999999998 112.244 -177.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.607 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 26.0 ttpt -135.31 138.59 43.58 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.015 -0.365 . . . . 63.109999999999999 110.015 177.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.48 HG13 ' HB ' ' A' ' 151' ' ' VAL . 2.1 pp -106.35 154.35 7.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.984 0.421 . . . . 74.310000000000002 110.759 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.421 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 62.4 t80 -102.23 127.21 49.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.586 -0.734 . . . . 71.140000000000001 109.996 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.505 HG21 ' HG ' ' A' ' 121' ' ' LEU . 46.7 t -102.31 110.03 27.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.88 0.372 . . . . 72.540000000000006 110.581 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.92 0 N-CA-C 110.957 -0.857 . . . . 71.109999999999999 110.957 175.46 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.739 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 12.2 pt-20 . . . . . 0 N--CA 1.45 -0.452 0 CA-C-O 120.725 0.298 . . . . 63.219999999999999 110.972 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.604 ' H ' HD11 ' A' ' 136' ' ' ILE . 8.5 tt0 -58.19 -46.41 85.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.877 -0.601 . . . . 73.349999999999994 112.347 -173.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.439 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 0.8 OUTLIER -62.41 -28.98 70.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.699 0.285 . . . . 74.409999999999997 110.673 -178.217 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.739 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 32.3 m80 -68.05 -56.37 9.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.355 -0.384 . . . . 73.129999999999995 110.791 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.505 ' HG ' HG21 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -60.79 -51.63 68.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.282 -0.417 . . . . 62.219999999999999 110.558 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.438 ' HB2' HG13 ' A' ' 134' ' ' ILE . 0.6 OUTLIER -55.06 -49.56 71.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 75.239999999999995 111.648 -177.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -59.15 -30.14 67.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 55.299999999999997 111.218 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.456 ' CD1' HG22 ' A' ' 170' ' ' VAL . 76.6 t80 -85.25 -47.92 9.6 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.814 -0.354 . . . . 64.099999999999994 111.111 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.521 ' CD1' HG21 ' A' ' 151' ' ' VAL . 42.8 m-85 -77.48 -18.15 57.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.373 0.508 . . . . 64.140000000000001 112.373 -172.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.55 -24.51 67.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.804 0.335 . . . . 62.43 111.618 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -76.19 -14.71 60.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.108 0.48 . . . . 54.340000000000003 110.202 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -87.72 -25.52 23.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 75.140000000000001 110.319 178.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.501 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 165.22 -151.17 19.82 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 119.912 -1.137 . . . . 44.130000000000003 113.689 175.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.614 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 20.4 tptm -91.23 117.07 29.33 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.394 0.616 . . . . 62.420000000000002 111.279 -172.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.454 HG12 ' CE1' ' A' ' 153' ' ' PHE . 38.2 mt -99.81 138.8 23.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.325 -0.852 . . . . 75.140000000000001 110.69 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.427 ' HG3' ' CA ' ' A' ' 154' ' ' ASP . 21.8 mt-10 -82.59 -75.38 0.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.021 -0.536 . . . . 73.140000000000001 110.341 172.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 m -143.97 152.4 15.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.616 -0.72 . . . . 71.540000000000006 110.079 -178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.609 ' CD1' HG13 ' A' ' 151' ' ' VAL . 22.7 mm -100.84 138.23 25.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.907 -0.775 . . . . 72.129999999999995 108.907 175.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 44.7 mt-10 -117.94 97.94 6.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.815 0.34 . . . . 72.329999999999998 110.743 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.604 HD11 ' H ' ' A' ' 118' ' ' GLU . 8.5 mt -76.21 105.51 5.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.066 -1.087 . . . . 71.420000000000002 108.066 172.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 10.4 tpt . . . . . 0 C--N 1.319 -0.726 0 CA-C-O 121.855 0.836 . . . . 53.32 111.272 -171.586 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 33.0 p90 . . . . . 0 C--O 1.233 0.216 0 CA-C-O 121.269 0.556 . . . . 72.420000000000002 111.841 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -135.26 171.9 13.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.514 -0.766 . . . . 54.409999999999997 110.274 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 70.1 m-85 -136.64 152.09 50.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.355 -0.384 . . . . 73.329999999999998 110.115 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.609 HG13 ' CD1' ' A' ' 134' ' ' ILE . 62.1 t -128.49 110.48 21.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.133 -0.485 . . . . 71.430000000000007 109.88 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.607 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 97.0 m -86.17 125.02 33.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.109 -0.496 . . . . 73.420000000000002 110.085 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.454 ' CE1' HG12 ' A' ' 131' ' ' ILE . 97.0 m-85 -106.06 146.79 29.68 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.871 0.367 . . . . 64.430000000000007 110.346 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.614 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 21.4 t0 -78.32 -19.13 54.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.535 0.683 . . . . 73.230000000000004 109.633 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -128.89 132.71 47.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.222 -0.899 . . . . 52.119999999999997 109.694 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.569 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.2 p-80 -73.96 -14.01 60.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.203 -0.453 . . . . 55.409999999999997 110.474 177.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -66.33 -40.84 90.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.195 0.522 . . . . 64.129999999999995 110.025 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.644 ' HA ' ' HE3' ' A' ' 161' ' ' LYS . 4.6 m -66.76 -28.54 68.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.419 -0.81 . . . . 52.149999999999999 110.986 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 105' ' ' LYS . 18.7 t -72.57 -35.11 49.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.722 -0.672 . . . . 62.039999999999999 111.22 -176.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -56.74 -51.47 68.73 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.084 -0.507 . . . . 71.129999999999995 111.897 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.644 ' HE3' ' HA ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -65.16 -14.08 59.72 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.996 0.369 . . . . 70.239999999999995 111.996 -178.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 94.5 mt -93.7 -48.27 13.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 120.661 0.267 . . . . 72.030000000000001 110.926 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.405 HG13 HG12 ' A' ' 159' ' ' VAL . 35.6 m -69.69 -19.42 22.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.343 0.497 . . . . 61.229999999999997 112.343 -175.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.39 -30.72 49.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.78 0.324 . . . . 63.340000000000003 111.529 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.506 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 14.0 pt20 -113.49 145.99 40.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.389 -0.369 . . . . 74.349999999999994 110.17 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.569 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 77.0 tttt -91.27 -60.09 1.98 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.051 -0.522 . . . . 73.120000000000005 110.513 -178.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.566 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 7.9 m-30 -72.47 110.53 6.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.259 0.552 . . . . 75.439999999999998 111.234 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.577 ' CD2' ' HB ' ' A' ' 177' ' ' VAL . 37.7 m-70 -110.85 170.92 7.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.303 -0.862 . . . . 64.340000000000003 109.583 173.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.7 m -119.41 96.04 5.04 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.841 0.353 . . . . 52.549999999999997 110.384 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.486 HG11 HD13 ' A' ' 121' ' ' LEU . 47.5 t -117.2 130.89 71.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.324 -0.398 . . . . 72.340000000000003 110.126 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.4 t30 59.7 31.49 20.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.509 0.671 . . . . 73.340000000000003 110.477 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 70.57 19.28 76.27 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.925 -0.58 . . . . 63.439999999999998 112.211 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 67.9 t60 -122.84 129.7 51.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.85 0.357 . . . . 71.200000000000003 110.617 -177.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -73.28 112.1 9.03 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.472 -0.566 . . . . 73.099999999999994 109.472 174.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 18.9 p -121.65 173.55 7.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.814 0.34 . . . . 75.510000000000005 111.382 -174.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.569 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 10.8 tt0 -108.41 116.92 32.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.838 -0.619 . . . . 75.109999999999999 110.064 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.577 ' HB ' ' CD2' ' A' ' 168' ' ' HIS . 59.4 t -120.26 134.68 62.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.233 -0.44 . . . . 71.510000000000005 110.493 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -150.54 -177.98 6.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.858 -0.61 . . . . 75.510000000000005 110.294 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -63.78 133.23 53.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.961 -0.385 . . . . 62.030000000000001 109.961 179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.41 ' HB2' ' C ' ' A' ' 107' ' ' ILE . . . -88.3 86.67 7.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.192 0.52 . . . . 73.030000000000001 110.538 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.734 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.3 pt? -80.8 127.55 32.65 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.764 -0.828 . . . . 72.299999999999997 108.764 174.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.5 t -56.02 156.66 5.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.105 -0.498 . . . . 62.43 110.548 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.897 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.3 pttp -63.73 -15.13 57.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.293 0.568 . . . . 63.520000000000003 109.83 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 184' ' ' GLN . 6.6 tp60 -71.7 -38.02 70.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.566 -0.743 . . . . 74.310000000000002 109.823 172.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -87.22 -41.34 13.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.483 -0.78 . . . . 74.319999999999993 111.116 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.897 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.7 ptm . . . . . 0 C--N 1.326 -0.454 0 CA-C-N 116.263 -0.426 . . . . 72.150000000000006 110.72 -177.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.499 HG22 ' H ' ' A' ' 106' ' ' LYS . 9.6 p . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 110.273 -0.269 . . . . 74.329999999999998 110.273 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 156' ' ' HIS . 0.0 OUTLIER -105.59 -0.85 25.35 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.931 0.396 . . . . 54.299999999999997 110.903 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.636 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 24.0 ttpt -133.98 136.69 44.3 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.107 0.479 . . . . 73.519999999999996 110.807 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.505 HG12 ' HB ' ' A' ' 151' ' ' VAL . 9.2 pt -107.95 162.57 6.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.132 -0.485 . . . . 71.5 110.642 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 61.6 t80 -110.23 118.05 35.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.846 -0.616 . . . . 61.030000000000001 110.078 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 30.6 t -106.84 103.04 14.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.506 -0.553 . . . . 73.299999999999997 109.506 175.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.627 0 C-N-CA 120.656 -0.783 . . . . 72.340000000000003 112.364 -178.224 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.599 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 1.8 pt-20 . . . . . 0 C--O 1.234 0.284 0 CA-C-O 121.253 0.549 . . . . 61.439999999999998 112.1 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.609 ' HG2' ' CG1' ' A' ' 134' ' ' ILE . 2.8 tm-20 -60.41 -47.14 87.37 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.181 -0.918 . . . . 74.340000000000003 111.475 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -30.8 71.85 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.883 -0.327 . . . . 75.530000000000001 110.524 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.599 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 43.6 m80 -66.68 -59.62 3.42 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.943 0.401 . . . . 64.420000000000002 110.611 178.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.524 ' HA ' HG21 ' A' ' 170' ' ' VAL . 8.5 mp -60.0 -47.94 83.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.769 -0.651 . . . . 43.409999999999997 111.359 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.472 ' HG3' HD12 ' A' ' 131' ' ' ILE . 3.1 ttp180 -62.06 -41.78 98.51 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.062 -0.255 . . . . 42.549999999999997 111.359 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -57.24 -30.42 64.61 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.339 0.59 . . . . 71.409999999999997 111.061 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -88.43 -47.04 8.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.788 -0.642 . . . . 73.099999999999994 111.156 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.408 ' HA ' ' HD2' ' A' ' 128' ' ' TYR . 51.8 m-85 -80.11 -12.12 59.7 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.528 0.566 . . . . 61.509999999999998 112.528 -173.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.67 -24.8 66.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.84 0.352 . . . . 71.239999999999995 111.568 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -72.57 -20.7 61.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.321 -0.4 . . . . 72.239999999999995 110.451 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.474 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 89.0 m-85 -82.15 -38.82 24.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.048 -0.524 . . . . 73.450000000000003 110.023 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.447 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 176.86 -168.47 40.42 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.229 -0.986 . . . . 75.329999999999998 113.277 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.566 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 40.1 tptt -74.33 116.41 14.96 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.405 0.621 . . . . 71.219999999999999 111.4 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.504 HG21 HD11 ' A' ' 134' ' ' ILE . 33.0 mt -92.53 140.51 16.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.324 -0.853 . . . . 74.329999999999998 110.542 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -86.91 -72.46 0.51 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.09 -0.504 . . . . 70.310000000000002 110.405 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.72 140.41 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 73.439999999999998 111.325 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.627 ' CD1' HG13 ' A' ' 151' ' ' VAL . 21.3 mm -95.1 101.61 12.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.611 -0.514 . . . . 63.450000000000003 109.611 174.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -84.67 94.74 8.71 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.939 -0.393 . . . . 60.520000000000003 109.939 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.538 HD11 ' H ' ' A' ' 118' ' ' GLU . 7.1 mt -73.05 100.91 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.005 -1.109 . . . . 63.149999999999999 108.005 175.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 10.7 tpt . . . . . 0 C--N 1.328 -0.363 0 CA-C-O 121.381 0.61 . . . . 73.140000000000001 110.494 -173.476 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 31.7 p90 . . . . . 0 N--CA 1.455 -0.188 0 N-CA-C 110.32 -0.252 . . . . 64.439999999999998 110.32 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.4 165.15 28.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.961 0.41 . . . . 53.109999999999999 110.952 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.564 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 65.9 m-85 -126.26 123.72 38.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.753 -0.658 . . . . 60.229999999999997 110.006 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.627 HG13 ' CD1' ' A' ' 134' ' ' ILE . 48.9 t -98.75 107.44 20.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 110.017 -0.364 . . . . 74.420000000000002 110.017 -179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.636 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 25.3 m -86.8 124.43 33.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.118 -0.492 . . . . 34.329999999999998 110.151 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.655 ' CD2' HG12 ' A' ' 159' ' ' VAL . 97.6 m-85 -104.92 157.63 17.08 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.916 -0.402 . . . . 65.420000000000002 109.916 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.566 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 16.0 t70 -69.59 -29.81 67.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.03 -0.532 . . . . 65.140000000000001 110.557 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -132.45 147.38 52.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.57 -0.741 . . . . 74.019999999999996 110.923 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.673 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.3 p-80 -75.45 -12.81 60.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.181 -0.463 . . . . 74.040000000000006 110.732 177.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -60.84 -49.83 75.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.173 0.511 . . . . 73.120000000000005 110.153 174.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.447 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 14.6 m -66.56 -22.14 66.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.377 -0.829 . . . . 71.209999999999994 112.373 -173.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 156' ' ' HIS . 4.1 m -81.49 -25.84 10.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.935 -0.306 . . . . 71.439999999999998 111.453 -176.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.566 ' HA ' HG22 ' A' ' 163' ' ' VAL . 36.1 t70 -70.31 -39.88 74.54 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.983 -0.287 . . . . 75.129999999999995 111.342 -171.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.485 ' HD2' ' H ' ' A' ' 161' ' ' LYS . 1.6 mptp? -62.21 -14.63 40.07 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.372 0.606 . . . . 71.239999999999995 110.586 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.5 HG21 HD13 ' A' ' 107' ' ' ILE . 94.5 mt -98.38 -49.21 11.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.455 -0.793 . . . . 70.340000000000003 110.886 -176.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.566 HG22 ' HA ' ' A' ' 160' ' ' ASP . 23.5 m -72.93 -15.57 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.104 -0.498 . . . . 75.409999999999997 112.078 -175.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.441 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.2 pp -64.68 -26.81 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.696 0.284 . . . . 72.329999999999998 111.572 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -116.0 -178.94 3.52 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.407 -0.59 . . . . 70.219999999999999 109.407 171.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.455 ' HE3' ' OE1' ' A' ' 176' ' ' GLU . 83.5 tttt -120.48 -67.79 0.95 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.655 0.264 . . . . 70.540000000000006 111.226 -173.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 11.1 m-30 -71.69 107.54 4.57 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.088 0.47 . . . . 63.020000000000003 111.401 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.432 ' CE1' HG23 ' A' ' 162' ' ' ILE . 32.9 m-70 -104.89 151.58 23.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.624 -0.716 . . . . 72.230000000000004 109.837 174.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 21.8 m -109.87 84.73 1.98 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.045 0.45 . . . . 73.230000000000004 110.424 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.524 HG21 ' HA ' ' A' ' 121' ' ' LEU . 4.1 p -102.57 132.86 47.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.892 -0.595 . . . . 70.450000000000003 109.719 178.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 170' ' ' VAL . 4.6 t30 71.92 -14.79 0.49 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.106 0.479 . . . . 72.450000000000003 110.544 -176.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 114.97 -3.08 22.76 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.905 -0.878 . . . . 61.130000000000003 110.905 -173.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.491 ' O ' ' HA ' ' A' ' 169' ' ' THR . 58.5 t-80 -93.97 148.7 21.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.303 -0.448 . . . . 63.219999999999999 110.286 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -94.24 102.78 14.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.999 0.428 . . . . 73.549999999999997 110.151 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 29.4 m -114.47 154.1 28.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.131 -0.486 . . . . 73.530000000000001 111.201 -175.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.51 ' OE2' ' HD3' ' A' ' 178' ' ' ARG . 20.5 tt0 -91.53 119.55 31.56 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.664 -0.495 . . . . 73.549999999999997 109.664 175.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 48.4 t -117.63 138.99 46.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.955 -0.566 . . . . 71.409999999999997 110.659 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.51 ' HD3' ' OE2' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -159.02 171.86 19.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.417 -0.81 . . . . 74.219999999999999 109.675 -177.658 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.485 ' HG2' HG11 ' A' ' 163' ' ' VAL . 8.6 mtpm? -63.26 122.1 15.33 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.104 -0.332 . . . . 73.200000000000003 110.104 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -74.89 91.25 2.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.985 0.422 . . . . 73.510000000000005 110.686 178.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.56 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -80.9 139.52 35.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.489 -0.56 . . . . 73.340000000000003 109.489 177.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.5 m -50.88 130.66 25.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.167 -0.469 . . . . 73.129999999999995 110.755 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.774 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.0 pttp -64.34 -23.24 67.23 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.843 0.354 . . . . 71.200000000000003 110.664 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.86 -37.14 86.28 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.484 -0.562 . . . . 65.140000000000001 109.484 176.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -88.16 -34.75 17.73 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.705 -0.679 . . . . 73.430000000000007 111.049 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.774 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 6.5 ptp . . . . . 0 C--N 1.333 -0.145 0 N-CA-C 109.632 -0.506 . . . . 75.109999999999999 109.632 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.467 0.405 0 CA-C-O 121.692 0.758 . . . . 75.439999999999998 112.824 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.56 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 2.4 mtmt -129.53 12.83 5.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.723 -0.671 . . . . 70.120000000000005 110.012 175.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.509 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 30.6 ttpt -144.23 137.26 27.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.295 -0.866 . . . . 72.340000000000003 109.379 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pp -107.59 153.6 8.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.35 -0.387 . . . . 71.530000000000001 110.537 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 75.6 t80 -105.0 125.29 50.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.28 -0.418 . . . . 72.450000000000003 110.881 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.9 t -105.94 107.32 22.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.468 -0.333 . . . . 74.099999999999994 110.394 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.62 0 C-N-CA 120.78 -0.724 . . . . 73.319999999999993 112.585 -179.401 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.571 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 12.0 pt-20 . . . . . 0 N--CA 1.453 -0.316 0 CA-C-O 120.652 0.263 . . . . 74.25 110.737 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.63 ' HA ' HG21 ' A' ' 134' ' ' ILE . 7.2 tt0 -59.62 -46.43 89.01 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.044 -0.526 . . . . 73.540000000000006 112.355 -176.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.428 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -65.0 -32.99 74.99 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.811 -0.355 . . . . 71.400000000000006 110.601 -176.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.571 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 38.6 m80 -61.8 -52.73 62.99 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.912 0.387 . . . . 71.310000000000002 110.709 178.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.447 HD23 HG21 ' A' ' 170' ' ' VAL . 70.3 mt -62.99 -47.91 81.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.625 -0.716 . . . . 73.129999999999995 110.288 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -56.17 -49.33 74.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.798 -0.637 . . . . 73.150000000000006 110.651 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -56.71 -32.66 65.72 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.179 0.514 . . . . 74.230000000000004 111.62 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -85.16 -40.8 16.31 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.035 -0.53 . . . . 73.319999999999993 111.104 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.508 ' CD1' HG21 ' A' ' 151' ' ' VAL . 57.1 m-85 -88.63 -18.02 28.86 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.78 0.659 . . . . 64.319999999999993 112.78 -173.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.4 ' N ' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -66.35 -21.52 66.25 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.142 0.496 . . . . 74.25 110.928 -179.448 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -70.08 -22.14 63.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.673 -0.694 . . . . 61.229999999999997 110.477 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.508 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 28.9 m-85 -86.74 -33.25 20.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.957 -0.565 . . . . 74.450000000000003 110.674 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 176.93 -170.38 43.07 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.285 -0.959 . . . . 45.420000000000002 113.151 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -75.17 124.02 26.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 122.924 0.49 . . . . 73.329999999999998 111.49 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.488 HG21 HD11 ' A' ' 134' ' ' ILE . 44.2 mt -100.31 137.31 28.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.876 -0.602 . . . . 62.32 111.149 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.14 -74.41 0.34 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.383 -0.826 . . . . 64.109999999999999 110.359 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.81 159.09 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.655 -0.498 . . . . 55.009999999999998 109.655 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.63 HG21 ' HA ' ' A' ' 118' ' ' GLU . 29.3 mm -112.41 104.45 17.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.928 0.394 . . . . 64.439999999999998 109.948 174.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -89.61 101.64 14.32 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.959 -0.386 . . . . 72.409999999999997 109.959 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.401 ' H ' HG13 ' A' ' 136' ' ' ILE . 4.3 mt -81.18 12.6 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.349 0.595 . . . . 74.120000000000005 109.84 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.714 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER . . . . . 0 CA--C 1.516 -0.36 0 CA-C-N 115.143 -0.935 . . . . 53.219999999999999 109.702 -174.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.714 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 42.9 p90 . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.601 0.239 . . . . 72.420000000000002 110.402 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.86 165.13 23.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.976 0.417 . . . . 61.229999999999997 111.206 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.48 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 43.7 m-85 -132.47 135.5 46.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.699 -0.682 . . . . 72.430000000000007 109.467 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.61 HG13 ' CD1' ' A' ' 134' ' ' ILE . 43.4 t -110.85 108.42 25.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.55 -0.537 . . . . 50.43 109.55 177.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.509 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 3.9 m -85.88 128.48 34.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.055 -0.52 . . . . 74.299999999999997 110.301 -178.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.587 ' CD2' HG12 ' A' ' 159' ' ' VAL . 94.7 m-85 -111.75 151.41 29.0 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.916 -0.401 . . . . 74.310000000000002 109.916 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -78.87 -6.56 56.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.249 0.547 . . . . 73.409999999999997 110.854 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.75 149.64 43.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.182 -0.463 . . . . 51.299999999999997 110.245 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.56 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.0 p-80 -89.48 -2.64 58.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.928 0.394 . . . . 71.519999999999996 110.897 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -75.04 -39.08 61.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.359 0.6 . . . . 64.150000000000006 109.476 173.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.4 m -64.9 -30.31 71.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.513 -0.767 . . . . 61.229999999999997 111.789 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.587 HG12 ' CD2' ' A' ' 153' ' ' PHE . 14.1 m -78.87 -20.81 12.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.634 -0.257 . . . . 54.149999999999999 111.68 -176.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.05 -46.14 75.27 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 120.596 0.236 . . . . 71.230000000000004 110.46 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.508 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.4 mptp? -59.29 -20.08 51.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.364 0.602 . . . . 63.299999999999997 111.038 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.437 HG22 HG11 ' A' ' 177' ' ' VAL . 79.5 mt -94.1 -49.07 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.529 -0.76 . . . . 71.400000000000006 111.206 -175.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.578 ' HB ' ' HE3' ' A' ' 179' ' ' LYS . 25.9 m -80.59 -10.72 12.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 112.287 0.477 . . . . 64.0 112.287 -173.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.6 pp -68.82 -31.35 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.998 0.428 . . . . 71.420000000000002 110.961 176.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.522 ' N ' HD12 ' A' ' 164' ' ' ILE . 14.5 pt20 -101.15 -162.0 0.9 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.116 -0.698 . . . . 65.140000000000001 109.116 172.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.518 ' HE3' ' CD ' ' A' ' 176' ' ' GLU . 44.3 tttt -134.67 -68.67 0.53 Allowed 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.811 -0.356 . . . . 62.43 111.568 -174.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 97.2 m-85 -88.32 113.41 23.89 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.133 0.492 . . . . 74.230000000000004 111.544 -175.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -105.35 147.36 28.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.57 -0.741 . . . . 73.430000000000007 110.248 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 47.2 m -100.73 98.92 9.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.075 0.464 . . . . 54.329999999999998 110.745 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.447 HG21 HD23 ' A' ' 121' ' ' LEU . 4.7 p -118.19 130.97 72.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.076 -0.511 . . . . 45.240000000000002 109.833 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.8 t30 64.67 15.73 9.91 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.643 0.735 . . . . 71.109999999999999 110.279 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.85 8.78 75.63 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.765 -0.731 . . . . 62.420000000000002 112.225 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -110.03 124.67 51.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.719 0.295 . . . . 72.540000000000006 110.367 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -81.42 105.3 12.48 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.427 -0.583 . . . . 70.219999999999999 109.427 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 10.5 m -118.15 154.31 32.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.926 -0.579 . . . . 53.25 110.589 -172.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.518 ' CD ' ' HE3' ' A' ' 166' ' ' LYS . 30.1 tt0 -88.73 126.0 35.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.001 0.429 . . . . 73.230000000000004 110.153 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 97.8 t -112.23 129.43 67.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.343 0.592 . . . . 73.540000000000006 111.034 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 80.7 mtt180 -119.0 179.58 4.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.24 -0.891 . . . . 75.129999999999995 110.083 179.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.578 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 9.6 mptt -81.69 126.52 31.88 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.327 -1.36 . . . . 71.209999999999994 107.327 168.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.88 83.95 6.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.055 0.455 . . . . 43.109999999999999 111.505 -174.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.587 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -84.04 140.79 31.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.88 -0.6 . . . . 72.430000000000007 109.444 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 46.4 t -50.15 142.14 10.17 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.423 0.452 . . . . 74.109999999999999 111.179 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.758 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.5 pttp -62.09 -20.05 63.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.188 -0.46 . . . . 74.349999999999994 111.29 -178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -54.31 14.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.886 -0.783 . . . . 61.520000000000003 108.886 174.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.9 -32.15 72.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.747 -0.66 . . . . 75.310000000000002 111.564 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.758 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 21.7 ptm . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 120.779 0.323 . . . . 75.420000000000002 110.523 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.609 HG23 HG11 ' A' ' 159' ' ' VAL . 6.6 m . . . . . 0 N--CA 1.451 -0.419 0 N-CA-C 109.798 -0.445 . . . . 61.520000000000003 109.798 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.772 ' HA ' HG21 ' A' ' 159' ' ' VAL . 14.0 mtmt -118.17 22.72 12.02 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.599 0.714 . . . . 73.530000000000001 109.46 177.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.727 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 42.0 tttt -149.88 129.5 13.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.802 -1.09 . . . . 65.540000000000006 109.361 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.527 HD13 HG21 ' A' ' 162' ' ' ILE . 7.9 pt -106.03 163.04 4.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.0 0.429 . . . . 75.019999999999996 111.225 -177.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -109.59 118.76 37.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.526 -0.761 . . . . 75.230000000000004 109.567 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.596 HG11 HD11 ' A' ' 121' ' ' LEU . 37.3 t -102.59 103.36 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.881 0.372 . . . . 65.219999999999999 110.757 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 175' ' ' CYS . . . . . . . . 0 N--CA 1.442 -0.954 0 N-CA-C 110.898 -0.881 . . . . 34.219999999999999 110.898 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.674 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 11.5 pt-20 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.919 0.39 . . . . 62.439999999999998 111.605 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.701 ' HA ' HG21 ' A' ' 134' ' ' ILE . 14.2 tt0 -53.42 -49.71 66.75 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.427 -0.806 . . . . 64.540000000000006 112.212 -174.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.434 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 0.8 OUTLIER -63.39 -31.44 72.6 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.1 -0.24 . . . . 42.299999999999997 110.678 -176.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.674 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 35.7 m80 -67.06 -56.81 8.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.476 -0.329 . . . . 73.409999999999997 110.376 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.596 HD11 HG11 ' A' ' 109' ' ' VAL . 0.5 OUTLIER -61.05 -49.55 76.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.48 . . . . 60.020000000000003 110.928 -178.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.509 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 1.5 tpp180 -58.08 -45.32 87.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.273 -0.422 . . . . 75.439999999999998 111.197 -177.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -56.61 -37.11 70.22 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.096 0.474 . . . . 70.010000000000005 111.44 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -84.96 -39.85 17.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.271 -0.422 . . . . 75.209999999999994 111.257 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -86.69 -17.5 33.57 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.47 0.545 . . . . 73.239999999999995 112.47 -172.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -21.7 65.58 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.334 0.588 . . . . 72.340000000000003 110.697 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -70.22 -24.82 63.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.336 -0.847 . . . . 72.019999999999996 110.406 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.462 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 31.0 m-85 -83.46 -32.06 26.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.951 -0.568 . . . . 74.299999999999997 110.139 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.7 177.78 43.17 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.162 -0.775 . . . . 73.430000000000007 111.162 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -67.25 133.88 50.55 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.656 0.741 . . . . 73.099999999999994 110.478 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 122' ' ' ARG . 46.6 mt -100.24 141.92 16.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 115.288 -0.869 . . . . 52.299999999999997 110.446 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -78.46 -70.63 0.48 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.081 -0.509 . . . . 70.310000000000002 110.419 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.3 m -148.08 157.04 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.456 -0.338 . . . . 23.32 110.659 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.701 HG21 ' HA ' ' A' ' 118' ' ' GLU . 12.9 mm -109.96 108.93 26.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.572 -0.899 . . . . 71.409999999999997 108.572 174.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -95.08 95.97 8.93 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.204 0.526 . . . . 74.129999999999995 110.519 -175.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.638 HD11 ' H ' ' A' ' 118' ' ' GLU . 20.6 mt -74.81 99.06 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.702 -0.851 . . . . 74.340000000000003 108.702 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.8 tpt . . . . . 0 C--N 1.325 -0.485 0 CA-C-O 121.287 0.565 . . . . 65.310000000000002 110.488 -174.385 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.7 p90 . . . . . 0 C--O 1.234 0.253 0 CA-C-O 120.947 0.403 . . . . 75.430000000000007 110.924 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.05 175.16 9.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.009 -0.541 . . . . 72.340000000000003 110.366 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.727 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 85.3 m-85 -132.03 152.06 51.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.351 -0.386 . . . . 71.530000000000001 110.333 -176.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.608 HG13 ' CD1' ' A' ' 134' ' ' ILE . 44.6 t -134.91 114.61 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.076 -0.713 . . . . 55.539999999999999 109.076 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.476 ' OG1' ' HD2' ' A' ' 106' ' ' LYS . 42.5 m -98.23 132.12 44.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.929 0.395 . . . . 75.439999999999998 110.558 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.481 ' CD2' HG22 ' A' ' 159' ' ' VAL . 91.2 m-85 -112.14 155.26 24.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.075 -0.511 . . . . 74.510000000000005 110.282 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -76.53 -23.82 53.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.244 0.545 . . . . 73.549999999999997 110.536 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.427 ' O ' HG23 ' A' ' 159' ' ' VAL . 9.5 t0 -131.47 138.88 49.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.587 -0.733 . . . . 73.150000000000006 109.73 -178.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.539 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.3 p-80 -75.83 -9.91 58.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.908 0.385 . . . . 64.049999999999997 110.605 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -66.61 -48.54 69.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 74.400000000000006 110.218 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 42.2 t -58.97 -37.16 76.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.611 . . . . 74.239999999999995 110.228 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.772 HG21 ' HA ' ' A' ' 105' ' ' LYS . 18.5 t -65.58 -36.99 78.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.451 -0.795 . . . . 71.049999999999997 111.017 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -55.45 -48.2 74.86 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.173 -0.467 . . . . 64.319999999999993 111.814 -176.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.462 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 4.0 mptt -60.19 -19.13 52.7 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.201 0.524 . . . . 65.329999999999998 111.063 -177.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.527 HG21 HD13 ' A' ' 107' ' ' ILE . 84.0 mt -99.84 -47.34 11.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.527 -0.76 . . . . 75.310000000000002 111.366 -175.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.422 ' CG2' ' HE3' ' A' ' 179' ' ' LYS . 28.9 m -71.26 -11.17 14.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.438 0.532 . . . . 74.540000000000006 112.438 -174.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.79 -24.29 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.909 0.385 . . . . 74.510000000000005 111.21 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -106.04 142.33 35.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.07 -0.514 . . . . 74.209999999999994 110.538 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.55 ' HG3' ' HG2' ' A' ' 176' ' ' GLU . 85.5 tttt -89.78 -67.3 0.85 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.005 -0.543 . . . . 64.0 111.199 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.596 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 22.8 m-85 -81.04 100.43 8.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.186 -0.461 . . . . 70.030000000000001 111.688 -177.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -101.51 153.38 19.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.944 -0.571 . . . . 74.340000000000003 109.79 174.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 23.9 m -106.38 96.23 6.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.982 0.42 . . . . 72.400000000000006 110.67 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' A' ' 172' ' ' GLY . 47.1 t -105.3 133.2 50.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.57 -0.53 . . . . 70.019999999999996 109.57 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.4 t30 70.48 -19.25 0.22 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.128 0.571 . . . . 71.0 111.728 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 128.52 -6.03 6.64 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.181 -0.533 . . . . 63.229999999999997 111.833 -177.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -112.62 151.18 30.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.038 0.447 . . . . 73.010000000000005 110.399 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.487 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 66.0 t30 -82.86 124.83 30.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.753 -0.658 . . . . 72.010000000000005 110.374 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 23.5 p -119.42 -171.86 2.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.955 -0.566 . . . . 40.329999999999998 110.253 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.55 ' HG2' ' HG3' ' A' ' 166' ' ' LYS . 0.9 OUTLIER -139.1 116.07 10.92 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.468 -0.567 . . . . 74.420000000000002 109.468 -176.531 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 93.4 t -116.41 140.15 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.018 -0.537 . . . . 54.240000000000002 112.062 -171.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -134.29 -178.83 5.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.69 -0.686 . . . . 74.430000000000007 109.801 178.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.422 ' HE3' ' CG2' ' A' ' 163' ' ' VAL . 11.9 mptt -75.01 128.43 35.54 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.267 -1.012 . . . . 74.239999999999995 108.267 168.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -74.04 97.83 2.95 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.582 -0.447 . . . . 73.209999999999994 110.773 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.7 pt? -106.6 149.18 27.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.936 -0.574 . . . . 64.109999999999999 110.204 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.5 t -49.62 139.63 12.27 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.579 0.55 . . . . 73.340000000000003 111.187 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.729 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 17.8 pttp -65.49 -12.7 55.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.135 0.493 . . . . 73.450000000000003 110.732 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -74.99 -52.92 9.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.857 -0.611 . . . . 72.439999999999998 109.94 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -73.38 -32.17 64.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.453 -0.794 . . . . 71.230000000000004 111.265 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.729 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.3 ptm . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.394 -0.367 . . . . 63.210000000000001 110.876 -177.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 106' ' ' LYS . 12.4 p . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 120.969 0.414 . . . . 71.530000000000001 110.176 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.601 ' HA ' HG21 ' A' ' 159' ' ' VAL . 15.2 mtmt -120.34 21.93 11.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.036 -0.529 . . . . 73.340000000000003 110.765 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.565 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.3 ttpt -153.89 142.49 20.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.327 -0.397 . . . . 71.030000000000001 109.944 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.561 HD13 HG21 ' A' ' 162' ' ' ILE . 4.0 pt -113.43 157.41 14.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.939 0.4 . . . . 53.200000000000003 110.915 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 66.7 t80 -105.61 119.89 40.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.608 -0.724 . . . . 72.129999999999995 109.932 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.0 t -101.1 108.89 24.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.796 0.331 . . . . 75.310000000000002 110.68 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.57 0 C-N-CA 121.165 -0.54 . . . . 61.409999999999997 112.331 -179.222 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.643 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 0.5 OUTLIER . . . . . 0 C--O 1.235 0.302 0 CA-C-O 120.939 0.399 . . . . 64.030000000000001 111.438 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.691 ' HG3' HG13 ' A' ' 134' ' ' ILE . 15.1 tt0 -57.77 -49.87 75.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.64 -0.709 . . . . 75.230000000000004 112.429 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -33.53 69.9 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 121.046 -0.262 . . . . 64.219999999999999 110.504 -175.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.643 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 41.8 m80 -64.47 -53.36 49.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.08 -0.509 . . . . 65.349999999999994 110.552 178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.541 HD12 HG11 ' A' ' 170' ' ' VAL . 9.3 mp -66.02 -49.62 67.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.727 -0.67 . . . . 75.310000000000002 111.193 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.5 -48.46 81.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.196 -0.456 . . . . 73.140000000000001 111.456 -176.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.3 -30.5 69.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.126 0.489 . . . . 64.510000000000005 110.832 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.483 ' CD1' HG22 ' A' ' 170' ' ' VAL . 50.8 t80 -81.64 -46.89 13.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.914 -0.584 . . . . 74.439999999999998 111.247 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -83.55 -16.89 43.72 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.725 0.639 . . . . 75.439999999999998 112.725 -173.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -23.9 67.38 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.989 0.423 . . . . 74.040000000000006 111.233 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -67.08 -25.02 66.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.821 -0.627 . . . . 54.530000000000001 110.508 178.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.509 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 45.7 m-85 -84.07 -34.25 24.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.968 -0.56 . . . . 74.420000000000002 110.477 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.95 -170.69 43.85 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.145 -1.026 . . . . 51.350000000000001 113.133 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -72.9 120.1 18.05 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.639 0.733 . . . . 73.049999999999997 112.092 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.539 HG21 HD11 ' A' ' 134' ' ' ILE . 41.1 mt -94.98 134.48 32.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.937 -1.029 . . . . 74.409999999999997 110.201 176.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 6.7 mm-40 -82.99 -67.42 0.79 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.032 -0.531 . . . . 63.310000000000002 110.717 178.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.0 m -146.53 152.62 13.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 72.219999999999999 110.259 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.691 HG13 ' HG3' ' A' ' 118' ' ' GLU . 33.5 mm -105.83 112.72 40.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.616 -0.513 . . . . 65.25 109.616 176.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -93.12 94.45 8.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.07 0.462 . . . . 74.010000000000005 110.212 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.0 mt -80.99 88.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.714 -0.847 . . . . 53.130000000000003 108.714 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.8 tpp . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 121.585 0.707 . . . . 63.329999999999998 110.864 -175.974 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 45.8 p90 . . . . . 0 N--CA 1.455 -0.21 0 CA-C-O 120.669 0.271 . . . . 51.530000000000001 110.486 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.91 163.39 33.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.332 -0.395 . . . . 74.310000000000002 110.405 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.453 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 50.2 m-85 -124.41 135.56 53.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.289 -0.414 . . . . 73.140000000000001 110.212 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.61 HG13 ' CD1' ' A' ' 134' ' ' ILE . 23.7 t -108.63 109.24 27.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.852 -0.425 . . . . 62.200000000000003 109.852 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.565 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 15.3 m -87.68 125.4 34.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.391 -0.368 . . . . 71.450000000000003 110.562 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.413 ' CE1' HG12 ' A' ' 131' ' ' ILE . 90.4 m-85 -109.84 154.41 23.06 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.703 -0.48 . . . . 74.140000000000001 109.703 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.426 ' HB2' ' HG2' ' A' ' 132' ' ' GLU . 23.9 t70 -77.57 -22.27 51.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.599 0.714 . . . . 43.409999999999997 110.213 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 157' ' ' ASP . 25.7 t70 -123.31 135.09 54.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.113 -0.949 . . . . 64.019999999999996 111.236 -171.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.554 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.4 p-80 -84.2 0.19 49.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 112.006 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.428 ' HB2' ' OD2' ' A' ' 155' ' ' ASP . 54.3 m-20 -98.08 -29.25 13.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.97 -0.752 . . . . 71.030000000000001 108.97 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.43 ' HA ' ' HE3' ' A' ' 161' ' ' LYS . 42.4 t -58.8 -32.8 69.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.551 -0.749 . . . . 64.439999999999998 109.704 170.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 105' ' ' LYS . 21.7 t -74.18 -29.77 25.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.355 -0.838 . . . . 64.140000000000001 110.434 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.03 -47.74 84.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 74.310000000000002 111.726 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.509 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -60.89 -18.65 57.59 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.324 0.583 . . . . 74.019999999999996 110.906 -178.313 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.561 HG21 HD13 ' A' ' 107' ' ' ILE . 80.5 mt -95.76 -52.33 9.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.451 -0.795 . . . . 54.229999999999997 111.158 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.534 ' HB ' ' HE3' ' A' ' 179' ' ' LYS . 26.4 m -74.77 -10.75 13.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.715 0.635 . . . . 71.420000000000002 112.715 -173.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.4 pp -68.61 -32.92 57.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.836 0.35 . . . . 72.319999999999993 111.052 176.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.475 ' N ' HD12 ' A' ' 164' ' ' ILE . 13.7 pt20 -107.51 -174.35 2.51 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.337 -0.616 . . . . 73.519999999999996 109.337 176.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.633 ' HE3' ' OE1' ' A' ' 176' ' ' GLU . 82.5 tttt -123.52 -56.52 1.69 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.933 0.397 . . . . 71.120000000000005 111.063 -174.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.586 ' HB3' ' OD1' ' A' ' 174' ' ' ASN . 21.8 m-30 -79.93 113.0 17.77 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.93 -0.577 . . . . 75.219999999999999 111.62 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -116.66 143.75 45.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.575 -0.739 . . . . 72.150000000000006 110.555 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 76.3 m -95.7 101.53 13.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.042 0.448 . . . . 64.140000000000001 111.202 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.541 HG11 HD12 ' A' ' 121' ' ' LEU . 42.4 t -118.62 127.96 75.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.285 -0.635 . . . . 63.32 109.285 177.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 58.5 t30 63.21 21.65 12.95 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.83 0.824 . . . . 73.400000000000006 110.112 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.58 -1.27 88.97 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.656 -0.702 . . . . 74.409999999999997 112.684 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -103.26 145.56 29.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.919 0.39 . . . . 71.430000000000007 110.541 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.586 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 64.5 t30 -88.87 106.58 18.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.907 -0.588 . . . . 73.150000000000006 110.072 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 12.0 p -116.55 159.86 21.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.088 -0.506 . . . . 61.039999999999999 110.993 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.633 ' OE1' ' HE3' ' A' ' 166' ' ' LYS . 14.5 tt0 -95.47 130.88 42.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.101 -0.5 . . . . 71.409999999999997 109.915 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 3.0 m -118.88 142.97 31.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.126 0.488 . . . . 61.409999999999997 110.135 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 72.9 mtt180 -130.53 177.68 7.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.157 -0.474 . . . . 72.329999999999998 110.199 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.534 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 10.1 mptt -75.79 120.01 20.57 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.908 -1.145 . . . . 51.140000000000001 107.908 171.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -74.23 93.09 2.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.139 0.495 . . . . 45.210000000000001 111.66 -176.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.731 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -95.94 144.59 26.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.755 -0.657 . . . . 75.439999999999998 109.655 175.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.501 ' HB3' ' HG3' ' A' ' 185' ' ' GLU . 30.6 t -50.28 143.34 8.74 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.405 0.44 . . . . 72.319999999999993 111.593 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -60.23 -23.54 64.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.762 -0.654 . . . . 51.119999999999997 110.182 175.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -73.76 -42.88 60.44 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.656 -0.702 . . . . 72.209999999999994 110.124 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 182' ' ' SER . 37.9 mt-10 -78.85 -32.48 46.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.654 -0.703 . . . . 72.519999999999996 111.295 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . . . . . . . . . 18.7 ptm . . . . . 0 C--N 1.327 -0.404 0 CA-C-N 116.326 -0.397 . . . . 54.329999999999998 110.666 -177.351 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.558 HG13 HG11 ' A' ' 159' ' ' VAL . 14.6 p . . . . . 0 N--CA 1.452 -0.344 0 CA-C-O 120.84 0.352 . . . . 40.119999999999997 111.266 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.762 ' HA ' HG21 ' A' ' 159' ' ' VAL . 12.1 mtmt -123.07 -1.41 8.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 74.140000000000001 111.865 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.622 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 27.0 ttpt -130.45 137.42 49.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.846 0.355 . . . . 71.140000000000001 110.171 175.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.577 ' CG2' HG13 ' A' ' 159' ' ' VAL . 10.8 pt -108.36 163.97 5.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.949 0.404 . . . . 74.549999999999997 111.258 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.461 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 75.0 t80 -112.67 120.19 40.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.567 -0.742 . . . . 74.439999999999998 109.452 176.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.4 t -105.9 115.45 47.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.947 0.403 . . . . 74.340000000000003 110.919 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.746 0 N-CA-C 111.65 -0.58 . . . . 44.109999999999999 111.65 177.512 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.452 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 0.9 OUTLIER . . . . . 0 CA--C 1.532 0.273 0 CA-C-O 120.931 0.396 . . . . 75.329999999999998 110.978 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.723 ' HA ' HG21 ' A' ' 134' ' ' ILE . 10.7 tt0 -57.68 -51.8 68.05 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.522 -0.763 . . . . 75.049999999999997 112.266 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.67 -33.97 76.15 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 120.921 -0.312 . . . . 72.310000000000002 110.619 -173.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.452 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 62.5 m80 -60.88 -56.19 24.07 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.281 -0.418 . . . . 63.549999999999997 110.314 177.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.575 HD23 HG11 ' A' ' 170' ' ' VAL . 59.2 mt -59.31 -54.75 43.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.435 -0.802 . . . . 72.540000000000006 111.191 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -55.36 -46.64 76.43 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.1 -0.5 . . . . 71.430000000000007 111.412 -177.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.65 -35.3 65.79 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.996 0.427 . . . . 73.040000000000006 111.436 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -84.31 -44.4 13.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.378 -0.374 . . . . 72.019999999999996 111.191 -178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -81.39 -16.88 50.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.387 0.514 . . . . 71.129999999999995 112.387 -172.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -24.03 67.4 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.998 0.427 . . . . 64.120000000000005 110.951 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -66.76 -28.29 68.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.832 -0.622 . . . . 73.040000000000006 110.234 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.464 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 69.3 m-85 -80.78 -34.58 34.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.642 -0.708 . . . . 72.420000000000002 110.948 -177.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 171.7 -164.28 36.98 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.964 -1.112 . . . . 75.430000000000007 113.118 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -75.85 118.7 18.92 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.512 0.673 . . . . 72.030000000000001 111.959 -176.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.481 HG21 HD11 ' A' ' 134' ' ' ILE . 36.2 mt -95.22 139.96 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.19 -0.914 . . . . 40.130000000000003 110.355 177.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.448 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 9.0 mm-40 -84.61 -76.28 0.31 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.132 -0.485 . . . . 74.329999999999998 110.011 176.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.02 158.36 26.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.008 -0.542 . . . . 74.329999999999998 110.136 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.723 HG21 ' HA ' ' A' ' 118' ' ' GLU . 23.4 mm -107.35 112.46 40.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.139 -0.689 . . . . 75.519999999999996 109.139 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -97.58 92.02 5.71 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.348 0.594 . . . . 72.340000000000003 110.68 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.7 mt -73.66 128.54 36.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.324 -0.991 . . . . 71.319999999999993 108.324 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.647 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.489 0 N-CA-C 109.265 -0.643 . . . . 60.009999999999998 109.265 -179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.647 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 42.4 p90 . . . . . 0 C--O 1.234 0.282 0 CA-C-O 120.865 0.364 . . . . 54.530000000000001 110.773 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.461 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -149.14 165.33 32.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.415 -0.357 . . . . 74.319999999999993 110.99 -177.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.461 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 53.7 m-85 -124.04 143.2 50.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 71.409999999999997 109.934 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.585 HG13 ' CD1' ' A' ' 134' ' ' ILE . 44.1 t -117.56 112.54 39.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.875 -0.417 . . . . 75.540000000000006 109.875 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.622 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 16.6 m -89.83 125.08 35.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.226 -0.443 . . . . 73.439999999999998 110.434 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.484 ' CD2' HG22 ' A' ' 159' ' ' VAL . 88.3 m-85 -108.63 152.24 25.06 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.432 -0.581 . . . . 61.5 109.432 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.448 ' HB2' ' HG2' ' A' ' 132' ' ' GLU . 28.4 t70 -81.3 -18.93 44.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.113 0.959 . . . . 54.119999999999997 109.07 176.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.526 ' OD2' ' HB3' ' A' ' 157' ' ' ASP . 26.0 t70 -116.05 126.16 53.41 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.227 -1.351 . . . . 74.430000000000007 110.548 -175.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.575 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.6 p-80 -78.81 -8.49 58.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.222 -0.445 . . . . 54.210000000000001 111.363 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.526 ' HB3' ' OD2' ' A' ' 155' ' ' ASP . 18.5 t70 -89.03 -36.26 15.9 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.308 -0.627 . . . . 71.420000000000002 109.308 -176.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.0 t -54.44 -40.79 68.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.315 -0.857 . . . . 50.43 109.713 168.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.762 HG21 ' HA ' ' A' ' 105' ' ' LYS . 11.3 t -67.75 -33.96 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.516 -0.766 . . . . 61.420000000000002 110.443 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -64.25 -28.85 70.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 73.420000000000002 110.752 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.464 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 20.9 mmtp -70.07 -24.36 63.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.621 0.724 . . . . 64.439999999999998 109.893 177.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.482 HG23 ' CE1' ' A' ' 168' ' ' HIS . 87.3 mt -99.71 -48.4 11.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.009 -0.996 . . . . 65.540000000000006 111.917 -169.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.421 HG13 HG12 ' A' ' 159' ' ' VAL . 31.6 m -73.05 -7.76 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 112.769 0.655 . . . . 71.209999999999994 112.769 -173.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.3 pp -78.45 -33.81 17.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.911 -0.316 . . . . 72.010000000000005 111.479 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.525 ' N ' HD12 ' A' ' 164' ' ' ILE . 12.8 pt20 -108.47 171.34 7.47 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.493 -0.558 . . . . 53.509999999999998 109.493 176.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.565 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 86.3 tttt -111.61 -59.38 1.99 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.831 0.348 . . . . 72.140000000000001 111.181 -174.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.602 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 19.8 m-30 -77.32 99.16 5.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.272 0.558 . . . . 63.539999999999999 112.042 -176.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.482 ' CE1' HG23 ' A' ' 162' ' ' ILE . 49.0 m-70 -98.61 159.19 15.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.551 -0.75 . . . . 72.510000000000005 110.009 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.9 m -104.67 83.77 2.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.927 0.394 . . . . 74.329999999999998 110.956 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.575 HG11 HD23 ' A' ' 121' ' ' LEU . 21.9 t -106.93 131.85 55.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.952 -0.388 . . . . 74.510000000000005 109.952 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.507 ' HB3' ' HD2' ' A' ' 173' ' ' HIS . 31.1 t-20 67.07 13.52 9.48 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.756 0.789 . . . . 73.109999999999999 109.776 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.05 17.69 71.53 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.758 -0.656 . . . . 74.010000000000005 112.072 -177.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . 0.507 ' HD2' ' HB3' ' A' ' 171' ' ' ASN . 86.9 m-70 -117.28 160.25 21.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.074 0.464 . . . . 72.549999999999997 110.553 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -87.2 105.98 17.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.703 -0.68 . . . . 71.409999999999997 109.449 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 66.8 m -114.15 158.43 21.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.151 -0.477 . . . . 75.340000000000003 111.02 -175.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.565 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 9.5 tt0 -103.16 125.74 50.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.15 -0.477 . . . . 74.329999999999998 110.152 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.435 HG11 ' CG2' ' A' ' 162' ' ' ILE . 78.5 t -123.06 135.16 64.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.308 0.575 . . . . 73.239999999999995 110.896 177.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.8 ptt180 -139.9 165.56 26.99 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.346 -0.843 . . . . 71.420000000000002 108.993 176.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.46 ' HB2' HG11 ' A' ' 104' ' ' VAL . 11.5 ptmm? -72.04 126.21 29.19 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.544 -0.462 . . . . 75.099999999999994 110.038 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -72.3 129.29 38.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.859 -0.61 . . . . 50.130000000000003 111.239 -176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.708 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.5 pt? -124.7 143.96 50.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.437 -0.801 . . . . 75.540000000000006 109.025 174.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 m -49.3 137.91 13.59 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.445 0.466 . . . . 70.25 111.246 -177.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.854 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.1 pttp -61.84 -25.63 67.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.17 0.51 . . . . 70.230000000000004 110.094 178.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -59.06 -41.48 88.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.34 -0.846 . . . . 73.109999999999999 110.762 172.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -93.11 -35.89 12.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.58 -0.736 . . . . 63.009999999999998 111.38 -172.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.854 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 23.9 ptm . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 120.753 0.311 . . . . 72.510000000000005 110.385 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.485 ' O ' HG21 ' A' ' 159' ' ' VAL . 4.1 p . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 110.323 -0.251 . . . . 65.310000000000002 110.323 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.548 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 2.5 mtmt -122.24 16.81 10.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.389 0.614 . . . . 62.450000000000003 110.547 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.576 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 24.8 ttpt -152.78 136.52 16.15 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.339 -0.846 . . . . 62.439999999999998 109.742 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.546 HG12 ' HB ' ' A' ' 151' ' ' VAL . 9.1 pt -103.93 162.7 4.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.904 0.383 . . . . 64.420000000000002 110.732 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.465 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 59.7 t80 -110.63 110.63 21.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.762 -0.653 . . . . 74.109999999999999 110.363 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.1 t -98.25 91.86 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.132 -0.692 . . . . 74.549999999999997 109.132 176.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.462 0 C-N-CA 120.669 -0.777 . . . . 52.130000000000003 112.928 -174.659 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.647 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.319 0 CA-C-O 121.215 0.531 . . . . 74.530000000000001 112.143 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.73 ' HA ' HG21 ' A' ' 134' ' ' ILE . 21.1 tt0 -58.13 -48.73 79.34 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.881 -1.054 . . . . 74.040000000000006 111.926 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -34.94 75.19 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.089 -0.244 . . . . 63.420000000000002 110.554 -177.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.647 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 44.0 m80 -64.4 -57.31 9.65 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.085 0.469 . . . . 75.439999999999998 110.453 178.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.599 HD23 HG11 ' A' ' 170' ' ' VAL . 79.4 mt -59.93 -52.4 65.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.306 -0.861 . . . . 52.409999999999997 110.848 -176.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.52 -44.09 93.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.007 -0.542 . . . . 74.439999999999998 111.419 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -63.16 -22.75 67.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.042 0.448 . . . . 73.239999999999995 110.938 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.417 ' CD1' HG22 ' A' ' 170' ' ' VAL . 85.9 t80 -89.83 -51.78 5.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.251 -0.432 . . . . 63.399999999999999 110.85 176.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.431 ' HA ' ' HD2' ' A' ' 128' ' ' TYR . 52.2 m-85 -74.49 -14.7 60.86 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.38 0.511 . . . . 74.340000000000003 112.38 -172.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -22.34 65.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.837 0.31 . . . . 74.25 111.837 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -74.66 -21.82 59.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 71.239999999999995 110.582 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.473 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 86.6 m-85 -86.04 -21.79 27.56 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.501 -0.318 . . . . 73.439999999999998 110.279 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 163.18 -167.69 37.6 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 119.822 -1.18 . . . . 44.509999999999998 113.373 174.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.567 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 37.7 tptt -75.74 117.09 17.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.633 0.73 . . . . 71.040000000000006 111.09 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.552 HG21 HD11 ' A' ' 134' ' ' ILE . 40.1 mt -93.69 133.78 33.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.023 -0.989 . . . . 73.420000000000002 110.557 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -82.2 -75.17 0.31 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.925 -0.58 . . . . 74.439999999999998 110.765 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.54 155.57 36.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.797 -0.446 . . . . 52.200000000000003 109.797 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.73 HG21 ' HA ' ' A' ' 118' ' ' GLU . 27.8 mm -113.01 123.08 68.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.493 -0.558 . . . . 74.129999999999995 109.493 173.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.3 96.13 6.31 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.017 0.437 . . . . 72.099999999999994 110.644 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.61 HD11 ' H ' ' A' ' 118' ' ' GLU . 7.9 mt -80.19 120.46 31.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.036 -1.098 . . . . 73.030000000000001 108.036 173.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.601 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 76.1 mmm . . . . . 0 CA--C 1.509 -0.615 0 C-N-CA 119.926 -0.71 . . . . 73.530000000000001 109.964 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.601 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 24.5 p90 . . . . . 0 C--O 1.235 0.298 0 CA-C-O 121.071 0.463 . . . . 73.230000000000004 111.853 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.53 165.52 27.34 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.173 -0.467 . . . . 60.420000000000002 110.938 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.552 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 69.1 m-85 -123.73 142.34 51.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.1 -0.5 . . . . 71.140000000000001 110.317 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.634 HG13 ' CD1' ' A' ' 134' ' ' ILE . 55.6 t -116.42 108.49 25.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.04 -0.527 . . . . 70.030000000000001 109.784 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.576 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 8.7 m -86.35 127.61 34.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.142 -0.481 . . . . 74.030000000000001 110.475 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.541 ' CD2' HG12 ' A' ' 159' ' ' VAL . 96.4 m-85 -110.47 153.5 24.96 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.936 0.398 . . . . 74.420000000000002 110.555 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.567 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 19.4 t70 -76.69 -15.26 59.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.905 -0.589 . . . . 71.219999999999999 110.606 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -136.15 139.85 43.2 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.809 -0.632 . . . . 72.340000000000003 110.609 -174.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.548 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.4 p-80 -83.99 -0.29 51.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.979 0.418 . . . . 70.510000000000005 111.018 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -80.44 -40.97 25.32 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.417 0.627 . . . . 74.109999999999999 109.48 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.4 m -61.17 -33.64 73.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.121 -0.945 . . . . 52.049999999999997 111.538 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.541 HG12 ' CD2' ' A' ' 153' ' ' PHE . 15.3 m -72.85 -27.92 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 50.020000000000003 111.396 -177.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . 0.495 ' HA ' HG22 ' A' ' 163' ' ' VAL . 35.6 t70 -65.53 -42.12 92.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.608 -0.269 . . . . 61.210000000000001 110.993 -173.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.473 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 4.9 mttt -58.86 -22.33 58.9 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.196 0.522 . . . . 71.519999999999996 110.807 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.522 HG21 HD13 ' A' ' 107' ' ' ILE . 79.6 mt -92.86 -49.37 12.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.397 -0.82 . . . . 51.5 110.939 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' ' 179' ' ' LYS . 30.3 m -77.83 -7.73 10.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.898 0.703 . . . . 63.130000000000003 112.898 -174.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.409 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.5 pp -72.84 -28.87 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.967 0.413 . . . . 75.430000000000007 110.561 174.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.432 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 11.9 pt20 -108.06 -171.17 1.81 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.172 -0.677 . . . . 72.040000000000006 109.172 172.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.41 ' HG2' ' HG3' ' A' ' 176' ' ' GLU . 87.6 tttt -130.3 -61.85 0.96 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.781 -0.368 . . . . 63.329999999999998 111.537 -174.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -82.6 115.51 21.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.949 0.404 . . . . 64.319999999999993 110.721 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.442 ' CE1' HG23 ' A' ' 162' ' ' ILE . 21.3 m-70 -110.15 140.04 44.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.702 -0.681 . . . . 72.040000000000006 110.655 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 34.3 m -88.85 87.72 7.34 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.047 -0.524 . . . . 71.530000000000001 110.354 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.599 HG11 HD23 ' A' ' 121' ' ' LEU . 33.0 t -106.07 131.07 56.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.597 -0.52 . . . . 74.25 109.597 178.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 63.46 20.83 12.47 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.879 0.847 . . . . 62.450000000000003 109.546 -177.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.08 -5.74 70.24 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.383 -0.826 . . . . 71.530000000000001 112.191 -176.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -96.46 151.24 19.75 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.207 -0.294 . . . . 73.409999999999997 110.207 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -86.78 99.49 11.83 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.008 -0.367 . . . . 71.409999999999997 110.008 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 58.5 m -110.46 128.85 55.8 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.363 -0.38 . . . . 72.439999999999998 110.979 -177.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.41 ' HG3' ' HG2' ' A' ' 166' ' ' LYS . 28.4 tt0 -76.72 123.52 26.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.173 -0.467 . . . . 74.140000000000001 110.534 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 1.1 m -119.31 151.75 21.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.185 -0.461 . . . . 55.32 110.354 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -138.23 -173.92 3.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.716 -0.846 . . . . 74.430000000000007 108.716 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.551 ' HB3' HG11 ' A' ' 163' ' ' VAL . 19.4 ptmt -91.07 132.88 35.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.253 -0.647 . . . . 75.040000000000006 109.253 170.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -82.15 114.36 20.62 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.101 0.408 . . . . 51.039999999999999 112.101 -173.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.576 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -102.66 144.62 30.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.076 -0.713 . . . . 61.119999999999997 109.076 173.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 m -52.86 133.13 37.7 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.312 0.383 . . . . 61.329999999999998 111.252 -176.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.743 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 39.0 pttt -62.35 -30.25 71.04 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 109.828 -0.434 . . . . 75.310000000000002 109.828 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -59.99 -41.26 91.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.517 -0.765 . . . . 63.039999999999999 110.358 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -85.26 -39.16 18.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.645 -0.707 . . . . 75.010000000000005 111.257 -175.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.743 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 25.3 ptm . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 73.530000000000001 110.49 -178.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.4 t . . . . . 0 CA--C 1.529 0.168 0 CA-C-O 120.391 0.138 . . . . 31.120000000000001 111.266 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.725 ' HA ' HG21 ' A' ' 159' ' ' VAL . 24.1 mtmt 69.45 12.27 8.22 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.163 -0.472 . . . . 74.099999999999994 112.206 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.58 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 27.9 ttpt -157.23 133.91 10.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.593 -0.521 . . . . 64.329999999999998 109.593 173.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.528 HD13 HG21 ' A' ' 162' ' ' ILE . 4.7 pt -108.42 158.49 8.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.106 0.479 . . . . 75.109999999999999 111.023 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 69.4 t80 -105.3 121.11 43.19 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.246 -0.888 . . . . 65.340000000000003 109.899 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . 0.455 HG11 HD11 ' A' ' 121' ' ' LEU . 41.9 t -108.43 111.56 36.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.44 -0.345 . . . . 73.230000000000004 110.405 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.279 0 C-N-CA 121.02 -0.61 . . . . 51.450000000000003 112.241 -178.925 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.654 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 10.9 pt-20 . . . . . 0 N--CA 1.448 -0.539 0 CA-C-O 120.46 0.171 . . . . 61.549999999999997 110.812 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.635 ' HA ' HG21 ' A' ' 134' ' ' ILE . 15.9 tt0 -49.47 -52.43 29.22 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.028 -0.533 . . . . 75.239999999999995 112.056 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.49 -29.29 70.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.525 -0.307 . . . . 71.040000000000006 110.663 -174.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.654 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 57.9 m80 -69.42 -56.46 7.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.533 -0.303 . . . . 64.540000000000006 110.918 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.455 HD11 HG11 ' A' ' 109' ' ' VAL . 0.7 OUTLIER -57.19 -49.07 77.15 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.969 0.414 . . . . 71.430000000000007 109.951 177.47 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 122' ' ' ARG . 0.7 OUTLIER -55.03 -49.94 70.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.725 -0.671 . . . . 53.340000000000003 111.03 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -53.29 -32.71 50.04 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.169 0.509 . . . . 73.400000000000006 111.8 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -89.88 -39.09 13.27 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.077 -0.511 . . . . 74.349999999999994 111.578 -177.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.457 ' CD1' HG21 ' A' ' 151' ' ' VAL . 56.4 m-85 -89.14 -14.35 36.37 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.358 0.503 . . . . 53.219999999999999 112.358 -173.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.407 ' N ' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -66.12 -20.47 66.16 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.413 0.625 . . . . 72.319999999999993 110.013 176.039 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -71.58 -23.64 61.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.996 -1.002 . . . . 54.049999999999997 110.755 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -87.17 -32.64 19.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.086 -0.506 . . . . 75.420000000000002 111.099 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.33 -152.35 16.69 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.829 -1.177 . . . . 63.530000000000001 113.7 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.464 ' HA ' ' HE3' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -87.97 113.95 24.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.421 0.629 . . . . 73.439999999999998 111.547 -175.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.407 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 34.3 mt -94.24 138.25 21.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.041 -0.982 . . . . 72.439999999999998 110.187 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -78.04 -74.58 0.26 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.483 -0.562 . . . . 72.530000000000001 109.483 172.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.6 m -146.57 165.48 7.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.917 -0.583 . . . . 64.109999999999999 109.816 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.635 HG21 ' HA ' ' A' ' 118' ' ' GLU . 19.6 mm -109.59 109.45 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.274 -0.639 . . . . 73.450000000000003 109.274 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 59.5 mt-10 -88.14 98.57 11.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.312 0.577 . . . . 63.119999999999997 110.231 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.57 HD11 ' H ' ' A' ' 118' ' ' GLU . 35.8 mt -78.48 116.26 21.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.637 -0.71 . . . . 64.239999999999995 109.571 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.765 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.585 0 CA-C-O 121.078 0.466 . . . . 64.439999999999998 109.809 -178.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.765 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 21.4 p90 . . . . . 0 N--CA 1.449 -0.488 0 CA-C-O 120.849 0.357 . . . . 64.310000000000002 110.477 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.49 174.23 10.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.757 -0.656 . . . . 72.099999999999994 110.069 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.518 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 82.2 m-85 -133.33 139.55 46.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.914 0.387 . . . . 63.119999999999997 110.095 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.605 HG13 ' CD1' ' A' ' 134' ' ' ILE . 26.3 t -114.02 106.61 21.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.598 -0.519 . . . . 73.25 109.598 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.58 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 17.7 m -85.28 124.11 31.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.23 -0.441 . . . . 72.329999999999998 110.313 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.447 ' CD2' HG22 ' A' ' 159' ' ' VAL . 97.5 m-85 -107.91 145.09 34.24 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.833 -0.432 . . . . 65.219999999999999 109.833 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -74.87 -21.32 59.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.688 0.756 . . . . 72.040000000000006 109.486 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.494 ' OD1' ' HB3' ' A' ' 157' ' ' ASP . 18.7 t70 -118.99 128.52 54.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.801 -1.09 . . . . 71.409999999999997 110.871 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.58 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 3.2 p-80 -76.23 -9.59 58.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.996 -0.547 . . . . 64.299999999999997 111.268 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.494 ' HB3' ' OD1' ' A' ' 155' ' ' ASP . 32.8 t70 -85.3 -39.84 17.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.207 0.527 . . . . 60.450000000000003 109.642 -176.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.4 t -57.68 -34.6 69.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.627 -0.715 . . . . 61.219999999999999 110.526 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.725 HG21 ' HA ' ' A' ' 105' ' ' LYS . 16.9 t -66.84 -35.54 74.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.004 -0.544 . . . . 72.239999999999995 110.134 178.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.12 -31.7 72.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.525 -0.761 . . . . 74.230000000000004 111.362 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 35.3 mmtt -71.36 -19.48 62.28 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.306 0.574 . . . . 71.319999999999993 110.184 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.528 HG21 HD13 ' A' ' 107' ' ' ILE . 86.8 mt -102.22 -48.88 10.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.262 -0.881 . . . . 74.329999999999998 111.433 -171.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.536 ' HB ' ' HG3' ' A' ' 179' ' ' LYS . 33.6 m -67.85 -19.25 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.216 0.451 . . . . 71.420000000000002 112.216 -174.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.423 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.4 pp -69.34 -25.44 29.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.096 0.474 . . . . 71.109999999999999 110.774 176.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.556 ' HB3' ' NE2' ' A' ' 168' ' ' HIS . 21.9 tt0 -106.96 159.62 16.14 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.414 -0.812 . . . . 73.340000000000003 109.114 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.522 ' HE2' ' CE2' ' A' ' 167' ' ' TYR . 80.6 tttt -109.66 -64.3 1.27 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.87 0.367 . . . . 72.109999999999999 110.762 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.522 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 22.9 m-85 -77.03 113.17 14.45 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.049 0.452 . . . . 73.329999999999998 110.829 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.556 ' NE2' ' HB3' ' A' ' 165' ' ' GLN . 36.0 m-70 -121.7 132.53 54.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.549 -0.75 . . . . 71.019999999999996 110.019 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 174' ' ' ASN . 55.2 m -90.45 102.56 15.29 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.062 0.458 . . . . 74.219999999999999 110.951 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.21 136.58 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.899 -0.591 . . . . 71.5 109.881 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 59.29 25.5 14.14 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.511 0.672 . . . . 70.25 110.718 -175.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 77.57 7.61 87.16 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.766 -0.73 . . . . 61.310000000000002 112.555 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -116.02 123.62 48.43 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.718 -0.475 . . . . 64.430000000000007 109.718 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 169' ' ' THR . 64.1 t30 -74.73 102.63 4.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.214 -0.448 . . . . 55.439999999999998 110.071 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 35.5 m -107.76 169.99 8.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.158 -0.474 . . . . 62.310000000000002 110.709 -175.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -103.0 122.22 44.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.232 -0.44 . . . . 61.219999999999999 109.948 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.0 OUTLIER -120.36 151.67 23.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.263 -0.643 . . . . 72.230000000000004 109.263 176.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -161.62 -171.67 3.03 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.835 -0.621 . . . . 63.100000000000001 109.758 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.718 ' HD2' ' H ' ' A' ' 179' ' ' LYS . 7.7 mptt -74.43 122.16 22.56 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.874 -0.417 . . . . 63.130000000000003 109.874 -177.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.405 ' HB2' ' C ' ' A' ' 107' ' ' ILE . . . -81.28 90.85 6.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.942 0.401 . . . . 54.310000000000002 111.321 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.692 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.5 pt? -88.76 134.95 33.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.259 -0.645 . . . . 71.400000000000006 109.259 174.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.4 m -51.91 144.47 11.55 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.567 0.542 . . . . 75.140000000000001 111.309 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.648 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 32.1 pttt -57.71 -29.78 64.99 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.227 0.537 . . . . 62.140000000000001 110.114 177.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -58.04 -47.78 82.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.416 -0.811 . . . . 73.519999999999996 110.713 173.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -82.31 -37.66 25.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.122 -0.945 . . . . 63.350000000000001 111.275 -173.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.648 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.7 ptm . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.494 -0.321 . . . . 71.099999999999994 110.638 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 106' ' ' LYS . 12.5 p . . . . . 0 N--CA 1.453 -0.32 0 CA-C-O 120.74 0.305 . . . . 62.130000000000003 111.089 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.812 ' HA ' HG21 ' A' ' 159' ' ' VAL . 21.7 mtmt -122.91 6.32 9.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 64.129999999999995 111.662 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.631 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.6 ttpt -139.55 139.95 36.98 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.967 -0.383 . . . . 64.25 109.967 174.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.563 HG12 ' HB ' ' A' ' 151' ' ' VAL . 5.5 pt -109.25 160.78 7.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.94 0.4 . . . . 75.400000000000006 111.157 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.477 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 62.7 t80 -110.82 127.79 55.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.571 -0.741 . . . . 74.040000000000006 109.681 177.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 45.8 t -108.83 117.72 54.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.966 0.412 . . . . 73.129999999999995 110.855 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.481 0 N-CA-C 111.042 -0.823 . . . . 70.439999999999998 111.042 177.196 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.674 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 10.6 pt-20 . . . . . 0 N--CA 1.453 -0.314 0 N-CA-C 112.466 0.543 . . . . 74.340000000000003 112.466 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.717 ' HA ' HG21 ' A' ' 134' ' ' ILE . 2.6 tm-20 -61.63 -47.44 85.37 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.536 -0.756 . . . . 75.219999999999999 111.826 -173.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.461 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.0 p80 -63.6 -33.43 75.6 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.632 -0.427 . . . . 74.329999999999998 110.573 -177.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.674 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 35.6 m80 -63.75 -59.36 4.67 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.232 0.539 . . . . 72.400000000000006 111.085 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.634 HD12 HG11 ' A' ' 170' ' ' VAL . 4.5 mp -59.41 -48.14 82.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.276 -0.875 . . . . 75.450000000000003 110.938 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.437 ' HG3' HD12 ' A' ' 131' ' ' ILE . 6.2 ttp180 -63.68 -38.97 93.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.147 -0.479 . . . . 72.049999999999997 111.414 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -58.99 -31.15 68.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.088 0.471 . . . . 75.200000000000003 110.987 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.594 ' CD1' HG22 ' A' ' 170' ' ' VAL . 59.4 t80 -93.03 -48.15 6.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.897 -0.592 . . . . 62.43 111.525 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.438 ' HA ' ' HD2' ' A' ' 128' ' ' TYR . 43.6 m-85 -76.07 -11.82 60.01 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.519 0.563 . . . . 72.209999999999994 112.519 -172.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.48 -25.16 67.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.674 0.273 . . . . 75.5 111.506 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -73.9 -23.11 59.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.017 0.437 . . . . 70.0 110.65 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.438 ' HD2' ' HA ' ' A' ' 125' ' ' PHE . 91.0 m-85 -81.42 -29.14 33.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 74.129999999999995 110.561 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.428 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 168.59 -156.4 27.78 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.085 -1.055 . . . . 75.120000000000005 113.223 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.492 ' HA ' ' HE3' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -86.17 114.91 23.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.359 0.599 . . . . 73.439999999999998 110.994 -177.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.49 HG21 HD11 ' A' ' 134' ' ' ILE . 27.4 mt -89.14 135.01 26.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.355 -0.839 . . . . 71.219999999999999 110.068 176.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 154' ' ' ASP . 29.2 mt-10 -78.61 -69.22 0.58 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.84 -0.429 . . . . 64.420000000000002 109.84 174.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.1 m -148.56 157.27 7.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.971 -0.559 . . . . 74.5 110.085 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.717 HG21 ' HA ' ' A' ' 118' ' ' GLU . 22.9 mm -104.71 107.63 22.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.571 -0.529 . . . . 71.420000000000002 109.571 175.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -90.68 91.7 8.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.842 -0.617 . . . . 72.450000000000003 110.449 -174.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.567 HD11 ' H ' ' A' ' 118' ' ' GLU . 21.3 mt -74.94 121.51 26.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.858 -0.793 . . . . 74.409999999999997 108.858 176.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.6 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.314 0 N-CA-C 108.767 -0.827 . . . . 73.209999999999994 108.767 178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.6 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 18.1 p90 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.82 0.343 . . . . 73.340000000000003 111.175 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.03 162.2 36.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.984 0.421 . . . . 60.140000000000001 111.3 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.477 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 49.6 m-85 -125.96 146.02 50.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.947 -0.57 . . . . 65.420000000000002 109.905 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.608 HG13 ' CD1' ' A' ' 134' ' ' ILE . 39.1 t -118.65 111.74 35.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 110.12 -0.326 . . . . 71.030000000000001 110.12 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.631 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 19.5 m -89.69 126.71 35.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.116 -0.493 . . . . 75.0 110.683 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.507 ' CD2' HG22 ' A' ' 159' ' ' VAL . 97.8 m-85 -110.97 145.95 37.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.435 -0.348 . . . . 62.450000000000003 110.306 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.516 ' N ' ' HG3' ' A' ' 132' ' ' GLU . 9.4 t70 -65.52 -29.93 70.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 73.109999999999999 110.747 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 159' ' ' VAL . 6.1 t70 -125.72 142.83 51.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.863 -0.608 . . . . 73.319999999999993 110.497 -174.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.485 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.4 p-80 -75.75 -16.99 60.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.098 -0.501 . . . . 74.530000000000001 110.909 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.53 -38.01 68.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.999 0.428 . . . . 51.210000000000001 109.983 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.428 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 13.6 m -64.84 -28.98 69.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.734 -0.666 . . . . 62.119999999999997 110.19 177.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.812 HG21 ' HA ' ' A' ' 105' ' ' LYS . 14.8 t -76.04 -34.67 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.444 -0.798 . . . . 75.109999999999999 110.516 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -52.18 -56.18 16.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.549 -0.75 . . . . 72.430000000000007 112.397 -176.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -9.7 29.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.753 0.311 . . . . 72.140000000000001 111.834 -176.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.486 HG22 HG11 ' A' ' 177' ' ' VAL . 84.4 mt -96.46 -50.11 11.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.391 -0.368 . . . . 74.430000000000007 111.019 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.435 HG13 HG12 ' A' ' 159' ' ' VAL . 34.6 m -72.13 -19.1 19.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.422 0.527 . . . . 71.430000000000007 112.422 -174.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.5 pp -68.86 -30.3 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 70.040000000000006 111.495 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.49 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 16.9 pt20 -106.06 167.78 9.57 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.613 -0.514 . . . . 72.230000000000004 109.613 175.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.552 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 83.8 tttt -109.18 -58.78 1.98 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.996 0.427 . . . . 62.140000000000001 110.662 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 21.4 m-85 -78.34 118.3 20.39 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.878 -0.601 . . . . 72.349999999999994 111.27 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.49 ' NE2' ' HG3' ' A' ' 165' ' ' GLN . 38.3 m-70 -118.07 151.54 37.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.25 -0.886 . . . . 62.439999999999998 110.046 177.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 m -93.81 84.99 4.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.991 0.424 . . . . 65.519999999999996 110.769 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.634 HG11 HD12 ' A' ' 121' ' ' LEU . 11.2 t -113.77 137.1 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.874 -0.417 . . . . 70.109999999999999 109.874 -178.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 57.2 t30 61.32 24.54 14.63 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.716 0.769 . . . . 61.409999999999997 109.889 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 69.47 25.0 75.91 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.573 -0.74 . . . . 73.140000000000001 112.208 -177.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -131.62 150.07 52.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.871 0.367 . . . . 64.329999999999998 110.556 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . 0.45 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 8.9 t30 -85.1 97.66 9.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.987 -0.551 . . . . 55.420000000000002 110.047 176.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 46.2 m -105.67 177.47 4.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.278 -0.419 . . . . 71.340000000000003 111.042 -176.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.552 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 12.6 tt0 -112.54 136.43 52.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.292 -0.413 . . . . 74.109999999999999 110.66 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.486 HG11 HG22 ' A' ' 162' ' ' ILE . 70.6 t -127.48 138.14 55.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.146 -0.479 . . . . 44.310000000000002 111.105 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 60.2 mtt180 -130.22 175.86 8.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 73.140000000000001 110.129 178.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.409 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 11.4 mptt -76.52 121.31 22.95 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.432 -0.951 . . . . 44.130000000000003 108.432 171.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.462 ' HB2' ' C ' ' A' ' 107' ' ' ILE . . . -79.96 100.04 7.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.105 0.479 . . . . 72.120000000000005 111.911 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.766 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.2 pt? -99.29 141.18 32.4 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.822 -0.806 . . . . 53.509999999999998 108.822 172.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.53 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 51.8 m -59.64 156.15 14.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.632 0.254 . . . . 74.230000000000004 111.337 -173.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.473 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.8 pttp -65.74 -25.74 67.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.962 0.411 . . . . 71.319999999999993 110.832 -175.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -36.63 59.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.282 0.563 . . . . 42.030000000000001 110.112 175.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.53 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 48.7 mt-10 -75.95 -42.96 46.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.792 -0.64 . . . . 64.329999999999998 110.595 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.678 ' HB3' ' HG ' ' A' ' 181' ' ' LEU . 22.5 ptm . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 116.134 -0.484 . . . . 51.240000000000002 110.387 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 p . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 109.229 -0.656 . . . . 63.119999999999997 109.229 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -119.88 19.32 12.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.402 0.62 . . . . 63.310000000000002 110.677 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.601 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 6.7 ttpm? -157.88 138.91 13.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.32 -0.854 . . . . 74.219999999999999 109.603 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.579 HD13 HG21 ' A' ' 162' ' ' ILE . 15.6 pt -107.14 165.27 4.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.096 0.474 . . . . 64.510000000000005 110.873 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 38.4 t80 -114.38 116.28 28.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.524 -0.762 . . . . 73.340000000000003 109.877 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 44.8 t -105.09 111.92 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.993 -0.373 . . . . 64.099999999999994 109.993 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.851 0 C-N-CA 120.608 -0.806 . . . . 74.099999999999994 112.385 -178.653 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.668 ' N ' ' HD1' ' A' ' 120' ' ' HIS . 11.4 pt-20 . . . . . 0 CA--C 1.534 0.342 0 N-CA-C 110.344 -0.243 . . . . 63.310000000000002 110.344 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.595 ' HA ' HG21 ' A' ' 134' ' ' ILE . 12.2 tt0 -54.75 -49.85 69.85 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.413 0.523 . . . . 63.130000000000003 112.413 -175.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.427 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.4 p80 -65.2 -29.07 69.85 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.794 -0.362 . . . . 73.239999999999995 110.675 -174.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' HIS . . . . . 0.668 ' HD1' ' N ' ' A' ' 117' ' ' GLU . 38.5 m80 -65.44 -52.59 52.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.004 0.43 . . . . 73.349999999999994 110.759 179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.52 -46.87 77.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 34.140000000000001 110.423 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.74 -48.49 79.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.103 -0.498 . . . . 75.450000000000003 111.309 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.36 -31.15 67.34 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.11 0.481 . . . . 43.310000000000002 111.116 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.465 ' CD1' HG22 ' A' ' 170' ' ' VAL . 31.2 t80 -83.88 -42.1 16.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.956 -0.565 . . . . 70.219999999999999 111.337 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -88.44 -16.43 32.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.645 0.609 . . . . 63.340000000000003 112.645 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -22.2 66.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.08 0.467 . . . . 64.430000000000007 110.874 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -70.14 -26.71 64.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.752 -0.658 . . . . 65.310000000000002 110.349 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' TYR . . . . . 0.499 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 57.6 m-85 -81.64 -38.56 25.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.646 -0.706 . . . . 74.400000000000006 111.272 -176.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -174.64 -155.84 13.0 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.118 -1.039 . . . . 63.329999999999998 112.888 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -91.86 119.17 31.4 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.42 0.628 . . . . 62.399999999999999 111.179 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.478 HG12 ' CE1' ' A' ' 153' ' ' PHE . 41.3 mt -95.86 137.79 23.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.262 -0.881 . . . . 61.409999999999997 110.103 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 154' ' ' ASP . 18.0 mt-10 -84.06 -73.34 0.42 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.334 -0.394 . . . . 55.329999999999998 110.533 174.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.1 m -143.29 163.25 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.082 -0.508 . . . . 63.240000000000002 110.072 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.595 HG21 ' HA ' ' A' ' 118' ' ' GLU . 26.7 mm -111.68 108.67 26.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.101 0.477 . . . . 72.319999999999993 109.843 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 30.5 mm-40 -84.69 91.43 7.93 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.608 -0.723 . . . . 70.049999999999997 110.466 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.552 HD11 ' CB ' ' A' ' 118' ' ' GLU . 16.9 mt -81.79 108.18 14.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.999 -0.741 . . . . 74.340000000000003 108.999 176.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' MET . . . . . 0.58 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.405 0 N-CA-C 108.773 -0.825 . . . . 73.219999999999999 108.773 179.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.58 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 11.2 p90 . . . . . 0 C--O 1.233 0.199 0 CA-C-O 121.028 0.442 . . . . 74.409999999999997 111.627 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.35 156.85 46.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 62.219999999999999 110.734 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 49.2 m-85 -121.59 125.4 46.65 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.025 -0.534 . . . . 64.239999999999995 110.061 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.572 HG13 ' CD1' ' A' ' 134' ' ' ILE . 30.9 t -100.08 109.07 24.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 110.076 -0.342 . . . . 74.150000000000006 110.076 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' THR . . . . . 0.601 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 27.7 m -85.56 125.16 32.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.18 -0.464 . . . . 73.329999999999998 110.32 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.554 ' CD2' HG12 ' A' ' 159' ' ' VAL . 98.0 m-85 -109.41 149.93 28.81 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.539 -0.541 . . . . 74.099999999999994 109.539 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.472 ' N ' ' HG3' ' A' ' 132' ' ' GLU . 20.9 t70 -68.73 -26.73 65.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.033 0.444 . . . . 71.319999999999993 110.912 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -129.95 150.7 51.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.286 -0.416 . . . . 70.310000000000002 111.184 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' HIS . . . . . 0.575 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.5 p-80 -83.28 -6.59 59.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.847 -0.615 . . . . 61.5 110.855 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -72.53 -40.71 66.54 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.654 -0.498 . . . . 63.329999999999998 109.654 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.7 m -63.92 -31.54 72.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.636 -0.711 . . . . 73.329999999999998 111.506 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 156' ' ' HIS . 5.7 m -78.03 -23.15 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 121.054 -0.258 . . . . 60.520000000000003 111.285 -175.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.79 -45.23 90.65 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 116.657 -0.247 . . . . 72.209999999999994 111.306 -173.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' LYS . . . . . 0.499 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.0 OUTLIER -62.03 -18.76 61.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.175 0.512 . . . . 72.239999999999995 110.68 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ILE . . . . . 0.579 HG21 HD13 ' A' ' 107' ' ' ILE . 72.3 mt -97.71 -54.69 6.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.618 -0.719 . . . . 75.450000000000003 111.527 -174.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.467 ' HB ' ' HG2' ' A' ' 179' ' ' LYS . 33.6 m -66.13 -19.83 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.452 0.538 . . . . 62.43 112.452 -172.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.449 HD12 ' HB2' ' A' ' 165' ' ' GLN . 2.6 pp -69.12 -24.75 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.32 0.581 . . . . 75.209999999999994 110.707 176.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLN . . . . . 0.479 ' HB3' ' NE2' ' A' ' 168' ' ' HIS . 23.0 tt0 -108.52 140.85 41.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.177 -0.919 . . . . 74.120000000000005 109.626 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.563 ' HE3' ' OE1' ' A' ' 176' ' ' GLU . 82.4 tttt -93.77 -61.69 1.5 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.794 0.33 . . . . 64.200000000000003 110.776 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -74.04 114.58 12.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.139 -0.482 . . . . 72.329999999999998 110.905 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.479 ' NE2' ' HB3' ' A' ' 165' ' ' GLN . 30.3 m-70 -120.99 162.25 20.23 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.642 -0.708 . . . . 72.420000000000002 109.257 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 11.7 m -118.09 102.27 8.89 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.468 -0.493 . . . . 75.150000000000006 111.218 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.465 HG22 ' CD1' ' A' ' 124' ' ' TYR . 47.5 t -111.51 130.0 65.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.813 -0.63 . . . . 65.540000000000006 109.508 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 62.54 23.59 14.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.609 0.718 . . . . 73.340000000000003 110.445 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 78.24 11.06 85.72 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.896 -0.669 . . . . 33.240000000000002 112.488 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -111.68 135.43 52.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.901 0.381 . . . . 70.540000000000006 110.521 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.88 114.91 13.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.922 -0.581 . . . . 42.520000000000003 110.441 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.32 169.16 13.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.964 0.411 . . . . 72.299999999999997 110.953 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.563 ' OE1' ' HE3' ' A' ' 166' ' ' LYS . 15.1 tt0 -108.85 127.37 53.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.896 -0.593 . . . . 71.019999999999996 109.548 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.6 m -117.88 144.9 24.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.391 -0.524 . . . . 73.010000000000005 110.543 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 66.5 mtt180 -132.75 -179.36 5.42 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.056 -0.52 . . . . 61.149999999999999 109.818 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.467 ' HG2' ' HB ' ' A' ' 163' ' ' VAL . 38.4 mtpt -81.2 119.09 23.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.964 -1.125 . . . . 72.409999999999997 107.964 170.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -70.17 95.06 0.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.902 0.382 . . . . 74.25 111.513 -175.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.571 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.5 pt? -92.98 144.96 24.74 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.368 -0.604 . . . . 71.549999999999997 109.368 175.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.421 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 7.5 m -53.83 142.54 23.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.141 -0.481 . . . . 52.340000000000003 110.96 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.661 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 18.8 pttp -59.88 -22.66 62.63 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.048 0.451 . . . . 73.140000000000001 110.524 177.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -64.26 -52.96 56.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.666 . . . . 75.239999999999995 110.275 171.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' GLU . . . . . 0.421 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 35.7 mt-10 -68.42 -41.35 80.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.38 -0.827 . . . . 63.229999999999997 111.021 -176.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' MET . . . . . 0.661 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 20.7 ptm . . . . . 0 C--N 1.327 -0.408 0 CA-C-N 115.891 -0.595 . . . . 55.200000000000003 111.163 -175.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.475 0.789 0 N-CA-C 109.805 -0.443 . . . . 43.140000000000001 109.805 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -105.14 -21.58 13.24 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.137 -0.483 . . . . 71.310000000000002 111.131 -173.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.443 ' HB3' ' HB2' ' A' ' 100' ' ' ALA . 0.1 OUTLIER 61.72 95.26 0.05 OUTLIER Pre-proline 0 N--CA 1.464 0.254 0 O-C-N 123.686 0.616 . . . . 72.109999999999999 109.713 -169.175 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.499 ' HB3' HD13 ' A' ' 181' ' ' LEU . 32.2 Cg_exo -58.81 102.37 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 123.142 2.561 . . . . 62.299999999999997 112.625 -175.006 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 65.44 55.05 22.82 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.806 -0.711 . . . . 63.310000000000002 111.669 -179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 97' ' ' ARG . . . -66.18 -36.16 82.35 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.973 0.416 . . . . 74.430000000000007 111.019 -177.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 2.5 p80 -79.68 -4.87 53.69 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.887 -0.597 . . . . 64.349999999999994 110.712 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 51.5 mt -101.68 144.88 29.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.99 -0.55 . . . . 75.430000000000007 110.49 -177.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 16.8 p -84.01 126.63 33.23 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.266 -0.424 . . . . 41.32 110.178 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.472 ' O ' HG21 ' A' ' 159' ' ' VAL . 9.1 p -118.64 155.01 20.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.881 -0.414 . . . . 64.340000000000003 109.881 -177.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 22.7 mtmt -128.56 18.69 6.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.168 0.509 . . . . 75.239999999999995 111.291 -178.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.584 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 23.6 ttpt -151.15 131.69 13.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.814 -0.63 . . . . 75.299999999999997 109.608 176.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.509 HG13 ' HB ' ' A' ' 151' ' ' VAL . 2.1 pp -106.43 153.55 7.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.21 -0.45 . . . . 72.120000000000005 110.397 -179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.516 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 81.9 t80 -103.25 130.53 50.52 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.978 -0.555 . . . . 74.129999999999995 110.276 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 11.7 t -111.09 110.17 31.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.294 -0.412 . . . . 72.340000000000003 110.436 178.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -121.72 165.22 14.67 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.205 -0.758 . . . . 61.149999999999999 111.205 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.543 ' H ' " C5'" ' B' ' 2' ' ' ' C' . . . 81.31 10.37 84.75 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.747 -0.739 . . . . 62.009999999999998 112.786 178.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.659 HG13 " H5'" ' B' ' 1' ' ' ' U' . 16.9 pt -71.11 89.64 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.473 0.654 . . . . 73.129999999999995 111.22 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -79.01 -30.15 44.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.103 -0.499 . . . . 75.530000000000001 110.08 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -83.19 151.62 25.6 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.971 -0.558 . . . . 61.539999999999999 109.901 175.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -68.61 90.22 0.39 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.484 0.659 . . . . 73.340000000000003 110.155 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.2 m -101.87 136.23 42.07 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.162 -0.926 . . . . 73.019999999999996 110.204 -177.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.432 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 8.1 pt-20 -125.79 -168.86 1.91 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.863 0.363 . . . . 71.109999999999999 110.854 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.695 ' HA ' HG21 ' A' ' 134' ' ' ILE . 13.3 tt0 -56.29 -50.25 71.95 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.449 -0.796 . . . . 75.030000000000001 112.41 -178.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -65.53 -33.65 76.41 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.877 -0.329 . . . . 74.129999999999995 110.665 -174.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.485 ' CD2' HD22 ' A' ' 171' ' ' ASN . 40.9 m80 -63.0 -53.64 50.86 Favored 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.012 0.434 . . . . 70.120000000000005 110.631 178.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.584 HD23 HG11 ' A' ' 170' ' ' VAL . 97.6 mt -62.25 -48.59 79.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.523 -0.762 . . . . 74.319999999999993 110.937 -177.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.4 ttp180 -59.47 -40.88 88.37 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.252 -0.431 . . . . 73.109999999999999 110.985 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -59.47 -30.39 68.49 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.99 0.424 . . . . 72.319999999999993 111.278 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 90.1 t80 -88.92 -47.37 8.2 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.408 -0.36 . . . . 65.109999999999999 111.346 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.408 ' CD1' HG21 ' A' ' 151' ' ' VAL . 53.1 m-85 -77.54 -14.63 59.62 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.308 0.484 . . . . 75.319999999999993 112.308 -172.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -65.3 -24.02 67.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.747 0.308 . . . . 75.219999999999999 111.414 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -65.24 -25.73 67.8 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 121.221 0.534 . . . . 74.329999999999998 110.641 177.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.495 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 88.5 m-85 -86.01 -37.84 18.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.675 -0.693 . . . . 61.229999999999997 111.148 -177.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 177.44 -166.77 37.43 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.012 -1.089 . . . . 60.009999999999998 113.422 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.569 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 38.3 tptt -75.78 118.78 18.95 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.4 0.619 . . . . 63.340000000000003 111.464 -177.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.505 HG21 HD11 ' A' ' 134' ' ' ILE . 34.3 mt -97.49 139.93 18.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.378 -0.828 . . . . 72.140000000000001 110.41 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 6.7 mm-40 -89.12 -71.2 0.61 Allowed 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.317 -0.401 . . . . 52.399999999999999 111.237 175.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 m -139.47 157.42 27.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 120.645 0.259 . . . . 64.400000000000006 110.57 -177.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.695 HG21 ' HA ' ' A' ' 118' ' ' GLU . 17.7 mm -113.02 111.64 37.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 109.174 -0.676 . . . . 71.109999999999999 109.174 176.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 22.4 mm-40 -90.27 95.0 9.98 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.988 -0.551 . . . . 74.329999999999998 110.786 -175.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.565 HD11 ' H ' ' A' ' 118' ' ' GLU . 11.1 mt -80.69 87.35 1.53 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.01 -1.107 . . . . 65.209999999999994 108.01 173.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 11.2 tpt -68.41 103.48 1.65 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.581 0.705 . . . . 72.420000000000002 111.252 -170.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.0 p -77.64 160.82 28.26 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.053 -0.976 . . . . 64.219999999999999 110.886 177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.531 ' HA ' ' HD2' ' A' ' 146' ' ' ARG . 25.6 t70 -65.86 135.99 55.55 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.672 -0.695 . . . . 55.149999999999999 110.137 175.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.56 ' HG2' ' C6 ' ' B' ' 5' ' ' ' U' . 0.0 OUTLIER -86.26 5.48 34.2 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.786 -0.643 . . . . 73.140000000000001 111.846 -176.437 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -111.11 -57.98 0.48 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.935 -0.65 . . . . 43.049999999999997 111.786 176.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 34.2 t -91.31 -28.57 17.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.95 0.405 . . . . 71.010000000000005 110.957 -177.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 79.61 53.63 4.26 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.405 -0.902 . . . . 63.340000000000003 111.319 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 57.7 pttt -131.7 170.47 14.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.901 -0.777 . . . . 75.209999999999994 108.901 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -69.69 103.93 2.27 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.243 -0.651 . . . . 71.209999999999994 109.243 176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.531 ' HD2' ' HA ' ' A' ' 139' ' ' ASP . 52.4 ttt180 -67.46 -25.97 66.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.575 -0.739 . . . . 72.319999999999993 112.215 -168.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.976 ' HA3' " H2'" ' B' ' 1' ' ' ' U' . . . 134.19 -11.82 4.72 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.018 -1.086 . . . . 64.319999999999993 113.139 178.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.578 ' CE2' " H4'" ' B' ' 3' ' ' ' A' . 40.6 p90 -139.24 160.5 39.66 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.818 0.309 . . . . 72.129999999999995 111.004 -177.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -144.42 165.78 26.97 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.994 -0.548 . . . . 72.230000000000004 110.193 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.562 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 42.2 m-85 -129.64 150.67 50.86 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.947 -0.39 . . . . 61.310000000000002 109.947 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.57 HG13 ' CD1' ' A' ' 134' ' ' ILE . 59.0 t -122.9 112.38 33.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 N-CA-C 109.981 -0.377 . . . . 63.310000000000002 109.981 176.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.584 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 26.1 m -88.08 127.52 35.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.027 -0.533 . . . . 74.120000000000005 110.591 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.514 ' CD2' HG12 ' A' ' 159' ' ' VAL . 92.4 m-85 -109.59 152.24 25.77 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.143 -0.317 . . . . 52.409999999999997 110.143 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.569 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 31.9 t70 -75.34 -18.31 60.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.225 0.536 . . . . 71.040000000000006 110.547 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.477 ' OD2' ' HB3' ' A' ' 157' ' ' ASP . 24.0 t70 -132.61 153.21 51.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.618 -0.719 . . . . 75.040000000000006 111.123 -177.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.41 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.1 p-80 -95.53 5.03 52.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.26 -0.427 . . . . 74.109999999999999 111.883 -178.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.477 ' HB3' ' OD2' ' A' ' 155' ' ' ASP . 13.2 t70 -91.81 -37.23 13.07 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.506 -0.553 . . . . 73.120000000000005 109.506 171.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 16.5 m -58.6 -27.59 64.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.749 -0.66 . . . . 64.510000000000005 110.901 177.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.514 HG12 ' CD2' ' A' ' 153' ' ' PHE . 13.0 m -80.42 -20.99 11.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 75.340000000000003 111.367 -179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.35 -38.4 71.63 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 120.691 0.281 . . . . 71.409999999999997 110.672 -169.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.495 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.1 mptp? -65.03 -19.22 65.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.302 0.572 . . . . 74.200000000000003 110.68 177.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 81.9 mt -96.78 -53.62 7.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.573 -0.739 . . . . 75.230000000000004 111.227 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.518 ' HB ' ' HG2' ' A' ' 179' ' ' LYS . 35.3 m -64.56 -20.82 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.586 0.587 . . . . 61.119999999999997 112.586 -172.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -69.74 -28.41 37.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.888 0.375 . . . . 74.329999999999998 111.072 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -105.16 142.19 35.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.004 -0.544 . . . . 71.319999999999993 109.655 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.441 ' CE ' ' HG3' ' A' ' 176' ' ' GLU . 87.4 tttt -87.04 -71.39 0.56 Allowed 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 121.033 -0.267 . . . . 75.299999999999997 110.997 -178.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.62 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 3.7 m-85 -79.19 116.62 19.57 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.207 0.527 . . . . 72.409999999999997 111.971 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 45.9 m-70 -117.51 140.63 49.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.19 -0.914 . . . . 63.310000000000002 109.492 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 174' ' ' ASN . 57.4 m -92.37 109.28 20.66 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-O 121.089 0.471 . . . . 62.420000000000002 111.232 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.584 HG11 HD23 ' A' ' 121' ' ' LEU . 43.3 t -120.06 136.27 57.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.928 -0.578 . . . . 72.109999999999999 109.464 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.485 HD22 ' CD2' ' A' ' 120' ' ' HIS . 23.5 t-20 70.57 -12.84 0.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 122.929 0.491 . . . . 73.319999999999993 111.497 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.405 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 122.2 -3.62 10.5 Favored Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 111.514 -0.634 . . . . 73.049999999999997 111.514 -177.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -112.34 138.68 48.72 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.662 -0.496 . . . . 73.349999999999994 109.662 179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 169' ' ' THR . 60.0 t30 -88.65 103.8 16.26 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.755 -0.461 . . . . 74.140000000000001 109.755 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 34.0 m -106.77 173.16 6.44 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.058 -0.519 . . . . 60.530000000000001 110.76 -174.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.441 ' HG3' ' CE ' ' A' ' 166' ' ' LYS . 9.0 tt0 -97.58 123.92 41.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.11 0.481 . . . . 74.019999999999996 110.756 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 48.4 t -118.84 131.13 72.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 115.926 -0.579 . . . . 71.120000000000005 110.475 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -144.34 173.38 11.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.857 -0.611 . . . . 74.540000000000006 109.842 177.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.518 ' HG2' ' HB ' ' A' ' 163' ' ' VAL . 31.9 mtpt -68.54 125.62 27.07 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.685 -0.487 . . . . 74.530000000000001 109.685 -178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.556 ' HA ' ' C2 ' ' B' ' 3' ' ' ' A' . . . -81.01 89.68 5.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.911 0.386 . . . . 62.409999999999997 111.482 -175.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.693 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.3 pt? -86.4 141.99 28.76 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.875 -0.602 . . . . 73.230000000000004 109.41 175.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.473 ' HB3' ' HG3' ' A' ' 185' ' ' GLU . 30.0 t -58.0 152.7 15.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.482 -0.326 . . . . 70.400000000000006 110.804 -178.167 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.565 ' CE ' " H3'" ' B' ' 4' ' ' ' G' . 22.1 pttp -60.07 -21.9 62.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.173 0.511 . . . . 72.030000000000001 110.368 176.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.499 ' HA ' ' C4 ' ' B' ' 6' ' ' ' U' . 0.6 OUTLIER -69.49 -49.32 55.87 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.542 -0.754 . . . . 71.230000000000004 109.197 174.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.473 ' HG3' ' HB3' ' A' ' 182' ' ' SER . 30.0 mt-10 -73.38 -37.97 65.82 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.209 -0.905 . . . . 74.109999999999999 111.138 -176.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.51 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 21.7 ptm -63.6 -23.84 67.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.252 -0.431 . . . . 71.319999999999993 111.129 -175.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -75.53 -48.26 23.26 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.25 0.547 . . . . 64.420000000000002 109.767 177.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.9 m -65.9 -45.68 81.11 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.483 -0.78 . . . . 52.420000000000002 110.861 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.27 -33.94 76.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.204 -0.453 . . . . 73.219999999999999 111.559 -177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 6.1 t -75.96 -40.23 54.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.272 -0.422 . . . . 64.430000000000007 110.194 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 27.9 t -66.8 -39.19 87.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.265 -0.425 . . . . 74.219999999999999 110.442 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 194' ' ' ARG . 8.6 t -92.74 24.52 3.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.087 -0.506 . . . . 53.340000000000003 110.594 -178.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -61.31 116.51 4.68 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 109.648 -0.501 . . . . 72.340000000000003 109.648 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 192' ' ' SER . 14.7 mmt180 -114.77 141.75 47.45 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.282 0.563 . . . . 72.420000000000002 112.196 -173.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -129.09 163.23 22.46 Favored Glycine 0 N--CA 1.443 -0.845 0 CA-C-N 115.22 -0.9 . . . . 23.239999999999998 111.04 175.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.0 tmm_? . . . . . 0 C--O 1.244 0.796 0 CA-C-O 118.434 -0.793 . . . . 70.230000000000004 109.524 -178.822 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 1.07 " C3'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.43 -0.654 0 O5'-C5'-C4' 111.69 1.064 . 0.0 '__' . 74.120000000000005 . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 1.07 H5'' " C3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.891 0 C4'-C3'-C2' 105.303 2.603 OUTLIER-EPSILON 0.0 OUTLIER alpha 71.239999999999995 . . . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.691 ' H8 ' H5'' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.886 0 P-O3'-C3' 122.477 2.315 . 0.0 OUTLIER epsilon-1 74.010000000000005 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.565 " H3'" ' CE ' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.427 -0.823 0 C4'-C3'-C2' 103.669 0.969 . 0.0 OUTLIER alpha 75.109999999999999 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.677 ' H6 ' ' P ' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.953 0 C4'-C3'-C2' 104.263 1.563 . 0.0 OUTLIER gamma 74.239999999999995 . . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.499 ' C4 ' ' HA ' ' A' ' 184' ' ' GLN . . . . . . . . 0 O5'--C5' 1.426 -0.876 0 C3'-C2'-C1' 100.676 -0.916 . 0.0 OUTLIER gamma 73.239999999999995 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.476 0.842 0 N-CA-C 109.916 -0.401 . . . . 74.019999999999996 109.916 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 10.8 mm100 -84.8 -38.7 19.25 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.485 -0.561 . . . . 74.219999999999999 109.485 178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 81.3 mtt180 -123.95 96.1 43.13 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.537 -0.756 . . . . 74.129999999999995 109.03 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.442 ' HG3' HD22 ' A' ' 181' ' ' LEU . 86.4 Cg_endo -84.34 37.49 0.63 Allowed 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 123.225 2.616 . . . . 72.329999999999998 113.291 -169.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 158.01 60.37 0.01 OUTLIER Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.784 -0.722 . . . . 62.039999999999999 111.668 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.86 -31.98 70.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.873 0.368 . . . . 61.219999999999999 111.021 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -88.3 8.85 25.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.96 -0.564 . . . . 73.319999999999993 110.805 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 69.9 mt -114.77 149.87 36.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.252 -0.431 . . . . 63.340000000000003 110.732 -176.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 11.5 p -93.04 117.39 30.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.059 -0.518 . . . . 73.030000000000001 110.815 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.628 HG13 HG11 ' A' ' 159' ' ' VAL . 11.5 p -111.71 143.31 21.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.656 -0.498 . . . . 73.230000000000004 109.656 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.484 ' N ' ' HE3' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -104.49 -6.34 20.73 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.736 0.303 . . . . 73.25 111.81 -175.038 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.725 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.0 ttpt -133.99 140.73 46.91 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.86 -0.422 . . . . 72.450000000000003 109.86 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.615 ' CG2' HG13 ' A' ' 159' ' ' VAL . 4.9 pt -108.07 158.03 8.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.991 0.424 . . . . 63.439999999999998 110.973 179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.445 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 46.8 t80 -107.72 121.61 45.05 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.469 -0.787 . . . . 73.540000000000006 109.296 177.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 5.7 t -105.21 102.46 13.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.864 0.364 . . . . 74.239999999999995 110.902 -178.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.5 ' HA2' H5'' ' B' ' 2' ' ' ' C' . . . -112.37 -177.6 19.88 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.849 -0.9 . . . . 61.439999999999998 110.849 175.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.451 ' H ' ' H6 ' ' B' ' 2' ' ' ' C' . . . 61.84 34.83 90.09 Favored Glycine 0 C--O 1.226 -0.352 0 C-N-CA 120.83 -0.7 . . . . 73.140000000000001 112.631 179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.592 HD11 ' O ' ' A' ' 147' ' ' GLY . 31.7 pt -102.87 -171.77 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.87 0.366 . . . . 73.109999999999999 111.319 -176.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.677 ' HA ' ' HE3' ' A' ' 113' ' ' LYS . 1.1 tpmt? -91.2 177.02 6.37 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.166 -0.47 . . . . 54.43 109.736 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.663 ' H ' ' HG3' ' A' ' 113' ' ' LYS . 10.9 mp0 -64.52 -44.62 90.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.061 0.458 . . . . 63.240000000000002 110.531 177.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -104.79 100.36 9.99 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.89 -0.595 . . . . 75.109999999999999 110.602 -177.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 31.7 m -145.6 120.87 10.22 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.092 -0.707 . . . . 73.099999999999994 109.092 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.419 ' CG ' ' HD2' ' A' ' 119' ' ' HIS . 11.5 pt-20 -120.1 -170.79 2.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.48 -0.327 . . . . 64.200000000000003 111.363 -173.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.738 ' HA ' HG21 ' A' ' 134' ' ' ILE . 10.9 tt0 -58.96 -45.46 90.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.882 -0.599 . . . . 75.140000000000001 112.242 -174.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.419 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -64.22 -30.33 71.39 Favored 'General case' 0 C--O 1.224 -0.284 0 C-N-CA 120.491 -0.484 . . . . 74.129999999999995 110.176 -176.42 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.407 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 34.3 m80 -64.38 -56.6 13.28 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.471 -0.331 . . . . 73.219999999999999 110.529 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.534 HD13 HG11 ' A' ' 170' ' ' VAL . 1.7 mm? -60.32 -51.9 67.54 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.233 -0.439 . . . . 73.439999999999998 110.737 178.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.4 tpp180 -58.29 -53.51 57.47 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.847 -0.615 . . . . 65.439999999999998 111.439 -175.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -57.73 -28.34 63.79 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.066 0.46 . . . . 73.109999999999999 111.843 -175.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 41.5 t80 -86.24 -43.16 13.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.939 0.4 . . . . 62.030000000000001 111.299 178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.428 ' CD1' HG21 ' A' ' 151' ' ' VAL . 41.8 m-85 -86.84 -15.5 38.96 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 112.718 0.636 . . . . 45.219999999999999 112.718 -172.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.41 -22.22 66.23 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.342 0.591 . . . . 71.400000000000006 110.352 177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -69.28 -19.11 63.91 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.264 -0.88 . . . . 74.25 110.479 177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.446 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 66.7 m-85 -90.63 -34.8 15.31 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.873 -0.603 . . . . 75.299999999999997 110.819 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 174.82 -168.02 40.46 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.072 -1.061 . . . . 74.25 113.299 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -74.91 116.78 16.02 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.528 0.68 . . . . 64.209999999999994 111.573 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.482 HG21 HD11 ' A' ' 134' ' ' ILE . 40.8 mt -94.76 139.63 18.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.194 -0.912 . . . . 73.310000000000002 110.401 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -84.2 -73.03 0.44 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.889 -0.596 . . . . 74.209999999999994 110.67 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.6 m -141.81 152.17 18.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.352 -0.386 . . . . 74.5 110.57 -178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.738 HG21 ' HA ' ' A' ' 118' ' ' GLU . 31.7 mm -105.22 107.92 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.489 -0.56 . . . . 71.439999999999998 109.489 176.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.48 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 57.7 mt-10 -89.58 96.49 10.72 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.332 0.586 . . . . 64.450000000000003 110.611 -176.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.6 mt -80.04 128.28 38.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.589 -0.732 . . . . 74.219999999999999 109.497 178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.497 ' HE1' " O3'" ' B' ' 4' ' ' ' G' . 22.1 tpp -78.87 102.91 8.46 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.352 0.596 . . . . 73.109999999999999 110.341 178.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.583 ' HB ' ' HA2' ' A' ' 143' ' ' GLY . 4.6 p -102.39 168.11 9.53 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.182 -0.917 . . . . 64.099999999999994 111.331 -179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.587 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 16.2 t70 -55.88 140.34 42.93 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.726 -0.472 . . . . 64.519999999999996 109.726 176.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.53 ' HD3' " H2'" ' B' ' 5' ' ' ' U' . 22.4 tpt180 -61.93 -21.2 64.56 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 123.427 0.455 . . . . 60.109999999999999 111.68 -172.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -119.36 -49.04 0.33 Allowed Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.403 -0.904 . . . . 62.130000000000003 113.002 -179.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.408 ' HB2' ' HG3' ' A' ' 144' ' ' LYS . 19.6 m -88.62 -11.88 44.17 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.059 0.392 . . . . 60.219999999999999 112.059 -172.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.583 ' HA2' ' HB ' ' A' ' 138' ' ' THR . . . 66.57 44.24 90.36 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.84 -0.695 . . . . 74.010000000000005 113.002 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.507 ' H ' ' HB3' ' A' ' 139' ' ' ASP . 27.8 mtmt -96.29 144.54 26.38 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.807 -0.442 . . . . 63.32 109.807 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -59.97 108.93 0.84 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.096 0.474 . . . . 42.219999999999999 109.927 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.02 -63.31 1.39 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.569 -0.741 . . . . 74.109999999999999 110.461 -174.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.592 ' O ' HD11 ' A' ' 112' ' ' ILE . . . -170.83 -96.97 0.1 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 120.539 -0.839 . . . . 52.240000000000002 111.95 -175.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.564 ' HB3' " O5'" ' B' ' 2' ' ' ' C' . 41.8 p90 -65.69 164.55 14.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.187 0.517 . . . . 73.340000000000003 111.847 -176.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -145.13 169.16 18.69 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.793 -0.64 . . . . 63.229999999999997 110.333 178.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.557 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 73.1 m-85 -130.84 145.01 51.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.066 -0.515 . . . . 73.439999999999998 110.297 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.608 HG13 ' CD1' ' A' ' 134' ' ' ILE . 15.8 t -120.52 108.33 22.75 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 N-CA-C 109.738 -0.467 . . . . 54.210000000000001 109.738 179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.725 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 62.7 m -88.64 123.84 33.49 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.527 -0.306 . . . . 62.329999999999998 110.289 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.527 ' CD2' HG22 ' A' ' 159' ' ' VAL . 90.8 m-85 -105.5 153.3 21.93 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.831 -0.433 . . . . 75.430000000000007 109.831 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -69.28 -30.81 69.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.364 0.602 . . . . 71.530000000000001 110.334 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.443 ' O ' HG23 ' A' ' 159' ' ' VAL . 5.0 t70 -122.36 145.54 48.16 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.416 -0.811 . . . . 72.230000000000004 110.185 -175.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -82.4 -13.58 56.59 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.291 -0.413 . . . . 71.329999999999998 110.907 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -72.96 -43.87 61.77 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.064 0.459 . . . . 51.43 110.506 -178.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.6 m -63.16 -28.11 69.83 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.758 -0.655 . . . . 70.129999999999995 110.468 176.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.628 HG11 HG13 ' A' ' 104' ' ' VAL . 29.1 t -70.99 -36.61 64.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.722 -0.672 . . . . 75.230000000000004 110.185 177.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.524 ' HA ' HG22 ' A' ' 163' ' ' VAL . 21.0 t70 -59.98 -36.46 77.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.724 -0.671 . . . . 74.530000000000001 110.86 -178.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.446 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 38.0 mmtt -60.68 -24.96 66.01 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.545 0.688 . . . . 73.129999999999995 110.222 178.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.544 HG21 HD13 ' A' ' 107' ' ' ILE . 86.3 mt -95.51 -50.39 11.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.142 -0.935 . . . . 63.119999999999997 111.338 -173.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.609 ' HB ' ' HG2' ' A' ' 179' ' ' LYS . 19.8 m -68.96 -17.53 22.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 112.469 0.544 . . . . 54.409999999999997 112.469 -173.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.469 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.2 pp -68.01 -29.92 46.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.013 0.375 . . . . 71.239999999999995 112.013 -179.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -110.26 174.58 5.8 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.465 -0.568 . . . . 74.120000000000005 109.465 173.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.573 ' HE3' ' HG3' ' A' ' 176' ' ' GLU . 53.2 tttp -114.65 -60.95 1.82 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.75 0.309 . . . . 73.329999999999998 111.224 -173.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.549 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 11.8 m-30 -77.06 104.17 7.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.448 0.642 . . . . 73.049999999999997 111.249 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.409 ' CE1' HG23 ' A' ' 162' ' ' ILE . 9.2 m-70 -102.27 173.16 6.49 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.097 -0.956 . . . . 75.510000000000005 109.988 178.242 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.522 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 28.1 m -124.48 98.56 5.79 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.081 0.467 . . . . 74.420000000000002 111.076 -178.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.534 HG11 HD13 ' A' ' 121' ' ' LEU . 58.2 t -109.52 131.8 59.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.603 -0.518 . . . . 74.340000000000003 109.603 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 63.67 14.94 8.56 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.588 0.709 . . . . 72.219999999999999 110.475 -178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.09 -4.64 81.34 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.851 -0.69 . . . . 62.450000000000003 112.413 -177.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.522 ' O ' ' HA ' ' A' ' 169' ' ' THR . 39.6 m80 -98.73 157.37 16.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.814 0.34 . . . . 64.420000000000002 110.512 -177.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 47.1 t-20 -84.74 118.48 24.46 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.059 -0.519 . . . . 74.400000000000006 109.724 178.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.549 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 36.8 m -118.38 173.47 6.8 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.833 -0.621 . . . . 64.209999999999994 110.305 -177.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.573 ' HG3' ' HE3' ' A' ' 166' ' ' LYS . 1.3 tm-20 -130.24 114.68 15.96 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.571 -0.529 . . . . 63.299999999999997 109.571 -177.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.428 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 2.3 m -113.71 147.34 17.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.202 0.525 . . . . 63.409999999999997 111.671 -171.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.457 ' NH2' ' C2 ' ' B' ' 2' ' ' ' C' . 64.6 mtt180 -134.2 172.09 13.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.715 -0.675 . . . . 73.109999999999999 110.643 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.609 ' HG2' ' HB ' ' A' ' 163' ' ' VAL . 28.6 mtpt -77.9 111.52 13.83 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.361 -0.978 . . . . 72.109999999999999 108.361 172.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.701 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -72.04 107.67 4.86 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.287 0.565 . . . . 64.129999999999995 112.32 -172.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -101.24 134.18 44.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.468 -0.787 . . . . 73.430000000000007 109.061 173.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 26.4 m -47.64 135.37 11.57 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 123.386 0.429 . . . . 63.43 111.535 -177.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.8 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 16.2 pttp -56.93 -32.48 66.01 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.175 -0.466 . . . . 72.209999999999994 111.203 -178.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -59.44 -34.4 72.47 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.888 -0.596 . . . . 71.310000000000002 110.458 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -93.0 -37.16 12.34 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.516 -0.766 . . . . 74.319999999999993 110.886 -176.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.8 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 25.3 ptm -63.66 -24.3 67.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.595 -0.275 . . . . 72.450000000000003 110.822 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.59 -36.9 79.33 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.079 0.466 . . . . 61.119999999999997 110.269 177.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 16.1 m -85.55 -36.86 20.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.749 -0.659 . . . . 55.109999999999999 110.922 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -70.2 -45.25 66.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.05 -0.523 . . . . 74.329999999999998 111.786 -174.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 28.6 m -72.94 122.28 21.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.54 -0.755 . . . . 51.43 111.682 -173.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 61.7 m -89.1 175.53 7.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.989 -0.55 . . . . 62.43 110.171 176.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 20.0 m -83.01 57.88 4.13 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.117 0.484 . . . . 72.299999999999997 110.545 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.53 ' OE1' ' HD2' ' A' ' 194' ' ' ARG . 6.6 tp-100 -155.27 120.78 4.99 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.096 -0.502 . . . . 64.400000000000006 110.447 -179.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.55 ' H ' ' HD2' ' A' ' 194' ' ' ARG . 0.0 OUTLIER -67.21 111.36 3.91 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.481 0.658 . . . . 60.509999999999998 110.181 177.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 117.17 -29.03 6.95 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.648 -0.705 . . . . 71.409999999999997 111.621 -176.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 196' ' ' ARG . 46.7 mtm180 . . . . . 0 C--O 1.252 1.215 0 CA-C-O 118.072 -0.966 . . . . 71.209999999999994 110.337 178.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 1.011 " H4'" " H5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.739 0 O4'-C4'-C3' 103.283 -1.584 OUTLIER-EPSILON 0.0 '__' . 71.109999999999999 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 1.011 " H5'" " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.97 0 C4'-C3'-C2' 105.571 2.871 . 0.0 OUTLIER epsilon-1 72.310000000000002 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.701 ' N1 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.426 -0.85 0 C4'-C3'-C2' 104.571 1.871 . 0.0 OUTLIER alpha 73.310000000000002 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.569 " C2'" ' HE3' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.425 -0.939 0 C3'-C2'-C1' 100.534 -1.074 . 0.0 OUTLIER alpha 73.010000000000005 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.587 ' O4 ' ' HA ' ' A' ' 139' ' ' ASP . . . . . . . . 0 O5'--C5' 1.423 -1.046 0 O4'-C1'-C2' 108.051 1.179 . 0.0 OUTLIER . 73.540000000000006 . . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.533 " H3'" ' HD2' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 C3'-C2'-C1' 104.102 2.891 . 0.0 OUTLIER . 73.209999999999994 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.3 p . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 110.107 -0.331 . . . . 71.209999999999994 110.107 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -79.07 90.86 4.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.104 0.478 . . . . 65.239999999999995 110.435 -176.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -115.48 94.17 38.97 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.758 -0.655 . . . . 73.430000000000007 110.509 177.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -89.66 153.85 5.19 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.913 2.408 . . . . 64.219999999999999 112.494 -178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.565 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 72.19 31.55 63.78 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.919 -0.657 . . . . 52.509999999999998 112.865 177.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -82.95 -27.79 30.27 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.317 0.58 . . . . 74.230000000000004 110.904 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -97.87 20.02 12.82 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.519 -0.764 . . . . 74.25 110.082 178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.565 HD12 ' HA2' ' A' ' 99' ' ' GLY . 44.6 mt -134.16 144.27 48.41 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.098 -0.501 . . . . 52.229999999999997 111.201 -174.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.6 p -84.94 101.4 12.31 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.186 -0.672 . . . . 74.409999999999997 109.186 169.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.442 HG11 ' CG ' ' A' ' 179' ' ' LYS . 13.0 p -102.32 142.8 15.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.666 -0.697 . . . . 74.200000000000003 110.439 -172.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.775 ' HA ' HG21 ' A' ' 159' ' ' VAL . 25.7 mtmt -119.29 -1.76 10.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.162 -0.472 . . . . 64.340000000000003 111.449 -177.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.635 ' HE3' ' O6 ' ' B' ' 4' ' ' ' G' . 28.6 ttpt -124.78 133.9 52.97 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.072 0.463 . . . . 74.439999999999998 109.936 176.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.529 HG12 ' HB ' ' A' ' 151' ' ' VAL . 10.5 pt -107.43 162.99 5.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 115.908 -0.587 . . . . 55.119999999999997 111.036 -178.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 55.9 t80 -113.74 119.28 36.85 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.53 -0.759 . . . . 72.150000000000006 109.884 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 16.3 t -109.85 106.41 20.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.147 -0.479 . . . . 65.439999999999998 109.878 177.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -117.78 159.9 13.96 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.901 -0.666 . . . . 75.409999999999997 112.068 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.431 ' HA2' ' P ' ' B' ' 2' ' ' ' C' . . . 83.18 20.05 61.47 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.482 -0.866 . . . . 71.239999999999995 112.287 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.586 HG22 ' SG ' ' A' ' 175' ' ' CYS . 18.6 pt -84.52 175.46 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.849 0.357 . . . . 75.200000000000003 110.302 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -93.58 162.99 13.73 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.921 -0.4 . . . . 65.409999999999997 109.921 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -69.2 -13.06 62.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.01 0.434 . . . . 74.209999999999994 110.405 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -77.2 -25.36 51.66 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.754 -0.657 . . . . 44.299999999999997 110.231 175.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 23.2 m -74.84 124.63 27.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.778 -0.646 . . . . 74.420000000000002 110.993 -175.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.426 ' CG ' ' HD2' ' A' ' 119' ' ' HIS . 12.6 pt-20 -130.84 -170.54 2.37 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.338 -0.392 . . . . 73.400000000000006 110.544 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.596 ' HA ' HG21 ' A' ' 134' ' ' ILE . 8.0 tt0 -52.52 -50.63 62.43 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.485 0.55 . . . . 71.430000000000007 112.485 -175.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.426 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 1.3 p80 -63.36 -27.23 69.17 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 121.15 -0.22 . . . . 75.120000000000005 110.864 -175.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.552 ' CD2' HD22 ' A' ' 171' ' ' ASN . 35.5 m80 -68.53 -50.03 55.1 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.829 -0.169 . . . . 71.040000000000006 110.726 179.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.495 HD13 HG11 ' A' ' 170' ' ' VAL . 1.2 mm? -60.4 -51.69 68.42 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 109.644 -0.502 . . . . 75.319999999999993 109.644 175.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 4.0 tpp180 -55.21 -50.37 69.58 Favored 'General case' 0 C--O 1.22 -0.481 0 CA-C-N 115.542 -0.753 . . . . 74.239999999999995 111.285 -178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -54.35 -36.12 63.49 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.89 0.376 . . . . 65.209999999999994 112.012 -177.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -84.64 -39.93 18.05 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.384 -0.371 . . . . 74.310000000000002 111.15 -177.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.428 ' CD1' HG21 ' A' ' 151' ' ' VAL . 50.9 m-85 -87.26 -17.05 33.43 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 112.461 0.541 . . . . 72.200000000000003 112.461 -173.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.44 -20.82 64.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.836 0.351 . . . . 73.140000000000001 111.923 -178.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -77.78 -16.44 58.37 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.024 0.44 . . . . 72.230000000000004 110.562 179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.5 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 52.9 m-85 -85.01 -41.28 15.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.086 -0.506 . . . . 73.349999999999994 110.279 178.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.44 ' HA3' ' CB ' ' A' ' 158' ' ' SER . . . -172.21 -170.11 35.71 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.987 -0.625 . . . . 62.299999999999997 112.151 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -79.59 122.06 26.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.384 0.612 . . . . 71.099999999999994 111.508 -178.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.529 HG21 HD11 ' A' ' 134' ' ' ILE . 43.5 mt -95.84 138.43 21.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.33 -0.85 . . . . 50.340000000000003 110.837 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -81.37 -76.65 0.24 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.665 -0.698 . . . . 73.329999999999998 110.362 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 23.2 m -141.48 161.27 21.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.347 -0.388 . . . . 71.409999999999997 110.47 -178.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.613 ' CD1' HG13 ' A' ' 151' ' ' VAL . 23.1 mm -116.42 122.7 70.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 110.03 -0.359 . . . . 75.230000000000004 110.03 176.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -104.46 121.54 43.65 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.79 -0.448 . . . . 71.310000000000002 109.79 177.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 9.7 mt -95.61 -8.43 9.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.706 0.289 . . . . 72.030000000000001 110.797 -176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.424 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 8.5 tpp 51.32 67.91 0.88 Allowed 'General case' 0 C--O 1.235 0.31 0 CA-C-O 122.113 0.958 . . . . 65.319999999999993 110.208 -177.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.518 HG22 ' HA ' ' A' ' 145' ' ' LYS . 7.4 p -80.91 164.38 22.65 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.549 -1.205 . . . . 53.119999999999997 112.025 -174.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.587 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 16.8 t70 -49.04 139.18 10.84 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.609 -0.723 . . . . 71.319999999999993 110.242 173.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.571 ' HD3' ' C6 ' ' B' ' 5' ' ' ' U' . 15.7 tpt180 -71.57 -12.04 61.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.388 -0.369 . . . . 72.349999999999994 111.285 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -114.47 -57.74 0.38 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.6 -0.809 . . . . 60.140000000000001 112.979 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.539 ' CB ' ' HE3' ' A' ' 144' ' ' LYS . 5.1 m -88.64 -27.69 21.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.902 0.382 . . . . 70.299999999999997 111.802 -171.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.18 41.91 6.07 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.492 -0.861 . . . . 54.43 112.14 -176.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.563 ' H ' ' HB3' ' A' ' 139' ' ' ASP . 27.4 mmtp -77.2 127.43 32.62 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.099 -0.704 . . . . 62.340000000000003 109.099 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.518 ' HA ' HG22 ' A' ' 138' ' ' THR . 96.3 mttt -73.82 113.9 11.49 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.064 0.459 . . . . 73.329999999999998 109.96 -179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.516 ' HG2' ' CE2' ' A' ' 148' ' ' PHE . 0.1 OUTLIER -70.24 170.95 10.64 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 115.262 -0.881 . . . . 70.239999999999995 111.877 -171.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.581 ' HA3' " O4'" ' B' ' 1' ' ' ' U' . . . -87.66 17.97 41.54 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.975 -0.557 . . . . 72.019999999999996 112.587 179.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.516 ' CE2' ' HG2' ' A' ' 146' ' ' ARG . 48.8 p90 -150.76 141.7 22.94 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.797 -0.816 . . . . 71.420000000000002 108.797 173.114 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -139.52 172.92 12.11 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.089 0.471 . . . . 61.420000000000002 111.141 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.411 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 58.4 m-85 -131.78 136.98 47.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.624 -0.716 . . . . 62.219999999999999 109.85 -177.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.613 HG13 ' CD1' ' A' ' 134' ' ' ILE . 42.2 t -116.06 110.37 31.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 116.379 -0.373 . . . . 71.019999999999996 110.315 -179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.613 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 9.0 m -87.05 125.45 34.12 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.386 -0.37 . . . . 60.310000000000002 110.094 178.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.464 ' CE1' HG12 ' A' ' 131' ' ' ILE . 98.2 m-85 -105.75 150.39 25.57 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 120.756 0.312 . . . . 71.439999999999998 110.175 178.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -69.73 -22.55 63.37 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.033 -0.531 . . . . 63.32 111.059 179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -136.77 144.86 43.98 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.896 -0.593 . . . . 73.519999999999996 109.711 -178.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.538 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.5 p-80 -75.46 -12.88 60.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.881 0.372 . . . . 70.019999999999996 110.293 177.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.93 -46.36 88.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.017 -0.538 . . . . 61.219999999999999 110.18 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.44 ' CB ' ' HA3' ' A' ' 129' ' ' GLY . 11.7 m -62.87 -21.64 66.13 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.051 -0.522 . . . . 74.319999999999993 111.08 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.775 HG21 ' HA ' ' A' ' 105' ' ' LYS . 20.2 t -80.75 -29.77 11.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.768 -0.651 . . . . 73.209999999999994 111.138 -177.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -36.9 85.34 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.424 -0.353 . . . . 62.210000000000001 111.869 -172.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.5 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.5 mptp? -70.24 -16.48 63.05 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.265 0.555 . . . . 65.040000000000006 110.572 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.439 ' CG2' HG11 ' A' ' 177' ' ' VAL . 95.9 mt -100.54 -55.06 6.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.742 0 CA-C-N 115.65 -0.705 . . . . 55.210000000000001 111.731 -172.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.526 ' HB ' ' HE3' ' A' ' 179' ' ' LYS . 28.9 m -61.07 -21.98 25.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 112.903 0.705 . . . . 64.109999999999999 112.903 -174.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.437 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.4 pp -67.27 -29.57 46.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.017 0.437 . . . . 63.299999999999997 111.095 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -106.23 142.65 35.57 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.949 -0.569 . . . . 65.209999999999994 109.722 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.543 ' HE3' ' HG3' ' A' ' 176' ' ' GLU . 79.2 tttt -92.17 -71.67 0.63 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 121.057 -0.257 . . . . 72.239999999999995 111.065 -177.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.501 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 22.7 m-85 -78.59 108.81 12.26 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.132 0.491 . . . . 42.210000000000001 111.307 -177.313 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 -106.38 158.55 16.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.486 -0.779 . . . . 65.319999999999993 110.046 177.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 20.2 m -96.33 100.75 12.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.801 0.334 . . . . 71.5 110.788 177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.495 HG11 HD13 ' A' ' 121' ' ' LEU . 46.9 t -116.5 132.61 65.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 109.622 -0.51 . . . . 71.299999999999997 109.622 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.552 HD22 ' CD2' ' A' ' 120' ' ' HIS . 28.1 t-20 63.92 20.43 12.2 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-O 122.056 0.931 . . . . 71.510000000000005 109.834 -177.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 73.39 19.45 79.67 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.558 -0.746 . . . . 63.409999999999997 111.624 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 45.4 t-80 -125.22 149.59 47.83 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.768 -0.456 . . . . 74.120000000000005 109.768 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.474 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 9.9 t30 -86.19 117.3 24.93 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.884 0.373 . . . . 60.520000000000003 110.847 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.586 ' SG ' HG22 ' A' ' 112' ' ' ILE . 30.9 m -129.23 158.74 38.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.989 -0.55 . . . . 63.25 110.206 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.543 ' HG3' ' HE3' ' A' ' 166' ' ' LYS . 16.1 tt0 -89.98 135.17 33.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.945 0.402 . . . . 72.420000000000002 110.681 179.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.516 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 64.5 t -128.8 132.0 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 115.945 -0.57 . . . . 70.230000000000004 110.562 175.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.0 ptt180 -150.85 -177.63 6.11 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.525 -0.761 . . . . 70.349999999999994 109.452 176.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.526 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 9.2 mptt -68.47 130.32 42.54 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.859 -0.336 . . . . 72.129999999999995 110.345 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.765 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -86.33 92.85 8.93 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.864 0.364 . . . . 73.299999999999997 111.129 176.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.564 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -81.5 135.23 35.6 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.568 -0.53 . . . . 62.530000000000001 109.568 176.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.5 m -50.73 142.65 10.92 Favored 'General case' 0 C--N 1.33 -0.27 0 O-C-N 123.382 0.426 . . . . 75.340000000000003 111.387 -177.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.744 ' HE3' " C2'" ' B' ' 4' ' ' ' G' . 8.3 pttp -58.78 -31.69 68.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.064 0.459 . . . . 60.420000000000002 110.306 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -65.08 -37.7 88.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.601 -0.727 . . . . 60.310000000000002 110.522 177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -83.44 -37.17 23.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.551 -0.749 . . . . 53.539999999999999 111.09 -176.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.667 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 9.3 ptp -67.5 -22.06 65.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.848 0.356 . . . . 71.040000000000006 110.247 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.96 -25.17 66.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.935 -0.575 . . . . 74.219999999999999 110.454 176.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 11.2 m -93.08 -50.74 5.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.94 -0.573 . . . . 62.43 110.495 178.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -64.51 -52.98 55.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.083 -0.508 . . . . 74.439999999999998 111.338 -175.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.1 t -91.17 83.88 5.6 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.062 0.458 . . . . 62.340000000000003 110.042 -177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 79.8 p -156.27 146.0 21.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.876 -0.602 . . . . 71.519999999999996 110.075 -179.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 14.7 m -97.19 -63.34 1.14 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.45 -0.341 . . . . 51.329999999999998 110.456 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -138.58 116.47 11.59 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.352 -0.385 . . . . 72.5 110.574 178.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 35.5 ttm-85 -97.01 -52.57 3.81 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.307 -0.627 . . . . 73.319999999999993 109.307 175.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -132.96 -177.04 14.68 Favored Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.254 -0.884 . . . . 71.340000000000003 111.463 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.042 0 CA-C-O 118.53 -0.747 . . . . 64.530000000000001 109.705 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.581 " O4'" ' HA3' ' A' ' 147' ' ' GLY . . . . . . . . 0 O5'--C5' 1.431 -0.542 0 C3'-C2'-C1' 100.512 -1.098 . 0.0 '__' . 73.129999999999995 . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.523 " H4'" H5'' ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.088 0 C3'-C2'-C1' 103.328 2.031 . 0.0 OUTLIER . 71.129999999999995 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.989 ' H8 ' H5'' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.98 0 C3'-C2'-C1' 104.26 3.066 OUTLIER-EPSILON 0.0 OUTLIER . 74.540000000000006 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.97 ' OP1' " H4'" ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.908 0 C4'-C3'-C2' 106.152 3.452 . 0.0 OUTLIER epsilon-1 74.420000000000002 . . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.743 " H4'" ' OP2' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.046 0 C4'-C3'-C2' 105.796 3.096 OUTLIER-DELTA 0.0 OUTLIER gamma 75.420000000000002 . . . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.473 " O5'" ' HE2' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.424 -1.003 0 C4'-C3'-C2' 104.209 1.509 . 0.0 OUTLIER . 64.299999999999997 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.478 0.949 0 N-CA-C 110.241 -0.281 . . . . 72.420000000000002 110.241 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.618 ' HB3' ' HD3' ' A' ' 178' ' ' ARG . 9.6 mm-40 -88.81 -13.14 40.06 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.95 0.405 . . . . 64.310000000000002 110.692 -178.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 20.6 ptt180 -113.61 78.85 3.95 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.937 -0.574 . . . . 73.299999999999997 110.195 172.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 96' ' ' GLN . 1.9 Cg_endo -83.4 -1.83 10.35 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 123.266 2.644 . . . . 60.219999999999999 112.632 -175.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -133.96 56.75 0.71 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.97 -0.633 . . . . 65.230000000000004 111.555 179.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -72.93 -30.4 63.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.874 0.369 . . . . 62.310000000000002 111.157 -177.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.44 ' CD2' ' H ' ' A' ' 101' ' ' HIS . 3.1 p80 -79.41 -14.51 58.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.104 -0.498 . . . . 72.5 110.49 177.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 70.6 mt -86.88 138.28 31.69 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.976 -0.556 . . . . 72.310000000000002 110.367 -178.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.4 p -82.88 96.99 8.43 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.169 0.509 . . . . 72.25 109.981 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.48 HG22 ' H ' ' A' ' 106' ' ' LYS . 13.1 p -91.25 134.03 31.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 115.446 -0.797 . . . . 75.230000000000004 110.491 -175.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.537 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 12.2 mtmt -119.0 18.0 13.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.308 0.575 . . . . 73.010000000000005 110.776 -177.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.565 ' HE2' ' O6 ' ' B' ' 4' ' ' ' G' . 4.8 ttpm? -146.02 132.6 19.82 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.532 -0.758 . . . . 54.420000000000002 109.48 177.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.555 HG12 ' HB ' ' A' ' 151' ' ' VAL . 13.3 pt -103.64 164.04 3.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.108 0.48 . . . . 60.549999999999997 111.059 -178.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.56 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 63.5 t80 -114.07 113.65 25.04 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.428 -0.805 . . . . 73.340000000000003 110.009 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 26.5 t -104.54 97.95 6.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.114 -0.494 . . . . 74.450000000000003 110.034 177.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -108.76 142.27 16.05 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.685 -0.769 . . . . 45.340000000000003 112.566 -176.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.763 ' N ' " H5'" ' B' ' 2' ' ' ' C' . . . 106.73 25.84 6.08 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.593 -0.813 . . . . 54.310000000000002 112.222 177.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.535 HG22 ' SG ' ' A' ' 175' ' ' CYS . 20.6 pt -100.59 151.17 5.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.981 0.42 . . . . 75.209999999999994 110.748 -177.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.402 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 0.5 OUTLIER -119.62 -154.72 0.59 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.409 -0.589 . . . . 74.120000000000005 109.409 177.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.402 ' H ' ' HB3' ' A' ' 113' ' ' LYS . 30.7 mm-40 -57.15 -23.46 47.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.055 0.455 . . . . 63.530000000000001 110.73 177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -55.81 -43.94 77.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.257 -0.883 . . . . 71.239999999999995 112.792 -177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.7 m -109.64 136.32 49.19 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 112.569 0.581 . . . . 73.409999999999997 112.569 -167.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.469 ' O ' HD22 ' A' ' 121' ' ' LEU . 10.6 pt-20 -138.23 -168.58 2.4 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.01 -0.541 . . . . 63.409999999999997 109.893 174.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.614 ' HA ' HG21 ' A' ' 134' ' ' ILE . 16.4 tt0 -55.2 -50.01 70.48 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.773 0.657 . . . . 71.450000000000003 112.773 -174.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.425 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.2 p80 -63.24 -27.29 69.25 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.753 -0.379 . . . . 74.549999999999997 110.694 -176.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -70.17 -51.53 30.48 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.318 -0.401 . . . . 70.329999999999998 110.356 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.562 HD13 HG11 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -58.59 -49.29 78.01 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 116.262 -0.426 . . . . 53.229999999999997 110.286 178.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -59.01 -53.62 56.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.745 -0.662 . . . . 71.25 111.717 -176.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 51.3 m-20 -59.99 -29.17 68.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.762 0.315 . . . . 73.340000000000003 111.702 -175.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.431 ' CD1' HG22 ' A' ' 170' ' ' VAL . 90.4 t80 -83.09 -43.42 16.28 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.499 -0.319 . . . . 72.340000000000003 110.966 179.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.435 ' CD1' HG21 ' A' ' 151' ' ' VAL . 46.0 m-85 -87.02 -15.3 39.08 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 112.729 0.64 . . . . 74.230000000000004 112.729 -173.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -22.12 66.51 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.088 0.471 . . . . 72.420000000000002 110.589 178.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -65.93 -31.06 71.76 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.761 -0.654 . . . . 64.439999999999998 110.082 175.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -80.85 -27.52 36.4 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.498 -0.773 . . . . 62.240000000000002 111.37 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.07 -166.84 39.75 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.352 -0.928 . . . . 74.310000000000002 112.689 177.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -80.68 120.45 24.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-O 121.326 0.584 . . . . 74.129999999999995 110.959 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.553 HG21 HD11 ' A' ' 134' ' ' ILE . 43.1 mt -93.28 141.38 14.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.46 -0.791 . . . . 70.430000000000007 110.572 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -85.9 -71.19 0.55 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.699 -0.682 . . . . 70.109999999999999 110.451 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 31.3 m -143.5 160.99 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.387 -0.369 . . . . 61.439999999999998 110.656 -178.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.614 HG21 ' HA ' ' A' ' 118' ' ' GLU . 18.8 mm -116.41 128.95 73.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.946 0.403 . . . . 63.32 110.275 176.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 59.8 mm-40 -115.28 115.2 26.26 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.857 -0.61 . . . . 75.530000000000001 109.733 177.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 19.0 mt -84.04 -11.52 11.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-O 121.058 0.456 . . . . 75.109999999999999 110.363 -177.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.447 ' HB3' ' O ' ' A' ' 148' ' ' PHE . 21.4 tpp 54.87 70.41 0.63 Allowed 'General case' 0 C--O 1.237 0.43 0 CA-C-O 122.325 1.059 . . . . 64.310000000000002 110.173 -174.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.0 p -92.27 152.55 19.76 Favored 'General case' 0 N--CA 1.438 -1.04 0 CA-C-N 114.513 -1.222 . . . . 72.209999999999994 109.72 174.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -53.71 119.38 4.86 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.092 -0.706 . . . . 72.540000000000006 109.092 175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.808 ' HD2' " H3'" ' B' ' 6' ' ' ' U' . 0.0 OUTLIER -77.16 15.53 0.7 Allowed 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 112.133 0.42 . . . . 62.399999999999999 112.133 -172.403 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -128.91 -45.44 0.19 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.104 -0.57 . . . . 53.030000000000001 111.69 173.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.468 ' HB2' ' HG2' ' A' ' 144' ' ' LYS . 32.1 m -90.01 -26.47 20.32 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.678 0.275 . . . . 75.209999999999994 111.522 -179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.91 50.88 9.88 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 121.106 -0.568 . . . . 72.010000000000005 112.414 -178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.468 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 12.0 ptpt -127.41 143.39 51.22 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.931 -0.396 . . . . 72.209999999999994 109.931 -179.306 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.467 ' HD3' ' H ' ' A' ' 145' ' ' LYS . 3.6 mppt? -64.47 131.62 47.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.687 0.279 . . . . 72.329999999999998 110.754 -178.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -84.38 -26.24 28.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.808 0.337 . . . . 73.120000000000005 111.055 -179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.512 ' HA3' " O4'" ' B' ' 1' ' ' ' U' . . . 120.11 -6.07 12.13 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.133 -1.032 . . . . 72.25 113.541 175.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.447 ' O ' ' HB3' ' A' ' 137' ' ' MET . 38.3 p90 -135.2 135.75 41.25 Favored 'General case' 0 C--N 1.318 -0.764 0 O-C-N 122.424 -0.457 . . . . 73.150000000000006 109.856 174.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -121.53 169.45 10.65 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.192 0.52 . . . . 72.140000000000001 111.055 -176.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 58.0 m-85 -135.49 128.89 32.23 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.541 -0.754 . . . . 74.409999999999997 109.574 -178.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.604 HG13 ' CD1' ' A' ' 134' ' ' ILE . 29.7 t -108.82 110.24 31.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.862 0 N-CA-C 109.755 -0.461 . . . . 73.219999999999999 109.755 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.431 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 16.4 m -86.47 125.35 33.66 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.451 -0.34 . . . . 74.129999999999995 110.272 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.555 ' CD2' HG12 ' A' ' 159' ' ' VAL . 97.1 m-85 -108.79 156.52 19.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.804 0.335 . . . . 73.140000000000001 110.279 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -70.21 -24.08 63.05 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.879 -0.6 . . . . 75.040000000000006 110.861 175.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -133.95 150.12 51.28 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.078 -0.51 . . . . 74.340000000000003 111.188 -173.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.55 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.5 p-80 -88.57 -5.13 58.38 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.053 -0.521 . . . . 75.420000000000002 110.723 177.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -73.39 -42.72 61.79 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.16 0.505 . . . . 71.319999999999993 110.119 174.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.7 m -63.85 -33.13 75.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.528 -0.76 . . . . 34.409999999999997 111.428 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.555 HG12 ' CD2' ' A' ' 153' ' ' PHE . 4.7 m -72.82 -22.24 19.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.501 -0.318 . . . . 74.349999999999994 110.987 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.416 ' HA ' HG22 ' A' ' 163' ' ' VAL . 33.2 t70 -63.84 -44.97 91.59 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.319 -0.4 . . . . 74.150000000000006 111.395 -174.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.43 -8.28 31.91 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-O 121.178 0.513 . . . . 71.540000000000006 110.508 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.507 HG21 HD13 ' A' ' 107' ' ' ILE . 69.6 mt -100.83 -50.04 10.64 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.665 -0.698 . . . . 64.519999999999996 110.688 -178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.416 HG22 ' HA ' ' A' ' 160' ' ' ASP . 27.0 m -73.37 -15.43 17.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.675 -0.693 . . . . 73.150000000000006 112.77 -175.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.5 pp -67.91 -30.05 46.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.85 0.357 . . . . 53.439999999999998 110.979 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.423 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 15.5 pt20 -105.52 -173.37 2.28 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.684 -0.487 . . . . 72.409999999999997 109.684 173.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.471 ' HE3' ' HG3' ' A' ' 176' ' ' GLU . 46.6 tttp -127.42 -69.37 0.75 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.706 0.288 . . . . 62.009999999999998 110.56 -176.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 13.6 m-30 -70.89 120.28 16.25 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.912 0.387 . . . . 71.310000000000002 110.681 178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.44 ' CE1' HG23 ' A' ' 162' ' ' ILE . 28.1 m-70 -116.62 141.56 48.03 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.812 -0.631 . . . . 75.319999999999993 110.006 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 17.5 m -93.52 81.96 4.38 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.249 0.547 . . . . 75.239999999999995 110.585 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.562 HG11 HD13 ' A' ' 121' ' ' LEU . 22.0 t -96.33 122.15 47.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.875 -0.602 . . . . 72.400000000000006 109.744 -179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 60.9 t30 63.39 16.37 9.48 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.866 0.841 . . . . 75.430000000000007 110.248 -176.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 87.5 -3.55 86.35 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.955 -0.641 . . . . 21.129999999999999 111.866 -176.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -88.77 150.42 22.95 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.611 -0.514 . . . . 75.209999999999994 109.611 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -97.34 103.51 15.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.871 0.367 . . . . 75.239999999999995 110.442 179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.535 ' SG ' HG22 ' A' ' 112' ' ' ILE . 31.2 m -116.74 155.08 29.51 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.153 -0.476 . . . . 65.140000000000001 110.436 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.471 ' HG3' ' HE3' ' A' ' 166' ' ' LYS . 11.4 tt0 -94.3 125.46 38.96 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.718 -0.475 . . . . 62.130000000000003 109.718 177.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 51.1 t -121.39 134.38 64.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-O 121.106 0.479 . . . . 74.310000000000002 111.258 -179.024 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.618 ' HD3' ' HB3' ' A' ' 96' ' ' GLN . 2.3 ptt180 -146.21 -176.97 5.37 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.46 -0.791 . . . . 73.299999999999997 108.911 174.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.423 ' HE3' HG11 ' A' ' 104' ' ' VAL . 2.5 ptpp? -75.32 126.93 32.03 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.532 -0.467 . . . . 64.010000000000005 110.756 178.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.714 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -79.61 101.66 8.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.963 -0.562 . . . . 33.409999999999997 111.07 -178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.712 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -94.24 138.45 32.23 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 109.01 -0.737 . . . . 64.239999999999995 109.01 174.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.456 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 4.3 m -50.97 140.32 15.74 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.55 0.531 . . . . 74.319999999999993 110.773 -176.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.764 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.7 pttp -62.57 -22.63 66.5 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.876 0.369 . . . . 74.25 110.856 -177.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -66.79 -42.3 86.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.868 -0.606 . . . . 73.340000000000003 109.728 173.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.456 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 35.1 mt-10 -77.1 -38.45 52.25 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.757 -0.656 . . . . 71.219999999999999 110.664 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.764 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 19.8 ptm -68.23 -17.22 64.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.354 -0.385 . . . . 74.349999999999994 110.791 -177.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -67.79 -32.2 72.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.293 0.568 . . . . 65.040000000000006 109.776 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.0 t -83.16 -36.0 25.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.402 -0.817 . . . . 62.450000000000003 109.788 176.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' A' ' 186' ' ' MET . . . -64.16 -38.46 91.13 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.564 -0.744 . . . . 53.420000000000002 111.191 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 69.3 m -76.25 112.45 12.74 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.262 -0.881 . . . . 73.430000000000007 111.192 -177.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.7 m -81.78 -19.53 41.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.833 -0.621 . . . . 73.319999999999993 109.757 175.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 11.4 p -86.78 116.93 25.19 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.68 -0.691 . . . . 72.400000000000006 110.074 176.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -85.11 156.02 21.24 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.055 -0.52 . . . . 60.109999999999999 110.828 -175.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -81.73 -44.45 17.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.728 -0.841 . . . . 71.5 108.728 174.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 68.51 -175.63 29.38 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 114.806 -1.088 . . . . 74.209999999999994 113.191 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? . . . . . 0 C--O 1.245 0.846 0 N-CA-C 108.29 -1.004 . . . . 65.430000000000007 108.29 175.632 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 1.066 " C4'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.732 0 C3'-C2'-C1' 99.926 -1.749 . 0.0 '__' . 73.519999999999996 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 1.066 H5'' " C4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.901 0 O4'-C4'-C3' 103.438 -1.473 . 0.0 OUTLIER '7D dist 6p' 74.209999999999994 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.725 " H2'" ' SD ' ' A' ' 186' ' ' MET . . . . . . . . 0 O5'--C5' 1.424 -1.002 0 O4'-C4'-C3' 103.481 -1.442 . 0.0 OUTLIER . 72.239999999999995 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.583 " H3'" ' HD3' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.423 -1.04 0 C4'-C3'-C2' 104.599 1.899 . 0.0 OUTLIER alpha 73.109999999999999 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 1.061 " H4'" " H5'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.419 -1.312 0 C3'-C2'-C1' 102.938 1.598 . 0.0 OUTLIER gamma 72.540000000000006 . . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 1.061 " H5'" " H4'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.06 0 O4'-C1'-C2' 107.908 1.077 . 0.0 OUTLIER gamma 74.129999999999995 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.476 0.871 0 CA-C-O 121.198 0.523 . . . . 64.530000000000001 110.28 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.633 ' NE2' ' HG2' ' A' ' 178' ' ' ARG . 6.0 pt20 -118.65 100.38 7.39 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.799 -0.637 . . . . 75.099999999999994 110.277 178.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.765 ' HD3' ' HB2' ' A' ' 100' ' ' ALA . 5.5 ppt_? -147.69 149.43 33.64 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.62 -0.718 . . . . 73.420000000000002 111.173 -174.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 97' ' ' ARG . 5.6 Cg_endo -87.7 -81.54 0.0 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 122.555 2.17 . . . . 75.010000000000005 110.265 167.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.07 103.13 2.68 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.879 -0.889 . . . . 72.0 110.879 172.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.765 ' HB2' ' HD3' ' A' ' 97' ' ' ARG . . . -80.24 -19.2 47.41 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 70.319999999999993 111.168 -175.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -83.46 -9.02 59.26 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.131 -0.486 . . . . 74.430000000000007 110.479 178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 84.8 mt -81.77 123.91 29.18 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.877 -0.601 . . . . 53.439999999999998 109.577 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.7 p -77.46 97.78 5.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.542 0.687 . . . . 75.25 111.583 -178.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.485 HG22 ' H ' ' A' ' 106' ' ' LYS . 12.8 p -90.62 144.51 8.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.991 -1.004 . . . . 54.539999999999999 109.598 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.574 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 19.8 mtmt -121.37 9.04 10.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.171 0.51 . . . . 73.150000000000006 111.578 -176.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.638 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 28.6 ttpt -138.58 135.97 35.52 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.915 -0.584 . . . . 63.009999999999998 109.466 175.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.594 HD13 HG21 ' A' ' 162' ' ' ILE . 6.7 pt -107.31 159.28 6.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.943 0.402 . . . . 74.530000000000001 110.638 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.515 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 57.1 t80 -108.43 115.18 29.63 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.847 -0.615 . . . . 63.549999999999997 109.847 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 4.7 t -102.77 103.48 15.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 109.796 -0.446 . . . . 74.030000000000001 109.796 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -113.87 161.95 12.54 Favored Glycine 0 N--CA 1.443 -0.839 0 CA-C-N 115.858 -0.61 . . . . 23.309999999999999 111.974 -177.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.474 ' HA2' ' OP2' ' B' ' 2' ' ' ' C' . . . 73.28 30.28 62.95 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.55 -0.833 . . . . 73.420000000000002 112.285 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.461 ' HA ' ' SG ' ' A' ' 175' ' ' CYS . 40.2 pt -95.58 -179.22 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.059 0.457 . . . . 60.009999999999998 110.765 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.874 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -98.68 159.96 14.6 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 108.843 -0.799 . . . . 74.219999999999999 108.843 178.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.591 ' OE2' ' HG3' ' A' ' 113' ' ' LYS . 0.6 OUTLIER -76.18 -6.04 49.48 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.093 0.473 . . . . 72.239999999999995 110.196 179.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -82.62 -34.33 27.62 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.69 -0.686 . . . . 73.420000000000002 110.084 176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 13.8 m -67.09 129.96 41.57 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 115.704 -0.68 . . . . 75.439999999999998 111.173 -179.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.512 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 11.9 pt-20 -134.7 -162.0 1.21 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.767 0.318 . . . . 71.219999999999999 111.644 -178.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.686 ' HG2' ' CG1' ' A' ' 134' ' ' ILE . 3.1 tm-20 -55.28 -54.75 39.56 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 115.634 -0.712 . . . . 60.530000000000001 111.714 -175.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -63.2 -31.02 72.07 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.961 -0.296 . . . . 74.239999999999995 111.089 -175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.512 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 65.3 m80 -63.46 -60.32 3.52 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-O 121.261 0.553 . . . . 73.109999999999999 110.539 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.538 ' HA ' HG21 ' A' ' 170' ' ' VAL . 89.0 mt -61.41 -44.13 97.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.337 -0.847 . . . . 54.310000000000002 110.602 -177.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.547 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 0.5 OUTLIER -60.21 -42.63 95.54 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.674 -0.694 . . . . 65.019999999999996 110.846 -179.958 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -58.1 -32.9 68.54 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.271 0.557 . . . . 75.430000000000007 111.438 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 43.9 t80 -88.2 -43.46 11.6 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.708 -0.678 . . . . 64.109999999999999 111.668 -177.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 43.1 m-85 -83.74 -15.03 50.12 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 112.596 0.591 . . . . 73.209999999999994 112.596 -173.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.8 -19.45 65.09 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.115 0.484 . . . . 45.509999999999998 111.394 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.8 mt-30 -69.56 -25.15 63.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.867 -0.606 . . . . 70.25 110.441 177.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.48 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 80.2 m-85 -86.44 -32.06 21.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.898 -0.592 . . . . 70.299999999999997 110.368 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.594 ' HA3' ' HB3' ' A' ' 158' ' ' SER . . . -178.95 179.16 48.93 Favored Glycine 0 N--CA 1.446 -0.655 0 N-CA-C 111.123 -0.791 . . . . 53.509999999999998 111.123 178.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -78.67 131.93 36.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.68 0.753 . . . . 74.340000000000003 109.846 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.628 HG21 HD11 ' A' ' 134' ' ' ILE . 50.2 mt -98.85 137.21 27.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.317 -0.856 . . . . 75.319999999999993 110.984 -176.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -81.35 -70.44 0.54 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.819 -0.628 . . . . 63.350000000000001 110.757 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.31 159.69 17.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.523 -0.308 . . . . 61.439999999999998 110.72 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.686 ' CG1' ' HG2' ' A' ' 118' ' ' GLU . 18.8 mm -117.13 109.34 27.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.802 -0.444 . . . . 44.439999999999998 109.802 176.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -85.24 95.77 9.29 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 109.202 -0.666 . . . . 62.149999999999999 109.202 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.511 HG21 ' HE3' ' A' ' 145' ' ' LYS . 18.8 mt -73.15 -15.84 17.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 121.133 0.492 . . . . 61.340000000000003 110.58 -176.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 19.7 tpp 61.0 70.78 0.59 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 122.023 0.916 . . . . 52.439999999999998 110.872 178.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 1.4 p -90.87 142.5 27.7 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.821 -1.081 . . . . 73.140000000000001 110.658 175.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -50.35 141.48 11.74 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 123.572 0.545 . . . . 75.420000000000002 111.108 179.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.559 ' H ' ' HD3' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -81.04 -1.94 46.07 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.543 -0.753 . . . . 72.340000000000003 111.327 -173.559 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -111.51 -55.26 0.49 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.876 -0.678 . . . . 73.129999999999995 112.326 179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.2 m -95.81 -21.2 18.26 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.94 0.348 . . . . 75.129999999999995 111.94 -178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 78.79 34.16 35.4 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.52 -0.848 . . . . 71.200000000000003 112.0 -177.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -101.02 141.15 34.32 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.815 0.341 . . . . 75.230000000000004 110.41 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.511 ' HE3' HG21 ' A' ' 136' ' ' ILE . 45.3 mtpt -73.64 123.28 23.73 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.924 -0.58 . . . . 52.32 110.65 -173.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.475 ' NH2' " H4'" ' B' ' 4' ' ' ' G' . 41.4 mtm180 -77.61 -4.25 44.97 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 113.383 0.882 . . . . 74.239999999999995 113.383 -171.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 98.19 4.04 57.61 Favored Glycine 0 CA--C 1.516 0.115 0 C-N-CA 120.311 -0.947 . . . . 55.020000000000003 113.446 173.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.1 p90 -144.56 143.64 30.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.448 -0.575 . . . . 74.299999999999997 109.448 173.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -133.07 158.28 43.15 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.036 0.446 . . . . 62.340000000000003 111.201 -175.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . . . . . . . . . 32.3 m-85 -119.58 122.85 42.51 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.904 -0.589 . . . . 73.140000000000001 109.768 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.619 HG13 ' CD1' ' A' ' 134' ' ' ILE . 61.7 t -99.92 109.86 25.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 120.569 0.223 . . . . 61.32 110.567 -178.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.638 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 19.1 m -88.63 126.8 35.46 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.313 -0.403 . . . . 74.099999999999994 110.858 179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.555 ' CD2' HG12 ' A' ' 159' ' ' VAL . 89.1 m-85 -108.64 154.35 22.11 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 109.514 -0.55 . . . . 64.439999999999998 109.514 177.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -69.27 -33.49 73.31 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.947 -0.76 . . . . 61.509999999999998 108.947 174.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -112.96 143.91 43.44 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.602 -1.181 . . . . 74.519999999999996 111.543 -172.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.63 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.9 p-80 -88.87 -12.72 41.01 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.716 -0.674 . . . . 71.219999999999999 110.178 174.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.62 -36.31 73.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.364 0.602 . . . . 74.519999999999996 109.605 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.595 ' HA ' ' HE2' ' A' ' 161' ' ' LYS . 13.0 m -75.67 -19.69 58.96 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.199 -0.909 . . . . 72.340000000000003 111.687 -175.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.63 HG22 ' O ' ' A' ' 156' ' ' HIS . 4.0 m -81.54 -22.31 10.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.758 0.313 . . . . 70.519999999999996 110.833 -179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.451 ' HA ' HG22 ' A' ' 163' ' ' VAL . 27.8 t70 -68.23 -40.53 82.02 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.342 -0.39 . . . . 73.109999999999999 111.429 -172.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.595 ' HE2' ' HA ' ' A' ' 158' ' ' SER . 0.6 OUTLIER -62.63 -19.08 63.43 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.327 0.584 . . . . 62.340000000000003 110.247 178.565 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.594 HG21 HD13 ' A' ' 107' ' ' ILE . 90.4 mt -94.66 -55.2 6.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.718 0 CA-C-N 115.412 -0.813 . . . . 65.030000000000001 111.23 -176.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.451 HG22 ' HA ' ' A' ' 160' ' ' ASP . 27.5 m -66.28 -14.62 17.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 112.645 0.609 . . . . 72.409999999999997 112.645 -173.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.428 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.6 pp -72.51 -28.67 28.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 120.901 0.381 . . . . 73.319999999999993 110.817 176.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.486 ' HB3' ' NE2' ' A' ' 168' ' ' HIS . 5.9 tt0 -101.97 148.82 24.88 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.436 -0.579 . . . . 71.200000000000003 109.436 177.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.641 ' HE2' ' CE2' ' A' ' 167' ' ' TYR . 83.7 tttt -93.83 -61.21 1.58 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.828 0.346 . . . . 70.430000000000007 111.014 179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.641 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 22.1 m-85 -82.51 108.6 16.04 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.188 0.518 . . . . 64.420000000000002 111.382 -176.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.486 ' NE2' ' HB3' ' A' ' 165' ' ' GLN . 27.5 m-70 -111.49 142.04 44.28 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.556 -0.747 . . . . 75.540000000000006 110.4 178.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 27.6 m -103.1 104.92 15.12 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.15 0.5 . . . . 73.310000000000002 111.096 -176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.538 HG21 ' HA ' ' A' ' 121' ' ' LEU . 6.3 p -130.17 140.89 47.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 115.782 -0.645 . . . . 73.319999999999993 109.403 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 74.14 -15.48 0.6 Allowed 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 121.569 0.7 . . . . 74.319999999999993 109.459 -178.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.455 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 113.34 2.22 24.65 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 110.64 -0.984 . . . . 54.229999999999997 110.64 -173.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 65.4 m-70 -109.48 134.24 52.12 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.311 -0.444 . . . . 73.530000000000001 109.818 -178.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.3 t30 -86.28 106.19 17.18 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.443 -0.577 . . . . 52.140000000000001 109.443 174.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.577 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 63.9 m -115.99 -177.86 3.26 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.986 -0.552 . . . . 55.109999999999999 110.797 -175.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.612 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 14.3 tt0 -111.31 132.64 54.24 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.625 -0.261 . . . . 74.200000000000003 110.593 -178.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.7 m -121.86 144.46 31.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.082 0.468 . . . . 63.219999999999999 110.495 178.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.633 ' HG2' ' NE2' ' A' ' 96' ' ' GLN . 51.3 mtt180 -135.33 173.72 11.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.118 -0.492 . . . . 60.420000000000002 110.215 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.558 ' HE3' ' HA ' ' A' ' 100' ' ' ALA . 66.4 mttm -70.09 119.03 13.68 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.645 -1.243 . . . . 75.430000000000007 107.645 167.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.562 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -75.87 93.05 3.14 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.111 0.482 . . . . 73.349999999999994 111.674 -175.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.695 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.4 pt? -90.73 138.3 31.69 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 108.935 -0.765 . . . . 75.200000000000003 108.935 173.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.427 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 12.7 m -56.43 151.83 12.53 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 123.136 0.273 . . . . 74.219999999999999 110.64 -176.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.77 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.1 pttp -59.14 -28.38 66.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.353 0.597 . . . . 75.230000000000004 109.7 177.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -60.51 -42.36 96.25 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.977 -1.011 . . . . 44.0 110.628 173.191 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 32.7 mt-10 -85.68 -35.21 21.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.395 -0.82 . . . . 72.099999999999994 110.768 -174.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.77 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.6 ptm -72.22 -16.05 61.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.07 -0.513 . . . . 43.100000000000001 110.587 -178.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.24 -26.7 60.39 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.087 -0.506 . . . . 71.010000000000005 110.13 173.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 43.4 m -88.82 -45.31 9.85 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.82 -0.627 . . . . 72.219999999999999 110.681 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.8 -37.09 85.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.897 -0.592 . . . . 74.219999999999999 111.336 -177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 35.1 t -113.52 131.68 55.98 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.942 0.401 . . . . 71.310000000000002 110.437 -178.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 24.3 m -114.19 -34.74 5.24 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.997 -0.547 . . . . 64.540000000000006 110.407 179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 13.1 t -158.95 -163.52 1.25 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.772 -0.455 . . . . 70.099999999999994 109.772 -176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -91.81 -13.5 31.35 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.219 0.533 . . . . 63.439999999999998 109.701 175.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 39.8 ttm180 -101.52 123.92 46.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.519 -0.764 . . . . 70.319999999999993 109.803 177.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 90.06 -84.81 1.36 Allowed Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 111.021 -0.831 . . . . 53.340000000000003 111.021 -176.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 68.6 mtt180 . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.492 -0.766 . . . . 72.099999999999994 109.674 176.329 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.954 H5'' " H4'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.665 0 C4'-C3'-C2' 103.754 1.054 . 0.0 '__' . 71.310000000000002 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.954 " H4'" H5'' ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.977 0 C3'-C2'-C1' 103.18 1.866 . 0.0 OUTLIER . 72.150000000000006 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.656 " H2'" ' SD ' ' A' ' 186' ' ' MET . . . . . . . . 0 O5'--C5' 1.425 -0.967 0 O4'-C4'-C3' 103.363 -1.527 . 0.0 OUTLIER . 74.129999999999995 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.475 " H4'" ' NH2' ' A' ' 146' ' ' ARG . . . . . . . . 0 O5'--C5' 1.424 -1.024 0 C3'-C2'-C1' 98.72 -3.089 . 0.0 OUTLIER alpha 73.510000000000005 . . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 1.005 ' C6 ' " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.99 0 C4'-C3'-C2' 105.23 2.53 OUTLIER-DELTA 0.0 OUTLIER . 73.030000000000001 . . . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.427 -0.835 0 C4'-C3'-C2' 103.416 0.716 . 0.0 OUTLIER . 73.519999999999996 . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 53.8 m . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 120.847 0.356 . . . . 61.350000000000001 110.949 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 61.6 mt-30 -96.36 141.04 30.15 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.831 -0.433 . . . . 75.310000000000002 109.831 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.829 ' HG3' ' HB2' ' A' ' 100' ' ' ALA . 11.7 ptm180 -69.45 129.31 91.72 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 108.417 -0.957 . . . . 71.200000000000003 108.417 171.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.686 ' HG2' ' HB2' ' A' ' 179' ' ' LYS . 15.0 Cg_endo -57.46 97.81 0.08 OUTLIER 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.219 2.612 . . . . 70.409999999999997 113.652 -167.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.444 ' HA3' HD12 ' A' ' 102' ' ' LEU . . . 55.56 64.09 4.69 Favored Glycine 0 C--O 1.224 -0.473 0 CA-C-N 115.415 -0.811 . . . . 65.530000000000001 112.835 176.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.829 ' HB2' ' HG3' ' A' ' 97' ' ' ARG . . . -70.74 -25.53 62.97 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.998 0.428 . . . . 63.119999999999997 110.8 -178.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.404 ' CD2' ' H ' ' A' ' 101' ' ' HIS . 4.5 p80 -84.93 0.66 50.45 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.901 -0.59 . . . . 72.25 110.247 176.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.444 HD12 ' HA3' ' A' ' 99' ' ' GLY . 51.6 mt -107.32 126.44 52.45 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.552 -0.749 . . . . 71.109999999999999 109.922 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.0 p -66.46 112.55 4.13 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.117 -0.492 . . . . 64.420000000000002 110.719 179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.578 ' HB ' ' HZ3' ' A' ' 179' ' ' LYS . 8.7 p -104.54 136.63 37.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.298 -0.41 . . . . 61.32 109.918 -178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 19.3 mtmt -122.32 20.13 10.53 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.324 0.583 . . . . 71.299999999999997 110.991 -177.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.62 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 30.0 ttpt -150.85 136.94 18.36 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.377 -0.829 . . . . 73.230000000000004 108.973 174.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.551 HD13 HG21 ' A' ' 162' ' ' ILE . 2.7 pt -110.12 153.95 11.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 120.937 0.399 . . . . 61.0 110.342 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.58 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 74.0 t80 -100.89 120.74 40.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.736 -0.665 . . . . 73.129999999999995 110.012 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.462 HG11 HD11 ' A' ' 121' ' ' LEU . 47.0 t -107.6 113.67 44.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.753 0.311 . . . . 73.510000000000005 110.411 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -128.05 155.56 20.33 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 120.657 -0.782 . . . . 73.019999999999996 112.598 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.461 ' H ' " H5'" ' B' ' 2' ' ' ' C' . . . 88.32 24.59 33.55 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 121.058 -0.591 . . . . 41.240000000000002 112.897 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 20.9 pt -81.61 69.18 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 121.432 0.634 . . . . 71.510000000000005 111.599 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.1 mtpm? -49.41 -57.09 7.58 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.105 -0.952 . . . . 72.409999999999997 113.004 -173.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -80.92 29.25 0.33 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.653 0.612 . . . . 71.129999999999995 112.653 -170.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.423 ' CG ' ' HZ3' ' A' ' 145' ' ' LYS . 34.1 t70 66.63 98.41 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.288 0 CA-C-O 121.618 0.723 . . . . 64.25 112.046 175.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.468 HG23 ' CB ' ' A' ' 120' ' ' HIS . 86.0 m -113.87 138.49 50.23 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.515 -0.766 . . . . 71.400000000000006 110.1 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.549 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 10.2 pt-20 -125.99 -170.85 2.26 Favored 'General case' 0 C--N 1.329 -0.29 0 O-C-N 122.415 -0.178 . . . . 71.209999999999994 110.862 -177.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.758 ' HA ' HG21 ' A' ' 134' ' ' ILE . 19.1 tt0 -55.87 -53.19 59.78 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 112.58 0.585 . . . . 74.540000000000006 112.58 -174.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.464 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.0 p80 -59.09 -30.51 68.15 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 121.071 -0.251 . . . . 74.340000000000003 110.581 -175.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.549 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 41.9 m80 -64.91 -55.95 16.27 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.157 -0.474 . . . . 71.329999999999998 110.327 177.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 117' ' ' GLU . 0.4 OUTLIER -61.24 -48.07 83.13 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-N 116.296 -0.411 . . . . 62.450000000000003 110.689 -179.408 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.418 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 3.1 tpp180 -61.65 -48.98 78.39 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.263 -0.426 . . . . 73.230000000000004 111.49 -176.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -58.55 -31.52 68.04 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 121.31 0.576 . . . . 64.450000000000003 110.958 -178.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.407 ' HE1' ' HB3' ' A' ' 168' ' ' HIS . 38.8 t80 -86.83 -44.21 11.9 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.834 -0.621 . . . . 74.0 111.305 -177.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.418 ' CD1' HG21 ' A' ' 151' ' ' VAL . 47.2 m-85 -86.16 -13.84 45.84 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 113.054 0.761 . . . . 71.209999999999994 113.054 -172.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.51 -22.27 65.45 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.047 0.451 . . . . 74.400000000000006 110.839 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -66.6 -25.8 66.79 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.731 -0.668 . . . . 61.350000000000001 110.463 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.467 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 72.1 m-85 -84.88 -30.24 24.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.663 -0.699 . . . . 70.129999999999995 110.851 -178.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.438 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 175.93 -174.8 47.14 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.717 -0.754 . . . . 75.129999999999995 111.881 178.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.475 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 20.1 ptmt -79.11 129.55 34.57 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.811 0.815 . . . . 74.230000000000004 109.976 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.55 HG21 HD11 ' A' ' 134' ' ' ILE . 48.1 mt -98.94 142.56 14.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.138 0 CA-C-N 115.246 -0.888 . . . . 62.299999999999997 110.528 -176.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -85.89 -75.63 0.37 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.953 -0.567 . . . . 72.329999999999998 110.159 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 24.6 m -139.35 155.56 26.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.327 -0.397 . . . . 71.140000000000001 110.611 -178.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.758 HG21 ' HA ' ' A' ' 118' ' ' GLU . 24.0 mm -110.87 107.8 23.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 109.25 -0.648 . . . . 63.420000000000002 109.25 175.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 88.0 mt-10 -91.2 97.54 11.19 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.098 0.475 . . . . 73.200000000000003 110.955 -175.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.615 HD11 ' H ' ' A' ' 118' ' ' GLU . 32.3 mt -81.1 103.75 8.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.313 -0.625 . . . . 62.310000000000002 109.313 176.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 24.6 tpp -67.41 122.92 19.0 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.425 0.631 . . . . 71.25 110.668 -177.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 6.7 p -108.53 163.91 12.81 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.103 -0.953 . . . . 72.219999999999999 111.509 -177.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.693 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 22.9 t70 -57.68 139.51 53.55 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.45 -0.796 . . . . 73.129999999999995 109.822 175.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.635 ' HD3' " H2'" ' B' ' 5' ' ' ' U' . 9.5 tpt180 -65.26 -23.18 66.98 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.094 -0.503 . . . . 71.340000000000003 111.288 -172.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -108.16 -54.28 0.63 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.557 -0.83 . . . . 45.43 113.059 -176.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 5.8 t -84.46 -19.56 33.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.991 0.424 . . . . 70.310000000000002 110.979 -173.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.33 30.41 69.3 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.606 -0.806 . . . . 73.400000000000006 111.898 -178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 55.8 pttt -95.93 162.17 13.69 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.334 -0.617 . . . . 74.049999999999997 109.334 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.423 ' HZ3' ' CG ' ' A' ' 115' ' ' ASP . 53.9 mtpt -65.17 115.12 5.19 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.028 0.442 . . . . 63.509999999999998 110.796 -176.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.415 ' HD3' ' O4 ' ' B' ' 5' ' ' ' U' . 23.6 tpt180 -66.79 -58.05 5.84 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.537 -0.756 . . . . 74.420000000000002 112.252 -173.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.787 ' HA3' " H2'" ' B' ' 1' ' ' ' U' . . . 158.95 -17.73 0.26 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 119.985 -1.102 . . . . 34.43 112.654 -175.048 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.743 ' HB3' " H4'" ' B' ' 2' ' ' ' C' . 35.4 p90 -136.68 158.23 44.92 Favored 'General case' 0 C--N 1.32 -0.706 0 O-C-N 122.69 -0.3 . . . . 73.340000000000003 110.245 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.96 169.48 17.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.212 -0.449 . . . . 72.349999999999994 110.764 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.578 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 66.6 m-85 -130.79 137.35 49.4 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.016 -0.538 . . . . 72.239999999999995 110.011 -177.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.602 HG13 ' CD1' ' A' ' 134' ' ' ILE . 18.7 t -112.27 107.13 22.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 109.811 -0.441 . . . . 75.140000000000001 109.811 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.62 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 18.4 m -86.94 126.03 34.43 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.323 -0.399 . . . . 70.329999999999998 110.359 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -109.41 152.1 25.8 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 109.776 -0.453 . . . . 70.239999999999995 109.776 178.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.475 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 26.9 t70 -75.45 -22.54 57.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.404 0.621 . . . . 74.120000000000005 109.735 176.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 16.9 t0 -124.84 139.52 53.77 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.327 -0.851 . . . . 73.540000000000006 110.441 -175.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.59 ' O ' HG22 ' A' ' 159' ' ' VAL . 3.8 p-80 -81.63 -5.65 58.26 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.345 0.593 . . . . 64.140000000000001 109.955 175.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -66.43 -44.11 83.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.751 -0.659 . . . . 71.150000000000006 109.991 173.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.438 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 3.3 m -60.15 -39.25 85.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.17 -0.923 . . . . 73.120000000000005 111.729 -177.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 156' ' ' HIS . 6.5 m -70.86 -25.91 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.391 -0.368 . . . . 73.319999999999993 111.452 -174.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.1 m-20 -69.44 -22.32 63.66 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 111.578 0.214 . . . . 74.439999999999998 111.578 -175.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.467 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 0.5 OUTLIER -89.32 -1.35 58.03 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.389 0.614 . . . . 61.030000000000001 109.644 177.142 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.551 HG21 HD13 ' A' ' 107' ' ' ILE . 92.5 mt -108.53 -54.6 5.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.432 -0.803 . . . . 63.030000000000001 110.782 -176.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.519 HG11 ' HG2' ' A' ' 179' ' ' LYS . 23.9 m -71.75 -3.55 3.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.851 -0.613 . . . . 54.240000000000002 112.589 -174.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.1 pp -74.39 -30.71 26.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.73 0.3 . . . . 70.5 111.227 176.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.525 ' N ' HD12 ' A' ' 164' ' ' ILE . 12.0 pt20 -114.34 176.54 5.0 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.916 -0.402 . . . . 73.439999999999998 109.916 173.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.591 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 79.8 tttt -113.24 -59.46 2.02 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.566 -0.288 . . . . 61.350000000000001 111.631 -174.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.556 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 21.0 m-85 -78.19 107.75 11.0 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.127 0.489 . . . . 71.230000000000004 111.083 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.407 ' HB3' ' HE1' ' A' ' 124' ' ' TYR . 16.5 m-70 -107.47 135.63 48.63 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.635 -0.711 . . . . 73.409999999999997 110.536 178.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 28.7 m -93.55 97.45 10.51 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.797 -0.638 . . . . 73.400000000000006 111.233 -175.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 7.2 p -123.99 139.44 50.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 N-CA-C 108.994 -0.743 . . . . 73.310000000000002 108.994 177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 71.43 -7.19 1.23 Allowed 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.292 0.568 . . . . 61.43 110.275 -179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 108.04 -0.29 33.61 Favored Glycine 0 N--CA 1.449 -0.477 0 N-CA-C 111.57 -0.612 . . . . 62.350000000000001 111.57 -176.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 72.9 t60 -115.93 146.57 41.97 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.178 -0.305 . . . . 72.319999999999993 110.178 -179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -90.3 104.86 17.39 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.981 0.896 . . . . 55.200000000000003 110.496 177.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 25.8 p -95.37 172.22 8.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.315 -0.857 . . . . 74.310000000000002 110.017 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.591 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 38.0 tt0 -107.99 121.39 44.71 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 109.85 -0.426 . . . . 75.400000000000006 109.85 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 2.8 m -109.86 145.78 16.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-O 120.983 0.42 . . . . 62.420000000000002 110.558 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 53.0 mtt180 -135.39 170.77 15.42 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.112 -0.495 . . . . 74.530000000000001 110.147 178.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.686 ' HB2' ' HG2' ' A' ' 98' ' ' PRO . 8.1 mtpm? -73.42 114.4 11.6 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.458 -0.941 . . . . 52.450000000000003 108.458 169.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.771 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -72.11 97.57 1.95 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.262 0.553 . . . . 62.219999999999999 111.735 -175.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.748 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.3 pt? -96.75 138.3 34.51 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.488 -0.778 . . . . 32.240000000000002 109.133 173.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.522 ' HB3' ' HG2' ' A' ' 185' ' ' GLU . 36.3 t -49.89 145.36 5.57 Favored 'General case' 0 C--N 1.329 -0.311 0 O-C-N 123.279 0.362 . . . . 40.310000000000002 110.959 -179.583 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.653 ' HE2' ' OP1' ' B' ' 5' ' ' ' U' . 22.4 pttp -62.64 -23.51 67.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.152 0.501 . . . . 75.019999999999996 109.908 177.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -73.75 -41.4 62.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.507 -0.77 . . . . 41.119999999999997 109.487 174.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.522 ' HG2' ' HB3' ' A' ' 182' ' ' SER . 56.1 mm-40 -73.44 -40.85 63.89 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.321 -0.854 . . . . 75.299999999999997 110.943 -177.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.606 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 12.5 ptp -64.12 -24.35 67.66 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.784 0.326 . . . . 72.239999999999995 110.734 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -80.0 -30.15 39.56 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.052 0.453 . . . . 75.400000000000006 110.312 178.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 21.8 t -87.45 -38.09 16.4 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.573 -0.739 . . . . 62.509999999999998 110.829 -178.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -79.09 -40.88 30.0 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.108 0.48 . . . . 44.539999999999999 110.674 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.2 m -108.52 96.87 6.64 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.901 -0.591 . . . . 62.140000000000001 110.36 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 14.5 m -121.42 152.46 39.03 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.569 -0.53 . . . . 62.240000000000002 109.569 178.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 1.1 p -59.38 125.3 23.09 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.255 0.55 . . . . 72.140000000000001 111.192 179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -91.78 131.01 37.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.551 -0.75 . . . . 62.420000000000002 110.261 -178.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 41.5 ttm180 -151.36 29.64 0.63 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.823 0.821 . . . . 75.209999999999994 109.809 -178.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -70.21 -31.68 69.0 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.495 -0.775 . . . . 63.219999999999999 112.27 178.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 2.6 ptp180 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 118.753 -0.641 . . . . 74.010000000000005 110.319 178.105 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 1.001 " H3'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.424 -1.031 0 C1'-O4'-C4' 106.957 -2.936 OUTLIER-EPSILON 0.0 '__' . 72.140000000000001 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 1.001 H5'' " H3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.868 0 C4'-C3'-C2' 105.777 3.077 . 0.0 OUTLIER epsilon-1 72.340000000000003 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.771 ' N1 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.424 -0.99 0 C4'-C3'-C2' 104.772 2.072 . 0.0 OUTLIER gamma 74.239999999999995 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.551 ' OP1' " H4'" ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -1.015 0 C3'-C2'-C1' 99.547 -2.17 . 0.0 OUTLIER alpha 72.409999999999997 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.693 ' O4 ' ' HA ' ' A' ' 139' ' ' ASP . . . . . . . . 0 O5'--C5' 1.426 -0.855 0 O4'-C4'-C3' 103.749 -1.251 . 0.0 OUTLIER gamma 72.519999999999996 . . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.582 ' H6 ' " O5'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.852 0 O4'-C1'-C2' 107.26 0.614 . 0.101 4b . 64.519999999999996 . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.432 0.158 . . . . 64.25 110.612 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER 56.66 4.81 0.17 Allowed 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 125.019 1.328 . . . . 71.140000000000001 113.518 178.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -122.01 85.95 46.19 Favored Pre-proline 0 C--N 1.326 -0.423 0 O-C-N 122.018 -0.426 . . . . 71.099999999999994 110.611 177.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.5 ' HG2' HD22 ' A' ' 181' ' ' LEU . 15.9 Cg_exo -69.1 -63.33 0.05 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.374 2.049 . . . . 75.109999999999999 110.763 175.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -101.85 93.58 1.12 Allowed Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 110.999 -0.841 . . . . 62.200000000000003 110.999 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -87.15 -41.11 14.02 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.07 0.462 . . . . 74.219999999999999 110.746 -179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.8 p-80 -91.65 13.9 16.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.658 -0.701 . . . . 73.099999999999994 110.534 179.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.1 mt -113.11 139.77 48.44 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.7 -0.682 . . . . 74.219999999999999 110.285 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.534 HG22 ' HB2' ' A' ' 156' ' ' HIS . 0.2 OUTLIER -90.72 118.81 30.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.807 -0.442 . . . . 71.010000000000005 109.807 178.658 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.52 HG21 ' HB3' ' A' ' 179' ' ' LYS . 2.1 t -112.0 153.63 13.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-N 116.24 -0.437 . . . . 73.319999999999993 110.365 -172.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.649 ' HA ' HG21 ' A' ' 159' ' ' VAL . 4.8 mtmt -118.33 9.04 12.35 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.886 0.374 . . . . 62.020000000000003 111.345 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.601 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.9 ttpt -147.02 138.4 24.1 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.88 0.372 . . . . 72.140000000000001 110.068 177.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.571 ' CG2' HG13 ' A' ' 159' ' ' VAL . 7.4 pt -109.18 162.42 6.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.208 -0.451 . . . . 62.240000000000002 111.203 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.443 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 54.3 t80 -109.14 121.28 44.81 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.747 -0.661 . . . . 54.210000000000001 109.912 177.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 24.1 t -105.05 104.71 17.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.899 0.38 . . . . 54.409999999999997 110.694 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -121.91 178.75 16.35 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 111.321 -0.712 . . . . 63.149999999999999 111.321 178.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.479 ' HA2' " O5'" ' B' ' 1' ' ' ' U' . . . 70.23 19.5 75.86 Favored Glycine 0 C--O 1.229 -0.164 0 C-N-CA 120.635 -0.793 . . . . 43.25 112.289 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.631 ' O ' " H2'" ' B' ' 1' ' ' ' U' . 27.6 pt -96.47 -167.72 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.753 0.311 . . . . 54.109999999999999 111.074 -177.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.449 ' HA ' " H2'" ' B' ' 1' ' ' ' U' . 47.8 pttt -120.88 163.36 18.31 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.105 -0.498 . . . . 74.049999999999997 110.14 174.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -61.21 -27.79 68.68 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 123.581 0.551 . . . . 73.420000000000002 112.256 -170.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -66.48 -31.04 71.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.588 -0.278 . . . . 62.450000000000003 111.593 -178.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.477 ' HB ' HD12 ' A' ' 112' ' ' ILE . 1.0 OUTLIER -61.54 144.37 54.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.084 -0.507 . . . . 72.450000000000003 111.166 -175.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.403 ' HB3' ' NZ ' ' A' ' 145' ' ' LYS . 11.2 pt-20 -158.32 -165.94 1.81 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.823 0.344 . . . . 70.040000000000006 111.71 -179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.744 ' HA ' HG21 ' A' ' 134' ' ' ILE . 21.5 tt0 -51.69 -56.58 12.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.282 -0.872 . . . . 63.130000000000003 112.318 -175.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.402 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.0 p80 -61.83 -31.05 71.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.352 -0.386 . . . . 65.329999999999998 111.065 -174.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -67.6 -59.38 3.39 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.25 0.548 . . . . 65.209999999999994 110.064 177.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.655 HD23 HG11 ' A' ' 170' ' ' VAL . 68.8 mt -57.2 -49.58 75.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.066 -0.97 . . . . 73.420000000000002 110.973 -177.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.424 ' HG3' HD12 ' A' ' 131' ' ' ILE . 4.7 ttp180 -62.03 -37.79 86.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.98 -0.554 . . . . 74.430000000000007 111.38 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -60.17 -29.61 68.8 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.982 0.42 . . . . 64.299999999999997 110.872 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.405 ' CD1' HG22 ' A' ' 170' ' ' VAL . 83.2 t80 -91.67 -46.98 7.63 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.045 -0.525 . . . . 72.340000000000003 111.622 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 38.6 m-85 -77.2 -14.01 59.85 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.595 0.591 . . . . 55.509999999999998 112.595 -172.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -64.83 -22.16 66.93 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.11 0.481 . . . . 64.219999999999999 110.912 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -66.81 -30.89 71.2 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.712 -0.676 . . . . 75.340000000000003 110.858 176.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.439 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 76.6 m-85 -82.48 -31.04 29.54 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.129 -0.487 . . . . 74.329999999999998 111.253 -175.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 158' ' ' SER . . . 172.66 -170.91 43.98 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 119.822 -1.18 . . . . 62.299999999999997 113.381 177.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -75.86 114.19 14.19 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 121.526 0.679 . . . . 74.209999999999994 111.342 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.517 HG21 HD11 ' A' ' 134' ' ' ILE . 35.3 mt -87.27 142.18 13.32 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.15 -0.932 . . . . 75.409999999999997 110.039 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -86.66 -74.68 0.42 Allowed 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.106 -0.497 . . . . 73.129999999999995 110.315 175.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.1 m -143.86 152.37 16.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.135 -0.484 . . . . 32.539999999999999 110.079 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.744 HG21 ' HA ' ' A' ' 118' ' ' GLU . 16.2 mm -103.47 105.63 18.69 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.867 -0.79 . . . . 54.409999999999997 108.867 175.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -85.42 94.7 9.05 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.052 -0.522 . . . . 75.329999999999998 110.247 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.609 HD11 ' H ' ' A' ' 118' ' ' GLU . 31.5 mt -80.79 119.94 31.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.653 -0.703 . . . . 73.329999999999998 109.802 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 21.4 tpp -73.68 94.94 2.27 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.709 0.766 . . . . 75.420000000000002 109.434 176.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 145' ' ' LYS . 16.7 p -81.85 165.37 20.9 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 114.871 -1.059 . . . . 54.439999999999998 111.118 -176.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.779 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 31.4 t70 -53.73 133.34 42.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.071 -0.513 . . . . 64.430000000000007 109.954 177.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.586 ' HD3' " H2'" ' B' ' 5' ' ' ' U' . 11.8 tpt180 -71.16 -9.23 57.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.777 0.322 . . . . 73.439999999999998 111.56 -171.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -106.92 -53.08 0.71 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.423 -0.894 . . . . 70.140000000000001 112.718 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.5 t -102.9 -11.35 18.3 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.695 -0.297 . . . . 74.209999999999994 111.618 -174.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.507 ' HA2' ' HB ' ' A' ' 138' ' ' THR . . . 60.12 53.22 47.51 Favored Glycine 0 C--N 1.329 0.182 0 C-N-CA 120.607 -0.806 . . . . 65.25 112.103 -177.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.406 ' H ' ' HB3' ' A' ' 139' ' ' ASP . 20.5 pttp -122.51 34.91 5.02 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.777 0.322 . . . . 50.130000000000003 111.708 -173.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.56 ' HA ' ' HA ' ' A' ' 138' ' ' THR . 56.5 mtpt 68.56 123.08 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 CA-C-N 115.525 -0.761 . . . . 65.109999999999999 111.724 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.508 ' HD2' ' C4 ' ' B' ' 5' ' ' ' U' . 68.2 ttt-85 -93.72 -52.73 4.33 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.738 -0.385 . . . . 72.310000000000002 110.302 173.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.501 ' O ' HD11 ' A' ' 112' ' ' ILE . . . 174.53 -85.3 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.695 -0.764 . . . . 65.409999999999997 112.154 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.748 ' HB3' H5'' ' B' ' 2' ' ' ' C' . 47.9 p90 -65.29 158.1 27.25 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.077 0.465 . . . . 71.140000000000001 111.384 -175.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -147.94 166.88 26.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.857 -0.611 . . . . 72.140000000000001 110.824 -178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.417 ' HE2' ' N3 ' ' B' ' 3' ' ' ' A' . 55.1 m-85 -122.38 131.42 53.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.949 -0.569 . . . . 73.219999999999999 109.707 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.599 HG13 ' CD1' ' A' ' 134' ' ' ILE . 47.7 t -104.56 109.66 28.17 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-O 120.776 0.322 . . . . 73.329999999999998 110.324 -178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.601 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 12.3 m -88.02 129.51 35.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.894 -0.593 . . . . 51.420000000000002 110.175 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.508 ' CD2' HG22 ' A' ' 159' ' ' VAL . 97.8 m-85 -111.58 150.61 29.79 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.821 -0.437 . . . . 74.099999999999994 109.821 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -78.49 -13.01 60.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.575 0.703 . . . . 54.329999999999998 110.235 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -129.41 147.63 51.24 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.312 -0.858 . . . . 75.230000000000004 109.969 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.534 ' HB2' HG22 ' A' ' 103' ' ' THR . 2.0 p-80 -85.57 -15.41 42.7 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.074 0.464 . . . . 71.430000000000007 110.441 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 36.9 m-20 -71.73 -39.67 69.92 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 116.079 -0.509 . . . . 44.310000000000002 110.047 178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.557 ' HB3' ' HA3' ' A' ' 129' ' ' GLY . 0.8 OUTLIER -59.94 -35.29 74.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.619 -0.719 . . . . 75.420000000000002 110.1 178.438 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.649 HG21 ' HA ' ' A' ' 105' ' ' LYS . 22.0 t -70.22 -35.86 65.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.04 -0.982 . . . . 50.210000000000001 110.816 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -64.35 -38.75 92.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.897 -0.592 . . . . 74.120000000000005 112.289 -171.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.439 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -66.25 -22.15 66.31 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 121.337 0.589 . . . . 73.219999999999999 110.316 178.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.493 HG21 HD13 ' A' ' 107' ' ' ILE . 96.0 mt -93.59 -49.3 12.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.377 -0.829 . . . . 73.150000000000006 111.478 -174.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.552 ' HB ' ' HE2' ' A' ' 179' ' ' LYS . 34.8 m -69.37 -14.94 19.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.591 0.589 . . . . 72.150000000000006 112.591 -173.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -75.73 -27.73 18.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.173 0.511 . . . . 72.439999999999998 110.664 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -103.36 143.84 32.15 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.773 -0.649 . . . . 60.340000000000003 110.158 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.641 ' HE2' ' CE2' ' A' ' 167' ' ' TYR . 83.0 tttt -91.85 -64.25 1.14 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.865 0.364 . . . . 75.109999999999999 110.714 -178.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.641 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 15.5 m-30 -84.27 105.22 14.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.423 0.63 . . . . 75.349999999999994 112.216 -175.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 60.6 m-70 -106.24 149.79 26.53 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.959 -1.018 . . . . 74.219999999999999 109.424 175.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 53.5 m -102.6 103.12 13.41 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 120.956 0.408 . . . . 61.399999999999999 110.975 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.655 HG11 HD23 ' A' ' 121' ' ' LEU . 31.3 t -116.8 131.38 69.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.06 -0.518 . . . . 73.439999999999998 109.85 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.7 t30 59.53 27.27 16.41 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.482 0.658 . . . . 73.519999999999996 110.401 -176.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 76.02 5.59 80.72 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.854 -0.689 . . . . 72.319999999999993 112.386 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.416 ' HB2' ' HE2' ' A' ' 113' ' ' LYS . 61.4 t60 -109.11 133.09 53.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.787 0.327 . . . . 74.430000000000007 110.127 -178.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.435 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 10.7 t30 -77.9 122.6 25.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.29 -0.414 . . . . 52.340000000000003 109.91 178.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 24.2 p -126.33 165.61 18.69 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.442 -0.345 . . . . 75.299999999999997 110.943 -177.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.571 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 15.7 tt0 -108.58 118.85 37.86 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.998 -0.546 . . . . 72.319999999999993 110.017 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.449 HG11 HG22 ' A' ' 162' ' ' ILE . 86.9 t -110.82 132.87 58.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.17 0.51 . . . . 65.420000000000002 111.297 -178.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 44.5 mtt180 -127.01 177.91 6.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.549 -0.75 . . . . 73.5 109.823 178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.552 ' HE2' ' HB ' ' A' ' 163' ' ' VAL . 0.0 OUTLIER -77.59 123.64 26.88 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.405 -0.961 . . . . 74.239999999999995 108.405 170.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.576 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -75.3 92.87 2.8 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.147 0.499 . . . . 72.140000000000001 112.089 -177.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.587 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.5 pt? -88.13 131.24 34.78 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.537 -0.912 . . . . 74.510000000000005 108.537 171.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.5 m -58.31 153.8 14.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.476 -0.329 . . . . 73.340000000000003 110.938 -174.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.621 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.4 pttp -63.45 -14.8 54.37 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.091 0.472 . . . . 74.109999999999999 111.238 -178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 11.4 tm0? -78.57 -43.51 26.38 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.099 -0.704 . . . . 61.5 109.099 173.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -73.0 -41.88 63.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.32 -0.854 . . . . 64.230000000000004 110.958 -178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.621 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 21.1 ptm -65.6 -21.04 66.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 63.509999999999998 110.442 -177.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -71.57 -21.15 61.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.859 -0.61 . . . . 64.329999999999998 110.199 176.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.3 m -94.76 -8.98 36.0 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.759 -0.655 . . . . 53.130000000000003 110.182 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -93.74 -45.45 7.67 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.863 -0.608 . . . . 72.239999999999995 110.793 -178.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.2 t -92.64 84.82 5.1 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.187 0.517 . . . . 74.140000000000001 109.844 178.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 55.2 m -157.97 173.06 17.34 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.496 -0.774 . . . . 73.439999999999998 109.338 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 49.2 m -66.16 -19.86 65.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.116 0.484 . . . . 55.100000000000001 110.632 177.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -123.43 101.76 7.52 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.987 -0.551 . . . . 70.420000000000002 109.945 173.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.566 ' H ' ' HD2' ' A' ' 194' ' ' ARG . 0.7 OUTLIER -107.46 20.59 18.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.939 -0.573 . . . . 75.319999999999993 110.225 -178.406 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 113.24 -69.92 0.23 Allowed Glycine 0 N--CA 1.445 -0.738 0 N-CA-C 110.697 -0.961 . . . . 74.319999999999993 110.697 -174.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 80.3 mmt-85 . . . . . 0 C--O 1.246 0.88 0 CA-C-O 118.337 -0.839 . . . . 72.239999999999995 109.062 171.884 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.89 " H4'" " H5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.813 0 O4'-C1'-C2' 108.017 1.155 OUTLIER-EPSILON 0.0 '__' . 73.549999999999997 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.89 " H5'" " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.819 0 P-O3'-C3' 122.159 2.049 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 75.219999999999999 . . . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.736 ' OP1' " H4'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 C3'-C2'-C1' 103.497 2.219 . 0.0 OUTLIER epsilon-1 75.439999999999998 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.839 ' OP1' " H4'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.896 0 C3'-C2'-C1' 100.496 -1.115 . 0.0 OUTLIER alpha 75.299999999999997 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.839 " H4'" ' OP1' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.426 -0.856 0 O4'-C4'-C3' 103.755 -1.246 . 0.0 OUTLIER gamma 72.420000000000002 . . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.425 -0.96 0 C4'-C3'-C2' 106.067 3.367 . 0.0 OUTLIER gamma 65.420000000000002 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . 0.503 ' HA ' ' HA ' ' A' ' 164' ' ' ILE . 24.9 t . . . . . 0 N--CA 1.474 0.775 0 N-CA-C 109.777 -0.453 . . . . 74.540000000000006 109.777 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.773 ' HG3' ' HA ' ' A' ' 178' ' ' ARG . 39.1 mm-40 -64.66 154.18 37.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 73.319999999999993 111.35 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 9.3 mpt_? -84.6 -49.99 0.6 Allowed Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 113.071 0.767 . . . . 73.420000000000002 113.071 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -64.26 102.4 0.39 Allowed 'Trans proline' 0 C--N 1.354 0.816 0 C-N-CA 121.821 1.681 . . . . 72.319999999999993 112.518 -174.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 68.31 49.87 42.68 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.854 -0.689 . . . . 64.439999999999998 111.968 -179.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 1.028 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . . . -64.6 -40.15 95.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.761 0.315 . . . . 74.540000000000006 111.302 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 56.5 p-80 -81.29 -5.64 58.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.059 -0.519 . . . . 72.310000000000002 110.777 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 96.4 mt -89.77 143.68 26.6 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.137 -0.483 . . . . 70.129999999999995 111.227 -176.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 5.2 p -80.83 100.35 8.77 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.458 -0.792 . . . . 74.109999999999999 110.355 175.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 179' ' ' LYS . 38.9 t -92.18 145.2 7.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.649 -0.705 . . . . 74.129999999999995 110.032 -177.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.577 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 6.4 mtmt -115.79 -3.96 12.18 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 112.132 0.419 . . . . 62.009999999999998 112.132 -178.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.585 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.8 ttpt -135.46 134.11 39.24 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.028 -0.36 . . . . 74.319999999999993 110.028 175.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.674 HG22 HG13 ' A' ' 159' ' ' VAL . 3.3 pt -104.45 155.3 6.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.064 0.459 . . . . 75.120000000000005 110.745 179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 41.8 t80 -104.83 122.93 46.78 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.551 -0.75 . . . . 74.299999999999997 109.785 178.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.434 HG12 HG23 ' A' ' 112' ' ' ILE . 3.2 t -110.65 98.59 7.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 N-CA-C 109.432 -0.581 . . . . 74.430000000000007 109.432 177.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.493 ' O ' " H5'" ' B' ' 2' ' ' ' C' . . . -91.42 -48.02 3.36 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.674 -0.774 . . . . 62.130000000000003 113.185 -173.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 175' ' ' CYS . . . -80.28 63.77 4.09 Favored Glycine 0 CA--C 1.518 0.221 0 C-N-CA 120.627 -0.797 . . . . 61.130000000000003 113.406 -174.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.604 HG22 ' SG ' ' A' ' 175' ' ' CYS . 32.8 pt -115.28 -175.9 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.954 0.377 . . . . 75.430000000000007 110.637 178.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 56.0 mtpt -124.42 172.37 9.21 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.099 -0.5 . . . . 54.009999999999998 109.989 178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -65.7 -18.6 65.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.909 0.385 . . . . 63.420000000000002 111.013 -179.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -72.39 -28.08 62.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.941 -0.572 . . . . 74.319999999999993 110.494 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 11.0 m -77.78 124.47 28.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.969 -0.56 . . . . 74.540000000000006 111.384 -174.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -127.72 -168.5 1.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.225 -0.443 . . . . 71.409999999999997 110.157 178.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.641 ' HA ' HG21 ' A' ' 134' ' ' ILE . 12.7 tt0 -55.79 -49.95 71.79 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 112.294 0.479 . . . . 65.140000000000001 112.294 -178.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.53 -29.86 69.39 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 120.752 -0.379 . . . . 72.299999999999997 110.25 -175.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.565 ' CD2' HD22 ' A' ' 171' ' ' ASN . 37.2 m80 -65.56 -55.87 15.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.374 -0.376 . . . . 61.43 111.009 179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.38 -47.71 84.4 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.944 0.402 . . . . 74.319999999999993 110.472 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.31 -46.32 90.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.042 -0.526 . . . . 72.439999999999998 111.385 -177.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -57.18 -32.01 66.01 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.106 0.479 . . . . 50.409999999999997 111.602 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.432 ' CE1' ' HB3' ' A' ' 168' ' ' HIS . 50.6 t80 -90.63 -44.1 9.74 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.182 -0.463 . . . . 73.519999999999996 111.411 -177.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -82.77 -12.83 57.21 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 112.674 0.62 . . . . 63.119999999999997 112.674 -172.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 pp20? -61.47 -27.25 68.44 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.68 0.276 . . . . 75.349999999999994 111.556 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -74.82 -14.96 60.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.906 0.384 . . . . 74.310000000000002 110.903 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -90.0 -26.63 20.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.312 -0.403 . . . . 64.120000000000005 110.868 179.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.494 ' HA3' ' CB ' ' A' ' 158' ' ' SER . . . 169.56 -170.97 43.02 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.508 -0.853 . . . . 63.229999999999997 112.533 176.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -75.86 122.27 23.87 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.28 0.562 . . . . 55.219999999999999 111.18 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.532 HG21 HD11 ' A' ' 134' ' ' ILE . 46.7 mt -95.59 137.9 22.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.415 -0.811 . . . . 74.340000000000003 110.296 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.455 ' HG2' ' N ' ' A' ' 154' ' ' ASP . 13.5 mm-40 -85.35 -70.57 0.58 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.934 -0.575 . . . . 73.430000000000007 110.403 176.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 17.2 m -143.22 158.75 17.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.531 -0.304 . . . . 73.239999999999995 110.472 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.641 HG21 ' HA ' ' A' ' 118' ' ' GLU . 23.5 mm -113.73 117.67 56.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.929 -0.397 . . . . 73.329999999999998 109.929 175.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.422 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 59.7 mt-10 -100.49 117.81 35.4 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.589 -0.522 . . . . 64.340000000000003 109.589 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 10.7 mt -91.65 3.76 7.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.53 0.681 . . . . 60.240000000000002 109.255 179.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.45 ' O ' ' HB2' ' A' ' 146' ' ' ARG . 8.4 tpp 52.03 50.51 18.37 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 114.857 -1.065 . . . . 72.049999999999997 109.588 -175.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 2.7 p -66.42 141.88 57.78 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 115.039 -0.982 . . . . 72.349999999999994 110.449 177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.46 ' HB3' ' H ' ' A' ' 144' ' ' LYS . 19.2 t70 -46.65 121.43 3.51 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.559 0.537 . . . . 71.200000000000003 110.213 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.581 ' NE ' ' H ' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -73.56 2.48 7.85 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.14 -0.482 . . . . 72.219999999999999 111.981 -173.327 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -107.65 -43.96 1.28 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.846 -0.692 . . . . 72.129999999999995 112.548 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.9 t -116.3 -19.99 9.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.106 0.453 . . . . 52.210000000000001 112.024 -176.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.02 56.09 2.13 Favored Glycine 0 CA--C 1.517 0.183 0 C-N-CA 120.673 -0.775 . . . . 75.299999999999997 111.965 -177.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.46 ' H ' ' HB3' ' A' ' 139' ' ' ASP . 0.0 OUTLIER -112.07 124.31 52.14 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.235 -0.283 . . . . 63.240000000000002 110.235 -175.12 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -61.02 130.59 47.18 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.079 0.466 . . . . 73.239999999999995 111.731 -176.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 137' ' ' MET . 25.4 tpt180 -84.36 171.76 12.37 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.484 -0.78 . . . . 74.209999999999994 110.018 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.506 ' O ' " H5'" ' B' ' 1' ' ' ' U' . . . -86.18 3.0 87.56 Favored Glycine 0 C--O 1.227 -0.323 0 C-N-CA 121.208 -0.52 . . . . 54.030000000000001 112.599 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 29.0 p90 -142.09 153.35 44.08 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.402 -0.592 . . . . 65.439999999999998 109.402 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -136.42 172.11 13.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.214 0.53 . . . . 70.129999999999995 111.827 -175.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.552 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 56.5 m-85 -133.32 134.97 44.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.334 -0.848 . . . . 74.519999999999996 109.433 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.61 HG13 ' CD1' ' A' ' 134' ' ' ILE . 21.2 t -112.93 108.52 25.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 N-CA-C 109.858 -0.423 . . . . 72.230000000000004 109.858 178.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.585 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 6.7 m -88.14 127.19 35.42 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.168 -0.469 . . . . 75.299999999999997 110.461 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.497 ' CD2' HG22 ' A' ' 159' ' ' VAL . 86.8 m-85 -111.81 151.33 29.16 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.923 -0.399 . . . . 61.149999999999999 109.923 179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.455 ' N ' ' HG2' ' A' ' 132' ' ' GLU . 28.1 t70 -76.91 -14.66 59.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.776 0.798 . . . . 74.140000000000001 110.042 176.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.43 ' OD1' ' HB3' ' A' ' 157' ' ' ASP . 37.0 t70 -123.93 133.32 53.75 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.002 -0.999 . . . . 32.399999999999999 111.043 -173.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.577 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.1 p-80 -85.11 -2.07 57.59 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.3 -0.409 . . . . 60.030000000000001 111.357 -178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.43 ' HB3' ' OD1' ' A' ' 155' ' ' ASP . 22.1 t70 -94.56 -37.05 11.55 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.183 0.516 . . . . 34.020000000000003 109.614 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.852 ' HA ' ' HE3' ' A' ' 161' ' ' LYS . 18.5 m -57.36 -32.03 66.36 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.482 -0.781 . . . . 64.519999999999996 110.482 175.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.674 HG13 HG22 ' A' ' 107' ' ' ILE . 46.9 t -70.83 -29.11 36.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.462 -0.79 . . . . 64.5 110.873 178.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -65.64 -45.57 82.54 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.907 -0.588 . . . . 72.319999999999993 111.608 -172.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.852 ' HE3' ' HA ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -65.99 -12.6 56.22 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 121.119 0.485 . . . . 61.210000000000001 111.148 178.072 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.515 HG21 HD13 ' A' ' 107' ' ' ILE . 96.9 mt -93.3 -51.8 10.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.036 -0.529 . . . . 72.540000000000006 110.84 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 25.7 m -68.25 -15.75 20.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 112.516 0.562 . . . . 52.130000000000003 112.516 -174.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.503 ' HA ' ' HA ' ' A' ' 95' ' ' SER . 2.7 pp -73.82 -27.26 22.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 120.976 0.417 . . . . 73.209999999999994 110.574 177.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -102.76 150.09 23.82 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.092 -0.707 . . . . 72.420000000000002 109.092 176.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.546 ' HE2' ' HG3' ' A' ' 176' ' ' GLU . 86.6 tttt -100.16 -59.6 1.68 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.794 -0.362 . . . . 71.040000000000006 111.1 -176.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -88.19 113.43 23.8 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.404 0.621 . . . . 72.299999999999997 111.177 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.432 ' HB3' ' CE1' ' A' ' 124' ' ' TYR . 32.7 m-70 -109.24 139.4 44.22 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.153 -0.931 . . . . 74.109999999999999 110.219 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 39.2 m -92.58 101.48 13.91 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.123 0.487 . . . . 71.049999999999997 111.124 -178.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.438 ' O ' ' HB3' ' A' ' 171' ' ' ASN . 4.2 p -134.15 140.02 47.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.956 -0.565 . . . . 61.009999999999998 109.728 177.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.565 HD22 ' CD2' ' A' ' 120' ' ' HIS . 24.7 t-20 71.71 1.16 3.78 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.729 0.776 . . . . 60.539999999999999 110.042 -178.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.67 8.32 63.93 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.478 -0.783 . . . . 50.43 111.556 -176.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -117.9 154.52 31.74 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.094 -0.336 . . . . 71.040000000000006 110.094 -177.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -83.31 98.71 9.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.101 0.477 . . . . 72.230000000000004 110.341 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.604 ' SG ' HG22 ' A' ' 112' ' ' ILE . 78.6 m -101.22 123.66 45.7 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.817 -0.629 . . . . 74.400000000000006 111.07 -176.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.546 ' HG3' ' HE2' ' A' ' 166' ' ' LYS . 3.8 tm-20 -83.7 122.92 29.27 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.518 -0.764 . . . . 73.120000000000005 109.738 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.4 m -118.74 148.77 21.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.202 -0.454 . . . . 70.329999999999998 111.189 -171.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.773 ' HA ' ' HG3' ' A' ' 96' ' ' GLN . 75.8 mtt180 -139.59 173.4 11.57 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.036 0.446 . . . . 60.109999999999999 111.503 -178.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 1.028 ' HE3' ' HA ' ' A' ' 100' ' ' ALA . 47.9 mttm -71.73 117.56 13.47 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.08 -1.081 . . . . 72.400000000000006 108.08 166.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.557 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -76.98 93.6 3.83 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.076 0.465 . . . . 72.299999999999997 111.862 -175.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.643 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.7 pt? -91.37 131.84 36.59 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.696 -0.853 . . . . 51.210000000000001 108.696 170.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 1.6 m -53.97 148.56 10.42 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.449 -0.341 . . . . 71.439999999999998 110.857 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.901 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.0 pttp -61.74 -26.54 68.13 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.288 0.566 . . . . 74.430000000000007 109.625 176.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -56.52 -38.6 72.05 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 114.994 -1.003 . . . . 73.299999999999997 110.525 172.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -95.17 -38.4 10.61 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.454 -0.794 . . . . 73.120000000000005 110.974 -174.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.901 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 23.1 ptm -66.05 -20.05 66.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 72.439999999999998 110.792 -177.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -77.65 -22.6 50.4 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.097 -0.501 . . . . 54.32 110.595 177.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 18.7 m -97.11 -41.93 8.1 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.909 -0.587 . . . . 73.510000000000005 110.43 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -66.13 -38.77 89.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.121 -0.491 . . . . 61.409999999999997 110.855 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 23.9 t -117.06 113.87 22.93 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.003 -0.544 . . . . 54.520000000000003 110.269 -179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 26.6 t -64.3 108.78 1.69 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.023 -0.535 . . . . 75.209999999999994 109.673 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 14.3 m -112.11 125.38 54.04 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.138 0.495 . . . . 73.409999999999997 110.783 -175.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -114.34 89.37 3.08 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.889 -0.782 . . . . 75.030000000000001 108.889 175.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -90.54 -28.94 18.17 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.948 -0.569 . . . . 75.310000000000002 110.015 -177.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 80.8 -52.54 4.45 Favored Glycine 0 N--CA 1.451 -0.337 0 CA-C-N 115.891 -0.595 . . . . 35.32 112.366 178.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 14.2 ptm180 . . . . . 0 C--O 1.246 0.906 0 CA-C-O 118.225 -0.893 . . . . 74.439999999999998 109.694 179.711 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.979 " C4'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.433 -0.462 0 O5'-C5'-C4' 111.559 0.971 . 0.0 '__' . 74.129999999999995 . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.979 H5'' " C4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.974 0 C3'-C2'-C1' 104.309 3.121 OUTLIER-EPSILON 0.0 OUTLIER zeta-1 72.340000000000003 . . . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.686 ' H8 ' H5'' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.424 -0.995 0 O4'-C4'-C3' 103.573 -1.377 . 0.0 OUTLIER epsilon-1 72.109999999999999 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.552 " H3'" ' HD3' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.424 -0.974 0 C4'-C3'-C2' 104.314 1.614 . 0.0 OUTLIER alpha 73.439999999999998 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.548 H5'' ' HD3' ' A' ' 140' ' ' ARG . . . . . . . . 0 O5'--C5' 1.422 -1.104 0 C3'-C2'-C1' 102.806 1.451 . 0.0 OUTLIER gamma 72.420000000000002 . . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.418 ' C5 ' ' HG3' ' A' ' 140' ' ' ARG . . . . . . . . 0 O5'--C5' 1.424 -0.983 0 C4'-C3'-C2' 104.138 1.438 . 0.0 OUTLIER gamma 73.430000000000007 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.477 0.895 0 N-CA-C 109.907 -0.405 . . . . 73.099999999999994 109.907 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 97' ' ' ARG . 15.2 mm100 -111.12 -5.58 14.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.713 -0.221 . . . . 70.409999999999997 111.124 -175.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.552 ' HB3' ' HB2' ' A' ' 100' ' ' ALA . 9.2 mmt180 68.75 107.49 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.206 0 O-C-N 123.744 0.653 . . . . 64.540000000000006 110.658 -176.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.512 ' O ' ' HB2' ' A' ' 179' ' ' LYS . 7.4 Cg_exo -71.55 120.36 6.88 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 123.0 2.467 . . . . 34.0 111.821 -175.365 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.457 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 70.94 32.22 66.44 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 121.011 -0.614 . . . . 63.219999999999999 112.499 178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.566 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . . . -77.94 -7.92 57.44 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.175 0.512 . . . . 71.239999999999995 111.168 -178.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -116.63 11.9 14.84 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.856 -0.611 . . . . 73.299999999999997 110.115 179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.457 HD12 ' HA2' ' A' ' 99' ' ' GLY . 62.5 mt -118.74 148.24 43.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.974 -0.557 . . . . 71.150000000000006 111.405 -172.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.7 p -81.06 100.08 8.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.232 -0.655 . . . . 74.329999999999998 109.232 169.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.471 HG21 ' HB3' ' A' ' 179' ' ' LYS . 31.9 t -102.49 138.39 26.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 CA-C-N 115.785 -0.643 . . . . 52.439999999999998 110.138 -175.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.667 ' HA ' HG21 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -110.33 -9.74 14.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.885 0.374 . . . . 40.130000000000003 110.501 -179.058 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.607 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 32.2 ttpt -126.18 135.57 51.79 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.065 0.46 . . . . 65.430000000000007 110.397 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.547 ' CG2' HG13 ' A' ' 159' ' ' VAL . 7.5 pt -104.61 161.28 4.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.163 0.506 . . . . 72.200000000000003 111.544 -177.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.501 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 67.8 t80 -108.21 115.64 30.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.157 -0.929 . . . . 64.340000000000003 109.802 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.422 HG12 ' CG2' ' A' ' 112' ' ' ILE . 5.2 t -104.24 106.33 20.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 110.134 -0.321 . . . . 70.420000000000002 110.134 178.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -119.36 155.34 16.12 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.948 -0.644 . . . . 61.130000000000003 112.524 -176.393 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 64.88 56.31 17.16 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 121.059 -0.591 . . . . 32.140000000000001 112.57 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.456 HG22 ' SG ' ' A' ' 175' ' ' CYS . 32.2 pt -111.36 -172.42 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 120.861 0.362 . . . . 74.540000000000006 110.969 -177.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -92.18 170.74 9.58 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.099 -0.5 . . . . 73.120000000000005 110.019 178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -74.24 -42.12 60.23 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 121.105 -0.238 . . . . 75.340000000000003 110.422 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -83.81 65.42 8.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.9 0.857 . . . . 71.239999999999995 109.241 173.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 45.6 m -146.33 100.49 3.37 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 114.665 -1.152 . . . . 54.43 108.574 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.476 ' CG ' ' HD2' ' A' ' 119' ' ' HIS . 12.0 pt-20 -121.15 -163.61 1.05 Allowed 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 115.034 -0.985 . . . . 72.030000000000001 110.524 -171.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.73 ' HA ' HG21 ' A' ' 134' ' ' ILE . 9.9 tt0 -54.45 -50.63 67.23 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.319 0.489 . . . . 43.340000000000003 112.319 -175.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.476 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.6 p80 -64.31 -26.56 68.54 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 121.068 -0.253 . . . . 74.129999999999995 110.97 -176.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.47 ' CD2' HD22 ' A' ' 171' ' ' ASN . 39.1 m80 -68.46 -61.49 1.81 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.623 -0.262 . . . . 54.5 110.649 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -55.89 -50.79 69.69 Favored 'General case' 0 N--CA 1.461 0.105 0 CA-C-N 116.131 -0.486 . . . . 52.439999999999998 110.434 178.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -53.46 -49.77 66.71 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.73 -0.668 . . . . 73.400000000000006 111.425 -177.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -60.69 -28.18 68.43 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.676 0.274 . . . . 71.219999999999999 111.713 -176.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 47.4 t80 -88.49 -34.86 17.3 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.83 0.347 . . . . 74.209999999999994 111.214 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.44 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 36.9 m-85 -92.22 -17.7 24.46 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.441 0.534 . . . . 60.310000000000002 112.441 -173.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.75 -22.01 66.25 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.13 0.491 . . . . 72.319999999999993 110.993 178.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -64.15 -35.85 82.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.75 -0.659 . . . . 70.120000000000005 110.752 175.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.459 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 41.8 m-85 -80.93 -21.07 40.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.009 -0.541 . . . . 72.230000000000004 111.12 -176.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.54 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 166.78 -167.4 39.64 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.016 -1.087 . . . . 53.229999999999997 113.066 175.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -79.18 120.97 24.45 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.447 0.642 . . . . 74.230000000000004 111.231 -179.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.534 HG21 HD11 ' A' ' 134' ' ' ILE . 45.6 mt -94.28 133.74 34.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.318 -0.855 . . . . 73.400000000000006 110.039 178.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 154' ' ' ASP . 20.0 mt-10 -78.03 -70.01 0.51 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.203 -0.453 . . . . 74.129999999999995 110.635 176.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 19.4 m -143.54 154.89 16.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.663 -0.244 . . . . 63.43 110.542 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.73 HG21 ' HA ' ' A' ' 118' ' ' GLU . 24.9 mm -107.34 112.69 41.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.574 -0.528 . . . . 62.549999999999997 109.574 174.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 89.6 mt-10 -92.63 99.85 12.47 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.155 0.502 . . . . 70.150000000000006 110.416 -177.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.598 HD11 ' H ' ' A' ' 118' ' ' GLU . 31.8 mt -83.91 108.19 16.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.985 -0.552 . . . . 65.209999999999994 109.652 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.742 ' HG3' ' HB3' ' A' ' 146' ' ' ARG . 24.5 tpp -69.13 108.45 3.6 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.65 0.738 . . . . 73.329999999999998 109.887 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.517 HG22 ' O ' ' A' ' 144' ' ' LYS . 5.0 p -103.35 176.62 5.09 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.104 -0.953 . . . . 60.509999999999998 111.514 -174.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.659 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 19.9 t70 -64.34 138.78 58.6 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.585 -0.734 . . . . 72.019999999999996 109.559 177.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -66.46 -21.97 66.2 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.4 -0.364 . . . . 65.219999999999999 111.193 -174.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -108.8 -57.14 0.55 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.537 -0.84 . . . . 72.519999999999996 112.522 -178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 26.8 t -83.82 -20.54 33.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.797 0.332 . . . . 64.430000000000007 111.035 -174.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 68.63 35.25 80.36 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.726 -0.749 . . . . 72.450000000000003 112.381 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.698 ' HG3' ' H ' ' A' ' 145' ' ' LYS . 39.4 pttt -93.25 -76.79 0.46 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.581 -0.155 . . . . 74.439999999999998 110.581 -178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.698 ' H ' ' HG3' ' A' ' 144' ' ' LYS . 26.3 mtpt -157.15 137.04 12.47 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 122.469 0.307 . . . . 63.350000000000001 110.386 174.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.742 ' HB3' ' HG3' ' A' ' 137' ' ' MET . 31.3 tpt180 -90.51 -26.79 19.59 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.563 -0.903 . . . . 64.329999999999998 108.563 170.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.673 ' C ' H5'' ' B' ' 1' ' ' ' U' . . . 136.97 -74.78 0.41 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.195 -0.911 . . . . 74.319999999999993 111.915 177.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.48 ' HB3' " H5'" ' B' ' 2' ' ' ' C' . 31.2 p90 -78.5 168.15 20.21 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 122.405 0.282 . . . . 72.510000000000005 111.096 -178.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.32 173.28 11.74 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.462 -0.336 . . . . 72.040000000000006 110.741 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.521 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 88.3 m-85 -133.87 148.35 51.25 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.111 -0.495 . . . . 73.120000000000005 110.373 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.63 HG13 ' CD1' ' A' ' 134' ' ' ILE . 55.8 t -127.17 110.94 23.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.189 -0.46 . . . . 74.030000000000001 110.072 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.607 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 25.0 m -89.35 126.71 35.64 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.282 -0.417 . . . . 51.43 110.533 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.495 ' CD2' HG22 ' A' ' 159' ' ' VAL . 96.6 m-85 -108.37 149.12 29.12 Favored 'General case' 0 C--N 1.319 -0.759 0 N-CA-C 110.237 -0.283 . . . . 75.409999999999997 110.237 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.505 ' N ' ' HG3' ' A' ' 132' ' ' GLU . 18.2 t70 -63.65 -29.07 70.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.101 -0.499 . . . . 70.430000000000007 111.439 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -132.21 147.63 52.42 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.289 -0.414 . . . . 64.319999999999993 110.616 -176.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -71.72 -21.1 61.81 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.812 -0.44 . . . . 73.010000000000005 109.812 177.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -58.42 -50.01 75.22 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.86 -0.609 . . . . 74.209999999999994 110.765 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.54 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 9.9 m -60.66 -29.1 69.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.922 -0.581 . . . . 72.340000000000003 110.957 179.231 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.667 HG21 ' HA ' ' A' ' 105' ' ' LYS . 20.9 t -74.29 -37.35 45.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.487 -0.779 . . . . 74.519999999999996 111.081 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.442 ' HA ' HG22 ' A' ' 163' ' ' VAL . 25.8 t70 -60.97 -38.91 87.61 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.361 -0.381 . . . . 72.0 112.025 -172.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.459 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 4.0 mttt -66.01 -18.56 65.42 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.207 0.527 . . . . 73.25 110.825 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.471 ' CG2' HG11 ' A' ' 177' ' ' VAL . 93.2 mt -98.84 -49.86 11.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.494 -0.775 . . . . 75.109999999999999 111.067 -176.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.566 ' HB ' ' HD2' ' A' ' 179' ' ' LYS . 24.7 m -67.36 -18.35 23.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 112.693 0.627 . . . . 73.409999999999997 112.693 -174.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.406 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.0 pp -69.46 -29.33 41.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.054 0.454 . . . . 60.329999999999998 111.063 177.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -108.23 144.62 35.44 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.04 -0.527 . . . . 74.519999999999996 109.887 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.613 ' HE3' ' OE2' ' A' ' 176' ' ' GLU . 84.3 tttt -93.64 -64.27 1.11 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.818 0.342 . . . . 74.430000000000007 111.167 -177.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.563 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 21.8 m-85 -83.17 106.83 15.28 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.076 0.465 . . . . 74.310000000000002 111.223 -176.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 46.9 m-70 -106.7 170.06 8.16 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.68 -0.691 . . . . 63.310000000000002 110.323 178.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 3.7 m -114.57 95.74 5.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.518 -0.31 . . . . 70.109999999999999 110.52 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.41 ' O ' ' HB3' ' A' ' 171' ' ' ASN . 6.7 p -122.75 137.72 55.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 109.629 -0.508 . . . . 71.420000000000002 109.629 178.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.47 HD22 ' CD2' ' A' ' 120' ' ' HIS . 26.0 t-20 69.73 1.93 3.61 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-O 121.641 0.734 . . . . 75.430000000000007 110.496 -178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 91.9 13.53 57.71 Favored Glycine 0 N--CA 1.447 -0.627 0 N-CA-C 111.539 -0.624 . . . . 72.329999999999998 111.539 -177.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 40.7 t-80 -122.88 145.12 48.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 110.071 -0.344 . . . . 74.109999999999999 110.071 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.501 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 9.0 t30 -80.64 105.99 12.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.108 -0.496 . . . . 73.219999999999999 110.214 176.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.456 ' SG ' HG22 ' A' ' 112' ' ' ILE . 25.4 m -115.39 165.85 12.52 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.106 -0.497 . . . . 72.200000000000003 110.294 -178.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.613 ' OE2' ' HE3' ' A' ' 166' ' ' LYS . 20.6 tt0 -99.04 134.51 41.78 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.949 0.404 . . . . 71.200000000000003 110.755 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 83.9 t -126.53 130.47 71.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 115.903 -0.59 . . . . 75.420000000000002 110.521 176.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.44 ' HD3' ' OE2' ' A' ' 176' ' ' GLU . 19.8 mtm-85 -133.58 177.89 7.35 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.075 -0.713 . . . . 74.420000000000002 109.075 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.566 ' HE3' ' HA ' ' A' ' 100' ' ' ALA . 0.3 OUTLIER -72.06 128.9 37.16 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.941 -0.763 . . . . 64.530000000000001 108.941 173.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.755 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -84.37 86.04 7.31 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.446 -0.502 . . . . 54.350000000000001 110.88 177.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.589 HD23 ' N1 ' ' B' ' 3' ' ' ' A' . 2.6 pt? -80.61 135.44 36.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.198 -0.667 . . . . 71.310000000000002 109.198 175.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 19.8 m -49.9 136.15 18.74 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.537 0.523 . . . . 45.340000000000003 111.091 -177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.662 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.8 pttp -63.65 -24.66 67.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.69 0.281 . . . . 73.040000000000006 110.809 -178.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -60.98 -41.06 95.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.195 0.522 . . . . 74.420000000000002 109.94 173.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -84.9 -35.87 21.87 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.507 -0.77 . . . . 74.310000000000002 110.709 -178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.662 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 12.7 ptm -65.22 -20.89 66.65 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.755 0.312 . . . . 74.109999999999999 110.22 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.86 -42.73 60.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.183 -0.462 . . . . 72.430000000000007 110.289 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.2 m -71.56 -31.2 66.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.388 0.614 . . . . 52.109999999999999 110.034 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -82.17 -6.99 59.6 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.424 -0.807 . . . . 61.039999999999999 111.224 178.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . 0.431 ' HB2' ' O ' ' A' ' 186' ' ' MET . 23.0 t -79.6 79.67 6.05 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.599 0.714 . . . . 74.549999999999997 110.577 -176.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 43.5 m -152.56 25.99 0.58 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.961 -1.018 . . . . 75.530000000000001 108.497 176.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 33.1 m -79.52 80.47 5.89 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.876 -1.056 . . . . 60.109999999999999 110.631 -176.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -115.56 11.68 15.93 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.574 -0.739 . . . . 74.400000000000006 109.755 177.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 32.8 mmt180 -93.75 2.47 56.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.941 -0.572 . . . . 62.109999999999999 110.674 -175.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -84.86 47.46 3.86 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.935 -0.65 . . . . 75.510000000000005 111.992 178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 . . . . . 0 C--O 1.245 0.84 0 CA-C-O 118.548 -0.739 . . . . 75.140000000000001 109.613 -178.56 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.908 " H3'" " C5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.726 0 C4'-C3'-C2' 104.958 2.258 . 0.0 '__' . 73.540000000000006 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.908 " C5'" " H3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.845 0 C4'-C3'-C2' 105.367 2.667 . 0.0 OUTLIER zeta-1 75.430000000000007 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.755 ' N1 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.424 -0.982 0 O4'-C4'-C3' 103.342 -1.542 . 0.0 OUTLIER . 74.519999999999996 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.612 " C4'" H5'' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.947 0 C3'-C2'-C1' 99.94 -1.733 . 0.0 OUTLIER alpha 73.420000000000002 . . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.683 ' C4 ' ' HD3' ' A' ' 146' ' ' ARG . . . . . . . . 0 O5'--C5' 1.426 -0.897 0 O4'-C4'-C3' 103.373 -1.519 OUTLIER-EPSILON 0.0 OUTLIER gamma 75.430000000000007 . . . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.53 ' H5 ' " H1'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.98 0 C4'-C3'-C2' 103.589 0.889 . 0.0 OUTLIER epsilon-1 72.409999999999997 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 33.7 p . . . . . 0 N--CA 1.476 0.851 0 CA-C-O 120.368 0.128 . . . . 60.130000000000003 110.71 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.883 ' HG2' ' HG2' ' A' ' 193' ' ' GLN . 77.9 mt-30 59.61 23.6 12.35 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 122.86 0.464 . . . . 62.329999999999998 111.442 178.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.492 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 13.7 mtp180 -118.65 143.88 34.34 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.218 -0.446 . . . . 63.329999999999998 111.603 -175.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.697 ' HA ' HD13 ' A' ' 181' ' ' LEU . 2.0 Cg_endo -86.06 -168.72 0.49 Allowed 'Trans proline' 0 N--CA 1.46 -0.457 0 C-N-CA 123.651 2.901 . . . . 70.519999999999996 111.524 172.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -75.67 80.57 1.04 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.653 -0.784 . . . . 74.519999999999996 111.263 173.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -66.6 -30.59 70.92 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 111.933 0.346 . . . . 63.43 111.933 -175.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.6 p-80 -88.74 9.4 24.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.405 -0.361 . . . . 74.25 111.236 -177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 89.0 mt -104.8 151.88 23.25 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.37 -0.377 . . . . 72.030000000000001 110.529 -178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 p -79.71 97.17 6.47 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.304 0.573 . . . . 65.430000000000007 110.814 176.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.539 HG21 ' HB3' ' A' ' 179' ' ' LYS . 2.7 t -92.39 148.71 4.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.575 -0.739 . . . . 74.209999999999994 109.836 -178.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.738 ' HA ' HG21 ' A' ' 159' ' ' VAL . 7.0 mtmt -122.48 24.15 9.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.379 0.609 . . . . 73.400000000000006 110.332 -179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.531 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.8 ttpt -159.42 135.08 8.54 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.407 -0.815 . . . . 74.340000000000003 109.454 178.048 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.556 HG12 ' HB ' ' A' ' 151' ' ' VAL . 6.1 pt -106.44 160.6 5.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.806 0.336 . . . . 72.109999999999999 111.064 -178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.432 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 58.9 t80 -107.07 119.35 39.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.784 -0.644 . . . . 64.340000000000003 110.171 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.418 HG11 HD11 ' A' ' 121' ' ' LEU . 43.0 t -101.3 103.16 14.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.945 0.403 . . . . 72.319999999999993 110.357 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -125.68 178.45 16.63 Favored Glycine 0 N--CA 1.445 -0.749 0 N-CA-C 111.284 -0.726 . . . . 63.439999999999998 111.284 178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.784 ' H ' H5'' ' B' ' 2' ' ' ' C' . . . 68.73 26.13 74.7 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.645 -0.788 . . . . 63.020000000000003 112.928 177.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.58 ' O ' " H3'" ' B' ' 1' ' ' ' U' . 28.4 pt -85.45 -163.64 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.255 -0.646 . . . . 74.340000000000003 109.255 176.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 53.9 tttp -140.08 -67.33 0.43 Allowed 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.335 -0.546 . . . . 64.040000000000006 110.875 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -88.9 168.9 12.03 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.778 -0.646 . . . . 72.349999999999994 110.431 -178.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -62.13 105.56 0.61 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.18 0.514 . . . . 64.109999999999999 110.732 -178.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.6 m -101.74 117.04 34.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.428 -0.805 . . . . 72.200000000000003 109.454 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.62 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 13.1 pt-20 -97.96 -177.33 3.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.826 0.346 . . . . 75.140000000000001 111.515 -172.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.645 ' HA ' HG21 ' A' ' 134' ' ' ILE . 13.7 tt0 -59.18 -45.88 89.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.01 -0.541 . . . . 75.400000000000006 111.555 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.419 ' HD2' ' CD ' ' A' ' 117' ' ' GLU . 0.0 OUTLIER -60.23 -27.54 67.29 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.324 -0.398 . . . . 44.210000000000001 110.715 -178.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.62 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 30.0 m80 -72.48 -60.75 2.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.56 -0.291 . . . . 64.209999999999994 111.017 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.43 HD13 HG11 ' A' ' 170' ' ' VAL . 0.9 OUTLIER -57.57 -49.22 77.09 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.983 0.421 . . . . 71.109999999999999 110.251 -179.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.408 ' HD3' HD12 ' A' ' 131' ' ' ILE . 0.9 OUTLIER -56.74 -44.68 81.91 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.811 -0.631 . . . . 73.25 111.144 -178.739 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -59.21 -31.11 68.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.804 0.335 . . . . 73.129999999999995 111.411 -175.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.412 ' CD1' HG22 ' A' ' 170' ' ' VAL . 78.7 t80 -86.97 -49.32 7.44 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.984 0.421 . . . . 73.140000000000001 111.09 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.506 ' CD1' HG21 ' A' ' 151' ' ' VAL . 65.3 m-85 -78.24 -14.01 59.61 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.579 0.585 . . . . 62.43 112.579 -171.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -65.07 -25.23 67.72 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 111.68 0.252 . . . . 60.119999999999997 111.68 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -72.78 -19.33 61.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.949 0.404 . . . . 62.509999999999998 110.615 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.448 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 88.7 m-85 -83.86 -35.19 24.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.11 -0.495 . . . . 73.219999999999999 110.485 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 178.41 -167.67 38.36 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.438 -0.887 . . . . 72.530000000000001 112.556 177.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.2 tttt -77.59 122.68 25.61 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.206 0.526 . . . . 74.109999999999999 111.173 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.542 HG21 HD11 ' A' ' 134' ' ' ILE . 42.0 mt -97.41 131.15 44.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.604 -0.725 . . . . 61.32 110.504 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.416 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 7.2 mm-40 -78.01 -72.28 0.37 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.652 -0.704 . . . . 75.219999999999999 110.566 176.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.7 m -145.49 147.29 18.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.524 -0.307 . . . . 64.129999999999995 110.725 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.645 HG21 ' HA ' ' A' ' 118' ' ' GLU . 30.3 mm -102.83 107.71 22.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.888 -0.412 . . . . 72.409999999999997 109.888 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.511 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 38.1 mt-10 -85.96 103.2 14.45 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.792 -0.447 . . . . 72.439999999999998 109.792 178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.612 HG21 ' HG2' ' A' ' 145' ' ' LYS . 23.9 mt -78.81 -11.24 13.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.089 0.471 . . . . 72.25 110.328 -178.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.602 ' HE1' " O3'" ' B' ' 4' ' ' ' G' . 14.0 tpp 62.31 96.99 0.03 OUTLIER 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.945 0.879 . . . . 72.230000000000004 110.651 -177.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 5.1 p -101.63 151.08 22.43 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 114.963 -1.017 . . . . 72.150000000000006 110.69 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.67 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 17.6 t70 -52.4 142.21 17.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.585 -0.734 . . . . 72.329999999999998 110.525 179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.418 ' HD3' ' C6 ' ' B' ' 5' ' ' ' U' . 15.8 tpt180 -65.43 -20.69 66.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.66 -0.7 . . . . 73.329999999999998 111.783 -171.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -122.52 -44.19 0.36 Allowed Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.491 -0.862 . . . . 44.020000000000003 113.063 -177.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.59 ' HB2' ' HG2' ' A' ' 144' ' ' LYS . 19.8 m -80.46 -21.85 41.66 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.787 0.327 . . . . 51.329999999999998 111.155 -175.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.84 33.54 80.2 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.062 -0.589 . . . . 51.140000000000001 112.385 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.59 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 14.0 ptpt -106.13 146.76 29.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.098 -0.334 . . . . 63.32 110.098 -179.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . 0.612 ' HG2' HG21 ' A' ' 136' ' ' ILE . 16.9 mtpt -58.41 124.05 18.24 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.699 0.285 . . . . 72.329999999999998 110.528 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.428 ' HD2' ' O4 ' ' B' ' 5' ' ' ' U' . 69.1 ttt180 -81.12 -55.58 4.66 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.925 -0.579 . . . . 74.219999999999999 111.663 -173.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 168.43 -77.32 0.11 Allowed Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.461 -0.876 . . . . 71.109999999999999 112.253 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.488 ' CE2' " H4'" ' B' ' 3' ' ' ' A' . 45.9 p90 -71.36 145.53 49.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 110.406 -0.22 . . . . 64.25 110.406 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -128.43 165.41 20.7 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.332 0.587 . . . . 54.130000000000003 111.443 -176.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.511 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 66.0 m-85 -132.06 136.28 47.09 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.442 -0.799 . . . . 73.409999999999997 109.757 -177.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.631 HG13 ' CD1' ' A' ' 134' ' ' ILE . 38.9 t -111.34 104.82 17.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 N-CA-C 109.864 -0.421 . . . . 64.319999999999993 109.864 178.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.531 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 7.5 m -83.79 125.87 32.36 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.941 -0.572 . . . . 75.409999999999997 110.065 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.541 ' CD2' HG22 ' A' ' 159' ' ' VAL . 98.7 m-85 -109.5 151.55 26.59 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 110.074 -0.343 . . . . 64.040000000000006 110.074 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.416 ' HB2' ' HG2' ' A' ' 132' ' ' GLU . 26.6 t70 -78.53 -6.38 55.29 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.209 0.528 . . . . 74.150000000000006 111.163 178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.444 ' O ' HG23 ' A' ' 159' ' ' VAL . 5.6 t70 -140.19 145.68 37.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.174 -0.466 . . . . 74.140000000000001 110.31 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -79.21 -18.44 52.93 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.148 -0.478 . . . . 65.120000000000005 110.56 178.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -73.07 -38.56 66.39 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.205 0.526 . . . . 71.010000000000005 110.064 -178.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 13.2 m -64.65 -28.66 69.76 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.518 -0.765 . . . . 52.450000000000003 110.371 177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.738 HG21 ' HA ' ' A' ' 105' ' ' LYS . 22.7 t -76.78 -36.56 26.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.66 -0.7 . . . . 74.310000000000002 110.201 178.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -61.29 -31.09 70.91 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.732 -0.667 . . . . 73.030000000000001 111.387 -177.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.448 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 13.0 mmtp -65.1 -27.57 68.84 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.47 0.652 . . . . 54.439999999999998 110.021 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.54 HG21 HD13 ' A' ' 107' ' ' ILE . 90.4 mt -100.23 -50.18 10.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 114.949 -1.023 . . . . 73.530000000000001 111.828 -168.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.607 ' HB ' ' HG3' ' A' ' 179' ' ' LYS . 28.1 m -65.73 -16.76 21.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 112.448 0.536 . . . . 70.340000000000003 112.448 -173.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.5 pp -74.48 -26.83 20.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 120.965 0.412 . . . . 65.349999999999994 110.781 176.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.407 ' N ' HD12 ' A' ' 164' ' ' ILE . 29.0 tt0 -100.42 146.2 27.3 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.695 -0.684 . . . . 71.200000000000003 109.2 175.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -100.63 -66.06 0.93 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.762 0.315 . . . . 62.399999999999999 110.598 -177.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 19.7 m-85 -82.49 101.85 10.97 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.131 0.491 . . . . 62.399999999999999 111.11 -177.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 42.5 m-70 -98.0 -172.8 2.44 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.721 -0.672 . . . . 74.129999999999995 109.593 176.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 61.4 m -141.64 106.63 4.94 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.222 0.534 . . . . 54.130000000000003 110.821 177.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.43 HG11 HD13 ' A' ' 121' ' ' LEU . 39.2 t -121.18 135.32 61.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.631 -0.713 . . . . 62.32 109.739 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.403 ' HB3' ' O ' ' A' ' 170' ' ' VAL . 7.9 t30 71.47 -4.62 1.81 Allowed 'General case' 0 N--CA 1.471 0.602 0 CA-C-O 121.277 0.56 . . . . 75.450000000000003 111.393 177.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 109.19 4.87 30.81 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.954 -0.641 . . . . 70.200000000000003 111.752 -176.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.469 ' CD2' ' HA ' ' A' ' 112' ' ' ILE . 80.3 t60 -114.63 131.61 56.65 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.917 0.389 . . . . 63.539999999999999 110.326 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -74.64 103.15 4.83 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.896 -0.593 . . . . 71.129999999999995 109.585 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.496 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 14.9 p -103.8 176.96 4.98 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.162 -0.472 . . . . 62.310000000000002 110.77 -175.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -118.34 120.38 37.44 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.083 0.468 . . . . 74.109999999999999 110.117 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.432 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 87.1 t -113.35 135.09 54.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.898 -0.592 . . . . 72.019999999999996 111.045 -175.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 78.5 mtt180 -129.12 179.67 5.63 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.553 -0.749 . . . . 73.400000000000006 109.742 177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.607 ' HG3' ' HB ' ' A' ' 163' ' ' VAL . 0.6 OUTLIER -77.67 122.07 24.84 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 107.918 -1.141 . . . . 70.109999999999999 107.918 172.391 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.544 ' HA ' ' C2 ' ' B' ' 3' ' ' ' A' . . . -77.12 89.8 3.63 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.513 -0.475 . . . . 63.009999999999998 111.199 -178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.697 HD13 ' HA ' ' A' ' 98' ' ' PRO . 2.3 pt? -81.35 138.96 35.6 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.805 -0.813 . . . . 53.200000000000003 108.805 175.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 5.1 m -54.15 145.9 16.19 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 110.085 -0.339 . . . . 52.039999999999999 110.085 -178.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.74 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.4 pttp -61.92 -17.51 57.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.921 0.391 . . . . 64.140000000000001 110.31 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -67.67 -51.98 43.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.377 0.608 . . . . 74.209999999999994 109.738 170.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -64.96 -41.64 95.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.309 -0.86 . . . . 75.019999999999996 110.553 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.74 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 16.4 ptm -72.76 -13.17 61.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.946 -0.57 . . . . 64.120000000000005 110.692 -177.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -86.27 -11.26 52.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.031 0.443 . . . . 42.43 110.334 175.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 16.0 m -111.57 -46.07 3.31 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.888 -0.596 . . . . 50.229999999999997 111.37 -178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -90.88 -38.22 13.06 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.002 0.429 . . . . 63.32 111.782 -176.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 9.8 m -107.75 31.51 5.41 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.235 -0.439 . . . . 70.209999999999994 110.651 -175.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 2.8 m -62.24 -28.8 69.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.922 -0.581 . . . . 65.219999999999999 111.415 -177.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 30.4 m -97.76 75.64 2.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.218 0.532 . . . . 63.299999999999997 111.341 -178.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . 0.883 ' HG2' ' HG2' ' A' ' 96' ' ' GLN . 0.0 OUTLIER -136.87 95.47 3.13 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.389 -0.967 . . . . 70.120000000000005 108.389 173.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 25.5 mmt180 -87.12 103.19 15.16 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.909 0.385 . . . . 72.319999999999993 111.178 -174.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -87.64 -10.82 69.52 Favored Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.198 -0.761 . . . . 55.009999999999998 111.198 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 7.7 tpm_? . . . . . 0 C--O 1.245 0.82 0 CA-C-O 118.395 -0.812 . . . . 73.120000000000005 110.089 178.579 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.948 " H4'" " C5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.43 -0.6 0 C4'-C3'-C2' 105.212 2.512 OUTLIER-EPSILON 0.0 '__' . 75.540000000000006 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.948 " C5'" " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.053 0 C4'-C3'-C2' 106.123 3.423 . 0.0 OUTLIER epsilon-1 75.420000000000002 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.544 ' C2 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.425 -0.955 0 C3'-C2'-C1' 103.189 1.876 . 0.0 OUTLIER alpha 75.219999999999999 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.602 " O3'" ' HE1' ' A' ' 137' ' ' MET . . . . . . . . 0 O5'--C5' 1.423 -1.043 0 C3'-C2'-C1' 99.722 -1.975 . 0.0 OUTLIER alpha 75.409999999999997 . . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.711 ' C6 ' " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.059 0 C4'-C3'-C2' 105.777 3.077 OUTLIER-DELTA 0.0 OUTLIER . 74.200000000000003 . . . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.576 ' H6 ' " O5'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 P-O3'-C3' 118.933 -0.639 . 0.0 OUTLIER gamma 75.430000000000007 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 21.8 t . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.635 -0.506 . . . . 42.420000000000002 109.635 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.574 ' O ' ' HD3' ' A' ' 98' ' ' PRO . 73.1 mt-30 71.94 -46.75 0.65 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 123.573 0.749 . . . . 61.210000000000001 111.702 -178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.633 ' HB3' ' HB2' ' A' ' 100' ' ' ALA . 12.5 mmt180 -110.63 87.64 6.83 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.726 -0.216 . . . . 74.019999999999996 110.519 -179.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.574 ' HD3' ' O ' ' A' ' 96' ' ' GLN . 6.1 Cg_exo -74.77 -39.18 1.41 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.637 2.225 . . . . 64.340000000000003 111.597 178.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.472 ' HA3' HD12 ' A' ' 102' ' ' LEU . . . -140.88 67.49 0.49 Allowed Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.379 -0.828 . . . . 51.130000000000003 111.47 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.818 ' HA ' ' HE3' ' A' ' 179' ' ' LYS . . . -74.82 -33.37 62.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.956 0.408 . . . . 55.240000000000002 110.833 -178.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 48.7 p-80 -83.3 -2.63 56.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.857 -0.61 . . . . 74.150000000000006 110.338 177.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.472 HD12 ' HA3' ' A' ' 99' ' ' GLY . 68.6 mt -99.5 177.61 5.12 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.702 -0.681 . . . . 75.319999999999993 109.62 179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.57 HG22 ' HB2' ' A' ' 156' ' ' HIS . 0.5 OUTLIER -118.13 129.51 55.57 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.167 0.508 . . . . 75.140000000000001 111.165 -177.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.456 HG12 ' H ' ' A' ' 106' ' ' LYS . 39.7 t -116.11 148.58 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-N 115.883 -0.599 . . . . 70.409999999999997 110.183 -175.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.641 ' HA ' HG21 ' A' ' 159' ' ' VAL . 0.0 OUTLIER -116.84 -3.75 11.64 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 112.244 0.461 . . . . 62.439999999999998 112.244 -177.602 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.607 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 26.0 ttpt -135.31 138.59 43.58 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.015 -0.365 . . . . 63.109999999999999 110.015 177.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.48 HG13 ' HB ' ' A' ' 151' ' ' VAL . 2.1 pp -106.35 154.35 7.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.984 0.421 . . . . 74.310000000000002 110.759 -179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.421 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 62.4 t80 -102.23 127.21 49.28 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.586 -0.734 . . . . 71.140000000000001 109.996 179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.505 HG21 ' HG ' ' A' ' 121' ' ' LEU . 46.7 t -102.31 110.03 27.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 120.88 0.372 . . . . 72.540000000000006 110.581 179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -129.85 -174.23 13.64 Favored Glycine 0 N--CA 1.442 -0.92 0 N-CA-C 110.957 -0.857 . . . . 71.109999999999999 110.957 175.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 67.38 16.91 67.86 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 121.219 -0.515 . . . . 63.240000000000002 113.313 177.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.632 ' O ' " H3'" ' B' ' 1' ' ' ' U' . 18.1 pt -91.58 173.38 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 117.115 0.458 . . . . 72.099999999999994 109.869 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -145.8 -48.32 0.22 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 121.002 -0.279 . . . . 75.120000000000005 110.742 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -74.91 165.85 24.59 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.361 -0.381 . . . . 73.409999999999997 110.523 178.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -64.93 103.67 0.75 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.11 0.481 . . . . 64.019999999999996 110.207 -179.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.6 m -113.05 116.76 30.42 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.645 -0.707 . . . . 64.019999999999996 109.948 -176.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.443 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 12.2 pt-20 -113.71 -171.95 1.99 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.359 -0.382 . . . . 63.219999999999999 110.972 -175.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.604 ' H ' HD11 ' A' ' 136' ' ' ILE . 8.5 tt0 -58.19 -46.41 85.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.877 -0.601 . . . . 73.349999999999994 112.347 -173.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.439 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 0.8 OUTLIER -62.41 -28.98 70.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.699 0.285 . . . . 74.409999999999997 110.673 -178.217 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.443 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 32.3 m80 -68.05 -56.37 9.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.355 -0.384 . . . . 73.129999999999995 110.791 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.505 ' HG ' HG21 ' A' ' 109' ' ' VAL . 0.8 OUTLIER -60.79 -51.63 68.5 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.282 -0.417 . . . . 62.219999999999999 110.558 179.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.438 ' HB2' HG13 ' A' ' 134' ' ' ILE . 0.6 OUTLIER -55.06 -49.56 71.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.023 -0.535 . . . . 75.239999999999995 111.648 -177.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -59.15 -30.14 67.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 55.299999999999997 111.218 -175.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.456 ' CD1' HG22 ' A' ' 170' ' ' VAL . 76.6 t80 -85.25 -47.92 9.6 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.814 -0.354 . . . . 64.099999999999994 111.111 179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.521 ' CD1' HG21 ' A' ' 151' ' ' VAL . 42.8 m-85 -77.48 -18.15 57.37 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.373 0.508 . . . . 64.140000000000001 112.373 -172.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.55 -24.51 67.63 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.804 0.335 . . . . 62.43 111.618 -179.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -76.19 -14.71 60.14 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.108 0.48 . . . . 54.340000000000003 110.202 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 75.5 m-85 -87.72 -25.52 23.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.009 -0.541 . . . . 75.140000000000001 110.319 178.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.501 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 165.22 -151.17 19.82 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 119.912 -1.137 . . . . 44.130000000000003 113.689 175.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.614 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 20.4 tptm -91.23 117.07 29.33 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 121.394 0.616 . . . . 62.420000000000002 111.279 -172.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.454 HG12 ' CE1' ' A' ' 153' ' ' PHE . 38.2 mt -99.81 138.8 23.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 115.325 -0.852 . . . . 75.140000000000001 110.69 -179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.427 ' HG3' ' CA ' ' A' ' 154' ' ' ASP . 21.8 mt-10 -82.59 -75.38 0.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.021 -0.536 . . . . 73.140000000000001 110.341 172.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 21.6 m -143.97 152.4 15.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.616 -0.72 . . . . 71.540000000000006 110.079 -178.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.609 ' CD1' HG13 ' A' ' 151' ' ' VAL . 22.7 mm -100.84 138.23 25.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.907 -0.775 . . . . 72.129999999999995 108.907 175.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.466 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 44.7 mt-10 -117.94 97.94 6.08 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 120.815 0.34 . . . . 72.329999999999998 110.743 -178.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.604 HD11 ' H ' ' A' ' 118' ' ' GLU . 8.5 mt -76.21 105.51 5.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 108.066 -1.087 . . . . 71.420000000000002 108.066 172.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.601 ' HE2' " H4'" ' B' ' 4' ' ' ' G' . 10.4 tpt -79.94 98.46 7.16 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.855 0.836 . . . . 53.32 111.272 -171.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 7.5 p -89.72 -170.28 2.76 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 115.002 -0.999 . . . . 64.219999999999999 110.339 176.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -88.68 129.47 35.51 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.53 -0.544 . . . . 61.409999999999997 109.53 174.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.41 ' HD3' ' N1 ' ' B' ' 5' ' ' ' U' . 22.1 tpt180 -62.29 -19.15 62.97 Favored 'General case' 0 C--N 1.323 -0.575 0 O-C-N 123.421 0.45 . . . . 65.150000000000006 111.984 -177.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -105.6 -53.45 0.77 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.343 -0.932 . . . . 72.150000000000006 112.73 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.568 ' HB2' ' HG2' ' A' ' 144' ' ' LYS . 43.1 m -86.19 -16.95 36.18 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 111.872 0.323 . . . . 72.549999999999997 111.872 -173.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.29 36.76 92.15 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.972 -0.632 . . . . 73.510000000000005 112.489 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.568 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 13.1 ptpt -114.1 146.29 40.46 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.771 -0.455 . . . . 72.109999999999999 109.771 -179.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -63.15 118.83 8.47 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.729 -0.389 . . . . 71.310000000000002 110.201 179.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 48.5 mtm180 -86.6 3.22 45.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.168 0.508 . . . . 72.340000000000003 110.598 179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.464 ' HA3' " H1'" ' B' ' 1' ' ' ' U' . . . 109.1 -65.94 0.24 Allowed Glycine 0 N--CA 1.444 -0.797 0 C-N-CA 120.943 -0.646 . . . . 64.219999999999999 112.799 174.723 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.505 ' HA ' ' OP2' ' B' ' 2' ' ' ' C' . 33.0 p90 -75.82 150.6 37.65 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.269 0.556 . . . . 72.420000000000002 111.841 -173.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -135.26 171.9 13.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.514 -0.766 . . . . 54.409999999999997 110.274 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.466 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 70.1 m-85 -136.64 152.09 50.03 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.355 -0.384 . . . . 73.329999999999998 110.115 -178.14 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.609 HG13 ' CD1' ' A' ' 134' ' ' ILE . 62.1 t -128.49 110.48 21.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-N 116.133 -0.485 . . . . 71.430000000000007 109.88 177.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.607 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 97.0 m -86.17 125.02 33.21 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.109 -0.496 . . . . 73.420000000000002 110.085 179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.454 ' CE1' HG12 ' A' ' 131' ' ' ILE . 97.0 m-85 -106.06 146.79 29.68 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 120.871 0.367 . . . . 64.430000000000007 110.346 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.614 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 21.4 t0 -78.32 -19.13 54.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.535 0.683 . . . . 73.230000000000004 109.633 179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -128.89 132.71 47.73 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.222 -0.899 . . . . 52.119999999999997 109.694 -178.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.57 ' HB2' HG22 ' A' ' 103' ' ' THR . 2.2 p-80 -73.96 -14.01 60.97 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.203 -0.453 . . . . 55.409999999999997 110.474 177.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -66.33 -40.84 90.13 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.195 0.522 . . . . 64.129999999999995 110.025 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.644 ' HA ' ' HE3' ' A' ' 161' ' ' LYS . 4.6 m -66.76 -28.54 68.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.419 -0.81 . . . . 52.149999999999999 110.986 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.641 HG21 ' HA ' ' A' ' 105' ' ' LYS . 18.7 t -72.57 -35.11 49.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.722 -0.672 . . . . 62.039999999999999 111.22 -176.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -56.74 -51.47 68.73 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.084 -0.507 . . . . 71.129999999999995 111.897 -174.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.644 ' HE3' ' HA ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -65.16 -14.08 59.72 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 111.996 0.369 . . . . 70.239999999999995 111.996 -178.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 94.5 mt -93.7 -48.27 13.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 120.661 0.267 . . . . 72.030000000000001 110.926 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.405 HG13 HG12 ' A' ' 159' ' ' VAL . 35.6 m -69.69 -19.42 22.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 112.343 0.497 . . . . 61.229999999999997 112.343 -175.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.5 pp -67.39 -30.72 49.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.78 0.324 . . . . 63.340000000000003 111.529 -179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.506 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 14.0 pt20 -113.49 145.99 40.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.389 -0.369 . . . . 74.349999999999994 110.17 177.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.569 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 77.0 tttt -91.27 -60.09 1.98 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.051 -0.522 . . . . 73.120000000000005 110.513 -178.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.566 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 7.9 m-30 -72.47 110.53 6.93 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.259 0.552 . . . . 75.439999999999998 111.234 -179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.577 ' CD2' ' HB ' ' A' ' 177' ' ' VAL . 37.7 m-70 -110.85 170.92 7.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.303 -0.862 . . . . 64.340000000000003 109.583 173.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.7 m -119.41 96.04 5.04 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.841 0.353 . . . . 52.549999999999997 110.384 177.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.486 HG11 HD13 ' A' ' 121' ' ' LEU . 47.5 t -117.2 130.89 71.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 116.324 -0.398 . . . . 72.340000000000003 110.126 -178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.4 t30 59.7 31.49 20.9 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.509 0.671 . . . . 73.340000000000003 110.477 179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 70.57 19.28 76.27 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.925 -0.58 . . . . 63.439999999999998 112.211 -178.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.459 ' CD2' ' HA ' ' A' ' 112' ' ' ILE . 67.9 t60 -122.84 129.7 51.99 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.85 0.357 . . . . 71.200000000000003 110.617 -177.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -73.28 112.1 9.03 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.472 -0.566 . . . . 73.099999999999994 109.472 174.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 18.9 p -121.65 173.55 7.37 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.814 0.34 . . . . 75.510000000000005 111.382 -174.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.569 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 10.8 tt0 -108.41 116.92 32.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.838 -0.619 . . . . 75.109999999999999 110.064 179.134 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.577 ' HB ' ' CD2' ' A' ' 168' ' ' HIS . 59.4 t -120.26 134.68 62.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.883 0 CA-C-N 116.233 -0.44 . . . . 71.510000000000005 110.493 179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -150.54 -177.98 6.28 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.858 -0.61 . . . . 75.510000000000005 110.294 178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.818 ' HE3' ' HA ' ' A' ' 100' ' ' ALA . 55.2 mttm -63.78 133.23 53.07 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.961 -0.385 . . . . 62.030000000000001 109.961 179.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.488 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -88.3 86.67 7.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.192 0.52 . . . . 73.030000000000001 110.538 178.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.734 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.3 pt? -80.8 127.55 32.65 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.764 -0.828 . . . . 72.299999999999997 108.764 174.377 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 47.5 t -56.02 156.66 5.16 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.105 -0.498 . . . . 62.43 110.548 -176.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.897 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.3 pttp -63.73 -15.13 57.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.293 0.568 . . . . 63.520000000000003 109.83 175.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . 0.437 ' HA ' ' OE1' ' A' ' 184' ' ' GLN . 6.6 tp60 -71.7 -38.02 70.6 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.566 -0.743 . . . . 74.310000000000002 109.823 172.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -87.22 -41.34 13.79 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.483 -0.78 . . . . 74.319999999999993 111.116 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.897 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.7 ptm -70.66 -16.24 62.79 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.263 -0.426 . . . . 72.150000000000006 110.72 -177.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -71.34 -24.66 62.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.375 0.607 . . . . 73.109999999999999 109.721 174.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.5 m -93.38 -35.17 13.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.103 -0.953 . . . . 50.25 110.459 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -76.55 -50.26 14.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.86 -0.609 . . . . 74.400000000000006 111.446 -176.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 49.6 m -78.04 108.97 11.71 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.94 -0.573 . . . . 71.319999999999993 110.697 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 21.3 m -66.08 -32.47 73.95 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.866 -0.606 . . . . 73.239999999999995 111.065 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 37.0 m -62.78 -25.84 68.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.813 0.34 . . . . 61.450000000000003 111.264 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -63.76 -24.7 67.87 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.213 0.53 . . . . 71.540000000000006 110.349 179.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 4.8 tpp180 -108.76 14.56 24.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.344 0.593 . . . . 72.439999999999998 109.675 179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -89.62 -69.74 1.24 Allowed Glycine 0 N--CA 1.446 -0.637 0 CA-C-N 115.667 -0.697 . . . . 71.400000000000006 111.918 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.754 ' HD3' ' H ' ' A' ' 196' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.158 0 CA-C-O 118.546 -0.74 . . . . 72.340000000000003 109.555 176.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 1.014 " H4'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.694 0 O5'-C5'-C4' 111.277 0.769 OUTLIER-EPSILON 0.0 '__' . 75.439999999999998 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 1.014 H5'' " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.422 -1.131 0 C4'-C3'-C2' 105.699 2.999 . 0.0 OUTLIER epsilon-1 75.299999999999997 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.658 ' H8 ' H5'' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.423 -1.07 0 O4'-C4'-C3' 103.135 -1.689 . 0.0 OUTLIER . 75.129999999999995 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.601 " H4'" ' HE2' ' A' ' 137' ' ' MET . . . . . . . . 0 O5'--C5' 1.424 -0.969 0 C4'-C3'-C2' 104.998 2.298 . 0.0 OUTLIER alpha 72.340000000000003 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.574 ' OP2' ' HE2' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.42 -1.246 0 O4'-C1'-C2' 108.16 1.257 . 0.0 OUTLIER gamma 61.020000000000003 . . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.424 -0.981 0 C4'-C3'-C2' 103.439 0.739 . 0.01 2u . 75.140000000000001 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 109.691 -0.485 . . . . 61.009999999999998 109.691 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -76.87 -65.85 0.89 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.757 -0.201 . . . . 72.5 110.961 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.485 ' HD2' ' HA ' ' A' ' 164' ' ' ILE . 42.9 mtp180 53.28 69.84 2.09 Favored Pre-proline 0 N--CA 1.465 0.322 0 CA-C-N 116.14 -0.482 . . . . 74.519999999999996 110.858 -174.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.508 ' HG2' ' HB2' ' A' ' 179' ' ' LYS . 28.9 Cg_endo -63.72 120.14 7.43 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.66 2.24 . . . . 74.030000000000001 112.416 -177.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 67.29 60.06 6.27 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 111.099 -0.8 . . . . 63.329999999999998 111.099 -177.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -70.26 -21.81 62.93 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.666 0.269 . . . . 72.230000000000004 111.605 -173.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 57.0 p-80 -83.05 -1.33 52.44 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.424 0.631 . . . . 75.239999999999995 110.287 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 66.4 mt -105.97 108.62 20.22 Favored 'General case' 0 C--O 1.238 0.491 0 CA-C-N 115.546 -0.752 . . . . 72.25 109.764 178.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 12.0 p -62.04 114.14 3.23 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.338 0.589 . . . . 71.200000000000003 110.504 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.499 HG22 ' H ' ' A' ' 106' ' ' LYS . 9.6 p -107.1 136.38 42.36 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-N 115.771 -0.649 . . . . 74.329999999999998 110.273 -173.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.442 ' HE2' ' HB3' ' A' ' 156' ' ' HIS . 0.0 OUTLIER -105.59 -0.85 25.35 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.931 0.396 . . . . 54.299999999999997 110.903 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.636 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 24.0 ttpt -133.98 136.69 44.3 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.107 0.479 . . . . 73.519999999999996 110.807 -179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.505 HG12 ' HB ' ' A' ' 151' ' ' VAL . 9.2 pt -107.95 162.57 6.05 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 116.132 -0.485 . . . . 71.5 110.642 178.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 61.6 t80 -110.23 118.05 35.3 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.846 -0.616 . . . . 61.030000000000001 110.078 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 30.6 t -106.84 103.04 14.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 109.506 -0.553 . . . . 73.299999999999997 109.506 175.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -117.77 136.27 12.33 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.656 -0.783 . . . . 72.340000000000003 112.364 -178.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.534 ' N ' " H5'" ' B' ' 2' ' ' ' C' . . . 131.27 -12.63 5.49 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.134 -1.032 . . . . 51.030000000000001 112.929 176.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.921 HD11 ' HA ' ' A' ' 148' ' ' PHE . 0.1 OUTLIER -68.2 91.06 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 122.091 0.948 . . . . 74.129999999999995 111.239 -179.006 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 18.8 ttpp -94.83 4.01 54.33 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.789 -1.096 . . . . 75.150000000000006 109.966 -177.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -121.83 -174.28 2.84 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.383 -0.826 . . . . 75.420000000000002 109.679 177.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -72.39 107.18 4.83 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.229 0.537 . . . . 52.509999999999998 110.899 -178.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 25.8 m -144.32 128.69 17.9 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.679 -0.691 . . . . 63.020000000000003 109.274 177.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -125.52 -166.17 1.51 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.253 0.549 . . . . 61.439999999999998 112.1 -173.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.609 ' HG2' ' CG1' ' A' ' 134' ' ' ILE . 2.8 tm-20 -60.41 -47.14 87.37 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.181 -0.918 . . . . 74.340000000000003 111.475 -179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -62.96 -30.8 71.85 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 120.883 -0.327 . . . . 75.530000000000001 110.524 -176.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -66.68 -59.62 3.42 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 120.943 0.401 . . . . 64.420000000000002 110.611 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.524 ' HA ' HG21 ' A' ' 170' ' ' VAL . 8.5 mp -60.0 -47.94 83.76 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.769 -0.651 . . . . 43.409999999999997 111.359 -177.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.472 ' HG3' HD12 ' A' ' 131' ' ' ILE . 3.1 ttp180 -62.06 -41.78 98.51 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 121.062 -0.255 . . . . 42.549999999999997 111.359 -177.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -57.24 -30.42 64.61 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.339 0.59 . . . . 71.409999999999997 111.061 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 46.9 t80 -88.43 -47.04 8.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.788 -0.642 . . . . 73.099999999999994 111.156 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.408 ' HA ' ' HD2' ' A' ' 128' ' ' TYR . 51.8 m-85 -80.11 -12.12 59.7 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 112.528 0.566 . . . . 61.509999999999998 112.528 -173.25 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.67 -24.8 66.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.84 0.352 . . . . 71.239999999999995 111.568 -179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -72.57 -20.7 61.27 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.321 -0.4 . . . . 72.239999999999995 110.451 -179.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.474 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 89.0 m-85 -82.15 -38.82 24.14 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.048 -0.524 . . . . 73.450000000000003 110.023 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.447 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 176.86 -168.47 40.42 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.229 -0.986 . . . . 75.329999999999998 113.277 178.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.566 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 40.1 tptt -74.33 116.41 14.96 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 121.405 0.621 . . . . 71.219999999999999 111.4 -177.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.504 HG21 HD11 ' A' ' 134' ' ' ILE . 33.0 mt -92.53 140.51 16.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.324 -0.853 . . . . 74.329999999999998 110.542 178.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -86.91 -72.46 0.51 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.09 -0.504 . . . . 70.310000000000002 110.405 175.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 16.0 m -143.72 140.41 25.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 73.439999999999998 111.325 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.627 ' CD1' HG13 ' A' ' 151' ' ' VAL . 21.3 mm -95.1 101.61 12.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.611 -0.514 . . . . 63.450000000000003 109.611 174.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -84.67 94.74 8.71 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.939 -0.393 . . . . 60.520000000000003 109.939 -178.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.538 HD11 ' H ' ' A' ' 118' ' ' GLU . 7.1 mt -73.05 100.91 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.005 -1.109 . . . . 63.149999999999999 108.005 175.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 10.7 tpt -61.38 108.89 1.01 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.381 0.61 . . . . 73.140000000000001 110.494 -173.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.6 p -121.78 158.82 27.99 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.018 -0.992 . . . . 71.319999999999993 110.257 -177.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.8 ' HA ' ' C4 ' ' B' ' 5' ' ' ' U' . 19.0 t0 -56.73 136.48 55.11 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.255 -0.429 . . . . 73.230000000000004 110.889 178.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.479 ' HD2' " H1'" ' B' ' 5' ' ' ' U' . 0.2 OUTLIER -71.95 -12.27 61.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.663 -0.699 . . . . 73.310000000000002 111.011 -175.216 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -109.95 -60.15 0.51 Allowed Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.609 -0.805 . . . . 72.209999999999994 112.328 178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.584 ' HB2' ' HG2' ' A' ' 144' ' ' LYS . 2.2 m -79.49 -25.02 41.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.944 0.402 . . . . 72.209999999999994 111.194 -174.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 71.91 38.21 60.34 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 121.019 -0.61 . . . . 74.140000000000001 112.456 -178.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.584 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 12.7 ptpt -108.67 152.35 24.93 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.918 -0.401 . . . . 73.239999999999995 109.918 179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 58.1 mttp -62.33 135.34 57.41 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 74.049999999999997 111.394 -174.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 146' ' ' ARG . 14.8 tpt180 -87.04 -5.61 59.01 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.932 -0.577 . . . . 73.319999999999993 110.314 178.309 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.77 ' O ' " H5'" ' B' ' 1' ' ' ' U' . . . 101.94 -6.93 54.62 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.867 -0.683 . . . . 75.340000000000003 112.925 176.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.921 ' HA ' HD11 ' A' ' 112' ' ' ILE . 31.7 p90 -145.03 164.06 32.32 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 122.514 -0.404 . . . . 64.439999999999998 110.32 177.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.4 165.15 28.31 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.961 0.41 . . . . 53.109999999999999 110.952 -177.104 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.564 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 65.9 m-85 -126.26 123.72 38.76 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.753 -0.658 . . . . 60.229999999999997 110.006 -177.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.627 HG13 ' CD1' ' A' ' 134' ' ' ILE . 48.9 t -98.75 107.44 20.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 110.017 -0.364 . . . . 74.420000000000002 110.017 -179.051 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.636 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 25.3 m -86.8 124.43 33.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.118 -0.492 . . . . 34.329999999999998 110.151 177.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.655 ' CD2' HG12 ' A' ' 159' ' ' VAL . 97.6 m-85 -104.92 157.63 17.08 Favored 'General case' 0 C--N 1.318 -0.786 0 N-CA-C 109.916 -0.402 . . . . 65.420000000000002 109.916 178.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.566 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 16.0 t70 -69.59 -29.81 67.43 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.03 -0.532 . . . . 65.140000000000001 110.557 177.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -132.45 147.38 52.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.57 -0.741 . . . . 74.019999999999996 110.923 -173.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.673 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.3 p-80 -75.45 -12.81 60.32 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.181 -0.463 . . . . 74.040000000000006 110.732 177.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -60.84 -49.83 75.89 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.173 0.511 . . . . 73.120000000000005 110.153 174.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.447 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 14.6 m -66.56 -22.14 66.15 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.377 -0.829 . . . . 71.209999999999994 112.373 -173.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.673 HG22 ' O ' ' A' ' 156' ' ' HIS . 4.1 m -81.49 -25.84 10.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 C-N-CA 120.935 -0.306 . . . . 71.439999999999998 111.453 -176.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.566 ' HA ' HG22 ' A' ' 163' ' ' VAL . 36.1 t70 -70.31 -39.88 74.54 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.983 -0.287 . . . . 75.129999999999995 111.342 -171.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.485 ' HD2' ' H ' ' A' ' 161' ' ' LYS . 1.6 mptp? -62.21 -14.63 40.07 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 121.372 0.606 . . . . 71.239999999999995 110.586 178.153 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.5 HG21 HD13 ' A' ' 107' ' ' ILE . 94.5 mt -98.38 -49.21 11.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 CA-C-N 115.455 -0.793 . . . . 70.340000000000003 110.886 -176.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.566 HG22 ' HA ' ' A' ' 160' ' ' ASP . 23.5 m -72.93 -15.57 17.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.104 -0.498 . . . . 75.409999999999997 112.078 -175.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.485 ' HA ' ' HD2' ' A' ' 97' ' ' ARG . 2.2 pp -64.68 -26.81 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-O 120.696 0.284 . . . . 72.329999999999998 111.572 178.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -116.0 -178.94 3.52 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.407 -0.59 . . . . 70.219999999999999 109.407 171.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.455 ' HE3' ' OE1' ' A' ' 176' ' ' GLU . 83.5 tttt -120.48 -67.79 0.95 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.655 0.264 . . . . 70.540000000000006 111.226 -173.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 11.1 m-30 -71.69 107.54 4.57 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.088 0.47 . . . . 63.020000000000003 111.401 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.432 ' CE1' HG23 ' A' ' 162' ' ' ILE . 32.9 m-70 -104.89 151.58 23.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.624 -0.716 . . . . 72.230000000000004 109.837 174.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 173' ' ' HIS . 21.8 m -109.87 84.73 1.98 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.045 0.45 . . . . 73.230000000000004 110.424 179.436 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.524 HG21 ' HA ' ' A' ' 121' ' ' LEU . 4.1 p -102.57 132.86 47.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.892 -0.595 . . . . 70.450000000000003 109.719 178.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.474 ' HB3' ' O ' ' A' ' 170' ' ' VAL . 4.6 t30 71.92 -14.79 0.49 Allowed 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.106 0.479 . . . . 72.450000000000003 110.544 -176.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 114.97 -3.08 22.76 Favored Glycine 0 N--CA 1.446 -0.7 0 N-CA-C 110.905 -0.878 . . . . 61.130000000000003 110.905 -173.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.491 ' O ' ' HA ' ' A' ' 169' ' ' THR . 58.5 t-80 -93.97 148.7 21.91 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.303 -0.448 . . . . 63.219999999999999 110.286 -177.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -94.24 102.78 14.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.999 0.428 . . . . 73.549999999999997 110.151 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 29.4 m -114.47 154.1 28.79 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.131 -0.486 . . . . 73.530000000000001 111.201 -175.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.51 ' OE2' ' HD3' ' A' ' 178' ' ' ARG . 20.5 tt0 -91.53 119.55 31.56 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.664 -0.495 . . . . 73.549999999999997 109.664 175.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 48.4 t -117.63 138.99 46.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-N 115.955 -0.566 . . . . 71.409999999999997 110.659 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.51 ' HD3' ' OE2' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -159.02 171.86 19.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.417 -0.81 . . . . 74.219999999999999 109.675 -177.658 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.508 ' HB2' ' HG2' ' A' ' 98' ' ' PRO . 8.6 mtpm? -63.26 122.1 15.33 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 110.104 -0.332 . . . . 73.200000000000003 110.104 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.756 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -74.89 91.25 2.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.985 0.422 . . . . 73.510000000000005 110.686 178.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.56 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -80.9 139.52 35.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.489 -0.56 . . . . 73.340000000000003 109.489 177.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 16.5 m -50.88 130.66 25.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.167 -0.469 . . . . 73.129999999999995 110.755 179.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.774 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.0 pttp -64.34 -23.24 67.23 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.843 0.354 . . . . 71.200000000000003 110.664 -177.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -63.86 -37.14 86.28 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.484 -0.562 . . . . 65.140000000000001 109.484 176.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -88.16 -34.75 17.73 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-N 115.705 -0.679 . . . . 73.430000000000007 111.049 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.774 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 6.5 ptp -63.64 -28.04 69.64 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 109.632 -0.506 . . . . 75.109999999999999 109.632 179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . 0.541 ' HA ' ' HB2' ' A' ' 192' ' ' SER . . . -65.47 -33.07 75.08 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 115.882 -0.599 . . . . 24.109999999999999 110.336 177.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 50.6 m -98.05 7.82 45.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.576 -0.738 . . . . 44.229999999999997 111.192 -178.226 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -123.16 -50.51 1.91 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.038 0.446 . . . . 73.239999999999995 111.385 -178.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 19.8 m -103.81 15.21 29.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.289 -0.414 . . . . 75.340000000000003 110.637 -178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 36.6 m 61.29 28.54 18.04 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.009 -0.541 . . . . 74.420000000000002 111.218 178.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.541 ' HB2' ' HA ' ' A' ' 187' ' ' ALA . 14.0 m -66.23 111.08 3.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.099 -0.501 . . . . 71.540000000000006 110.635 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -140.76 -44.71 0.39 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.347 0.594 . . . . 73.329999999999998 109.707 179.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -99.33 153.72 18.75 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.405 -0.816 . . . . 72.109999999999999 110.664 -175.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -82.18 86.29 1.44 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.922 -0.656 . . . . 42.229999999999997 112.191 178.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.66 ' HA ' ' HE ' ' A' ' 196' ' ' ARG . 1.4 tpm_? . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.385 -0.817 . . . . 72.430000000000007 109.595 176.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 1.077 " C4'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.66 0 C4'-C3'-C2' 104.832 2.132 . 0.0 '__' . 75.109999999999999 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 1.077 H5'' " C4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.9 0 C3'-C2'-C1' 103.84 2.601 . 0.0 OUTLIER zeta-1 64.549999999999997 . . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.791 " H4'" ' OP1' ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.424 -0.992 0 C3'-C2'-C1' 103.636 2.373 OUTLIER-EPSILON 0.0 OUTLIER alpha 72.530000000000001 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.791 ' OP1' " H4'" ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.426 -0.863 0 C4'-C3'-C2' 106.034 3.334 OUTLIER-DELTA 0.0 OUTLIER epsilon-1 75.420000000000002 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.8 ' C4 ' ' HA ' ' A' ' 139' ' ' ASP . . . . . . . . 0 O5'--C5' 1.423 -1.043 0 C1'-O4'-C4' 106.843 -3.063 OUTLIER-DELTA 0.0 OUTLIER gamma 73.409999999999997 . . . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . . . . . . . . . . . . . . . . 0 O5'--C5' 1.426 -0.864 0 C3'-C2'-C1' 100.557 -1.047 . 0.0 OUTLIER . 74.219999999999999 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 19.4 m . . . . . 0 N--CA 1.477 0.888 0 CA-C-O 120.696 0.284 . . . . 60.210000000000001 111.141 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.553 ' O ' ' HD3' ' A' ' 98' ' ' PRO . 5.6 tp-100 -104.11 -15.05 15.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.799 0.333 . . . . 73.340000000000003 111.044 -174.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -106.11 94.06 8.82 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 109.981 -0.377 . . . . 64.519999999999996 109.981 176.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' A' ' 96' ' ' GLN . 56.4 Cg_endo -99.34 97.13 0.05 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.236 0 C-N-CA 123.366 2.711 . . . . 72.329999999999998 112.494 178.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 80.11 19.62 69.3 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.672 -0.775 . . . . 42.009999999999998 112.436 176.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -77.5 -11.32 59.84 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.261 0.553 . . . . 44.0 110.373 -178.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.3 p-80 -86.34 2.3 47.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.406 -0.816 . . . . 75.319999999999993 110.308 176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 84.3 mt -111.11 162.02 15.34 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.807 -0.633 . . . . 75.099999999999994 110.057 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 6.1 m -80.95 -43.31 19.93 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.159 -0.682 . . . . 73.140000000000001 109.159 176.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 67.38 145.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 O-C-N 124.455 1.097 . . . . 75.439999999999998 112.824 172.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.56 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 2.4 mtmt -129.53 12.83 5.95 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.723 -0.671 . . . . 70.120000000000005 110.012 175.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.509 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 30.6 ttpt -144.23 137.26 27.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.295 -0.866 . . . . 72.340000000000003 109.379 177.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 1.8 pp -107.59 153.6 8.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.35 -0.387 . . . . 71.530000000000001 110.537 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 75.6 t80 -105.0 125.29 50.82 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.28 -0.418 . . . . 72.450000000000003 110.881 -178.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 15.9 t -105.94 107.32 22.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.468 -0.333 . . . . 74.099999999999994 110.394 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.539 ' HA2' " H5'" ' B' ' 2' ' ' ' C' . . . -120.92 114.9 2.73 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.78 -0.724 . . . . 73.319999999999993 112.585 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 124.43 29.63 1.07 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.613 -0.804 . . . . 50.100000000000001 113.015 175.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.555 HG12 " O5'" ' B' ' 1' ' ' ' U' . 40.1 pt -91.51 -165.76 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-N 117.073 0.436 . . . . 73.349999999999994 111.484 -178.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.401 ' HD3' ' H ' ' A' ' 115' ' ' ASP . 13.6 tmtt? -131.13 159.63 37.07 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.152 -1.055 . . . . 74.150000000000006 108.152 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -61.14 -17.69 54.15 Favored 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 112.657 0.614 . . . . 75.099999999999994 112.657 -174.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.401 ' H ' ' HD3' ' A' ' 113' ' ' LYS . 25.4 t70 -70.34 -38.16 74.81 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.877 0.37 . . . . 61.310000000000002 111.134 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.4 m -64.63 138.32 58.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.818 -0.628 . . . . 70.129999999999995 110.753 -178.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.479 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 12.0 pt-20 -136.53 -168.66 2.29 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.449 -0.341 . . . . 74.25 110.737 179.394 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.63 ' HA ' HG21 ' A' ' 134' ' ' ILE . 7.2 tt0 -59.62 -46.43 89.01 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.044 -0.526 . . . . 73.540000000000006 112.355 -176.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.428 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 0.7 OUTLIER -65.0 -32.99 74.99 Favored 'General case' 0 C--N 1.331 -0.216 0 C-N-CA 120.811 -0.355 . . . . 71.400000000000006 110.601 -176.631 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.479 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 38.6 m80 -61.8 -52.73 62.99 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 120.912 0.387 . . . . 71.310000000000002 110.709 178.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.447 HD23 HG21 ' A' ' 170' ' ' VAL . 70.3 mt -62.99 -47.91 81.12 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.625 -0.716 . . . . 73.129999999999995 110.288 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 3.1 tpp180 -56.17 -49.33 74.31 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.798 -0.637 . . . . 73.150000000000006 110.651 178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -56.71 -32.66 65.72 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-O 121.179 0.514 . . . . 74.230000000000004 111.62 -178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 62.8 t80 -85.16 -40.8 16.31 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.035 -0.53 . . . . 73.319999999999993 111.104 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.508 ' CD1' HG21 ' A' ' 151' ' ' VAL . 57.1 m-85 -88.63 -18.02 28.86 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.78 0.659 . . . . 64.319999999999993 112.78 -173.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.4 ' N ' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -66.35 -21.52 66.25 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.142 0.496 . . . . 74.25 110.928 -179.448 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -70.08 -22.14 63.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.673 -0.694 . . . . 61.229999999999997 110.477 177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.508 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 28.9 m-85 -86.74 -33.25 20.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.957 -0.565 . . . . 74.450000000000003 110.674 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 176.93 -170.38 43.07 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.285 -0.959 . . . . 45.420000000000002 113.151 179.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 72.8 tttt -75.17 124.02 26.3 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 122.924 0.49 . . . . 73.329999999999998 111.49 -178.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.488 HG21 HD11 ' A' ' 134' ' ' ILE . 44.2 mt -100.31 137.31 28.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.876 -0.602 . . . . 62.32 111.149 -178.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -82.14 -74.41 0.34 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.383 -0.826 . . . . 64.109999999999999 110.359 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.6 t -140.81 159.09 23.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 109.655 -0.498 . . . . 55.009999999999998 109.655 -178.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.63 HG21 ' HA ' ' A' ' 118' ' ' GLU . 29.3 mm -112.41 104.45 17.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 120.928 0.394 . . . . 64.439999999999998 109.948 174.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -89.61 101.64 14.32 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.959 -0.386 . . . . 72.409999999999997 109.959 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.795 ' HB ' HG23 ' A' ' 138' ' ' THR . 4.3 mt -81.18 12.6 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.349 0.595 . . . . 74.120000000000005 109.84 -179.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.714 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER 59.44 26.23 15.12 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-N 115.143 -0.935 . . . . 53.219999999999999 109.702 -174.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.795 HG23 ' HB ' ' A' ' 136' ' ' ILE . 1.4 p -64.5 146.55 54.39 Favored 'General case' 0 N--CA 1.439 -0.996 0 CA-C-N 114.841 -1.072 . . . . 54.549999999999997 111.05 -178.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.448 ' HB3' ' H ' ' A' ' 144' ' ' LYS . 22.7 t70 -47.2 130.56 12.93 Favored 'General case' 0 CA--C 1.515 -0.369 0 O-C-N 123.482 0.489 . . . . 74.239999999999995 110.053 177.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.598 ' HD2' H5'' ' B' ' 5' ' ' ' U' . 0.0 OUTLIER -84.7 12.66 6.8 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.992 -0.549 . . . . 61.020000000000003 110.947 -170.566 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -118.44 -50.99 0.32 Allowed Glycine 0 N--CA 1.444 -0.822 0 CA-C-N 115.643 -0.708 . . . . 45.32 111.946 173.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.5 ' HB2' ' HE2' ' A' ' 144' ' ' LYS . 50.9 m -111.14 -13.13 14.07 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 112.397 0.517 . . . . 73.409999999999997 112.397 -175.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.14 70.35 1.3 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.331 -0.938 . . . . 65.340000000000003 112.183 -176.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.693 ' O ' ' HA ' ' A' ' 138' ' ' THR . 62.6 mmtt -110.67 135.49 51.2 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.763 -0.458 . . . . 74.319999999999993 109.763 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -69.86 115.11 8.7 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.923 0.392 . . . . 70.310000000000002 110.913 -179.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.498 ' HB3' ' HB3' ' A' ' 137' ' ' MET . 68.8 ttt180 -83.6 -54.98 4.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.992 -0.549 . . . . 74.230000000000004 111.107 -178.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.632 ' C ' H5'' ' B' ' 1' ' ' ' U' . . . 161.16 -93.07 0.12 Allowed Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.693 -0.765 . . . . 61.130000000000003 111.934 -177.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.714 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 42.9 p90 -61.57 145.16 52.93 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.601 0.239 . . . . 72.420000000000002 110.402 177.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -130.86 165.13 23.72 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.976 0.417 . . . . 61.229999999999997 111.206 -176.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.48 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 43.7 m-85 -132.47 135.5 46.08 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.699 -0.682 . . . . 72.430000000000007 109.467 -179.091 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.61 HG13 ' CD1' ' A' ' 134' ' ' ILE . 43.4 t -110.85 108.42 25.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.55 -0.537 . . . . 50.43 109.55 177.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.509 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 3.9 m -85.88 128.48 34.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.055 -0.52 . . . . 74.299999999999997 110.301 -178.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.587 ' CD2' HG12 ' A' ' 159' ' ' VAL . 94.7 m-85 -111.75 151.41 29.0 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.916 -0.401 . . . . 74.310000000000002 109.916 178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -78.87 -6.56 56.42 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.249 0.547 . . . . 73.409999999999997 110.854 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -139.75 149.64 43.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.182 -0.463 . . . . 51.299999999999997 110.245 -179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.56 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.0 p-80 -89.48 -2.64 58.44 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.928 0.394 . . . . 71.519999999999996 110.897 179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -75.04 -39.08 61.22 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.359 0.6 . . . . 64.150000000000006 109.476 173.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.4 m -64.9 -30.31 71.3 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.513 -0.767 . . . . 61.229999999999997 111.789 -177.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.587 HG12 ' CD2' ' A' ' 153' ' ' PHE . 14.1 m -78.87 -20.81 12.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.634 -0.257 . . . . 54.149999999999999 111.68 -176.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -67.05 -46.14 75.27 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 120.596 0.236 . . . . 71.230000000000004 110.46 -172.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.508 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.4 mptp? -59.29 -20.08 51.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.364 0.602 . . . . 63.299999999999997 111.038 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.437 HG22 HG11 ' A' ' 177' ' ' VAL . 79.5 mt -94.1 -49.07 12.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.529 -0.76 . . . . 71.400000000000006 111.206 -175.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.578 ' HB ' ' HE3' ' A' ' 179' ' ' LYS . 25.9 m -80.59 -10.72 12.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 112.287 0.477 . . . . 64.0 112.287 -173.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.522 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.6 pp -68.82 -31.35 50.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.21 0 CA-C-O 120.998 0.428 . . . . 71.420000000000002 110.961 176.704 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.522 ' N ' HD12 ' A' ' 164' ' ' ILE . 14.5 pt20 -101.15 -162.0 0.9 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.116 -0.698 . . . . 65.140000000000001 109.116 172.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.518 ' HE3' ' CD ' ' A' ' 176' ' ' GLU . 44.3 tttt -134.67 -68.67 0.53 Allowed 'General case' 0 C--N 1.318 -0.801 0 C-N-CA 120.811 -0.356 . . . . 62.43 111.568 -174.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.509 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 97.2 m-85 -88.32 113.41 23.89 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-O 121.133 0.492 . . . . 74.230000000000004 111.544 -175.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 42.3 m-70 -105.35 147.36 28.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.57 -0.741 . . . . 73.430000000000007 110.248 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 47.2 m -100.73 98.92 9.4 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.075 0.464 . . . . 54.329999999999998 110.745 176.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.447 HG21 HD23 ' A' ' 121' ' ' LEU . 4.7 p -118.19 130.97 72.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.076 -0.511 . . . . 45.240000000000002 109.833 178.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 62.8 t30 64.67 15.73 9.91 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.643 0.735 . . . . 71.109999999999999 110.279 -177.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 86.85 8.78 75.63 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.765 -0.731 . . . . 62.420000000000002 112.225 -178.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 43.1 m80 -110.03 124.67 51.88 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.719 0.295 . . . . 72.540000000000006 110.367 178.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -81.42 105.3 12.48 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.427 -0.583 . . . . 70.219999999999999 109.427 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 10.5 m -118.15 154.31 32.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.926 -0.579 . . . . 53.25 110.589 -172.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.518 ' CD ' ' HE3' ' A' ' 166' ' ' LYS . 30.1 tt0 -88.73 126.0 35.12 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.001 0.429 . . . . 73.230000000000004 110.153 179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 97.8 t -112.23 129.43 67.76 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-O 121.343 0.592 . . . . 73.540000000000006 111.034 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.441 ' HB3' ' HG2' ' A' ' 98' ' ' PRO . 80.7 mtt180 -119.0 179.58 4.11 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.24 -0.891 . . . . 75.129999999999995 110.083 179.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.578 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 9.6 mptt -81.69 126.52 31.88 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.327 -1.36 . . . . 71.209999999999994 107.327 168.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.687 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -80.88 83.95 6.5 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.055 0.455 . . . . 43.109999999999999 111.505 -174.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.587 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -84.04 140.79 31.62 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.88 -0.6 . . . . 72.430000000000007 109.444 175.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 46.4 t -50.15 142.14 10.17 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 123.423 0.452 . . . . 74.109999999999999 111.179 -178.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.758 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.5 pttp -62.09 -20.05 63.61 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.188 -0.46 . . . . 74.349999999999994 111.29 -178.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.56 -54.31 14.71 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.886 -0.783 . . . . 61.520000000000003 108.886 174.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -67.9 -32.15 72.43 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.747 -0.66 . . . . 75.310000000000002 111.564 -177.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.758 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 21.7 ptm -72.84 -17.24 61.57 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.779 0.323 . . . . 75.420000000000002 110.523 -178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.43 -39.83 62.34 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.531 -0.544 . . . . 73.230000000000004 109.531 173.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 4.6 m -70.93 -35.0 72.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.584 -0.735 . . . . 74.239999999999995 109.949 175.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -70.31 -20.28 63.02 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.514 -0.766 . . . . 65.420000000000002 110.763 177.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 34.7 t -76.44 87.17 3.19 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-O 121.273 0.559 . . . . 64.239999999999995 109.994 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 48.1 m -140.53 117.71 11.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.602 -0.726 . . . . 55.32 109.895 176.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 5.7 t 67.49 26.4 8.23 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.741 -0.663 . . . . 62.130000000000003 110.582 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -88.47 153.69 20.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 72.140000000000001 110.155 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 35.8 ttt180 -108.22 119.84 40.65 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.833 0.349 . . . . 72.239999999999995 110.261 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 91.49 -136.84 13.51 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.758 -0.734 . . . . 74.349999999999994 111.975 179.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 . . . . . 0 C--O 1.246 0.883 0 CA-C-O 118.501 -0.761 . . . . 73.019999999999996 110.088 179.754 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.934 " H3'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.673 0 C4'-C3'-C2' 105.259 2.559 . 0.0 '__' . 72.319999999999993 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.934 H5'' " H3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.879 0 C4'-C3'-C2' 104.851 2.151 . 0.0 OUTLIER . 73.409999999999997 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.687 ' N1 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.426 -0.882 0 O4'-C1'-C2' 108.391 1.422 . 0.0 OUTLIER gamma 72.120000000000005 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.575 " H3'" ' HD3' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.424 -1.026 0 C4'-C3'-C2' 104.043 1.343 . 0.0 OUTLIER alpha 74.209999999999994 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.598 H5'' ' HD2' ' A' ' 140' ' ' ARG . . . . . . . . 0 O5'--C5' 1.422 -1.122 0 O4'-C1'-C2' 108.2 1.285 . 0.0 OUTLIER gamma 75.319999999999993 . . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.6 H5'' ' C6 ' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.012 0 C4'-C3'-C2' 105.999 3.299 . 0.0 OUTLIER gamma 74.420000000000002 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 14.3 m . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 109.74 -0.467 . . . . 63.299999999999997 109.74 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.672 ' NE2' ' HG2' ' A' ' 178' ' ' ARG . 46.5 tp60 -79.54 -26.83 41.35 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.37 0.605 . . . . 72.439999999999998 109.772 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -114.05 84.16 8.65 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.557 -0.747 . . . . 73.310000000000002 110.471 178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.497 ' HD3' ' O ' ' A' ' 96' ' ' GLN . 4.9 Cg_exo -80.74 -65.23 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.604 2.203 . . . . 60.149999999999999 111.585 176.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -112.21 97.63 0.92 Allowed Glycine 0 N--CA 1.445 -0.763 0 N-CA-C 111.342 -0.703 . . . . 64.540000000000006 111.342 177.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -95.9 -35.85 11.31 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.088 0.471 . . . . 72.420000000000002 110.66 -179.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -73.81 -19.74 60.67 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.776 -0.647 . . . . 65.109999999999999 110.243 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 77.7 mt -80.09 111.99 16.97 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.623 -0.717 . . . . 72.140000000000001 110.183 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.8 p -73.66 98.06 2.79 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.331 0.586 . . . . 73.049999999999997 110.477 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.609 HG23 HG11 ' A' ' 159' ' ' VAL . 6.6 m -93.52 152.46 3.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.869 -0.605 . . . . 61.520000000000003 109.798 -179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.772 ' HA ' HG21 ' A' ' 159' ' ' VAL . 14.0 mtmt -118.17 22.72 12.02 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.599 0.714 . . . . 73.530000000000001 109.46 177.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.727 ' HE3' ' HB3' ' A' ' 150' ' ' PHE . 42.0 tttt -149.88 129.5 13.15 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.802 -1.09 . . . . 65.540000000000006 109.361 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.527 HD13 HG21 ' A' ' 162' ' ' ILE . 7.9 pt -106.03 163.04 4.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 121.0 0.429 . . . . 75.019999999999996 111.225 -177.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -109.59 118.76 37.44 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.526 -0.761 . . . . 75.230000000000004 109.567 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.596 HG11 HD11 ' A' ' 121' ' ' LEU . 37.3 t -102.59 103.36 14.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 120.881 0.372 . . . . 65.219999999999999 110.757 179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.489 ' HA2' H5'' ' B' ' 2' ' ' ' C' . . . -119.69 -167.9 13.74 Favored Glycine 0 N--CA 1.442 -0.954 0 N-CA-C 110.898 -0.881 . . . . 34.219999999999999 110.898 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.501 ' HA2' ' C5 ' ' B' ' 2' ' ' ' C' . . . 71.21 5.48 59.1 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.785 -0.721 . . . . 61.439999999999998 113.042 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.636 HD11 ' O ' ' A' ' 147' ' ' GLY . 23.8 pt -87.38 122.02 38.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.27 0.557 . . . . 55.299999999999997 110.551 -178.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -88.31 -27.64 21.56 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.079 -0.51 . . . . 72.349999999999994 110.631 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.1 mm-40 -98.48 154.89 17.56 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.037 -0.529 . . . . 73.150000000000006 109.81 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -63.1 91.56 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.053 0.454 . . . . 72.409999999999997 109.804 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.435 ' HB ' HD12 ' A' ' 112' ' ' ILE . 9.7 m -90.28 118.13 29.55 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.73 -0.668 . . . . 73.040000000000006 109.638 -178.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.552 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 11.5 pt-20 -109.86 -174.08 2.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.919 0.39 . . . . 62.439999999999998 111.605 -172.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.701 ' HA ' HG21 ' A' ' 134' ' ' ILE . 14.2 tt0 -53.42 -49.71 66.75 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.427 -0.806 . . . . 64.540000000000006 112.212 -174.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.434 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 0.8 OUTLIER -63.39 -31.44 72.6 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 121.1 -0.24 . . . . 42.299999999999997 110.678 -176.534 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.552 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 35.7 m80 -67.06 -56.81 8.47 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.476 -0.329 . . . . 73.409999999999997 110.376 178.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.596 HD11 HG11 ' A' ' 109' ' ' VAL . 0.5 OUTLIER -61.05 -49.55 76.91 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.145 -0.48 . . . . 60.020000000000003 110.928 -178.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.509 ' HA ' ' CD1' ' A' ' 131' ' ' ILE . 1.5 tpp180 -58.08 -45.32 87.32 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.273 -0.422 . . . . 75.439999999999998 111.197 -177.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -56.61 -37.11 70.22 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.096 0.474 . . . . 70.010000000000005 111.44 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 86.7 t80 -84.96 -39.85 17.64 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.271 -0.422 . . . . 75.209999999999994 111.257 -176.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -86.69 -17.5 33.57 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 112.47 0.545 . . . . 73.239999999999995 112.47 -172.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.4 -21.7 65.58 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-O 121.334 0.588 . . . . 72.340000000000003 110.697 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -70.22 -24.82 63.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.336 -0.847 . . . . 72.019999999999996 110.406 179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.462 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 31.0 m-85 -83.46 -32.06 26.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.951 -0.568 . . . . 74.299999999999997 110.139 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.7 177.78 43.17 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.162 -0.775 . . . . 73.430000000000007 111.162 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -67.25 133.88 50.55 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.656 0.741 . . . . 73.099999999999994 110.478 -179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.509 ' CD1' ' HA ' ' A' ' 122' ' ' ARG . 46.6 mt -100.24 141.92 16.4 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 115.288 -0.869 . . . . 52.299999999999997 110.446 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -78.46 -70.63 0.48 Allowed 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.081 -0.509 . . . . 70.310000000000002 110.419 174.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.3 m -148.08 157.04 8.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.456 -0.338 . . . . 23.32 110.659 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.701 HG21 ' HA ' ' A' ' 118' ' ' GLU . 12.9 mm -109.96 108.93 26.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.572 -0.899 . . . . 71.409999999999997 108.572 174.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -95.08 95.97 8.93 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.204 0.526 . . . . 74.129999999999995 110.519 -175.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.638 HD11 ' H ' ' A' ' 118' ' ' GLU . 20.6 mt -74.81 99.06 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.702 -0.851 . . . . 74.340000000000003 108.702 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 12.8 tpt -67.29 108.94 2.92 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.287 0.565 . . . . 65.310000000000002 110.488 -174.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.8 p -86.5 166.77 15.22 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 115.654 -0.703 . . . . 73.510000000000005 111.754 -177.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.411 ' CG ' ' H ' ' A' ' 141' ' ' GLY . 19.6 t0 -76.85 153.09 35.15 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.021 -0.99 . . . . 63.409999999999997 110.567 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.495 ' CD ' ' H ' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -92.89 0.9 57.5 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.806 -0.634 . . . . 74.219999999999999 110.535 -178.735 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.411 ' H ' ' CG ' ' A' ' 139' ' ' ASP . . . -109.66 -62.37 0.52 Allowed Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 121.009 -0.615 . . . . 41.109999999999999 112.213 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.544 ' HB2' ' HD2' ' A' ' 144' ' ' LYS . 21.2 m -87.56 -17.59 31.66 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 122.532 -0.393 . . . . 63.32 111.225 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 69.38 33.03 72.19 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.576 -1.01 . . . . 42.25 110.576 -174.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.544 ' HD2' ' HB2' ' A' ' 142' ' ' SER . 12.9 ptmm? -105.15 171.66 7.2 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.737 -0.731 . . . . 73.430000000000007 109.731 -172.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 89.3 mttt -69.08 99.19 1.07 Allowed 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.171 -0.677 . . . . 71.409999999999997 109.171 174.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.633 HH12 H5'' ' B' ' 5' ' ' ' U' . 65.0 ttt180 -58.24 -46.11 86.55 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.139 -0.937 . . . . 74.140000000000001 111.886 -172.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.636 ' O ' HD11 ' A' ' 112' ' ' ILE . . . 166.96 -78.75 0.11 Allowed Glycine 0 N--CA 1.442 -0.955 0 N-CA-C 110.973 -0.851 . . . . 62.200000000000003 110.973 -177.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 34.7 p90 -76.52 163.54 26.82 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.947 0.403 . . . . 75.430000000000007 110.924 179.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.05 175.16 9.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.009 -0.541 . . . . 72.340000000000003 110.366 177.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.727 ' HB3' ' HE3' ' A' ' 106' ' ' LYS . 85.3 m-85 -132.03 152.06 51.38 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.351 -0.386 . . . . 71.530000000000001 110.333 -176.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.608 HG13 ' CD1' ' A' ' 134' ' ' ILE . 44.6 t -134.91 114.61 17.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.076 -0.713 . . . . 55.539999999999999 109.076 -178.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.476 ' OG1' ' HD2' ' A' ' 106' ' ' LYS . 42.5 m -98.23 132.12 44.0 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.929 0.395 . . . . 75.439999999999998 110.558 -178.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.481 ' CD2' HG22 ' A' ' 159' ' ' VAL . 91.2 m-85 -112.14 155.26 24.21 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.075 -0.511 . . . . 74.510000000000005 110.282 -177.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -76.53 -23.82 53.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.244 0.545 . . . . 73.549999999999997 110.536 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.427 ' O ' HG23 ' A' ' 159' ' ' VAL . 9.5 t0 -131.47 138.88 49.19 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.587 -0.733 . . . . 73.150000000000006 109.73 -178.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.539 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.3 p-80 -75.83 -9.91 58.99 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.908 0.385 . . . . 64.049999999999997 110.605 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -66.61 -48.54 69.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.136 -0.483 . . . . 74.400000000000006 110.218 175.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 42.2 t -58.97 -37.16 76.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.857 -0.611 . . . . 74.239999999999995 110.228 176.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.772 HG21 ' HA ' ' A' ' 105' ' ' LYS . 18.5 t -65.58 -36.99 78.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.451 -0.795 . . . . 71.049999999999997 111.017 -178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -55.45 -48.2 74.86 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.173 -0.467 . . . . 64.319999999999993 111.814 -176.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.462 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 4.0 mptt -60.19 -19.13 52.7 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 121.201 0.524 . . . . 65.329999999999998 111.063 -177.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.527 HG21 HD13 ' A' ' 107' ' ' ILE . 84.0 mt -99.84 -47.34 11.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.527 -0.76 . . . . 75.310000000000002 111.366 -175.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.422 ' CG2' ' HE3' ' A' ' 179' ' ' LYS . 28.9 m -71.26 -11.17 14.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 112.438 0.532 . . . . 74.540000000000006 112.438 -174.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 2.7 pp -82.79 -24.29 8.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.909 0.385 . . . . 74.510000000000005 111.21 178.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -106.04 142.33 35.92 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.07 -0.514 . . . . 74.209999999999994 110.538 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.55 ' HG3' ' HG2' ' A' ' 176' ' ' GLU . 85.5 tttt -89.78 -67.3 0.85 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.005 -0.543 . . . . 64.0 111.199 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.596 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 22.8 m-85 -81.04 100.43 8.99 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 116.186 -0.461 . . . . 70.030000000000001 111.688 -177.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -101.51 153.38 19.77 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.944 -0.571 . . . . 74.340000000000003 109.79 174.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 23.9 m -106.38 96.23 6.32 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.982 0.42 . . . . 72.400000000000006 110.67 178.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.45 ' C ' ' H ' ' A' ' 172' ' ' GLY . 47.1 t -105.3 133.2 50.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.57 -0.53 . . . . 70.019999999999996 109.57 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 7.4 t30 70.48 -19.25 0.22 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.128 0.571 . . . . 71.0 111.728 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.45 ' H ' ' C ' ' A' ' 170' ' ' VAL . . . 128.52 -6.03 6.64 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 121.181 -0.533 . . . . 63.229999999999997 111.833 -177.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 18.6 p-80 -112.62 151.18 30.42 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.038 0.447 . . . . 73.010000000000005 110.399 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.487 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 66.0 t30 -82.86 124.83 30.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.753 -0.658 . . . . 72.010000000000005 110.374 -177.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.596 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 23.5 p -119.42 -171.86 2.2 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.955 -0.566 . . . . 40.329999999999998 110.253 -179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.55 ' HG2' ' HG3' ' A' ' 166' ' ' LYS . 0.9 OUTLIER -139.1 116.07 10.92 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.468 -0.567 . . . . 74.420000000000002 109.468 -176.531 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 93.4 t -116.41 140.15 39.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.018 -0.537 . . . . 54.240000000000002 112.062 -171.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.728 ' HD2' ' H62' ' B' ' 3' ' ' ' A' . 43.7 mtt180 -134.29 -178.83 5.22 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.69 -0.686 . . . . 74.430000000000007 109.801 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.422 ' HE3' ' CG2' ' A' ' 163' ' ' VAL . 11.9 mptt -75.01 128.43 35.54 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.267 -1.012 . . . . 74.239999999999995 108.267 168.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.555 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -74.04 97.83 2.95 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.582 -0.447 . . . . 73.209999999999994 110.773 178.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.688 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.7 pt? -106.6 149.18 27.45 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.936 -0.574 . . . . 64.109999999999999 110.204 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 38.5 t -49.62 139.63 12.27 Favored 'General case' 0 C--N 1.328 -0.355 0 O-C-N 123.579 0.55 . . . . 73.340000000000003 111.187 -179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.729 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 17.8 pttp -65.49 -12.7 55.04 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.135 0.493 . . . . 73.450000000000003 110.732 178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -74.99 -52.92 9.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.857 -0.611 . . . . 72.439999999999998 109.94 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -73.38 -32.17 64.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.453 -0.794 . . . . 71.230000000000004 111.265 -176.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.729 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.3 ptm -65.18 -24.53 67.4 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.394 -0.367 . . . . 63.210000000000001 110.876 -177.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -69.68 -38.19 76.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.99 0.424 . . . . 44.43 110.074 177.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 3.8 m -77.78 -33.01 52.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.676 -0.693 . . . . 71.239999999999995 110.643 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -77.76 -42.68 33.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.888 -0.596 . . . . 73.209999999999994 111.234 -177.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 33.6 m -90.06 -63.3 1.3 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.935 -0.575 . . . . 75.219999999999999 111.095 -176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 49.9 m 61.24 28.73 18.26 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.133 -0.485 . . . . 63.409999999999997 111.115 -178.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 13.8 t -119.76 97.68 5.74 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.313 -0.625 . . . . 74.5 109.313 178.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -87.69 126.5 35.01 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.946 -0.57 . . . . 70.129999999999995 110.537 -177.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -62.69 94.03 0.06 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.603 -0.726 . . . . 70.219999999999999 110.859 179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -163.3 21.05 0.16 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 111.407 -0.677 . . . . 41.030000000000001 111.407 178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.176 -0.916 . . . . 73.450000000000003 109.167 -177.629 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.995 " H4'" " C5'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.789 0 O4'-C4'-C3' 103.631 -1.335 OUTLIER-EPSILON 0.0 '__' . 74.510000000000005 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.995 " C5'" " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.021 0 C4'-C3'-C2' 104.37 1.67 . 0.0 OUTLIER epsilon-1 72.420000000000002 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.728 ' H62' ' HD2' ' A' ' 178' ' ' ARG . . . . . . . . 0 O5'--C5' 1.426 -0.889 0 O4'-C1'-C2' 108.101 1.215 . 0.0 OUTLIER . 74.420000000000002 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.585 " H3'" ' CE ' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.426 -0.87 0 C3'-C2'-C1' 99.82 -1.867 . 0.0 OUTLIER . 73.430000000000007 . . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.647 ' H6 ' ' P ' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.947 0 C4'-C3'-C2' 106.459 3.759 OUTLIER-DELTA 0.0 OUTLIER gamma 71.519999999999996 . . . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.44 ' H6 ' " O5'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.946 0 C3'-C2'-C1' 100.828 -0.747 . 0.01 4p . 63.310000000000002 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.4 m . . . . . 0 N--CA 1.476 0.866 0 CA-C-O 120.919 0.39 . . . . 53.119999999999997 110.232 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -110.21 145.03 38.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.398 -0.365 . . . . 71.349999999999994 110.398 179.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.496 ' HA ' ' HD3' ' A' ' 98' ' ' PRO . 0.0 OUTLIER -148.32 137.59 12.13 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.901 -0.59 . . . . 72.109999999999999 109.695 179.498 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 97' ' ' ARG . 4.0 Cg_exo -76.22 146.45 28.45 Favored 'Trans proline' 0 N--CA 1.462 -0.349 0 C-N-CA 122.941 2.428 . . . . 60.130000000000003 112.605 -172.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.414 ' HA2' HD12 ' A' ' 102' ' ' LEU . . . 78.13 -26.67 2.11 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 116.036 -0.529 . . . . 31.510000000000002 113.996 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.64 ' HB2' ' HE2' ' A' ' 179' ' ' LYS . . . -72.83 -25.3 61.08 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.997 0.399 . . . . 65.409999999999997 111.955 -174.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 49.5 p-80 -91.92 12.78 20.54 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.271 0.557 . . . . 74.420000000000002 110.156 177.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.414 HD12 ' HA2' ' A' ' 99' ' ' GLY . 23.1 mt -129.24 -176.31 3.84 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.385 -0.825 . . . . 71.239999999999995 109.709 -177.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 25.4 p -102.86 95.37 6.13 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.482 0.658 . . . . 72.319999999999993 109.531 170.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 106' ' ' LYS . 12.4 p -98.69 132.74 43.32 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.634 -0.712 . . . . 71.530000000000001 110.176 -176.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.601 ' HA ' HG21 ' A' ' 159' ' ' VAL . 15.2 mtmt -120.34 21.93 11.5 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.036 -0.529 . . . . 73.340000000000003 110.765 -175.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.565 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.3 ttpt -153.89 142.49 20.83 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.327 -0.397 . . . . 71.030000000000001 109.944 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.561 HD13 HG21 ' A' ' 162' ' ' ILE . 4.0 pt -113.43 157.41 14.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 120.939 0.4 . . . . 53.200000000000003 110.915 -178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.486 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 66.7 t80 -105.61 119.89 40.26 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.608 -0.724 . . . . 72.129999999999995 109.932 178.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 48.0 t -101.1 108.89 24.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-O 120.796 0.331 . . . . 75.310000000000002 110.68 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.464 ' HA2' " H5'" ' B' ' 2' ' ' ' C' . . . -128.42 112.35 1.41 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 121.165 -0.54 . . . . 61.409999999999997 112.331 -179.222 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 134.38 14.16 1.24 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.445 -0.884 . . . . 61.32 113.197 176.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.851 HD12 ' HB ' ' A' ' 116' ' ' THR . 9.0 pt -80.78 87.68 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.387 0.613 . . . . 74.519999999999996 110.311 177.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 58.1 tttp -61.25 -30.82 70.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.461 -0.79 . . . . 71.109999999999999 112.147 -174.106 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -93.64 162.58 13.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.347 -0.388 . . . . 61.210000000000001 110.292 -179.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -58.69 108.13 0.6 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.977 0.418 . . . . 71.209999999999994 110.082 176.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.851 ' HB ' HD12 ' A' ' 112' ' ' ILE . 27.1 m -125.58 131.98 52.62 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.809 -0.632 . . . . 72.209999999999994 110.138 -175.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.14 -168.66 1.71 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.939 0.399 . . . . 64.030000000000001 111.438 -175.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.691 ' HG3' HG13 ' A' ' 134' ' ' ILE . 15.1 tt0 -57.77 -49.87 75.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.64 -0.709 . . . . 75.230000000000004 112.429 -179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -58.49 -33.53 69.9 Favored 'General case' 0 N--CA 1.462 0.161 0 C-N-CA 121.046 -0.262 . . . . 64.219999999999999 110.504 -175.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 41.8 m80 -64.47 -53.36 49.37 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.08 -0.509 . . . . 65.349999999999994 110.552 178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.541 HD12 HG11 ' A' ' 170' ' ' VAL . 9.3 mp -66.02 -49.62 67.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.727 -0.67 . . . . 75.310000000000002 111.193 -179.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.5 -48.46 81.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.196 -0.456 . . . . 73.140000000000001 111.456 -176.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -60.3 -30.5 69.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.126 0.489 . . . . 64.510000000000005 110.832 -177.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.483 ' CD1' HG22 ' A' ' 170' ' ' VAL . 50.8 t80 -81.64 -46.89 13.71 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.914 -0.584 . . . . 74.439999999999998 111.247 -179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -83.55 -16.89 43.72 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.725 0.639 . . . . 75.439999999999998 112.725 -173.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -23.9 67.38 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.989 0.423 . . . . 74.040000000000006 111.233 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -67.08 -25.02 66.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.821 -0.627 . . . . 54.530000000000001 110.508 178.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.509 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 45.7 m-85 -84.07 -34.25 24.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.968 -0.56 . . . . 74.420000000000002 110.477 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 173.95 -170.69 43.85 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.145 -1.026 . . . . 51.350000000000001 113.133 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -72.9 120.1 18.05 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.639 0.733 . . . . 73.049999999999997 112.092 -177.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.539 HG21 HD11 ' A' ' 134' ' ' ILE . 41.1 mt -94.98 134.48 32.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.937 -1.029 . . . . 74.409999999999997 110.201 176.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.426 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 6.7 mm-40 -82.99 -67.42 0.79 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.032 -0.531 . . . . 63.310000000000002 110.717 178.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 18.0 m -146.53 152.62 13.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.116 -0.493 . . . . 72.219999999999999 110.259 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.691 HG13 ' HG3' ' A' ' 118' ' ' GLU . 33.5 mm -105.83 112.72 40.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.616 -0.513 . . . . 65.25 109.616 176.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -93.12 94.45 8.85 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.07 0.462 . . . . 74.010000000000005 110.212 -178.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.0 mt -80.99 88.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 108.714 -0.847 . . . . 53.130000000000003 108.714 176.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . . . . . . . . . 26.8 tpp -60.93 112.82 2.21 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.585 0.707 . . . . 63.329999999999998 110.864 -175.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.4 p -88.26 169.98 11.4 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 114.854 -1.066 . . . . 61.149999999999999 110.81 -179.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -58.89 126.2 26.7 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.245 -0.65 . . . . 75.219999999999999 109.245 174.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.643 ' HD3' ' C2 ' ' B' ' 5' ' ' ' U' . 4.3 ppt_? -84.14 17.55 2.45 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-O 121.244 0.545 . . . . 72.109999999999999 111.211 -172.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -126.69 -53.16 0.15 Allowed Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.545 -0.752 . . . . 63.109999999999999 111.706 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 50.8 m -97.36 -13.35 21.92 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.252 0.464 . . . . 72.409999999999997 112.252 -177.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 70.52 45.93 50.92 Favored Glycine 0 CA--C 1.516 0.131 0 C-N-CA 120.527 -0.845 . . . . 73.099999999999994 112.819 177.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -121.74 159.4 26.71 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.217 -0.66 . . . . 71.340000000000003 109.217 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -56.56 107.51 0.39 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.117 0.484 . . . . 73.010000000000005 110.452 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -72.2 -66.65 0.62 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.368 -0.833 . . . . 64.0 112.005 -169.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.674 ' C ' H5'' ' B' ' 1' ' ' ' U' . . . 172.28 -66.28 0.13 Allowed Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.339 -0.934 . . . . 64.540000000000006 111.991 -177.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.537 ' CZ ' " H4'" ' B' ' 3' ' ' ' A' . 45.8 p90 -85.06 154.81 21.83 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.669 0.271 . . . . 51.530000000000001 110.486 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -141.91 163.39 33.01 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.332 -0.395 . . . . 74.310000000000002 110.405 -178.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.453 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 50.2 m-85 -124.41 135.56 53.37 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.289 -0.414 . . . . 73.140000000000001 110.212 -178.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.61 HG13 ' CD1' ' A' ' 134' ' ' ILE . 23.7 t -108.63 109.24 27.6 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 109.852 -0.425 . . . . 62.200000000000003 109.852 179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.565 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 15.3 m -87.68 125.4 34.37 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.391 -0.368 . . . . 71.450000000000003 110.562 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.413 ' CE1' HG12 ' A' ' 131' ' ' ILE . 90.4 m-85 -109.84 154.41 23.06 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 109.703 -0.48 . . . . 74.140000000000001 109.703 178.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.426 ' HB2' ' HG2' ' A' ' 132' ' ' GLU . 23.9 t70 -77.57 -22.27 51.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.599 0.714 . . . . 43.409999999999997 110.213 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.428 ' OD2' ' HB2' ' A' ' 157' ' ' ASP . 25.7 t70 -123.31 135.09 54.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.113 -0.949 . . . . 64.019999999999996 111.236 -171.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.554 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.4 p-80 -84.2 0.19 49.72 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.221 -0.445 . . . . 74.329999999999998 112.006 -177.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.428 ' HB2' ' OD2' ' A' ' 155' ' ' ASP . 54.3 m-20 -98.08 -29.25 13.36 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.97 -0.752 . . . . 71.030000000000001 108.97 175.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.43 ' HA ' ' HE3' ' A' ' 161' ' ' LYS . 42.4 t -58.8 -32.8 69.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.551 -0.749 . . . . 64.439999999999998 109.704 170.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.601 HG21 ' HA ' ' A' ' 105' ' ' LYS . 21.7 t -74.18 -29.77 25.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.355 -0.838 . . . . 64.140000000000001 110.434 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.03 -47.74 84.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.858 -0.61 . . . . 74.310000000000002 111.726 -175.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.509 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 0.0 OUTLIER -60.89 -18.65 57.59 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-O 121.324 0.583 . . . . 74.019999999999996 110.906 -178.313 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.561 HG21 HD13 ' A' ' 107' ' ' ILE . 80.5 mt -95.76 -52.33 9.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.451 -0.795 . . . . 54.229999999999997 111.158 -175.834 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.534 ' HB ' ' HE3' ' A' ' 179' ' ' LYS . 26.4 m -74.77 -10.75 13.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 112.715 0.635 . . . . 71.420000000000002 112.715 -173.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.4 pp -68.61 -32.92 57.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.836 0.35 . . . . 72.319999999999993 111.052 176.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.475 ' N ' HD12 ' A' ' 164' ' ' ILE . 13.7 pt20 -107.51 -174.35 2.51 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.337 -0.616 . . . . 73.519999999999996 109.337 176.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.633 ' HE3' ' OE1' ' A' ' 176' ' ' GLU . 82.5 tttt -123.52 -56.52 1.69 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.933 0.397 . . . . 71.120000000000005 111.063 -174.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.586 ' HB3' ' OD1' ' A' ' 174' ' ' ASN . 21.8 m-30 -79.93 113.0 17.77 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.93 -0.577 . . . . 75.219999999999999 111.62 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 20.8 m-70 -116.66 143.75 45.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.575 -0.739 . . . . 72.150000000000006 110.555 177.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 76.3 m -95.7 101.53 13.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.042 0.448 . . . . 64.140000000000001 111.202 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.541 HG11 HD12 ' A' ' 121' ' ' LEU . 42.4 t -118.62 127.96 75.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.285 -0.635 . . . . 63.32 109.285 177.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 58.5 t30 63.21 21.65 12.95 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.83 0.824 . . . . 73.400000000000006 110.112 -178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 84.58 -1.27 88.97 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.656 -0.702 . . . . 74.409999999999997 112.684 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 52.9 m-70 -103.26 145.56 29.76 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.919 0.39 . . . . 71.430000000000007 110.541 -179.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.586 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 64.5 t30 -88.87 106.58 18.48 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.907 -0.588 . . . . 73.150000000000006 110.072 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 12.0 p -116.55 159.86 21.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.088 -0.506 . . . . 61.039999999999999 110.993 -177.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.633 ' OE1' ' HE3' ' A' ' 166' ' ' LYS . 14.5 tt0 -95.47 130.88 42.14 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.101 -0.5 . . . . 71.409999999999997 109.915 178.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 3.0 m -118.88 142.97 31.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.126 0.488 . . . . 61.409999999999997 110.135 177.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.419 ' HD2' ' H62' ' B' ' 3' ' ' ' A' . 72.9 mtt180 -130.53 177.68 7.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.157 -0.474 . . . . 72.329999999999998 110.199 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.64 ' HE2' ' HB2' ' A' ' 100' ' ' ALA . 10.1 mptt -75.79 120.01 20.57 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.908 -1.145 . . . . 51.140000000000001 107.908 171.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.574 ' HB1' ' O6 ' ' B' ' 4' ' ' ' G' . . . -74.23 93.09 2.3 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.139 0.495 . . . . 45.210000000000001 111.66 -176.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.731 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -95.94 144.59 26.12 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.755 -0.657 . . . . 75.439999999999998 109.655 175.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.501 ' HB3' ' HG3' ' A' ' 185' ' ' GLU . 30.6 t -50.28 143.34 8.74 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.405 0.44 . . . . 72.319999999999993 111.593 -179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.848 ' HB2' " H5'" ' B' ' 6' ' ' ' U' . 21.5 pttp -60.23 -23.54 64.15 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.762 -0.654 . . . . 51.119999999999997 110.182 175.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 52.2 tp60 -73.76 -42.88 60.44 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 115.656 -0.702 . . . . 72.209999999999994 110.124 176.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 182' ' ' SER . 37.9 mt-10 -78.85 -32.48 46.05 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.654 -0.703 . . . . 72.519999999999996 111.295 -176.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.403 ' SD ' " H2'" ' B' ' 3' ' ' ' A' . 18.7 ptm -65.93 -26.0 67.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.326 -0.397 . . . . 54.329999999999998 110.666 -177.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.96 -42.27 57.95 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.006 0.432 . . . . 64.540000000000006 110.267 179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.5 t -69.64 -32.6 71.38 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.786 -0.643 . . . . 70.420000000000002 110.319 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -69.12 -31.4 70.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.218 0.532 . . . . 71.099999999999994 110.821 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 46.3 m -96.25 35.51 1.45 Allowed 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.59 -0.732 . . . . 53.229999999999997 111.281 -174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 15.7 m -90.03 3.88 51.89 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.183 -0.462 . . . . 72.540000000000006 110.657 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 28.2 t -98.73 102.4 14.11 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.224 -0.444 . . . . 43.32 110.535 -179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 21.6 mp0 -111.18 118.76 36.84 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.138 -0.483 . . . . 73.049999999999997 109.969 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -91.29 122.72 34.15 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.106 -0.497 . . . . 61.329999999999998 110.283 -178.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 73.48 -125.74 9.55 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.922 -0.656 . . . . 65.019999999999996 112.142 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 9.2 mmt180 . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.384 -0.817 . . . . 75.409999999999997 110.502 -179.632 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.817 " H3'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.427 -0.831 0 C4'-C3'-C2' 103.99 1.29 . 0.0 '__' . 71.209999999999994 . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.817 H5'' " H3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.848 0 C4'-C3'-C2' 104.095 1.395 . 0.0 OUTLIER . 74.140000000000001 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.595 ' N1 ' HD23 ' A' ' 181' ' ' LEU . . . . . . . . 0 O5'--C5' 1.423 -1.038 0 C4'-C3'-C2' 103.883 1.183 . 0.0 OUTLIER . 73.209999999999994 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.664 " O5'" H5'' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.892 0 C3'-C2'-C1' 99.651 -2.055 . 0.0 OUTLIER alpha 72.319999999999993 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.664 H5'' " O5'" ' B' ' 4' ' ' ' G' . . . . . . . . 0 O5'--C5' 1.427 -0.839 0 O4'-C1'-C2' 108.34 1.385 . 0.0 OUTLIER . 65.329999999999998 . . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.848 " H5'" ' HB2' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.425 -0.913 0 C3'-C2'-C1' 103.731 2.479 . 0.0 OUTLIER . 74.430000000000007 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 29.7 m . . . . . 0 N--CA 1.478 0.967 0 N-CA-C 110.379 -0.23 . . . . 74.140000000000001 110.379 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.495 ' HG2' ' HD3' ' A' ' 98' ' ' PRO . 61.3 tt0 -59.4 119.55 7.66 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-O 121.021 0.438 . . . . 70.329999999999998 110.906 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -149.94 79.28 7.79 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.774 -0.648 . . . . 72.109999999999999 110.639 177.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.495 ' HD3' ' HG2' ' A' ' 96' ' ' GLN . 17.1 Cg_exo -66.53 -54.27 0.49 Allowed 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.632 2.221 . . . . 53.420000000000002 110.57 176.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -99.77 78.35 0.48 Allowed Glycine 0 N--CA 1.444 -0.81 0 N-CA-C 110.734 -0.946 . . . . 50.340000000000003 110.734 172.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -81.19 -25.16 36.97 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.203 0.525 . . . . 64.109999999999999 110.48 -178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 53.0 p-80 -70.96 -21.52 62.32 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.679 -0.692 . . . . 61.210000000000001 109.724 175.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 81.9 mt -82.76 107.31 15.29 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 115.405 -0.816 . . . . 75.329999999999998 109.858 176.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.512 HG22 ' HB2' ' A' ' 156' ' ' HIS . 1.8 m -63.96 130.85 45.74 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.083 -0.508 . . . . 71.430000000000007 109.65 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.558 HG13 HG11 ' A' ' 159' ' ' VAL . 14.6 p -114.74 147.18 18.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-N 116.149 -0.478 . . . . 40.119999999999997 111.266 -168.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.762 ' HA ' HG21 ' A' ' 159' ' ' VAL . 12.1 mtmt -123.07 -1.41 8.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.147 -0.479 . . . . 74.140000000000001 111.865 -178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.622 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 27.0 ttpt -130.45 137.42 49.8 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.846 0.355 . . . . 71.140000000000001 110.171 175.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.577 ' CG2' HG13 ' A' ' 159' ' ' VAL . 10.8 pt -108.36 163.97 5.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.949 0.404 . . . . 74.549999999999997 111.258 -178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.461 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 75.0 t80 -112.67 120.19 40.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.567 -0.742 . . . . 74.439999999999998 109.452 176.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 14.4 t -105.9 115.45 47.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.947 0.403 . . . . 74.340000000000003 110.919 -179.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.86 171.53 18.5 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 111.65 -0.58 . . . . 44.109999999999999 111.65 177.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.53 ' H ' H5'' ' B' ' 2' ' ' ' C' . . . 66.97 36.95 91.76 Favored Glycine 0 N--CA 1.454 -0.119 0 C-N-CA 120.675 -0.774 . . . . 53.119999999999997 112.186 -179.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.661 ' CD1' " H3'" ' B' ' 1' ' ' ' U' . 0.2 OUTLIER -94.62 -167.28 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.613 0.244 . . . . 71.140000000000001 110.828 -177.51 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -109.29 163.1 13.69 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.042 -0.355 . . . . 62.049999999999997 110.042 179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.33 -34.36 46.92 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.386 0.675 . . . . 73.5 112.094 -176.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -93.87 -3.64 51.45 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.466 0.543 . . . . 73.209999999999994 112.466 -173.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 28.7 m -69.14 115.85 8.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.019 0.437 . . . . 65.340000000000003 111.418 -172.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.408 ' O ' ' HG ' ' A' ' 121' ' ' LEU . 0.9 OUTLIER -123.31 -161.13 0.94 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.592 -0.731 . . . . 75.329999999999998 110.978 -177.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.723 ' HA ' HG21 ' A' ' 134' ' ' ILE . 10.7 tt0 -57.68 -51.8 68.05 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.522 -0.763 . . . . 75.049999999999997 112.266 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.67 -33.97 76.15 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 120.921 -0.312 . . . . 72.310000000000002 110.619 -173.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 62.5 m80 -60.88 -56.19 24.07 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 116.281 -0.418 . . . . 63.549999999999997 110.314 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.575 HD23 HG11 ' A' ' 170' ' ' VAL . 59.2 mt -59.31 -54.75 43.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.435 -0.802 . . . . 72.540000000000006 111.191 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.3 tpp180 -55.36 -46.64 76.43 Favored 'General case' 0 C--O 1.223 -0.318 0 CA-C-N 116.1 -0.5 . . . . 71.430000000000007 111.412 -177.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -55.65 -35.3 65.79 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.996 0.427 . . . . 73.040000000000006 111.436 -178.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -84.31 -44.4 13.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.378 -0.374 . . . . 72.019999999999996 111.191 -178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -81.39 -16.88 50.87 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 112.387 0.514 . . . . 71.129999999999995 112.387 -172.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.92 -24.03 67.4 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 120.998 0.427 . . . . 64.120000000000005 110.951 179.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -66.76 -28.29 68.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.832 -0.622 . . . . 73.040000000000006 110.234 178.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.464 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 69.3 m-85 -80.78 -34.58 34.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.642 -0.708 . . . . 72.420000000000002 110.948 -177.45 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 171.7 -164.28 36.98 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 119.964 -1.112 . . . . 75.430000000000007 113.118 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -75.85 118.7 18.92 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 121.512 0.673 . . . . 72.030000000000001 111.959 -176.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.481 HG21 HD11 ' A' ' 134' ' ' ILE . 36.2 mt -95.22 139.96 17.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.19 -0.914 . . . . 40.130000000000003 110.355 177.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.448 ' HG2' ' HB2' ' A' ' 154' ' ' ASP . 9.0 mm-40 -84.61 -76.28 0.31 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.132 -0.485 . . . . 74.329999999999998 110.011 176.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.02 158.36 26.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.008 -0.542 . . . . 74.329999999999998 110.136 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.723 HG21 ' HA ' ' A' ' 118' ' ' GLU . 23.4 mm -107.35 112.46 40.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.139 -0.689 . . . . 75.519999999999996 109.139 176.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -97.58 92.02 5.71 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 121.348 0.594 . . . . 72.340000000000003 110.68 -175.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 11.7 mt -73.66 128.54 36.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 108.324 -0.991 . . . . 71.319999999999993 108.324 176.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.647 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -71.36 96.91 1.52 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.265 -0.643 . . . . 60.009999999999998 109.265 -179.115 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.447 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 3.3 p -114.72 154.16 28.98 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.664 -0.698 . . . . 62.229999999999997 110.889 -178.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.665 ' HA ' ' C4 ' ' B' ' 5' ' ' ' U' . 33.0 t70 -56.93 142.44 41.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.082 -0.508 . . . . 72.25 110.917 178.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.43 ' CD ' ' H ' ' A' ' 140' ' ' ARG . 0.1 OUTLIER -74.01 -15.36 61.09 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.858 -0.61 . . . . 55.049999999999997 111.486 -175.29 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.61 -56.76 0.81 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.699 -0.762 . . . . 72.329999999999998 112.815 -178.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 28.3 t -101.13 -8.23 22.45 Favored 'General case' 0 C--N 1.327 -0.391 0 O-C-N 122.652 -0.322 . . . . 71.519999999999996 111.536 -175.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 66.87 43.61 91.07 Favored Glycine 0 N--CA 1.454 -0.107 0 C-N-CA 120.58 -0.819 . . . . 62.409999999999997 112.214 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.484 ' H ' ' HB3' ' A' ' 139' ' ' ASP . 2.9 mtpt -93.08 141.97 27.81 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.869 -0.419 . . . . 62.32 109.869 -177.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -65.82 109.84 2.62 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.091 0.472 . . . . 73.329999999999998 110.934 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 61.2 ttt180 -70.35 -30.66 67.66 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.671 -0.695 . . . . 61.210000000000001 110.216 178.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 140.08 -79.0 0.29 Allowed Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.738 -0.665 . . . . 23.23 112.127 178.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.647 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 42.4 p90 -69.94 165.16 22.29 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.865 0.364 . . . . 54.530000000000001 110.773 -179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.461 ' HB3' HD11 ' A' ' 121' ' ' LEU . . . -149.14 165.33 32.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.415 -0.357 . . . . 74.319999999999993 110.99 -177.4 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.461 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 53.7 m-85 -124.04 143.2 50.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.021 -0.536 . . . . 71.409999999999997 109.934 -178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.585 HG13 ' CD1' ' A' ' 134' ' ' ILE . 44.1 t -117.56 112.54 39.24 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.875 -0.417 . . . . 75.540000000000006 109.875 178.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.622 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 16.6 m -89.83 125.08 35.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.226 -0.443 . . . . 73.439999999999998 110.434 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.484 ' CD2' HG22 ' A' ' 159' ' ' VAL . 88.3 m-85 -108.63 152.24 25.06 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.432 -0.581 . . . . 61.5 109.432 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.448 ' HB2' ' HG2' ' A' ' 132' ' ' GLU . 28.4 t70 -81.3 -18.93 44.12 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 122.113 0.959 . . . . 54.119999999999997 109.07 176.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.526 ' OD2' ' HB3' ' A' ' 157' ' ' ASP . 26.0 t70 -116.05 126.16 53.41 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.227 -1.351 . . . . 74.430000000000007 110.548 -175.149 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.575 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.6 p-80 -78.81 -8.49 58.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.222 -0.445 . . . . 54.210000000000001 111.363 -178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.526 ' HB3' ' OD2' ' A' ' 155' ' ' ASP . 18.5 t70 -89.03 -36.26 15.9 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.308 -0.627 . . . . 71.420000000000002 109.308 -176.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.0 t -54.44 -40.79 68.68 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.315 -0.857 . . . . 50.43 109.713 168.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.762 HG21 ' HA ' ' A' ' 105' ' ' LYS . 11.3 t -67.75 -33.96 64.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.516 -0.766 . . . . 61.420000000000002 110.443 178.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -64.25 -28.85 70.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 73.420000000000002 110.752 -178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.464 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 20.9 mmtp -70.07 -24.36 63.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.621 0.724 . . . . 64.439999999999998 109.893 177.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.482 HG23 ' CE1' ' A' ' 168' ' ' HIS . 87.3 mt -99.71 -48.4 11.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.009 -0.996 . . . . 65.540000000000006 111.917 -169.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.421 HG13 HG12 ' A' ' 159' ' ' VAL . 31.6 m -73.05 -7.76 10.33 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 N-CA-C 112.769 0.655 . . . . 71.209999999999994 112.769 -173.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.3 pp -78.45 -33.81 17.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 C-N-CA 120.911 -0.316 . . . . 72.010000000000005 111.479 179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.525 ' N ' HD12 ' A' ' 164' ' ' ILE . 12.8 pt20 -108.47 171.34 7.47 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.493 -0.558 . . . . 53.509999999999998 109.493 176.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.565 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 86.3 tttt -111.61 -59.38 1.99 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.831 0.348 . . . . 72.140000000000001 111.181 -174.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.602 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 19.8 m-30 -77.32 99.16 5.43 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.272 0.558 . . . . 63.539999999999999 112.042 -176.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.482 ' CE1' HG23 ' A' ' 162' ' ' ILE . 49.0 m-70 -98.61 159.19 15.12 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.551 -0.75 . . . . 72.510000000000005 110.009 174.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 8.9 m -104.67 83.77 2.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.927 0.394 . . . . 74.329999999999998 110.956 -178.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.575 HG11 HD23 ' A' ' 121' ' ' LEU . 21.9 t -106.93 131.85 55.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 109.952 -0.388 . . . . 74.510000000000005 109.952 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.507 ' HB3' ' HD2' ' A' ' 173' ' ' HIS . 31.1 t-20 67.07 13.52 9.48 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.756 0.789 . . . . 73.109999999999999 109.776 178.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 81.05 17.69 71.53 Favored Glycine 0 N--CA 1.45 -0.426 0 CA-C-N 115.758 -0.656 . . . . 74.010000000000005 112.072 -177.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . 0.507 ' HD2' ' HB3' ' A' ' 171' ' ' ASN . 86.9 m-70 -117.28 160.25 21.4 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.074 0.464 . . . . 72.549999999999997 110.553 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -87.2 105.98 17.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.703 -0.68 . . . . 71.409999999999997 109.449 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.602 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 66.8 m -114.15 158.43 21.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.151 -0.477 . . . . 75.340000000000003 111.02 -175.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.565 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 9.5 tt0 -103.16 125.74 50.0 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.15 -0.477 . . . . 74.329999999999998 110.152 178.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.435 HG11 ' CG2' ' A' ' 162' ' ' ILE . 78.5 t -123.06 135.16 64.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 121.308 0.575 . . . . 73.239999999999995 110.896 177.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.485 ' HD2' ' OE1' ' A' ' 96' ' ' GLN . 2.8 ptt180 -139.9 165.56 26.99 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.346 -0.843 . . . . 71.420000000000002 108.993 176.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.46 ' HB2' HG11 ' A' ' 104' ' ' VAL . 11.5 ptmm? -72.04 126.21 29.19 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 120.544 -0.462 . . . . 75.099999999999994 110.038 -177.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.695 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -72.3 129.29 38.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.859 -0.61 . . . . 50.130000000000003 111.239 -176.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.708 ' HG ' ' HB3' ' A' ' 186' ' ' MET . 2.5 pt? -124.7 143.96 50.47 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.437 -0.801 . . . . 75.540000000000006 109.025 174.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 m -49.3 137.91 13.59 Favored 'General case' 0 C--N 1.328 -0.36 0 O-C-N 123.445 0.466 . . . . 70.25 111.246 -177.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.854 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 21.1 pttp -61.84 -25.63 67.64 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.17 0.51 . . . . 70.230000000000004 110.094 178.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 6.6 tt0 -59.06 -41.48 88.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.34 -0.846 . . . . 73.109999999999999 110.762 172.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -93.11 -35.89 12.96 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.58 -0.736 . . . . 63.009999999999998 111.38 -172.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.854 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 23.9 ptm -67.42 -22.59 65.51 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.753 0.311 . . . . 72.510000000000005 110.385 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -65.77 -39.35 90.93 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.7 -0.481 . . . . 74.209999999999994 109.7 175.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 16.0 m -70.64 -38.4 73.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.706 -0.679 . . . . 51.299999999999997 110.333 177.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -65.01 -34.73 79.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.205 -0.452 . . . . 45.350000000000001 110.729 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.7 t -75.24 -37.46 61.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.959 -0.564 . . . . 44.049999999999997 110.022 176.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 49.0 m -70.27 171.48 9.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.928 -0.578 . . . . 72.120000000000005 110.283 176.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . 0.449 ' HB3' ' O ' ' A' ' 195' ' ' GLY . 14.7 m -96.71 88.6 4.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 120.932 0.396 . . . . 72.25 110.542 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -83.96 -46.77 11.7 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.024 0.44 . . . . 73.319999999999993 110.241 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -87.39 -42.29 12.95 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.091 -0.504 . . . . 72.129999999999995 110.183 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 192' ' ' SER . . . 168.87 -76.25 0.11 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.635 -0.793 . . . . 34.229999999999997 112.328 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.686 -0.673 . . . . 74.200000000000003 110.161 -177.884 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.661 " H3'" ' CD1' ' A' ' 112' ' ' ILE . . . . . . . . 0 O5'--C5' 1.423 -1.074 0 C3'-C2'-C1' 100.405 -1.216 . 0.0 '__' . 74.530000000000001 . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.615 ' OP2' " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.96 0 C3'-C2'-C1' 100.806 -0.771 . 0.0 OUTLIER . 73.450000000000003 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.695 ' N1 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.426 -0.864 0 O4'-C1'-C2' 108.051 1.18 . 0.0 OUTLIER . 74.310000000000002 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.644 " O5'" ' HD3' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.424 -0.993 0 C3'-C2'-C1' 100.547 -1.059 . 0.0 OUTLIER alpha 73.439999999999998 . . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.929 ' C6 ' " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.97 0 C3'-C2'-C1' 103.722 2.469 OUTLIER-DELTA 0.0 OUTLIER . 75.430000000000007 . . . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.464 " O5'" " H4'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.923 0 C3'-C2'-C1' 100.343 -1.285 . 0.0 OUTLIER . 72.030000000000001 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 N--CA 1.476 0.86 0 CA-C-O 121.102 0.477 . . . . 63.149999999999999 110.948 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -84.63 128.4 34.58 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.016 -0.735 . . . . 74.400000000000006 109.016 173.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 97' ' ' ARG . 46.8 mtm105 58.86 96.11 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.292 0 O-C-N 123.874 0.734 . . . . 64.450000000000003 110.85 -172.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.631 ' HG2' ' O ' ' A' ' 179' ' ' LYS . 34.9 Cg_exo -64.57 -169.49 0.12 Allowed 'Trans proline' 0 N--CA 1.472 0.212 0 C-N-CA 123.27 2.646 . . . . 74.530000000000001 113.463 -179.342 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -56.58 98.86 0.07 OUTLIER Glycine 0 C--N 1.333 0.388 0 CA-C-N 115.647 -0.706 . . . . 54.350000000000001 112.552 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.94 -14.38 59.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.318 0.58 . . . . 63.100000000000001 110.499 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 51.5 p-80 -83.34 -6.29 59.42 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.453 -0.794 . . . . 73.540000000000006 110.391 176.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 85.5 mt -101.06 130.85 47.15 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.901 -0.591 . . . . 71.109999999999999 110.52 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -72.91 104.09 3.94 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.17 0.51 . . . . 65.219999999999999 110.349 175.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.485 ' O ' HG21 ' A' ' 159' ' ' VAL . 4.1 p -89.56 144.76 8.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.866 -0.607 . . . . 65.310000000000002 110.323 -176.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.548 ' HG3' ' HB3' ' A' ' 156' ' ' HIS . 2.5 mtmt -122.24 16.81 10.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.389 0.614 . . . . 62.450000000000003 110.547 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.576 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 24.8 ttpt -152.78 136.52 16.15 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.339 -0.846 . . . . 62.439999999999998 109.742 178.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.546 HG12 ' HB ' ' A' ' 151' ' ' VAL . 9.1 pt -103.93 162.7 4.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.904 0.383 . . . . 64.420000000000002 110.732 -178.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.465 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 59.7 t80 -110.63 110.63 21.4 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.762 -0.653 . . . . 74.109999999999999 110.363 -177.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 20.1 t -98.25 91.86 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 109.132 -0.692 . . . . 74.549999999999997 109.132 176.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.691 ' O ' " H5'" ' B' ' 2' ' ' ' C' . . . -106.64 -38.99 2.12 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.669 -0.777 . . . . 52.130000000000003 112.928 -174.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.647 ' HA3' ' HB3' ' A' ' 176' ' ' GLU . . . -79.54 59.43 4.4 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.589 -0.815 . . . . 75.439999999999998 113.229 -174.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.483 HG22 ' SG ' ' A' ' 175' ' ' CYS . 44.9 pt -110.97 169.87 3.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 110.123 -0.325 . . . . 64.200000000000003 110.123 176.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.452 ' HA ' ' O2 ' ' B' ' 1' ' ' ' U' . 49.6 mttm -138.35 -48.72 0.54 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.337 -0.392 . . . . 74.319999999999993 111.175 -179.374 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.75 173.58 8.2 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.193 -0.458 . . . . 73.519999999999996 111.011 -176.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.27 97.36 0.54 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.956 -0.565 . . . . 74.109999999999999 110.052 -177.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 9.1 m -117.8 120.48 38.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.346 -0.843 . . . . 53.43 109.393 -178.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -113.61 -169.37 1.49 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.215 0.531 . . . . 74.530000000000001 112.143 -173.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.73 ' HA ' HG21 ' A' ' 134' ' ' ILE . 21.1 tt0 -58.13 -48.73 79.34 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 114.881 -1.054 . . . . 74.040000000000006 111.926 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -34.94 75.19 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 121.089 -0.244 . . . . 63.420000000000002 110.554 -177.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -64.4 -57.31 9.65 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-O 121.085 0.469 . . . . 75.439999999999998 110.453 178.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.599 HD23 HG11 ' A' ' 170' ' ' VAL . 79.4 mt -59.93 -52.4 65.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.306 -0.861 . . . . 52.409999999999997 110.848 -176.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -59.52 -44.09 93.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.007 -0.542 . . . . 74.439999999999998 111.419 -177.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -63.16 -22.75 67.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.042 0.448 . . . . 73.239999999999995 110.938 -175.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.417 ' CD1' HG22 ' A' ' 170' ' ' VAL . 85.9 t80 -89.83 -51.78 5.32 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.251 -0.432 . . . . 63.399999999999999 110.85 176.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.431 ' HA ' ' HD2' ' A' ' 128' ' ' TYR . 52.2 m-85 -74.49 -14.7 60.86 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 112.38 0.511 . . . . 74.340000000000003 112.38 -172.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.64 -22.34 65.19 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.837 0.31 . . . . 74.25 111.837 178.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -74.66 -21.82 59.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.821 0.343 . . . . 71.239999999999995 110.582 178.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.473 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 86.6 m-85 -86.04 -21.79 27.56 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-N 116.501 -0.318 . . . . 73.439999999999998 110.279 179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 163.18 -167.69 37.6 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 119.822 -1.18 . . . . 44.509999999999998 113.373 174.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.567 ' HG3' ' HB3' ' A' ' 154' ' ' ASP . 37.7 tptt -75.74 117.09 17.12 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-O 121.633 0.73 . . . . 71.040000000000006 111.09 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.552 HG21 HD11 ' A' ' 134' ' ' ILE . 40.1 mt -93.69 133.78 33.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.023 -0.989 . . . . 73.420000000000002 110.557 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -82.2 -75.17 0.31 Allowed 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.925 -0.58 . . . . 74.439999999999998 110.765 178.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 2.2 t -135.54 155.57 36.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.797 -0.446 . . . . 52.200000000000003 109.797 -178.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.73 HG21 ' HA ' ' A' ' 118' ' ' GLU . 27.8 mm -113.01 123.08 68.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.817 0 N-CA-C 109.493 -0.558 . . . . 74.129999999999995 109.493 173.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -105.3 96.13 6.31 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.017 0.437 . . . . 72.099999999999994 110.644 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.61 HD11 ' H ' ' A' ' 118' ' ' GLU . 7.9 mt -80.19 120.46 31.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 108.036 -1.098 . . . . 73.030000000000001 108.036 173.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.601 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 76.1 mmm -74.15 94.39 2.43 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 119.926 -0.71 . . . . 73.530000000000001 109.964 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 10.2 p -99.56 173.71 6.6 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 114.704 -1.135 . . . . 53.520000000000003 109.983 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.754 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 22.1 t70 -60.61 138.6 58.03 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.349 -0.612 . . . . 63.240000000000002 109.349 173.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.458 ' HD3' " H2'" ' B' ' 5' ' ' ' U' . 5.1 tpt180 -72.04 -2.38 18.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.006 0.431 . . . . 70.209999999999994 111.214 -172.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -128.67 -49.47 0.14 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.032 -0.604 . . . . 73.0 112.852 178.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.544 ' HB2' ' HG2' ' A' ' 144' ' ' LYS . 24.5 m -83.51 -18.93 36.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.745 0.307 . . . . 61.020000000000003 111.61 -175.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 67.76 32.54 78.19 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.765 -0.731 . . . . 55.030000000000001 112.855 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.544 ' HG2' ' HB2' ' A' ' 142' ' ' SER . 8.3 ptpt -105.6 139.62 39.92 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.76 -0.459 . . . . 72.439999999999998 109.76 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -52.89 130.05 32.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.919 0.39 . . . . 74.409999999999997 112.028 -172.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 56.6 ttt180 -91.04 -32.1 16.03 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.258 -0.645 . . . . 72.319999999999993 109.258 175.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.683 ' HA3' " O5'" ' B' ' 1' ' ' ' U' . . . 154.68 -101.91 0.21 Allowed Glycine 0 N--CA 1.445 -0.751 0 CA-C-N 115.508 -0.769 . . . . 73.409999999999997 112.283 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.649 ' H ' " H5'" ' B' ' 1' ' ' ' U' . 24.5 p90 -57.22 157.64 6.05 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.921 0.488 . . . . 73.230000000000004 111.853 -175.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.53 165.52 27.34 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.173 -0.467 . . . . 60.420000000000002 110.938 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.552 ' HB3' ' HD2' ' A' ' 106' ' ' LYS . 69.1 m-85 -123.73 142.34 51.18 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.1 -0.5 . . . . 71.140000000000001 110.317 -179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.634 HG13 ' CD1' ' A' ' 134' ' ' ILE . 55.6 t -116.42 108.49 25.2 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 116.04 -0.527 . . . . 70.030000000000001 109.784 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.576 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 8.7 m -86.35 127.61 34.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.142 -0.481 . . . . 74.030000000000001 110.475 -178.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.541 ' CD2' HG12 ' A' ' 159' ' ' VAL . 96.4 m-85 -110.47 153.5 24.96 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.936 0.398 . . . . 74.420000000000002 110.555 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.567 ' HB3' ' HG3' ' A' ' 130' ' ' LYS . 19.4 t70 -76.69 -15.26 59.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.905 -0.589 . . . . 71.219999999999999 110.606 177.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -136.15 139.85 43.2 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.809 -0.632 . . . . 72.340000000000003 110.609 -174.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.548 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.4 p-80 -83.99 -0.29 51.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.979 0.418 . . . . 70.510000000000005 111.018 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -80.44 -40.97 25.32 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.417 0.627 . . . . 74.109999999999999 109.48 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.4 m -61.17 -33.64 73.76 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.121 -0.945 . . . . 52.049999999999997 111.538 -179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.541 HG12 ' CD2' ' A' ' 153' ' ' PHE . 15.3 m -72.85 -27.92 26.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.296 -0.411 . . . . 50.020000000000003 111.396 -177.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . 0.495 ' HA ' HG22 ' A' ' 163' ' ' VAL . 35.6 t70 -65.53 -42.12 92.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.608 -0.269 . . . . 61.210000000000001 110.993 -173.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.473 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 4.9 mttt -58.86 -22.33 58.9 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-O 121.196 0.522 . . . . 71.519999999999996 110.807 178.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.522 HG21 HD13 ' A' ' 107' ' ' ILE . 79.6 mt -92.86 -49.37 12.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.397 -0.82 . . . . 51.5 110.939 -177.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.551 HG11 ' HB3' ' A' ' 179' ' ' LYS . 30.3 m -77.83 -7.73 10.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 112.898 0.703 . . . . 63.130000000000003 112.898 -174.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.409 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.5 pp -72.84 -28.87 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 120.967 0.413 . . . . 75.430000000000007 110.561 174.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.432 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 11.9 pt20 -108.06 -171.17 1.81 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.172 -0.677 . . . . 72.040000000000006 109.172 172.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.41 ' HG2' ' HG3' ' A' ' 176' ' ' GLU . 87.6 tttt -130.3 -61.85 0.96 Allowed 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 120.781 -0.368 . . . . 63.329999999999998 111.537 -174.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 20.8 m-30 -82.6 115.51 21.59 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.949 0.404 . . . . 64.319999999999993 110.721 -178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.442 ' CE1' HG23 ' A' ' 162' ' ' ILE . 21.3 m-70 -110.15 140.04 44.66 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.702 -0.681 . . . . 72.040000000000006 110.655 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 34.3 m -88.85 87.72 7.34 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 116.047 -0.524 . . . . 71.530000000000001 110.354 179.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.599 HG11 HD23 ' A' ' 121' ' ' LEU . 33.0 t -106.07 131.07 56.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.597 -0.52 . . . . 74.25 109.597 178.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 63.46 20.83 12.47 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.879 0.847 . . . . 62.450000000000003 109.546 -177.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 82.08 -5.74 70.24 Favored Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.383 -0.826 . . . . 71.530000000000001 112.191 -176.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 49.7 t-80 -96.46 151.24 19.75 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.207 -0.294 . . . . 73.409999999999997 110.207 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -86.78 99.49 11.83 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.008 -0.367 . . . . 71.409999999999997 110.008 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 111' ' ' GLY . 58.5 m -110.46 128.85 55.8 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.363 -0.38 . . . . 72.439999999999998 110.979 -177.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.647 ' HB3' ' HA3' ' A' ' 111' ' ' GLY . 28.4 tt0 -76.72 123.52 26.3 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.173 -0.467 . . . . 74.140000000000001 110.534 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 1.1 m -119.31 151.75 21.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.185 -0.461 . . . . 55.32 110.354 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 72.7 mtt180 -138.23 -173.92 3.66 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.716 -0.846 . . . . 74.430000000000007 108.716 175.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.631 ' O ' ' HG2' ' A' ' 98' ' ' PRO . 19.4 ptmt -91.07 132.88 35.75 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.253 -0.647 . . . . 75.040000000000006 109.253 170.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -82.15 114.36 20.62 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.101 0.408 . . . . 51.039999999999999 112.101 -173.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.576 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.6 pt? -102.66 144.62 30.8 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.076 -0.713 . . . . 61.119999999999997 109.076 173.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 2.0 m -52.86 133.13 37.7 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 123.312 0.383 . . . . 61.329999999999998 111.252 -176.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.743 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 39.0 pttt -62.35 -30.25 71.04 Favored 'General case' 0 CA--C 1.521 -0.143 0 N-CA-C 109.828 -0.434 . . . . 75.310000000000002 109.828 -179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -59.99 -41.26 91.67 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.517 -0.765 . . . . 63.039999999999999 110.358 176.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -85.26 -39.16 18.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.645 -0.707 . . . . 75.010000000000005 111.257 -175.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.743 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 25.3 ptm -68.14 -21.33 64.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.779 0.323 . . . . 73.530000000000001 110.49 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -72.75 -43.08 63.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 64.310000000000002 109.864 175.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 18.8 m -69.41 -31.49 69.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.912 -0.586 . . . . 42.420000000000002 110.479 177.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -66.24 -46.53 76.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.395 0.616 . . . . 71.219999999999999 110.326 176.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 64.6 m -69.51 -53.99 16.41 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.19 -0.913 . . . . 74.140000000000001 110.894 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 28.5 m -111.16 88.3 2.75 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.124 0.488 . . . . 35.32 110.363 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 15.1 m -89.74 95.49 10.27 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.856 -0.611 . . . . 62.329999999999998 110.605 -178.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 27.1 tt0 -83.95 136.93 33.88 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.979 -0.555 . . . . 72.099999999999994 109.576 178.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 26.7 mmm180 -101.68 24.43 9.83 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.005 0.431 . . . . 65.430000000000007 110.291 -174.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 94.17 -74.15 1.09 Allowed Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.09 -0.804 . . . . 64.329999999999998 111.09 -174.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.727 -0.654 . . . . 70.420000000000002 109.431 175.9 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 1.011 " C4'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.428 -0.725 0 C4'-C3'-C2' 104.199 1.499 . 0.0 '__' . 75.549999999999997 . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 1.011 H5'' " C4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -1.006 0 C3'-C2'-C1' 104.404 3.227 OUTLIER-DELTA 0.0 OUTLIER alpha 75.129999999999995 . . . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.573 ' N1 ' HD23 ' A' ' 181' ' ' LEU . . . . . . . . 0 O5'--C5' 1.424 -1.03 0 C4'-C3'-C2' 104.545 1.845 . 0.0 OUTLIER . 75.0 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.649 ' H21' ' HB3' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.424 -1.01 0 C3'-C2'-C1' 98.582 -3.243 . 0.0 OUTLIER alpha 74.450000000000003 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.932 " H3'" " H5'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.422 -1.135 0 O4'-C1'-C2' 107.797 0.998 . 0.0 OUTLIER zeta-1 71.439999999999998 . . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.932 " H5'" " H3'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.887 0 C3'-C2'-C1' 100.765 -0.817 . 0.0 OUTLIER . 65.329999999999998 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 59.2 m . . . . . 0 N--CA 1.475 0.804 0 N-CA-C 110.313 -0.254 . . . . 62.009999999999998 110.313 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 65.28 19.92 11.78 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 123.296 0.639 . . . . 70.120000000000005 111.401 177.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -135.69 78.11 50.13 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 120.96 0.41 . . . . 74.239999999999995 110.578 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -91.47 46.35 0.54 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.144 2.563 . . . . 64.420000000000002 111.912 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 86.79 -28.26 5.53 Favored Glycine 0 N--CA 1.451 -0.302 0 N-CA-C 110.961 -0.856 . . . . 61.219999999999999 110.961 -173.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.499 ' HB2' ' HB3' ' A' ' 181' ' ' LEU . . . -85.91 96.47 9.81 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.656 -0.498 . . . . 64.049999999999997 109.656 172.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.766 ' HA ' ' HG2' ' A' ' 179' ' ' LYS . 8.5 p80 -173.14 8.5 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.523 -0.762 . . . . 74.200000000000003 110.01 177.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.416 ' H ' ' H ' ' A' ' 101' ' ' HIS . 31.2 mt -102.22 -140.09 0.35 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.315 -0.857 . . . . 74.010000000000005 109.641 -177.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.2 p -74.16 96.66 2.78 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.915 0.388 . . . . 75.430000000000007 110.307 174.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 16.4 t -103.31 -46.74 10.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.364 -0.38 . . . . 31.120000000000001 111.266 -176.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.725 ' HA ' HG21 ' A' ' 159' ' ' VAL . 24.1 mtmt 69.45 12.27 8.22 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-N 116.163 -0.472 . . . . 74.099999999999994 112.206 178.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.58 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 27.9 ttpt -157.23 133.91 10.01 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.593 -0.521 . . . . 64.329999999999998 109.593 173.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.528 HD13 HG21 ' A' ' 162' ' ' ILE . 4.7 pt -108.42 158.49 8.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.106 0.479 . . . . 75.109999999999999 111.023 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.535 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 69.4 t80 -105.3 121.11 43.19 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.246 -0.888 . . . . 65.340000000000003 109.899 179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . 0.465 HG12 ' CG2' ' A' ' 112' ' ' ILE . 41.9 t -108.43 111.56 36.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.44 -0.345 . . . . 73.230000000000004 110.405 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -126.53 162.05 20.75 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.02 -0.61 . . . . 51.450000000000003 112.241 -178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 62.43 62.81 5.22 Favored Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.948 -0.644 . . . . 71.25 111.59 -177.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.577 ' H ' " C5'" ' B' ' 1' ' ' ' U' . 17.6 pt -111.71 -170.23 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.339 0.59 . . . . 73.409999999999997 112.475 -169.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.451 ' HB3' ' OG1' ' A' ' 116' ' ' THR . 44.4 tttm -96.46 153.45 17.83 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.014 -0.993 . . . . 75.239999999999995 109.763 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -47.2 -67.51 0.27 Allowed 'General case' 0 C--O 1.235 0.302 0 O-C-N 123.485 0.491 . . . . 62.119999999999997 111.249 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -87.48 80.59 8.04 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.316 0.579 . . . . 33.200000000000003 110.139 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.451 ' OG1' ' HB3' ' A' ' 113' ' ' LYS . 62.3 m -140.64 106.87 5.23 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.125 -0.943 . . . . 65.420000000000002 109.356 173.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -123.22 -162.9 1.06 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.706 -0.679 . . . . 61.549999999999997 110.812 -174.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.635 ' HA ' HG21 ' A' ' 134' ' ' ILE . 15.9 tt0 -49.47 -52.43 29.22 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.028 -0.533 . . . . 75.239999999999995 112.056 -179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -64.49 -29.29 70.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.525 -0.307 . . . . 71.040000000000006 110.663 -174.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -69.42 -56.46 7.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.533 -0.303 . . . . 64.540000000000006 110.918 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.455 HD11 HG11 ' A' ' 109' ' ' VAL . 0.7 OUTLIER -57.19 -49.07 77.15 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-O 120.969 0.414 . . . . 71.430000000000007 109.951 177.47 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 122' ' ' ARG . 0.7 OUTLIER -55.03 -49.94 70.32 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.725 -0.671 . . . . 53.340000000000003 111.03 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -53.29 -32.71 50.04 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.169 0.509 . . . . 73.400000000000006 111.8 -177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 41.1 t80 -89.88 -39.09 13.27 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.077 -0.511 . . . . 74.349999999999994 111.578 -177.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.457 ' CD1' HG21 ' A' ' 151' ' ' VAL . 56.4 m-85 -89.14 -14.35 36.37 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.358 0.503 . . . . 53.219999999999999 112.358 -173.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.407 ' N ' HD11 ' A' ' 131' ' ' ILE . 0.0 OUTLIER -66.12 -20.47 66.16 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.413 0.625 . . . . 72.319999999999993 110.013 176.039 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -71.58 -23.64 61.77 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.996 -1.002 . . . . 54.049999999999997 110.755 177.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . . . . . . . . . 64.2 m-85 -87.17 -32.64 19.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.086 -0.506 . . . . 75.420000000000002 111.099 -177.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 172.33 -152.35 16.69 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 119.829 -1.177 . . . . 63.530000000000001 113.7 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.464 ' HA ' ' HE3' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -87.97 113.95 24.1 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.421 0.629 . . . . 73.439999999999998 111.547 -175.656 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.407 ' O ' ' HE2' ' A' ' 130' ' ' LYS . 34.3 mt -94.24 138.25 21.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 115.041 -0.982 . . . . 72.439999999999998 110.187 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -78.04 -74.58 0.26 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.483 -0.562 . . . . 72.530000000000001 109.483 172.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 12.6 m -146.57 165.48 7.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.917 -0.583 . . . . 64.109999999999999 109.816 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.635 HG21 ' HA ' ' A' ' 118' ' ' GLU . 19.6 mm -109.59 109.45 28.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 N-CA-C 109.274 -0.639 . . . . 73.450000000000003 109.274 176.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.402 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 59.5 mt-10 -88.14 98.57 11.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.312 0.577 . . . . 63.119999999999997 110.231 -176.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.57 HD11 ' H ' ' A' ' 118' ' ' GLU . 35.8 mt -78.48 116.26 21.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.637 -0.71 . . . . 64.239999999999995 109.571 179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.765 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -77.05 98.67 5.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.078 0.466 . . . . 64.439999999999998 109.809 -178.632 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 2.9 p -90.74 144.06 26.11 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.896 -0.593 . . . . 63.329999999999998 110.97 178.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.401 ' HA ' ' HD2' ' A' ' 146' ' ' ARG . 34.5 t70 -59.55 141.07 55.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.228 -0.896 . . . . 71.310000000000002 110.524 178.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.474 ' H ' ' HD3' ' A' ' 140' ' ' ARG . 0.0 OUTLIER -96.06 14.68 22.97 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.07 -0.513 . . . . 53.149999999999999 110.961 -174.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -120.28 -45.8 0.39 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.97 -0.633 . . . . 62.229999999999997 111.717 175.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 21.1 t -100.86 -34.35 9.84 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.878 0.37 . . . . 63.310000000000002 111.035 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 85.67 54.32 2.82 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.64 -0.791 . . . . 45.030000000000001 111.526 -174.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 58.1 pttt -134.19 159.86 39.6 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.595 -0.52 . . . . 74.400000000000006 109.595 -176.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -60.47 113.56 2.49 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.344 -0.614 . . . . 44.140000000000001 109.344 174.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.459 ' O ' " H2'" ' B' ' 1' ' ' ' U' . 21.9 ttt-85 -82.38 6.33 17.44 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.516 0.561 . . . . 55.409999999999997 112.516 -167.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 1.053 ' HA3' " H2'" ' B' ' 1' ' ' ' U' . . . 106.74 -11.44 41.92 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.139 -1.029 . . . . 74.530000000000001 112.964 176.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.765 ' CE1' ' HG3' ' A' ' 137' ' ' MET . 21.4 p90 -141.92 150.76 41.91 Favored 'General case' 0 C--N 1.319 -0.732 0 O-C-N 122.485 -0.42 . . . . 64.310000000000002 110.477 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.49 174.23 10.72 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.757 -0.656 . . . . 72.099999999999994 110.069 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.518 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 82.2 m-85 -133.33 139.55 46.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.914 0.387 . . . . 63.119999999999997 110.095 -177.133 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.605 HG13 ' CD1' ' A' ' 134' ' ' ILE . 26.3 t -114.02 106.61 21.01 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 109.598 -0.519 . . . . 73.25 109.598 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.58 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 17.7 m -85.28 124.11 31.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.23 -0.441 . . . . 72.329999999999998 110.313 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.447 ' CD2' HG22 ' A' ' 159' ' ' VAL . 97.5 m-85 -107.91 145.09 34.24 Favored 'General case' 0 C--N 1.317 -0.833 0 N-CA-C 109.833 -0.432 . . . . 65.219999999999999 109.833 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -74.87 -21.32 59.31 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.688 0.756 . . . . 72.040000000000006 109.486 176.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.494 ' OD1' ' HB3' ' A' ' 157' ' ' ASP . 18.7 t70 -118.99 128.52 54.47 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.801 -1.09 . . . . 71.409999999999997 110.871 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.58 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 3.2 p-80 -76.23 -9.59 58.75 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.996 -0.547 . . . . 64.299999999999997 111.268 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.494 ' HB3' ' OD1' ' A' ' 155' ' ' ASP . 32.8 t70 -85.3 -39.84 17.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.207 0.527 . . . . 60.450000000000003 109.642 -176.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 41.4 t -57.68 -34.6 69.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.627 -0.715 . . . . 61.219999999999999 110.526 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.725 HG21 ' HA ' ' A' ' 105' ' ' LYS . 16.9 t -66.84 -35.54 74.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.004 -0.544 . . . . 72.239999999999995 110.134 178.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -63.12 -31.7 72.9 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.525 -0.761 . . . . 74.230000000000004 111.362 -175.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 35.3 mmtt -71.36 -19.48 62.28 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-O 121.306 0.574 . . . . 71.319999999999993 110.184 -179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.528 HG21 HD13 ' A' ' 107' ' ' ILE . 86.8 mt -102.22 -48.88 10.88 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 CA-C-N 115.262 -0.881 . . . . 74.329999999999998 111.433 -171.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.536 ' HB ' ' HG3' ' A' ' 179' ' ' LYS . 33.6 m -67.85 -19.25 24.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.216 0.451 . . . . 71.420000000000002 112.216 -174.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.423 ' H ' HG13 ' A' ' 164' ' ' ILE . 2.4 pp -69.34 -25.44 29.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.096 0.474 . . . . 71.109999999999999 110.774 176.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.556 ' HB3' ' NE2' ' A' ' 168' ' ' HIS . 21.9 tt0 -106.96 159.62 16.14 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.414 -0.812 . . . . 73.340000000000003 109.114 177.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.522 ' HE2' ' CE2' ' A' ' 167' ' ' TYR . 80.6 tttt -109.66 -64.3 1.27 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.87 0.367 . . . . 72.109999999999999 110.762 -179.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.522 ' CE2' ' HE2' ' A' ' 166' ' ' LYS . 22.9 m-85 -77.03 113.17 14.45 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.049 0.452 . . . . 73.329999999999998 110.829 -178.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.556 ' NE2' ' HB3' ' A' ' 165' ' ' GLN . 36.0 m-70 -121.7 132.53 54.68 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.549 -0.75 . . . . 71.019999999999996 110.019 178.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . 0.416 ' HA ' ' HA ' ' A' ' 174' ' ' ASN . 55.2 m -90.45 102.56 15.29 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.062 0.458 . . . . 74.219999999999999 110.951 -178.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 2.7 p -118.21 136.58 54.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.899 -0.591 . . . . 71.5 109.881 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 59.29 25.5 14.14 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-O 121.511 0.672 . . . . 70.25 110.718 -175.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 77.57 7.61 87.16 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.766 -0.73 . . . . 61.310000000000002 112.555 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 23.1 t60 -116.02 123.62 48.43 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.718 -0.475 . . . . 64.430000000000007 109.718 179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 169' ' ' THR . 64.1 t30 -74.73 102.63 4.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.214 -0.448 . . . . 55.439999999999998 110.071 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.509 ' SG ' ' HA ' ' A' ' 112' ' ' ILE . 35.5 m -107.76 169.99 8.26 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.158 -0.474 . . . . 62.310000000000002 110.709 -175.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -103.0 122.22 44.17 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.232 -0.44 . . . . 61.219999999999999 109.948 178.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.535 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.0 OUTLIER -120.36 151.67 23.17 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.263 -0.643 . . . . 72.230000000000004 109.263 176.646 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.3 ptt180 -161.62 -171.67 3.03 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 115.835 -0.621 . . . . 63.100000000000001 109.758 178.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.766 ' HG2' ' HA ' ' A' ' 101' ' ' HIS . 7.7 mptt -74.43 122.16 22.56 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.874 -0.417 . . . . 63.130000000000003 109.874 -177.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.666 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -81.28 90.85 6.14 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.942 0.401 . . . . 54.310000000000002 111.321 179.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.692 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.5 pt? -88.76 134.95 33.76 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.259 -0.645 . . . . 71.400000000000006 109.259 174.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 4.4 m -51.91 144.47 11.55 Favored 'General case' 0 C--N 1.327 -0.404 0 O-C-N 123.567 0.542 . . . . 75.140000000000001 111.309 -176.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.753 ' NZ ' " H3'" ' B' ' 5' ' ' ' U' . 32.1 pttt -57.71 -29.78 64.99 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 121.227 0.537 . . . . 62.140000000000001 110.114 177.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -58.04 -47.78 82.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.416 -0.811 . . . . 73.519999999999996 110.713 173.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -82.31 -37.66 25.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.122 -0.945 . . . . 63.350000000000001 111.275 -173.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.648 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 22.7 ptm -64.17 -24.42 67.68 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.494 -0.321 . . . . 71.099999999999994 110.638 -178.067 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -73.11 -30.05 63.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.011 0.434 . . . . 72.040000000000006 110.599 178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 22.4 m -88.95 -45.86 9.34 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.03 -0.532 . . . . 72.530000000000001 110.65 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -73.02 -54.22 9.14 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 116.117 -0.492 . . . . 75.329999999999998 111.392 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 7.8 t -83.39 93.57 7.79 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.402 0.62 . . . . 63.210000000000001 109.769 -178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.3 t -165.14 145.21 7.02 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.281 -0.872 . . . . 74.400000000000006 109.193 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 16.9 m -69.18 120.93 15.78 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.195 -0.669 . . . . 62.539999999999999 109.195 176.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 5.4 pm0 -59.72 119.08 6.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.558 0.694 . . . . 74.109999999999999 110.654 -177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 67.2 ttp85 -94.02 -24.7 17.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.349 -0.841 . . . . 61.420000000000002 109.449 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 93.61 -103.88 3.09 Favored Glycine 0 N--CA 1.443 -0.885 0 CA-C-N 115.429 -0.805 . . . . 65.219999999999999 112.502 177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 8.4 mtm-85 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.451 -0.785 . . . . 71.129999999999995 110.452 -174.284 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 1.053 " H2'" ' HA3' ' A' ' 147' ' ' GLY . . . . . . . . 0 O5'--C5' 1.425 -0.914 0 C4'-C3'-C2' 105.509 2.809 . 0.0 '__' . 74.319999999999993 . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.979 H5'' " H3'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.427 -0.812 0 C4'-C3'-C2' 105.955 3.255 . 0.0 OUTLIER . 71.319999999999993 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.666 ' N1 ' ' HA ' ' A' ' 180' ' ' ALA . . . . . . . . 0 O5'--C5' 1.427 -0.834 0 O4'-C1'-C2' 108.279 1.342 . 0.0 OUTLIER gamma 75.219999999999999 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.579 " H4'" ' SD ' ' A' ' 137' ' ' MET . . . . . . . . 0 O5'--C5' 1.424 -0.973 0 C3'-C2'-C1' 99.954 -1.717 . 0.0 OUTLIER alpha 65.209999999999994 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.753 " H3'" ' NZ ' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.424 -0.988 0 O4'-C4'-C3' 103.772 -1.234 . 0.0 OUTLIER gamma 74.219999999999999 . . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.519 " C5'" ' HZ2' ' A' ' 183' ' ' LYS . . . . . . . . 0 O5'--C5' 1.423 -1.054 0 O4'-C1'-C2' 107.703 0.931 . 0.0 OUTLIER zeta-1 74.040000000000006 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 39.5 m . . . . . 0 N--CA 1.479 1.023 0 N-CA-C 111.518 0.192 . . . . 52.039999999999999 111.518 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.503 ' NE2' ' HG2' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -92.72 157.49 16.42 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.968 0.413 . . . . 61.049999999999997 111.121 -174.177 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 81.2 mtt85 -144.74 82.89 9.92 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.377 -0.374 . . . . 70.439999999999998 111.163 -176.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -89.9 0.9 5.59 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.876 2.384 . . . . 73.129999999999995 112.269 176.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 176.49 53.09 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.985 -0.846 . . . . 71.310000000000002 110.985 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -85.55 -13.12 49.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.241 0.543 . . . . 73.519999999999996 110.27 -177.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . 0.433 ' CD2' ' H ' ' A' ' 101' ' ' HIS . 1.9 p80 -76.71 -6.18 51.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.404 -0.816 . . . . 71.439999999999998 110.264 175.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 37.3 mt -114.02 145.56 41.41 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.569 -0.741 . . . . 75.340000000000003 109.99 -178.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -83.06 119.68 24.79 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.057 -0.72 . . . . 75.519999999999996 109.057 174.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . 0.461 HG22 ' H ' ' A' ' 106' ' ' LYS . 12.5 p -111.3 144.09 19.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.728 -0.669 . . . . 62.130000000000003 111.089 -168.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.812 ' HA ' HG21 ' A' ' 159' ' ' VAL . 21.7 mtmt -122.91 6.32 9.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.139 -0.482 . . . . 64.129999999999995 111.662 -177.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.631 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 29.6 ttpt -139.55 139.95 36.98 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.967 -0.383 . . . . 64.25 109.967 174.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.563 HG12 ' HB ' ' A' ' 151' ' ' VAL . 5.5 pt -109.25 160.78 7.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.94 0.4 . . . . 75.400000000000006 111.157 -179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.477 ' HD1' ' CE2' ' A' ' 150' ' ' PHE . 62.7 t80 -110.82 127.79 55.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.571 -0.741 . . . . 74.040000000000006 109.681 177.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 45.8 t -108.83 117.72 54.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.966 0.412 . . . . 73.129999999999995 110.855 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -130.97 171.08 21.08 Favored Glycine 0 N--CA 1.449 -0.481 0 N-CA-C 111.042 -0.823 . . . . 70.439999999999998 111.042 177.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 68.66 31.69 73.68 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 121.102 -0.571 . . . . 74.230000000000004 113.401 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.753 HD12 ' HB ' ' A' ' 116' ' ' THR . 18.8 pt -87.17 -21.87 7.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.783 0.291 . . . . 72.120000000000005 110.707 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.709 ' HG3' ' O ' ' A' ' 112' ' ' ILE . 0.0 OUTLIER 58.97 -51.73 0.06 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 125.851 1.66 . . . . 71.120000000000005 114.028 179.029 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.489 ' HG3' ' H ' ' A' ' 115' ' ' ASP . 2.9 tp10 -95.79 171.11 8.86 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.314 -0.625 . . . . 63.399999999999999 109.314 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.489 ' H ' ' HG3' ' A' ' 114' ' ' GLU . 3.3 p-10 -65.71 121.23 14.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.543 0.687 . . . . 63.420000000000002 110.183 -178.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.753 ' HB ' HD12 ' A' ' 112' ' ' ILE . 23.0 m -134.8 123.36 23.44 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.311 -0.859 . . . . 73.120000000000005 108.799 -179.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.528 ' HG2' ' ND1' ' A' ' 120' ' ' HIS . 10.6 pt-20 -119.99 -164.26 1.06 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.466 0.543 . . . . 74.340000000000003 112.466 -167.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.717 ' HA ' HG21 ' A' ' 134' ' ' ILE . 2.6 tm-20 -61.63 -47.44 85.37 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 115.536 -0.756 . . . . 75.219999999999999 111.826 -173.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.461 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.0 p80 -63.6 -33.43 75.6 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.632 -0.427 . . . . 74.329999999999998 110.573 -177.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . 0.528 ' ND1' ' HG2' ' A' ' 117' ' ' GLU . 35.6 m80 -63.75 -59.36 4.67 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.232 0.539 . . . . 72.400000000000006 111.085 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.634 HD12 HG11 ' A' ' 170' ' ' VAL . 4.5 mp -59.41 -48.14 82.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.276 -0.875 . . . . 75.450000000000003 110.938 -177.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.437 ' HG3' HD12 ' A' ' 131' ' ' ILE . 6.2 ttp180 -63.68 -38.97 93.1 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.147 -0.479 . . . . 72.049999999999997 111.414 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -58.99 -31.15 68.52 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.088 0.471 . . . . 75.200000000000003 110.987 -178.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.594 ' CD1' HG22 ' A' ' 170' ' ' VAL . 59.4 t80 -93.03 -48.15 6.64 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.897 -0.592 . . . . 62.43 111.525 -178.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.438 ' HA ' ' HD2' ' A' ' 128' ' ' TYR . 43.6 m-85 -76.07 -11.82 60.01 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.519 0.563 . . . . 72.209999999999994 112.519 -172.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.48 -25.16 67.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.674 0.273 . . . . 75.5 111.506 178.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -73.9 -23.11 59.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.017 0.437 . . . . 70.0 110.65 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.438 ' HD2' ' HA ' ' A' ' 125' ' ' PHE . 91.0 m-85 -81.42 -29.14 33.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.239 -0.437 . . . . 74.129999999999995 110.561 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.428 ' HA3' ' OG ' ' A' ' 158' ' ' SER . . . 168.59 -156.4 27.78 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.085 -1.055 . . . . 75.120000000000005 113.223 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.492 ' HA ' ' HE3' ' A' ' 130' ' ' LYS . 0.4 OUTLIER -86.17 114.91 23.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.359 0.599 . . . . 73.439999999999998 110.994 -177.501 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.49 HG21 HD11 ' A' ' 134' ' ' ILE . 27.4 mt -89.14 135.01 26.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.355 -0.839 . . . . 71.219999999999999 110.068 176.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.516 ' HG3' ' N ' ' A' ' 154' ' ' ASP . 29.2 mt-10 -78.61 -69.22 0.58 Allowed 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.84 -0.429 . . . . 64.420000000000002 109.84 174.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 13.1 m -148.56 157.27 7.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.971 -0.559 . . . . 74.5 110.085 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.717 HG21 ' HA ' ' A' ' 118' ' ' GLU . 22.9 mm -104.71 107.63 22.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 109.571 -0.529 . . . . 71.420000000000002 109.571 175.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -90.68 91.7 8.51 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.842 -0.617 . . . . 72.450000000000003 110.449 -174.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.567 HD11 ' H ' ' A' ' 118' ' ' GLU . 21.3 mt -74.94 121.51 26.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 108.858 -0.793 . . . . 74.409999999999997 108.858 176.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.6 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -61.99 103.09 0.33 Allowed 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 108.767 -0.827 . . . . 73.209999999999994 108.767 178.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -124.2 159.97 28.93 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.741 -0.663 . . . . 74.319999999999993 110.797 -174.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.635 ' HA ' ' C4 ' ' B' ' 5' ' ' ' U' . 34.1 t70 -60.48 141.74 56.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.039 -0.528 . . . . 72.329999999999998 110.744 178.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.551 ' NH1' " H1'" ' B' ' 5' ' ' ' U' . 0.0 OUTLIER -69.18 -17.0 63.76 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.607 -0.724 . . . . 65.019999999999996 111.46 -174.211 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -111.96 -58.23 0.45 Allowed Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.523 -0.846 . . . . 73.430000000000007 112.86 -179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 51.0 m -82.96 -15.4 51.44 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.742 -0.269 . . . . 62.100000000000001 111.522 -174.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 65.87 29.35 74.87 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.78 -0.724 . . . . 61.439999999999998 112.208 -179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.407 ' HG2' ' HB3' ' A' ' 139' ' ' ASP . 20.3 pttp -85.77 143.03 28.54 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.854 -0.425 . . . . 71.400000000000006 109.854 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -66.3 114.54 5.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.209 -0.451 . . . . 63.149999999999999 111.072 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 55.0 ttt180 -68.82 -40.96 79.22 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.653 -0.703 . . . . 75.239999999999995 110.652 -179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 158.05 -72.28 0.24 Allowed Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.644 -0.788 . . . . 53.240000000000002 112.608 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.753 ' HA ' ' OP2' ' B' ' 2' ' ' ' C' . 18.1 p90 -82.58 165.74 19.82 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.82 0.343 . . . . 73.340000000000003 111.175 -178.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -143.03 162.2 36.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.984 0.421 . . . . 60.140000000000001 111.3 -177.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.477 ' CE2' ' HD1' ' A' ' 108' ' ' PHE . 49.6 m-85 -125.96 146.02 50.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.947 -0.57 . . . . 65.420000000000002 109.905 -179.221 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.608 HG13 ' CD1' ' A' ' 134' ' ' ILE . 39.1 t -118.65 111.74 35.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 N-CA-C 110.12 -0.326 . . . . 71.030000000000001 110.12 178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.631 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 19.5 m -89.69 126.71 35.75 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.116 -0.493 . . . . 75.0 110.683 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.507 ' CD2' HG22 ' A' ' 159' ' ' VAL . 97.8 m-85 -110.97 145.95 37.49 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.435 -0.348 . . . . 62.450000000000003 110.306 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.516 ' N ' ' HG3' ' A' ' 132' ' ' GLU . 9.4 t70 -65.52 -29.93 70.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.786 -0.643 . . . . 73.109999999999999 110.747 177.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . 0.422 ' O ' HG23 ' A' ' 159' ' ' VAL . 6.1 t70 -125.72 142.83 51.32 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.863 -0.608 . . . . 73.319999999999993 110.497 -174.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.485 ' HB3' ' HG3' ' A' ' 105' ' ' LYS . 2.4 p-80 -75.75 -16.99 60.05 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.098 -0.501 . . . . 74.530000000000001 110.909 179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -72.53 -38.01 68.17 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.999 0.428 . . . . 51.210000000000001 109.983 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.428 ' OG ' ' HA3' ' A' ' 129' ' ' GLY . 13.6 m -64.84 -28.98 69.93 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.734 -0.666 . . . . 62.119999999999997 110.19 177.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.812 HG21 ' HA ' ' A' ' 105' ' ' LYS . 14.8 t -76.04 -34.67 27.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.444 -0.798 . . . . 75.109999999999999 110.516 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -52.18 -56.18 16.29 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.549 -0.75 . . . . 72.430000000000007 112.397 -176.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.68 -9.7 29.86 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.753 0.311 . . . . 72.140000000000001 111.834 -176.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.486 HG22 HG11 ' A' ' 177' ' ' VAL . 84.4 mt -96.46 -50.11 11.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 CA-C-N 116.391 -0.368 . . . . 74.430000000000007 111.019 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.435 HG13 HG12 ' A' ' 159' ' ' VAL . 34.6 m -72.13 -19.1 19.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.422 0.527 . . . . 71.430000000000007 112.422 -174.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 165' ' ' GLN . 2.5 pp -68.86 -30.3 46.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.827 0.346 . . . . 70.040000000000006 111.495 179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.49 ' HG3' ' NE2' ' A' ' 168' ' ' HIS . 16.9 pt20 -106.06 167.78 9.57 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.613 -0.514 . . . . 72.230000000000004 109.613 175.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.552 ' HG3' ' HG3' ' A' ' 176' ' ' GLU . 83.8 tttt -109.18 -58.78 1.98 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.996 0.427 . . . . 62.140000000000001 110.662 -177.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.653 ' HA ' ' O ' ' A' ' 175' ' ' CYS . 21.4 m-85 -78.34 118.3 20.39 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.878 -0.601 . . . . 72.349999999999994 111.27 -178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.49 ' NE2' ' HG3' ' A' ' 165' ' ' GLN . 38.3 m-70 -118.07 151.54 37.33 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.25 -0.886 . . . . 62.439999999999998 110.046 177.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 6.3 m -93.81 84.99 4.68 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.991 0.424 . . . . 65.519999999999996 110.769 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.634 HG11 HD12 ' A' ' 121' ' ' LEU . 11.2 t -113.77 137.1 48.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 109.874 -0.417 . . . . 70.109999999999999 109.874 -178.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 57.2 t30 61.32 24.54 14.63 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.716 0.769 . . . . 61.409999999999997 109.889 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 69.47 25.0 75.91 Favored Glycine 0 N--CA 1.449 -0.459 0 CA-C-N 115.573 -0.74 . . . . 73.140000000000001 112.208 -177.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -131.62 150.07 52.28 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.871 0.367 . . . . 64.329999999999998 110.556 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . 0.45 ' OD1' ' HB3' ' A' ' 167' ' ' TYR . 8.9 t30 -85.1 97.66 9.99 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.987 -0.551 . . . . 55.420000000000002 110.047 176.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 167' ' ' TYR . 46.2 m -105.67 177.47 4.84 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.278 -0.419 . . . . 71.340000000000003 111.042 -176.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.552 ' HG3' ' HG3' ' A' ' 166' ' ' LYS . 12.6 tt0 -112.54 136.43 52.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.292 -0.413 . . . . 74.109999999999999 110.66 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.486 HG11 HG22 ' A' ' 162' ' ' ILE . 70.6 t -127.48 138.14 55.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.146 -0.479 . . . . 44.310000000000002 111.105 178.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.503 ' HG2' ' NE2' ' A' ' 96' ' ' GLN . 60.2 mtt180 -130.22 175.86 8.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.787 -0.642 . . . . 73.140000000000001 110.129 178.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.409 ' HE3' ' HB ' ' A' ' 163' ' ' VAL . 11.4 mptt -76.52 121.31 22.95 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.432 -0.951 . . . . 44.130000000000003 108.432 171.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.756 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -79.96 100.04 7.91 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.105 0.479 . . . . 72.120000000000005 111.911 -177.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.766 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.2 pt? -99.29 141.18 32.4 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.822 -0.806 . . . . 53.509999999999998 108.822 172.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.53 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 51.8 m -59.64 156.15 14.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.632 0.254 . . . . 74.230000000000004 111.337 -173.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.473 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 20.8 pttp -65.74 -25.74 67.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.962 0.411 . . . . 71.319999999999993 110.832 -175.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.69 -36.63 59.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.282 0.563 . . . . 42.030000000000001 110.112 175.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.53 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 48.7 mt-10 -75.95 -42.96 46.98 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.792 -0.64 . . . . 64.329999999999998 110.595 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.678 ' HB3' ' HG ' ' A' ' 181' ' ' LEU . 22.5 ptm -67.16 -23.29 65.77 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.134 -0.484 . . . . 51.240000000000002 110.387 -179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -79.82 -16.75 54.88 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.377 0.608 . . . . 64.209999999999994 110.088 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 15.0 m -101.75 3.78 39.89 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.471 -0.786 . . . . 74.200000000000003 110.329 -179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -130.76 -60.92 0.96 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.047 -0.524 . . . . 64.400000000000006 111.038 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 22.1 m -84.38 111.28 19.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.213 -0.449 . . . . 72.219999999999999 110.358 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 23.0 t -138.37 159.99 40.66 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.9 -0.408 . . . . 44.43 109.9 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 3.2 p -60.98 121.05 11.43 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.284 -0.416 . . . . 70.129999999999995 111.171 -179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 79.6 mm-40 68.0 17.79 9.53 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.592 -0.731 . . . . 61.420000000000002 111.653 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 56.7 ttt180 -109.27 94.37 5.01 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.092 0.473 . . . . 53.420000000000002 109.753 174.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 90.2 -64.72 2.94 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.975 -0.631 . . . . 62.130000000000003 112.449 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . . . . . . . . . 46.8 mtp85 . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.417 -0.801 . . . . 71.239999999999995 110.701 -177.987 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 1.082 " H4'" H5'' ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.429 -0.666 0 O5'-C5'-C4' 111.267 0.762 . 0.0 '__' . 71.540000000000006 . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 1.082 H5'' " H4'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.422 -1.102 0 C4'-C3'-C2' 105.639 2.939 OUTLIER-EPSILON 0.0 OUTLIER alpha 74.510000000000005 . . . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.845 ' H8 ' H5'' ' B' ' 3' ' ' ' A' . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 P-O3'-C3' 121.661 1.634 . 0.0 OUTLIER epsilon-1 73.329999999999998 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.527 ' O6 ' ' HE3' ' A' ' 106' ' ' LYS . . . . . . . . 0 O5'--C5' 1.425 -0.941 0 C3'-C2'-C1' 100.42 -1.2 . 0.0 OUTLIER alpha 74.219999999999999 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.834 ' C6 ' " H5'" ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.423 -1.079 0 C3'-C2'-C1' 103.534 2.26 . 0.0 OUTLIER . 71.430000000000007 . . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.609 " H4'" ' OP2' ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.918 0 O4'-C1'-C2' 107.593 0.852 . 0.0 OUTLIER . 74.439999999999998 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.476 0.841 0 N-CA-C 109.771 -0.455 . . . . 74.120000000000005 109.771 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLN . . . . . 0.674 ' NE2' ' HG2' ' A' ' 178' ' ' ARG . 0.0 OUTLIER -107.85 19.26 20.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.045 0.45 . . . . 75.239999999999995 110.784 179.036 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 58.3 mtm180 -99.88 104.73 30.38 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.784 -0.643 . . . . 74.239999999999995 110.177 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . 0.537 ' HG3' HD22 ' A' ' 181' ' ' LEU . 74.2 Cg_endo -85.57 127.6 3.27 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 122.475 2.117 . . . . 75.409999999999997 111.991 178.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.536 ' HA3' HD12 ' A' ' 102' ' ' LEU . . . 60.5 68.43 1.68 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.164 -0.541 . . . . 54.310000000000002 112.473 179.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.08 -30.45 68.76 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 111.733 0.272 . . . . 71.510000000000005 111.733 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -85.37 -12.21 52.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.932 0.396 . . . . 71.430000000000007 110.82 179.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.536 HD12 ' HA3' ' A' ' 99' ' ' GLY . 83.2 mt -82.86 148.36 27.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.169 -0.468 . . . . 63.340000000000003 110.782 -177.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 7.1 p -89.32 106.0 18.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.016 0.436 . . . . 72.239999999999995 111.357 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' VAL . . . . . . . . . . . . . 4.6 p -98.16 147.45 6.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.229 -0.656 . . . . 63.119999999999997 109.229 177.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 14.8 mtmt -119.88 19.32 12.43 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.402 0.62 . . . . 63.310000000000002 110.677 -178.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.601 ' HD3' ' OG1' ' A' ' 152' ' ' THR . 6.7 ttpm? -157.88 138.91 13.29 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.32 -0.854 . . . . 74.219999999999999 109.603 178.113 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.579 HD13 HG21 ' A' ' 162' ' ' ILE . 15.6 pt -107.14 165.27 4.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.096 0.474 . . . . 64.510000000000005 110.873 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.508 ' O ' ' HA ' ' A' ' 177' ' ' VAL . 38.4 t80 -114.38 116.28 28.67 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.524 -0.762 . . . . 73.340000000000003 109.877 178.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 44.8 t -105.09 111.92 36.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.993 -0.373 . . . . 64.099999999999994 109.993 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.709 ' HA2' " H5'" ' B' ' 2' ' ' ' C' . . . -123.45 156.39 17.73 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.608 -0.806 . . . . 74.099999999999994 112.385 -178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . 0.805 ' HA2' " H4'" ' B' ' 1' ' ' ' U' . . . 78.66 46.16 8.89 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.987 -0.625 . . . . 65.230000000000004 112.723 178.459 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.527 ' H ' HD13 ' A' ' 112' ' ' ILE . 0.2 OUTLIER -116.02 -179.84 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.659 0.266 . . . . 75.230000000000004 110.427 178.162 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.454 ' HE2' ' OE1' ' A' ' 114' ' ' GLU . 14.4 mmmm -98.3 169.43 9.57 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.779 0.323 . . . . 73.140000000000001 110.951 -177.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.458 ' H ' ' CD ' ' A' ' 114' ' ' GLU . 0.8 OUTLIER -77.74 -6.74 55.03 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.117 0.484 . . . . 72.219999999999999 110.521 178.848 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -74.17 -29.23 61.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.93 -0.577 . . . . 71.400000000000006 109.643 173.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.1 m -79.51 133.95 36.5 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.021 -0.99 . . . . 71.109999999999999 111.479 -173.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.427 ' CG ' ' HD2' ' A' ' 119' ' ' HIS . 11.4 pt-20 -140.95 -166.46 2.16 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 115.998 -0.547 . . . . 63.310000000000002 110.344 -179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.595 ' HA ' HG21 ' A' ' 134' ' ' ILE . 12.2 tt0 -54.75 -49.85 69.85 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.413 0.523 . . . . 63.130000000000003 112.413 -175.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.427 ' HD2' ' CG ' ' A' ' 117' ' ' GLU . 2.4 p80 -65.2 -29.07 69.85 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.794 -0.362 . . . . 73.239999999999995 110.675 -174.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -65.44 -52.59 52.05 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.004 0.43 . . . . 73.349999999999994 110.759 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.4 mp -65.52 -46.87 77.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.902 -0.59 . . . . 34.140000000000001 110.423 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.74 -48.49 79.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.103 -0.498 . . . . 75.450000000000003 111.309 -179.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.36 -31.15 67.34 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.11 0.481 . . . . 43.310000000000002 111.116 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.465 ' CD1' HG22 ' A' ' 170' ' ' VAL . 31.2 t80 -83.88 -42.1 16.73 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.956 -0.565 . . . . 70.219999999999999 111.337 -178.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -88.44 -16.43 32.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 112.645 0.609 . . . . 63.340000000000003 112.645 -173.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.79 -22.2 66.55 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.08 0.467 . . . . 64.430000000000007 110.874 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -70.14 -26.71 64.06 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.752 -0.658 . . . . 65.310000000000002 110.349 178.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' TYR . . . . . 0.499 ' HD1' ' HB2' ' A' ' 161' ' ' LYS . 57.6 m-85 -81.64 -38.56 25.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.646 -0.706 . . . . 74.400000000000006 111.272 -176.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -174.64 -155.84 13.0 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.118 -1.039 . . . . 63.329999999999998 112.888 -179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -91.86 119.17 31.4 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-O 121.42 0.628 . . . . 62.399999999999999 111.179 -177.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.478 HG12 ' CE1' ' A' ' 153' ' ' PHE . 41.3 mt -95.86 137.79 23.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 115.262 -0.881 . . . . 61.409999999999997 110.103 -179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLU . . . . . 0.472 ' HG3' ' N ' ' A' ' 154' ' ' ASP . 18.0 mt-10 -84.06 -73.34 0.42 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.334 -0.394 . . . . 55.329999999999998 110.533 174.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 15.1 m -143.29 163.25 16.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.082 -0.508 . . . . 63.240000000000002 110.072 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.595 HG21 ' HA ' ' A' ' 118' ' ' GLU . 26.7 mm -111.68 108.67 26.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.101 0.477 . . . . 72.319999999999993 109.843 177.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.556 ' HB2' ' HB2' ' A' ' 150' ' ' PHE . 30.5 mm-40 -84.69 91.43 7.93 Favored 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 115.608 -0.723 . . . . 70.049999999999997 110.466 -178.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.552 HD11 ' CB ' ' A' ' 118' ' ' GLU . 16.9 mt -81.79 108.18 14.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 108.999 -0.741 . . . . 74.340000000000003 108.999 176.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' MET . . . . . 0.58 ' HG3' ' CE1' ' A' ' 148' ' ' PHE . 0.0 OUTLIER -57.25 112.57 1.42 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.773 -0.825 . . . . 73.219999999999999 108.773 179.288 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.76 153.04 38.78 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.011 0.434 . . . . 74.420000000000002 111.733 -174.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.502 ' HA ' ' O4 ' ' B' ' 5' ' ' ' U' . 14.1 t70 -54.49 136.38 44.62 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.013 -0.994 . . . . 70.299999999999997 110.399 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.73 -9.94 59.17 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.763 -0.653 . . . . 74.299999999999997 112.456 -172.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -128.29 -42.05 0.26 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.994 -1.098 . . . . 72.340000000000003 113.363 -178.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.559 ' OG ' ' HE3' ' A' ' 144' ' ' LYS . 27.1 t -89.24 -17.0 29.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.745 0.307 . . . . 22.239999999999998 111.086 -177.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 68.82 31.75 73.25 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.994 -0.622 . . . . 71.510000000000005 113.111 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.559 ' HE3' ' OG ' ' A' ' 142' ' ' SER . 13.7 ptpt -109.15 148.41 30.94 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.39 -0.596 . . . . 71.219999999999999 109.39 178.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LYS . . . . . . . . . . . . . 38.2 mtmm -55.95 129.09 38.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.385 0.612 . . . . 75.230000000000004 111.849 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -78.35 -25.84 46.53 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.0 -1.0 . . . . 75.019999999999996 110.693 -177.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 145.85 -91.47 0.15 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.771 -0.65 . . . . 54.420000000000002 111.719 -176.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.713 ' HB3' " C5'" ' B' ' 2' ' ' ' C' . 11.2 p90 -70.72 162.28 29.34 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 123.028 0.531 . . . . 74.409999999999997 111.627 -177.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -140.35 156.85 46.27 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.043 -0.526 . . . . 62.219999999999999 110.734 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.556 ' HB2' ' HB2' ' A' ' 135' ' ' GLU . 49.2 m-85 -121.59 125.4 46.65 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.025 -0.534 . . . . 64.239999999999995 110.061 -177.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.572 HG13 ' CD1' ' A' ' 134' ' ' ILE . 30.9 t -100.08 109.07 24.07 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 N-CA-C 110.076 -0.342 . . . . 74.150000000000006 110.076 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' THR . . . . . 0.601 ' OG1' ' HD3' ' A' ' 106' ' ' LYS . 27.7 m -85.56 125.16 32.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.18 -0.464 . . . . 73.329999999999998 110.32 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.554 ' CD2' HG12 ' A' ' 159' ' ' VAL . 98.0 m-85 -109.41 149.93 28.81 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.539 -0.541 . . . . 74.099999999999994 109.539 179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.472 ' N ' ' HG3' ' A' ' 132' ' ' GLU . 20.9 t70 -68.73 -26.73 65.41 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.033 0.444 . . . . 71.319999999999993 110.912 178.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -129.95 150.7 51.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.286 -0.416 . . . . 70.310000000000002 111.184 -175.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.575 ' O ' HG22 ' A' ' 159' ' ' VAL . 2.5 p-80 -83.28 -6.59 59.52 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.847 -0.615 . . . . 61.5 110.855 178.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -72.53 -40.71 66.54 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.654 -0.498 . . . . 63.329999999999998 109.654 174.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.7 m -63.92 -31.54 72.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.636 -0.711 . . . . 73.329999999999998 111.506 -179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 156' ' ' HIS . 5.7 m -78.03 -23.15 13.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 121.054 -0.258 . . . . 60.520000000000003 111.285 -175.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.79 -45.23 90.65 Favored 'General case' 0 C--O 1.224 -0.247 0 CA-C-N 116.657 -0.247 . . . . 72.209999999999994 111.306 -173.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' LYS . . . . . 0.499 ' HB2' ' HD1' ' A' ' 128' ' ' TYR . 1.0 OUTLIER -62.03 -18.76 61.63 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.175 0.512 . . . . 72.239999999999995 110.68 -179.59 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.579 HG21 HD13 ' A' ' 107' ' ' ILE . 72.3 mt -97.71 -54.69 6.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.618 -0.719 . . . . 75.450000000000003 111.527 -174.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.467 ' HB ' ' HG2' ' A' ' 179' ' ' LYS . 33.6 m -66.13 -19.83 26.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 N-CA-C 112.452 0.538 . . . . 62.43 112.452 -172.67 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.449 HD12 ' HB2' ' A' ' 165' ' ' GLN . 2.6 pp -69.12 -24.75 28.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 121.32 0.581 . . . . 75.209999999999994 110.707 176.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLN . . . . . 0.479 ' HB3' ' NE2' ' A' ' 168' ' ' HIS . 23.0 tt0 -108.52 140.85 41.27 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.177 -0.919 . . . . 74.120000000000005 109.626 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.563 ' HE3' ' OE1' ' A' ' 176' ' ' GLU . 82.4 tttt -93.77 -61.69 1.5 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.794 0.33 . . . . 64.200000000000003 110.776 -178.08 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -74.04 114.58 12.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.139 -0.482 . . . . 72.329999999999998 110.905 179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.479 ' NE2' ' HB3' ' A' ' 165' ' ' GLN . 30.3 m-70 -120.99 162.25 20.23 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.642 -0.708 . . . . 72.420000000000002 109.257 176.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' THR . . . . . . . . . . . . . 11.7 m -118.09 102.27 8.89 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.468 -0.493 . . . . 75.150000000000006 111.218 -177.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.465 HG22 ' CD1' ' A' ' 124' ' ' TYR . 47.5 t -111.51 130.0 65.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.813 -0.63 . . . . 65.540000000000006 109.508 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 62.54 23.59 14.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.609 0.718 . . . . 73.340000000000003 110.445 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . . . . . . . . . . . 78.24 11.06 85.72 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.896 -0.669 . . . . 33.240000000000002 112.488 -178.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -111.68 135.43 52.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.901 0.381 . . . . 70.540000000000006 110.521 -179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -74.88 114.91 13.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.922 -0.581 . . . . 42.520000000000003 110.441 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' CYS . . . . . . . . . . . . . 26.4 p -126.32 169.16 13.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.964 0.411 . . . . 72.299999999999997 110.953 -179.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.563 ' OE1' ' HE3' ' A' ' 166' ' ' LYS . 15.1 tt0 -108.85 127.37 53.97 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.896 -0.593 . . . . 71.019999999999996 109.548 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 108' ' ' PHE . 1.6 m -117.88 144.9 24.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 120.391 -0.524 . . . . 73.010000000000005 110.543 179.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.674 ' HG2' ' NE2' ' A' ' 96' ' ' GLN . 66.5 mtt180 -132.75 -179.36 5.42 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.056 -0.52 . . . . 61.149999999999999 109.818 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.467 ' HG2' ' HB ' ' A' ' 163' ' ' VAL . 38.4 mtpt -81.2 119.09 23.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 107.964 -1.125 . . . . 72.409999999999997 107.964 170.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.635 ' HA ' ' N1 ' ' B' ' 3' ' ' ' A' . . . -70.17 95.06 0.95 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.902 0.382 . . . . 74.25 111.513 -175.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.571 HD23 ' H ' ' A' ' 181' ' ' LEU . 2.5 pt? -92.98 144.96 24.74 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.368 -0.604 . . . . 71.549999999999997 109.368 175.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.421 ' HB2' ' HG3' ' A' ' 185' ' ' GLU . 7.5 m -53.83 142.54 23.71 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.141 -0.481 . . . . 52.340000000000003 110.96 -178.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.661 ' HA ' ' HG2' ' A' ' 186' ' ' MET . 18.8 pttp -59.88 -22.66 62.63 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.048 0.451 . . . . 73.140000000000001 110.524 177.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -64.26 -52.96 56.14 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.734 -0.666 . . . . 75.239999999999995 110.275 171.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' GLU . . . . . 0.421 ' HG3' ' HB2' ' A' ' 182' ' ' SER . 35.7 mt-10 -68.42 -41.35 80.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.38 -0.827 . . . . 63.229999999999997 111.021 -176.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' MET . . . . . 0.661 ' HG2' ' HA ' ' A' ' 183' ' ' LYS . 20.7 ptm -68.24 -16.56 64.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.891 -0.595 . . . . 55.200000000000003 111.163 -175.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -74.79 -36.55 62.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.197 0.522 . . . . 75.400000000000006 109.868 176.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.8 t -73.17 -32.26 64.74 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.426 -0.806 . . . . 74.120000000000005 110.051 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -74.74 -24.73 58.76 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.917 -0.583 . . . . 74.109999999999999 110.922 178.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' SER . . . . . . . . . . . . . 46.6 t -71.86 131.44 43.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.928 -0.578 . . . . 74.25 110.372 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 10.5 t -148.11 97.55 2.8 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.601 -0.518 . . . . 51.130000000000003 109.601 177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' SER . . . . . . . . . . . . . 2.4 p -81.7 -67.9 0.74 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.151 -0.477 . . . . 73.439999999999998 110.817 -178.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -108.88 105.21 14.66 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.453 -0.573 . . . . 73.450000000000003 109.453 178.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -93.95 153.85 17.99 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.066 -0.515 . . . . 73.200000000000003 111.523 -174.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 81.57 -64.31 4.21 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.708 -0.678 . . . . 73.450000000000003 112.007 179.192 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 196' ' ' ARG . 11.6 tpp85 . . . . . 0 C--O 1.243 0.759 0 CA-C-O 118.127 -0.94 . . . . 73.0 109.244 178.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' ' U' . . . . . 0.805 " H4'" ' HA2' ' A' ' 111' ' ' GLY . . . . . . . . 0 O5'--C5' 1.429 -0.663 0 C4'-C3'-C2' 104.405 1.705 OUTLIER-EPSILON 0.0 '__' . 75.140000000000001 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ' C' . . . . . 0.713 ' OP2' " H1'" ' B' ' 1' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.426 -0.892 0 C4'-C3'-C2' 104.884 2.184 OUTLIER-EPSILON 0.0 OUTLIER epsilon-1 74.030000000000001 . . . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ' A' . . . . . 0.71 ' OP2' " H4'" ' B' ' 2' ' ' ' C' . . . . . . . . 0 O5'--C5' 1.425 -0.907 0 O4'-C4'-C3' 103.635 -1.332 . 0.0 OUTLIER epsilon-1 73.450000000000003 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ' G' . . . . . 0.518 ' O6 ' ' HE2' ' A' ' 106' ' ' LYS . . . . . . . . 0 O5'--C5' 1.425 -0.953 0 C3'-C2'-C1' 99.118 -2.646 . 0.0 OUTLIER alpha 73.5 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ' U' . . . . . 0.752 " H3'" ' OP1' ' B' ' 5' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.425 -0.915 0 O4'-C4'-C3' 103.732 -1.263 . 0.0 OUTLIER gamma 75.209999999999994 . . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' ' U' . . . . . 0.524 ' OP1' " H4'" ' B' ' 6' ' ' ' U' . . . . . . . . 0 O5'--C5' 1.424 -0.998 0 C4'-C3'-C2' 105.959 3.259 . 0.0 OUTLIER . 73.319999999999993 . . . . . . . . . . 2 2 . 1 stop_ save_